id	sid	tid	token	lemma	pos
admet-2551	1	1	natural	natural	ADJ
admet-2551	1	2	serine	serine	NOUN
admet-2551	1	3	proteases	protease	NOUN
admet-2551	1	4	and	and	CCONJ
admet-2551	1	5	their	their	PRON
admet-2551	1	6	applications	application	NOUN
admet-2551	1	7	in	in	ADP
admet-2551	1	8	combating	combat	VERB
admet-2551	1	9	amyloid	amyloid	NOUN
admet-2551	1	10	formation	formation	NOUN
admet-2551	1	11	doi	doi	NOUN
admet-2551	1	12	:	:	PUNCT
admet-2551	1	13	https://doi.org/10.5599/admet.2551	https://doi.org/10.5599/admet.2551	NOUN
admet-2551	1	14	797	797	NUM
admet-2551	1	15	admet	admet	X
admet-2551	1	16	&	&	CCONJ
admet-2551	1	17	dmpk	dmpk	PROPN
admet-2551	1	18	12(6	12(6	NUM
admet-2551	1	19	)	)	PUNCT
admet-2551	1	20	(	(	PUNCT
admet-2551	1	21	2024	2024	NUM
admet-2551	1	22	)	)	PUNCT
admet-2551	1	23	797	797	NUM
admet-2551	1	24	-	-	SYM
admet-2551	1	25	820	820	NUM
admet-2551	1	26	;	;	PUNCT
admet-2551	1	27	doi	doi	NOUN
admet-2551	1	28	:	:	PUNCT
admet-2551	1	29	https://doi.org/10.5599/admet.2551	https://doi.org/10.5599/admet.2551	NOUN
admet-2551	1	30	open	open	ADJ
admet-2551	1	31	access	access	NOUN
admet-2551	1	32	:	:	PUNCT
admet-2551	1	33	issn	issn	PROPN
admet-2551	1	34	:	:	PUNCT
admet-2551	1	35	1848	1848	NUM
admet-2551	1	36	-	-	SYM
admet-2551	1	37	7718	7718	NUM
admet-2551	1	38	http://www.pub.iapchem.org/ojs/index.php/admet/index	http://www.pub.iapchem.org/ojs/index.php/admet/index	NOUN
admet-2551	1	39	review	review	VERB
admet-2551	1	40	natural	natural	ADJ
admet-2551	1	41	serine	serine	NOUN
admet-2551	1	42	proteases	protease	NOUN
admet-2551	1	43	and	and	CCONJ
admet-2551	1	44	their	their	PRON
admet-2551	1	45	applications	application	NOUN
admet-2551	1	46	in	in	ADP
admet-2551	1	47	combating	combat	VERB
admet-2551	1	48	amyloid	amyloid	NOUN
admet-2551	1	49	formation	formation	NOUN
admet-2551	1	50	sanjay	sanjay	PROPN
admet-2551	1	51	kisan	kisan	PROPN
admet-2551	1	52	metkar1,§	metkar1,§	PROPN
admet-2551	1	53	,	,	PUNCT
admet-2551	1	54	saranya	saranya	PROPN
admet-2551	1	55	udayakumar1	udayakumar1	PROPN
admet-2551	1	56	,	,	PUNCT
admet-2551	1	57	agnishwar	agnishwar	VERB
admet-2551	1	58	girigoswami1	girigoswami1	NOUN
admet-2551	1	59	and	and	CCONJ
admet-2551	1	60	koyeli	koyeli	PROPN
admet-2551	1	61	girigoswami1,2	girigoswami1,2	PROPN
admet-2551	1	62	,	,	PUNCT
admet-2551	1	63	*	*	PROPN
admet-2551	1	64	1medical	1medical	NUM
admet-2551	1	65	bionanotechnology	bionanotechnology	NOUN
admet-2551	1	66	,	,	PUNCT
admet-2551	1	67	faculty	faculty	NOUN
admet-2551	1	68	of	of	ADP
admet-2551	1	69	allied	ally	VERB
admet-2551	1	70	health	health	NOUN
admet-2551	1	71	sciences	science	NOUN
admet-2551	1	72	,	,	PUNCT
admet-2551	1	73	chettinad	chettinad	PROPN
admet-2551	1	74	hospital	hospital	PROPN
admet-2551	1	75	and	and	CCONJ
admet-2551	1	76	research	research	PROPN
admet-2551	1	77	institute	institute	PROPN
admet-2551	1	78	,	,	PUNCT
admet-2551	1	79	chettinad	chettinad	PROPN
admet-2551	1	80	academy	academy	PROPN
admet-2551	1	81	of	of	ADP
admet-2551	1	82	research	research	NOUN
admet-2551	1	83	and	and	CCONJ
admet-2551	1	84	education	education	NOUN
admet-2551	1	85	,	,	PUNCT
admet-2551	1	86	chettinad	chettinad	PROPN
admet-2551	1	87	health	health	PROPN
admet-2551	1	88	city	city	PROPN
admet-2551	1	89	,	,	PUNCT
admet-2551	1	90	kelambakkam	kelambakkam	PROPN
admet-2551	1	91	,	,	PUNCT
admet-2551	1	92	chennai-603103	chennai-603103	NOUN
admet-2551	1	93	,	,	PUNCT
admet-2551	1	94	india	india	PROPN
admet-2551	1	95	2centre	2centre	PROPN
admet-2551	1	96	for	for	ADP
admet-2551	1	97	global	global	ADJ
admet-2551	1	98	health	health	NOUN
admet-2551	1	99	research	research	NOUN
admet-2551	1	100	,	,	PUNCT
admet-2551	1	101	saveetha	saveetha	PROPN
admet-2551	1	102	medical	medical	PROPN
admet-2551	1	103	college	college	PROPN
admet-2551	1	104	,	,	PUNCT
admet-2551	1	105	saveetha	saveetha	PROPN
admet-2551	1	106	institute	institute	PROPN
admet-2551	1	107	of	of	ADP
admet-2551	1	108	medical	medical	ADJ
admet-2551	1	109	and	and	CCONJ
admet-2551	1	110	technical	technical	ADJ
admet-2551	1	111	sciences	science	NOUN
admet-2551	1	112	,	,	PUNCT
admet-2551	1	113	india	india	PROPN
admet-2551	1	114	§	§	PROPN
admet-2551	1	115	present	present	ADJ
admet-2551	1	116	address	address	NOUN
admet-2551	1	117	:	:	PUNCT
admet-2551	1	118	department	department	NOUN
admet-2551	1	119	of	of	ADP
admet-2551	1	120	anesthesiology	anesthesiology	NOUN
admet-2551	1	121	,	,	PUNCT
admet-2551	1	122	rutgers	rutgers	PROPN
admet-2551	1	123	university	university	PROPN
admet-2551	1	124	,	,	PUNCT
admet-2551	1	125	newark	newark	PROPN
admet-2551	1	126	,	,	PUNCT
admet-2551	1	127	new	new	PROPN
admet-2551	1	128	jersey	jersey	PROPN
admet-2551	1	129	07103	07103	NUM
admet-2551	1	130	,	,	PUNCT
admet-2551	1	131	usa	usa	PROPN
admet-2551	1	132	*	*	PUNCT
admet-2551	1	133	corresponding	correspond	VERB
admet-2551	1	134	author	author	NOUN
admet-2551	1	135	:	:	PUNCT
admet-2551	1	136	e	e	NOUN
admet-2551	1	137	-	-	NOUN
admet-2551	1	138	mail	mail	NOUN
admet-2551	1	139	:	:	PUNCT
admet-2551	1	140	koyelig@gmail.com	koyelig@gmail.com	X
admet-2551	1	141	;	;	PUNCT
admet-2551	1	142	tel	tel	PROPN
admet-2551	1	143	.	.	PUNCT
admet-2551	1	144	:	:	PUNCT
admet-2551	2	1	+91	+91	NOUN
admet-2551	2	2	-	-	PUNCT
admet-2551	2	3	44	44	NUM
admet-2551	2	4	-	-	PUNCT
admet-2551	2	5	47429607	47429607	NUM
admet-2551	2	6	;	;	PUNCT
admet-2551	2	7	fax	fax	NOUN
admet-2551	2	8	:	:	PUNCT
admet-2551	2	9	+91	+91	PROPN
admet-2551	2	10	-	-	PUNCT
admet-2551	2	11	44	44	NUM
admet-2551	2	12	-	-	PUNCT
admet-2551	2	13	4741	4741	NUM
admet-2551	2	14	-	-	SYM
admet-2551	2	15	1011	1011	NUM
admet-2551	2	16	received	receive	VERB
admet-2551	2	17	:	:	PUNCT
admet-2551	2	18	june	june	PROPN
admet-2551	2	19	11	11	NUM
admet-2551	2	20	,	,	PUNCT
admet-2551	2	21	2024	2024	NUM
admet-2551	2	22	;	;	PUNCT
admet-2551	2	23	revised	revise	VERB
admet-2551	2	24	:	:	PUNCT
admet-2551	2	25	november	november	PROPN
admet-2551	2	26	10	10	NUM
admet-2551	2	27	,	,	PUNCT
admet-2551	2	28	2024	2024	NUM
admet-2551	2	29	;	;	PUNCT
admet-2551	2	30	published	publish	VERB
admet-2551	2	31	:	:	PUNCT
admet-2551	2	32	november	november	PROPN
admet-2551	2	33	16,2024	16,2024	NUM
admet-2551	2	34	abstract	abstract	ADJ
admet-2551	2	35	background	background	NOUN
admet-2551	2	36	and	and	CCONJ
admet-2551	2	37	purpose	purpose	NOUN
admet-2551	2	38	:	:	PUNCT
admet-2551	2	39	amyloidosis	amyloidosis	NOUN
admet-2551	2	40	is	be	AUX
admet-2551	2	41	a	a	DET
admet-2551	2	42	group	group	NOUN
admet-2551	2	43	of	of	ADP
admet-2551	2	44	diseases	disease	NOUN
admet-2551	2	45	including	include	VERB
admet-2551	2	46	diabetes	diabetes	NOUN
admet-2551	2	47	type	type	NOUN
admet-2551	2	48	ii	ii	PROPN
admet-2551	2	49	and	and	CCONJ
admet-2551	2	50	neurological	neurological	ADJ
admet-2551	2	51	disorders	disorder	NOUN
admet-2551	2	52	,	,	PUNCT
admet-2551	2	53	such	such	ADJ
admet-2551	2	54	as	as	ADP
admet-2551	2	55	alzheimer	alzheimer	PROPN
admet-2551	2	56	’s	’s	PART
admet-2551	2	57	disease	disease	NOUN
admet-2551	2	58	,	,	PUNCT
admet-2551	2	59	parkinson	parkinson	NOUN
admet-2551	2	60	’s	’s	PART
admet-2551	2	61	disease	disease	NOUN
admet-2551	2	62	,	,	PUNCT
admet-2551	2	63	prion	prion	NOUN
admet-2551	2	64	disease	disease	NOUN
admet-2551	2	65	,	,	PUNCT
admet-2551	2	66	etc	etc	X
admet-2551	2	67	.	.	X
admet-2551	2	68	,	,	PUNCT
admet-2551	2	69	where	where	SCONJ
admet-2551	2	70	a	a	DET
admet-2551	2	71	common	common	ADJ
admet-2551	2	72	trait	trait	NOUN
admet-2551	2	73	is	be	AUX
admet-2551	2	74	observed	observe	VERB
admet-2551	2	75	;	;	PUNCT
admet-2551	2	76	accumulation	accumulation	NOUN
admet-2551	2	77	of	of	ADP
admet-2551	2	78	misfolded	misfolded	ADJ
admet-2551	2	79	protein	protein	NOUN
admet-2551	2	80	at	at	ADP
admet-2551	2	81	different	different	ADJ
admet-2551	2	82	parts	part	NOUN
admet-2551	2	83	of	of	ADP
admet-2551	2	84	the	the	DET
admet-2551	2	85	body	body	NOUN
admet-2551	2	86	,	,	PUNCT
admet-2551	2	87	especially	especially	ADV
admet-2551	2	88	the	the	DET
admet-2551	2	89	brain	brain	NOUN
admet-2551	2	90	which	which	PRON
admet-2551	2	91	manifests	manifest	VERB
admet-2551	2	92	the	the	DET
admet-2551	2	93	typical	typical	ADJ
admet-2551	2	94	symptoms	symptom	NOUN
admet-2551	2	95	like	like	ADP
admet-2551	2	96	dementia	dementia	NOUN
admet-2551	2	97	,	,	PUNCT
admet-2551	2	98	movement	movement	NOUN
admet-2551	2	99	disorders	disorder	NOUN
admet-2551	2	100	,	,	PUNCT
admet-2551	2	101	etc	etc	X
admet-2551	2	102	.	.	X
admet-2551	2	103	these	these	DET
admet-2551	2	104	misfolded	misfolde	VERB
admet-2551	2	105	proteins	protein	NOUN
admet-2551	2	106	,	,	PUNCT
admet-2551	2	107	named	name	VERB
admet-2551	2	108	amyloids	amyloid	NOUN
admet-2551	2	109	,	,	PUNCT
admet-2551	2	110	are	be	AUX
admet-2551	2	111	protease	protease	NOUN
admet-2551	2	112	resistant	resistant	ADJ
admet-2551	2	113	and	and	CCONJ
admet-2551	2	114	thus	thus	ADV
admet-2551	2	115	it	it	PRON
admet-2551	2	116	becomes	become	VERB
admet-2551	2	117	difficult	difficult	ADJ
admet-2551	2	118	to	to	PART
admet-2551	2	119	manage	manage	VERB
admet-2551	2	120	these	these	DET
admet-2551	2	121	diseases	disease	NOUN
admet-2551	2	122	in	in	ADP
admet-2551	2	123	vivo	vivo	NOUN
admet-2551	2	124	.	.	PUNCT
admet-2551	3	1	enzymes	enzyme	NOUN
admet-2551	3	2	that	that	PRON
admet-2551	3	3	catalyse	catalyse	VERB
admet-2551	3	4	the	the	DET
admet-2551	3	5	complete	complete	ADJ
admet-2551	3	6	breakdown	breakdown	NOUN
admet-2551	3	7	of	of	ADP
admet-2551	3	8	proteins	protein	NOUN
admet-2551	3	9	are	be	AUX
admet-2551	3	10	known	know	VERB
admet-2551	3	11	as	as	ADP
admet-2551	3	12	proteases	protease	NOUN
admet-2551	3	13	.	.	PUNCT
admet-2551	4	1	the	the	DET
admet-2551	4	2	peptide	peptide	ADJ
admet-2551	4	3	bonds	bond	NOUN
admet-2551	4	4	in	in	ADP
admet-2551	4	5	proteins	protein	NOUN
admet-2551	4	6	are	be	AUX
admet-2551	4	7	degraded	degrade	VERB
admet-2551	4	8	by	by	ADP
admet-2551	4	9	these	these	DET
admet-2551	4	10	serine	serine	NOUN
admet-2551	4	11	proteases	protease	NOUN
admet-2551	4	12	,	,	PUNCT
admet-2551	4	13	which	which	PRON
admet-2551	4	14	cause	cause	VERB
admet-2551	4	15	amyloid	amyloid	NOUN
admet-2551	4	16	disaggregation	disaggregation	NOUN
admet-2551	4	17	.	.	PUNCT
admet-2551	5	1	experimental	experimental	ADJ
admet-2551	5	2	approach	approach	NOUN
admet-2551	5	3	:	:	PUNCT
admet-2551	5	4	we	we	PRON
admet-2551	5	5	have	have	AUX
admet-2551	5	6	searched	search	VERB
admet-2551	5	7	for	for	ADP
admet-2551	5	8	related	related	ADJ
admet-2551	5	9	articles	article	NOUN
admet-2551	5	10	using	use	VERB
admet-2551	5	11	the	the	DET
admet-2551	5	12	search	search	NOUN
admet-2551	5	13	engines	engine	NOUN
admet-2551	5	14	google	google	PROPN
admet-2551	5	15	scholar	scholar	NOUN
admet-2551	5	16	,	,	PUNCT
admet-2551	5	17	pubmed	pubmed	PROPN
admet-2551	5	18	,	,	PUNCT
admet-2551	5	19	and	and	CCONJ
admet-2551	5	20	scopus	scopus	NOUN
admet-2551	5	21	for	for	ADP
admet-2551	5	22	the	the	DET
admet-2551	5	23	past	past	ADJ
admet-2551	5	24	10	10	NUM
admet-2551	5	25	years	year	NOUN
admet-2551	5	26	,	,	PUNCT
admet-2551	5	27	selected	select	VERB
admet-2551	5	28	the	the	DET
admet-2551	5	29	relevant	relevant	ADJ
admet-2551	5	30	articles	article	NOUN
admet-2551	5	31	,	,	PUNCT
admet-2551	5	32	and	and	CCONJ
admet-2551	5	33	written	write	VERB
admet-2551	5	34	the	the	DET
admet-2551	5	35	outcomes	outcome	NOUN
admet-2551	5	36	and	and	CCONJ
admet-2551	5	37	benefits	benefit	NOUN
admet-2551	5	38	of	of	ADP
admet-2551	5	39	protease	protease	NOUN
admet-2551	5	40	using	use	VERB
admet-2551	5	41	the	the	DET
admet-2551	5	42	medical	medical	ADJ
admet-2551	5	43	topic	topic	NOUN
admet-2551	5	44	“	"	PUNCT
admet-2551	5	45	serine	serine	NOUN
admet-2551	5	46	protease	protease	NOUN
admet-2551	5	47	”	"	PUNCT
admet-2551	5	48	and	and	CCONJ
admet-2551	5	49	the	the	DET
admet-2551	5	50	following	follow	VERB
admet-2551	5	51	text	text	NOUN
admet-2551	5	52	phrases	phrase	NOUN
admet-2551	5	53	-keratinase	-keratinase	PROPN
admet-2551	5	54	,	,	PUNCT
admet-2551	5	55	lumbrokinase	lumbrokinase	NOUN
admet-2551	5	56	,	,	PUNCT
admet-2551	5	57	serratiopeptidase	serratiopeptidase	ADJ
admet-2551	5	58	,	,	PUNCT
admet-2551	5	59	nattokinase	nattokinase	NOUN
admet-2551	5	60	.	.	PUNCT
admet-2551	6	1	key	key	ADJ
admet-2551	6	2	results	result	NOUN
admet-2551	6	3	:	:	PUNCT
admet-2551	6	4	alkaline	alkaline	NOUN
admet-2551	6	5	serine	serine	NOUN
admet-2551	6	6	proteases	protease	NOUN
admet-2551	6	7	exhibit	exhibit	VERB
admet-2551	6	8	activity	activity	NOUN
admet-2551	6	9	within	within	ADP
admet-2551	6	10	the	the	DET
admet-2551	6	11	neutral	neutral	ADJ
admet-2551	6	12	to	to	ADP
admet-2551	6	13	alkaline	alkaline	ADJ
admet-2551	6	14	ph	ph	ADJ
admet-2551	6	15	range	range	NOUN
admet-2551	6	16	.	.	PUNCT
admet-2551	7	1	they	they	PRON
admet-2551	7	2	are	be	AUX
admet-2551	7	3	most	most	ADV
admet-2551	7	4	capable	capable	ADJ
admet-2551	7	5	of	of	ADP
admet-2551	7	6	degrading	degrade	VERB
admet-2551	7	7	host	host	NOUN
admet-2551	7	8	complement	complement	NOUN
admet-2551	7	9	proteins	protein	NOUN
admet-2551	7	10	,	,	PUNCT
admet-2551	7	11	cytokines	cytokine	NOUN
admet-2551	7	12	,	,	PUNCT
admet-2551	7	13	and	and	CCONJ
admet-2551	7	14	host	host	NOUN
admet-2551	7	15	clotting	clotting	NOUN
admet-2551	7	16	factors	factor	NOUN
admet-2551	7	17	mostly	mostly	ADV
admet-2551	7	18	due	due	ADJ
admet-2551	7	19	to	to	ADP
admet-2551	7	20	their	their	PRON
admet-2551	7	21	serine	serine	NOUN
admet-2551	7	22	centre	centre	NOUN
admet-2551	7	23	or	or	CCONJ
admet-2551	7	24	metallotype	metallotype	NOUN
admet-2551	7	25	.	.	PUNCT
admet-2551	8	1	because	because	SCONJ
admet-2551	8	2	of	of	ADP
admet-2551	8	3	its	its	PRON
admet-2551	8	4	potential	potential	ADJ
admet-2551	8	5	usage	usage	NOUN
admet-2551	8	6	in	in	ADP
admet-2551	8	7	food	food	NOUN
admet-2551	8	8	,	,	PUNCT
admet-2551	8	9	pharmaceutical	pharmaceutical	NOUN
admet-2551	8	10	,	,	PUNCT
admet-2551	8	11	and	and	CCONJ
admet-2551	8	12	other	other	ADJ
admet-2551	8	13	industrial	industrial	ADJ
admet-2551	8	14	domains	domain	NOUN
admet-2551	8	15	,	,	PUNCT
admet-2551	8	16	this	this	DET
admet-2551	8	17	category	category	NOUN
admet-2551	8	18	of	of	ADP
admet-2551	8	19	enzymes	enzyme	NOUN
admet-2551	8	20	has	have	AUX
admet-2551	8	21	been	be	AUX
admet-2551	8	22	extensively	extensively	ADV
admet-2551	8	23	investigated	investigate	VERB
admet-2551	8	24	.	.	PUNCT
admet-2551	9	1	specifically	specifically	ADV
admet-2551	9	2	,	,	PUNCT
admet-2551	9	3	serine	serine	ADJ
admet-2551	9	4	proteases	protease	NOUN
admet-2551	9	5	are	be	AUX
admet-2551	9	6	a	a	DET
admet-2551	9	7	group	group	NOUN
admet-2551	9	8	of	of	ADP
admet-2551	9	9	enzymes	enzyme	NOUN
admet-2551	9	10	that	that	PRON
admet-2551	9	11	can	can	AUX
admet-2551	9	12	be	be	AUX
admet-2551	9	13	consumed	consume	VERB
admet-2551	9	14	orally	orally	ADV
admet-2551	9	15	and	and	CCONJ
admet-2551	9	16	are	be	AUX
admet-2551	9	17	stable	stable	ADJ
admet-2551	9	18	in	in	ADP
admet-2551	9	19	our	our	PRON
admet-2551	9	20	gastrointestinal	gastrointestinal	ADJ
admet-2551	9	21	tract	tract	NOUN
admet-2551	9	22	.	.	PUNCT
admet-2551	10	1	conclusion	conclusion	NOUN
admet-2551	10	2	:	:	PUNCT
admet-2551	10	3	in	in	ADP
admet-2551	10	4	this	this	DET
admet-2551	10	5	review	review	NOUN
admet-2551	10	6	,	,	PUNCT
admet-2551	10	7	we	we	PRON
admet-2551	10	8	discussed	discuss	VERB
admet-2551	10	9	the	the	DET
admet-2551	10	10	role	role	NOUN
admet-2551	10	11	of	of	ADP
admet-2551	10	12	different	different	ADJ
admet-2551	10	13	serine	serine	NOUN
admet-2551	10	14	proteases	protease	NOUN
admet-2551	10	15	in	in	ADP
admet-2551	10	16	amyloid	amyloid	NOUN
admet-2551	10	17	aggregate	aggregate	NOUN
admet-2551	10	18	inhibition	inhibition	NOUN
admet-2551	10	19	and	and	CCONJ
admet-2551	10	20	their	their	PRON
admet-2551	10	21	potential	potential	ADJ
admet-2551	10	22	application	application	NOUN
admet-2551	10	23	in	in	ADP
admet-2551	10	24	treating	treat	VERB
admet-2551	10	25	amyloidosis	amyloidosis	NOUN
admet-2551	10	26	.	.	PUNCT
admet-2551	11	1	©	©	NOUN
admet-2551	11	2	2024	2024	NUM
admet-2551	11	3	by	by	ADP
admet-2551	11	4	the	the	DET
admet-2551	11	5	authors	author	NOUN
admet-2551	11	6	.	.	PUNCT
admet-2551	12	1	this	this	DET
admet-2551	12	2	article	article	NOUN
admet-2551	12	3	is	be	AUX
admet-2551	12	4	an	an	DET
admet-2551	12	5	open	open	ADJ
admet-2551	12	6	-	-	PUNCT
admet-2551	12	7	access	access	NOUN
admet-2551	12	8	article	article	NOUN
admet-2551	12	9	distributed	distribute	VERB
admet-2551	12	10	under	under	ADP
admet-2551	12	11	the	the	DET
admet-2551	12	12	terms	term	NOUN
admet-2551	12	13	and	and	CCONJ
admet-2551	12	14	conditions	condition	NOUN
admet-2551	12	15	of	of	ADP
admet-2551	12	16	the	the	DET
admet-2551	12	17	creative	creative	ADJ
admet-2551	12	18	commons	common	NOUN
admet-2551	12	19	attribution	attribution	NOUN
admet-2551	12	20	license	license	NOUN
admet-2551	12	21	(	(	PUNCT
admet-2551	12	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	PROPN
admet-2551	12	23	)	)	PUNCT
admet-2551	12	24	.	.	PUNCT
admet-2551	13	1	keywords	keyword	VERB
admet-2551	13	2	amyloidosis	amyloidosis	NOUN
admet-2551	13	3	;	;	PUNCT
admet-2551	13	4	lumbrokinase	lumbrokinase	NOUN
admet-2551	13	5	;	;	PUNCT
admet-2551	13	6	serratiopeptidase	serratiopeptidase	ADJ
admet-2551	13	7	;	;	PUNCT
admet-2551	13	8	nattokinase	nattokinase	NOUN
admet-2551	13	9	;	;	PUNCT
admet-2551	13	10	prion	prion	NOUN
admet-2551	13	11	disease	disease	NOUN
admet-2551	13	12	;	;	PUNCT
admet-2551	13	13	alzheimer	alzheimer	PROPN
admet-2551	13	14	’s	’s	PART
admet-2551	13	15	disease	disease	NOUN
admet-2551	13	16	introduction	introduction	NOUN
admet-2551	13	17	amyloidogenic	amyloidogenic	ADJ
admet-2551	13	18	proteins	protein	NOUN
admet-2551	13	19	are	be	AUX
admet-2551	13	20	well	well	ADV
admet-2551	13	21	known	known	ADJ
admet-2551	13	22	for	for	ADP
admet-2551	13	23	their	their	PRON
admet-2551	13	24	ability	ability	NOUN
admet-2551	13	25	to	to	PART
admet-2551	13	26	misfold	misfold	VERB
admet-2551	13	27	and	and	CCONJ
admet-2551	13	28	aggregate	aggregate	VERB
admet-2551	13	29	normal	normal	ADJ
admet-2551	13	30	proteins	protein	NOUN
admet-2551	13	31	into	into	ADP
admet-2551	13	32	insoluble	insoluble	ADJ
admet-2551	13	33	fibrils	fibril	NOUN
admet-2551	13	34	.	.	PUNCT
admet-2551	14	1	it	it	PRON
admet-2551	14	2	plays	play	VERB
admet-2551	14	3	a	a	DET
admet-2551	14	4	crucial	crucial	ADJ
admet-2551	14	5	role	role	NOUN
admet-2551	14	6	in	in	ADP
admet-2551	14	7	the	the	DET
admet-2551	14	8	pathogenesis	pathogenesis	NOUN
admet-2551	14	9	of	of	ADP
admet-2551	14	10	several	several	ADJ
admet-2551	14	11	neurodegenerative	neurodegenerative	ADJ
admet-2551	14	12	diseases	disease	NOUN
admet-2551	14	13	,	,	PUNCT
admet-2551	14	14	including	include	VERB
admet-2551	14	15	alzheimer	alzheimer	PROPN
admet-2551	14	16	's	's	PART
admet-2551	14	17	,	,	PUNCT
admet-2551	14	18	parkinson	parkinson	NOUN
admet-2551	14	19	's	's	PART
admet-2551	14	20	,	,	PUNCT
admet-2551	14	21	huntington	huntington	PROPN
admet-2551	14	22	's	's	PART
admet-2551	14	23	,	,	PUNCT
admet-2551	14	24	and	and	CCONJ
admet-2551	14	25	other	other	ADJ
admet-2551	14	26	diseases	disease	NOUN
admet-2551	14	27	like	like	ADP
admet-2551	14	28	diabetes	diabetes	NOUN
admet-2551	14	29	type	type	NOUN
admet-2551	14	30	ii	ii	PROPN
admet-2551	14	31	.	.	PUNCT
admet-2551	15	1	this	this	DET
admet-2551	15	2	aggregation	aggregation	NOUN
admet-2551	15	3	of	of	ADP
admet-2551	15	4	amyloid	amyloid	NOUN
admet-2551	15	5	fibrils	fibril	NOUN
admet-2551	15	6	disrupts	disrupt	VERB
admet-2551	15	7	cell	cell	NOUN
admet-2551	15	8	function	function	NOUN
admet-2551	15	9	,	,	PUNCT
admet-2551	15	10	resulting	result	VERB
admet-2551	15	11	in	in	ADP
admet-2551	15	12	gradual	gradual	ADJ
admet-2551	15	13	tissue	tissue	NOUN
admet-2551	15	14	impairment	impairment	NOUN
admet-2551	15	15	.	.	PUNCT
admet-2551	16	1	to	to	PART
admet-2551	16	2	degrade	degrade	VERB
admet-2551	16	3	these	these	DET
admet-2551	16	4	aggregates	aggregate	NOUN
admet-2551	16	5	,	,	PUNCT
admet-2551	16	6	the	the	DET
admet-2551	16	7	body	body	NOUN
admet-2551	16	8	employs	employ	VERB
admet-2551	16	9	a	a	DET
admet-2551	16	10	range	range	NOUN
admet-2551	16	11	of	of	ADP
admet-2551	16	12	proteolytic	proteolytic	ADJ
admet-2551	16	13	enzymes	enzyme	NOUN
admet-2551	16	14	.	.	PUNCT
admet-2551	17	1	serine	serine	NOUN
admet-2551	17	2	proteases	protease	NOUN
admet-2551	17	3	have	have	AUX
admet-2551	17	4	created	create	VERB
admet-2551	17	5	widespread	widespread	ADJ
admet-2551	17	6	interest	interest	NOUN
admet-2551	17	7	due	due	ADP
admet-2551	17	8	to	to	ADP
admet-2551	17	9	their	their	PRON
admet-2551	17	10	https://doi.org/10.5599/admet.2551	https://doi.org/10.5599/admet.2551	NOUN
admet-2551	17	11	https://doi.org/10.5599/admet.2551	https://doi.org/10.5599/admet.2551	NOUN
admet-2551	17	12	http://www.pub.iapchem.org/ojs/index.php/admet/index	http://www.pub.iapchem.org/ojs/index.php/admet/index	X
admet-2551	17	13	mailto:koyelig@gmail.com	mailto:koyelig@gmail.com	PROPN
admet-2551	18	1	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	PROPN
admet-2551	18	2	s.	s.	PROPN
admet-2551	18	3	k.	k.	PROPN
admet-2551	18	4	metkar	metkar	PROPN
admet-2551	18	5	et	et	PROPN
admet-2551	18	6	al	al	PROPN
admet-2551	18	7	.	.	PROPN
admet-2551	18	8	admet	admet	PROPN
admet-2551	18	9	&	&	CCONJ
admet-2551	18	10	dmpk	dmpk	PROPN
admet-2551	18	11	12(6	12(6	NUM
admet-2551	18	12	)	)	PUNCT
admet-2551	18	13	(	(	PUNCT
admet-2551	18	14	2024	2024	NUM
admet-2551	18	15	)	)	PUNCT
admet-2551	18	16	797	797	NUM
admet-2551	18	17	-	-	SYM
admet-2551	18	18	820	820	NUM
admet-2551	18	19	798	798	NUM
admet-2551	18	20	broad	broad	ADJ
admet-2551	18	21	substrate	substrate	NOUN
admet-2551	18	22	specificity	specificity	NOUN
admet-2551	18	23	and	and	CCONJ
admet-2551	18	24	potent	potent	ADJ
admet-2551	18	25	catalytic	catalytic	ADJ
admet-2551	18	26	activity	activity	NOUN
admet-2551	18	27	[	[	X
admet-2551	18	28	1	1	NUM
admet-2551	18	29	]	]	PUNCT
admet-2551	18	30	.	.	PUNCT
admet-2551	19	1	on	on	ADP
admet-2551	19	2	the	the	DET
admet-2551	19	3	other	other	ADJ
admet-2551	19	4	hand	hand	NOUN
admet-2551	19	5	,	,	PUNCT
admet-2551	19	6	evidence	evidence	NOUN
admet-2551	19	7	exists	exist	VERB
admet-2551	19	8	that	that	SCONJ
admet-2551	19	9	amyloids	amyloid	NOUN
admet-2551	19	10	can	can	AUX
admet-2551	19	11	be	be	AUX
admet-2551	19	12	degraded	degrade	VERB
admet-2551	19	13	in	in	ADP
admet-2551	19	14	vitro	vitro	X
admet-2551	19	15	using	use	VERB
admet-2551	19	16	zinc	zinc	NOUN
admet-2551	19	17	oxide	oxide	NOUN
admet-2551	19	18	nanoflowers	nanoflower	NOUN
admet-2551	19	19	[	[	X
admet-2551	19	20	2	2	NUM
admet-2551	19	21	]	]	PUNCT
admet-2551	19	22	and	and	CCONJ
admet-2551	19	23	nanoformulated	nanoformulate	VERB
admet-2551	19	24	carrageenan	carrageenan	NOUN
admet-2551	20	1	[	[	X
admet-2551	20	2	3	3	NUM
admet-2551	20	3	]	]	PUNCT
admet-2551	20	4	.	.	PUNCT
admet-2551	21	1	hydrolytic	hydrolytic	ADJ
admet-2551	21	2	enzymes	enzyme	NOUN
admet-2551	21	3	,	,	PUNCT
admet-2551	21	4	such	such	ADJ
admet-2551	21	5	as	as	ADP
admet-2551	21	6	proteases	protease	NOUN
admet-2551	21	7	,	,	PUNCT
admet-2551	21	8	phytases	phytase	NOUN
admet-2551	21	9	,	,	PUNCT
admet-2551	21	10	lipases	lipase	NOUN
admet-2551	21	11	,	,	PUNCT
admet-2551	21	12	amylases	amylase	NOUN
admet-2551	21	13	,	,	PUNCT
admet-2551	21	14	amidases	amidase	NOUN
admet-2551	21	15	,	,	PUNCT
admet-2551	21	16	and	and	CCONJ
admet-2551	21	17	others	other	NOUN
admet-2551	21	18	,	,	PUNCT
admet-2551	21	19	dominate	dominate	VERB
admet-2551	21	20	the	the	DET
admet-2551	21	21	enzyme	enzyme	NOUN
admet-2551	21	22	market	market	NOUN
admet-2551	21	23	today	today	NOUN
admet-2551	21	24	.	.	PUNCT
admet-2551	22	1	most	most	ADJ
admet-2551	22	2	of	of	ADP
admet-2551	22	3	the	the	DET
admet-2551	22	4	proteases	protease	NOUN
admet-2551	22	5	belong	belong	VERB
admet-2551	22	6	to	to	ADP
admet-2551	22	7	the	the	DET
admet-2551	22	8	serine	serine	ADJ
admet-2551	22	9	protease	protease	NOUN
admet-2551	22	10	family	family	NOUN
admet-2551	22	11	and	and	CCONJ
admet-2551	22	12	are	be	AUX
admet-2551	22	13	characterized	characterize	VERB
admet-2551	22	14	by	by	ADP
admet-2551	22	15	a	a	DET
admet-2551	22	16	serine	serine	ADJ
admet-2551	22	17	residue	residue	NOUN
admet-2551	22	18	[	[	X
admet-2551	22	19	4	4	NUM
admet-2551	22	20	]	]	PUNCT
admet-2551	22	21	.	.	PUNCT
admet-2551	23	1	serine	serine	ADJ
admet-2551	23	2	protease	protease	NOUN
admet-2551	23	3	acts	act	VERB
admet-2551	23	4	as	as	ADP
admet-2551	23	5	an	an	DET
admet-2551	23	6	endopeptidase	endopeptidase	NOUN
admet-2551	23	7	by	by	ADP
admet-2551	23	8	breaking	break	VERB
admet-2551	23	9	down	down	ADP
admet-2551	23	10	peptide	peptide	NOUN
admet-2551	23	11	bonds	bond	NOUN
admet-2551	23	12	like	like	ADP
admet-2551	23	13	other	other	ADJ
admet-2551	23	14	proteins	protein	NOUN
admet-2551	23	15	.	.	PUNCT
admet-2551	24	1	however	however	ADV
admet-2551	24	2	,	,	PUNCT
admet-2551	24	3	these	these	DET
admet-2551	24	4	residues	residue	NOUN
admet-2551	24	5	in	in	ADP
admet-2551	24	6	active	active	ADJ
admet-2551	24	7	sites	site	NOUN
admet-2551	24	8	play	play	VERB
admet-2551	24	9	a	a	DET
admet-2551	24	10	crucial	crucial	ADJ
admet-2551	24	11	role	role	NOUN
admet-2551	24	12	in	in	ADP
admet-2551	24	13	coordinating	coordinate	VERB
admet-2551	24	14	functions	function	NOUN
admet-2551	24	15	through	through	ADP
admet-2551	24	16	protein	protein	NOUN
admet-2551	24	17	hydrolysis	hydrolysis	NOUN
admet-2551	24	18	[	[	X
admet-2551	24	19	5	5	NUM
admet-2551	24	20	]	]	PUNCT
admet-2551	24	21	.	.	PUNCT
admet-2551	25	1	moreover	moreover	ADV
admet-2551	25	2	,	,	PUNCT
admet-2551	25	3	these	these	DET
admet-2551	25	4	types	type	NOUN
admet-2551	25	5	of	of	ADP
admet-2551	25	6	protease	protease	NOUN
admet-2551	25	7	are	be	AUX
admet-2551	25	8	widely	widely	ADV
admet-2551	25	9	distributed	distribute	VERB
admet-2551	25	10	in	in	ADP
admet-2551	25	11	every	every	DET
admet-2551	25	12	living	living	NOUN
admet-2551	25	13	organism	organism	NOUN
admet-2551	25	14	,	,	PUNCT
admet-2551	25	15	including	include	VERB
admet-2551	25	16	viruses	virus	NOUN
admet-2551	25	17	,	,	PUNCT
admet-2551	25	18	bacteria	bacteria	NOUN
admet-2551	25	19	,	,	PUNCT
admet-2551	25	20	fungi	fungus	NOUN
admet-2551	25	21	,	,	PUNCT
admet-2551	25	22	insects	insect	NOUN
admet-2551	25	23	,	,	PUNCT
admet-2551	25	24	and	and	CCONJ
admet-2551	25	25	humans	human	NOUN
admet-2551	25	26	,	,	PUNCT
admet-2551	25	27	and	and	CCONJ
admet-2551	25	28	function	function	VERB
admet-2551	25	29	both	both	CCONJ
admet-2551	25	30	within	within	ADP
admet-2551	25	31	and	and	CCONJ
admet-2551	25	32	outside	outside	ADP
admet-2551	25	33	the	the	DET
admet-2551	25	34	cells	cell	NOUN
admet-2551	25	35	[	[	X
admet-2551	25	36	6	6	NUM
admet-2551	25	37	]	]	PUNCT
admet-2551	25	38	.	.	PUNCT
admet-2551	26	1	serine	serine	NOUN
admet-2551	26	2	proteases	protease	NOUN
admet-2551	26	3	are	be	AUX
admet-2551	26	4	traditionally	traditionally	ADV
admet-2551	26	5	classified	classify	VERB
admet-2551	26	6	into	into	ADP
admet-2551	26	7	various	various	ADJ
admet-2551	26	8	categories	category	NOUN
admet-2551	26	9	,	,	PUNCT
admet-2551	26	10	including	include	VERB
admet-2551	26	11	chymotrypsin	chymotrypsin	NOUN
admet-2551	26	12	-	-	PUNCT
admet-2551	26	13	like	like	ADJ
admet-2551	26	14	,	,	PUNCT
admet-2551	26	15	trypsin	trypsin	NOUN
admet-2551	26	16	-	-	PUNCT
admet-2551	26	17	like	like	ADJ
admet-2551	26	18	,	,	PUNCT
admet-2551	26	19	subtilisin	subtilisin	NOUN
admet-2551	26	20	-	-	PUNCT
admet-2551	26	21	like	like	ADJ
admet-2551	26	22	,	,	PUNCT
admet-2551	26	23	elastase	elastase	NOUN
admet-2551	26	24	-	-	PUNCT
admet-2551	26	25	like	like	ADJ
admet-2551	26	26	,	,	PUNCT
admet-2551	26	27	and	and	CCONJ
admet-2551	26	28	thrombin	thrombin	NOUN
admet-2551	26	29	-	-	PUNCT
admet-2551	26	30	like	like	ADJ
admet-2551	26	31	protease	protease	NOUN
admet-2551	26	32	.	.	PUNCT
admet-2551	27	1	chymotrypsin	chymotrypsin	NOUN
admet-2551	27	2	-	-	PUNCT
admet-2551	27	3	like	like	ADJ
admet-2551	27	4	proteases	protease	NOUN
admet-2551	27	5	can	can	AUX
admet-2551	27	6	be	be	AUX
admet-2551	27	7	found	find	VERB
admet-2551	27	8	in	in	ADP
admet-2551	27	9	both	both	DET
admet-2551	27	10	prokaryotes	prokaryote	NOUN
admet-2551	27	11	and	and	CCONJ
admet-2551	27	12	eukaryotes	eukaryote	NOUN
admet-2551	27	13	.	.	PUNCT
admet-2551	28	1	over	over	ADP
admet-2551	28	2	240	240	NUM
admet-2551	28	3	chymotrypsin	chymotrypsin	NOUN
admet-2551	28	4	-	-	PUNCT
admet-2551	28	5	like	like	ADJ
admet-2551	28	6	proteases	protease	NOUN
admet-2551	28	7	have	have	AUX
admet-2551	28	8	been	be	AUX
admet-2551	28	9	identified	identify	VERB
admet-2551	28	10	in	in	ADP
admet-2551	28	11	the	the	DET
admet-2551	28	12	merops	merop	NOUN
admet-2551	28	13	peptide	peptide	PROPN
admet-2551	28	14	database	database	NOUN
admet-2551	28	15	.	.	PUNCT
admet-2551	29	1	chymas	chymas	PROPN
admet-2551	29	2	,	,	PUNCT
admet-2551	29	3	synthesized	synthesize	VERB
admet-2551	29	4	by	by	ADP
admet-2551	29	5	mast	mast	NOUN
admet-2551	29	6	cells	cell	NOUN
admet-2551	29	7	,	,	PUNCT
admet-2551	29	8	play	play	VERB
admet-2551	29	9	essential	essential	ADJ
admet-2551	29	10	roles	role	NOUN
admet-2551	29	11	in	in	ADP
admet-2551	29	12	various	various	ADJ
admet-2551	29	13	peptide	peptide	ADJ
admet-2551	29	14	hormones	hormone	NOUN
admet-2551	29	15	and	and	CCONJ
admet-2551	29	16	other	other	ADJ
admet-2551	29	17	physiological	physiological	ADJ
admet-2551	29	18	processes	process	NOUN
admet-2551	29	19	,	,	PUNCT
admet-2551	29	20	such	such	ADJ
admet-2551	29	21	as	as	ADP
admet-2551	29	22	hemostasis	hemostasis	NOUN
admet-2551	29	23	,	,	PUNCT
admet-2551	29	24	inflammation	inflammation	NOUN
admet-2551	29	25	,	,	PUNCT
admet-2551	29	26	apoptosis	apoptosis	NOUN
admet-2551	29	27	,	,	PUNCT
admet-2551	29	28	signal	signal	ADJ
admet-2551	29	29	transduction	transduction	NOUN
admet-2551	29	30	,	,	PUNCT
admet-2551	29	31	immunological	immunological	ADJ
admet-2551	29	32	responses	response	NOUN
admet-2551	29	33	,	,	PUNCT
admet-2551	29	34	and	and	CCONJ
admet-2551	29	35	digestion	digestion	NOUN
admet-2551	29	36	.	.	PUNCT
admet-2551	30	1	it	it	PRON
admet-2551	30	2	also	also	ADV
admet-2551	30	3	breaks	break	VERB
admet-2551	30	4	down	down	ADP
admet-2551	30	5	the	the	DET
admet-2551	30	6	peptide	peptide	ADJ
admet-2551	30	7	bonds	bond	NOUN
admet-2551	30	8	on	on	ADP
admet-2551	30	9	the	the	DET
admet-2551	30	10	carboxyl	carboxyl	NOUN
admet-2551	30	11	side	side	NOUN
admet-2551	30	12	of	of	ADP
admet-2551	30	13	tryptophan	tryptophan	NOUN
admet-2551	30	14	,	,	PUNCT
admet-2551	30	15	phenylalanine	phenylalanine	NOUN
admet-2551	30	16	,	,	PUNCT
admet-2551	30	17	and	and	CCONJ
admet-2551	30	18	tyrosine	tyrosine	NOUN
admet-2551	30	19	.	.	PUNCT
admet-2551	31	1	this	this	DET
admet-2551	31	2	particular	particular	ADJ
admet-2551	31	3	type	type	NOUN
admet-2551	31	4	of	of	ADP
admet-2551	31	5	protease	protease	NOUN
admet-2551	31	6	sequentially	sequentially	ADV
admet-2551	31	7	activates	activate	VERB
admet-2551	31	8	blood	blood	NOUN
admet-2551	31	9	clotting	clotting	NOUN
admet-2551	31	10	,	,	PUNCT
admet-2551	31	11	fibrinolysis	fibrinolysis	NOUN
admet-2551	31	12	and	and	CCONJ
admet-2551	31	13	wound	wound	NOUN
admet-2551	31	14	healing	healing	NOUN
admet-2551	31	15	[	[	X
admet-2551	31	16	7	7	NUM
admet-2551	31	17	]	]	PUNCT
admet-2551	31	18	.	.	PUNCT
admet-2551	32	1	trypsin	trypsin	NOUN
admet-2551	32	2	-	-	PUNCT
admet-2551	32	3	like	like	ADJ
admet-2551	32	4	protease	protease	NOUN
admet-2551	32	5	is	be	AUX
admet-2551	32	6	a	a	DET
admet-2551	32	7	homologous	homologous	ADJ
admet-2551	32	8	protease	protease	NOUN
admet-2551	32	9	found	find	VERB
admet-2551	32	10	in	in	ADP
admet-2551	32	11	the	the	DET
admet-2551	32	12	human	human	ADJ
admet-2551	32	13	genome	genome	NOUN
admet-2551	32	14	.	.	PUNCT
admet-2551	33	1	out	out	ADP
admet-2551	33	2	of	of	ADP
admet-2551	33	3	699	699	NUM
admet-2551	33	4	proteases	protease	NOUN
admet-2551	33	5	in	in	ADP
admet-2551	33	6	humans	human	NOUN
admet-2551	33	7	,	,	PUNCT
admet-2551	33	8	138	138	NUM
admet-2551	33	9	belong	belong	VERB
admet-2551	33	10	to	to	ADP
admet-2551	33	11	the	the	DET
admet-2551	33	12	s1	s1	NOUN
admet-2551	33	13	protease	protease	NOUN
admet-2551	33	14	family	family	NOUN
admet-2551	33	15	and	and	CCONJ
admet-2551	33	16	the	the	DET
admet-2551	33	17	other	other	ADJ
admet-2551	33	18	178	178	NUM
admet-2551	33	19	are	be	AUX
admet-2551	33	20	serine	serine	NOUN
admet-2551	33	21	proteases	protease	NOUN
admet-2551	33	22	[	[	X
admet-2551	33	23	8	8	NUM
admet-2551	33	24	]	]	PUNCT
admet-2551	33	25	.	.	PUNCT
admet-2551	34	1	this	this	DET
admet-2551	34	2	trypsin	trypsin	NOUN
admet-2551	34	3	-	-	PUNCT
admet-2551	34	4	like	like	ADJ
admet-2551	34	5	protease	protease	NOUN
admet-2551	34	6	performs	perform	VERB
admet-2551	34	7	a	a	DET
admet-2551	34	8	key	key	ADJ
admet-2551	34	9	function	function	NOUN
admet-2551	34	10	in	in	ADP
admet-2551	34	11	boosting	boost	VERB
admet-2551	34	12	the	the	DET
admet-2551	34	13	body	body	NOUN
admet-2551	34	14	’s	’s	PART
admet-2551	34	15	response	response	NOUN
admet-2551	34	16	to	to	ADP
admet-2551	34	17	blood	blood	NOUN
admet-2551	34	18	clots	clot	NOUN
admet-2551	34	19	,	,	PUNCT
admet-2551	34	20	protein	protein	NOUN
admet-2551	34	21	digestion	digestion	NOUN
admet-2551	34	22	,	,	PUNCT
admet-2551	34	23	and	and	CCONJ
admet-2551	34	24	immunity	immunity	NOUN
admet-2551	34	25	[	[	X
admet-2551	34	26	9	9	NUM
admet-2551	34	27	]	]	PUNCT
admet-2551	34	28	.	.	PUNCT
admet-2551	35	1	subtilisin	subtilisin	PROPN
admet-2551	35	2	is	be	AUX
admet-2551	35	3	a	a	DET
admet-2551	35	4	serine	serine	ADJ
admet-2551	35	5	protease	protease	NOUN
admet-2551	35	6	found	find	VERB
admet-2551	35	7	in	in	ADP
admet-2551	35	8	prokaryotes	prokaryote	NOUN
admet-2551	35	9	.	.	PUNCT
admet-2551	36	1	according	accord	VERB
admet-2551	36	2	to	to	ADP
admet-2551	36	3	the	the	DET
admet-2551	36	4	merops	merop	NOUN
admet-2551	36	5	database	database	NOUN
admet-2551	36	6	,	,	PUNCT
admet-2551	36	7	subtilases	subtilase	NOUN
admet-2551	36	8	are	be	AUX
admet-2551	36	9	a	a	DET
admet-2551	36	10	subfamily	subfamily	NOUN
admet-2551	36	11	of	of	ADP
admet-2551	36	12	the	the	DET
admet-2551	36	13	clan	clan	PROPN
admet-2551	36	14	sb	sb	PROPN
admet-2551	36	15	of	of	ADP
admet-2551	36	16	serine	serine	NOUN
admet-2551	36	17	peptidases	peptidase	NOUN
admet-2551	36	18	and	and	CCONJ
admet-2551	36	19	belong	belong	VERB
admet-2551	36	20	to	to	ADP
admet-2551	36	21	s8a	s8a	ADJ
admet-2551	36	22	family	family	NOUN
admet-2551	36	23	.	.	PUNCT
admet-2551	37	1	generally	generally	ADV
admet-2551	37	2	,	,	PUNCT
admet-2551	37	3	they	they	PRON
admet-2551	37	4	act	act	VERB
admet-2551	37	5	as	as	ADP
admet-2551	37	6	a	a	DET
admet-2551	37	7	detergent	detergent	NOUN
admet-2551	37	8	to	to	PART
admet-2551	37	9	remove	remove	VERB
admet-2551	37	10	proteinaceous	proteinaceous	ADJ
admet-2551	37	11	dyes	dye	NOUN
admet-2551	37	12	.	.	PUNCT
admet-2551	38	1	compared	compare	VERB
admet-2551	38	2	to	to	ADP
admet-2551	38	3	other	other	ADJ
admet-2551	38	4	protease	protease	NOUN
admet-2551	38	5	types	type	NOUN
admet-2551	38	6	like	like	ADP
admet-2551	38	7	trypsin	trypsin	NOUN
admet-2551	38	8	and	and	CCONJ
admet-2551	38	9	chymotrypsin	chymotrypsin	NOUN
admet-2551	38	10	,	,	PUNCT
admet-2551	38	11	elastase	elastase	ADJ
admet-2551	38	12	-	-	PUNCT
admet-2551	38	13	like	like	ADJ
admet-2551	38	14	protease	protease	NOUN
admet-2551	38	15	has	have	VERB
admet-2551	38	16	a	a	DET
admet-2551	38	17	smaller	small	ADJ
admet-2551	38	18	s1	s1	NOUN
admet-2551	38	19	cleft	cleft	NOUN
admet-2551	38	20	.	.	PUNCT
admet-2551	39	1	these	these	DET
admet-2551	39	2	proteases	protease	NOUN
admet-2551	39	3	cleave	cleave	VERB
admet-2551	39	4	bonds	bond	NOUN
admet-2551	39	5	at	at	ADP
admet-2551	39	6	the	the	DET
admet-2551	39	7	non	non	ADJ
admet-2551	39	8	-	-	ADJ
admet-2551	39	9	polar	polar	ADJ
admet-2551	39	10	amino	amino	ADJ
admet-2551	39	11	acids	acid	NOUN
admet-2551	39	12	such	such	ADJ
admet-2551	39	13	as	as	ADP
admet-2551	39	14	alanine	alanine	NOUN
admet-2551	39	15	,	,	PUNCT
admet-2551	39	16	glycine	glycine	NOUN
admet-2551	39	17	,	,	PUNCT
admet-2551	39	18	and	and	CCONJ
admet-2551	39	19	valine	valine	NOUN
admet-2551	40	1	[	[	X
admet-2551	40	2	5,10	5,10	NUM
admet-2551	40	3	]	]	PUNCT
admet-2551	40	4	.	.	PUNCT
admet-2551	41	1	snake	snake	NOUN
admet-2551	41	2	venoms	venom	NOUN
admet-2551	41	3	contain	contain	VERB
admet-2551	41	4	numerous	numerous	ADJ
admet-2551	41	5	highly	highly	ADV
admet-2551	41	6	toxic	toxic	ADJ
admet-2551	41	7	thrombin	thrombin	NOUN
admet-2551	41	8	-	-	PUNCT
admet-2551	41	9	like	like	ADJ
admet-2551	41	10	serine	serine	NOUN
admet-2551	41	11	protease	protease	NOUN
admet-2551	41	12	isoforms	isoform	NOUN
admet-2551	41	13	.	.	PUNCT
admet-2551	42	1	it	it	PRON
admet-2551	42	2	consists	consist	VERB
admet-2551	42	3	of	of	ADP
admet-2551	42	4	two	two	NUM
admet-2551	42	5	chains	chain	NOUN
admet-2551	42	6	linked	link	VERB
admet-2551	42	7	by	by	ADP
admet-2551	42	8	disulfide	disulfide	NOUN
admet-2551	42	9	bonds	bond	NOUN
admet-2551	42	10	:	:	PUNCT
admet-2551	42	11	the	the	DET
admet-2551	42	12	a	a	PRON
admet-2551	42	13	and	and	CCONJ
admet-2551	42	14	b	b	NOUN
admet-2551	42	15	chains	chain	NOUN
admet-2551	42	16	.	.	PUNCT
admet-2551	43	1	it	it	PRON
admet-2551	43	2	is	be	AUX
admet-2551	43	3	involved	involve	VERB
admet-2551	43	4	in	in	ADP
admet-2551	43	5	fibrinolysis	fibrinolysis	NOUN
admet-2551	43	6	,	,	PUNCT
admet-2551	43	7	and	and	CCONJ
admet-2551	43	8	alzheimer	alzheimer	PROPN
admet-2551	43	9	's	's	PART
admet-2551	43	10	and	and	CCONJ
admet-2551	43	11	parkinson's	parkinson's	NOUN
admet-2551	43	12	-	-	PUNCT
admet-2551	43	13	induced	induce	VERB
admet-2551	43	14	dementia	dementia	NOUN
admet-2551	43	15	and	and	CCONJ
admet-2551	43	16	other	other	ADJ
admet-2551	43	17	neurodegenerative	neurodegenerative	ADJ
admet-2551	43	18	conditions	condition	NOUN
admet-2551	43	19	[	[	X
admet-2551	43	20	5,11	5,11	NUM
admet-2551	43	21	]	]	X
admet-2551	43	22	.	.	PUNCT
admet-2551	44	1	among	among	ADP
admet-2551	44	2	those	those	DET
admet-2551	44	3	serine	serine	NOUN
admet-2551	44	4	proteases	protease	NOUN
admet-2551	44	5	,	,	PUNCT
admet-2551	44	6	lumbrokinase	lumbrokinase	NOUN
admet-2551	44	7	(	(	PUNCT
admet-2551	44	8	lk	lk	NOUN
admet-2551	44	9	)	)	PUNCT
admet-2551	44	10	and	and	CCONJ
admet-2551	44	11	serratiopeptidase	serratiopeptidase	PROPN
admet-2551	44	12	(	(	PUNCT
admet-2551	44	13	sp	sp	NOUN
admet-2551	44	14	)	)	PUNCT
admet-2551	44	15	are	be	AUX
admet-2551	44	16	the	the	DET
admet-2551	44	17	world	world	NOUN
admet-2551	44	18	's	's	PART
admet-2551	44	19	most	most	ADV
admet-2551	44	20	exciting	exciting	ADJ
admet-2551	44	21	enzymes	enzyme	NOUN
admet-2551	44	22	being	be	AUX
admet-2551	44	23	studied	study	VERB
admet-2551	44	24	for	for	ADP
admet-2551	44	25	their	their	PRON
admet-2551	44	26	potential	potential	ADJ
admet-2551	44	27	application	application	NOUN
admet-2551	44	28	in	in	ADP
admet-2551	44	29	the	the	DET
admet-2551	44	30	medical	medical	ADJ
admet-2551	44	31	field	field	NOUN
admet-2551	44	32	[	[	X
admet-2551	44	33	5	5	NUM
admet-2551	44	34	]	]	PUNCT
admet-2551	44	35	.	.	PUNCT
admet-2551	45	1	a	a	DET
admet-2551	45	2	new	new	ADJ
admet-2551	45	3	dimension	dimension	NOUN
admet-2551	45	4	has	have	AUX
admet-2551	45	5	emerged	emerge	VERB
admet-2551	45	6	with	with	ADP
admet-2551	45	7	the	the	DET
admet-2551	45	8	discovery	discovery	NOUN
admet-2551	45	9	of	of	ADP
admet-2551	45	10	nattokinase	nattokinase	NOUN
admet-2551	45	11	(	(	PUNCT
admet-2551	45	12	nk	nk	PROPN
admet-2551	45	13	)	)	PUNCT
admet-2551	45	14	and	and	CCONJ
admet-2551	45	15	keratinase	keratinase	PROPN
admet-2551	45	16	(	(	PUNCT
admet-2551	45	17	ker	ker	NOUN
admet-2551	45	18	)	)	PUNCT
admet-2551	45	19	,	,	PUNCT
admet-2551	45	20	which	which	PRON
admet-2551	45	21	are	be	AUX
admet-2551	45	22	unique	unique	ADJ
admet-2551	45	23	proteases	protease	NOUN
admet-2551	45	24	that	that	PRON
admet-2551	45	25	are	be	AUX
admet-2551	45	26	capable	capable	ADJ
admet-2551	45	27	of	of	ADP
admet-2551	45	28	destroying	destroy	VERB
admet-2551	45	29	recalcitrant	recalcitrant	ADJ
admet-2551	45	30	proteins	protein	NOUN
admet-2551	45	31	like	like	ADP
admet-2551	45	32	amyloid	amyloid	NOUN
admet-2551	45	33	,	,	PUNCT
admet-2551	45	34	known	know	VERB
admet-2551	45	35	as	as	ADP
admet-2551	45	36	protease	protease	NOUN
admet-2551	45	37	-	-	PUNCT
admet-2551	45	38	resistant	resistant	ADJ
admet-2551	45	39	proteins	protein	NOUN
admet-2551	45	40	[	[	X
admet-2551	45	41	12,13	12,13	NUM
admet-2551	45	42	]	]	PUNCT
admet-2551	45	43	.	.	PUNCT
admet-2551	46	1	the	the	DET
admet-2551	46	2	mechanism	mechanism	NOUN
admet-2551	46	3	of	of	ADP
admet-2551	46	4	protease	protease	NOUN
admet-2551	46	5	in	in	ADP
admet-2551	46	6	the	the	DET
admet-2551	46	7	clearance	clearance	NOUN
admet-2551	46	8	of	of	ADP
admet-2551	46	9	amyloid	amyloid	NOUN
admet-2551	46	10	misfolded	misfolde	VERB
admet-2551	46	11	proteins	protein	NOUN
admet-2551	46	12	is	be	AUX
admet-2551	46	13	depicted	depict	VERB
admet-2551	46	14	in	in	ADP
admet-2551	46	15	figure	figure	NOUN
admet-2551	46	16	1	1	NUM
admet-2551	46	17	.	.	PUNCT
admet-2551	47	1	figure	figure	NOUN
admet-2551	47	2	1	1	NUM
admet-2551	47	3	.	.	PUNCT
admet-2551	47	4	action	action	NOUN
admet-2551	47	5	of	of	ADP
admet-2551	47	6	protease	protease	NOUN
admet-2551	47	7	in	in	ADP
admet-2551	47	8	amyloid	amyloid	NOUN
admet-2551	47	9	degradation	degradation	NOUN
admet-2551	47	10	admet	admet	PROPN
admet-2551	47	11	&	&	CCONJ
admet-2551	47	12	dmpk	dmpk	PROPN
admet-2551	47	13	12(6	12(6	NUM
admet-2551	47	14	)	)	PUNCT
admet-2551	47	15	(	(	PUNCT
admet-2551	47	16	2024	2024	NUM
admet-2551	47	17	)	)	PUNCT
admet-2551	47	18	797	797	NUM
admet-2551	47	19	-	-	SYM
admet-2551	47	20	820	820	NUM
admet-2551	47	21	natural	natural	ADJ
admet-2551	47	22	serine	serine	NOUN
admet-2551	47	23	proteases	protease	NOUN
admet-2551	47	24	in	in	ADP
admet-2551	47	25	combating	combat	VERB
admet-2551	47	26	amyloid	amyloid	NOUN
admet-2551	47	27	formation	formation	NOUN
admet-2551	47	28	doi	doi	NOUN
admet-2551	47	29	:	:	PUNCT
admet-2551	47	30	https://doi.org/10.5599/admet.2551	https://doi.org/10.5599/admet.2551	NOUN
admet-2551	47	31	799	799	NUM
admet-2551	47	32	specific	specific	ADJ
admet-2551	47	33	types	type	NOUN
admet-2551	47	34	of	of	ADP
admet-2551	47	35	serine	serine	NOUN
admet-2551	47	36	proteases	protease	NOUN
admet-2551	47	37	lumbrokinase	lumbrokinase	NOUN
admet-2551	47	38	since	since	SCONJ
admet-2551	47	39	ancient	ancient	ADJ
admet-2551	47	40	times	time	NOUN
admet-2551	47	41	(	(	PUNCT
admet-2551	47	42	<	<	NOUN
admet-2551	47	43	4000	4000	NUM
admet-2551	47	44	years	year	NOUN
admet-2551	47	45	,	,	PUNCT
admet-2551	47	46	2600	2600	NUM
admet-2551	47	47	b.c	b.c	PROPN
admet-2551	47	48	.	.	PROPN
admet-2551	47	49	)	)	PUNCT
admet-2551	48	1	,	,	PUNCT
admet-2551	48	2	earthworms	earthworm	NOUN
admet-2551	48	3	have	have	AUX
admet-2551	48	4	been	be	AUX
admet-2551	48	5	closely	closely	ADV
admet-2551	48	6	linked	link	VERB
admet-2551	48	7	with	with	ADP
admet-2551	48	8	human	human	ADJ
admet-2551	48	9	beings	being	NOUN
admet-2551	48	10	.	.	PUNCT
admet-2551	49	1	they	they	PRON
admet-2551	49	2	have	have	AUX
admet-2551	49	3	been	be	AUX
admet-2551	49	4	utilized	utilize	VERB
admet-2551	49	5	as	as	ADP
admet-2551	49	6	food	food	NOUN
admet-2551	49	7	and	and	CCONJ
admet-2551	49	8	medicine	medicine	NOUN
admet-2551	49	9	to	to	PART
admet-2551	49	10	treat	treat	VERB
admet-2551	49	11	various	various	ADJ
admet-2551	49	12	human	human	ADJ
admet-2551	49	13	ailments	ailment	NOUN
admet-2551	49	14	in	in	ADP
admet-2551	49	15	different	different	ADJ
admet-2551	49	16	parts	part	NOUN
admet-2551	49	17	of	of	ADP
admet-2551	49	18	the	the	DET
admet-2551	49	19	world	world	NOUN
admet-2551	49	20	,	,	PUNCT
admet-2551	49	21	including	include	VERB
admet-2551	49	22	china	china	PROPN
admet-2551	49	23	,	,	PUNCT
admet-2551	49	24	japan	japan	PROPN
admet-2551	49	25	,	,	PUNCT
admet-2551	49	26	korea	korea	PROPN
admet-2551	49	27	,	,	PUNCT
admet-2551	49	28	india	india	PROPN
admet-2551	49	29	,	,	PUNCT
admet-2551	49	30	cambodia	cambodia	PROPN
admet-2551	49	31	,	,	PUNCT
admet-2551	49	32	myanmar	myanmar	PROPN
admet-2551	49	33	(	(	PUNCT
admet-2551	49	34	burma	burma	PROPN
admet-2551	49	35	)	)	PUNCT
admet-2551	49	36	,	,	PUNCT
admet-2551	49	37	vietnam	vietnam	PROPN
admet-2551	49	38	,	,	PUNCT
admet-2551	49	39	iran	iran	PROPN
admet-2551	49	40	,	,	PUNCT
admet-2551	49	41	and	and	CCONJ
admet-2551	49	42	the	the	DET
admet-2551	49	43	middle	middle	PROPN
admet-2551	49	44	east	east	PROPN
admet-2551	50	1	[	[	X
admet-2551	50	2	14	14	NUM
admet-2551	50	3	]	]	PUNCT
admet-2551	50	4	.	.	PUNCT
admet-2551	51	1	the	the	DET
admet-2551	51	2	greek	greek	PROPN
admet-2551	51	3	philosopher	philosopher	NOUN
admet-2551	51	4	aristotle	aristotle	PROPN
admet-2551	51	5	(	(	PUNCT
admet-2551	51	6	384	384	NUM
admet-2551	51	7	-	-	SYM
admet-2551	51	8	322	322	NUM
admet-2551	51	9	b.c	b.c	NOUN
admet-2551	51	10	.	.	PUNCT
admet-2551	51	11	)	)	PUNCT
admet-2551	51	12	mentioned	mention	VERB
admet-2551	51	13	the	the	DET
admet-2551	51	14	importance	importance	NOUN
admet-2551	51	15	of	of	ADP
admet-2551	51	16	earthworms	earthworm	NOUN
admet-2551	51	17	and	and	CCONJ
admet-2551	51	18	termed	term	VERB
admet-2551	51	19	them	they	PRON
admet-2551	51	20	“	"	PUNCT
admet-2551	51	21	the	the	DET
admet-2551	51	22	intestine	intestine	NOUN
admet-2551	51	23	of	of	ADP
admet-2551	51	24	earth	earth	NOUN
admet-2551	51	25	”	"	PUNCT
admet-2551	52	1	[	[	X
admet-2551	52	2	15	15	NUM
admet-2551	52	3	-	-	SYM
admet-2551	52	4	17	17	NUM
admet-2551	52	5	]	]	PUNCT
admet-2551	52	6	.	.	PUNCT
admet-2551	53	1	they	they	PRON
admet-2551	53	2	also	also	ADV
admet-2551	53	3	have	have	AUX
admet-2551	53	4	been	be	AUX
admet-2551	53	5	used	use	VERB
admet-2551	53	6	for	for	ADP
admet-2551	53	7	sore	sore	ADJ
admet-2551	53	8	throat	throat	NOUN
admet-2551	53	9	,	,	PUNCT
admet-2551	53	10	healing	healing	NOUN
admet-2551	53	11	wounds	wound	NOUN
admet-2551	53	12	,	,	PUNCT
admet-2551	53	13	piles	pile	NOUN
admet-2551	53	14	,	,	PUNCT
admet-2551	53	15	chronic	chronic	NOUN
admet-2551	53	16	boils	boil	VERB
admet-2551	53	17	,	,	PUNCT
admet-2551	53	18	and	and	CCONJ
admet-2551	53	19	so	so	ADV
admet-2551	53	20	forth	forth	ADV
admet-2551	53	21	for	for	ADP
admet-2551	53	22	an	an	DET
admet-2551	53	23	exterior	exterior	ADJ
admet-2551	53	24	application	application	NOUN
admet-2551	53	25	,	,	PUNCT
admet-2551	53	26	and	and	CCONJ
admet-2551	53	27	traditional	traditional	ADJ
admet-2551	53	28	treatment	treatment	NOUN
admet-2551	53	29	of	of	ADP
admet-2551	53	30	internal	internal	ADJ
admet-2551	53	31	diseases	disease	NOUN
admet-2551	53	32	like	like	ADP
admet-2551	53	33	chronic	chronic	ADJ
admet-2551	53	34	cough	cough	NOUN
admet-2551	53	35	,	,	PUNCT
admet-2551	53	36	diphtheria	diphtheria	NOUN
admet-2551	53	37	,	,	PUNCT
admet-2551	53	38	jaundice	jaundice	NOUN
admet-2551	53	39	,	,	PUNCT
admet-2551	53	40	rheumatic	rheumatic	ADJ
admet-2551	53	41	pains	pain	NOUN
admet-2551	53	42	,	,	PUNCT
admet-2551	53	43	tuberculosis	tuberculosis	NOUN
admet-2551	53	44	,	,	PUNCT
admet-2551	53	45	bronchitis	bronchitis	NOUN
admet-2551	53	46	,	,	PUNCT
admet-2551	53	47	facial	facial	ADJ
admet-2551	53	48	paralysis	paralysis	NOUN
admet-2551	53	49	,	,	PUNCT
admet-2551	53	50	and	and	CCONJ
admet-2551	53	51	impotence	impotence	NOUN
admet-2551	54	1	[	[	X
admet-2551	54	2	18	18	NUM
admet-2551	54	3	]	]	PUNCT
admet-2551	54	4	.	.	PUNCT
admet-2551	55	1	the	the	DET
admet-2551	55	2	epithelial	epithelial	ADJ
admet-2551	55	3	cells	cell	NOUN
admet-2551	55	4	in	in	ADP
admet-2551	55	5	the	the	DET
admet-2551	55	6	gizzard	gizzard	PROPN
admet-2551	55	7	segment	segment	NOUN
admet-2551	55	8	,	,	PUNCT
admet-2551	55	9	especially	especially	ADV
admet-2551	55	10	in	in	ADP
admet-2551	55	11	the	the	DET
admet-2551	55	12	anterior	anterior	ADJ
admet-2551	55	13	alimentary	alimentary	ADJ
admet-2551	55	14	regions	region	NOUN
admet-2551	55	15	,	,	PUNCT
admet-2551	55	16	express	express	VERB
admet-2551	55	17	and	and	CCONJ
admet-2551	55	18	produce	produce	VERB
admet-2551	55	19	earthworm	earthworm	NOUN
admet-2551	55	20	fibrinolytic	fibrinolytic	ADJ
admet-2551	55	21	proteases	protease	NOUN
admet-2551	55	22	.	.	PUNCT
admet-2551	56	1	in	in	ADP
admet-2551	56	2	these	these	DET
admet-2551	56	3	parts	part	NOUN
admet-2551	56	4	,	,	PUNCT
admet-2551	56	5	the	the	DET
admet-2551	56	6	proteases	protease	NOUN
admet-2551	56	7	possibly	possibly	ADV
admet-2551	56	8	play	play	VERB
admet-2551	56	9	a	a	DET
admet-2551	56	10	role	role	NOUN
admet-2551	56	11	in	in	ADP
admet-2551	56	12	digesting	digest	VERB
admet-2551	56	13	protein	protein	NOUN
admet-2551	56	14	and	and	CCONJ
admet-2551	56	15	peptides	peptide	NOUN
admet-2551	56	16	in	in	ADP
admet-2551	56	17	food	food	NOUN
admet-2551	56	18	[	[	X
admet-2551	56	19	19	19	NUM
admet-2551	56	20	]	]	PUNCT
admet-2551	56	21	.	.	PUNCT
admet-2551	57	1	lk	lk	PROPN
admet-2551	57	2	was	be	AUX
admet-2551	57	3	isolated	isolate	VERB
admet-2551	57	4	chiefly	chiefly	ADV
admet-2551	57	5	from	from	ADP
admet-2551	57	6	lumbricus	lumbricus	NOUN
admet-2551	57	7	rubellus	rubellus	NOUN
admet-2551	57	8	,	,	PUNCT
admet-2551	57	9	and	and	CCONJ
admet-2551	57	10	eisenia	eisenia	NOUN
admet-2551	57	11	fetida	fetida	PROPN
admet-2551	57	12	.	.	PUNCT
admet-2551	58	1	earthworm	earthworm	NOUN
admet-2551	58	2	protease	protease	NOUN
admet-2551	58	3	enzymes	enzyme	NOUN
admet-2551	58	4	(	(	PUNCT
admet-2551	58	5	epe	epe	NOUN
admet-2551	58	6	)	)	PUNCT
admet-2551	58	7	and	and	CCONJ
admet-2551	58	8	fibrinolytic	fibrinolytic	ADJ
admet-2551	58	9	enzymes	enzyme	NOUN
admet-2551	58	10	(	(	PUNCT
admet-2551	58	11	efe	efe	NOUN
admet-2551	58	12	)	)	PUNCT
admet-2551	58	13	are	be	AUX
admet-2551	58	14	some	some	DET
admet-2551	58	15	names	name	NOUN
admet-2551	58	16	given	give	VERB
admet-2551	58	17	to	to	ADP
admet-2551	58	18	lk	lk	PROPN
admet-2551	58	19	[	[	X
admet-2551	58	20	20	20	NUM
admet-2551	58	21	]	]	PUNCT
admet-2551	58	22	.	.	PUNCT
admet-2551	59	1	in	in	ADP
admet-2551	59	2	some	some	DET
admet-2551	59	3	cases	case	NOUN
admet-2551	59	4	,	,	PUNCT
admet-2551	59	5	proteases	protease	NOUN
admet-2551	59	6	are	be	AUX
admet-2551	59	7	named	name	VERB
admet-2551	59	8	after	after	ADP
admet-2551	59	9	the	the	DET
admet-2551	59	10	latin	latin	ADJ
admet-2551	59	11	binomial	binomial	NOUN
admet-2551	59	12	for	for	ADP
admet-2551	59	13	the	the	DET
admet-2551	59	14	species	specie	NOUN
admet-2551	59	15	of	of	ADP
admet-2551	59	16	earthworm	earthworm	NOUN
admet-2551	59	17	from	from	ADP
admet-2551	59	18	which	which	PRON
admet-2551	59	19	they	they	PRON
admet-2551	59	20	are	be	AUX
admet-2551	59	21	derived	derive	VERB
admet-2551	59	22	.	.	PUNCT
admet-2551	60	1	for	for	ADP
admet-2551	60	2	example	example	NOUN
admet-2551	60	3	,	,	PUNCT
admet-2551	60	4	e.	e.	PROPN
admet-2551	60	5	fetida	fetida	PROPN
admet-2551	60	6	protease	protease	NOUN
admet-2551	60	7	(	(	PUNCT
admet-2551	60	8	efp	efp	PROPN
admet-2551	60	9	)	)	PUNCT
admet-2551	60	10	is	be	AUX
admet-2551	60	11	a	a	DET
admet-2551	60	12	protease	protease	NOUN
admet-2551	60	13	extracted	extract	VERB
admet-2551	60	14	from	from	ADP
admet-2551	60	15	e.	e.	PROPN
admet-2551	60	16	fetida	fetida	PROPN
admet-2551	60	17	.	.	PUNCT
admet-2551	61	1	several	several	ADJ
admet-2551	61	2	fibrinolytic	fibrinolytic	ADJ
admet-2551	61	3	enzymes	enzyme	NOUN
admet-2551	61	4	were	be	AUX
admet-2551	61	5	extracted	extract	VERB
admet-2551	61	6	from	from	ADP
admet-2551	61	7	l.	l.	PROPN
admet-2551	61	8	rubellus	rubellus	PROPN
admet-2551	61	9	,	,	PUNCT
admet-2551	61	10	including	include	VERB
admet-2551	61	11	f-1	f-1	NOUN
admet-2551	61	12	-	-	SYM
admet-2551	61	13	0	0	NUM
admet-2551	61	14	,	,	PUNCT
admet-2551	61	15	f-1	f-1	NOUN
admet-2551	61	16	-	-	SYM
admet-2551	61	17	1	1	NUM
admet-2551	61	18	,	,	PUNCT
admet-2551	61	19	f	f	X
admet-2551	61	20	-	-	PUNCT
admet-2551	61	21	i-2	i-2	PROPN
admet-2551	61	22	,	,	PUNCT
admet-2551	61	23	f	f	PROPN
admet-2551	61	24	-	-	PUNCT
admet-2551	61	25	ii	ii	PROPN
admet-2551	61	26	,	,	PUNCT
admet-2551	61	27	f	f	X
admet-2551	61	28	-	-	PUNCT
admet-2551	61	29	iii-1	iii-1	NUM
admet-2551	61	30	,	,	PUNCT
admet-2551	61	31	and	and	CCONJ
admet-2551	61	32	f	f	AUX
admet-2551	61	33	-	-	PUNCT
admet-2551	61	34	iii-2	iii-2	NOUN
admet-2551	61	35	[	[	X
admet-2551	61	36	21	21	NUM
admet-2551	61	37	]	]	PUNCT
admet-2551	61	38	.	.	PUNCT
admet-2551	62	1	zhou	zhou	PROPN
admet-2551	62	2	et	et	PROPN
admet-2551	62	3	al	al	PROPN
admet-2551	62	4	.	.	PROPN
admet-2551	62	5	purified	purify	VERB
admet-2551	62	6	seven	seven	NUM
admet-2551	62	7	fibrinolytic	fibrinolytic	ADJ
admet-2551	62	8	proteins	protein	NOUN
admet-2551	62	9	from	from	ADP
admet-2551	62	10	e.	e.	PROPN
admet-2551	62	11	fetida	fetida	PROPN
admet-2551	62	12	in	in	ADP
admet-2551	62	13	1988	1988	NUM
admet-2551	62	14	[	[	X
admet-2551	62	15	22	22	NUM
admet-2551	62	16	]	]	PUNCT
admet-2551	62	17	.	.	PUNCT
admet-2551	63	1	lk	lk	ADJ
admet-2551	63	2	isozymes	isozyme	NOUN
admet-2551	63	3	were	be	AUX
admet-2551	63	4	also	also	ADV
admet-2551	63	5	extracted	extract	VERB
admet-2551	63	6	from	from	ADP
admet-2551	63	7	l.	l.	PROPN
admet-2551	63	8	biomass	biomass	PROPN
admet-2551	63	9	and	and	CCONJ
admet-2551	63	10	e.	e.	PROPN
admet-2551	63	11	andrei	andrei	PROPN
admet-2551	63	12	.	.	PUNCT
admet-2551	64	1	lk	lk	PROPN
admet-2551	64	2	can	can	AUX
admet-2551	64	3	sustain	sustain	VERB
admet-2551	64	4	its	its	PRON
admet-2551	64	5	activity	activity	NOUN
admet-2551	64	6	in	in	ADP
admet-2551	64	7	both	both	CCONJ
admet-2551	64	8	basic	basic	ADJ
admet-2551	64	9	and	and	CCONJ
admet-2551	64	10	acidic	acidic	ADJ
admet-2551	64	11	conditions	condition	NOUN
admet-2551	64	12	,	,	PUNCT
admet-2551	64	13	having	have	VERB
admet-2551	64	14	a	a	DET
admet-2551	64	15	wide	wide	ADJ
admet-2551	64	16	ph	ph	ADJ
admet-2551	64	17	range	range	NOUN
admet-2551	64	18	from	from	ADP
admet-2551	64	19	1	1	NUM
admet-2551	64	20	to	to	ADP
admet-2551	64	21	11	11	NUM
admet-2551	64	22	.	.	PUNCT
admet-2551	65	1	the	the	DET
admet-2551	65	2	molecular	molecular	ADJ
admet-2551	65	3	weight	weight	NOUN
admet-2551	65	4	of	of	ADP
admet-2551	65	5	lk	lk	PROPN
admet-2551	65	6	lies	lie	NOUN
admet-2551	65	7	between	between	ADP
admet-2551	65	8	20	20	NUM
admet-2551	65	9	and	and	CCONJ
admet-2551	65	10	35	35	NUM
admet-2551	65	11	kda	kda	NOUN
admet-2551	65	12	,	,	PUNCT
admet-2551	65	13	with	with	ADP
admet-2551	65	14	a	a	DET
admet-2551	65	15	range	range	NOUN
admet-2551	65	16	of	of	ADP
admet-2551	65	17	isoelectric	isoelectric	ADJ
admet-2551	65	18	ph	ph	PROPN
admet-2551	65	19	(	(	PUNCT
admet-2551	65	20	pi	pi	NOUN
admet-2551	65	21	)	)	PUNCT
admet-2551	65	22	from	from	ADP
admet-2551	65	23	3	3	NUM
admet-2551	65	24	to	to	PART
admet-2551	65	25	5	5	NUM
admet-2551	65	26	[	[	X
admet-2551	65	27	21	21	NUM
admet-2551	65	28	]	]	PUNCT
admet-2551	65	29	.	.	PUNCT
admet-2551	66	1	moreover	moreover	ADV
admet-2551	66	2	,	,	PUNCT
admet-2551	66	3	some	some	DET
admet-2551	66	4	lk	lk	NOUN
admet-2551	66	5	are	be	AUX
admet-2551	66	6	resistant	resistant	ADJ
admet-2551	66	7	to	to	ADP
admet-2551	66	8	high	high	ADJ
admet-2551	66	9	temperatures	temperature	NOUN
admet-2551	66	10	and	and	CCONJ
admet-2551	66	11	can	can	AUX
admet-2551	66	12	withstand	withstand	VERB
admet-2551	66	13	up	up	ADP
admet-2551	66	14	to	to	PART
admet-2551	66	15	60	60	NUM
admet-2551	66	16	°	°	PART
admet-2551	66	17	c.	c.	NOUN
admet-2551	67	1	the	the	DET
admet-2551	67	2	same	same	ADJ
admet-2551	67	3	fibrinolytic	fibrinolytic	ADJ
admet-2551	67	4	enzyme	enzyme	NOUN
admet-2551	67	5	has	have	VERB
admet-2551	67	6	multiple	multiple	ADJ
admet-2551	67	7	names	name	NOUN
admet-2551	67	8	because	because	SCONJ
admet-2551	67	9	each	each	DET
admet-2551	67	10	enzyme	enzyme	NOUN
admet-2551	67	11	was	be	AUX
admet-2551	67	12	isolated	isolate	VERB
admet-2551	67	13	and	and	CCONJ
admet-2551	67	14	named	name	VERB
admet-2551	67	15	independently	independently	ADV
admet-2551	67	16	by	by	ADP
admet-2551	67	17	different	different	ADJ
admet-2551	67	18	research	research	NOUN
admet-2551	67	19	groups	group	NOUN
admet-2551	67	20	,	,	PUNCT
admet-2551	67	21	making	make	VERB
admet-2551	67	22	accurate	accurate	ADJ
admet-2551	67	23	determination	determination	NOUN
admet-2551	67	24	of	of	ADP
admet-2551	67	25	the	the	DET
admet-2551	67	26	total	total	ADJ
admet-2551	67	27	number	number	NOUN
admet-2551	67	28	of	of	ADP
admet-2551	67	29	lk	lk	NOUN
admet-2551	67	30	difficult	difficult	ADJ
admet-2551	67	31	.	.	PUNCT
admet-2551	68	1	nomenclature	nomenclature	NOUN
admet-2551	68	2	for	for	ADP
admet-2551	68	3	lks	lks	PROPN
admet-2551	68	4	should	should	AUX
admet-2551	68	5	be	be	AUX
admet-2551	68	6	standardized	standardize	VERB
admet-2551	68	7	according	accord	VERB
admet-2551	68	8	to	to	ADP
admet-2551	68	9	their	their	PRON
admet-2551	68	10	function	function	NOUN
admet-2551	68	11	,	,	PUNCT
admet-2551	68	12	properties	property	NOUN
admet-2551	68	13	,	,	PUNCT
admet-2551	68	14	and	and	CCONJ
admet-2551	68	15	sources	source	NOUN
admet-2551	68	16	[	[	X
admet-2551	68	17	23	23	NUM
admet-2551	68	18	]	]	PUNCT
admet-2551	68	19	.	.	PUNCT
admet-2551	69	1	conventional	conventional	ADJ
admet-2551	69	2	approaches	approach	NOUN
admet-2551	69	3	to	to	ADP
admet-2551	69	4	lk	lk	NOUN
admet-2551	69	5	extraction	extraction	NOUN
admet-2551	69	6	and	and	CCONJ
admet-2551	69	7	earthworm	earthworm	NOUN
admet-2551	69	8	purification	purification	NOUN
admet-2551	69	9	are	be	AUX
admet-2551	69	10	complex	complex	ADJ
admet-2551	69	11	and	and	CCONJ
admet-2551	69	12	time	time	NOUN
admet-2551	69	13	-	-	PUNCT
admet-2551	69	14	consuming	consume	VERB
admet-2551	69	15	.	.	PUNCT
admet-2551	70	1	in	in	ADP
admet-2551	70	2	order	order	NOUN
admet-2551	70	3	to	to	PART
admet-2551	70	4	assess	assess	VERB
admet-2551	70	5	the	the	DET
admet-2551	70	6	potential	potential	ADJ
admet-2551	70	7	clinical	clinical	ADJ
admet-2551	70	8	application	application	NOUN
admet-2551	70	9	of	of	ADP
admet-2551	70	10	lk	lk	ADJ
admet-2551	70	11	protein	protein	NOUN
admet-2551	70	12	,	,	PUNCT
admet-2551	70	13	researchers	researcher	NOUN
admet-2551	70	14	used	use	VERB
admet-2551	70	15	recombinant	recombinant	ADJ
admet-2551	70	16	dna	dna	NOUN
admet-2551	70	17	technology	technology	NOUN
admet-2551	70	18	to	to	PART
admet-2551	70	19	express	express	VERB
admet-2551	70	20	and	and	CCONJ
admet-2551	70	21	characterize	characterize	VERB
admet-2551	70	22	a	a	DET
admet-2551	70	23	single	single	ADJ
admet-2551	70	24	lk	lk	NOUN
admet-2551	70	25	protein	protein	NOUN
admet-2551	70	26	[	[	X
admet-2551	70	27	24	24	NUM
admet-2551	70	28	]	]	PUNCT
admet-2551	70	29	.	.	PUNCT
admet-2551	71	1	the	the	DET
admet-2551	71	2	plasminogen	plasminogen	NOUN
admet-2551	71	3	activation	activation	NOUN
admet-2551	71	4	system	system	NOUN
admet-2551	71	5	mechanism	mechanism	NOUN
admet-2551	71	6	of	of	ADP
admet-2551	71	7	lk	lk	PROPN
admet-2551	71	8	differs	differ	NOUN
admet-2551	71	9	from	from	ADP
admet-2551	71	10	other	other	ADJ
admet-2551	71	11	thrombolytic	thrombolytic	ADJ
admet-2551	71	12	enzymes	enzyme	NOUN
admet-2551	71	13	,	,	PUNCT
admet-2551	71	14	such	such	ADJ
admet-2551	71	15	as	as	ADP
admet-2551	71	16	streptokinase	streptokinase	PROPN
admet-2551	71	17	,	,	PUNCT
admet-2551	71	18	urokinase	urokinase	NOUN
admet-2551	71	19	,	,	PUNCT
admet-2551	71	20	staphylokinase	staphylokinase	NOUN
admet-2551	71	21	,	,	PUNCT
admet-2551	71	22	recombinant	recombinant	ADJ
admet-2551	71	23	tissue	tissue	NOUN
admet-2551	71	24	-	-	PUNCT
admet-2551	71	25	type	type	NOUN
admet-2551	71	26	plasminogen	plasminogen	NOUN
admet-2551	71	27	activator	activator	NOUN
admet-2551	71	28	,	,	PUNCT
admet-2551	71	29	and	and	CCONJ
admet-2551	71	30	recombinant	recombinant	ADJ
admet-2551	71	31	prourokinase	prourokinase	NOUN
admet-2551	71	32	.	.	PUNCT
admet-2551	72	1	lk	lk	PROPN
admet-2551	72	2	is	be	AUX
admet-2551	72	3	not	not	PART
admet-2551	72	4	only	only	ADV
admet-2551	72	5	involved	involve	VERB
admet-2551	72	6	in	in	ADP
admet-2551	72	7	the	the	DET
admet-2551	72	8	activation	activation	NOUN
admet-2551	72	9	of	of	ADP
admet-2551	72	10	plasminogen	plasminogen	NOUN
admet-2551	72	11	but	but	CCONJ
admet-2551	72	12	can	can	AUX
admet-2551	72	13	also	also	ADV
admet-2551	72	14	activate	activate	VERB
admet-2551	72	15	fibrin	fibrin	NOUN
admet-2551	72	16	directly	directly	ADV
admet-2551	72	17	[	[	X
admet-2551	72	18	25	25	NUM
admet-2551	72	19	]	]	PUNCT
admet-2551	72	20	.	.	PUNCT
admet-2551	73	1	these	these	DET
admet-2551	73	2	enzymes	enzyme	NOUN
admet-2551	73	3	execute	execute	VERB
admet-2551	73	4	predominantly	predominantly	ADV
admet-2551	73	5	proteolysis	proteolysis	NOUN
admet-2551	73	6	of	of	ADP
admet-2551	73	7	fibrinogen	fibrinogen	NOUN
admet-2551	73	8	and	and	CCONJ
admet-2551	73	9	fibrin	fibrin	NOUN
admet-2551	73	10	and	and	CCONJ
admet-2551	73	11	hardly	hardly	ADV
admet-2551	73	12	hydrolyse	hydrolyse	VERB
admet-2551	73	13	other	other	ADJ
admet-2551	73	14	plasma	plasma	NOUN
admet-2551	73	15	proteins	protein	NOUN
admet-2551	73	16	,	,	PUNCT
admet-2551	73	17	such	such	ADJ
admet-2551	73	18	as	as	ADP
admet-2551	73	19	plasminogen	plasminogen	NOUN
admet-2551	73	20	and	and	CCONJ
admet-2551	73	21	albumin	albumin	NOUN
admet-2551	73	22	[	[	X
admet-2551	73	23	25,26	25,26	NUM
admet-2551	73	24	]	]	PUNCT
admet-2551	73	25	.	.	PUNCT
admet-2551	74	1	according	accord	VERB
admet-2551	74	2	to	to	ADP
admet-2551	74	3	the	the	DET
admet-2551	74	4	data	datum	NOUN
admet-2551	74	5	available	available	ADJ
admet-2551	74	6	in	in	ADP
admet-2551	74	7	genbank	genbank	PROPN
admet-2551	74	8	,	,	PUNCT
admet-2551	74	9	eight	eight	NUM
admet-2551	74	10	clones	clone	NOUN
admet-2551	74	11	of	of	ADP
admet-2551	74	12	accessible	accessible	ADJ
admet-2551	74	13	cdna	cdna	PROPN
admet-2551	74	14	of	of	ADP
admet-2551	74	15	lk	lk	PROPN
admet-2551	74	16	(	(	PUNCT
admet-2551	74	17	genbank	genbank	PROPN
admet-2551	74	18	accession	accession	NOUN
admet-2551	74	19	no	no	INTJ
admet-2551	74	20	.	.	PUNCT
admet-2551	74	21	;	;	PUNCT
admet-2551	74	22	ay187629	ay187629	PROPN
admet-2551	74	23	,	,	PUNCT
admet-2551	74	24	u25644	u25644	PROPN
admet-2551	74	25	,	,	PUNCT
admet-2551	74	26	ay438622	ay438622	ADJ
admet-2551	74	27	,	,	PUNCT
admet-2551	74	28	ay178854	ay178854	PROPN
admet-2551	74	29	,	,	PUNCT
admet-2551	74	30	af304199	af304199	PROPN
admet-2551	74	31	,	,	PUNCT
admet-2551	74	32	u25648	u25648	PROPN
admet-2551	74	33	,	,	PUNCT
admet-2551	74	34	af433650	af433650	PROPN
admet-2551	74	35	)	)	PUNCT
admet-2551	74	36	are	be	AUX
admet-2551	74	37	available	available	ADJ
admet-2551	74	38	.	.	PUNCT
admet-2551	75	1	the	the	DET
admet-2551	75	2	coding	code	VERB
admet-2551	75	3	sequence	sequence	NOUN
admet-2551	75	4	of	of	ADP
admet-2551	75	5	lks	lks	PROPN
admet-2551	75	6	cdna	cdna	PROPN
admet-2551	75	7	has	have	VERB
admet-2551	75	8	a	a	DET
admet-2551	75	9	length	length	NOUN
admet-2551	75	10	of	of	ADP
admet-2551	75	11	852	852	NUM
admet-2551	75	12	bp	bp	NOUN
admet-2551	75	13	and	and	CCONJ
admet-2551	75	14	encodes	encodes	DET
admet-2551	75	15	283	283	NUM
admet-2551	75	16	amino	amino	ADJ
admet-2551	75	17	acids	acid	NOUN
admet-2551	75	18	,	,	PUNCT
admet-2551	75	19	in	in	ADP
admet-2551	75	20	which	which	PRON
admet-2551	75	21	36	36	NUM
admet-2551	75	22	amino	amino	NOUN
admet-2551	75	23	acid	acid	NOUN
admet-2551	75	24	codes	code	NOUN
admet-2551	75	25	for	for	ADP
admet-2551	75	26	the	the	DET
admet-2551	75	27	signal	signal	ADJ
admet-2551	75	28	peptide	peptide	NOUN
admet-2551	75	29	and	and	CCONJ
admet-2551	75	30	the	the	DET
admet-2551	75	31	remaining	remain	VERB
admet-2551	75	32	247	247	NUM
admet-2551	75	33	amino	amino	NOUN
admet-2551	75	34	acids	acid	NOUN
admet-2551	75	35	code	code	NOUN
admet-2551	75	36	for	for	ADP
admet-2551	75	37	the	the	DET
admet-2551	75	38	whole	whole	ADJ
admet-2551	75	39	protein	protein	NOUN
admet-2551	76	1	[	[	X
admet-2551	76	2	24,27,28	24,27,28	NUM
admet-2551	76	3	]	]	X
admet-2551	76	4	.	.	PUNCT
admet-2551	77	1	the	the	DET
admet-2551	77	2	nucleotide	nucleotide	ADJ
admet-2551	77	3	arrangement	arrangement	NOUN
admet-2551	77	4	in	in	ADP
admet-2551	77	5	each	each	DET
admet-2551	77	6	clone	clone	NOUN
admet-2551	77	7	of	of	ADP
admet-2551	77	8	cdna	cdna	PROPN
admet-2551	77	9	starts	start	VERB
admet-2551	77	10	with	with	ADP
admet-2551	77	11	13	13	NUM
admet-2551	77	12	codons	codon	NOUN
admet-2551	77	13	containing	contain	VERB
admet-2551	77	14	"	"	PUNCT
admet-2551	77	15	cg	cg	NOUN
admet-2551	77	16	"	"	PUNCT
admet-2551	77	17	motifs	motif	NOUN
admet-2551	77	18	in	in	ADP
admet-2551	77	19	the	the	DET
admet-2551	77	20	complete	complete	ADJ
admet-2551	77	21	sequence	sequence	NOUN
admet-2551	77	22	,	,	PUNCT
admet-2551	77	23	which	which	PRON
admet-2551	77	24	is	be	AUX
admet-2551	77	25	almost	almost	ADV
admet-2551	77	26	rare	rare	ADJ
admet-2551	77	27	for	for	ADP
admet-2551	77	28	mammals	mammal	NOUN
admet-2551	77	29	.	.	PUNCT
admet-2551	78	1	this	this	PRON
admet-2551	78	2	makes	make	VERB
admet-2551	78	3	the	the	DET
admet-2551	78	4	translation	translation	NOUN
admet-2551	78	5	of	of	ADP
admet-2551	78	6	such	such	ADJ
admet-2551	78	7	dna	dna	NOUN
admet-2551	78	8	in	in	ADP
admet-2551	78	9	mammalian	mammalian	ADJ
admet-2551	78	10	cells	cell	NOUN
admet-2551	78	11	or	or	CCONJ
admet-2551	78	12	tissues	tissue	NOUN
admet-2551	78	13	inefficient	inefficient	ADJ
admet-2551	78	14	[	[	X
admet-2551	78	15	29	29	NUM
admet-2551	78	16	]	]	PUNCT
admet-2551	78	17	.	.	PUNCT
admet-2551	79	1	a	a	DET
admet-2551	79	2	cdna	cdna	PROPN
admet-2551	79	3	of	of	ADP
admet-2551	79	4	gene	gene	NOUN
admet-2551	79	5	efe-3	efe-3	PUNCT
admet-2551	79	6	of	of	ADP
admet-2551	79	7	eisenia	eisenia	NOUN
admet-2551	79	8	fetida	fetida	PROPN
admet-2551	79	9	has	have	VERB
admet-2551	79	10	859	859	NUM
admet-2551	79	11	independent	independent	ADJ
admet-2551	79	12	nucleotides	nucleotide	NOUN
admet-2551	79	13	,	,	PUNCT
admet-2551	79	14	with	with	ADP
admet-2551	79	15	an	an	DET
admet-2551	79	16	open	open	ADJ
admet-2551	79	17	reading	reading	NOUN
admet-2551	79	18	frame	frame	NOUN
admet-2551	79	19	accessible	accessible	ADJ
admet-2551	79	20	from	from	ADP
admet-2551	79	21	112	112	NUM
admet-2551	79	22	-	-	SYM
admet-2551	79	23	853	853	NUM
admet-2551	79	24	,	,	PUNCT
admet-2551	79	25	which	which	PRON
admet-2551	79	26	encodes	encode	VERB
admet-2551	79	27	a	a	DET
admet-2551	79	28	polypeptide	polypeptide	NOUN
admet-2551	79	29	with	with	ADP
admet-2551	79	30	247	247	NUM
admet-2551	79	31	amino	amino	NOUN
admet-2551	79	32	acid	acid	NOUN
admet-2551	79	33	residues	residue	NOUN
admet-2551	79	34	[	[	X
admet-2551	79	35	27	27	NUM
admet-2551	79	36	]	]	PUNCT
admet-2551	79	37	.	.	PUNCT
admet-2551	80	1	the	the	DET
admet-2551	80	2	sequence	sequence	NOUN
admet-2551	80	3	of	of	ADP
admet-2551	80	4	lk	lk	NOUN
admet-2551	80	5	isolated	isolate	VERB
admet-2551	80	6	from	from	ADP
admet-2551	80	7	different	different	ADJ
admet-2551	80	8	earthworm	earthworm	NOUN
admet-2551	80	9	species	specie	NOUN
admet-2551	80	10	was	be	AUX
admet-2551	80	11	analysed	analyse	VERB
admet-2551	80	12	to	to	PART
admet-2551	80	13	get	get	VERB
admet-2551	80	14	the	the	DET
admet-2551	80	15	full	full	ADJ
admet-2551	80	16	proteomics	proteomic	NOUN
admet-2551	80	17	data	datum	NOUN
admet-2551	80	18	.	.	PUNCT
admet-2551	81	1	the	the	DET
admet-2551	81	2	protein	protein	NOUN
admet-2551	81	3	sequence	sequence	NOUN
admet-2551	81	4	from	from	ADP
admet-2551	81	5	l.	l.	PROPN
admet-2551	81	6	rubellus	rubellus	PROPN
admet-2551	81	7	and	and	CCONJ
admet-2551	81	8	e.	e.	PROPN
admet-2551	81	9	fetida	fetida	PROPN
admet-2551	81	10	had	have	VERB
admet-2551	81	11	more	more	ADJ
admet-2551	81	12	residues	residue	NOUN
admet-2551	81	13	than	than	ADP
admet-2551	81	14	the	the	DET
admet-2551	81	15	secondary	secondary	ADJ
admet-2551	81	16	structures	structure	NOUN
admet-2551	81	17	,	,	PUNCT
admet-2551	81	18	including	include	VERB
admet-2551	81	19	α	α	NOUN
admet-2551	81	20	-	-	PUNCT
admet-2551	81	21	helix	helix	NOUN
admet-2551	81	22	,	,	PUNCT
admet-2551	81	23	turn	turn	NOUN
admet-2551	81	24	,	,	PUNCT
admet-2551	81	25	β	β	NOUN
admet-2551	81	26	-	-	NOUN
admet-2551	81	27	sheet	sheet	NOUN
admet-2551	81	28	,	,	PUNCT
admet-2551	81	29	and	and	CCONJ
admet-2551	81	30	coil	coil	NOUN
admet-2551	81	31	.	.	PUNCT
admet-2551	82	1	the	the	DET
admet-2551	82	2	arrangement	arrangement	NOUN
admet-2551	82	3	of	of	ADP
admet-2551	82	4	an	an	DET
admet-2551	82	5	lk	lk	NOUN
admet-2551	82	6	isoform	isoform	NOUN
admet-2551	82	7	known	know	VERB
admet-2551	82	8	as	as	ADP
admet-2551	82	9	earthworm	earthworm	NOUN
admet-2551	82	10	fibrinolytic	fibrinolytic	ADJ
admet-2551	82	11	protease	protease	NOUN
admet-2551	82	12	ii	ii	NOUN
admet-2551	82	13	(	(	PUNCT
admet-2551	82	14	ef	ef	PROPN
admet-2551	82	15	p	p	PROPN
admet-2551	82	16	-	-	PUNCT
admet-2551	82	17	ii	ii	NOUN
admet-2551	82	18	(	(	PUNCT
admet-2551	82	19	efea	efea	PROPN
admet-2551	82	20	)	)	PUNCT
admet-2551	82	21	)	)	PUNCT
admet-2551	82	22	is	be	AUX
admet-2551	82	23	remarkably	remarkably	ADV
admet-2551	82	24	identical	identical	ADJ
admet-2551	82	25	with	with	ADP
admet-2551	82	26	other	other	ADJ
admet-2551	82	27	serine	serine	NOUN
admet-2551	82	28	proteases	protease	NOUN
admet-2551	82	29	with	with	ADP
admet-2551	82	30	its	its	PRON
admet-2551	82	31	known	know	VERB
admet-2551	82	32	structures	structure	NOUN
admet-2551	82	33	[	[	X
admet-2551	82	34	30	30	NUM
admet-2551	82	35	,	,	PUNCT
admet-2551	82	36	31	31	NUM
admet-2551	82	37	]	]	PUNCT
admet-2551	82	38	or	or	CCONJ
admet-2551	82	39	serine	serine	NOUN
admet-2551	82	40	protease	protease	NOUN
admet-2551	82	41	related	relate	VERB
admet-2551	82	42	to	to	AUX
admet-2551	82	43	earthworm	earthworm	NOUN
admet-2551	82	44	[	[	X
admet-2551	82	45	29	29	NUM
admet-2551	82	46	]	]	PUNCT
admet-2551	82	47	.	.	PUNCT
admet-2551	83	1	the	the	DET
admet-2551	83	2	earthworm	earthworm	NOUN
admet-2551	83	3	protease	protease	NOUN
admet-2551	83	4	catalytic	catalytic	ADJ
admet-2551	83	5	characterization	characterization	NOUN
admet-2551	83	6	is	be	AUX
admet-2551	83	7	directly	directly	ADV
admet-2551	83	8	affected	affect	VERB
admet-2551	83	9	by	by	ADP
admet-2551	83	10	https://doi.org/10.5599/admet.2551	https://doi.org/10.5599/admet.2551	X
admet-2551	83	11	s.	s.	PROPN
admet-2551	83	12	k.	k.	PROPN
admet-2551	83	13	metkar	metkar	PROPN
admet-2551	83	14	et	et	PROPN
admet-2551	83	15	al	al	PROPN
admet-2551	83	16	.	.	PROPN
admet-2551	83	17	admet	admet	PROPN
admet-2551	83	18	&	&	CCONJ
admet-2551	83	19	dmpk	dmpk	PROPN
admet-2551	83	20	12(6	12(6	NUM
admet-2551	83	21	)	)	PUNCT
admet-2551	83	22	(	(	PUNCT
admet-2551	83	23	2024	2024	NUM
admet-2551	83	24	)	)	PUNCT
admet-2551	83	25	797	797	NUM
admet-2551	83	26	-	-	SYM
admet-2551	83	27	820	820	NUM
admet-2551	83	28	800	800	NUM
admet-2551	83	29	its	its	PRON
admet-2551	83	30	tertiary	tertiary	ADJ
admet-2551	83	31	structure	structure	NOUN
admet-2551	83	32	.	.	PUNCT
admet-2551	84	1	the	the	DET
admet-2551	84	2	studies	study	NOUN
admet-2551	84	3	on	on	ADP
admet-2551	84	4	nmr	nmr	NOUN
admet-2551	84	5	and	and	CCONJ
admet-2551	84	6	x	x	NOUN
admet-2551	84	7	-	-	NOUN
admet-2551	84	8	ray	ray	NOUN
admet-2551	84	9	analysis	analysis	NOUN
admet-2551	84	10	revealed	reveal	VERB
admet-2551	84	11	that	that	SCONJ
admet-2551	84	12	ef	ef	PROPN
admet-2551	84	13	p	p	NOUN
admet-2551	84	14	-	-	PUNCT
admet-2551	84	15	iii-1	iii-1	NUM
admet-2551	84	16	(	(	PUNCT
admet-2551	84	17	efe	efe	NOUN
admet-2551	84	18	-	-	PUNCT
admet-2551	84	19	b	b	NOUN
admet-2551	84	20	)	)	PUNCT
admet-2551	84	21	belongs	belong	VERB
admet-2551	84	22	to	to	ADP
admet-2551	84	23	the	the	DET
admet-2551	84	24	group	group	NOUN
admet-2551	84	25	of	of	ADP
admet-2551	84	26	trypsin	trypsin	NOUN
admet-2551	84	27	-	-	PUNCT
admet-2551	84	28	like	like	ADJ
admet-2551	84	29	protease	protease	NOUN
admet-2551	84	30	possessing	possess	VERB
admet-2551	84	31	two	two	NUM
admet-2551	84	32	chainsa	chainsa	ADJ
admet-2551	84	33	light	light	NOUN
admet-2551	84	34	chain	chain	NOUN
admet-2551	84	35	at	at	ADP
admet-2551	84	36	the	the	DET
admet-2551	84	37	n	n	CCONJ
admet-2551	84	38	-	-	PUNCT
admet-2551	84	39	terminal	terminal	NOUN
admet-2551	84	40	of	of	ADP
admet-2551	84	41	pyroglutamate	pyroglutamate	NOUN
admet-2551	84	42	and	and	CCONJ
admet-2551	84	43	an	an	DET
admet-2551	84	44	nglycosylated	nglycosylated	ADJ
admet-2551	84	45	heavy	heavy	ADJ
admet-2551	84	46	chain	chain	NOUN
admet-2551	84	47	[	[	X
admet-2551	84	48	32	32	NUM
admet-2551	84	49	]	]	PUNCT
admet-2551	84	50	.	.	PUNCT
admet-2551	85	1	the	the	DET
admet-2551	85	2	structural	structural	ADJ
admet-2551	85	3	aspect	aspect	NOUN
admet-2551	85	4	showed	show	VERB
admet-2551	85	5	ef	ef	PROPN
admet-2551	85	6	p	p	NOUN
admet-2551	85	7	-	-	PUNCT
admet-2551	85	8	iii-1	iii-1	NUM
admet-2551	85	9	having	have	VERB
admet-2551	85	10	high	high	ADJ
admet-2551	85	11	stability	stability	NOUN
admet-2551	85	12	regarding	regard	VERB
admet-2551	85	13	heat	heat	NOUN
admet-2551	85	14	resistance	resistance	NOUN
admet-2551	85	15	and	and	CCONJ
admet-2551	85	16	resistance	resistance	NOUN
admet-2551	85	17	to	to	ADP
admet-2551	85	18	proteases	protease	NOUN
admet-2551	85	19	and	and	CCONJ
admet-2551	85	20	organic	organic	ADJ
admet-2551	85	21	solvents	solvent	NOUN
admet-2551	85	22	[	[	X
admet-2551	85	23	33	33	NUM
admet-2551	85	24	]	]	PUNCT
admet-2551	85	25	.	.	PUNCT
admet-2551	86	1	further	far	ADV
admet-2551	86	2	,	,	PUNCT
admet-2551	86	3	it	it	PRON
admet-2551	86	4	was	be	AUX
admet-2551	86	5	noted	note	VERB
admet-2551	86	6	that	that	SCONJ
admet-2551	86	7	another	another	DET
admet-2551	86	8	lk	lk	NOUN
admet-2551	86	9	isoform	isoform	NOUN
admet-2551	86	10	,	,	PUNCT
admet-2551	86	11	ef	ef	PROPN
admet-2551	86	12	p	p	PROPN
admet-2551	86	13	-	-	PUNCT
admet-2551	86	14	ii	ii	PROPN
admet-2551	86	15	is	be	AUX
admet-2551	86	16	a	a	DET
admet-2551	86	17	serine	serine	ADJ
admet-2551	86	18	protease	protease	NOUN
admet-2551	86	19	type	type	NOUN
admet-2551	86	20	chymotrypsin	chymotrypsin	NOUN
admet-2551	86	21	possessing	possess	VERB
admet-2551	86	22	an	an	DET
admet-2551	86	23	essential	essential	ADJ
admet-2551	86	24	s1	s1	NOUN
admet-2551	86	25	binding	bind	VERB
admet-2551	86	26	pocket	pocket	NOUN
admet-2551	87	1	[	[	X
admet-2551	87	2	31	31	NUM
admet-2551	87	3	]	]	PUNCT
admet-2551	87	4	.	.	PUNCT
admet-2551	88	1	figure	figure	NOUN
admet-2551	88	2	2	2	NUM
admet-2551	88	3	.	.	PUNCT
admet-2551	89	1	the	the	DET
admet-2551	89	2	structure	structure	NOUN
admet-2551	89	3	of	of	ADP
admet-2551	89	4	lumbrokinase	lumbrokinase	PROPN
admet-2551	89	5	(	(	PUNCT
admet-2551	89	6	source	source	NOUN
admet-2551	89	7	:	:	PUNCT
admet-2551	89	8	pdb	pdb	PROPN
admet-2551	89	9	i	i	PROPN
admet-2551	89	10	d	d	PROPN
admet-2551	89	11	1m9u	1m9u	NUM
admet-2551	89	12	)	)	PUNCT
admet-2551	89	13	extracted	extract	VERB
admet-2551	89	14	from	from	ADP
admet-2551	89	15	pymol	pymol	PROPN
admet-2551	89	16	.	.	PUNCT
admet-2551	90	1	lk	lk	PROPN
admet-2551	90	2	structure	structure	NOUN
admet-2551	90	3	extracted	extract	VERB
admet-2551	90	4	from	from	ADP
admet-2551	90	5	pymol	pymol	PROPN
admet-2551	90	6	with	with	ADP
admet-2551	90	7	pdb	pdb	PROPN
admet-2551	90	8	i	i	PROPN
admet-2551	90	9	d	d	PROPN
admet-2551	90	10	1m9u	1m9u	NUM
admet-2551	90	11	,	,	PUNCT
admet-2551	90	12	as	as	SCONJ
admet-2551	90	13	depicted	depict	VERB
admet-2551	90	14	in	in	ADP
admet-2551	90	15	figure	figure	NOUN
admet-2551	90	16	2	2	NUM
admet-2551	90	17	,	,	PUNCT
admet-2551	90	18	showed	show	VERB
admet-2551	90	19	the	the	DET
admet-2551	90	20	chymotrypsinlike	chymotrypsinlike	ADJ
admet-2551	90	21	serine	serine	NOUN
admet-2551	90	22	proteases	protease	NOUN
admet-2551	90	23	with	with	ADP
admet-2551	90	24	characteristics	characteristic	NOUN
admet-2551	90	25	of	of	ADP
admet-2551	90	26	s1	s1	NOUN
admet-2551	90	27	elastase	elastase	NOUN
admet-2551	90	28	.	.	PUNCT
admet-2551	91	1	the	the	DET
admet-2551	91	2	s1	s1	PROPN
admet-2551	91	3	specificity	specificity	NOUN
admet-2551	91	4	of	of	ADP
admet-2551	91	5	the	the	DET
admet-2551	91	6	beta	beta	NOUN
admet-2551	91	7	strand	strand	NOUN
admet-2551	91	8	significantly	significantly	ADV
admet-2551	91	9	showed	show	VERB
admet-2551	91	10	four	four	NUM
admet-2551	91	11	different	different	ADJ
admet-2551	91	12	residues	residue	NOUN
admet-2551	91	13	(	(	PUNCT
admet-2551	91	14	ser	ser	NOUN
admet-2551	91	15	-	-	PUNCT
admet-2551	91	16	ser	ser	NOUN
admet-2551	91	17	-	-	PUNCT
admet-2551	91	18	gly	gly	NOUN
admet-2551	91	19	-	-	PUNCT
admet-2551	91	20	leu	leu	NOUN
admet-2551	91	21	)	)	PUNCT
admet-2551	91	22	after	after	ADP
admet-2551	91	23	val217	val217	PROPN
admet-2551	91	24	,	,	PUNCT
admet-2551	91	25	which	which	PRON
admet-2551	91	26	can	can	AUX
admet-2551	91	27	provide	provide	VERB
admet-2551	91	28	additional	additional	ADJ
admet-2551	91	29	substrate	substrate	NOUN
admet-2551	91	30	for	for	ADP
admet-2551	91	31	the	the	DET
admet-2551	91	32	hydrogen	hydrogen	NOUN
admet-2551	91	33	binding	bind	VERB
admet-2551	91	34	sites	site	NOUN
admet-2551	91	35	for	for	ADP
admet-2551	91	36	distal	distal	ADJ
admet-2551	91	37	p	p	NOUN
admet-2551	91	38	residues	residue	NOUN
admet-2551	91	39	and	and	CCONJ
admet-2551	91	40	gives	give	VERB
admet-2551	91	41	elongation	elongation	NOUN
admet-2551	91	42	for	for	ADP
admet-2551	91	43	the	the	DET
admet-2551	91	44	s1	s1	NOUN
admet-2551	91	45	pocket	pocket	NOUN
admet-2551	91	46	.	.	PUNCT
admet-2551	92	1	the	the	DET
admet-2551	92	2	s1	s1	PROPN
admet-2551	92	3	pocket	pocket	NOUN
admet-2551	92	4	prefers	prefer	VERB
admet-2551	92	5	elastase	elastase	ADJ
admet-2551	92	6	-	-	PUNCT
admet-2551	92	7	specific	specific	ADJ
admet-2551	92	8	small	small	ADJ
admet-2551	92	9	hydrophobic	hydrophobic	NOUN
admet-2551	92	10	,	,	PUNCT
admet-2551	92	11	strong	strong	ADJ
admet-2551	92	12	,	,	PUNCT
admet-2551	92	13	and	and	CCONJ
admet-2551	92	14	bulky	bulky	ADJ
admet-2551	92	15	p1	p1	NOUN
admet-2551	92	16	residues	residue	NOUN
admet-2551	92	17	that	that	PRON
admet-2551	92	18	support	support	VERB
admet-2551	92	19	the	the	DET
admet-2551	92	20	tight	tight	ADJ
admet-2551	92	21	substrate	substrate	NOUN
admet-2551	92	22	binding	bind	VERB
admet-2551	92	23	and	and	CCONJ
admet-2551	92	24	induced	induce	VERB
admet-2551	92	25	s1	s1	NOUN
admet-2551	92	26	pocket	pocket	NOUN
admet-2551	92	27	fitting	fitting	ADJ
admet-2551	92	28	.	.	PUNCT
admet-2551	93	1	this	this	DET
admet-2551	93	2	structure	structure	NOUN
admet-2551	93	3	was	be	AUX
admet-2551	93	4	first	first	ADV
admet-2551	93	5	labelled	label	VERB
admet-2551	93	6	to	to	PART
admet-2551	93	7	represent	represent	VERB
admet-2551	93	8	earthworm	earthworm	NOUN
admet-2551	93	9	fibrinolytic	fibrinolytic	ADJ
admet-2551	93	10	enzyme	enzyme	NOUN
admet-2551	93	11	components	component	NOUN
admet-2551	93	12	as	as	ADV
admet-2551	93	13	well	well	ADV
admet-2551	93	14	as	as	ADP
admet-2551	93	15	serine	serine	ADJ
admet-2551	93	16	protease	protease	NOUN
admet-2551	93	17	,	,	PUNCT
admet-2551	93	18	which	which	PRON
admet-2551	93	19	originated	originate	VERB
admet-2551	93	20	from	from	ADP
admet-2551	93	21	the	the	DET
admet-2551	93	22	annelid	annelid	NOUN
admet-2551	93	23	worms	worm	NOUN
admet-2551	93	24	[	[	X
admet-2551	93	25	34	34	NUM
admet-2551	93	26	]	]	PUNCT
admet-2551	93	27	.	.	PUNCT
admet-2551	94	1	fibrinolytic	fibrinolytic	ADJ
admet-2551	94	2	and	and	CCONJ
admet-2551	94	3	proteolytic	proteolytic	ADJ
admet-2551	94	4	activities	activity	NOUN
admet-2551	94	5	of	of	ADP
admet-2551	94	6	lumbrokinase	lumbrokinase	NOUN
admet-2551	94	7	lumbrokinase	lumbrokinase	PROPN
admet-2551	94	8	(	(	PUNCT
admet-2551	94	9	lk	lk	PROPN
admet-2551	94	10	)	)	PUNCT
admet-2551	94	11	has	have	AUX
admet-2551	94	12	been	be	AUX
admet-2551	94	13	utilized	utilize	VERB
admet-2551	94	14	as	as	ADP
admet-2551	94	15	a	a	DET
admet-2551	94	16	fibrinolytic	fibrinolytic	ADJ
admet-2551	94	17	agent	agent	NOUN
admet-2551	94	18	in	in	ADP
admet-2551	94	19	china	china	PROPN
admet-2551	94	20	,	,	PUNCT
admet-2551	94	21	japan	japan	PROPN
admet-2551	94	22	,	,	PUNCT
admet-2551	94	23	and	and	CCONJ
admet-2551	94	24	korea	korea	PROPN
admet-2551	94	25	.	.	PUNCT
admet-2551	95	1	the	the	DET
admet-2551	95	2	arrangement	arrangement	NOUN
admet-2551	95	3	of	of	ADP
admet-2551	95	4	thrombus	thrombus	NOUN
admet-2551	95	5	inside	inside	ADP
admet-2551	95	6	the	the	DET
admet-2551	95	7	vessels	vessel	NOUN
admet-2551	95	8	of	of	ADP
admet-2551	95	9	blood	blood	NOUN
admet-2551	95	10	causes	cause	VERB
admet-2551	95	11	numerous	numerous	ADJ
admet-2551	95	12	inconveniences	inconvenience	NOUN
admet-2551	95	13	,	,	PUNCT
admet-2551	95	14	for	for	ADP
admet-2551	95	15	example	example	NOUN
admet-2551	95	16	,	,	PUNCT
admet-2551	95	17	myocardial	myocardial	ADJ
admet-2551	95	18	infarction	infarction	NOUN
admet-2551	95	19	and	and	CCONJ
admet-2551	95	20	stroke	stroke	NOUN
admet-2551	95	21	.	.	PUNCT
admet-2551	96	1	a	a	DET
admet-2551	96	2	considerable	considerable	ADJ
admet-2551	96	3	lot	lot	NOUN
admet-2551	96	4	of	of	ADP
admet-2551	96	5	local	local	ADJ
admet-2551	96	6	and	and	CCONJ
admet-2551	96	7	recombinant	recombinant	ADJ
admet-2551	96	8	proteins	protein	NOUN
admet-2551	96	9	with	with	ADP
admet-2551	96	10	proteolytic	proteolytic	ADJ
admet-2551	96	11	properties	property	NOUN
admet-2551	96	12	have	have	AUX
admet-2551	96	13	been	be	AUX
admet-2551	96	14	utilized	utilize	VERB
admet-2551	96	15	as	as	ADP
admet-2551	96	16	effective	effective	ADJ
admet-2551	96	17	thrombolytic	thrombolytic	ADJ
admet-2551	96	18	agents	agent	NOUN
admet-2551	96	19	,	,	PUNCT
admet-2551	96	20	such	such	ADJ
admet-2551	96	21	as	as	ADP
admet-2551	96	22	urokinase	urokinase	NOUN
admet-2551	96	23	(	(	PUNCT
admet-2551	96	24	uk	uk	PROPN
admet-2551	96	25	)	)	PUNCT
admet-2551	96	26	,	,	PUNCT
admet-2551	96	27	streptokinase	streptokinase	PROPN
admet-2551	96	28	,	,	PUNCT
admet-2551	96	29	recombinant	recombinant	ADJ
admet-2551	96	30	tissue	tissue	NOUN
admet-2551	96	31	-	-	PUNCT
admet-2551	96	32	type	type	NOUN
admet-2551	96	33	plasminogen	plasminogen	NOUN
admet-2551	96	34	activator	activator	NOUN
admet-2551	96	35	,	,	PUNCT
admet-2551	96	36	recombinant	recombinant	ADJ
admet-2551	96	37	prourokinase	prourokinase	NOUN
admet-2551	96	38	,	,	PUNCT
admet-2551	96	39	and	and	CCONJ
admet-2551	96	40	staphylokinase	staphylokinase	NOUN
admet-2551	96	41	[	[	X
admet-2551	96	42	35	35	NUM
admet-2551	96	43	-	-	SYM
admet-2551	96	44	38	38	NUM
admet-2551	96	45	]	]	PUNCT
admet-2551	96	46	.	.	PUNCT
admet-2551	97	1	a	a	DET
admet-2551	97	2	considerable	considerable	ADJ
admet-2551	97	3	lot	lot	NOUN
admet-2551	97	4	of	of	ADP
admet-2551	97	5	them	they	PRON
admet-2551	97	6	have	have	AUX
admet-2551	97	7	indicated	indicate	VERB
admet-2551	97	8	great	great	ADJ
admet-2551	97	9	outcomes	outcome	NOUN
admet-2551	97	10	.	.	PUNCT
admet-2551	98	1	however	however	ADV
admet-2551	98	2	,	,	PUNCT
admet-2551	98	3	they	they	PRON
admet-2551	98	4	additionally	additionally	ADV
admet-2551	98	5	have	have	VERB
admet-2551	98	6	a	a	DET
admet-2551	98	7	few	few	ADJ
admet-2551	98	8	confinements	confinement	NOUN
admet-2551	98	9	,	,	PUNCT
admet-2551	98	10	for	for	ADP
admet-2551	98	11	example	example	NOUN
admet-2551	98	12	,	,	PUNCT
admet-2551	98	13	quick	quick	ADJ
admet-2551	98	14	clearance	clearance	NOUN
admet-2551	98	15	,	,	PUNCT
admet-2551	98	16	the	the	DET
admet-2551	98	17	absence	absence	NOUN
admet-2551	98	18	of	of	ADP
admet-2551	98	19	protection	protection	NOUN
admet-2551	98	20	from	from	ADP
admet-2551	98	21	reocclusion	reocclusion	NOUN
admet-2551	98	22	,	,	PUNCT
admet-2551	98	23	bleeding	bleed	VERB
admet-2551	98	24	complications	complication	NOUN
admet-2551	98	25	,	,	PUNCT
admet-2551	98	26	and	and	CCONJ
admet-2551	98	27	other	other	ADJ
admet-2551	98	28	adverse	adverse	ADJ
admet-2551	98	29	impacts	impact	NOUN
admet-2551	98	30	[	[	X
admet-2551	98	31	39	39	NUM
admet-2551	98	32	]	]	PUNCT
admet-2551	98	33	.	.	PUNCT
admet-2551	99	1	lk	lk	PROPN
admet-2551	99	2	has	have	VERB
admet-2551	99	3	both	both	DET
admet-2551	99	4	functions	function	NOUN
admet-2551	99	5	,	,	PUNCT
admet-2551	99	6	like	like	ADP
admet-2551	99	7	plasminogen	plasminogen	NOUN
admet-2551	99	8	activation	activation	NOUN
admet-2551	99	9	and	and	CCONJ
admet-2551	99	10	fibrinolysis	fibrinolysis	NOUN
admet-2551	99	11	and	and	CCONJ
admet-2551	99	12	has	have	AUX
admet-2551	99	13	been	be	AUX
admet-2551	99	14	used	use	VERB
admet-2551	99	15	to	to	PART
admet-2551	99	16	treat	treat	VERB
admet-2551	99	17	thrombosis	thrombosis	NOUN
admet-2551	100	1	[	[	X
admet-2551	100	2	40	40	NUM
admet-2551	100	3	]	]	PUNCT
admet-2551	100	4	.	.	PUNCT
admet-2551	101	1	when	when	SCONJ
admet-2551	101	2	consumed	consume	VERB
admet-2551	101	3	orally	orally	ADV
admet-2551	101	4	,	,	PUNCT
admet-2551	101	5	the	the	DET
admet-2551	101	6	animal	animal	NOUN
admet-2551	101	7	experiments	experiment	NOUN
admet-2551	101	8	showed	show	VERB
admet-2551	101	9	that	that	SCONJ
admet-2551	101	10	lk	lk	PROPN
admet-2551	101	11	had	have	VERB
admet-2551	101	12	a	a	DET
admet-2551	101	13	significant	significant	ADJ
admet-2551	101	14	fibrinolytic	fibrinolytic	ADJ
admet-2551	101	15	efficacy	efficacy	NOUN
admet-2551	101	16	.	.	PUNCT
admet-2551	102	1	additionally	additionally	ADV
admet-2551	102	2	,	,	PUNCT
admet-2551	102	3	distinct	distinct	ADJ
admet-2551	102	4	improvement	improvement	NOUN
admet-2551	102	5	was	be	AUX
admet-2551	102	6	witnessed	witness	VERB
admet-2551	102	7	in	in	ADP
admet-2551	102	8	the	the	DET
admet-2551	102	9	management	management	NOUN
admet-2551	102	10	of	of	ADP
admet-2551	102	11	high	high	ADJ
admet-2551	102	12	blood	blood	NOUN
admet-2551	102	13	viscosity	viscosity	NOUN
admet-2551	102	14	syndrome	syndrome	NOUN
admet-2551	102	15	and	and	CCONJ
admet-2551	102	16	thrombocytosis	thrombocytosis	NOUN
admet-2551	102	17	[	[	X
admet-2551	102	18	41	41	NUM
admet-2551	102	19	]	]	PUNCT
admet-2551	102	20	.	.	PUNCT
admet-2551	103	1	moreover	moreover	ADV
admet-2551	103	2	,	,	PUNCT
admet-2551	103	3	lk	lk	PROPN
admet-2551	103	4	is	be	AUX
admet-2551	103	5	relatively	relatively	ADV
admet-2551	103	6	stable	stable	ADJ
admet-2551	103	7	under	under	ADP
admet-2551	103	8	long	long	ADJ
admet-2551	103	9	-	-	PUNCT
admet-2551	103	10	term	term	NOUN
admet-2551	103	11	storage	storage	NOUN
admet-2551	103	12	at	at	ADP
admet-2551	103	13	ambient	ambient	ADJ
admet-2551	103	14	temperature	temperature	NOUN
admet-2551	103	15	.	.	PUNCT
admet-2551	104	1	as	as	ADP
admet-2551	104	2	an	an	DET
admet-2551	104	3	oral	oral	ADJ
admet-2551	104	4	medication	medication	NOUN
admet-2551	104	5	,	,	PUNCT
admet-2551	104	6	lk	lk	PROPN
admet-2551	104	7	is	be	AUX
admet-2551	104	8	known	know	VERB
admet-2551	104	9	to	to	PART
admet-2551	104	10	avert	avert	VERB
admet-2551	104	11	and	and	CCONJ
admet-2551	104	12	treat	treat	VERB
admet-2551	104	13	clotting	clot	VERB
admet-2551	104	14	diseases	disease	NOUN
admet-2551	104	15	,	,	PUNCT
admet-2551	104	16	including	include	VERB
admet-2551	104	17	cerebral	cerebral	ADJ
admet-2551	104	18	thrombosis	thrombosis	NOUN
admet-2551	104	19	and	and	CCONJ
admet-2551	104	20	myocardial	myocardial	ADJ
admet-2551	104	21	infarction	infarction	NOUN
admet-2551	105	1	[	[	X
admet-2551	105	2	42	42	NUM
admet-2551	105	3	]	]	PUNCT
admet-2551	105	4	.	.	PUNCT
admet-2551	106	1	specifically	specifically	ADV
admet-2551	106	2	,	,	PUNCT
admet-2551	106	3	lumbricus	lumbricus	NOUN
admet-2551	106	4	rubellus	rubellus	NOUN
admet-2551	106	5	and	and	CCONJ
admet-2551	106	6	lumbricus	lumbricus	PROPN
admet-2551	106	7	bimastus	bimastus	PROPN
admet-2551	106	8	,	,	PUNCT
admet-2551	106	9	are	be	AUX
admet-2551	106	10	the	the	DET
admet-2551	106	11	essential	essential	ADJ
admet-2551	106	12	resources	resource	NOUN
admet-2551	106	13	for	for	ADP
admet-2551	106	14	a	a	DET
admet-2551	106	15	fibrinolytic	fibrinolytic	ADJ
admet-2551	106	16	agent	agent	NOUN
admet-2551	106	17	in	in	ADP
admet-2551	106	18	southeast	southeast	ADJ
admet-2551	106	19	-	-	PUNCT
admet-2551	106	20	asian	asian	ADJ
admet-2551	106	21	nations	nation	NOUN
admet-2551	106	22	,	,	PUNCT
admet-2551	106	23	for	for	ADP
admet-2551	106	24	example	example	NOUN
admet-2551	106	25	,	,	PUNCT
admet-2551	106	26	china	china	PROPN
admet-2551	106	27	,	,	PUNCT
admet-2551	106	28	korea	korea	PROPN
admet-2551	106	29	,	,	PUNCT
admet-2551	106	30	japan	japan	PROPN
admet-2551	106	31	and	and	CCONJ
admet-2551	106	32	so	so	ADV
admet-2551	106	33	on	on	ADP
admet-2551	106	34	[	[	X
admet-2551	106	35	43	43	NUM
admet-2551	106	36	,	,	PUNCT
admet-2551	106	37	44	44	NUM
admet-2551	106	38	]	]	PUNCT
admet-2551	106	39	.	.	PUNCT
admet-2551	107	1	the	the	DET
admet-2551	107	2	isolation	isolation	NOUN
admet-2551	107	3	and	and	CCONJ
admet-2551	107	4	purification	purification	NOUN
admet-2551	107	5	of	of	ADP
admet-2551	107	6	efes	efes	PROPN
admet-2551	107	7	included	include	VERB
admet-2551	107	8	centrifugation	centrifugation	NOUN
admet-2551	107	9	,	,	PUNCT
admet-2551	107	10	filtration	filtration	NOUN
admet-2551	107	11	,	,	PUNCT
admet-2551	107	12	ammonium	ammonium	NOUN
admet-2551	107	13	sulphate	sulphate	NOUN
admet-2551	107	14	precipitation	precipitation	NOUN
admet-2551	107	15	and	and	CCONJ
admet-2551	107	16	dialysis	dialysis	NOUN
admet-2551	107	17	,	,	PUNCT
admet-2551	107	18	ion	ion	NOUN
admet-2551	107	19	exchange	exchange	NOUN
admet-2551	107	20	chromatography	chromatography	NOUN
admet-2551	107	21	,	,	PUNCT
admet-2551	107	22	and	and	CCONJ
admet-2551	107	23	affinity	affinity	NOUN
admet-2551	107	24	chromatography	chromatography	NOUN
admet-2551	107	25	[	[	X
admet-2551	107	26	45	45	NUM
admet-2551	107	27	]	]	PUNCT
admet-2551	107	28	,	,	PUNCT
admet-2551	107	29	which	which	PRON
admet-2551	107	30	made	make	VERB
admet-2551	107	31	the	the	DET
admet-2551	107	32	scaling	scaling	NOUN
admet-2551	107	33	up	up	ADP
admet-2551	107	34	difficult	difficult	ADJ
admet-2551	107	35	.	.	PUNCT
admet-2551	108	1	a	a	DET
admet-2551	108	2	simple	simple	ADJ
admet-2551	108	3	admet	admet	NOUN
admet-2551	108	4	&	&	CCONJ
admet-2551	108	5	dmpk	dmpk	PROPN
admet-2551	108	6	12(6	12(6	NUM
admet-2551	108	7	)	)	PUNCT
admet-2551	108	8	(	(	PUNCT
admet-2551	109	1	2024	2024	NUM
admet-2551	109	2	)	)	PUNCT
admet-2551	109	3	797	797	NUM
admet-2551	109	4	-	-	SYM
admet-2551	109	5	820	820	NUM
admet-2551	109	6	natural	natural	ADJ
admet-2551	109	7	serine	serine	NOUN
admet-2551	109	8	proteases	protease	NOUN
admet-2551	109	9	in	in	ADP
admet-2551	109	10	combating	combat	VERB
admet-2551	109	11	amyloid	amyloid	NOUN
admet-2551	109	12	formation	formation	NOUN
admet-2551	109	13	doi	doi	NOUN
admet-2551	109	14	:	:	PUNCT
admet-2551	109	15	https://doi.org/10.5599/admet.2551	https://doi.org/10.5599/admet.2551	NOUN
admet-2551	109	16	801	801	NUM
admet-2551	109	17	method	method	NOUN
admet-2551	109	18	was	be	AUX
admet-2551	109	19	employed	employ	VERB
admet-2551	109	20	to	to	PART
admet-2551	109	21	scale	scale	VERB
admet-2551	109	22	up	up	ADP
admet-2551	109	23	,	,	PUNCT
admet-2551	109	24	like	like	ADP
admet-2551	109	25	aqueous	aqueous	ADJ
admet-2551	109	26	-	-	PUNCT
admet-2551	109	27	two	two	NUM
admet-2551	109	28	phase	phase	NOUN
admet-2551	109	29	systems	system	NOUN
admet-2551	109	30	(	(	PUNCT
admet-2551	109	31	atps	atps	NOUN
admet-2551	109	32	)	)	PUNCT
admet-2551	109	33	,	,	PUNCT
admet-2551	109	34	which	which	PRON
admet-2551	109	35	included	include	VERB
admet-2551	109	36	separation	separation	NOUN
admet-2551	109	37	and	and	CCONJ
admet-2551	109	38	the	the	DET
admet-2551	109	39	target	target	NOUN
admet-2551	109	40	protein	protein	NOUN
admet-2551	109	41	concentration	concentration	NOUN
admet-2551	109	42	,	,	PUNCT
admet-2551	109	43	giving	give	VERB
admet-2551	109	44	a	a	DET
admet-2551	109	45	clear	clear	ADJ
admet-2551	109	46	extract	extract	NOUN
admet-2551	109	47	[	[	X
admet-2551	109	48	46	46	NUM
admet-2551	109	49	]	]	PUNCT
admet-2551	109	50	.	.	PUNCT
admet-2551	110	1	seven	seven	NUM
admet-2551	110	2	types	type	NOUN
admet-2551	110	3	of	of	ADP
admet-2551	110	4	purified	purified	ADJ
admet-2551	110	5	fibrinolytic	fibrinolytic	ADJ
admet-2551	110	6	enzymes	enzyme	NOUN
admet-2551	110	7	(	(	PUNCT
admet-2551	110	8	efe	efe	NOUN
admet-2551	110	9	-	-	PUNCT
admet-2551	110	10	a	a	NOUN
admet-2551	110	11	to	to	ADP
admet-2551	110	12	efe	efe	VERB
admet-2551	110	13	-	-	PUNCT
admet-2551	110	14	g	g	NOUN
admet-2551	110	15	)	)	PUNCT
admet-2551	110	16	and	and	CCONJ
admet-2551	110	17	eight	eight	NUM
admet-2551	110	18	glycosylated	glycosylated	ADJ
admet-2551	110	19	purified	purify	VERB
admet-2551	110	20	fibrinolytic	fibrinolytic	ADJ
admet-2551	110	21	enzymes	enzyme	NOUN
admet-2551	110	22	(	(	PUNCT
admet-2551	110	23	efp-0	efp-0	NOUN
admet-2551	110	24	-	-	X
admet-2551	110	25	1	1	NUM
admet-2551	110	26	to	to	ADP
admet-2551	110	27	efp	efp	PROPN
admet-2551	110	28	-	-	PUNCT
admet-2551	110	29	iii-2	iii-2	NOUN
admet-2551	110	30	)	)	PUNCT
admet-2551	110	31	were	be	AUX
admet-2551	110	32	identified	identify	VERB
admet-2551	110	33	from	from	ADP
admet-2551	110	34	the	the	DET
admet-2551	110	35	source	source	NOUN
admet-2551	110	36	of	of	ADP
admet-2551	110	37	eisenia	eisenia	NOUN
admet-2551	110	38	fetida	fetida	PROPN
admet-2551	110	39	till	till	SCONJ
admet-2551	110	40	today	today	NOUN
admet-2551	110	41	[	[	X
admet-2551	110	42	21,47,48	21,47,48	NUM
admet-2551	110	43	]	]	PUNCT
admet-2551	110	44	.	.	PUNCT
admet-2551	111	1	six	six	NUM
admet-2551	111	2	fractions	fraction	NOUN
admet-2551	111	3	of	of	ADP
admet-2551	111	4	lumbrokinase	lumbrokinase	NOUN
admet-2551	111	5	(	(	PUNCT
admet-2551	111	6	f	f	X
admet-2551	111	7	-	-	PUNCT
admet-2551	111	8	i-0	i-0	NOUN
admet-2551	111	9	to	to	ADP
admet-2551	111	10	f	f	NOUN
admet-2551	111	11	-	-	PUNCT
admet-2551	111	12	iii-2	iii-2	NOUN
admet-2551	111	13	)	)	PUNCT
admet-2551	111	14	having	have	VERB
admet-2551	111	15	fibrinolytic	fibrinolytic	ADJ
admet-2551	111	16	activity	activity	NOUN
admet-2551	111	17	are	be	AUX
admet-2551	111	18	purified	purify	VERB
admet-2551	111	19	from	from	ADP
admet-2551	111	20	lumbricus	lumbricus	NOUN
admet-2551	111	21	rubellus	rubellus	NOUN
admet-2551	111	22	lysates	lysate	NOUN
admet-2551	111	23	using	use	VERB
admet-2551	111	24	autolysis	autolysis	NOUN
admet-2551	111	25	,	,	PUNCT
admet-2551	111	26	fractionation	fractionation	NOUN
admet-2551	111	27	with	with	ADP
admet-2551	111	28	ammonium	ammonium	NOUN
admet-2551	111	29	sulphate	sulphate	NOUN
admet-2551	111	30	and	and	CCONJ
admet-2551	111	31	column	column	NOUN
admet-2551	111	32	chromatography	chromatography	NOUN
admet-2551	111	33	.	.	PUNCT
admet-2551	112	1	lumbrokinase	lumbrokinase	PROPN
admet-2551	112	2	’s	’s	PART
admet-2551	112	3	f	f	NOUN
admet-2551	112	4	-	-	PUNCT
admet-2551	112	5	iii-1	iii-1	NUM
admet-2551	112	6	and	and	CCONJ
admet-2551	112	7	f	f	X
admet-2551	112	8	-	-	PUNCT
admet-2551	112	9	iii-2	iii-2	NOUN
admet-2551	112	10	,	,	PUNCT
admet-2551	112	11	f	f	PROPN
admet-2551	112	12	-	-	PUNCT
admet-2551	112	13	i-1and	i-1and	NOUN
admet-2551	112	14	f	f	NOUN
admet-2551	112	15	-	-	PUNCT
admet-2551	112	16	i-1	i-1	NOUN
admet-2551	113	1	both	both	CCONJ
admet-2551	113	2	showed	show	VERB
admet-2551	113	3	a	a	DET
admet-2551	113	4	similar	similar	ADJ
admet-2551	113	5	activity	activity	NOUN
admet-2551	113	6	although	although	SCONJ
admet-2551	113	7	they	they	PRON
admet-2551	113	8	have	have	VERB
admet-2551	113	9	different	different	ADJ
admet-2551	113	10	molecular	molecular	ADJ
admet-2551	113	11	weights	weight	NOUN
admet-2551	113	12	[	[	X
admet-2551	113	13	23	23	NUM
admet-2551	113	14	]	]	PUNCT
admet-2551	113	15	.	.	PUNCT
admet-2551	114	1	table	table	NOUN
admet-2551	114	2	1	1	NUM
admet-2551	114	3	summarizes	summarize	NOUN
admet-2551	114	4	the	the	DET
admet-2551	114	5	various	various	ADJ
admet-2551	114	6	physiological	physiological	ADJ
admet-2551	114	7	and	and	CCONJ
admet-2551	114	8	biological	biological	ADJ
admet-2551	114	9	properties	property	NOUN
admet-2551	114	10	of	of	ADP
admet-2551	114	11	these	these	DET
admet-2551	114	12	enzymes	enzyme	NOUN
admet-2551	114	13	.	.	PUNCT
admet-2551	115	1	table	table	NOUN
admet-2551	115	2	1	1	NUM
admet-2551	115	3	.	.	PUNCT
admet-2551	116	1	the	the	DET
admet-2551	116	2	biological	biological	ADJ
admet-2551	116	3	and	and	CCONJ
admet-2551	116	4	physiological	physiological	ADJ
admet-2551	116	5	properties	property	NOUN
admet-2551	116	6	of	of	ADP
admet-2551	116	7	different	different	ADJ
admet-2551	116	8	efes	efe	NOUN
admet-2551	116	9	[	[	X
admet-2551	116	10	43	43	NUM
admet-2551	116	11	]	]	X
admet-2551	116	12	organism	organism	ADJ
admet-2551	116	13	enzyme	enzyme	NOUN
admet-2551	116	14	name	name	NOUN
admet-2551	116	15	enzyme	enzyme	NOUN
admet-2551	116	16	activity	activity	NOUN
admet-2551	116	17	physiological	physiological	ADJ
admet-2551	116	18	properties	property	NOUN
admet-2551	116	19	biological	biological	ADJ
admet-2551	116	20	properties	property	NOUN
admet-2551	116	21	eisenia	eisenia	NOUN
admet-2551	116	22	fetida	fetida	PROPN
admet-2551	116	23	efp-0	efp-0	NOUN
admet-2551	116	24	-	-	X
admet-2551	116	25	1	1	NUM
admet-2551	116	26	to	to	ADP
admet-2551	116	27	efp	efp	PROPN
admet-2551	116	28	-	-	PUNCT
admet-2551	116	29	iii-2	iii-2	NOUN
admet-2551	116	30	relative	relative	ADJ
admet-2551	116	31	activity	activity	NOUN
admet-2551	116	32	:	:	PUNCT
admet-2551	116	33	6.2	6.2	NUM
admet-2551	116	34	,	,	PUNCT
admet-2551	116	35	12.8	12.8	NUM
admet-2551	116	36	,	,	PUNCT
admet-2551	116	37	25.8	25.8	NUM
admet-2551	116	38	,	,	PUNCT
admet-2551	116	39	31.6	31.6	NUM
admet-2551	116	40	,	,	PUNCT
admet-2551	116	41	8.8	8.8	NUM
admet-2551	116	42	,	,	PUNCT
admet-2551	116	43	2.1	2.1	NUM
admet-2551	116	44	,	,	PUNCT
admet-2551	116	45	12.5	12.5	NUM
admet-2551	116	46	,	,	PUNCT
admet-2551	116	47	2.3	2.3	NUM
admet-2551	116	48	%	%	NOUN
admet-2551	116	49	(	(	PUNCT
admet-2551	116	50	the	the	DET
admet-2551	116	51	activity	activity	NOUN
admet-2551	116	52	of	of	ADP
admet-2551	116	53	mixture	mixture	NOUN
admet-2551	116	54	as	as	ADP
admet-2551	116	55	100	100	NUM
admet-2551	116	56	%	%	NOUN
admet-2551	116	57	)	)	PUNCT
admet-2551	116	58	.	.	PUNCT
admet-2551	117	1	efp-0	efp-0	VERB
admet-2551	117	2	-	-	SYM
admet-2551	117	3	2	2	NUM
admet-2551	117	4	and	and	CCONJ
admet-2551	117	5	efp	efp	PROPN
admet-2551	117	6	-	-	PUNCT
admet-2551	117	7	ii-2	ii-2	NOUN
admet-2551	117	8	were	be	AUX
admet-2551	117	9	newly	newly	ADV
admet-2551	117	10	isolated	isolate	VERB
admet-2551	117	11	trypsin	trypsin	NOUN
admet-2551	117	12	-	-	PUNCT
admet-2551	117	13	like	like	ADJ
admet-2551	117	14	fibrinolytic	fibrinolytic	ADJ
admet-2551	117	15	enzymes	enzyme	NOUN
admet-2551	117	16	in	in	ADP
admet-2551	117	17	glycosylated	glycosylated	ADJ
admet-2551	117	18	form	form	NOUN
admet-2551	117	19	efp	efp	PROPN
admet-2551	117	20	-	-	PUNCT
admet-2551	117	21	ii	ii	PROPN
admet-2551	117	22	and	and	CCONJ
admet-2551	117	23	efp	efp	PROPN
admet-2551	117	24	-	-	PUNCT
admet-2551	117	25	iii-1	iii-1	NUM
admet-2551	117	26	were	be	AUX
admet-2551	117	27	strongly	strongly	ADV
admet-2551	117	28	inhibited	inhibit	VERB
admet-2551	117	29	by	by	ADP
admet-2551	117	30	sbti	sbti	PROPN
admet-2551	117	31	lumbrokinase	lumbrokinase	PROPN
admet-2551	117	32	fibrinolytic	fibrinolytic	ADJ
admet-2551	117	33	and	and	CCONJ
admet-2551	117	34	thrombolytic	thrombolytic	ADJ
admet-2551	117	35	activity	activity	NOUN
admet-2551	117	36	no	no	DET
admet-2551	117	37	data	data	NOUN
admet-2551	117	38	proteins	protein	NOUN
admet-2551	117	39	with	with	ADP
admet-2551	117	40	isoelectric	isoelectric	ADJ
admet-2551	117	41	point	point	NOUN
admet-2551	117	42	in	in	ADP
admet-2551	117	43	the	the	DET
admet-2551	117	44	range	range	NOUN
admet-2551	117	45	4.6	4.6	NUM
admet-2551	117	46	to	to	PART
admet-2551	117	47	7.4	7.4	NUM
admet-2551	117	48	efe	efe	NOUN
admet-2551	117	49	-	-	PUNCT
admet-2551	117	50	a	a	NOUN
admet-2551	117	51	to	to	ADP
admet-2551	117	52	efe	efe	VERB
admet-2551	117	53	-	-	PUNCT
admet-2551	117	54	f	f	NOUN
admet-2551	117	55	efe	efe	PROPN
admet-2551	117	56	-	-	PUNCT
admet-2551	117	57	b	b	NOUN
admet-2551	117	58	,	,	PUNCT
admet-2551	117	59	efe	efe	NOUN
admet-2551	117	60	-	-	PUNCT
admet-2551	117	61	c	c	NOUN
admet-2551	117	62	,	,	PUNCT
admet-2551	117	63	and	and	CCONJ
admet-2551	117	64	efe	efe	PROPN
admet-2551	117	65	-	-	PUNCT
admet-2551	117	66	g	g	NOUN
admet-2551	117	67	had	have	VERB
admet-2551	117	68	relatively	relatively	ADV
admet-2551	117	69	higher	high	ADJ
admet-2551	117	70	fibrinolytic	fibrinolytic	ADJ
admet-2551	117	71	activity	activity	NOUN
admet-2551	117	72	efe	efe	NOUN
admet-2551	117	73	-	-	PUNCT
admet-2551	117	74	d	d	NOUN
admet-2551	117	75	and	and	CCONJ
admet-2551	117	76	efe	efe	NOUN
admet-2551	117	77	-	-	PUNCT
admet-2551	117	78	e	e	NOUN
admet-2551	117	79	had	have	VERB
admet-2551	117	80	average	average	ADJ
admet-2551	117	81	fibrinolytic	fibrinolytic	ADJ
admet-2551	117	82	activity	activity	NOUN
admet-2551	117	83	,	,	PUNCT
admet-2551	117	84	and	and	CCONJ
admet-2551	117	85	efe	efe	NOUN
admet-2551	117	86	-	-	PUNCT
admet-2551	117	87	a	a	NOUN
admet-2551	117	88	and	and	CCONJ
admet-2551	117	89	efe	efe	NOUN
admet-2551	117	90	-	-	PUNCT
admet-2551	117	91	f	f	PROPN
admet-2551	117	92	had	have	AUX
admet-2551	117	93	relatively	relatively	ADV
admet-2551	117	94	lower	low	ADJ
admet-2551	117	95	activity	activity	NOUN
admet-2551	117	96	efe	efe	NOUN
admet-2551	117	97	-	-	PUNCT
admet-2551	117	98	a	a	PRON
admet-2551	117	99	has	have	AUX
admet-2551	117	100	plasminogenactivating	plasminogenactivate	VERB
admet-2551	117	101	activity	activity	NOUN
admet-2551	117	102	and	and	CCONJ
admet-2551	117	103	fibrinolytic	fibrinolytic	ADJ
admet-2551	117	104	activity	activity	NOUN
admet-2551	117	105	efe	efe	NOUN
admet-2551	117	106	-	-	PUNCT
admet-2551	117	107	b	b	NOUN
admet-2551	117	108	,	,	PUNCT
admet-2551	117	109	efe	efe	NOUN
admet-2551	117	110	-	-	PUNCT
admet-2551	117	111	c	c	NOUN
admet-2551	117	112	,	,	PUNCT
admet-2551	117	113	and	and	CCONJ
admet-2551	117	114	efe	efe	PROPN
admet-2551	117	115	-	-	PUNCT
admet-2551	117	116	g	g	NOUN
admet-2551	117	117	represent	represent	VERB
admet-2551	117	118	trypsin	trypsin	NOUN
admet-2551	117	119	-	-	PUNCT
admet-2551	117	120	like	like	ADJ
admet-2551	117	121	enzymes	enzyme	NOUN
admet-2551	117	122	,	,	PUNCT
admet-2551	117	123	efe	efe	NOUN
admet-2551	117	124	-	-	PUNCT
admet-2551	117	125	d	d	NOUN
admet-2551	117	126	,	,	PUNCT
admet-2551	117	127	efe	efe	NOUN
admet-2551	117	128	-	-	PUNCT
admet-2551	117	129	e	e	NOUN
admet-2551	117	130	and	and	CCONJ
admet-2551	117	131	efe	efe	PROPN
admet-2551	117	132	-	-	PUNCT
admet-2551	117	133	f	f	PROPN
admet-2551	117	134	represent	represent	VERB
admet-2551	117	135	chymotrypsin	chymotrypsin	NOUN
admet-2551	117	136	-	-	PUNCT
admet-2551	117	137	like	like	ADJ
admet-2551	117	138	enzymes	enzyme	NOUN
admet-2551	117	139	.	.	PUNCT
admet-2551	118	1	efe	efe	NOUN
admet-2551	118	2	-	-	PUNCT
admet-2551	118	3	a	a	DET
admet-2551	118	4	unknown	unknown	ADJ
admet-2551	118	5	acid	acid	NOUN
admet-2551	118	6	enzymes	enzyme	NOUN
admet-2551	118	7	eisenia	eisenia	NOUN
admet-2551	118	8	fetida	fetida	PROPN
admet-2551	118	9	pi	pi	NOUN
admet-2551	118	10	and	and	CCONJ
admet-2551	118	11	p	p	PROPN
admet-2551	118	12	ii	ii	PROPN
admet-2551	118	13	(	(	PUNCT
admet-2551	118	14	tissue	tissue	NOUN
admet-2551	118	15	homogenate	homogenate	NOUN
admet-2551	118	16	(	(	PUNCT
admet-2551	118	17	g-90	g-90	X
admet-2551	118	18	)	)	PUNCT
admet-2551	118	19	of	of	ADP
admet-2551	118	20	eisenia	eisenia	NOUN
admet-2551	118	21	foetida	foetida	PROPN
admet-2551	118	22	)	)	PUNCT
admet-2551	118	23	all	all	ADV
admet-2551	118	24	with	with	ADP
admet-2551	118	25	the	the	DET
admet-2551	118	26	esterase	esterase	NOUN
admet-2551	118	27	activity	activity	NOUN
admet-2551	118	28	,	,	PUNCT
admet-2551	118	29	but	but	CCONJ
admet-2551	118	30	only	only	ADV
admet-2551	118	31	fraction	fraction	NOUN
admet-2551	118	32	pi	pi	NOUN
admet-2551	118	33	displayed	display	VERB
admet-2551	118	34	amidase	amidase	NOUN
admet-2551	118	35	activity	activity	NOUN
admet-2551	118	36	,	,	PUNCT
admet-2551	118	37	and	and	CCONJ
admet-2551	118	38	the	the	DET
admet-2551	118	39	majority	majority	NOUN
admet-2551	118	40	of	of	ADP
admet-2551	118	41	activity	activity	NOUN
admet-2551	118	42	was	be	AUX
admet-2551	118	43	represented	represent	VERB
admet-2551	118	44	by	by	ADP
admet-2551	118	45	pi	pi	NOUN
admet-2551	118	46	they	they	PRON
admet-2551	118	47	belong	belong	VERB
admet-2551	118	48	into	into	ADP
admet-2551	118	49	the	the	DET
admet-2551	118	50	tyrosine	tyrosine	NOUN
admet-2551	118	51	family	family	NOUN
admet-2551	118	52	pmsf	pmsf	NOUN
admet-2551	118	53	at	at	ADP
admet-2551	118	54	the	the	DET
admet-2551	118	55	concentration	concentration	NOUN
admet-2551	118	56	of	of	ADP
admet-2551	118	57	10	10	NUM
admet-2551	118	58	to	to	PART
admet-2551	118	59	4	4	NUM
admet-2551	118	60	m	m	VERB
admet-2551	118	61	inhibited	inhibited	ADJ
admet-2551	118	62	pi	pi	NOUN
admet-2551	118	63	(	(	PUNCT
admet-2551	118	64	baee	baee	ADV
admet-2551	118	65	as	as	ADP
admet-2551	118	66	substrate	substrate	NOUN
admet-2551	118	67	)	)	PUNCT
admet-2551	118	68	arspi	arspi	NOUN
admet-2551	118	69	a	a	DET
admet-2551	118	70	plasmin	plasmin	NOUN
admet-2551	118	71	and	and	CCONJ
admet-2551	118	72	also	also	ADV
admet-2551	118	73	a	a	DET
admet-2551	118	74	plasminogen	plasminogen	NOUN
admet-2551	118	75	activator	activator	NOUN
admet-2551	118	76	glycoprotein	glycoprotein	NOUN
admet-2551	118	77	or	or	CCONJ
admet-2551	118	78	glycopeptide	glycopeptide	NOUN
admet-2551	118	79	inhibited	inhibit	VERB
admet-2551	118	80	by	by	ADP
admet-2551	118	81	pmsf	pmsf	NOUN
admet-2551	118	82	lumbricus	lumbricus	NOUN
admet-2551	118	83	rubellus	rubellus	NOUN
admet-2551	118	84	isozymes	isozyme	NOUN
admet-2551	118	85	a	a	PRON
admet-2551	118	86	to	to	ADP
admet-2551	118	87	f	f	PROPN
admet-2551	118	88	(	(	PUNCT
admet-2551	118	89	formerly	formerly	ADV
admet-2551	118	90	named	name	VERB
admet-2551	118	91	f	f	NOUN
admet-2551	118	92	-	-	PUNCT
admet-2551	118	93	iii-2	iii-2	NOUN
admet-2551	118	94	,	,	PUNCT
admet-2551	118	95	f	f	X
admet-2551	118	96	-	-	PUNCT
admet-2551	118	97	iii-1	iii-1	NUM
admet-2551	118	98	,	,	PUNCT
admet-2551	118	99	f	f	X
admet-2551	118	100	-	-	PUNCT
admet-2551	118	101	ii	ii	PROPN
admet-2551	118	102	,	,	PUNCT
admet-2551	118	103	f-12	f-12	NOUN
admet-2551	118	104	,	,	PUNCT
admet-2551	118	105	f	f	X
admet-2551	118	106	-	-	PUNCT
admet-2551	118	107	i-1	i-1	NUM
admet-2551	118	108	and	and	CCONJ
admet-2551	118	109	f	f	X
admet-2551	118	110	-	-	PUNCT
admet-2551	118	111	i-0	i-0	NOUN
admet-2551	118	112	,	,	PUNCT
admet-2551	118	113	respectively	respectively	ADV
admet-2551	118	114	)	)	PUNCT
admet-2551	118	115	they	they	PRON
admet-2551	118	116	have	have	AUX
admet-2551	118	117	acted	act	VERB
admet-2551	118	118	on	on	ADP
admet-2551	118	119	elastin	elastin	NOUN
admet-2551	118	120	,	,	PUNCT
admet-2551	118	121	fibrin	fibrin	NOUN
admet-2551	118	122	,	,	PUNCT
admet-2551	118	123	and	and	CCONJ
admet-2551	118	124	actual	actual	ADJ
admet-2551	118	125	fibrin	fibrin	NOUN
admet-2551	118	126	clots	clot	NOUN
admet-2551	118	127	of	of	ADP
admet-2551	118	128	whole	whole	ADJ
admet-2551	118	129	blood	blood	NOUN
admet-2551	118	130	in	in	ADP
admet-2551	118	131	a	a	DET
admet-2551	118	132	rat	rat	NOUN
admet-2551	118	133	’s	’s	PART
admet-2551	118	134	vena	vena	NOUN
admet-2551	118	135	cava	cava	NOUN
admet-2551	118	136	.	.	PUNCT
admet-2551	119	1	they	they	PRON
admet-2551	119	2	also	also	ADV
admet-2551	119	3	catalysed	catalyse	VERB
admet-2551	119	4	the	the	DET
admet-2551	119	5	hydrolysis	hydrolysis	NOUN
admet-2551	119	6	of	of	ADP
admet-2551	119	7	various	various	ADJ
admet-2551	119	8	esters	ester	NOUN
admet-2551	119	9	.	.	PUNCT
admet-2551	120	1	especially	especially	ADV
admet-2551	120	2	a	a	PRON
admet-2551	120	3	and	and	CCONJ
admet-2551	120	4	b	b	NOUN
admet-2551	120	5	have	have	VERB
admet-2551	120	6	much	much	ADV
admet-2551	120	7	higher	high	ADJ
admet-2551	120	8	strong	strong	ADJ
admet-2551	120	9	caseinolytic	caseinolytic	ADJ
admet-2551	120	10	and	and	CCONJ
admet-2551	120	11	fibrinolytic	fibrinolytic	ADJ
admet-2551	120	12	activities	activity	NOUN
admet-2551	120	13	than	than	ADP
admet-2551	120	14	plasmin	plasmin	ADJ
admet-2551	120	15	.	.	PUNCT
admet-2551	121	1	the	the	DET
admet-2551	121	2	enzymes	enzyme	NOUN
admet-2551	121	3	have	have	VERB
admet-2551	121	4	also	also	ADV
admet-2551	121	5	strong	strong	ADJ
admet-2551	121	6	amydolytic	amydolytic	ADJ
admet-2551	121	7	activity	activity	NOUN
admet-2551	121	8	.	.	PUNCT
admet-2551	122	1	trypsin	trypsin	NOUN
admet-2551	122	2	-	-	PUNCT
admet-2551	122	3	like	like	ADJ
admet-2551	122	4	serine	serine	NOUN
admet-2551	122	5	proteases	protease	NOUN
admet-2551	122	6	with	with	ADP
admet-2551	122	7	single	single	ADJ
admet-2551	122	8	polypeptide	polypeptide	ADJ
admet-2551	122	9	chains	chain	NOUN
admet-2551	122	10	and	and	CCONJ
admet-2551	122	11	are	be	AUX
admet-2551	122	12	not	not	PART
admet-2551	122	13	glycoproteins	glycoprotein	NOUN
admet-2551	122	14	.	.	PUNCT
admet-2551	123	1	isozymes	isozyme	NOUN
admet-2551	123	2	a	a	PRON
admet-2551	123	3	,	,	PUNCT
admet-2551	123	4	b	b	NOUN
admet-2551	123	5	,	,	PUNCT
admet-2551	123	6	d	d	PROPN
admet-2551	123	7	,	,	PUNCT
admet-2551	123	8	e	e	NOUN
admet-2551	123	9	,	,	PUNCT
admet-2551	123	10	and	and	CCONJ
admet-2551	123	11	f	f	PROPN
admet-2551	123	12	represent	represent	VERB
admet-2551	123	13	both	both	CCONJ
admet-2551	123	14	trypsin	trypsin	NOUN
admet-2551	123	15	and	and	CCONJ
admet-2551	123	16	chymotrypsin	chymotrypsin	NOUN
admet-2551	123	17	-	-	PUNCT
admet-2551	123	18	like	like	ADJ
admet-2551	123	19	activities	activity	NOUN
admet-2551	123	20	,	,	PUNCT
admet-2551	123	21	but	but	CCONJ
admet-2551	123	22	isozymes	isozyme	NOUN
admet-2551	123	23	c	c	NOUN
admet-2551	123	24	also	also	ADV
admet-2551	123	25	serves	serve	VERB
admet-2551	123	26	as	as	ADP
admet-2551	123	27	an	an	DET
admet-2551	123	28	elastaselike	elastaselike	ADJ
admet-2551	123	29	enzymes	enzyme	NOUN
admet-2551	123	30	the	the	DET
admet-2551	123	31	enzymes	enzyme	NOUN
admet-2551	123	32	were	be	AUX
admet-2551	123	33	stable	stable	ADJ
admet-2551	123	34	at	at	ADP
admet-2551	123	35	below	below	ADP
admet-2551	123	36	60	60	NUM
admet-2551	123	37	°	°	NOUN
admet-2551	123	38	c	c	NOUN
admet-2551	123	39	,	,	PUNCT
admet-2551	123	40	over	over	ADP
admet-2551	123	41	a	a	DET
admet-2551	123	42	range	range	NOUN
admet-2551	123	43	of	of	ADP
admet-2551	123	44	ph	ph	NOUN
admet-2551	123	45	2	2	NUM
admet-2551	123	46	to	to	ADP
admet-2551	123	47	11	11	NUM
admet-2551	123	48	,	,	PUNCT
admet-2551	123	49	most	most	ADV
admet-2551	123	50	active	active	ADJ
admet-2551	123	51	at	at	ADP
admet-2551	123	52	55	55	NUM
admet-2551	123	53	°	°	NOUN
admet-2551	123	54	c	c	NOUN
admet-2551	123	55	,	,	PUNCT
admet-2551	123	56	on	on	ADP
admet-2551	123	57	heating	heat	VERB
admet-2551	123	58	at	at	ADP
admet-2551	123	59	80	80	NUM
admet-2551	123	60	°	°	NUM
admet-2551	123	61	c	c	NOUN
admet-2551	123	62	for	for	ADP
admet-2551	123	63	30	30	NUM
admet-2551	123	64	min	min	NOUN
admet-2551	123	65	,	,	PUNCT
admet-2551	123	66	the	the	DET
admet-2551	123	67	activity	activity	NOUN
admet-2551	123	68	completely	completely	ADV
admet-2551	123	69	disappeared	disappear	VERB
admet-2551	123	70	they	they	PRON
admet-2551	123	71	retain	retain	VERB
admet-2551	123	72	full	full	ADJ
admet-2551	123	73	activity	activity	NOUN
admet-2551	123	74	for	for	ADP
admet-2551	123	75	long	long	ADJ
admet-2551	123	76	years	year	NOUN
admet-2551	123	77	at	at	ADP
admet-2551	123	78	room	room	NOUN
admet-2551	123	79	temperature	temperature	NOUN
admet-2551	123	80	.	.	PUNCT
admet-2551	124	1	high	high	ADJ
admet-2551	124	2	stability	stability	NOUN
admet-2551	124	3	toward	toward	ADP
admet-2551	124	4	organic	organic	ADJ
admet-2551	124	5	solvents	solvent	NOUN
admet-2551	124	6	and	and	CCONJ
admet-2551	124	7	detergents	detergent	NOUN
admet-2551	124	8	,	,	PUNCT
admet-2551	124	9	the	the	DET
admet-2551	124	10	activity	activity	NOUN
admet-2551	124	11	of	of	ADP
admet-2551	124	12	isozymes	isozyme	NOUN
admet-2551	124	13	a	a	DET
admet-2551	124	14	,	,	PUNCT
admet-2551	124	15	b	b	NOUN
admet-2551	124	16	,	,	PUNCT
admet-2551	124	17	and	and	CCONJ
admet-2551	124	18	c	c	PROPN
admet-2551	124	19	was	be	AUX
admet-2551	124	20	inhibited	inhibit	VERB
admet-2551	124	21	strongly	strongly	ADV
admet-2551	124	22	by	by	ADP
admet-2551	124	23	soybean	soybean	NOUN
admet-2551	124	24	trypsin	trypsin	NOUN
admet-2551	124	25	inhibitor	inhibitor	NOUN
admet-2551	124	26	and	and	CCONJ
admet-2551	124	27	aprotinin	aprotinin	NOUN
admet-2551	124	28	,	,	PUNCT
admet-2551	124	29	but	but	CCONJ
admet-2551	124	30	the	the	DET
admet-2551	124	31	enzyme	enzyme	NOUN
admet-2551	124	32	activity	activity	NOUN
admet-2551	124	33	of	of	ADP
admet-2551	124	34	d	d	PROPN
admet-2551	124	35	,	,	PUNCT
admet-2551	124	36	e	e	NOUN
admet-2551	124	37	,	,	PUNCT
admet-2551	124	38	and	and	CCONJ
admet-2551	124	39	f	f	PROPN
admet-2551	124	40	was	be	AUX
admet-2551	124	41	partially	partially	ADV
admet-2551	124	42	inhibited	inhibit	VERB
admet-2551	124	43	by	by	ADP
admet-2551	124	44	these	these	DET
admet-2551	124	45	inhibitors	inhibitor	NOUN
admet-2551	124	46	.	.	PUNCT
admet-2551	125	1	f1	f1	NOUN
admet-2551	125	2	to	to	ADP
admet-2551	125	3	f6	f6	PROPN
admet-2551	125	4	the	the	DET
admet-2551	125	5	rank	rank	NOUN
admet-2551	125	6	activity	activity	NOUN
admet-2551	125	7	orders	order	NOUN
admet-2551	125	8	of	of	ADP
admet-2551	125	9	proteolytic	proteolytic	ADJ
admet-2551	125	10	activities	activity	NOUN
admet-2551	125	11	and	and	CCONJ
admet-2551	125	12	fibrinolytic	fibrinolytic	ADJ
admet-2551	125	13	activities	activity	NOUN
admet-2551	125	14	are	be	AUX
admet-2551	125	15	f2	f2	PROPN
admet-2551	125	16	>	>	SYM
admet-2551	125	17	f1	f1	PROPN
admet-2551	125	18	>	>	X
admet-2551	125	19	f5	f5	PROPN
admet-2551	125	20	>	>	SYM
admet-2551	125	21	f6	f6	PROPN
admet-2551	125	22	>	>	X
admet-2551	125	23	f3	f3	PROPN
admet-2551	125	24	>	>	X
admet-2551	125	25	f4	f4	PROPN
admet-2551	125	26	>	>	X
admet-2551	125	27	and	and	CCONJ
admet-2551	125	28	f6	f6	PROPN
admet-2551	125	29	>	>	X
admet-2551	125	30	f2	f2	PROPN
admet-2551	125	31	>	>	SYM
admet-2551	125	32	f5	f5	PROPN
admet-2551	125	33	>	>	SYM
admet-2551	125	34	f3	f3	PROPN
admet-2551	125	35	>	>	X
admet-2551	125	36	f1	f1	PROPN
admet-2551	125	37	>	>	X
admet-2551	125	38	f4	f4	NOUN
admet-2551	125	39	separately	separately	ADV
admet-2551	125	40	all	all	PRON
admet-2551	125	41	of	of	ADP
admet-2551	125	42	them	they	PRON
admet-2551	125	43	are	be	AUX
admet-2551	125	44	serine	serine	ADJ
admet-2551	125	45	protease	protease	NOUN
admet-2551	125	46	,	,	PUNCT
admet-2551	125	47	f5	f5	VERB
admet-2551	125	48	a	a	PRON
admet-2551	125	49	and	and	CCONJ
admet-2551	125	50	f6	f6	PROPN
admet-2551	125	51	are	be	AUX
admet-2551	125	52	trypsin	trypsin	NOUN
admet-2551	125	53	-	-	PUNCT
admet-2551	125	54	like	like	ADJ
admet-2551	125	55	serine	serine	NOUN
admet-2551	125	56	protease	protease	NOUN
admet-2551	125	57	.	.	PUNCT
admet-2551	126	1	iso	iso	NOUN
admet-2551	126	2	-	-	PUNCT
admet-2551	126	3	enzymes	enzyme	NOUN
admet-2551	126	4	.	.	PUNCT
admet-2551	127	1	f1	f1	NOUN
admet-2551	127	2	is	be	AUX
admet-2551	127	3	chymotrypsin	chymotrypsin	NOUN
admet-2551	127	4	-	-	PUNCT
admet-2551	127	5	like	like	ADJ
admet-2551	127	6	protease	protease	NOUN
admet-2551	127	7	.	.	PUNCT
admet-2551	128	1	f1	f1	NOUN
admet-2551	128	2	-	-	PUNCT
admet-2551	128	3	f4	f4	PROPN
admet-2551	128	4	were	be	AUX
admet-2551	128	5	completely	completely	ADV
admet-2551	128	6	inhibited	inhibit	VERB
admet-2551	128	7	by	by	ADP
admet-2551	128	8	pmsf	pmsf	NOUN
admet-2551	128	9	.	.	PUNCT
admet-2551	129	1	f5	f5	NOUN
admet-2551	129	2	and	and	CCONJ
admet-2551	129	3	f6	f6	PROPN
admet-2551	129	4	were	be	AUX
admet-2551	129	5	completely	completely	ADV
admet-2551	129	6	inhibited	inhibit	VERB
admet-2551	129	7	by	by	ADP
admet-2551	129	8	aprotinin	aprotinin	NOUN
admet-2551	129	9	,	,	PUNCT
admet-2551	129	10	tlck	tlck	ADJ
admet-2551	129	11	,	,	PUNCT
admet-2551	129	12	tpck	tpck	NOUN
admet-2551	129	13	,	,	PUNCT
admet-2551	129	14	sbti	sbti	PROPN
admet-2551	129	15	lbti	lbti	NOUN
admet-2551	129	16	,	,	PUNCT
admet-2551	129	17	and	and	CCONJ
admet-2551	129	18	leupeptin	leupeptin	NOUN
admet-2551	129	19	.	.	PUNCT
admet-2551	130	1	the	the	DET
admet-2551	130	2	six	six	NUM
admet-2551	130	3	isoenzymes	isoenzyme	NOUN
admet-2551	130	4	were	be	AUX
admet-2551	130	5	stable	stable	ADJ
admet-2551	130	6	at	at	ADP
admet-2551	130	7	ph	ph	PROPN
admet-2551	130	8	4	4	NUM
admet-2551	130	9	to-12	to-12	NOUN
admet-2551	130	10	.	.	PUNCT
admet-2551	131	1	there	there	PRON
admet-2551	131	2	has	have	AUX
admet-2551	131	3	been	be	AUX
admet-2551	131	4	an	an	DET
admet-2551	131	5	increase	increase	NOUN
admet-2551	131	6	in	in	ADP
admet-2551	131	7	the	the	DET
admet-2551	131	8	use	use	NOUN
admet-2551	131	9	of	of	ADP
admet-2551	131	10	the	the	DET
admet-2551	131	11	lk	lk	ADJ
admet-2551	131	12	protein	protein	NOUN
admet-2551	131	13	in	in	ADP
admet-2551	131	14	the	the	DET
admet-2551	131	15	field	field	NOUN
admet-2551	131	16	of	of	ADP
admet-2551	131	17	medicine	medicine	NOUN
admet-2551	131	18	today	today	NOUN
admet-2551	131	19	,	,	PUNCT
admet-2551	131	20	mainly	mainly	ADV
admet-2551	131	21	due	due	ADP
admet-2551	131	22	to	to	ADP
admet-2551	131	23	its	its	PRON
admet-2551	131	24	ability	ability	NOUN
admet-2551	131	25	to	to	PART
admet-2551	131	26	perform	perform	VERB
admet-2551	131	27	thrombolytic	thrombolytic	ADJ
admet-2551	131	28	therapy	therapy	NOUN
admet-2551	131	29	.	.	PUNCT
admet-2551	132	1	because	because	SCONJ
admet-2551	132	2	lk	lk	PROPN
admet-2551	132	3	is	be	AUX
admet-2551	132	4	a	a	DET
admet-2551	132	5	eukaryotic	eukaryotic	ADJ
admet-2551	132	6	protein	protein	NOUN
admet-2551	132	7	,	,	PUNCT
admet-2551	132	8	it	it	PRON
admet-2551	132	9	is	be	AUX
admet-2551	132	10	even	even	ADV
admet-2551	132	11	more	more	ADV
admet-2551	132	12	important	important	ADJ
admet-2551	132	13	in	in	ADP
admet-2551	132	14	the	the	DET
admet-2551	132	15	https://doi.org/10.5599/admet.2551	https://doi.org/10.5599/admet.2551	NOUN
admet-2551	133	1	s.	s.	PROPN
admet-2551	133	2	k.	k.	PROPN
admet-2551	133	3	metkar	metkar	PROPN
admet-2551	133	4	et	et	PROPN
admet-2551	133	5	al	al	PROPN
admet-2551	133	6	.	.	PROPN
admet-2551	133	7	admet	admet	PROPN
admet-2551	133	8	&	&	CCONJ
admet-2551	133	9	dmpk	dmpk	PROPN
admet-2551	133	10	12(6	12(6	NUM
admet-2551	133	11	)	)	PUNCT
admet-2551	133	12	(	(	PUNCT
admet-2551	133	13	2024	2024	NUM
admet-2551	133	14	)	)	PUNCT
admet-2551	133	15	797	797	NUM
admet-2551	133	16	-	-	SYM
admet-2551	133	17	820	820	NUM
admet-2551	133	18	802	802	NUM
admet-2551	133	19	treatment	treatment	NOUN
admet-2551	133	20	of	of	ADP
admet-2551	133	21	cardiovascular	cardiovascular	ADJ
admet-2551	133	22	and	and	CCONJ
admet-2551	133	23	cerebrovascular	cerebrovascular	ADJ
admet-2551	133	24	diseases	disease	NOUN
admet-2551	133	25	.	.	PUNCT
admet-2551	134	1	lk	lk	PROPN
admet-2551	134	2	has	have	AUX
admet-2551	134	3	been	be	AUX
admet-2551	134	4	produced	produce	VERB
admet-2551	134	5	both	both	CCONJ
admet-2551	134	6	in	in	ADP
admet-2551	134	7	bacterial	bacterial	ADJ
admet-2551	134	8	and	and	CCONJ
admet-2551	134	9	eukaryotic	eukaryotic	ADJ
admet-2551	134	10	systems	system	NOUN
admet-2551	134	11	as	as	ADP
admet-2551	134	12	a	a	DET
admet-2551	134	13	result	result	NOUN
admet-2551	134	14	of	of	ADP
admet-2551	134	15	advances	advance	NOUN
admet-2551	134	16	in	in	ADP
admet-2551	134	17	recombinant	recombinant	ADJ
admet-2551	134	18	technology	technology	NOUN
admet-2551	134	19	.	.	PUNCT
admet-2551	135	1	as	as	SCONJ
admet-2551	135	2	a	a	DET
admet-2551	135	3	result	result	NOUN
admet-2551	135	4	of	of	ADP
admet-2551	135	5	advanced	advanced	ADJ
admet-2551	135	6	design	design	NOUN
admet-2551	135	7	of	of	ADP
admet-2551	135	8	the	the	DET
admet-2551	135	9	appropriate	appropriate	ADJ
admet-2551	135	10	host	host	NOUN
admet-2551	135	11	system	system	NOUN
admet-2551	135	12	and	and	CCONJ
admet-2551	135	13	alteration	alteration	NOUN
admet-2551	135	14	of	of	ADP
admet-2551	135	15	the	the	DET
admet-2551	135	16	genetic	genetic	ADJ
admet-2551	135	17	level	level	NOUN
admet-2551	135	18	of	of	ADP
admet-2551	135	19	a	a	DET
admet-2551	135	20	drug	drug	NOUN
admet-2551	135	21	to	to	PART
admet-2551	135	22	make	make	VERB
admet-2551	135	23	it	it	PRON
admet-2551	135	24	more	more	ADV
admet-2551	135	25	effective	effective	ADJ
admet-2551	135	26	,	,	PUNCT
admet-2551	135	27	there	there	PRON
admet-2551	135	28	have	have	AUX
admet-2551	135	29	been	be	AUX
admet-2551	135	30	attempts	attempt	NOUN
admet-2551	135	31	to	to	PART
admet-2551	135	32	improve	improve	VERB
admet-2551	135	33	the	the	DET
admet-2551	135	34	expression	expression	NOUN
admet-2551	135	35	of	of	ADP
admet-2551	135	36	the	the	DET
admet-2551	135	37	recombinant	recombinant	ADJ
admet-2551	135	38	enzyme	enzyme	NOUN
admet-2551	135	39	,	,	PUNCT
admet-2551	135	40	immobilization	immobilization	NOUN
admet-2551	135	41	for	for	ADP
admet-2551	135	42	reuse	reuse	NOUN
admet-2551	135	43	of	of	ADP
admet-2551	135	44	the	the	DET
admet-2551	135	45	enzyme	enzyme	NOUN
admet-2551	135	46	,	,	PUNCT
admet-2551	135	47	and	and	CCONJ
admet-2551	135	48	chemical	chemical	NOUN
admet-2551	135	49	modification	modification	NOUN
admet-2551	135	50	in	in	ADP
admet-2551	135	51	order	order	NOUN
admet-2551	135	52	to	to	PART
admet-2551	135	53	reduce	reduce	VERB
admet-2551	135	54	antigenicity	antigenicity	NOUN
admet-2551	135	55	and	and	CCONJ
admet-2551	135	56	improve	improve	VERB
admet-2551	135	57	its	its	PRON
admet-2551	135	58	activity	activity	NOUN
admet-2551	135	59	in	in	ADP
admet-2551	135	60	order	order	NOUN
admet-2551	135	61	to	to	PART
admet-2551	135	62	make	make	VERB
admet-2551	135	63	a	a	DET
admet-2551	135	64	drug	drug	NOUN
admet-2551	135	65	more	more	ADV
admet-2551	135	66	effective	effective	ADJ
admet-2551	135	67	.	.	PUNCT
admet-2551	136	1	it	it	PRON
admet-2551	136	2	is	be	AUX
admet-2551	136	3	expected	expect	VERB
admet-2551	136	4	that	that	SCONJ
admet-2551	136	5	it	it	PRON
admet-2551	136	6	will	will	AUX
admet-2551	136	7	be	be	AUX
admet-2551	136	8	the	the	DET
admet-2551	136	9	right	right	ADJ
admet-2551	136	10	drug	drug	NOUN
admet-2551	136	11	candidate	candidate	NOUN
admet-2551	136	12	in	in	ADP
admet-2551	136	13	the	the	DET
admet-2551	136	14	future	future	NOUN
admet-2551	136	15	for	for	ADP
admet-2551	136	16	the	the	DET
admet-2551	136	17	treatment	treatment	NOUN
admet-2551	136	18	of	of	ADP
admet-2551	136	19	thrombosis	thrombosis	NOUN
admet-2551	137	1	[	[	X
admet-2551	137	2	49	49	NUM
admet-2551	137	3	]	]	PUNCT
admet-2551	137	4	.	.	PUNCT
admet-2551	138	1	moreover	moreover	ADV
admet-2551	138	2	,	,	PUNCT
admet-2551	138	3	an	an	DET
admet-2551	138	4	in	in	ADP
admet-2551	138	5	vivo	vivo	NOUN
admet-2551	138	6	study	study	NOUN
admet-2551	138	7	demonstrated	demonstrate	VERB
admet-2551	138	8	that	that	SCONJ
admet-2551	138	9	the	the	DET
admet-2551	138	10	fibrinolytic	fibrinolytic	ADJ
admet-2551	138	11	enzyme	enzyme	NOUN
admet-2551	138	12	from	from	ADP
admet-2551	138	13	earthworm	earthworm	NOUN
admet-2551	138	14	has	have	AUX
admet-2551	138	15	reduced	reduce	VERB
admet-2551	138	16	intra	intra	ADJ
admet-2551	138	17	-	-	ADJ
admet-2551	138	18	abdominal	abdominal	ADJ
admet-2551	138	19	adhesion	adhesion	NOUN
admet-2551	138	20	and	and	CCONJ
admet-2551	138	21	peritoneal	peritoneal	ADJ
admet-2551	138	22	thickening	thickening	NOUN
admet-2551	138	23	[	[	X
admet-2551	138	24	50	50	NUM
admet-2551	138	25	]	]	PUNCT
admet-2551	138	26	.	.	PUNCT
admet-2551	139	1	role	role	NOUN
admet-2551	139	2	of	of	ADP
admet-2551	139	3	lumbrokinase	lumbrokinase	PROPN
admet-2551	139	4	in	in	ADP
admet-2551	139	5	cerebral	cerebral	ADJ
admet-2551	139	6	ischemia	ischemia	NOUN
admet-2551	139	7	and	and	CCONJ
admet-2551	139	8	implantation	implantation	NOUN
admet-2551	139	9	by	by	ADP
admet-2551	139	10	increasing	increase	VERB
admet-2551	139	11	the	the	DET
admet-2551	139	12	level	level	NOUN
admet-2551	139	13	of	of	ADP
admet-2551	139	14	c	c	NOUN
admet-2551	139	15	-	-	PUNCT
admet-2551	139	16	amp	amp	NOUN
admet-2551	139	17	and	and	CCONJ
admet-2551	139	18	reducing	reduce	VERB
admet-2551	139	19	calcium	calcium	NOUN
admet-2551	139	20	release	release	NOUN
admet-2551	139	21	from	from	ADP
admet-2551	139	22	calcium	calcium	NOUN
admet-2551	139	23	reserves	reserve	NOUN
admet-2551	139	24	,	,	PUNCT
admet-2551	139	25	lk	lk	PROPN
admet-2551	139	26	has	have	VERB
admet-2551	139	27	anti	anti	ADJ
admet-2551	139	28	-	-	ADJ
admet-2551	139	29	ischemic	ischemic	ADJ
admet-2551	139	30	activity	activity	NOUN
admet-2551	139	31	due	due	ADP
admet-2551	139	32	to	to	ADP
admet-2551	139	33	its	its	PRON
admet-2551	139	34	antiplatelet	antiplatelet	NOUN
admet-2551	139	35	activity	activity	NOUN
admet-2551	139	36	.	.	PUNCT
admet-2551	140	1	lk	lk	PROPN
admet-2551	140	2	had	have	VERB
admet-2551	140	3	an	an	DET
admet-2551	140	4	antithrombotic	antithrombotic	ADJ
admet-2551	140	5	effect	effect	NOUN
admet-2551	140	6	due	due	ADP
admet-2551	140	7	to	to	ADP
admet-2551	140	8	the	the	DET
admet-2551	140	9	inhibition	inhibition	NOUN
admet-2551	140	10	of	of	ADP
admet-2551	140	11	expression	expression	NOUN
admet-2551	140	12	of	of	ADP
admet-2551	140	13	icam-1	icam-1	NUM
admet-2551	140	14	and	and	CCONJ
admet-2551	140	15	an	an	DET
admet-2551	140	16	antiapoptotic	antiapoptotic	ADJ
admet-2551	140	17	effect	effect	NOUN
admet-2551	140	18	due	due	ADP
admet-2551	140	19	to	to	ADP
admet-2551	140	20	the	the	DET
admet-2551	140	21	activation	activation	NOUN
admet-2551	140	22	of	of	ADP
admet-2551	140	23	the	the	DET
admet-2551	140	24	jak1	jak1	PROPN
admet-2551	140	25	/	/	SYM
admet-2551	140	26	stat1	stat1	PROPN
admet-2551	140	27	pathway	pathway	NOUN
admet-2551	140	28	,	,	PUNCT
admet-2551	140	29	which	which	PRON
admet-2551	140	30	causes	cause	VERB
admet-2551	140	31	the	the	DET
admet-2551	140	32	antithrombotic	antithrombotic	ADJ
admet-2551	140	33	effect	effect	NOUN
admet-2551	140	34	.	.	PUNCT
admet-2551	141	1	as	as	ADP
admet-2551	141	2	a	a	DET
admet-2551	141	3	result	result	NOUN
admet-2551	141	4	of	of	ADP
admet-2551	141	5	the	the	DET
admet-2551	141	6	antithrombotic	antithrombotic	ADJ
admet-2551	141	7	and	and	CCONJ
admet-2551	141	8	antiapoptotic	antiapoptotic	ADJ
admet-2551	141	9	functions	function	NOUN
admet-2551	141	10	of	of	ADP
admet-2551	141	11	the	the	DET
admet-2551	141	12	janus	janus	PROPN
admet-2551	141	13	kinase	kinase	PROPN
admet-2551	141	14	1	1	NUM
admet-2551	141	15	/	/	SYM
admet-2551	141	16	signal	signal	NOUN
admet-2551	141	17	transducers	transducer	NOUN
admet-2551	141	18	and	and	CCONJ
admet-2551	141	19	transcriptional	transcriptional	ADJ
admet-2551	141	20	activators	activator	NOUN
admet-2551	141	21	1	1	NUM
admet-2551	141	22	(	(	PUNCT
admet-2551	141	23	jak1	jak1	PROPN
admet-2551	141	24	/	/	SYM
admet-2551	141	25	stat1	stat1	PROPN
admet-2551	141	26	)	)	PUNCT
admet-2551	141	27	,	,	PUNCT
admet-2551	141	28	the	the	DET
admet-2551	141	29	brain	brain	NOUN
admet-2551	141	30	was	be	AUX
admet-2551	141	31	protected	protect	VERB
admet-2551	141	32	from	from	ADP
admet-2551	141	33	ischemic	ischemic	ADJ
admet-2551	141	34	damage	damage	NOUN
admet-2551	141	35	through	through	ADP
admet-2551	141	36	the	the	DET
admet-2551	141	37	action	action	NOUN
admet-2551	141	38	of	of	ADP
admet-2551	141	39	icam-1	icam-1	NUM
admet-2551	141	40	and	and	CCONJ
admet-2551	141	41	janus	janus	PROPN
admet-2551	141	42	kinase	kinase	PROPN
admet-2551	141	43	1	1	NUM
admet-2551	141	44	on	on	ADP
admet-2551	141	45	the	the	DET
admet-2551	141	46	brain	brain	NOUN
admet-2551	141	47	's	's	PART
admet-2551	141	48	intercellular	intercellular	ADJ
admet-2551	141	49	adhesion	adhesion	NOUN
admet-2551	141	50	mechanisms	mechanism	NOUN
admet-2551	141	51	[	[	X
admet-2551	141	52	51	51	NUM
admet-2551	141	53	]	]	PUNCT
admet-2551	141	54	.	.	PUNCT
admet-2551	142	1	when	when	SCONJ
admet-2551	142	2	an	an	DET
admet-2551	142	3	artificial	artificial	ADJ
admet-2551	142	4	organ	organ	NOUN
admet-2551	142	5	is	be	AUX
admet-2551	142	6	transplanted	transplant	VERB
admet-2551	142	7	,	,	PUNCT
admet-2551	142	8	a	a	DET
admet-2551	142	9	small	small	ADJ
admet-2551	142	10	thrombus	thrombus	NOUN
admet-2551	142	11	usually	usually	ADV
admet-2551	142	12	forms	form	VERB
admet-2551	142	13	on	on	ADP
admet-2551	142	14	the	the	DET
admet-2551	142	15	surface	surface	NOUN
admet-2551	142	16	of	of	ADP
admet-2551	142	17	the	the	DET
admet-2551	142	18	graft	graft	NOUN
admet-2551	142	19	,	,	PUNCT
admet-2551	142	20	which	which	PRON
admet-2551	142	21	may	may	AUX
admet-2551	142	22	lead	lead	VERB
admet-2551	142	23	to	to	ADP
admet-2551	142	24	serious	serious	ADJ
admet-2551	142	25	complications	complication	NOUN
admet-2551	142	26	,	,	PUNCT
admet-2551	142	27	such	such	ADJ
admet-2551	142	28	as	as	ADP
admet-2551	142	29	the	the	DET
admet-2551	142	30	rejection	rejection	NOUN
admet-2551	142	31	of	of	ADP
admet-2551	142	32	the	the	DET
admet-2551	142	33	graft	graft	NOUN
admet-2551	142	34	if	if	SCONJ
admet-2551	142	35	the	the	DET
admet-2551	142	36	thrombus	thrombus	NOUN
admet-2551	142	37	is	be	AUX
admet-2551	142	38	not	not	PART
admet-2551	142	39	removed	remove	VERB
admet-2551	142	40	.	.	PUNCT
admet-2551	143	1	despite	despite	SCONJ
admet-2551	143	2	the	the	DET
admet-2551	143	3	fact	fact	NOUN
admet-2551	143	4	that	that	SCONJ
admet-2551	143	5	there	there	PRON
admet-2551	143	6	has	have	AUX
admet-2551	143	7	been	be	AUX
admet-2551	143	8	considerable	considerable	ADJ
admet-2551	143	9	achievement	achievement	NOUN
admet-2551	143	10	in	in	ADP
admet-2551	143	11	the	the	DET
admet-2551	143	12	field	field	NOUN
admet-2551	143	13	of	of	ADP
admet-2551	143	14	medicine	medicine	NOUN
admet-2551	143	15	,	,	PUNCT
admet-2551	143	16	there	there	PRON
admet-2551	143	17	is	be	VERB
admet-2551	143	18	still	still	ADV
admet-2551	143	19	a	a	DET
admet-2551	143	20	concern	concern	NOUN
admet-2551	143	21	about	about	ADP
admet-2551	143	22	the	the	DET
admet-2551	143	23	compatibility	compatibility	NOUN
admet-2551	143	24	of	of	ADP
admet-2551	143	25	the	the	DET
admet-2551	143	26	organ	organ	NOUN
admet-2551	143	27	with	with	ADP
admet-2551	143	28	the	the	DET
admet-2551	143	29	improvement	improvement	NOUN
admet-2551	143	30	in	in	ADP
admet-2551	143	31	blood	blood	NOUN
admet-2551	143	32	circulation	circulation	NOUN
admet-2551	143	33	,	,	PUNCT
admet-2551	143	34	which	which	PRON
admet-2551	143	35	leads	lead	VERB
admet-2551	143	36	to	to	ADP
admet-2551	143	37	offensive	offensive	ADJ
admet-2551	143	38	results	result	NOUN
admet-2551	143	39	in	in	ADP
admet-2551	143	40	transplantations	transplantation	NOUN
admet-2551	143	41	.	.	PUNCT
admet-2551	144	1	maleic	maleic	VERB
admet-2551	144	2	anhydride	anhydride	NOUN
admet-2551	144	3	-	-	PUNCT
admet-2551	144	4	methyl	methyl	NOUN
admet-2551	144	5	vinyl	vinyl	NOUN
admet-2551	144	6	ether	ether	NOUN
admet-2551	144	7	(	(	PUNCT
admet-2551	144	8	ma	ma	NOUN
admet-2551	144	9	-	-	PUNCT
admet-2551	144	10	mve	mve	NOUN
admet-2551	144	11	)	)	PUNCT
admet-2551	144	12	has	have	AUX
admet-2551	144	13	been	be	AUX
admet-2551	144	14	used	use	VERB
admet-2551	144	15	as	as	ADP
admet-2551	144	16	a	a	DET
admet-2551	144	17	catalyst	catalyst	NOUN
admet-2551	144	18	for	for	ADP
admet-2551	144	19	immobilizing	immobilize	VERB
admet-2551	144	20	the	the	DET
admet-2551	144	21	lk	lk	NOUN
admet-2551	144	22	on	on	ADP
admet-2551	144	23	polyurethane	polyurethane	NOUN
admet-2551	144	24	and	and	CCONJ
admet-2551	144	25	,	,	PUNCT
admet-2551	144	26	as	as	ADP
admet-2551	144	27	a	a	DET
admet-2551	144	28	result	result	NOUN
admet-2551	144	29	,	,	PUNCT
admet-2551	144	30	has	have	AUX
admet-2551	144	31	shown	show	VERB
admet-2551	144	32	high	high	ADJ
admet-2551	144	33	anti	anti	ADJ
admet-2551	144	34	-	-	ADJ
admet-2551	144	35	thrombogenic	thrombogenic	ADJ
admet-2551	144	36	activity	activity	NOUN
admet-2551	144	37	,	,	PUNCT
admet-2551	144	38	and	and	CCONJ
admet-2551	144	39	has	have	AUX
admet-2551	144	40	reduced	reduce	VERB
admet-2551	144	41	the	the	DET
admet-2551	144	42	formation	formation	NOUN
admet-2551	144	43	of	of	ADP
admet-2551	144	44	surface	surface	NOUN
admet-2551	144	45	-	-	PUNCT
admet-2551	144	46	induced	induce	VERB
admet-2551	144	47	thrombi	thrombi	NOUN
admet-2551	144	48	.	.	PUNCT
admet-2551	145	1	there	there	PRON
admet-2551	145	2	is	be	VERB
admet-2551	145	3	a	a	DET
admet-2551	145	4	possibility	possibility	NOUN
admet-2551	145	5	that	that	SCONJ
admet-2551	145	6	an	an	DET
admet-2551	145	7	immobilized	immobilized	ADJ
admet-2551	145	8	lk	lk	NOUN
admet-2551	145	9	surface	surface	NOUN
admet-2551	145	10	may	may	AUX
admet-2551	145	11	reduce	reduce	VERB
admet-2551	145	12	the	the	DET
admet-2551	145	13	adhesion	adhesion	NOUN
admet-2551	145	14	and	and	CCONJ
admet-2551	145	15	activation	activation	NOUN
admet-2551	145	16	of	of	ADP
admet-2551	145	17	platelets	platelet	NOUN
admet-2551	145	18	by	by	ADP
admet-2551	145	19	inhibiting	inhibit	VERB
admet-2551	145	20	fibrinogen	fibrinogen	NOUN
admet-2551	145	21	adsorption	adsorption	NOUN
admet-2551	145	22	or	or	CCONJ
admet-2551	145	23	by	by	ADP
admet-2551	145	24	altering	alter	VERB
admet-2551	145	25	the	the	DET
admet-2551	145	26	conformation	conformation	NOUN
admet-2551	145	27	of	of	ADP
admet-2551	145	28	adsorbed	adsorb	VERB
admet-2551	145	29	fibrinogen	fibrinogen	NOUN
admet-2551	145	30	at	at	ADP
admet-2551	145	31	an	an	DET
admet-2551	145	32	early	early	ADJ
admet-2551	145	33	stage	stage	NOUN
admet-2551	145	34	of	of	ADP
admet-2551	145	35	blood	blood	NOUN
admet-2551	145	36	contact	contact	NOUN
admet-2551	145	37	by	by	ADP
admet-2551	145	38	decreasing	decrease	VERB
admet-2551	145	39	their	their	PRON
admet-2551	145	40	adhesion	adhesion	NOUN
admet-2551	145	41	and	and	CCONJ
admet-2551	145	42	activation	activation	NOUN
admet-2551	145	43	[	[	X
admet-2551	145	44	52	52	NUM
admet-2551	145	45	]	]	PUNCT
admet-2551	145	46	.	.	PUNCT
admet-2551	146	1	the	the	DET
admet-2551	146	2	oral	oral	ADJ
admet-2551	146	3	administration	administration	NOUN
admet-2551	146	4	of	of	ADP
admet-2551	146	5	lk	lk	PROPN
admet-2551	146	6	led	lead	VERB
admet-2551	146	7	to	to	ADP
admet-2551	146	8	a	a	DET
admet-2551	146	9	significant	significant	ADJ
admet-2551	146	10	increase	increase	NOUN
admet-2551	146	11	in	in	ADP
admet-2551	146	12	the	the	DET
admet-2551	146	13	levels	level	NOUN
admet-2551	146	14	of	of	ADP
admet-2551	146	15	silent	silent	ADJ
admet-2551	146	16	information	information	NOUN
admet-2551	146	17	regulators	regulator	NOUN
admet-2551	146	18	(	(	PUNCT
admet-2551	146	19	sirt1	sirt1	NOUN
admet-2551	146	20	)	)	PUNCT
admet-2551	146	21	,	,	PUNCT
admet-2551	146	22	respectively	respectively	ADV
admet-2551	146	23	.	.	PUNCT
admet-2551	147	1	the	the	DET
admet-2551	147	2	study	study	NOUN
admet-2551	147	3	report	report	NOUN
admet-2551	147	4	suggested	suggest	VERB
admet-2551	147	5	that	that	SCONJ
admet-2551	147	6	the	the	DET
admet-2551	147	7	post	post	ADJ
admet-2551	147	8	-	-	ADJ
admet-2551	147	9	ischemic	ischemic	ADJ
admet-2551	147	10	treatment	treatment	NOUN
admet-2551	147	11	with	with	ADP
admet-2551	147	12	lk	lk	NOUN
admet-2551	147	13	from	from	ADP
admet-2551	147	14	earthworm	earthworm	NOUN
admet-2551	147	15	mitigated	mitigate	VERB
admet-2551	147	16	myocardial	myocardial	ADJ
admet-2551	147	17	ir	ir	PROPN
admet-2551	147	18	injury	injury	NOUN
admet-2551	147	19	by	by	ADP
admet-2551	147	20	stimulating	stimulate	VERB
admet-2551	147	21	sirt1	sirt1	NOUN
admet-2551	147	22	and	and	CCONJ
admet-2551	147	23	,	,	PUNCT
admet-2551	147	24	enhancing	enhance	VERB
admet-2551	147	25	autophagic	autophagic	ADJ
admet-2551	147	26	flux	flux	NOUN
admet-2551	147	27	,	,	PUNCT
admet-2551	147	28	and	and	CCONJ
admet-2551	147	29	reducing	reduce	VERB
admet-2551	147	30	ir	ir	NOUN
admet-2551	147	31	-	-	ADJ
admet-2551	147	32	induced	induced	ADJ
admet-2551	147	33	injury	injury	NOUN
admet-2551	148	1	[	[	X
admet-2551	148	2	53	53	NUM
admet-2551	148	3	]	]	PUNCT
admet-2551	148	4	.	.	PUNCT
admet-2551	149	1	another	another	DET
admet-2551	149	2	study	study	NOUN
admet-2551	149	3	conducted	conduct	VERB
admet-2551	149	4	by	by	ADP
admet-2551	149	5	wang	wang	PROPN
admet-2551	149	6	et	et	PROPN
admet-2551	149	7	al	al	PROPN
admet-2551	149	8	.	.	PROPN
admet-2551	149	9	evaluated	evaluate	VERB
admet-2551	149	10	that	that	SCONJ
admet-2551	149	11	lk	lk	PROPN
admet-2551	149	12	(	(	PUNCT
admet-2551	149	13	10	10	NUM
admet-2551	149	14	µg	µg	NOUN
admet-2551	149	15	/	/	SYM
admet-2551	149	16	kg	kg	NOUN
admet-2551	149	17	)	)	PUNCT
admet-2551	149	18	exhibits	exhibit	VERB
admet-2551	149	19	protective	protective	ADJ
admet-2551	149	20	effects	effect	NOUN
admet-2551	149	21	against	against	ADP
admet-2551	149	22	heart	heart	NOUN
admet-2551	149	23	disorder	disorder	NOUN
admet-2551	149	24	in	in	ADP
admet-2551	149	25	a	a	DET
admet-2551	149	26	rat	rat	NOUN
admet-2551	149	27	model	model	NOUN
admet-2551	149	28	[	[	X
admet-2551	149	29	54	54	NUM
admet-2551	149	30	]	]	PUNCT
admet-2551	149	31	.	.	PUNCT
admet-2551	150	1	this	this	DET
admet-2551	150	2	collection	collection	NOUN
admet-2551	150	3	of	of	ADP
admet-2551	150	4	evidence	evidence	NOUN
admet-2551	150	5	could	could	AUX
admet-2551	150	6	successfully	successfully	ADV
admet-2551	150	7	conclude	conclude	VERB
admet-2551	150	8	that	that	SCONJ
admet-2551	150	9	lk	lk	PROPN
admet-2551	150	10	has	have	AUX
admet-2551	150	11	promising	promise	VERB
admet-2551	150	12	applications	application	NOUN
admet-2551	150	13	in	in	ADP
admet-2551	150	14	biomedicine	biomedicine	NOUN
admet-2551	150	15	.	.	PUNCT
admet-2551	151	1	serratiopeptidase	serratiopeptidase	PROPN
admet-2551	151	2	serratiopeptidase	serratiopeptidase	PROPN
admet-2551	151	3	(	(	PUNCT
admet-2551	151	4	sp	sp	NOUN
admet-2551	151	5	)	)	PUNCT
admet-2551	151	6	(	(	PUNCT
admet-2551	151	7	ec	ec	PROPN
admet-2551	151	8	number	number	NOUN
admet-2551	151	9	3.4.24.40	3.4.24.40	NUM
admet-2551	151	10	)	)	PUNCT
admet-2551	151	11	is	be	AUX
admet-2551	151	12	an	an	DET
admet-2551	151	13	active	active	ADJ
admet-2551	151	14	proteolytic	proteolytic	ADJ
admet-2551	151	15	enzyme	enzyme	NOUN
admet-2551	151	16	found	find	VERB
admet-2551	151	17	in	in	ADP
admet-2551	151	18	enterobacteria	enterobacteria	PROPN
admet-2551	151	19	serratia	serratia	PROPN
admet-2551	151	20	marcescens	marcescen	NOUN
admet-2551	151	21	(	(	PUNCT
admet-2551	151	22	gram	gram	NOUN
admet-2551	151	23	-	-	PUNCT
admet-2551	151	24	negative	negative	ADJ
admet-2551	151	25	bacteria	bacteria	NOUN
admet-2551	151	26	)	)	PUNCT
admet-2551	151	27	and	and	CCONJ
admet-2551	151	28	belongs	belong	VERB
admet-2551	151	29	to	to	ADP
admet-2551	151	30	the	the	DET
admet-2551	151	31	family	family	NOUN
admet-2551	151	32	of	of	ADP
admet-2551	151	33	alkaline	alkaline	ADJ
admet-2551	151	34	serine	serine	NOUN
admet-2551	151	35	protease	protease	NOUN
admet-2551	151	36	.	.	PUNCT
admet-2551	152	1	it	it	PRON
admet-2551	152	2	has	have	VERB
admet-2551	152	3	a	a	DET
admet-2551	152	4	molecular	molecular	ADJ
admet-2551	152	5	weight	weight	NOUN
admet-2551	152	6	of	of	ADP
admet-2551	152	7	45	45	NUM
admet-2551	152	8	kda	kda	NOUN
admet-2551	152	9	to	to	ADP
admet-2551	152	10	60	60	NUM
admet-2551	152	11	kda	kda	NOUN
admet-2551	152	12	and	and	CCONJ
admet-2551	152	13	comprises	comprise	VERB
admet-2551	152	14	three	three	NUM
admet-2551	152	15	zinc	zinc	NOUN
admet-2551	152	16	atoms	atom	NOUN
admet-2551	152	17	as	as	ADP
admet-2551	152	18	ligands	ligand	NOUN
admet-2551	152	19	at	at	ADP
admet-2551	152	20	the	the	DET
admet-2551	152	21	active	active	ADJ
admet-2551	152	22	site	site	NOUN
admet-2551	152	23	[	[	X
admet-2551	152	24	55	55	NUM
admet-2551	152	25	]	]	PUNCT
admet-2551	152	26	.	.	PUNCT
admet-2551	153	1	sp	sp	AUX
admet-2551	153	2	can	can	AUX
admet-2551	153	3	not	not	PART
admet-2551	153	4	bind	bind	VERB
admet-2551	153	5	proteins	protein	NOUN
admet-2551	153	6	in	in	ADP
admet-2551	153	7	healthy	healthy	ADJ
admet-2551	153	8	tissues	tissue	NOUN
admet-2551	153	9	since	since	SCONJ
admet-2551	153	10	its	its	PRON
admet-2551	153	11	chemical	chemical	NOUN
admet-2551	153	12	structure	structure	NOUN
admet-2551	153	13	prevents	prevent	VERB
admet-2551	153	14	it	it	PRON
admet-2551	153	15	from	from	ADP
admet-2551	153	16	doing	do	VERB
admet-2551	153	17	so	so	ADV
admet-2551	153	18	[	[	X
admet-2551	153	19	56	56	NUM
admet-2551	153	20	]	]	PUNCT
admet-2551	153	21	.	.	PUNCT
admet-2551	154	1	sp	sp	NOUN
admet-2551	154	2	depends	depend	VERB
admet-2551	154	3	on	on	ADP
admet-2551	154	4	secretory	secretory	ADJ
admet-2551	154	5	protein	protein	NOUN
admet-2551	154	6	on	on	ADP
admet-2551	154	7	the	the	DET
admet-2551	154	8	membrane	membrane	NOUN
admet-2551	154	9	for	for	ADP
admet-2551	154	10	its	its	PRON
admet-2551	154	11	production	production	NOUN
admet-2551	154	12	,	,	PUNCT
admet-2551	154	13	and	and	CCONJ
admet-2551	154	14	the	the	DET
admet-2551	154	15	n	n	CCONJ
admet-2551	154	16	-	-	PUNCT
admet-2551	154	17	terminal	terminal	ADJ
admet-2551	154	18	signal	signal	NOUN
admet-2551	154	19	peptide	peptide	NOUN
admet-2551	154	20	-	-	PUNCT
admet-2551	154	21	independent	independent	ADJ
admet-2551	154	22	pathway	pathway	NOUN
admet-2551	154	23	secretes	secrete	NOUN
admet-2551	154	24	it	it	PRON
admet-2551	155	1	[	[	X
admet-2551	155	2	57	57	NUM
admet-2551	155	3	]	]	PUNCT
admet-2551	155	4	.	.	PUNCT
admet-2551	156	1	sp	sp	NOUN
admet-2551	156	2	is	be	AUX
admet-2551	156	3	considered	consider	VERB
admet-2551	156	4	by	by	ADP
admet-2551	156	5	high	high	ADJ
admet-2551	156	6	-	-	PUNCT
admet-2551	156	7	level	level	NOUN
admet-2551	156	8	specificity	specificity	NOUN
admet-2551	156	9	towards	towards	ADP
admet-2551	156	10	its	its	PRON
admet-2551	156	11	substrate	substrate	NOUN
admet-2551	156	12	.	.	PUNCT
admet-2551	157	1	the	the	DET
admet-2551	157	2	fibrinolytic	fibrinolytic	ADJ
admet-2551	157	3	enzyme	enzyme	NOUN
admet-2551	157	4	activity	activity	NOUN
admet-2551	157	5	of	of	ADP
admet-2551	157	6	sp	sp	NOUN
admet-2551	157	7	is	be	AUX
admet-2551	157	8	due	due	ADJ
admet-2551	157	9	to	to	ADP
admet-2551	157	10	its	its	PRON
admet-2551	157	11	activity	activity	NOUN
admet-2551	157	12	in	in	ADP
admet-2551	157	13	the	the	DET
admet-2551	157	14	degradation	degradation	NOUN
admet-2551	157	15	of	of	ADP
admet-2551	157	16	insoluble	insoluble	ADJ
admet-2551	157	17	proteins	protein	NOUN
admet-2551	157	18	,	,	PUNCT
admet-2551	157	19	such	such	ADJ
admet-2551	157	20	as	as	ADP
admet-2551	157	21	fibrin	fibrin	NOUN
admet-2551	157	22	and	and	CCONJ
admet-2551	157	23	other	other	ADJ
admet-2551	157	24	mediators	mediator	NOUN
admet-2551	157	25	of	of	ADP
admet-2551	157	26	inflammation	inflammation	NOUN
admet-2551	157	27	[	[	X
admet-2551	157	28	58	58	NUM
admet-2551	157	29	]	]	PUNCT
admet-2551	157	30	.	.	PUNCT
admet-2551	158	1	they	they	PRON
admet-2551	158	2	were	be	AUX
admet-2551	158	3	also	also	ADV
admet-2551	158	4	used	use	VERB
admet-2551	158	5	to	to	PART
admet-2551	158	6	treat	treat	VERB
admet-2551	158	7	several	several	ADJ
admet-2551	158	8	chronic	chronic	ADJ
admet-2551	158	9	disorders	disorder	NOUN
admet-2551	158	10	like	like	ADP
admet-2551	158	11	arthritis	arthritis	NOUN
admet-2551	158	12	,	,	PUNCT
admet-2551	158	13	atherosclerosis	atherosclerosis	NOUN
admet-2551	158	14	,	,	PUNCT
admet-2551	158	15	bronchitis	bronchitis	NOUN
admet-2551	158	16	,	,	PUNCT
admet-2551	158	17	fibrocystic	fibrocystic	ADJ
admet-2551	158	18	breast	breast	NOUN
admet-2551	158	19	disease	disease	NOUN
admet-2551	158	20	,	,	PUNCT
admet-2551	158	21	carpal	carpal	NOUN
admet-2551	158	22	tunnel	tunnel	NOUN
admet-2551	158	23	syndrome	syndrome	PROPN
admet-2551	158	24	,	,	PUNCT
admet-2551	158	25	crohn	crohn	PROPN
admet-2551	158	26	’s	’s	PART
admet-2551	158	27	disease	disease	NOUN
admet-2551	158	28	,	,	PUNCT
admet-2551	158	29	traumatic	traumatic	ADJ
admet-2551	158	30	swelling	swelling	NOUN
admet-2551	158	31	,	,	PUNCT
admet-2551	158	32	leg	leg	NOUN
admet-2551	158	33	ulcers	ulcer	NOUN
admet-2551	158	34	,	,	PUNCT
admet-2551	158	35	fibromyalgia	fibromyalgia	NOUN
admet-2551	158	36	,	,	PUNCT
admet-2551	158	37	migraine	migraine	NOUN
admet-2551	158	38	,	,	PUNCT
admet-2551	158	39	breast	breast	NOUN
admet-2551	158	40	engorgement	engorgement	NOUN
admet-2551	158	41	,	,	PUNCT
admet-2551	158	42	sinusitis	sinusitis	NOUN
admet-2551	158	43	,	,	PUNCT
admet-2551	158	44	lung	lung	NOUN
admet-2551	158	45	disorders	disorder	NOUN
admet-2551	158	46	,	,	PUNCT
admet-2551	158	47	hepatitis	hepatitis	NOUN
admet-2551	158	48	,	,	PUNCT
admet-2551	158	49	diabetes	diabetes	NOUN
admet-2551	158	50	,	,	PUNCT
admet-2551	158	51	thrombosis	thrombosis	NOUN
admet-2551	158	52	,	,	PUNCT
admet-2551	158	53	carotid	carotid	NOUN
admet-2551	158	54	artery	artery	NOUN
admet-2551	158	55	blockage	blockage	NOUN
admet-2551	158	56	,	,	PUNCT
admet-2551	158	57	and	and	CCONJ
admet-2551	158	58	uterine	uterine	ADJ
admet-2551	158	59	fibroids	fibroid	NOUN
admet-2551	158	60	[	[	X
admet-2551	158	61	59,60	59,60	NUM
admet-2551	158	62	]	]	PUNCT
admet-2551	158	63	.	.	PUNCT
admet-2551	159	1	this	this	DET
admet-2551	159	2	enzyme	enzyme	NOUN
admet-2551	159	3	is	be	AUX
admet-2551	159	4	available	available	ADJ
admet-2551	159	5	as	as	ADP
admet-2551	159	6	a	a	DET
admet-2551	159	7	supplement	supplement	NOUN
admet-2551	159	8	to	to	PART
admet-2551	159	9	enhance	enhance	VERB
admet-2551	159	10	the	the	DET
admet-2551	159	11	cardiovascular	cardiovascular	ADJ
admet-2551	159	12	system	system	NOUN
admet-2551	159	13	and	and	CCONJ
admet-2551	159	14	overall	overall	ADJ
admet-2551	159	15	health	health	NOUN
admet-2551	159	16	.	.	PUNCT
admet-2551	160	1	the	the	DET
admet-2551	160	2	enzyme	enzyme	NOUN
admet-2551	160	3	sp	sp	NOUN
admet-2551	160	4	is	be	AUX
admet-2551	160	5	also	also	ADV
admet-2551	160	6	considered	consider	VERB
admet-2551	160	7	to	to	PART
admet-2551	160	8	be	be	AUX
admet-2551	160	9	a	a	DET
admet-2551	160	10	healing	healing	NOUN
admet-2551	160	11	enzyme	enzyme	NOUN
admet-2551	160	12	because	because	SCONJ
admet-2551	160	13	it	it	PRON
admet-2551	160	14	admet	admet	PROPN
admet-2551	160	15	&	&	CCONJ
admet-2551	160	16	dmpk	dmpk	PROPN
admet-2551	160	17	12(6	12(6	NUM
admet-2551	160	18	)	)	PUNCT
admet-2551	160	19	(	(	PUNCT
admet-2551	160	20	2024	2024	NUM
admet-2551	160	21	)	)	PUNCT
admet-2551	160	22	797	797	NUM
admet-2551	160	23	-	-	SYM
admet-2551	160	24	820	820	NUM
admet-2551	160	25	natural	natural	ADJ
admet-2551	160	26	serine	serine	NOUN
admet-2551	160	27	proteases	protease	NOUN
admet-2551	160	28	in	in	ADP
admet-2551	160	29	combating	combat	VERB
admet-2551	160	30	amyloid	amyloid	NOUN
admet-2551	160	31	formation	formation	NOUN
admet-2551	160	32	doi	doi	NOUN
admet-2551	160	33	:	:	PUNCT
admet-2551	160	34	https://doi.org/10.5599/admet.2551	https://doi.org/10.5599/admet.2551	NOUN
admet-2551	160	35	803	803	NUM
admet-2551	160	36	heals	heal	VERB
admet-2551	160	37	sprained	sprain	VERB
admet-2551	160	38	muscles	muscle	NOUN
admet-2551	160	39	,	,	PUNCT
admet-2551	160	40	traumatic	traumatic	ADJ
admet-2551	160	41	injuries	injury	NOUN
admet-2551	160	42	,	,	PUNCT
admet-2551	160	43	leg	leg	NOUN
admet-2551	160	44	ulcers	ulcer	NOUN
admet-2551	160	45	,	,	PUNCT
admet-2551	160	46	and	and	CCONJ
admet-2551	160	47	torn	torn	ADJ
admet-2551	160	48	ligaments	ligament	NOUN
admet-2551	160	49	,	,	PUNCT
admet-2551	160	50	drains	drain	VERB
admet-2551	160	51	mucus	mucus	NOUN
admet-2551	160	52	,	,	PUNCT
admet-2551	160	53	postoperative	postoperative	ADJ
admet-2551	160	54	inflammation	inflammation	NOUN
admet-2551	160	55	,	,	PUNCT
admet-2551	160	56	and	and	CCONJ
admet-2551	160	57	reduces	reduce	VERB
admet-2551	160	58	the	the	DET
admet-2551	160	59	viscosity	viscosity	NOUN
admet-2551	160	60	and	and	CCONJ
admet-2551	160	61	elasticity	elasticity	NOUN
admet-2551	160	62	of	of	ADP
admet-2551	160	63	nasal	nasal	PROPN
admet-2551	160	64	mucus	mucus	NOUN
admet-2551	161	1	[	[	X
admet-2551	161	2	61	61	NUM
admet-2551	161	3	]	]	PUNCT
admet-2551	161	4	.	.	PUNCT
admet-2551	162	1	the	the	DET
admet-2551	162	2	gene	gene	NOUN
admet-2551	162	3	encoding	encoding	NOUN
admet-2551	162	4	sp	sp	NOUN
admet-2551	162	5	is	be	AUX
admet-2551	162	6	composed	compose	VERB
admet-2551	162	7	of	of	ADP
admet-2551	162	8	470	470	NUM
admet-2551	162	9	amino	amino	NOUN
admet-2551	162	10	acids	acid	NOUN
admet-2551	162	11	.	.	PUNCT
admet-2551	163	1	sp	sp	ADP
admet-2551	163	2	amino	amino	NOUN
admet-2551	163	3	acid	acid	NOUN
admet-2551	163	4	sequence	sequence	NOUN
admet-2551	163	5	is	be	AUX
admet-2551	163	6	free	free	ADJ
admet-2551	163	7	from	from	ADP
admet-2551	163	8	sulfur	sulfur	NOUN
admet-2551	163	9	,	,	PUNCT
admet-2551	163	10	methionine	methionine	NOUN
admet-2551	163	11	,	,	PUNCT
admet-2551	163	12	and	and	CCONJ
admet-2551	163	13	cysteine	cysteine	NOUN
admet-2551	164	1	[	[	X
admet-2551	164	2	62	62	NUM
admet-2551	164	3	]	]	PUNCT
admet-2551	164	4	with	with	ADP
admet-2551	164	5	a	a	DET
admet-2551	164	6	g	g	NOUN
admet-2551	164	7	+	+	NOUN
admet-2551	164	8	c	c	NOUN
admet-2551	164	9	content	content	NOUN
admet-2551	164	10	of	of	ADP
admet-2551	164	11	58	58	NUM
admet-2551	164	12	%	%	NOUN
admet-2551	165	1	[	[	X
admet-2551	165	2	63	63	NUM
admet-2551	165	3	]	]	PUNCT
admet-2551	165	4	.	.	PUNCT
admet-2551	166	1	the	the	DET
admet-2551	166	2	maximum	maximum	ADJ
admet-2551	166	3	sp	sp	ADP
admet-2551	166	4	activity	activity	NOUN
admet-2551	166	5	is	be	AUX
admet-2551	166	6	at	at	ADP
admet-2551	166	7	ph	ph	PROPN
admet-2551	166	8	9.0	9.0	NUM
admet-2551	166	9	and	and	CCONJ
admet-2551	166	10	a	a	DET
admet-2551	166	11	temperature	temperature	NOUN
admet-2551	166	12	of	of	ADP
admet-2551	166	13	up	up	ADP
admet-2551	166	14	to	to	PART
admet-2551	166	15	40	40	NUM
admet-2551	166	16	°	°	NOUN
admet-2551	166	17	c	c	NOUN
admet-2551	166	18	[	[	X
admet-2551	166	19	58	58	NUM
admet-2551	166	20	]	]	PUNCT
admet-2551	166	21	.	.	PUNCT
admet-2551	167	1	the	the	DET
admet-2551	167	2	saturation	saturation	NOUN
admet-2551	167	3	point	point	NOUN
admet-2551	167	4	where	where	SCONJ
admet-2551	167	5	sp	sp	NOUN
admet-2551	167	6	is	be	AUX
admet-2551	167	7	thoroughly	thoroughly	ADV
admet-2551	167	8	degraded	degraded	ADJ
admet-2551	167	9	was	be	AUX
admet-2551	167	10	found	find	VERB
admet-2551	167	11	to	to	PART
admet-2551	167	12	be	be	AUX
admet-2551	167	13	at	at	ADP
admet-2551	167	14	55	55	NUM
admet-2551	167	15	°	°	NOUN
admet-2551	167	16	c	c	NOUN
admet-2551	167	17	[	[	X
admet-2551	167	18	62	62	NUM
admet-2551	167	19	]	]	PUNCT
admet-2551	167	20	.	.	PUNCT
admet-2551	168	1	the	the	DET
admet-2551	168	2	isoelectric	isoelectric	ADJ
admet-2551	168	3	point	point	NOUN
admet-2551	168	4	of	of	ADP
admet-2551	168	5	sp	sp	NOUN
admet-2551	168	6	is	be	AUX
admet-2551	168	7	found	find	VERB
admet-2551	168	8	to	to	PART
admet-2551	168	9	be	be	AUX
admet-2551	168	10	5.3	5.3	NUM
admet-2551	168	11	[	[	X
admet-2551	168	12	64	64	NUM
admet-2551	168	13	]	]	PUNCT
admet-2551	168	14	.	.	PUNCT
admet-2551	169	1	the	the	DET
admet-2551	169	2	gene	gene	NOUN
admet-2551	169	3	sequence	sequence	NOUN
admet-2551	169	4	of	of	ADP
admet-2551	169	5	sp	sp	NOUN
admet-2551	169	6	is	be	AUX
admet-2551	169	7	cloned	clone	VERB
admet-2551	169	8	and	and	CCONJ
admet-2551	169	9	sequenced	sequence	VERB
admet-2551	169	10	,	,	PUNCT
admet-2551	169	11	and	and	CCONJ
admet-2551	169	12	its	its	PRON
admet-2551	169	13	crystal	crystal	NOUN
admet-2551	169	14	structure	structure	NOUN
admet-2551	169	15	has	have	AUX
admet-2551	169	16	been	be	AUX
admet-2551	169	17	determined	determine	VERB
admet-2551	169	18	,	,	PUNCT
admet-2551	169	19	as	as	SCONJ
admet-2551	169	20	shown	show	VERB
admet-2551	169	21	in	in	ADP
admet-2551	169	22	figure	figure	NOUN
admet-2551	169	23	3	3	NUM
admet-2551	169	24	[	[	X
admet-2551	169	25	63	63	NUM
admet-2551	169	26	]	]	PUNCT
admet-2551	169	27	.	.	PUNCT
admet-2551	170	1	serratia	serratia	PROPN
admet-2551	170	2	marcescens	marcescens	PROPN
admet-2551	170	3	hr-3	hr-3	PROPN
admet-2551	170	4	,	,	PUNCT
admet-2551	170	5	sp	sp	ADP
admet-2551	170	6	gene	gene	NOUN
admet-2551	170	7	was	be	AUX
admet-2551	170	8	expressed	express	VERB
admet-2551	170	9	in	in	ADP
admet-2551	170	10	e.	e.	PROPN
admet-2551	170	11	coli	coli	PROPN
admet-2551	170	12	(	(	PUNCT
admet-2551	170	13	de3	de3	NOUN
admet-2551	170	14	)	)	PUNCT
admet-2551	170	15	/	/	SYM
admet-2551	170	16	plyss	plyss	NOUN
admet-2551	170	17	using	use	VERB
admet-2551	170	18	the	the	DET
admet-2551	170	19	pet32a	pet32a	NOUN
admet-2551	170	20	(	(	PUNCT
admet-2551	170	21	+	+	ADJ
admet-2551	170	22	)	)	PUNCT
admet-2551	170	23	expression	expression	NOUN
admet-2551	170	24	vector	vector	NOUN
admet-2551	170	25	.	.	PUNCT
admet-2551	171	1	it	it	PRON
admet-2551	171	2	has	have	AUX
admet-2551	171	3	been	be	AUX
admet-2551	171	4	reported	report	VERB
admet-2551	171	5	that	that	SCONJ
admet-2551	171	6	the	the	DET
admet-2551	171	7	enzyme	enzyme	NOUN
admet-2551	171	8	is	be	AUX
admet-2551	171	9	highly	highly	ADV
admet-2551	171	10	expressed	express	VERB
admet-2551	171	11	as	as	ADP
admet-2551	171	12	inclusion	inclusion	NOUN
admet-2551	171	13	bodies	body	NOUN
admet-2551	171	14	and	and	CCONJ
admet-2551	171	15	that	that	SCONJ
admet-2551	171	16	purified	purify	VERB
admet-2551	171	17	sp	sp	NOUN
admet-2551	171	18	contains	contain	VERB
admet-2551	171	19	no	no	DET
admet-2551	171	20	activity	activity	NOUN
admet-2551	171	21	[	[	X
admet-2551	171	22	65	65	NUM
admet-2551	171	23	]	]	PUNCT
admet-2551	171	24	.	.	PUNCT
admet-2551	172	1	similarly	similarly	ADV
admet-2551	172	2	,	,	PUNCT
admet-2551	172	3	the	the	DET
admet-2551	172	4	sp	sp	NOUN
admet-2551	172	5	gene	gene	NOUN
admet-2551	172	6	from	from	ADP
admet-2551	172	7	serratia	serratia	PROPN
admet-2551	172	8	marcescens	marcescen	NOUN
admet-2551	172	9	strain	strain	VERB
admet-2551	172	10	sm6	sm6	ADV
admet-2551	172	11	was	be	AUX
admet-2551	172	12	allowed	allow	VERB
admet-2551	172	13	to	to	PART
admet-2551	172	14	express	express	VERB
admet-2551	172	15	in	in	ADP
admet-2551	172	16	e.	e.	PROPN
admet-2551	172	17	coli	coli	NOUN
admet-2551	172	18	by	by	ADP
admet-2551	172	19	using	use	VERB
admet-2551	172	20	the	the	DET
admet-2551	172	21	lac	lac	PROPN
admet-2551	172	22	promoter	promoter	NOUN
admet-2551	172	23	,	,	PUNCT
admet-2551	172	24	which	which	PRON
admet-2551	172	25	secreted	secrete	VERB
admet-2551	172	26	the	the	DET
admet-2551	172	27	enzyme	enzyme	NOUN
admet-2551	172	28	into	into	ADP
admet-2551	172	29	the	the	DET
admet-2551	172	30	medium	medium	NOUN
admet-2551	172	31	,	,	PUNCT
admet-2551	172	32	but	but	CCONJ
admet-2551	172	33	the	the	DET
admet-2551	172	34	enzyme	enzyme	NOUN
admet-2551	172	35	was	be	AUX
admet-2551	172	36	found	find	VERB
admet-2551	172	37	to	to	PART
admet-2551	172	38	be	be	AUX
admet-2551	172	39	inactive	inactive	ADJ
admet-2551	172	40	with	with	ADP
admet-2551	172	41	a	a	DET
admet-2551	172	42	high	high	ADJ
admet-2551	172	43	molecular	molecular	ADJ
admet-2551	172	44	weight	weight	NOUN
admet-2551	173	1	[	[	X
admet-2551	173	2	66	66	NUM
admet-2551	173	3	]	]	PUNCT
admet-2551	173	4	.	.	PUNCT
admet-2551	174	1	the	the	DET
admet-2551	174	2	structural	structural	ADJ
admet-2551	174	3	gene	gene	NOUN
admet-2551	174	4	of	of	ADP
admet-2551	174	5	sp	sp	NOUN
admet-2551	174	6	is	be	AUX
admet-2551	174	7	not	not	PART
admet-2551	174	8	clustered	cluster	VERB
admet-2551	174	9	with	with	ADP
admet-2551	174	10	the	the	DET
admet-2551	174	11	secretion	secretion	NOUN
admet-2551	174	12	genes	gene	NOUN
admet-2551	174	13	,	,	PUNCT
admet-2551	174	14	which	which	PRON
admet-2551	174	15	makes	make	VERB
admet-2551	174	16	improper	improper	ADJ
admet-2551	174	17	processing	processing	NOUN
admet-2551	174	18	of	of	ADP
admet-2551	174	19	the	the	DET
admet-2551	174	20	zymogen	zymogen	NOUN
admet-2551	174	21	protease	protease	NOUN
admet-2551	174	22	that	that	PRON
admet-2551	174	23	is	be	AUX
admet-2551	174	24	dysfunctional	dysfunctional	ADJ
admet-2551	174	25	in	in	ADP
admet-2551	174	26	the	the	DET
admet-2551	174	27	e.coli	e.coli	NOUN
admet-2551	174	28	expression	expression	NOUN
admet-2551	174	29	system	system	NOUN
admet-2551	174	30	,	,	PUNCT
admet-2551	174	31	making	make	VERB
admet-2551	174	32	the	the	DET
admet-2551	174	33	recombinant	recombinant	NOUN
admet-2551	174	34	sp	sp	ADP
admet-2551	174	35	inactive	inactive	ADJ
admet-2551	174	36	[	[	X
admet-2551	174	37	67	67	NUM
admet-2551	174	38	]	]	PUNCT
admet-2551	174	39	.	.	PUNCT
admet-2551	175	1	further	far	ADV
admet-2551	175	2	,	,	PUNCT
admet-2551	175	3	the	the	DET
admet-2551	175	4	sp	sp	NOUN
admet-2551	175	5	gene	gene	NOUN
admet-2551	175	6	was	be	AUX
admet-2551	175	7	cloned	clone	VERB
admet-2551	175	8	into	into	ADP
admet-2551	175	9	the	the	DET
admet-2551	175	10	ppiczαa	ppiczαa	NOUN
admet-2551	175	11	pichia	pichia	NOUN
admet-2551	175	12	expression	expression	NOUN
admet-2551	175	13	vector	vector	NOUN
admet-2551	175	14	and	and	CCONJ
admet-2551	175	15	electrotransformed	electrotransforme	VERB
admet-2551	175	16	into	into	ADP
admet-2551	175	17	the	the	DET
admet-2551	175	18	pichia	pichia	NOUN
admet-2551	175	19	pastoris	pastoris	PROPN
admet-2551	175	20	gs115	gs115	PROPN
admet-2551	175	21	,	,	PUNCT
admet-2551	175	22	outputting	output	VERB
admet-2551	175	23	the	the	DET
admet-2551	175	24	maximum	maximum	ADJ
admet-2551	175	25	expression	expression	NOUN
admet-2551	175	26	at	at	ADP
admet-2551	175	27	72	72	NUM
admet-2551	175	28	h	h	NOUN
admet-2551	175	29	using	use	VERB
admet-2551	175	30	the	the	DET
admet-2551	175	31	e.coli	e.coli	NOUN
admet-2551	175	32	expression	expression	NOUN
admet-2551	175	33	system	system	NOUN
admet-2551	175	34	.	.	PUNCT
admet-2551	176	1	yeast	yeast	NOUN
admet-2551	176	2	can	can	AUX
admet-2551	176	3	be	be	AUX
admet-2551	176	4	a	a	DET
admet-2551	176	5	suitable	suitable	ADJ
admet-2551	176	6	alternative	alternative	ADJ
admet-2551	176	7	host	host	NOUN
admet-2551	176	8	for	for	ADP
admet-2551	176	9	such	such	ADJ
admet-2551	176	10	types	type	NOUN
admet-2551	176	11	of	of	ADP
admet-2551	176	12	secretory	secretory	ADJ
admet-2551	176	13	proteins	protein	NOUN
admet-2551	176	14	[	[	X
admet-2551	176	15	31	31	NUM
admet-2551	176	16	]	]	PUNCT
admet-2551	176	17	.	.	PUNCT
admet-2551	177	1	figure	figure	NOUN
admet-2551	177	2	3	3	NUM
admet-2551	177	3	.	.	PUNCT
admet-2551	178	1	the	the	DET
admet-2551	178	2	crystal	crystal	NOUN
admet-2551	178	3	structure	structure	NOUN
admet-2551	178	4	of	of	ADP
admet-2551	178	5	sp	sp	ADP
admet-2551	178	6	generated	generate	VERB
admet-2551	178	7	by	by	ADP
admet-2551	178	8	using	use	VERB
admet-2551	178	9	pymol	pymol	PROPN
admet-2551	178	10	[	[	X
admet-2551	178	11	pdb	pdb	X
admet-2551	178	12	id-1sat	id-1sat	PROPN
admet-2551	178	13	]	]	PUNCT
admet-2551	178	14	.	.	PUNCT
admet-2551	179	1	fibrinolytic	fibrinolytic	ADJ
admet-2551	179	2	activity	activity	NOUN
admet-2551	179	3	sp	sp	NOUN
admet-2551	179	4	is	be	AUX
admet-2551	179	5	known	know	VERB
admet-2551	179	6	to	to	PART
admet-2551	179	7	be	be	AUX
admet-2551	179	8	safe	safe	ADJ
admet-2551	179	9	as	as	SCONJ
admet-2551	179	10	it	it	PRON
admet-2551	179	11	is	be	AUX
admet-2551	179	12	regularly	regularly	ADV
admet-2551	179	13	taken	take	VERB
admet-2551	179	14	by	by	ADP
admet-2551	179	15	the	the	DET
admet-2551	179	16	oral	oral	ADJ
admet-2551	179	17	route	route	NOUN
admet-2551	179	18	as	as	ADP
admet-2551	179	19	a	a	DET
admet-2551	179	20	fibrinolytic	fibrinolytic	ADJ
admet-2551	179	21	drug	drug	NOUN
admet-2551	179	22	and	and	CCONJ
admet-2551	179	23	has	have	VERB
admet-2551	179	24	the	the	DET
admet-2551	179	25	potential	potential	NOUN
admet-2551	179	26	to	to	PART
admet-2551	179	27	circulate	circulate	VERB
admet-2551	179	28	in	in	ADP
admet-2551	179	29	the	the	DET
admet-2551	179	30	blood	blood	NOUN
admet-2551	179	31	due	due	ADP
admet-2551	179	32	to	to	ADP
admet-2551	179	33	its	its	PRON
admet-2551	179	34	ability	ability	NOUN
admet-2551	179	35	to	to	PART
admet-2551	179	36	be	be	AUX
admet-2551	179	37	absorbed	absorb	VERB
admet-2551	179	38	by	by	ADP
admet-2551	179	39	the	the	DET
admet-2551	179	40	intestine	intestine	NOUN
admet-2551	180	1	[	[	X
admet-2551	180	2	68,69	68,69	NOUN
admet-2551	180	3	]	]	PUNCT
admet-2551	180	4	.	.	PUNCT
admet-2551	181	1	the	the	DET
admet-2551	181	2	therapeutic	therapeutic	ADJ
admet-2551	181	3	use	use	NOUN
admet-2551	181	4	of	of	ADP
admet-2551	181	5	sp	sp	NOUN
admet-2551	181	6	may	may	AUX
admet-2551	181	7	lead	lead	VERB
admet-2551	181	8	to	to	ADP
admet-2551	181	9	less	less	ADJ
admet-2551	181	10	bioavailability	bioavailability	NOUN
admet-2551	181	11	because	because	SCONJ
admet-2551	181	12	of	of	ADP
admet-2551	181	13	its	its	PRON
admet-2551	181	14	lower	low	ADJ
admet-2551	181	15	membrane	membrane	NOUN
admet-2551	181	16	permeability	permeability	NOUN
admet-2551	181	17	and	and	CCONJ
admet-2551	181	18	high	high	ADJ
admet-2551	181	19	tendency	tendency	NOUN
admet-2551	181	20	to	to	PART
admet-2551	181	21	undergo	undergo	VERB
admet-2551	181	22	degradation	degradation	NOUN
admet-2551	181	23	by	by	ADP
admet-2551	181	24	the	the	DET
admet-2551	181	25	enzymes	enzyme	NOUN
admet-2551	181	26	present	present	ADJ
admet-2551	181	27	in	in	ADP
admet-2551	181	28	the	the	DET
admet-2551	181	29	gastrointestinal	gastrointestinal	ADJ
admet-2551	181	30	tract	tract	NOUN
admet-2551	181	31	[	[	X
admet-2551	181	32	69	69	NUM
admet-2551	181	33	]	]	PUNCT
admet-2551	181	34	.	.	PUNCT
admet-2551	182	1	in	in	ADP
admet-2551	182	2	rats	rat	NOUN
admet-2551	182	3	,	,	PUNCT
admet-2551	182	4	after	after	ADP
admet-2551	182	5	taking	take	VERB
admet-2551	182	6	a	a	DET
admet-2551	182	7	dose	dose	NOUN
admet-2551	182	8	of	of	ADP
admet-2551	182	9	100	100	NUM
admet-2551	182	10	mg	mg	NUM
admet-2551	182	11	/	/	SYM
admet-2551	182	12	kg	kg	PROPN
admet-2551	182	13	of	of	ADP
admet-2551	182	14	sp	sp	NOUN
admet-2551	182	15	,	,	PUNCT
admet-2551	182	16	sp	sp	NOUN
admet-2551	182	17	can	can	AUX
admet-2551	182	18	be	be	AUX
admet-2551	182	19	detected	detect	VERB
admet-2551	182	20	in	in	ADP
admet-2551	182	21	the	the	DET
admet-2551	182	22	serum	serum	NOUN
admet-2551	182	23	and	and	CCONJ
admet-2551	182	24	lymph	lymph	NOUN
admet-2551	182	25	at	at	ADP
admet-2551	182	26	concentrations	concentration	NOUN
admet-2551	182	27	of	of	ADP
admet-2551	182	28	0.87	0.87	NUM
admet-2551	182	29	and	and	CCONJ
admet-2551	182	30	43	43	NUM
admet-2551	182	31	ng	ng	PROPN
admet-2551	182	32	/	/	SYM
admet-2551	182	33	ml	ml	PROPN
admet-2551	182	34	,	,	PUNCT
admet-2551	182	35	respectively	respectively	ADV
admet-2551	182	36	[	[	X
admet-2551	182	37	32,33	32,33	NUM
admet-2551	182	38	]	]	PUNCT
admet-2551	182	39	.	.	PUNCT
admet-2551	183	1	the	the	DET
admet-2551	183	2	exact	exact	ADJ
admet-2551	183	3	bioavailability	bioavailability	NOUN
admet-2551	183	4	data	datum	NOUN
admet-2551	183	5	of	of	ADP
admet-2551	183	6	sp	sp	NOUN
admet-2551	183	7	in	in	ADP
admet-2551	183	8	humans	human	NOUN
admet-2551	183	9	is	be	AUX
admet-2551	183	10	not	not	PART
admet-2551	183	11	yet	yet	ADV
admet-2551	183	12	reported	report	VERB
admet-2551	183	13	anywhere	anywhere	ADV
admet-2551	183	14	in	in	ADP
admet-2551	183	15	the	the	DET
admet-2551	183	16	literature	literature	NOUN
admet-2551	183	17	[	[	X
admet-2551	183	18	69	69	NUM
admet-2551	183	19	]	]	PUNCT
admet-2551	183	20	.	.	PUNCT
admet-2551	184	1	fibrin	fibrin	PROPN
admet-2551	184	2	can	can	AUX
admet-2551	184	3	repair	repair	VERB
admet-2551	184	4	injuries	injury	NOUN
admet-2551	184	5	caused	cause	VERB
admet-2551	184	6	by	by	ADP
admet-2551	184	7	trauma	trauma	NOUN
admet-2551	184	8	,	,	PUNCT
admet-2551	184	9	surgery	surgery	NOUN
admet-2551	184	10	and	and	CCONJ
admet-2551	184	11	damage	damage	NOUN
admet-2551	184	12	to	to	ADP
admet-2551	184	13	old	old	ADJ
admet-2551	184	14	cells	cell	NOUN
admet-2551	184	15	,	,	PUNCT
admet-2551	184	16	replacement	replacement	NOUN
admet-2551	184	17	by	by	ADP
admet-2551	184	18	new	new	ADJ
admet-2551	184	19	cells	cell	NOUN
admet-2551	184	20	,	,	PUNCT
admet-2551	184	21	tissues	tissue	NOUN
admet-2551	184	22	,	,	PUNCT
admet-2551	184	23	and	and	CCONJ
admet-2551	184	24	muscles	muscle	NOUN
admet-2551	184	25	[	[	X
admet-2551	184	26	70	70	NUM
admet-2551	184	27	]	]	PUNCT
admet-2551	184	28	.	.	PUNCT
admet-2551	185	1	the	the	DET
admet-2551	185	2	blood	blood	NOUN
admet-2551	185	3	vessels	vessel	NOUN
admet-2551	185	4	of	of	ADP
admet-2551	185	5	the	the	DET
admet-2551	185	6	damaged	damage	VERB
admet-2551	185	7	tissue	tissue	NOUN
admet-2551	185	8	form	form	VERB
admet-2551	185	9	a	a	DET
admet-2551	185	10	composite	composite	ADJ
admet-2551	185	11	substance	substance	NOUN
admet-2551	185	12	called	call	VERB
admet-2551	185	13	thromboplastin	thromboplastin	PROPN
admet-2551	185	14	,	,	PUNCT
admet-2551	185	15	which	which	PRON
admet-2551	185	16	binds	bind	VERB
admet-2551	185	17	to	to	ADP
admet-2551	185	18	the	the	DET
admet-2551	185	19	broken	broken	ADJ
admet-2551	185	20	blood	blood	NOUN
admet-2551	185	21	vessels	vessel	NOUN
admet-2551	185	22	of	of	ADP
admet-2551	185	23	the	the	DET
admet-2551	185	24	tissue	tissue	NOUN
admet-2551	185	25	and	and	CCONJ
admet-2551	185	26	emits	emit	VERB
admet-2551	185	27	a	a	DET
admet-2551	185	28	platelet	platelet	NOUN
admet-2551	185	29	factor	factor	NOUN
admet-2551	185	30	if	if	SCONJ
admet-2551	185	31	the	the	DET
admet-2551	185	32	blood	blood	NOUN
admet-2551	185	33	https://doi.org/10.5599/admet.2551	https://doi.org/10.5599/admet.2551	NOUN
admet-2551	186	1	s.	s.	PROPN
admet-2551	186	2	k.	k.	PROPN
admet-2551	186	3	metkar	metkar	PROPN
admet-2551	186	4	et	et	PROPN
admet-2551	186	5	al	al	PROPN
admet-2551	186	6	.	.	PROPN
admet-2551	186	7	admet	admet	PROPN
admet-2551	186	8	&	&	CCONJ
admet-2551	186	9	dmpk	dmpk	PROPN
admet-2551	186	10	12(6	12(6	NUM
admet-2551	186	11	)	)	PUNCT
admet-2551	186	12	(	(	PUNCT
admet-2551	186	13	2024	2024	NUM
admet-2551	186	14	)	)	PUNCT
admet-2551	186	15	797	797	NUM
admet-2551	186	16	-	-	SYM
admet-2551	186	17	820	820	NUM
admet-2551	186	18	804	804	NUM
admet-2551	186	19	vessels	vessel	NOUN
admet-2551	186	20	are	be	AUX
admet-2551	186	21	damaged	damage	VERB
admet-2551	186	22	.	.	PUNCT
admet-2551	187	1	a	a	DET
admet-2551	187	2	prothrombin	prothrombin	NOUN
admet-2551	187	3	activator	activator	NOUN
admet-2551	187	4	is	be	AUX
admet-2551	187	5	created	create	VERB
admet-2551	187	6	when	when	SCONJ
admet-2551	187	7	thromboplastin	thromboplastin	NOUN
admet-2551	187	8	and	and	CCONJ
admet-2551	187	9	platelet	platelet	NOUN
admet-2551	187	10	factor	factor	NOUN
admet-2551	187	11	react	react	VERB
admet-2551	187	12	with	with	ADP
admet-2551	187	13	calcium	calcium	NOUN
admet-2551	187	14	ions	ion	NOUN
admet-2551	187	15	and	and	CCONJ
admet-2551	187	16	other	other	ADJ
admet-2551	187	17	elements	element	NOUN
admet-2551	187	18	to	to	PART
admet-2551	187	19	form	form	VERB
admet-2551	187	20	an	an	DET
admet-2551	187	21	insoluble	insoluble	ADJ
admet-2551	187	22	fibrin	fibrin	NOUN
admet-2551	187	23	that	that	PRON
admet-2551	187	24	blocks	block	VERB
admet-2551	187	25	blood	blood	NOUN
admet-2551	187	26	flow	flow	NOUN
admet-2551	187	27	and	and	CCONJ
admet-2551	187	28	oxygen	oxygen	NOUN
admet-2551	187	29	supply	supply	NOUN
admet-2551	187	30	in	in	ADP
admet-2551	187	31	the	the	DET
admet-2551	187	32	body	body	NOUN
admet-2551	187	33	,	,	PUNCT
admet-2551	187	34	causing	cause	VERB
admet-2551	187	35	infarction	infarction	NOUN
admet-2551	187	36	of	of	ADP
admet-2551	187	37	myocardium	myocardium	ADJ
admet-2551	187	38	,	,	PUNCT
admet-2551	187	39	stroke	stroke	NOUN
admet-2551	187	40	,	,	PUNCT
admet-2551	187	41	pulmonary	pulmonary	ADJ
admet-2551	187	42	embolism	embolism	NOUN
admet-2551	187	43	,	,	PUNCT
admet-2551	187	44	and	and	CCONJ
admet-2551	187	45	vein	vein	VERB
admet-2551	187	46	clots	clot	NOUN
admet-2551	187	47	[	[	X
admet-2551	187	48	59	59	NUM
admet-2551	187	49	]	]	PUNCT
admet-2551	187	50	.	.	PUNCT
admet-2551	188	1	thus	thus	ADV
admet-2551	188	2	,	,	PUNCT
admet-2551	188	3	fibrinolytic	fibrinolytic	ADJ
admet-2551	188	4	enzymes	enzyme	NOUN
admet-2551	188	5	like	like	ADP
admet-2551	188	6	sp	sp	NOUN
admet-2551	188	7	,	,	PUNCT
admet-2551	188	8	which	which	PRON
admet-2551	188	9	dissolve	dissolve	VERB
admet-2551	188	10	clots	clot	NOUN
admet-2551	188	11	,	,	PUNCT
admet-2551	188	12	are	be	AUX
admet-2551	188	13	crucial	crucial	ADJ
admet-2551	188	14	to	to	ADP
admet-2551	188	15	the	the	DET
admet-2551	188	16	human	human	ADJ
admet-2551	188	17	body	body	NOUN
admet-2551	188	18	to	to	PART
admet-2551	188	19	avoid	avoid	VERB
admet-2551	188	20	the	the	DET
admet-2551	188	21	considerable	considerable	ADJ
admet-2551	188	22	risk	risk	NOUN
admet-2551	188	23	of	of	ADP
admet-2551	188	24	damage	damage	NOUN
admet-2551	188	25	.	.	PUNCT
admet-2551	189	1	mei	mei	PROPN
admet-2551	189	2	et	et	PROPN
admet-2551	189	3	al	al	PROPN
admet-2551	189	4	.	.	PUNCT
admet-2551	190	1	[	[	X
admet-2551	190	2	71	71	NUM
admet-2551	190	3	]	]	PUNCT
admet-2551	190	4	demonstrated	demonstrate	VERB
admet-2551	190	5	strong	strong	ADJ
admet-2551	190	6	thrombolytic	thrombolytic	ADJ
admet-2551	190	7	effects	effect	NOUN
admet-2551	190	8	in	in	ADP
admet-2551	190	9	in	in	ADP
admet-2551	190	10	vitro	vitro	X
admet-2551	190	11	model	model	NOUN
admet-2551	190	12	,	,	PUNCT
admet-2551	190	13	with	with	ADP
admet-2551	190	14	96.6	96.6	NUM
admet-2551	190	15	%	%	NOUN
admet-2551	190	16	clot	clot	NOUN
admet-2551	190	17	lysis	lysis	NOUN
admet-2551	190	18	at	at	ADP
admet-2551	190	19	a	a	DET
admet-2551	190	20	concentration	concentration	NOUN
admet-2551	190	21	of	of	ADP
admet-2551	190	22	300	300	NUM
admet-2551	190	23	u	u	NOUN
admet-2551	190	24	/	/	SYM
admet-2551	190	25	mg	mg	PROPN
admet-2551	190	26	of	of	ADP
admet-2551	190	27	sp	sp	PROPN
admet-2551	190	28	.	.	PUNCT
admet-2551	191	1	therefore	therefore	ADV
admet-2551	191	2	,	,	PUNCT
admet-2551	191	3	the	the	DET
admet-2551	191	4	study	study	NOUN
admet-2551	191	5	indicates	indicate	VERB
admet-2551	191	6	that	that	SCONJ
admet-2551	191	7	sp	sp	NOUN
admet-2551	191	8	could	could	AUX
admet-2551	191	9	be	be	AUX
admet-2551	191	10	a	a	DET
admet-2551	191	11	suitable	suitable	ADJ
admet-2551	191	12	candidate	candidate	NOUN
admet-2551	191	13	for	for	ADP
admet-2551	191	14	both	both	CCONJ
admet-2551	191	15	the	the	DET
admet-2551	191	16	prevention	prevention	NOUN
admet-2551	191	17	and	and	CCONJ
admet-2551	191	18	therapy	therapy	NOUN
admet-2551	191	19	of	of	ADP
admet-2551	191	20	thrombotic	thrombotic	ADJ
admet-2551	191	21	disorders	disorder	NOUN
admet-2551	191	22	[	[	X
admet-2551	191	23	71	71	NUM
admet-2551	191	24	]	]	PUNCT
admet-2551	191	25	.	.	PUNCT
admet-2551	192	1	anti	anti	ADJ
admet-2551	192	2	-	-	ADJ
admet-2551	192	3	inflammatory	inflammatory	ADJ
admet-2551	192	4	effect	effect	NOUN
admet-2551	192	5	of	of	ADP
admet-2551	192	6	serratiopeptidase	serratiopeptidase	PROPN
admet-2551	192	7	most	most	ADV
admet-2551	192	8	diseased	diseased	ADJ
admet-2551	192	9	conditions	condition	NOUN
admet-2551	192	10	produce	produce	VERB
admet-2551	192	11	a	a	DET
admet-2551	192	12	certain	certain	ADJ
admet-2551	192	13	level	level	NOUN
admet-2551	192	14	of	of	ADP
admet-2551	192	15	inflammation	inflammation	NOUN
admet-2551	192	16	,	,	PUNCT
admet-2551	192	17	which	which	PRON
admet-2551	192	18	causes	cause	VERB
admet-2551	192	19	hostility	hostility	NOUN
admet-2551	192	20	in	in	ADP
admet-2551	192	21	the	the	DET
admet-2551	192	22	disease	disease	NOUN
admet-2551	192	23	.	.	PUNCT
admet-2551	193	1	this	this	DET
admet-2551	193	2	inflammation	inflammation	NOUN
admet-2551	193	3	aggravates	aggravate	VERB
admet-2551	193	4	the	the	DET
admet-2551	193	5	immune	immune	ADJ
admet-2551	193	6	system	system	NOUN
admet-2551	193	7	to	to	PART
admet-2551	193	8	activate	activate	VERB
admet-2551	193	9	white	white	ADJ
admet-2551	193	10	blood	blood	NOUN
admet-2551	193	11	cells	cell	NOUN
admet-2551	193	12	(	(	PUNCT
admet-2551	193	13	wbcs	wbcs	PROPN
admet-2551	193	14	)	)	PUNCT
admet-2551	193	15	,	,	PUNCT
admet-2551	193	16	which	which	PRON
admet-2551	193	17	travel	travel	VERB
admet-2551	193	18	via	via	ADP
admet-2551	193	19	the	the	DET
admet-2551	193	20	circulatory	circulatory	ADJ
admet-2551	193	21	system	system	NOUN
admet-2551	193	22	to	to	PART
admet-2551	193	23	destroy	destroy	VERB
admet-2551	193	24	pathogenic	pathogenic	ADJ
admet-2551	193	25	bacteria	bacteria	NOUN
admet-2551	193	26	and	and	CCONJ
admet-2551	193	27	foreign	foreign	ADJ
admet-2551	193	28	substances	substance	NOUN
admet-2551	193	29	and	and	CCONJ
admet-2551	193	30	kills	kill	VERB
admet-2551	193	31	cancer	cancer	NOUN
admet-2551	193	32	cells	cell	NOUN
admet-2551	193	33	.	.	PUNCT
admet-2551	194	1	during	during	ADP
admet-2551	194	2	the	the	DET
admet-2551	194	3	repair	repair	NOUN
admet-2551	194	4	mechanism	mechanism	NOUN
admet-2551	194	5	,	,	PUNCT
admet-2551	194	6	the	the	DET
admet-2551	194	7	wbcs	wbc	NOUN
admet-2551	194	8	can	can	AUX
admet-2551	194	9	translocate	translocate	VERB
admet-2551	194	10	into	into	ADP
admet-2551	194	11	organs	organ	NOUN
admet-2551	194	12	or	or	CCONJ
admet-2551	194	13	tissues	tissue	NOUN
admet-2551	194	14	,	,	PUNCT
admet-2551	194	15	and	and	CCONJ
admet-2551	194	16	such	such	ADJ
admet-2551	194	17	elevated	elevated	ADJ
admet-2551	194	18	activity	activity	NOUN
admet-2551	194	19	of	of	ADP
admet-2551	194	20	wbcs	wbc	NOUN
admet-2551	194	21	results	result	NOUN
admet-2551	194	22	in	in	ADP
admet-2551	194	23	cell	cell	NOUN
admet-2551	194	24	damage	damage	NOUN
admet-2551	194	25	[	[	X
admet-2551	194	26	61	61	NUM
admet-2551	194	27	]	]	PUNCT
admet-2551	194	28	.	.	PUNCT
admet-2551	195	1	sp	sp	NOUN
admet-2551	195	2	was	be	AUX
admet-2551	195	3	initially	initially	ADV
admet-2551	195	4	utilized	utilize	VERB
admet-2551	195	5	for	for	ADP
admet-2551	195	6	its	its	PRON
admet-2551	195	7	anti	anti	ADJ
admet-2551	195	8	-	-	ADJ
admet-2551	195	9	inflammatory	inflammatory	ADJ
admet-2551	195	10	properties	property	NOUN
admet-2551	195	11	in	in	ADP
admet-2551	195	12	japan	japan	PROPN
admet-2551	195	13	in	in	ADP
admet-2551	195	14	1957	1957	NUM
admet-2551	195	15	[	[	X
admet-2551	195	16	56	56	NUM
admet-2551	195	17	]	]	PUNCT
admet-2551	195	18	.	.	PUNCT
admet-2551	196	1	khateeb	khateeb	PROPN
admet-2551	196	2	et	et	PROPN
admet-2551	196	3	al	al	PROPN
admet-2551	196	4	.	.	PUNCT
admet-2551	197	1	[	[	X
admet-2551	197	2	72	72	NUM
admet-2551	197	3	]	]	PUNCT
admet-2551	197	4	examined	examine	VERB
admet-2551	197	5	the	the	DET
admet-2551	197	6	anti	anti	ADJ
admet-2551	197	7	-	-	ADJ
admet-2551	197	8	inflammatory	inflammatory	ADJ
admet-2551	197	9	impact	impact	NOUN
admet-2551	197	10	of	of	ADP
admet-2551	197	11	sp	sp	NOUN
admet-2551	197	12	on	on	ADP
admet-2551	197	13	orthodontal	orthodontal	ADJ
admet-2551	197	14	inflammatory	inflammatory	ADJ
admet-2551	197	15	syndrome	syndrome	NOUN
admet-2551	197	16	.	.	PUNCT
admet-2551	198	1	in	in	ADP
admet-2551	198	2	general	general	ADJ
admet-2551	198	3	,	,	PUNCT
admet-2551	198	4	pathogen	pathogen	NOUN
admet-2551	198	5	-	-	PUNCT
admet-2551	198	6	induced	induce	VERB
admet-2551	198	7	inflammation	inflammation	NOUN
admet-2551	198	8	can	can	AUX
admet-2551	198	9	manifest	manifest	VERB
admet-2551	198	10	as	as	ADP
admet-2551	198	11	either	either	CCONJ
admet-2551	198	12	acute	acute	ADJ
admet-2551	198	13	or	or	CCONJ
admet-2551	198	14	chronic	chronic	ADJ
admet-2551	198	15	inflammation	inflammation	NOUN
admet-2551	198	16	.	.	PUNCT
admet-2551	199	1	acute	acute	ADJ
admet-2551	199	2	inflammation	inflammation	NOUN
admet-2551	199	3	is	be	AUX
admet-2551	199	4	a	a	DET
admet-2551	199	5	protective	protective	ADJ
admet-2551	199	6	response	response	NOUN
admet-2551	199	7	to	to	ADP
admet-2551	199	8	infection	infection	NOUN
admet-2551	199	9	,	,	PUNCT
admet-2551	199	10	while	while	SCONJ
admet-2551	199	11	uncontrolled	uncontrolled	ADJ
admet-2551	199	12	resolution	resolution	NOUN
admet-2551	199	13	leads	lead	VERB
admet-2551	199	14	to	to	ADP
admet-2551	199	15	chronic	chronic	ADJ
admet-2551	199	16	inflammation	inflammation	NOUN
admet-2551	199	17	[	[	X
admet-2551	199	18	72	72	NUM
admet-2551	199	19	]	]	PUNCT
admet-2551	199	20	.	.	PUNCT
admet-2551	200	1	the	the	DET
admet-2551	200	2	remarkable	remarkable	ADJ
admet-2551	200	3	anti	anti	ADJ
admet-2551	200	4	-	-	ADJ
admet-2551	200	5	inflammatory	inflammatory	ADJ
admet-2551	200	6	effects	effect	NOUN
admet-2551	200	7	of	of	ADP
admet-2551	200	8	sp	sp	ADP
admet-2551	200	9	and	and	CCONJ
admet-2551	200	10	diclofenac	diclofenac	NOUN
admet-2551	200	11	in	in	ADP
admet-2551	200	12	acute	acute	ADJ
admet-2551	200	13	and	and	CCONJ
admet-2551	200	14	subacute	subacute	VERB
admet-2551	200	15	inflammation	inflammation	NOUN
admet-2551	200	16	were	be	AUX
admet-2551	200	17	evaluated	evaluate	VERB
admet-2551	200	18	by	by	ADP
admet-2551	200	19	jadav	jadav	PROPN
admet-2551	200	20	et	et	PROPN
admet-2551	200	21	al	al	PROPN
admet-2551	200	22	.	.	PUNCT
admet-2551	201	1	[	[	X
admet-2551	201	2	73	73	NUM
admet-2551	201	3	]	]	PUNCT
admet-2551	201	4	.	.	PUNCT
admet-2551	202	1	nonsteroidal	nonsteroidal	ADJ
admet-2551	202	2	anti	anti	ADJ
admet-2551	202	3	-	-	ADJ
admet-2551	202	4	inflammatory	inflammatory	ADJ
admet-2551	202	5	drugs	drug	NOUN
admet-2551	202	6	(	(	PUNCT
admet-2551	202	7	nsaids	nsaid	NOUN
admet-2551	202	8	)	)	PUNCT
admet-2551	202	9	are	be	AUX
admet-2551	202	10	recommended	recommend	VERB
admet-2551	202	11	for	for	ADP
admet-2551	202	12	acute	acute	ADJ
admet-2551	202	13	inflammation	inflammation	NOUN
admet-2551	202	14	,	,	PUNCT
admet-2551	202	15	while	while	SCONJ
admet-2551	202	16	nsaids	nsaid	NOUN
admet-2551	202	17	,	,	PUNCT
admet-2551	202	18	in	in	ADP
admet-2551	202	19	combination	combination	NOUN
admet-2551	202	20	with	with	ADP
admet-2551	202	21	steroidal	steroidal	NOUN
admet-2551	202	22	drugs	drug	NOUN
admet-2551	202	23	and	and	CCONJ
admet-2551	202	24	sp	sp	NOUN
admet-2551	202	25	,	,	PUNCT
admet-2551	202	26	are	be	AUX
admet-2551	202	27	used	use	VERB
admet-2551	202	28	to	to	PART
admet-2551	202	29	address	address	VERB
admet-2551	202	30	chronic	chronic	ADJ
admet-2551	202	31	inflammation	inflammation	NOUN
admet-2551	203	1	[	[	X
admet-2551	203	2	74	74	NUM
admet-2551	203	3	]	]	PUNCT
admet-2551	203	4	.	.	PUNCT
admet-2551	204	1	recent	recent	ADJ
admet-2551	204	2	investigations	investigation	NOUN
admet-2551	204	3	established	establish	VERB
admet-2551	204	4	that	that	PRON
admet-2551	204	5	sp	sp	ADP
admet-2551	204	6	combined	combine	VERB
admet-2551	204	7	with	with	ADP
admet-2551	204	8	paracetamol	paracetamol	NOUN
admet-2551	204	9	can	can	AUX
admet-2551	204	10	successfully	successfully	ADV
admet-2551	204	11	reduce	reduce	VERB
admet-2551	204	12	edema	edema	NOUN
admet-2551	204	13	and	and	CCONJ
admet-2551	204	14	acute	acute	ADJ
admet-2551	204	15	inflammation	inflammation	NOUN
admet-2551	204	16	in	in	ADP
admet-2551	204	17	rat	rat	NOUN
admet-2551	204	18	models	model	NOUN
admet-2551	204	19	.	.	PUNCT
admet-2551	205	1	hence	hence	ADV
admet-2551	205	2	,	,	PUNCT
admet-2551	205	3	this	this	DET
admet-2551	205	4	study	study	NOUN
admet-2551	205	5	also	also	ADV
admet-2551	205	6	suggests	suggest	VERB
admet-2551	205	7	that	that	SCONJ
admet-2551	205	8	sp	sp	NOUN
admet-2551	205	9	could	could	AUX
admet-2551	205	10	be	be	AUX
admet-2551	205	11	a	a	DET
admet-2551	205	12	promising	promising	ADJ
admet-2551	205	13	candidate	candidate	NOUN
admet-2551	205	14	for	for	ADP
admet-2551	205	15	anti	anti	ADJ
admet-2551	205	16	-	-	ADJ
admet-2551	205	17	inflammatory	inflammatory	ADJ
admet-2551	205	18	drugs	drug	NOUN
admet-2551	205	19	[	[	X
admet-2551	205	20	75	75	NUM
admet-2551	205	21	]	]	PUNCT
admet-2551	205	22	.	.	PUNCT
admet-2551	206	1	a	a	DET
admet-2551	206	2	study	study	NOUN
admet-2551	206	3	by	by	ADP
admet-2551	206	4	krishna	krishna	PROPN
admet-2551	206	5	et	et	PROPN
admet-2551	206	6	al	al	PROPN
admet-2551	206	7	.	.	PROPN
admet-2551	206	8	also	also	ADV
admet-2551	206	9	highlighted	highlight	VERB
admet-2551	206	10	the	the	DET
admet-2551	206	11	anti	anti	ADJ
admet-2551	206	12	-	-	ADJ
admet-2551	206	13	inflammatory	inflammatory	ADJ
admet-2551	206	14	activity	activity	NOUN
admet-2551	206	15	of	of	ADP
admet-2551	206	16	sp	sp	NOUN
admet-2551	206	17	,	,	PUNCT
admet-2551	206	18	demonstrating	demonstrate	VERB
admet-2551	206	19	its	its	PRON
admet-2551	206	20	effectiveness	effectiveness	NOUN
admet-2551	206	21	in	in	ADP
admet-2551	206	22	reducing	reduce	VERB
admet-2551	206	23	postoperative	postoperative	ADJ
admet-2551	206	24	swelling	swelling	NOUN
admet-2551	206	25	compared	compare	VERB
admet-2551	206	26	to	to	ADP
admet-2551	206	27	dexamethasone	dexamethasone	NOUN
admet-2551	206	28	[	[	X
admet-2551	206	29	76	76	NUM
admet-2551	206	30	]	]	PUNCT
admet-2551	206	31	.	.	PUNCT
admet-2551	207	1	the	the	DET
admet-2551	207	2	role	role	NOUN
admet-2551	207	3	of	of	ADP
admet-2551	207	4	sp	sp	ADP
admet-2551	207	5	in	in	ADP
admet-2551	207	6	vascular	vascular	ADJ
admet-2551	207	7	inflammation	inflammation	NOUN
admet-2551	207	8	induced	induce	VERB
admet-2551	207	9	by	by	ADP
admet-2551	207	10	lipopolysaccharide	lipopolysaccharide	ADJ
admet-2551	207	11	(	(	PUNCT
admet-2551	207	12	lps	lps	PROPN
admet-2551	207	13	)	)	PUNCT
admet-2551	207	14	was	be	AUX
admet-2551	207	15	also	also	ADV
admet-2551	207	16	investigated	investigate	VERB
admet-2551	207	17	.	.	PUNCT
admet-2551	208	1	the	the	DET
admet-2551	208	2	result	result	NOUN
admet-2551	208	3	showed	show	VERB
admet-2551	208	4	that	that	SCONJ
admet-2551	208	5	sp	sp	ADP
admet-2551	208	6	reduced	reduce	VERB
admet-2551	208	7	lps	lps	PROPN
admet-2551	208	8	-	-	PUNCT
admet-2551	208	9	induced	induce	VERB
admet-2551	208	10	oxidative	oxidative	ADJ
admet-2551	208	11	stress	stress	NOUN
admet-2551	208	12	in	in	ADP
admet-2551	208	13	mice	mouse	NOUN
admet-2551	208	14	and	and	CCONJ
admet-2551	208	15	decreased	decrease	VERB
admet-2551	208	16	the	the	DET
admet-2551	208	17	expression	expression	NOUN
admet-2551	208	18	and	and	CCONJ
admet-2551	208	19	activity	activity	NOUN
admet-2551	208	20	of	of	ADP
admet-2551	208	21	monocyte	monocyte	NOUN
admet-2551	208	22	chemoattractant	chemoattractant	PROPN
admet-2551	208	23	protein-1	protein-1	PROPN
admet-2551	208	24	(	(	PUNCT
admet-2551	208	25	mcp-1	mcp-1	NOUN
admet-2551	208	26	)	)	PUNCT
admet-2551	209	1	[	[	X
admet-2551	209	2	77	77	NUM
admet-2551	209	3	]	]	PUNCT
admet-2551	209	4	.	.	PUNCT
admet-2551	210	1	the	the	DET
admet-2551	210	2	author	author	NOUN
admet-2551	210	3	evaluated	evaluate	VERB
admet-2551	210	4	the	the	DET
admet-2551	210	5	effectiveness	effectiveness	NOUN
admet-2551	210	6	of	of	ADP
admet-2551	210	7	two	two	NUM
admet-2551	210	8	drug	drug	NOUN
admet-2551	210	9	combinations	combination	NOUN
admet-2551	210	10	for	for	ADP
admet-2551	210	11	reducing	reduce	VERB
admet-2551	210	12	postoperative	postoperative	ADJ
admet-2551	210	13	pain	pain	NOUN
admet-2551	210	14	and	and	CCONJ
admet-2551	210	15	swelling	swell	VERB
admet-2551	210	16	after	after	ADP
admet-2551	210	17	the	the	DET
admet-2551	210	18	surgical	surgical	ADJ
admet-2551	210	19	removal	removal	NOUN
admet-2551	210	20	of	of	ADP
admet-2551	210	21	impacted	impact	VERB
admet-2551	210	22	mandibular	mandibular	ADJ
admet-2551	210	23	third	third	ADJ
admet-2551	210	24	molars	molar	NOUN
admet-2551	210	25	.	.	PUNCT
admet-2551	211	1	in	in	ADP
admet-2551	211	2	this	this	DET
admet-2551	211	3	study	study	NOUN
admet-2551	211	4	,	,	PUNCT
admet-2551	211	5	two	two	NUM
admet-2551	211	6	drug	drug	NOUN
admet-2551	211	7	combinations	combination	NOUN
admet-2551	211	8	were	be	AUX
admet-2551	211	9	orally	orally	ADV
admet-2551	211	10	administered	administer	VERB
admet-2551	211	11	to	to	ADP
admet-2551	211	12	sixty	sixty	NUM
admet-2551	211	13	patients	patient	NOUN
admet-2551	211	14	three	three	NUM
admet-2551	211	15	times	time	NOUN
admet-2551	211	16	continuously	continuously	ADV
admet-2551	211	17	for	for	ADP
admet-2551	211	18	three	three	NUM
admet-2551	211	19	days	day	NOUN
admet-2551	211	20	.	.	PUNCT
admet-2551	212	1	the	the	DET
admet-2551	212	2	drug	drug	NOUN
admet-2551	212	3	combination	combination	NOUN
admet-2551	212	4	of	of	ADP
admet-2551	212	5	trypsin	trypsin	NOUN
admet-2551	212	6	,	,	PUNCT
admet-2551	212	7	rutoside	rutoside	NOUN
admet-2551	212	8	,	,	PUNCT
admet-2551	212	9	and	and	CCONJ
admet-2551	212	10	bromelain	bromelain	NOUN
admet-2551	212	11	showed	show	VERB
admet-2551	212	12	less	less	ADJ
admet-2551	212	13	swelling	swelling	NOUN
admet-2551	212	14	.	.	PUNCT
admet-2551	213	1	whereas	whereas	SCONJ
admet-2551	213	2	diclofenac	diclofenac	NOUN
admet-2551	213	3	and	and	CCONJ
admet-2551	213	4	serratiopeptidase	serratiopeptidase	PROPN
admet-2551	213	5	drug	drug	NOUN
admet-2551	213	6	exhibited	exhibit	VERB
admet-2551	213	7	higher	high	ADJ
admet-2551	213	8	swelling	swelling	NOUN
admet-2551	213	9	and	and	CCONJ
admet-2551	213	10	less	less	ADJ
admet-2551	213	11	pain	pain	NOUN
admet-2551	213	12	.	.	PUNCT
admet-2551	214	1	hence	hence	ADV
admet-2551	214	2	,	,	PUNCT
admet-2551	214	3	the	the	DET
admet-2551	214	4	study	study	NOUN
admet-2551	214	5	concluded	conclude	VERB
admet-2551	214	6	that	that	SCONJ
admet-2551	214	7	bromelain	bromelain	NOUN
admet-2551	214	8	drug	drug	NOUN
admet-2551	214	9	is	be	AUX
admet-2551	214	10	effective	effective	ADJ
admet-2551	214	11	in	in	ADP
admet-2551	214	12	reducing	reduce	VERB
admet-2551	214	13	swelling	swelling	NOUN
admet-2551	214	14	,	,	PUNCT
admet-2551	214	15	and	and	CCONJ
admet-2551	214	16	diclofenac	diclofenac	NOUN
admet-2551	214	17	,	,	PUNCT
admet-2551	214	18	sp	sp	NOUN
admet-2551	214	19	-	-	PUNCT
admet-2551	214	20	based	base	VERB
admet-2551	214	21	therapy	therapy	NOUN
admet-2551	214	22	provides	provide	VERB
admet-2551	214	23	superior	superior	ADJ
admet-2551	214	24	pain	pain	NOUN
admet-2551	214	25	relief	relief	NOUN
admet-2551	214	26	[	[	X
admet-2551	214	27	78	78	NUM
admet-2551	214	28	]	]	PUNCT
admet-2551	214	29	.	.	PUNCT
admet-2551	215	1	the	the	DET
admet-2551	215	2	anti	anti	ADJ
admet-2551	215	3	-	-	ADJ
admet-2551	215	4	inflammatory	inflammatory	ADJ
admet-2551	215	5	effect	effect	NOUN
admet-2551	215	6	of	of	ADP
admet-2551	215	7	sp	sp	ADP
admet-2551	215	8	ointment	ointment	NOUN
admet-2551	215	9	was	be	AUX
admet-2551	215	10	evaluated	evaluate	VERB
admet-2551	215	11	in	in	ADP
admet-2551	215	12	mice	mouse	NOUN
admet-2551	215	13	.	.	PUNCT
admet-2551	216	1	compared	compare	VERB
admet-2551	216	2	to	to	ADP
admet-2551	216	3	control	control	PROPN
admet-2551	216	4	group	group	NOUN
admet-2551	216	5	,	,	PUNCT
admet-2551	216	6	sp	sp	ADP
admet-2551	216	7	ointment	ointment	NOUN
admet-2551	216	8	treated	treat	VERB
admet-2551	216	9	mice	mouse	NOUN
admet-2551	216	10	demonstrated	demonstrate	VERB
admet-2551	216	11	significant	significant	ADJ
admet-2551	216	12	antiinflammatory	antiinflammatory	NOUN
admet-2551	216	13	effect	effect	NOUN
admet-2551	216	14	[	[	X
admet-2551	216	15	79	79	NUM
admet-2551	216	16	]	]	PUNCT
admet-2551	216	17	.	.	PUNCT
admet-2551	217	1	clinical	clinical	ADJ
admet-2551	217	2	applications	application	NOUN
admet-2551	217	3	of	of	ADP
admet-2551	217	4	serratiopeptidase	serratiopeptidase	NOUN
admet-2551	217	5	sp	sp	ADP
admet-2551	217	6	reduces	reduce	VERB
admet-2551	217	7	pain	pain	NOUN
admet-2551	217	8	by	by	ADP
admet-2551	217	9	arresting	arrest	VERB
admet-2551	217	10	the	the	DET
admet-2551	217	11	discharge	discharge	NOUN
admet-2551	217	12	of	of	ADP
admet-2551	217	13	pain	pain	NOUN
admet-2551	217	14	,	,	PUNCT
admet-2551	217	15	which	which	PRON
admet-2551	217	16	influences	influence	VERB
admet-2551	217	17	amines	amine	NOUN
admet-2551	217	18	such	such	ADJ
admet-2551	217	19	as	as	ADP
admet-2551	217	20	bradykinin	bradykinin	NOUN
admet-2551	217	21	from	from	ADP
admet-2551	217	22	inflamed	inflamed	ADJ
admet-2551	217	23	tissues	tissue	NOUN
admet-2551	217	24	[	[	X
admet-2551	217	25	80	80	NUM
admet-2551	217	26	]	]	PUNCT
admet-2551	217	27	.	.	PUNCT
admet-2551	218	1	sp	sp	NOUN
admet-2551	218	2	has	have	VERB
admet-2551	218	3	the	the	DET
admet-2551	218	4	capacity	capacity	NOUN
admet-2551	218	5	to	to	PART
admet-2551	218	6	cause	cause	VERB
admet-2551	218	7	hydrolysis	hydrolysis	NOUN
admet-2551	218	8	of	of	ADP
admet-2551	218	9	histamine	histamine	NOUN
admet-2551	218	10	,	,	PUNCT
admet-2551	218	11	serotonin	serotonin	NOUN
admet-2551	218	12	,	,	PUNCT
admet-2551	218	13	and	and	CCONJ
admet-2551	218	14	bradykinin	bradykinin	PROPN
admet-2551	218	15	,	,	PUNCT
admet-2551	218	16	which	which	PRON
admet-2551	218	17	are	be	AUX
admet-2551	218	18	accountable	accountable	ADJ
admet-2551	218	19	for	for	ADP
admet-2551	218	20	eliciting	elicit	VERB
admet-2551	218	21	oedemic	oedemic	ADJ
admet-2551	218	22	responses	response	NOUN
admet-2551	218	23	[	[	X
admet-2551	218	24	81	81	NUM
admet-2551	218	25	]	]	PUNCT
admet-2551	218	26	.	.	PUNCT
admet-2551	219	1	the	the	DET
admet-2551	219	2	substrate	substrate	NOUN
admet-2551	219	3	bradykinin	bradykinin	NOUN
admet-2551	219	4	binds	bind	VERB
admet-2551	219	5	in	in	ADP
admet-2551	219	6	the	the	DET
admet-2551	219	7	vicinity	vicinity	NOUN
admet-2551	219	8	of	of	ADP
admet-2551	219	9	the	the	DET
admet-2551	219	10	zinc	zinc	NOUN
admet-2551	219	11	-	-	PUNCT
admet-2551	219	12	binding	bind	VERB
admet-2551	219	13	site	site	NOUN
admet-2551	219	14	of	of	ADP
admet-2551	219	15	sp	sp	NOUN
admet-2551	219	16	,	,	PUNCT
admet-2551	219	17	which	which	PRON
admet-2551	219	18	efficiently	efficiently	ADV
admet-2551	219	19	cleaves	cleave	VERB
admet-2551	219	20	the	the	DET
admet-2551	219	21	peptide	peptide	ADJ
admet-2551	219	22	bond	bond	NOUN
admet-2551	219	23	of	of	ADP
admet-2551	219	24	bradykinin	bradykinin	PROPN
admet-2551	219	25	[	[	X
admet-2551	219	26	82	82	NUM
admet-2551	219	27	]	]	PUNCT
admet-2551	219	28	.	.	PUNCT
admet-2551	220	1	at	at	ADP
admet-2551	220	2	the	the	DET
admet-2551	220	3	infection	infection	NOUN
admet-2551	220	4	site	site	NOUN
admet-2551	220	5	,	,	PUNCT
admet-2551	220	6	they	they	PRON
admet-2551	220	7	modulate	modulate	VERB
admet-2551	220	8	the	the	DET
admet-2551	220	9	transformation	transformation	NOUN
admet-2551	220	10	of	of	ADP
admet-2551	220	11	cell	cell	NOUN
admet-2551	220	12	adhesion	adhesion	NOUN
admet-2551	220	13	molecules	molecule	NOUN
admet-2551	220	14	,	,	PUNCT
admet-2551	220	15	which	which	PRON
admet-2551	220	16	are	be	AUX
admet-2551	220	17	intricate	intricate	ADJ
admet-2551	220	18	in	in	ADP
admet-2551	220	19	the	the	DET
admet-2551	220	20	inflammatory	inflammatory	ADJ
admet-2551	220	21	regulatory	regulatory	ADJ
admet-2551	220	22	cells	cell	NOUN
admet-2551	220	23	.	.	PUNCT
admet-2551	221	1	sp	sp	NOUN
admet-2551	221	2	is	be	AUX
admet-2551	221	3	taken	take	VERB
admet-2551	221	4	orally	orally	ADV
admet-2551	221	5	to	to	PART
admet-2551	221	6	control	control	VERB
admet-2551	221	7	the	the	DET
admet-2551	221	8	inflammation	inflammation	NOUN
admet-2551	221	9	that	that	PRON
admet-2551	221	10	occurs	occur	VERB
admet-2551	221	11	due	due	ADJ
admet-2551	221	12	to	to	ADP
admet-2551	221	13	sinusitis	sinusitis	NOUN
admet-2551	221	14	,	,	PUNCT
admet-2551	221	15	prostate	prostate	NOUN
admet-2551	221	16	gland	gland	NOUN
admet-2551	221	17	inflammation	inflammation	NOUN
admet-2551	221	18	,	,	PUNCT
admet-2551	221	19	carpal	carpal	NOUN
admet-2551	221	20	tunnel	tunnel	NOUN
admet-2551	221	21	syndrome	syndrome	NOUN
admet-2551	221	22	,	,	PUNCT
admet-2551	221	23	breast	breast	NOUN
admet-2551	221	24	engorgement	engorgement	NOUN
admet-2551	221	25	,	,	PUNCT
admet-2551	221	26	chronic	chronic	ADJ
admet-2551	221	27	emphysema	emphysema	NOUN
admet-2551	221	28	,	,	PUNCT
admet-2551	221	29	and	and	CCONJ
admet-2551	221	30	acute	acute	ADJ
admet-2551	221	31	and	and	CCONJ
admet-2551	221	32	chronic	chronic	ADJ
admet-2551	221	33	earnose	earnose	ADJ
admet-2551	221	34	-	-	PUNCT
admet-2551	221	35	throat	throat	NOUN
admet-2551	221	36	disease	disease	NOUN
admet-2551	221	37	[	[	X
admet-2551	221	38	55	55	NUM
admet-2551	221	39	]	]	PUNCT
admet-2551	221	40	.	.	PUNCT
admet-2551	222	1	in	in	ADP
admet-2551	222	2	2021	2021	NUM
admet-2551	222	3	,	,	PUNCT
admet-2551	222	4	gupta	gupta	NOUN
admet-2551	222	5	and	and	CCONJ
admet-2551	222	6	colleagues	colleague	NOUN
admet-2551	222	7	illustrated	illustrate	VERB
admet-2551	222	8	the	the	DET
admet-2551	222	9	efficacy	efficacy	NOUN
admet-2551	222	10	of	of	ADP
admet-2551	222	11	using	use	VERB
admet-2551	222	12	sp	sp	ADP
admet-2551	222	13	and	and	CCONJ
admet-2551	222	14	vitamin	vitamin	NOUN
admet-2551	222	15	d	d	PROPN
admet-2551	222	16	together	together	ADV
admet-2551	222	17	to	to	PART
admet-2551	222	18	combat	combat	VERB
admet-2551	222	19	the	the	DET
admet-2551	222	20	severe	severe	ADJ
admet-2551	222	21	consequences	consequence	NOUN
admet-2551	222	22	of	of	ADP
admet-2551	222	23	covid-19	covid-19	PROPN
admet-2551	222	24	conditions	condition	NOUN
admet-2551	222	25	[	[	X
admet-2551	222	26	83	83	NUM
admet-2551	222	27	]	]	PUNCT
admet-2551	222	28	.	.	PUNCT
admet-2551	223	1	during	during	ADP
admet-2551	223	2	the	the	DET
admet-2551	223	3	pandemic	pandemic	NOUN
admet-2551	223	4	,	,	PUNCT
admet-2551	223	5	covid-19	covid-19	PROPN
admet-2551	223	6	has	have	AUX
admet-2551	223	7	led	lead	VERB
admet-2551	223	8	to	to	ADP
admet-2551	223	9	various	various	ADJ
admet-2551	223	10	respiratory	respiratory	ADJ
admet-2551	223	11	diseases	disease	NOUN
admet-2551	223	12	,	,	PUNCT
admet-2551	223	13	including	include	VERB
admet-2551	223	14	nasal	nasal	PROPN
admet-2551	223	15	congestion	congestion	NOUN
admet-2551	223	16	and	and	CCONJ
admet-2551	223	17	cough	cough	NOUN
admet-2551	223	18	among	among	ADP
admet-2551	223	19	patients	patient	NOUN
admet-2551	223	20	.	.	PUNCT
admet-2551	224	1	various	various	ADJ
admet-2551	224	2	studies	study	NOUN
admet-2551	224	3	admet	admet	PROPN
admet-2551	224	4	&	&	CCONJ
admet-2551	224	5	dmpk	dmpk	PROPN
admet-2551	224	6	12(6	12(6	NUM
admet-2551	224	7	)	)	PUNCT
admet-2551	224	8	(	(	PUNCT
admet-2551	224	9	2024	2024	NUM
admet-2551	224	10	)	)	PUNCT
admet-2551	224	11	797	797	NUM
admet-2551	224	12	-	-	SYM
admet-2551	224	13	820	820	NUM
admet-2551	224	14	natural	natural	ADJ
admet-2551	224	15	serine	serine	NOUN
admet-2551	224	16	proteases	protease	NOUN
admet-2551	224	17	in	in	ADP
admet-2551	224	18	combating	combat	VERB
admet-2551	224	19	amyloid	amyloid	NOUN
admet-2551	224	20	formation	formation	NOUN
admet-2551	224	21	doi	doi	NOUN
admet-2551	224	22	:	:	PUNCT
admet-2551	224	23	https://doi.org/10.5599/admet.2551	https://doi.org/10.5599/admet.2551	NOUN
admet-2551	224	24	805	805	NUM
admet-2551	224	25	reported	report	VERB
admet-2551	224	26	that	that	SCONJ
admet-2551	224	27	mucolytic	mucolytic	ADJ
admet-2551	224	28	drugs	drug	NOUN
admet-2551	224	29	can	can	AUX
admet-2551	224	30	help	help	VERB
admet-2551	224	31	boost	boost	VERB
admet-2551	224	32	bronchial	bronchial	ADJ
admet-2551	224	33	mucus	mucus	NOUN
admet-2551	224	34	secretion	secretion	NOUN
admet-2551	224	35	or	or	CCONJ
admet-2551	224	36	reduce	reduce	VERB
admet-2551	224	37	mucus	mucus	NOUN
admet-2551	224	38	viscosity	viscosity	NOUN
admet-2551	224	39	[	[	X
admet-2551	224	40	55	55	NUM
admet-2551	224	41	]	]	PUNCT
admet-2551	224	42	.	.	PUNCT
admet-2551	225	1	furthermore	furthermore	ADV
admet-2551	225	2	,	,	PUNCT
admet-2551	225	3	a	a	DET
admet-2551	225	4	comparison	comparison	NOUN
admet-2551	225	5	of	of	ADP
admet-2551	225	6	sp	sp	NOUN
admet-2551	225	7	’s	’s	PART
admet-2551	225	8	mucolytic	mucolytic	ADJ
admet-2551	225	9	activity	activity	NOUN
admet-2551	225	10	with	with	ADP
admet-2551	225	11	seaprose	seaprose	ADV
admet-2551	225	12	indicated	indicate	VERB
admet-2551	225	13	that	that	SCONJ
admet-2551	225	14	proteolytic	proteolytic	ADJ
admet-2551	225	15	enzyme	enzyme	NOUN
admet-2551	225	16	were	be	AUX
admet-2551	225	17	active	active	ADJ
admet-2551	225	18	in	in	ADP
admet-2551	225	19	in	in	ADP
admet-2551	225	20	vivo	vivo	NOUN
admet-2551	225	21	animal	animal	NOUN
admet-2551	225	22	models	model	NOUN
admet-2551	225	23	[	[	X
admet-2551	225	24	84	84	NUM
admet-2551	225	25	]	]	PUNCT
admet-2551	225	26	.	.	PUNCT
admet-2551	226	1	gioia	gioia	PROPN
admet-2551	226	2	’s	’s	PART
admet-2551	226	3	2020	2020	NUM
admet-2551	226	4	study	study	NOUN
admet-2551	226	5	on	on	ADP
admet-2551	226	6	patients	patient	NOUN
admet-2551	226	7	with	with	ADP
admet-2551	226	8	respiratory	respiratory	ADJ
admet-2551	226	9	disease	disease	NOUN
admet-2551	226	10	found	find	VERB
admet-2551	226	11	that	that	SCONJ
admet-2551	226	12	sp	sp	ADP
admet-2551	226	13	enhanced	enhanced	ADJ
admet-2551	226	14	mucus	mucus	NOUN
admet-2551	226	15	clearance	clearance	NOUN
admet-2551	226	16	by	by	ADP
admet-2551	226	17	lowering	lower	VERB
admet-2551	226	18	the	the	DET
admet-2551	226	19	neutrophils	neutrophil	NOUN
admet-2551	226	20	,	,	PUNCT
admet-2551	226	21	which	which	PRON
admet-2551	226	22	changed	change	VERB
admet-2551	226	23	sputum	sputum	NOUN
admet-2551	226	24	viscosity	viscosity	NOUN
admet-2551	226	25	.	.	PUNCT
admet-2551	227	1	this	this	PRON
admet-2551	227	2	shows	show	VERB
admet-2551	227	3	that	that	SCONJ
admet-2551	227	4	sp	sp	NOUN
admet-2551	227	5	could	could	AUX
admet-2551	227	6	be	be	AUX
admet-2551	227	7	an	an	DET
admet-2551	227	8	effective	effective	ADJ
admet-2551	227	9	therapy	therapy	NOUN
admet-2551	227	10	for	for	ADP
admet-2551	227	11	respiratory	respiratory	ADJ
admet-2551	227	12	problems	problem	NOUN
admet-2551	227	13	and	and	CCONJ
admet-2551	227	14	covid-19	covid-19	PROPN
admet-2551	227	15	consequences	consequence	VERB
admet-2551	227	16	[	[	X
admet-2551	227	17	85	85	NUM
admet-2551	227	18	]	]	PUNCT
admet-2551	227	19	.	.	PUNCT
admet-2551	228	1	the	the	DET
admet-2551	228	2	bacterium	bacterium	NOUN
admet-2551	228	3	thrives	thrive	VERB
admet-2551	228	4	by	by	ADP
admet-2551	228	5	making	make	VERB
admet-2551	228	6	biofilm	biofilm	NOUN
admet-2551	228	7	within	within	ADP
admet-2551	228	8	the	the	DET
admet-2551	228	9	microbiome	microbiome	NOUN
admet-2551	228	10	.	.	PUNCT
admet-2551	229	1	these	these	DET
admet-2551	229	2	biofilms	biofilm	NOUN
admet-2551	229	3	usually	usually	ADV
admet-2551	229	4	form	form	VERB
admet-2551	229	5	surfaces	surface	NOUN
admet-2551	229	6	of	of	ADP
admet-2551	229	7	the	the	DET
admet-2551	229	8	bacteria	bacteria	NOUN
admet-2551	229	9	;	;	PUNCT
admet-2551	229	10	for	for	ADP
admet-2551	229	11	example	example	NOUN
admet-2551	229	12	,	,	PUNCT
admet-2551	229	13	staphylococcus	staphylococcus	NOUN
admet-2551	229	14	aureus	aureus	NOUN
admet-2551	229	15	,	,	PUNCT
admet-2551	229	16	which	which	PRON
admet-2551	229	17	has	have	VERB
admet-2551	229	18	a	a	DET
admet-2551	229	19	variety	variety	NOUN
admet-2551	229	20	of	of	ADP
admet-2551	229	21	virulence	virulence	NOUN
admet-2551	229	22	factors	factor	NOUN
admet-2551	229	23	and	and	CCONJ
admet-2551	229	24	possesses	possess	VERB
admet-2551	229	25	the	the	DET
admet-2551	229	26	potential	potential	NOUN
admet-2551	229	27	to	to	PART
admet-2551	229	28	invade	invade	VERB
admet-2551	229	29	the	the	DET
admet-2551	229	30	eukaryotic	eukaryotic	ADJ
admet-2551	229	31	cells	cell	NOUN
admet-2551	229	32	by	by	ADP
admet-2551	229	33	making	make	VERB
admet-2551	229	34	surface	surface	NOUN
admet-2551	229	35	biofilm	biofilm	NOUN
admet-2551	229	36	and	and	CCONJ
admet-2551	229	37	dominates	dominate	VERB
admet-2551	229	38	with	with	ADP
admet-2551	229	39	staphylococcal	staphylococcal	ADJ
admet-2551	229	40	infections	infection	NOUN
admet-2551	229	41	.	.	PUNCT
admet-2551	230	1	blocking	block	VERB
admet-2551	230	2	of	of	ADP
admet-2551	230	3	such	such	ADJ
admet-2551	230	4	staphylococcus	staphylococcus	NOUN
admet-2551	230	5	aureus	aureus	NOUN
admet-2551	230	6	colonization	colonization	NOUN
admet-2551	230	7	can	can	AUX
admet-2551	230	8	inhibit	inhibit	VERB
admet-2551	230	9	the	the	DET
admet-2551	230	10	quick	quick	ADJ
admet-2551	230	11	spread	spread	NOUN
admet-2551	230	12	of	of	ADP
admet-2551	230	13	biofilm	biofilm	NOUN
admet-2551	230	14	[	[	X
admet-2551	230	15	86	86	NUM
admet-2551	230	16	]	]	PUNCT
admet-2551	230	17	.	.	PUNCT
admet-2551	231	1	the	the	DET
admet-2551	231	2	anti	anti	ADJ
admet-2551	231	3	-	-	ADJ
admet-2551	231	4	infective	infective	ADJ
admet-2551	231	5	effect	effect	NOUN
admet-2551	231	6	of	of	ADP
admet-2551	231	7	sp	sp	NOUN
admet-2551	231	8	is	be	AUX
admet-2551	231	9	exerted	exert	VERB
admet-2551	231	10	through	through	ADP
admet-2551	231	11	inert	inert	ADJ
admet-2551	231	12	surface	surface	NOUN
admet-2551	231	13	attachment	attachment	NOUN
admet-2551	231	14	,	,	PUNCT
admet-2551	231	15	thereby	thereby	ADV
admet-2551	231	16	inhibiting	inhibit	VERB
admet-2551	231	17	staphylococcus	staphylococcus	NOUN
admet-2551	231	18	adherence	adherence	NOUN
admet-2551	231	19	and	and	CCONJ
admet-2551	231	20	ceasing	cease	VERB
admet-2551	231	21	invasion	invasion	NOUN
admet-2551	231	22	of	of	ADP
admet-2551	231	23	eukaryotic	eukaryotic	ADJ
admet-2551	231	24	cells	cell	NOUN
admet-2551	231	25	.	.	PUNCT
admet-2551	232	1	the	the	DET
admet-2551	232	2	detailed	detailed	ADJ
admet-2551	232	3	mechanism	mechanism	NOUN
admet-2551	232	4	is	be	AUX
admet-2551	232	5	yet	yet	ADV
admet-2551	232	6	to	to	PART
admet-2551	232	7	be	be	AUX
admet-2551	232	8	explored	explore	VERB
admet-2551	232	9	.	.	PUNCT
admet-2551	233	1	sp	sp	NOUN
admet-2551	233	2	has	have	AUX
admet-2551	233	3	also	also	ADV
admet-2551	233	4	shown	show	VERB
admet-2551	233	5	an	an	DET
admet-2551	233	6	antibacterial	antibacterial	ADJ
admet-2551	233	7	effect	effect	NOUN
admet-2551	233	8	against	against	ADP
admet-2551	233	9	escherichia	escherichia	NOUN
admet-2551	233	10	coli	coli	NOUN
admet-2551	233	11	and	and	CCONJ
admet-2551	233	12	pseudomonas	pseudomona	NOUN
admet-2551	233	13	aeruginosa	aeruginosa	NOUN
admet-2551	234	1	[	[	X
admet-2551	234	2	87,88	87,88	NUM
admet-2551	234	3	]	]	PUNCT
admet-2551	234	4	.	.	PUNCT
admet-2551	235	1	mecikoglu	mecikoglu	NOUN
admet-2551	235	2	et	et	PROPN
admet-2551	235	3	al	al	PROPN
admet-2551	235	4	.	.	PUNCT
admet-2551	236	1	[	[	X
admet-2551	236	2	89	89	NUM
admet-2551	236	3	]	]	PUNCT
admet-2551	236	4	conducted	conduct	VERB
admet-2551	236	5	an	an	DET
admet-2551	236	6	in	in	ADP
admet-2551	236	7	vivo	vivo	NOUN
admet-2551	236	8	study	study	NOUN
admet-2551	236	9	that	that	PRON
admet-2551	236	10	used	use	VERB
admet-2551	236	11	sp	sp	ADP
admet-2551	236	12	to	to	PART
admet-2551	236	13	treat	treat	VERB
admet-2551	236	14	bacterial	bacterial	ADJ
admet-2551	236	15	infections	infection	NOUN
admet-2551	236	16	.	.	PUNCT
admet-2551	237	1	94.4	94.4	NUM
admet-2551	237	2	%	%	NOUN
admet-2551	237	3	of	of	ADP
admet-2551	237	4	the	the	DET
admet-2551	237	5	infected	infect	VERB
admet-2551	237	6	rats	rat	NOUN
admet-2551	237	7	treated	treat	VERB
admet-2551	237	8	with	with	ADP
admet-2551	237	9	sp	sp	ADP
admet-2551	237	10	recovered	recover	VERB
admet-2551	237	11	,	,	PUNCT
admet-2551	237	12	showing	show	VERB
admet-2551	237	13	its	its	PRON
admet-2551	237	14	potential	potential	NOUN
admet-2551	237	15	in	in	ADP
admet-2551	237	16	combating	combat	VERB
admet-2551	237	17	biofilm	biofilm	NOUN
admet-2551	237	18	-	-	PUNCT
admet-2551	237	19	forming	form	VERB
admet-2551	237	20	activity	activity	NOUN
admet-2551	237	21	.	.	PUNCT
admet-2551	238	1	using	use	VERB
admet-2551	238	2	proteolytic	proteolytic	ADJ
admet-2551	238	3	enzymes	enzyme	NOUN
admet-2551	238	4	like	like	ADP
admet-2551	238	5	sp	sp	ADP
admet-2551	238	6	in	in	ADP
admet-2551	238	7	combination	combination	NOUN
admet-2551	238	8	with	with	ADP
admet-2551	238	9	antibiotics	antibiotic	NOUN
admet-2551	238	10	could	could	AUX
admet-2551	238	11	be	be	AUX
admet-2551	238	12	effective	effective	ADJ
admet-2551	238	13	against	against	ADP
admet-2551	238	14	microbes	microbe	NOUN
admet-2551	238	15	[	[	X
admet-2551	238	16	89	89	NUM
admet-2551	238	17	]	]	PUNCT
admet-2551	238	18	.	.	PUNCT
admet-2551	239	1	keratinase	keratinase	PROPN
admet-2551	239	2	keratinases	keratinase	NOUN
admet-2551	239	3	(	(	PUNCT
admet-2551	239	4	ker	ker	NOUN
admet-2551	239	5	)	)	PUNCT
admet-2551	239	6	are	be	AUX
admet-2551	239	7	extracellular	extracellular	ADJ
admet-2551	239	8	enzymes	enzyme	NOUN
admet-2551	239	9	usually	usually	ADV
admet-2551	239	10	produced	produce	VERB
admet-2551	239	11	from	from	ADP
admet-2551	239	12	bacillus	bacillus	NOUN
admet-2551	239	13	,	,	PUNCT
admet-2551	239	14	streptomyces	streptomyce	NOUN
admet-2551	239	15	,	,	PUNCT
admet-2551	239	16	aspergillus	aspergillus	NOUN
admet-2551	239	17	,	,	PUNCT
admet-2551	239	18	fervido	fervido	NOUN
admet-2551	239	19	bacterium	bacterium	NOUN
admet-2551	239	20	,	,	PUNCT
admet-2551	239	21	xanthomonas	xanthomonas	PROPN
admet-2551	239	22	,	,	PUNCT
admet-2551	239	23	chryseo	chryseo	PROPN
admet-2551	239	24	bacterium	bacterium	NOUN
admet-2551	239	25	,	,	PUNCT
admet-2551	239	26	and	and	CCONJ
admet-2551	239	27	vibrio	vibrio	NOUN
admet-2551	239	28	,	,	PUNCT
admet-2551	239	29	which	which	PRON
admet-2551	239	30	are	be	AUX
admet-2551	239	31	known	know	VERB
admet-2551	239	32	to	to	PART
admet-2551	239	33	degrade	degrade	VERB
admet-2551	239	34	keratin	keratin	NOUN
admet-2551	239	35	protein	protein	NOUN
admet-2551	239	36	in	in	ADP
admet-2551	239	37	eukaryotes	eukaryote	NOUN
admet-2551	239	38	.	.	PUNCT
admet-2551	240	1	ker	ker	PROPN
admet-2551	240	2	is	be	AUX
admet-2551	240	3	especially	especially	ADV
admet-2551	240	4	known	know	VERB
admet-2551	240	5	for	for	ADP
admet-2551	240	6	its	its	PRON
admet-2551	240	7	use	use	NOUN
admet-2551	240	8	in	in	ADP
admet-2551	240	9	de	de	ADJ
admet-2551	240	10	-	-	ADJ
admet-2551	240	11	hairing	haire	VERB
admet-2551	240	12	leather	leather	NOUN
admet-2551	240	13	before	before	ADP
admet-2551	240	14	processing	processing	NOUN
admet-2551	240	15	and	and	CCONJ
admet-2551	240	16	in	in	ADP
admet-2551	240	17	the	the	DET
admet-2551	240	18	cosmetic	cosmetic	ADJ
admet-2551	240	19	industry	industry	NOUN
admet-2551	241	1	[	[	X
admet-2551	241	2	90,91	90,91	NUM
admet-2551	241	3	]	]	PUNCT
admet-2551	241	4	.	.	PUNCT
admet-2551	242	1	prion	prion	NOUN
admet-2551	242	2	disease	disease	NOUN
admet-2551	242	3	or	or	CCONJ
admet-2551	242	4	transmissible	transmissible	ADJ
admet-2551	242	5	spongiform	spongiform	NOUN
admet-2551	242	6	encephalopathy	encephalopathy	ADJ
admet-2551	242	7	(	(	PUNCT
admet-2551	242	8	tse	tse	PROPN
admet-2551	242	9	)	)	PUNCT
admet-2551	242	10	is	be	AUX
admet-2551	242	11	a	a	DET
admet-2551	242	12	neurological	neurological	ADJ
admet-2551	242	13	disease	disease	NOUN
admet-2551	242	14	manifested	manifest	VERB
admet-2551	242	15	due	due	ADP
admet-2551	242	16	to	to	ADP
admet-2551	242	17	the	the	DET
admet-2551	242	18	aggregation	aggregation	NOUN
admet-2551	242	19	of	of	ADP
admet-2551	242	20	misfolded	misfolde	VERB
admet-2551	242	21	proteins	protein	NOUN
admet-2551	242	22	called	call	VERB
admet-2551	242	23	prions	prion	NOUN
admet-2551	242	24	.	.	PUNCT
admet-2551	243	1	prion	prion	NOUN
admet-2551	243	2	protein	protein	NOUN
admet-2551	243	3	gets	get	AUX
admet-2551	243	4	transmitted	transmit	VERB
admet-2551	243	5	from	from	ADP
admet-2551	243	6	infected	infected	ADJ
admet-2551	243	7	animals	animal	NOUN
admet-2551	243	8	through	through	ADP
admet-2551	243	9	the	the	DET
admet-2551	243	10	consumption	consumption	NOUN
admet-2551	243	11	of	of	ADP
admet-2551	243	12	cattle	cattle	NOUN
admet-2551	243	13	feed	feed	NOUN
admet-2551	243	14	prepared	prepare	VERB
admet-2551	243	15	from	from	ADP
admet-2551	243	16	dried	dry	VERB
admet-2551	243	17	brains	brain	NOUN
admet-2551	243	18	and	and	CCONJ
admet-2551	243	19	carcasses	carcass	NOUN
admet-2551	243	20	of	of	ADP
admet-2551	243	21	dead	dead	ADJ
admet-2551	243	22	infected	infected	ADJ
admet-2551	243	23	animals	animal	NOUN
admet-2551	243	24	[	[	X
admet-2551	243	25	92,93	92,93	X
admet-2551	243	26	]	]	X
admet-2551	243	27	.	.	PUNCT
admet-2551	244	1	the	the	DET
admet-2551	244	2	types	type	NOUN
admet-2551	244	3	of	of	ADP
admet-2551	244	4	tses	tse	NOUN
admet-2551	244	5	in	in	ADP
admet-2551	244	6	humans	human	NOUN
admet-2551	244	7	are	be	AUX
admet-2551	244	8	cjd	cjd	ADJ
admet-2551	244	9	,	,	PUNCT
admet-2551	244	10	transmissible	transmissible	ADJ
admet-2551	244	11	mink	mink	NOUN
admet-2551	244	12	encephalopathy	encephalopathy	NOUN
admet-2551	244	13	(	(	PUNCT
admet-2551	244	14	tmc	tmc	NOUN
admet-2551	244	15	)	)	PUNCT
admet-2551	244	16	in	in	ADP
admet-2551	244	17	mink	mink	NOUN
admet-2551	244	18	and	and	CCONJ
admet-2551	244	19	kuru	kuru	NOUN
admet-2551	245	1	[	[	X
admet-2551	245	2	94	94	NUM
admet-2551	245	3	]	]	PUNCT
admet-2551	245	4	.	.	PUNCT
admet-2551	246	1	a	a	DET
admet-2551	246	2	reported	report	VERB
admet-2551	246	3	novel	novel	ADJ
admet-2551	246	4	application	application	NOUN
admet-2551	246	5	of	of	ADP
admet-2551	246	6	ker	ker	NOUN
admet-2551	246	7	(	(	PUNCT
admet-2551	246	8	also	also	ADV
admet-2551	246	9	known	know	VERB
admet-2551	246	10	as	as	ADP
admet-2551	246	11	prionzyme	prionzyme	NOUN
admet-2551	246	12	)	)	PUNCT
admet-2551	246	13	is	be	AUX
admet-2551	246	14	the	the	DET
admet-2551	246	15	hydrolysis	hydrolysis	NOUN
admet-2551	246	16	of	of	ADP
admet-2551	246	17	the	the	DET
admet-2551	246	18	pathogenic	pathogenic	ADJ
admet-2551	246	19	form	form	NOUN
admet-2551	246	20	of	of	ADP
admet-2551	246	21	prion	prion	NOUN
admet-2551	246	22	protein	protein	NOUN
admet-2551	246	23	,	,	PUNCT
admet-2551	246	24	which	which	PRON
admet-2551	246	25	is	be	AUX
admet-2551	246	26	known	know	VERB
admet-2551	246	27	to	to	PART
admet-2551	246	28	be	be	AUX
admet-2551	246	29	resistant	resistant	ADJ
admet-2551	246	30	to	to	ADP
admet-2551	246	31	any	any	DET
admet-2551	246	32	other	other	ADJ
admet-2551	246	33	protease	protease	NOUN
admet-2551	246	34	[	[	X
admet-2551	246	35	95	95	NUM
admet-2551	246	36	]	]	PUNCT
admet-2551	246	37	.	.	PUNCT
admet-2551	247	1	the	the	DET
admet-2551	247	2	present	present	ADJ
admet-2551	247	3	prion	prion	NOUN
admet-2551	247	4	treatment	treatment	NOUN
admet-2551	247	5	methods	method	NOUN
admet-2551	247	6	comprise	comprise	VERB
admet-2551	247	7	its	its	PRON
admet-2551	247	8	inactivation	inactivation	NOUN
admet-2551	247	9	using	use	VERB
admet-2551	247	10	chemicals	chemical	NOUN
admet-2551	247	11	and	and	CCONJ
admet-2551	247	12	heat	heat	NOUN
admet-2551	247	13	,	,	PUNCT
admet-2551	247	14	which	which	PRON
admet-2551	247	15	has	have	VERB
admet-2551	247	16	limitations	limitation	NOUN
admet-2551	247	17	regarding	regard	VERB
admet-2551	247	18	environmental	environmental	ADJ
admet-2551	247	19	acceptability	acceptability	NOUN
admet-2551	247	20	,	,	PUNCT
admet-2551	247	21	application	application	NOUN
admet-2551	247	22	and	and	CCONJ
admet-2551	247	23	cost	cost	NOUN
admet-2551	247	24	compatibility	compatibility	NOUN
admet-2551	247	25	,	,	PUNCT
admet-2551	247	26	making	make	VERB
admet-2551	247	27	way	way	NOUN
admet-2551	247	28	for	for	ADP
admet-2551	247	29	enzyme	enzyme	NOUN
admet-2551	247	30	inactivation	inactivation	NOUN
admet-2551	247	31	of	of	ADP
admet-2551	247	32	prion	prion	NOUN
admet-2551	247	33	[	[	X
admet-2551	247	34	96	96	NUM
admet-2551	247	35	]	]	PUNCT
admet-2551	247	36	.	.	PUNCT
admet-2551	248	1	ker	ker	NOUN
admet-2551	248	2	-	-	PUNCT
admet-2551	248	3	mediated	mediate	VERB
admet-2551	248	4	prion	prion	NOUN
admet-2551	248	5	protein	protein	NOUN
admet-2551	248	6	destruction	destruction	NOUN
admet-2551	248	7	is	be	AUX
admet-2551	248	8	feasible	feasible	ADJ
admet-2551	248	9	at	at	ADP
admet-2551	248	10	a	a	DET
admet-2551	248	11	nominal	nominal	ADJ
admet-2551	248	12	cost	cost	NOUN
admet-2551	248	13	and	and	CCONJ
admet-2551	248	14	is	be	AUX
admet-2551	248	15	eco	eco	NOUN
admet-2551	248	16	-	-	PUNCT
admet-2551	248	17	friendly	friendly	ADJ
admet-2551	248	18	[	[	X
admet-2551	248	19	97	97	NUM
admet-2551	248	20	]	]	PUNCT
admet-2551	248	21	.	.	PUNCT
admet-2551	249	1	the	the	DET
admet-2551	249	2	structure	structure	NOUN
admet-2551	249	3	of	of	ADP
admet-2551	249	4	keratinase	keratinase	PROPN
admet-2551	249	5	is	be	AUX
admet-2551	249	6	extracted	extract	VERB
admet-2551	249	7	from	from	ADP
admet-2551	249	8	the	the	DET
admet-2551	249	9	protein	protein	NOUN
admet-2551	249	10	database	database	NOUN
admet-2551	249	11	and	and	CCONJ
admet-2551	249	12	given	give	VERB
admet-2551	249	13	in	in	ADP
admet-2551	249	14	figure	figure	NOUN
admet-2551	249	15	4	4	NUM
admet-2551	249	16	.	.	PUNCT
admet-2551	249	17	figure	figure	VERB
admet-2551	249	18	4	4	NUM
admet-2551	249	19	.	.	PUNCT
admet-2551	250	1	the	the	DET
admet-2551	250	2	structure	structure	NOUN
admet-2551	250	3	of	of	ADP
admet-2551	250	4	keratinase	keratinase	PROPN
admet-2551	250	5	(	(	PUNCT
admet-2551	250	6	source	source	NOUN
admet-2551	250	7	:	:	PUNCT
admet-2551	250	8	pdb	pdb	PROPN
admet-2551	250	9	i	i	PROPN
admet-2551	250	10	d	d	PROPN
admet-2551	250	11	5wsl	5wsl	NUM
admet-2551	250	12	)	)	PUNCT
admet-2551	250	13	extracted	extract	VERB
admet-2551	250	14	from	from	ADP
admet-2551	250	15	pymol	pymol	PROPN
admet-2551	250	16	[	[	X
admet-2551	250	17	98	98	NUM
admet-2551	250	18	]	]	SYM
admet-2551	250	19	.	.	PUNCT
admet-2551	251	1	amyloidogenic	amyloidogenic	ADJ
admet-2551	251	2	activity	activity	NOUN
admet-2551	251	3	of	of	ADP
admet-2551	251	4	keratinase	keratinase	PROPN
admet-2551	251	5	amyloid	amyloid	NOUN
admet-2551	251	6	β	β	X
admet-2551	251	7	peptides	peptide	NOUN
admet-2551	251	8	(	(	PUNCT
admet-2551	251	9	aβ	aβ	NOUN
admet-2551	251	10	)	)	PUNCT
admet-2551	251	11	are	be	AUX
admet-2551	251	12	poisonous	poisonous	ADJ
admet-2551	251	13	peptides	peptide	NOUN
admet-2551	251	14	composed	compose	VERB
admet-2551	251	15	of	of	ADP
admet-2551	251	16	39	39	NUM
admet-2551	251	17	to	to	PART
admet-2551	251	18	43	43	NUM
admet-2551	251	19	amino	amino	NOUN
admet-2551	251	20	acid	acid	NOUN
admet-2551	251	21	residues	residue	NOUN
admet-2551	251	22	.	.	PUNCT
admet-2551	252	1	when	when	SCONJ
admet-2551	252	2	aβ	aβ	DET
admet-2551	252	3	aggregates	aggregate	NOUN
admet-2551	252	4	are	be	AUX
admet-2551	252	5	deposited	deposit	VERB
admet-2551	252	6	in	in	ADP
admet-2551	252	7	brain	brain	NOUN
admet-2551	252	8	tissues	tissue	NOUN
admet-2551	252	9	,	,	PUNCT
admet-2551	252	10	they	they	PRON
admet-2551	252	11	block	block	VERB
admet-2551	252	12	synaptic	synaptic	ADJ
admet-2551	252	13	transmission	transmission	NOUN
admet-2551	252	14	and	and	CCONJ
admet-2551	252	15	cause	cause	VERB
admet-2551	252	16	neurodegenerative	neurodegenerative	ADJ
admet-2551	252	17	illnesses	illness	NOUN
admet-2551	252	18	.	.	PUNCT
admet-2551	253	1	several	several	ADJ
admet-2551	253	2	experiments	experiment	NOUN
admet-2551	253	3	have	have	AUX
admet-2551	253	4	been	be	AUX
admet-2551	253	5	done	do	VERB
admet-2551	253	6	to	to	PART
admet-2551	253	7	disintegrate	disintegrate	VERB
admet-2551	253	8	these	these	DET
admet-2551	253	9	hazardous	hazardous	ADJ
admet-2551	253	10	aggregates	aggregate	NOUN
admet-2551	253	11	.	.	PUNCT
admet-2551	254	1	amycolatopsis	amycolatopsis	NOUN
admet-2551	254	2	ker1	ker1	PROPN
admet-2551	254	3	and	and	CCONJ
admet-2551	254	4	ker2	ker2	PROPN
admet-2551	254	5	https://doi.org/10.5599/admet.2551	https://doi.org/10.5599/admet.2551	NOUN
admet-2551	254	6	s.	s.	PROPN
admet-2551	254	7	k.	k.	PROPN
admet-2551	255	1	metkar	metkar	PROPN
admet-2551	255	2	et	et	PROPN
admet-2551	255	3	al	al	PROPN
admet-2551	255	4	.	.	PROPN
admet-2551	255	5	admet	admet	PROPN
admet-2551	255	6	&	&	CCONJ
admet-2551	255	7	dmpk	dmpk	PROPN
admet-2551	255	8	12(6	12(6	NUM
admet-2551	255	9	)	)	PUNCT
admet-2551	255	10	(	(	PUNCT
admet-2551	255	11	2024	2024	NUM
admet-2551	255	12	)	)	PUNCT
admet-2551	255	13	797	797	NUM
admet-2551	255	14	-	-	SYM
admet-2551	255	15	820	820	NUM
admet-2551	255	16	806	806	NUM
admet-2551	255	17	were	be	AUX
admet-2551	255	18	tested	test	VERB
admet-2551	255	19	for	for	ADP
admet-2551	255	20	their	their	PRON
admet-2551	255	21	ability	ability	NOUN
admet-2551	255	22	to	to	PART
admet-2551	255	23	break	break	VERB
admet-2551	255	24	down	down	ADP
admet-2551	255	25	aβ	aβ	DET
admet-2551	255	26	fibrils	fibril	NOUN
admet-2551	255	27	.	.	PUNCT
admet-2551	256	1	in	in	ADP
admet-2551	256	2	this	this	DET
admet-2551	256	3	study	study	NOUN
admet-2551	256	4	,	,	PUNCT
admet-2551	256	5	aβ	aβ	ADP
admet-2551	256	6	fibrils	fibril	NOUN
admet-2551	256	7	of	of	ADP
admet-2551	256	8	lysozymes	lysozyme	NOUN
admet-2551	256	9	were	be	AUX
admet-2551	256	10	treated	treat	VERB
admet-2551	256	11	with	with	ADP
admet-2551	256	12	varying	vary	VERB
admet-2551	256	13	doses	dose	NOUN
admet-2551	256	14	(	(	PUNCT
admet-2551	256	15	50	50	NUM
admet-2551	256	16	,	,	PUNCT
admet-2551	256	17	100	100	NUM
admet-2551	256	18	,	,	PUNCT
admet-2551	256	19	125	125	NUM
admet-2551	256	20	,	,	PUNCT
admet-2551	256	21	250	250	NUM
admet-2551	256	22	,	,	PUNCT
admet-2551	256	23	500	500	NUM
admet-2551	256	24	mg	mg	NUM
admet-2551	256	25	/	/	SYM
admet-2551	256	26	ml	ml	NOUN
admet-2551	256	27	)	)	PUNCT
admet-2551	256	28	of	of	ADP
admet-2551	256	29	keratinase	keratinase	NOUN
admet-2551	256	30	,	,	PUNCT
admet-2551	256	31	and	and	CCONJ
admet-2551	256	32	their	their	PRON
admet-2551	256	33	degraded	degraded	ADJ
admet-2551	256	34	structure	structure	NOUN
admet-2551	256	35	was	be	AUX
admet-2551	256	36	analysed	analyse	VERB
admet-2551	256	37	over	over	ADP
admet-2551	256	38	time	time	NOUN
admet-2551	256	39	intervals	interval	NOUN
admet-2551	256	40	.	.	PUNCT
admet-2551	257	1	at	at	ADP
admet-2551	257	2	24	24	NUM
admet-2551	257	3	h	h	NOUN
admet-2551	257	4	,	,	PUNCT
admet-2551	257	5	ker1	ker1	PROPN
admet-2551	257	6	had	have	VERB
admet-2551	257	7	a	a	DET
admet-2551	257	8	larger	large	ADJ
admet-2551	257	9	effect	effect	NOUN
admet-2551	257	10	than	than	ADP
admet-2551	257	11	ker2	ker2	PROPN
admet-2551	257	12	[	[	X
admet-2551	257	13	99	99	NUM
admet-2551	257	14	]	]	PUNCT
admet-2551	257	15	.	.	PUNCT
admet-2551	258	1	in	in	ADP
admet-2551	258	2	recent	recent	ADJ
admet-2551	258	3	years	year	NOUN
admet-2551	258	4	,	,	PUNCT
admet-2551	258	5	numerous	numerous	ADJ
admet-2551	258	6	studies	study	NOUN
admet-2551	258	7	have	have	AUX
admet-2551	258	8	suggested	suggest	VERB
admet-2551	258	9	that	that	SCONJ
admet-2551	258	10	keratinolytic	keratinolytic	ADJ
admet-2551	258	11	enzymes	enzyme	NOUN
admet-2551	258	12	could	could	AUX
admet-2551	258	13	potentially	potentially	ADV
admet-2551	258	14	be	be	AUX
admet-2551	258	15	utilized	utilize	VERB
admet-2551	258	16	in	in	ADP
admet-2551	258	17	degrading	degrade	VERB
admet-2551	258	18	aβ	aβ	NOUN
admet-2551	258	19	aggregates	aggregate	NOUN
admet-2551	258	20	and	and	CCONJ
admet-2551	258	21	prion	prion	NOUN
admet-2551	258	22	protein	protein	NOUN
admet-2551	258	23	(	(	PUNCT
admet-2551	258	24	prpsc	prpsc	NOUN
admet-2551	258	25	)	)	PUNCT
admet-2551	258	26	.	.	PUNCT
admet-2551	259	1	keratinase	keratinase	PROPN
admet-2551	259	2	msk103	msk103	PROPN
admet-2551	259	3	from	from	ADP
admet-2551	259	4	bacillus	bacillus	NOUN
admet-2551	259	5	licheniformis	licheniformis	NOUN
admet-2551	259	6	efficiently	efficiently	ADV
admet-2551	259	7	degraded	degrade	VERB
admet-2551	259	8	prpsc	prpsc	NOUN
admet-2551	259	9	in	in	ADP
admet-2551	259	10	brain	brain	NOUN
admet-2551	259	11	tissue	tissue	NOUN
admet-2551	259	12	homogenates	homogenate	NOUN
admet-2551	259	13	infected	infect	VERB
admet-2551	259	14	with	with	ADP
admet-2551	259	15	scrapie	scrapie	NOUN
admet-2551	259	16	in	in	ADP
admet-2551	259	17	2	2	NUM
admet-2551	259	18	h	h	NOUN
admet-2551	259	19	at	at	ADP
admet-2551	259	20	50	50	NUM
admet-2551	259	21	°	°	NOUN
admet-2551	259	22	c	c	NOUN
admet-2551	259	23	.	.	PUNCT
admet-2551	260	1	after	after	ADP
admet-2551	260	2	20	20	NUM
admet-2551	260	3	hours	hour	NOUN
admet-2551	260	4	of	of	ADP
admet-2551	260	5	decontamination	decontamination	NOUN
admet-2551	260	6	,	,	PUNCT
admet-2551	260	7	prions	prion	NOUN
admet-2551	260	8	were	be	AUX
admet-2551	260	9	reduced	reduce	VERB
admet-2551	260	10	to	to	ADP
admet-2551	260	11	lower	low	ADJ
admet-2551	260	12	levels	level	NOUN
admet-2551	260	13	.	.	PUNCT
admet-2551	261	1	hence	hence	ADV
admet-2551	261	2	,	,	PUNCT
admet-2551	261	3	it	it	PRON
admet-2551	261	4	proves	prove	VERB
admet-2551	261	5	that	that	SCONJ
admet-2551	261	6	msk103	msk103	PROPN
admet-2551	261	7	keratinase	keratinase	NOUN
admet-2551	261	8	can	can	AUX
admet-2551	261	9	also	also	ADV
admet-2551	261	10	degrade	degrade	VERB
admet-2551	261	11	prpsc	prpsc	NOUN
admet-2551	261	12	[	[	X
admet-2551	261	13	100	100	NUM
admet-2551	261	14	]	]	PUNCT
admet-2551	261	15	.	.	PUNCT
admet-2551	262	1	the	the	DET
admet-2551	262	2	researchers	researcher	NOUN
admet-2551	262	3	discovered	discover	VERB
admet-2551	262	4	that	that	SCONJ
admet-2551	262	5	the	the	DET
admet-2551	262	6	combination	combination	NOUN
admet-2551	262	7	of	of	ADP
admet-2551	262	8	b.	b.	PROPN
admet-2551	262	9	licheniformis	licheniformis	PROPN
admet-2551	262	10	n22	n22	PROPN
admet-2551	262	11	keratinase	keratinase	PROPN
admet-2551	262	12	and	and	CCONJ
admet-2551	262	13	pseudomonas	pseudomonas	PROPN
admet-2551	262	14	aeruginosa	aeruginosa	PROPN
admet-2551	262	15	ncimb	ncimb	PROPN
admet-2551	262	16	8626	8626	NUM
admet-2551	262	17	biosurfactant	biosurfactant	PROPN
admet-2551	262	18	formulation	formulation	NOUN
admet-2551	262	19	was	be	AUX
admet-2551	262	20	capable	capable	ADJ
admet-2551	262	21	of	of	ADP
admet-2551	262	22	partially	partially	ADV
admet-2551	262	23	degrading	degrade	VERB
admet-2551	262	24	me7	me7	NOUN
admet-2551	262	25	scrapie	scrapie	NOUN
admet-2551	262	26	prions	prion	NOUN
admet-2551	262	27	after	after	ADP
admet-2551	262	28	treating	treat	VERB
admet-2551	262	29	them	they	PRON
admet-2551	262	30	for	for	ADP
admet-2551	262	31	1	1	NUM
admet-2551	262	32	h	h	NOUN
admet-2551	262	33	at	at	ADP
admet-2551	262	34	50	50	NUM
admet-2551	262	35	°	°	NOUN
admet-2551	262	36	c	c	NOUN
admet-2551	262	37	.	.	PUNCT
admet-2551	263	1	when	when	SCONJ
admet-2551	263	2	the	the	DET
admet-2551	263	3	temperature	temperature	NOUN
admet-2551	263	4	increased	increase	VERB
admet-2551	263	5	from	from	ADP
admet-2551	263	6	50	50	NUM
admet-2551	263	7	to	to	PART
admet-2551	263	8	65	65	NUM
admet-2551	263	9	°	°	NOUN
admet-2551	263	10	c	c	NOUN
admet-2551	263	11	,	,	PUNCT
admet-2551	263	12	the	the	DET
admet-2551	263	13	prpsc	prpsc	ADJ
admet-2551	263	14	proteins	protein	NOUN
admet-2551	263	15	became	become	VERB
admet-2551	263	16	undetectable	undetectable	ADJ
admet-2551	263	17	in	in	ADP
admet-2551	263	18	just	just	ADV
admet-2551	263	19	10	10	NUM
admet-2551	263	20	min	min	NOUN
admet-2551	263	21	.	.	PROPN
admet-2551	263	22	interestingly	interestingly	ADV
admet-2551	263	23	,	,	PUNCT
admet-2551	263	24	it	it	PRON
admet-2551	263	25	was	be	AUX
admet-2551	263	26	noted	note	VERB
admet-2551	263	27	that	that	SCONJ
admet-2551	263	28	the	the	DET
admet-2551	263	29	b.	b.	PROPN
admet-2551	263	30	licheniformis	licheniformis	PROPN
admet-2551	263	31	n22	n22	PROPN
admet-2551	263	32	keratinase	keratinase	PROPN
admet-2551	263	33	alone	alone	ADV
admet-2551	263	34	could	could	AUX
admet-2551	263	35	not	not	PART
admet-2551	263	36	completely	completely	ADV
admet-2551	263	37	break	break	VERB
admet-2551	263	38	down	down	ADP
admet-2551	263	39	the	the	DET
admet-2551	263	40	me7	me7	NOUN
admet-2551	263	41	scrapie	scrapie	NOUN
admet-2551	263	42	prions	prion	NOUN
admet-2551	263	43	even	even	ADV
admet-2551	263	44	after	after	ADP
admet-2551	263	45	extending	extend	VERB
admet-2551	263	46	the	the	DET
admet-2551	263	47	period	period	NOUN
admet-2551	263	48	for	for	ADP
admet-2551	263	49	1	1	NUM
admet-2551	263	50	h.	h.	PROPN
admet-2551	263	51	however	however	ADV
admet-2551	263	52	,	,	PUNCT
admet-2551	263	53	the	the	DET
admet-2551	263	54	biosurfactant	biosurfactant	NOUN
admet-2551	263	55	ncimb	ncimb	PROPN
admet-2551	263	56	8626	8626	NUM
admet-2551	263	57	combined	combine	VERB
admet-2551	263	58	with	with	ADP
admet-2551	263	59	enzyme	enzyme	NOUN
admet-2551	263	60	n22	n22	ADJ
admet-2551	263	61	keratinase	keratinase	NOUN
admet-2551	263	62	showed	show	VERB
admet-2551	263	63	complete	complete	ADJ
admet-2551	263	64	degradation	degradation	NOUN
admet-2551	263	65	of	of	ADP
admet-2551	263	66	infectious	infectious	ADJ
admet-2551	263	67	prion	prion	NOUN
admet-2551	263	68	protein	protein	NOUN
admet-2551	264	1	[	[	X
admet-2551	264	2	101	101	NUM
admet-2551	264	3	]	]	PUNCT
admet-2551	264	4	.	.	PUNCT
admet-2551	265	1	ker	ker	PROPN
admet-2551	265	2	isolated	isolate	VERB
admet-2551	265	3	from	from	ADP
admet-2551	265	4	the	the	DET
admet-2551	265	5	moderate	moderate	ADJ
admet-2551	265	6	thermophile	thermophile	PROPN
admet-2551	265	7	b.	b.	PROPN
admet-2551	265	8	licheniformis	licheniformis	PROPN
admet-2551	265	9	pwd-1	pwd-1	X
admet-2551	265	10	strain	strain	NOUN
admet-2551	265	11	was	be	AUX
admet-2551	265	12	the	the	DET
admet-2551	265	13	first	first	ADJ
admet-2551	265	14	described	describe	VERB
admet-2551	265	15	enzyme	enzyme	NOUN
admet-2551	265	16	that	that	PRON
admet-2551	265	17	was	be	AUX
admet-2551	265	18	capable	capable	ADJ
admet-2551	265	19	of	of	ADP
admet-2551	265	20	disintegrating	disintegrate	VERB
admet-2551	265	21	pretreated	pretreate	VERB
admet-2551	265	22	prion	prion	NOUN
admet-2551	265	23	(	(	PUNCT
admet-2551	265	24	i.e.	i.e.	X
admet-2551	265	25	,	,	PUNCT
admet-2551	265	26	heated	heat	VERB
admet-2551	265	27	at	at	ADP
admet-2551	265	28	115	115	NUM
admet-2551	265	29	°	°	ADP
admet-2551	265	30	c	c	NOUN
admet-2551	265	31	for	for	ADP
admet-2551	265	32	40	40	NUM
admet-2551	265	33	min	min	NOUN
admet-2551	265	34	along	along	ADP
admet-2551	265	35	with	with	ADP
admet-2551	265	36	sds	sds	PROPN
admet-2551	265	37	)	)	PUNCT
admet-2551	266	1	[	[	X
admet-2551	266	2	102	102	NUM
admet-2551	266	3	]	]	PUNCT
admet-2551	266	4	.	.	PUNCT
admet-2551	267	1	the	the	DET
admet-2551	267	2	purified	purified	ADJ
admet-2551	267	3	version	version	NOUN
admet-2551	267	4	of	of	ADP
admet-2551	267	5	ker	ker	NOUN
admet-2551	267	6	(	(	PUNCT
admet-2551	267	7	strain	strain	PROPN
admet-2551	267	8	msk	msk	PROPN
admet-2551	267	9	103	103	NUM
admet-2551	267	10	)	)	PUNCT
admet-2551	267	11	showed	show	VERB
admet-2551	267	12	the	the	DET
admet-2551	267	13	degradation	degradation	NOUN
admet-2551	267	14	and	and	CCONJ
admet-2551	267	15	decontamination	decontamination	NOUN
admet-2551	267	16	of	of	ADP
admet-2551	267	17	prion	prion	NOUN
admet-2551	267	18	-	-	PUNCT
admet-2551	267	19	infected	infect	VERB
admet-2551	267	20	brain	brain	NOUN
admet-2551	267	21	homogenates	homogenate	NOUN
admet-2551	267	22	at	at	ADP
admet-2551	267	23	50	50	NUM
admet-2551	267	24	°	°	ADP
admet-2551	267	25	c	c	NOUN
admet-2551	267	26	without	without	ADP
admet-2551	267	27	prior	prior	ADJ
admet-2551	267	28	heat	heat	NOUN
admet-2551	267	29	treatments	treatment	NOUN
admet-2551	267	30	with	with	ADP
admet-2551	267	31	detergents	detergent	NOUN
admet-2551	267	32	.	.	PUNCT
admet-2551	268	1	this	this	DET
admet-2551	268	2	ker	ker	NOUN
admet-2551	268	3	has	have	AUX
admet-2551	268	4	shown	show	VERB
admet-2551	268	5	intense	intense	ADJ
admet-2551	268	6	activity	activity	NOUN
admet-2551	268	7	in	in	ADP
admet-2551	268	8	the	the	DET
admet-2551	268	9	60	60	NUM
admet-2551	268	10	-	-	SYM
admet-2551	268	11	70	70	NUM
admet-2551	268	12	°	°	NOUN
admet-2551	268	13	c	c	NOUN
admet-2551	268	14	range	range	NOUN
admet-2551	268	15	with	with	ADP
admet-2551	268	16	ph	ph	NOUN
admet-2551	268	17	9	9	NUM
admet-2551	268	18	to	to	PART
admet-2551	268	19	10	10	NUM
admet-2551	268	20	[	[	X
admet-2551	268	21	103	103	NUM
admet-2551	268	22	]	]	PUNCT
admet-2551	268	23	.	.	PUNCT
admet-2551	269	1	using	use	VERB
admet-2551	269	2	an	an	DET
admet-2551	269	3	alkaline	alkaline	NOUN
admet-2551	269	4	serine	serine	NOUN
admet-2551	269	5	protease	protease	NOUN
admet-2551	269	6	isolated	isolate	VERB
admet-2551	269	7	from	from	ADP
admet-2551	269	8	streptomyces	streptomyce	NOUN
admet-2551	269	9	99	99	NUM
admet-2551	269	10	-	-	PUNCT
admet-2551	269	11	gp-2d-5	gp-2d-5	NOUN
admet-2551	269	12	strain	strain	NOUN
admet-2551	269	13	,	,	PUNCT
admet-2551	269	14	scrapie	scrapie	NOUN
admet-2551	269	15	prion	prion	NOUN
admet-2551	269	16	degradation	degradation	NOUN
admet-2551	269	17	could	could	AUX
admet-2551	269	18	be	be	AUX
admet-2551	269	19	achieved	achieve	VERB
admet-2551	269	20	within	within	ADP
admet-2551	269	21	3	3	NUM
admet-2551	269	22	min	min	NOUN
admet-2551	269	23	.	.	PROPN
admet-2551	269	24	at	at	ADP
admet-2551	269	25	a	a	DET
admet-2551	269	26	temperature	temperature	NOUN
admet-2551	269	27	of	of	ADP
admet-2551	269	28	60	60	NUM
admet-2551	269	29	°	°	NOUN
admet-2551	269	30	c	c	NOUN
admet-2551	269	31	and	and	CCONJ
admet-2551	269	32	a	a	DET
admet-2551	269	33	ph	ph	ADJ
admet-2551	269	34	level	level	NOUN
admet-2551	269	35	of	of	ADP
admet-2551	269	36	11	11	NUM
admet-2551	269	37	,	,	PUNCT
admet-2551	269	38	the	the	DET
admet-2551	269	39	enzyme	enzyme	NOUN
admet-2551	269	40	has	have	AUX
admet-2551	269	41	been	be	AUX
admet-2551	269	42	shown	show	VERB
admet-2551	269	43	to	to	PART
admet-2551	269	44	exhibit	exhibit	VERB
admet-2551	269	45	its	its	PRON
admet-2551	269	46	maximum	maximum	ADJ
admet-2551	269	47	activity	activity	NOUN
admet-2551	269	48	[	[	X
admet-2551	269	49	104	104	NUM
admet-2551	269	50	]	]	PUNCT
admet-2551	269	51	.	.	PUNCT
admet-2551	270	1	therefore	therefore	ADV
admet-2551	270	2	,	,	PUNCT
admet-2551	270	3	most	most	ADJ
admet-2551	270	4	studies	study	NOUN
admet-2551	270	5	concluded	conclude	VERB
admet-2551	270	6	that	that	SCONJ
admet-2551	270	7	combination	combination	NOUN
admet-2551	270	8	therapy	therapy	NOUN
admet-2551	270	9	of	of	ADP
admet-2551	270	10	keratinase	keratinase	PROPN
admet-2551	270	11	enzyme	enzyme	NOUN
admet-2551	270	12	has	have	AUX
admet-2551	270	13	enhanced	enhance	VERB
admet-2551	270	14	anti	anti	ADJ
admet-2551	270	15	-	-	ADJ
admet-2551	270	16	amyloidogenic	amyloidogenic	ADJ
admet-2551	270	17	activity	activity	NOUN
admet-2551	270	18	against	against	ADP
admet-2551	270	19	aβ	aβ	NOUN
admet-2551	270	20	and	and	CCONJ
admet-2551	270	21	prion	prion	NOUN
admet-2551	271	1	[	[	X
admet-2551	271	2	105	105	NUM
admet-2551	271	3	]	]	PUNCT
admet-2551	271	4	.	.	PUNCT
admet-2551	272	1	the	the	DET
admet-2551	272	2	limitation	limitation	NOUN
admet-2551	272	3	of	of	ADP
admet-2551	272	4	keratinase	keratinase	PROPN
admet-2551	272	5	action	action	NOUN
admet-2551	272	6	is	be	AUX
admet-2551	272	7	the	the	DET
admet-2551	272	8	high	high	ADJ
admet-2551	272	9	temperature	temperature	NOUN
admet-2551	272	10	it	it	PRON
admet-2551	272	11	needs	need	VERB
admet-2551	272	12	to	to	PART
admet-2551	272	13	degrade	degrade	VERB
admet-2551	272	14	the	the	DET
admet-2551	272	15	amyloids	amyloid	NOUN
admet-2551	272	16	in	in	ADP
admet-2551	272	17	most	most	ADJ
admet-2551	272	18	cases	case	NOUN
admet-2551	272	19	,	,	PUNCT
admet-2551	272	20	which	which	PRON
admet-2551	272	21	can	can	AUX
admet-2551	272	22	not	not	PART
admet-2551	272	23	be	be	AUX
admet-2551	272	24	achieved	achieve	VERB
admet-2551	272	25	under	under	ADP
admet-2551	272	26	physiological	physiological	ADJ
admet-2551	272	27	conditions	condition	NOUN
admet-2551	272	28	.	.	PUNCT
admet-2551	273	1	keratinase	keratinase	PROPN
admet-2551	273	2	can	can	AUX
admet-2551	273	3	be	be	AUX
admet-2551	273	4	used	use	VERB
admet-2551	273	5	for	for	ADP
admet-2551	273	6	surface	surface	NOUN
admet-2551	273	7	sterilizations	sterilization	NOUN
admet-2551	273	8	and	and	CCONJ
admet-2551	273	9	sterilizations	sterilization	NOUN
admet-2551	273	10	of	of	ADP
admet-2551	273	11	surgical	surgical	ADJ
admet-2551	273	12	equipment	equipment	NOUN
admet-2551	273	13	.	.	PUNCT
admet-2551	274	1	nattokinase	nattokinase	NOUN
admet-2551	274	2	the	the	DET
admet-2551	274	3	consumption	consumption	NOUN
admet-2551	274	4	of	of	ADP
admet-2551	274	5	boiled	boil	VERB
admet-2551	274	6	soybeans	soybean	NOUN
admet-2551	274	7	has	have	AUX
admet-2551	274	8	been	be	AUX
admet-2551	274	9	practiced	practice	VERB
admet-2551	274	10	for	for	ADP
admet-2551	274	11	almost	almost	ADV
admet-2551	274	12	100	100	NUM
admet-2551	274	13	years	year	NOUN
admet-2551	274	14	in	in	ADP
admet-2551	274	15	different	different	ADJ
admet-2551	274	16	asian	asian	ADJ
admet-2551	274	17	regions	region	NOUN
admet-2551	274	18	.	.	PUNCT
admet-2551	275	1	the	the	DET
admet-2551	275	2	microbe	microbe	NOUN
admet-2551	275	3	present	present	ADJ
admet-2551	275	4	in	in	ADP
admet-2551	275	5	fermented	fermented	ADJ
admet-2551	275	6	natto	natto	NOUN
admet-2551	275	7	is	be	AUX
admet-2551	275	8	a	a	DET
admet-2551	275	9	gram	gram	NOUN
admet-2551	275	10	-	-	PUNCT
admet-2551	275	11	positive	positive	ADJ
admet-2551	275	12	bacteria	bacteria	NOUN
admet-2551	275	13	that	that	PRON
admet-2551	275	14	can	can	AUX
admet-2551	275	15	also	also	ADV
admet-2551	275	16	produce	produce	VERB
admet-2551	275	17	endospores	endospore	NOUN
admet-2551	275	18	and	and	CCONJ
admet-2551	275	19	is	be	AUX
admet-2551	275	20	named	name	VERB
admet-2551	275	21	bacillus	bacillus	NOUN
admet-2551	275	22	subtilis	subtili	NOUN
admet-2551	275	23	natto	natto	NOUN
admet-2551	275	24	(	(	PUNCT
admet-2551	275	25	formerly	formerly	ADV
admet-2551	275	26	known	know	VERB
admet-2551	275	27	as	as	ADP
admet-2551	275	28	bacillus	bacillus	NOUN
admet-2551	275	29	natto	natto	NOUN
admet-2551	275	30	)	)	PUNCT
admet-2551	276	1	[	[	X
admet-2551	276	2	106,107	106,107	NUM
admet-2551	276	3	]	]	PUNCT
admet-2551	276	4	.	.	PUNCT
admet-2551	276	5	nattokinase	nattokinase	NOUN
admet-2551	276	6	(	(	PUNCT
admet-2551	276	7	nk	nk	PROPN
admet-2551	276	8	)	)	PUNCT
admet-2551	276	9	is	be	AUX
admet-2551	276	10	known	know	VERB
admet-2551	276	11	as	as	ADP
admet-2551	276	12	subtilisin	subtilisin	PROPN
admet-2551	276	13	nat	nat	PROPN
admet-2551	276	14	,	,	PUNCT
admet-2551	276	15	an	an	DET
admet-2551	276	16	extracellular	extracellular	ADJ
admet-2551	276	17	enzyme	enzyme	NOUN
admet-2551	276	18	produced	produce	VERB
admet-2551	276	19	by	by	ADP
admet-2551	276	20	bacillus	bacillus	NOUN
admet-2551	276	21	subtilis	subtili	NOUN
admet-2551	276	22	natto	natto	NOUN
admet-2551	276	23	[	[	X
admet-2551	276	24	108	108	NUM
admet-2551	276	25	]	]	PUNCT
admet-2551	276	26	.	.	PUNCT
admet-2551	277	1	nk	nk	PROPN
admet-2551	277	2	comes	come	VERB
admet-2551	277	3	into	into	ADP
admet-2551	277	4	the	the	DET
admet-2551	277	5	serine	serine	NOUN
admet-2551	277	6	protease	protease	NOUN
admet-2551	277	7	family	family	NOUN
admet-2551	277	8	with	with	ADP
admet-2551	277	9	the	the	DET
admet-2551	277	10	catalytic	catalytic	ADJ
admet-2551	277	11	triad	triad	NOUN
admet-2551	277	12	that	that	PRON
admet-2551	277	13	is	be	AUX
admet-2551	277	14	conserved	conserve	VERB
admet-2551	277	15	with	with	ADP
admet-2551	277	16	three	three	NUM
admet-2551	277	17	residues	residue	NOUN
admet-2551	277	18	like	like	ADP
admet-2551	277	19	asp-32	asp-32	NOUN
admet-2551	277	20	,	,	PUNCT
admet-2551	277	21	his-64	his-64	ADV
admet-2551	277	22	,	,	PUNCT
admet-2551	277	23	and	and	CCONJ
admet-2551	277	24	ser221	ser221	NOUN
admet-2551	277	25	[	[	X
admet-2551	277	26	109	109	NUM
admet-2551	277	27	]	]	PUNCT
admet-2551	277	28	;	;	PUNCT
admet-2551	277	29	it	it	PRON
admet-2551	277	30	has	have	VERB
admet-2551	277	31	an	an	DET
admet-2551	277	32	isoelectric	isoelectric	ADJ
admet-2551	277	33	point	point	NOUN
admet-2551	277	34	at	at	ADP
admet-2551	277	35	ph	ph	PROPN
admet-2551	277	36	8.7	8.7	NUM
admet-2551	277	37	,	,	PUNCT
admet-2551	277	38	and	and	CCONJ
admet-2551	277	39	the	the	DET
admet-2551	277	40	molecular	molecular	ADJ
admet-2551	277	41	weight	weight	NOUN
admet-2551	277	42	is	be	AUX
admet-2551	277	43	about	about	ADV
admet-2551	277	44	27.7	27.7	NUM
admet-2551	277	45	kda	kda	NOUN
admet-2551	278	1	[	[	X
admet-2551	278	2	110	110	NUM
admet-2551	278	3	]	]	PUNCT
admet-2551	278	4	.	.	PUNCT
admet-2551	279	1	nk	nk	PROPN
admet-2551	279	2	is	be	AUX
admet-2551	279	3	made	make	VERB
admet-2551	279	4	up	up	ADP
admet-2551	279	5	of	of	ADP
admet-2551	279	6	275	275	NUM
admet-2551	279	7	amino	amino	ADJ
admet-2551	279	8	acids	acid	NOUN
admet-2551	279	9	,	,	PUNCT
admet-2551	279	10	and	and	CCONJ
admet-2551	279	11	its	its	PRON
admet-2551	279	12	gene	gene	NOUN
admet-2551	279	13	sequence	sequence	NOUN
admet-2551	279	14	is	be	AUX
admet-2551	279	15	identical	identical	ADJ
admet-2551	279	16	with	with	ADP
admet-2551	279	17	various	various	ADJ
admet-2551	279	18	members	member	NOUN
admet-2551	279	19	of	of	ADP
admet-2551	279	20	the	the	DET
admet-2551	279	21	subtilisin	subtilisin	NOUN
admet-2551	279	22	family	family	NOUN
admet-2551	279	23	(	(	PUNCT
admet-2551	279	24	86	86	NUM
admet-2551	279	25	%	%	NOUN
admet-2551	279	26	with	with	ADP
admet-2551	279	27	subtilisin	subtilisin	PROPN
admet-2551	279	28	bpn	bpn	NOUN
admet-2551	279	29	,	,	PUNCT
admet-2551	279	30	and	and	CCONJ
admet-2551	279	31	72	72	NUM
admet-2551	279	32	%	%	NOUN
admet-2551	279	33	with	with	ADP
admet-2551	279	34	carlsberg	carlsberg	PROPN
admet-2551	279	35	subtilisin	subtilisin	PROPN
admet-2551	279	36	type	type	NOUN
admet-2551	279	37	,	,	PUNCT
admet-2551	279	38	99.5	99.5	NUM
admet-2551	279	39	%	%	NOUN
admet-2551	279	40	homology	homology	NOUN
admet-2551	279	41	with	with	ADP
admet-2551	279	42	subtilisin	subtilisin	NOUN
admet-2551	279	43	e	e	PROPN
admet-2551	279	44	)	)	PUNCT
admet-2551	279	45	.	.	PUNCT
admet-2551	280	1	it	it	PRON
admet-2551	280	2	disintegrates	disintegrate	VERB
admet-2551	280	3	fibrin	fibrin	NOUN
admet-2551	280	4	in	in	ADP
admet-2551	280	5	thrombi	thrombi	NOUN
admet-2551	280	6	as	as	ADV
admet-2551	280	7	well	well	ADV
admet-2551	280	8	as	as	ADP
admet-2551	280	9	cleaves	cleave	VERB
admet-2551	280	10	plasminogen	plasminogen	NOUN
admet-2551	280	11	activator	activator	NOUN
admet-2551	280	12	inhibitor	inhibitor	NOUN
admet-2551	280	13	type	type	NOUN
admet-2551	281	1	i	i	PRON
admet-2551	281	2	[	[	X
admet-2551	281	3	111	111	NUM
admet-2551	281	4	]	]	PUNCT
admet-2551	281	5	.	.	PUNCT
admet-2551	282	1	the	the	DET
admet-2551	282	2	structure	structure	NOUN
admet-2551	282	3	of	of	ADP
admet-2551	282	4	nattokinase	nattokinase	NOUN
admet-2551	282	5	from	from	ADP
admet-2551	282	6	the	the	DET
admet-2551	282	7	protein	protein	NOUN
admet-2551	282	8	data	datum	NOUN
admet-2551	282	9	bank	bank	NOUN
admet-2551	282	10	is	be	AUX
admet-2551	282	11	shown	show	VERB
admet-2551	282	12	in	in	ADP
admet-2551	282	13	figure	figure	NOUN
admet-2551	282	14	5	5	NUM
admet-2551	282	15	.	.	PUNCT
admet-2551	283	1	nk	nk	PROPN
admet-2551	283	2	supersedes	supersede	VERB
admet-2551	283	3	plasmin	plasmin	NOUN
admet-2551	283	4	toward	toward	ADP
admet-2551	283	5	thrombolytic	thrombolytic	ADJ
admet-2551	283	6	activity	activity	NOUN
admet-2551	283	7	[	[	X
admet-2551	283	8	112	112	NUM
admet-2551	283	9	]	]	PUNCT
admet-2551	283	10	,	,	PUNCT
admet-2551	283	11	and	and	CCONJ
admet-2551	283	12	oral	oral	ADJ
admet-2551	283	13	administration	administration	NOUN
admet-2551	283	14	causes	cause	VERB
admet-2551	283	15	absorption	absorption	NOUN
admet-2551	283	16	from	from	ADP
admet-2551	283	17	the	the	DET
admet-2551	283	18	intestinal	intestinal	ADJ
admet-2551	283	19	tract	tract	NOUN
admet-2551	283	20	to	to	PART
admet-2551	283	21	induce	induce	VERB
admet-2551	283	22	fibrinolysis	fibrinolysis	NOUN
admet-2551	283	23	.	.	PUNCT
admet-2551	284	1	this	this	PRON
admet-2551	284	2	makes	make	VERB
admet-2551	284	3	nk	nk	PROPN
admet-2551	284	4	a	a	DET
admet-2551	284	5	potential	potential	ADJ
admet-2551	284	6	anticoagulant	anticoagulant	NOUN
admet-2551	284	7	for	for	ADP
admet-2551	284	8	cardiovascular	cardiovascular	ADJ
admet-2551	284	9	disease	disease	NOUN
admet-2551	284	10	treatment	treatment	NOUN
admet-2551	284	11	and	and	CCONJ
admet-2551	284	12	coronary	coronary	ADJ
admet-2551	284	13	artery	artery	NOUN
admet-2551	284	14	disease	disease	NOUN
admet-2551	284	15	[	[	X
admet-2551	284	16	113	113	NUM
admet-2551	284	17	]	]	PUNCT
admet-2551	284	18	.	.	PUNCT
admet-2551	285	1	the	the	DET
admet-2551	285	2	nutritional	nutritional	ADJ
admet-2551	285	3	supplement	supplement	NOUN
admet-2551	285	4	natto	natto	NOUN
admet-2551	285	5	helps	help	VERB
admet-2551	285	6	to	to	PART
admet-2551	285	7	destroy	destroy	VERB
admet-2551	285	8	the	the	DET
admet-2551	285	9	intima	intima	NOUN
admet-2551	285	10	of	of	ADP
admet-2551	285	11	arteries	artery	NOUN
admet-2551	285	12	thickening	thickening	NOUN
admet-2551	285	13	and	and	CCONJ
admet-2551	285	14	aids	aid	NOUN
admet-2551	285	15	in	in	ADP
admet-2551	285	16	the	the	DET
admet-2551	285	17	breakdown	breakdown	NOUN
admet-2551	285	18	of	of	ADP
admet-2551	285	19	mural	mural	ADJ
admet-2551	285	20	thrombi	thrombi	NOUN
admet-2551	285	21	seen	see	VERB
admet-2551	285	22	as	as	ADP
admet-2551	285	23	a	a	DET
admet-2551	285	24	result	result	NOUN
admet-2551	285	25	of	of	ADP
admet-2551	285	26	endothelial	endothelial	ADJ
admet-2551	285	27	injury	injury	NOUN
admet-2551	285	28	[	[	X
admet-2551	285	29	66	66	NUM
admet-2551	285	30	]	]	PUNCT
admet-2551	285	31	.	.	PUNCT
admet-2551	286	1	the	the	DET
admet-2551	286	2	results	result	NOUN
admet-2551	286	3	showed	show	VERB
admet-2551	286	4	a	a	DET
admet-2551	286	5	reduction	reduction	NOUN
admet-2551	286	6	in	in	ADP
admet-2551	286	7	fluorescence	fluorescence	ADJ
admet-2551	286	8	emission	emission	NOUN
admet-2551	286	9	at	at	ADP
admet-2551	286	10	487	487	NUM
admet-2551	286	11	nm	nm	NOUN
admet-2551	286	12	of	of	ADP
admet-2551	286	13	thioflavin	thioflavin	PROPN
admet-2551	286	14	-	-	PUNCT
admet-2551	286	15	t	t	PROPN
admet-2551	286	16	(	(	PUNCT
admet-2551	286	17	tht	tht	NOUN
admet-2551	286	18	)	)	PUNCT
admet-2551	286	19	dye	dye	NOUN
admet-2551	286	20	(	(	PUNCT
admet-2551	286	21	a	a	DET
admet-2551	286	22	dye	dye	NOUN
admet-2551	286	23	that	that	PRON
admet-2551	286	24	specifically	specifically	ADV
admet-2551	286	25	binds	bind	VERB
admet-2551	286	26	to	to	ADP
admet-2551	286	27	amyloids	amyloid	NOUN
admet-2551	286	28	)	)	PUNCT
admet-2551	286	29	,	,	PUNCT
admet-2551	286	30	negative	negative	ADJ
admet-2551	286	31	ellipticity	ellipticity	NOUN
admet-2551	286	32	at	at	ADP
admet-2551	286	33	218	218	NUM
admet-2551	286	34	nm	nm	NOUN
admet-2551	286	35	in	in	ADP
admet-2551	286	36	circular	circular	ADJ
admet-2551	286	37	dichroism	dichroism	NOUN
admet-2551	286	38	(	(	PUNCT
admet-2551	286	39	cd	cd	NOUN
admet-2551	286	40	)	)	PUNCT
admet-2551	286	41	spectrum	spectrum	NOUN
admet-2551	286	42	,	,	PUNCT
admet-2551	286	43	and	and	CCONJ
admet-2551	286	44	less	less	ADV
admet-2551	286	45	fibril	fibril	ADJ
admet-2551	286	46	morphology	morphology	NOUN
admet-2551	286	47	in	in	ADP
admet-2551	286	48	electron	electron	NOUN
admet-2551	286	49	microscopic	microscopic	ADJ
admet-2551	286	50	observation	observation	NOUN
admet-2551	286	51	.	.	PUNCT
admet-2551	287	1	overall	overall	ADV
admet-2551	287	2	,	,	PUNCT
admet-2551	287	3	this	this	DET
admet-2551	287	4	study	study	NOUN
admet-2551	287	5	explored	explore	VERB
admet-2551	287	6	the	the	DET
admet-2551	287	7	potential	potential	NOUN
admet-2551	287	8	of	of	ADP
admet-2551	287	9	nk	nk	PROPN
admet-2551	287	10	for	for	ADP
admet-2551	287	11	the	the	DET
admet-2551	287	12	degradation	degradation	NOUN
admet-2551	287	13	of	of	ADP
admet-2551	287	14	amyloid	amyloid	NOUN
admet-2551	287	15	at	at	ADP
admet-2551	287	16	a	a	DET
admet-2551	287	17	temperature	temperature	NOUN
admet-2551	287	18	of	of	ADP
admet-2551	287	19	40	40	NUM
admet-2551	287	20	°	°	NOUN
admet-2551	287	21	c	c	NOUN
admet-2551	287	22	and	and	CCONJ
admet-2551	287	23	ph	ph	X
admet-2551	287	24	7	7	NUM
admet-2551	287	25	[	[	X
admet-2551	287	26	12	12	NUM
admet-2551	287	27	]	]	PUNCT
admet-2551	287	28	.	.	PUNCT
admet-2551	288	1	admet	admet	PROPN
admet-2551	288	2	&	&	CCONJ
admet-2551	288	3	dmpk	dmpk	PROPN
admet-2551	288	4	12(6	12(6	NUM
admet-2551	288	5	)	)	PUNCT
admet-2551	288	6	(	(	PUNCT
admet-2551	288	7	2024	2024	NUM
admet-2551	288	8	)	)	PUNCT
admet-2551	288	9	797	797	NUM
admet-2551	288	10	-	-	SYM
admet-2551	288	11	820	820	NUM
admet-2551	288	12	natural	natural	ADJ
admet-2551	288	13	serine	serine	NOUN
admet-2551	288	14	proteases	protease	NOUN
admet-2551	288	15	in	in	ADP
admet-2551	288	16	combating	combat	VERB
admet-2551	288	17	amyloid	amyloid	NOUN
admet-2551	288	18	formation	formation	NOUN
admet-2551	288	19	doi	doi	NOUN
admet-2551	288	20	:	:	PUNCT
admet-2551	288	21	https://doi.org/10.5599/admet.2551	https://doi.org/10.5599/admet.2551	NOUN
admet-2551	288	22	807	807	NUM
admet-2551	288	23	figure	figure	NOUN
admet-2551	288	24	5	5	NUM
admet-2551	288	25	.	.	PUNCT
admet-2551	289	1	the	the	DET
admet-2551	289	2	structure	structure	NOUN
admet-2551	289	3	of	of	ADP
admet-2551	289	4	nattokinase	nattokinase	NOUN
admet-2551	289	5	(	(	PUNCT
admet-2551	289	6	source	source	NOUN
admet-2551	289	7	:	:	PUNCT
admet-2551	289	8	pdb	pdb	PROPN
admet-2551	289	9	i	i	PROPN
admet-2551	289	10	d	d	PROPN
admet-2551	289	11	4dww	4dww	PROPN
admet-2551	289	12	)	)	PUNCT
admet-2551	289	13	extracted	extract	VERB
admet-2551	289	14	from	from	ADP
admet-2551	289	15	pymol	pymol	PROPN
admet-2551	289	16	[	[	X
admet-2551	289	17	114	114	NUM
admet-2551	289	18	]	]	PUNCT
admet-2551	289	19	.	.	PUNCT
admet-2551	290	1	fibrinolytic	fibrinolytic	PROPN
admet-2551	290	2	of	of	ADP
admet-2551	290	3	nattokinase	nattokinase	NOUN
admet-2551	290	4	nattokinase	nattokinase	NOUN
admet-2551	290	5	(	(	PUNCT
admet-2551	290	6	nk	nk	PROPN
admet-2551	290	7	)	)	PUNCT
admet-2551	290	8	has	have	AUX
admet-2551	290	9	been	be	AUX
admet-2551	290	10	recognized	recognize	VERB
admet-2551	290	11	for	for	ADP
admet-2551	290	12	its	its	PRON
admet-2551	290	13	fibrinolytic	fibrinolytic	ADJ
admet-2551	290	14	activity	activity	NOUN
admet-2551	290	15	by	by	ADP
admet-2551	290	16	disintegrating	disintegrate	VERB
admet-2551	290	17	amyloid	amyloid	NOUN
admet-2551	290	18	at	at	ADP
admet-2551	290	19	normal	normal	ADJ
admet-2551	290	20	body	body	NOUN
admet-2551	290	21	temperature	temperature	NOUN
admet-2551	290	22	and	and	CCONJ
admet-2551	290	23	neutral	neutral	ADJ
admet-2551	290	24	ph	ph	NOUN
admet-2551	290	25	.	.	PUNCT
admet-2551	291	1	this	this	PRON
admet-2551	291	2	makes	make	VERB
admet-2551	291	3	it	it	PRON
admet-2551	291	4	a	a	DET
admet-2551	291	5	promising	promising	ADJ
admet-2551	291	6	candidate	candidate	NOUN
admet-2551	291	7	for	for	ADP
admet-2551	291	8	treating	treat	VERB
admet-2551	291	9	amyloid	amyloid	NOUN
admet-2551	291	10	-	-	PUNCT
admet-2551	291	11	related	relate	VERB
admet-2551	291	12	diseases	disease	NOUN
admet-2551	291	13	and	and	CCONJ
admet-2551	291	14	other	other	ADJ
admet-2551	291	15	neurodegenerative	neurodegenerative	ADJ
admet-2551	291	16	diseases	disease	NOUN
admet-2551	291	17	.	.	PUNCT
admet-2551	292	1	numerous	numerous	ADJ
admet-2551	292	2	studies	study	NOUN
admet-2551	292	3	have	have	AUX
admet-2551	292	4	reported	report	VERB
admet-2551	292	5	that	that	SCONJ
admet-2551	292	6	both	both	PRON
admet-2551	292	7	in	in	ADP
admet-2551	292	8	vitro	vitro	X
admet-2551	292	9	and	and	CCONJ
admet-2551	292	10	in	in	ADP
admet-2551	292	11	vivo	vivo	NOUN
admet-2551	292	12	nk	nk	PROPN
admet-2551	292	13	has	have	VERB
admet-2551	292	14	neuroprotective	neuroprotective	ADJ
admet-2551	292	15	properties	property	NOUN
admet-2551	292	16	[	[	X
admet-2551	292	17	115	115	NUM
admet-2551	292	18	]	]	PUNCT
admet-2551	292	19	.	.	PUNCT
admet-2551	293	1	for	for	ADP
admet-2551	293	2	instance	instance	NOUN
admet-2551	293	3	,	,	PUNCT
admet-2551	293	4	oral	oral	ADJ
admet-2551	293	5	administration	administration	NOUN
admet-2551	293	6	of	of	ADP
admet-2551	293	7	nk	nk	PROPN
admet-2551	293	8	has	have	AUX
admet-2551	293	9	been	be	AUX
admet-2551	293	10	shown	show	VERB
admet-2551	293	11	to	to	PART
admet-2551	293	12	be	be	AUX
admet-2551	293	13	effective	effective	ADJ
admet-2551	293	14	against	against	ADP
admet-2551	293	15	cerebral	cerebral	ADJ
admet-2551	293	16	ischemia	ischemia	NOUN
admet-2551	293	17	,	,	PUNCT
admet-2551	293	18	resulting	result	VERB
admet-2551	293	19	in	in	ADP
admet-2551	293	20	reduced	reduced	ADJ
admet-2551	293	21	infarct	infarct	ADJ
admet-2551	293	22	quantity	quantity	NOUN
admet-2551	293	23	in	in	ADP
admet-2551	293	24	gerbils	gerbil	NOUN
admet-2551	293	25	due	due	ADJ
admet-2551	293	26	to	to	ADP
admet-2551	293	27	enhanced	enhanced	ADJ
admet-2551	293	28	fibrinolytic	fibrinolytic	ADJ
admet-2551	293	29	activity	activity	NOUN
admet-2551	293	30	[	[	X
admet-2551	293	31	116	116	NUM
admet-2551	293	32	]	]	PUNCT
admet-2551	293	33	.	.	PUNCT
admet-2551	294	1	the	the	DET
admet-2551	294	2	enzyme	enzyme	NOUN
admet-2551	294	3	nk	nk	VERB
admet-2551	294	4	not	not	PART
admet-2551	294	5	only	only	ADV
admet-2551	294	6	dissolves	dissolve	VERB
admet-2551	294	7	blood	blood	NOUN
admet-2551	294	8	clots	clot	NOUN
admet-2551	294	9	but	but	CCONJ
admet-2551	294	10	also	also	ADV
admet-2551	294	11	breaks	break	VERB
admet-2551	294	12	down	down	ADP
admet-2551	294	13	aβ	aβ	PROPN
admet-2551	294	14	.	.	PUNCT
admet-2551	295	1	the	the	DET
admet-2551	295	2	study	study	NOUN
admet-2551	295	3	result	result	NOUN
admet-2551	295	4	showed	show	VERB
admet-2551	295	5	fibrinolytic	fibrinolytic	ADJ
admet-2551	295	6	activity	activity	NOUN
admet-2551	295	7	in	in	ADP
admet-2551	295	8	nk	nk	PROPN
admet-2551	295	9	that	that	PRON
admet-2551	295	10	has	have	AUX
admet-2551	295	11	lowered	lower	VERB
admet-2551	295	12	factor	factor	NOUN
admet-2551	295	13	vii	vii	PROPN
admet-2551	295	14	and	and	CCONJ
admet-2551	295	15	factor	factor	NOUN
admet-2551	295	16	viii	viii	NOUN
admet-2551	296	1	[	[	X
admet-2551	296	2	117	117	NUM
admet-2551	296	3	]	]	PUNCT
admet-2551	296	4	.	.	PUNCT
admet-2551	297	1	the	the	DET
admet-2551	297	2	study	study	NOUN
admet-2551	297	3	conducted	conduct	VERB
admet-2551	297	4	by	by	ADP
admet-2551	297	5	guangbo	guangbo	PROPN
admet-2551	297	6	et	et	PROPN
admet-2551	297	7	al	al	PROPN
admet-2551	297	8	.	.	PROPN
admet-2551	297	9	revealed	reveal	VERB
admet-2551	297	10	that	that	SCONJ
admet-2551	297	11	the	the	DET
admet-2551	297	12	nk	nk	PROPN
admet-2551	297	13	extracted	extract	VERB
admet-2551	297	14	from	from	ADP
admet-2551	297	15	b.	b.	PROPN
admet-2551	297	16	subtilis	subtilis	PROPN
admet-2551	297	17	has	have	VERB
admet-2551	297	18	significant	significant	ADJ
admet-2551	297	19	fibrinolytic	fibrinolytic	ADJ
admet-2551	297	20	activity	activity	NOUN
admet-2551	297	21	.	.	PUNCT
admet-2551	298	1	the	the	DET
admet-2551	298	2	recombinant	recombinant	ADJ
admet-2551	298	3	nk	nk	PROPN
admet-2551	298	4	displayed	display	VERB
admet-2551	298	5	a	a	DET
admet-2551	298	6	clear	clear	ADJ
admet-2551	298	7	thrombolytic	thrombolytic	ADJ
admet-2551	298	8	effect	effect	NOUN
admet-2551	298	9	and	and	CCONJ
admet-2551	298	10	exhibited	exhibit	VERB
admet-2551	298	11	strong	strong	ADJ
admet-2551	298	12	ph	ph	NOUN
admet-2551	298	13	and	and	CCONJ
admet-2551	298	14	thermostability	thermostability	NOUN
admet-2551	298	15	[	[	X
admet-2551	298	16	118	118	NUM
admet-2551	298	17	]	]	PUNCT
admet-2551	298	18	.	.	PUNCT
admet-2551	299	1	nk	nk	PROPN
admet-2551	299	2	has	have	AUX
admet-2551	299	3	exhibited	exhibit	VERB
admet-2551	299	4	strong	strong	ADJ
admet-2551	299	5	clot	clot	NOUN
admet-2551	299	6	-	-	PUNCT
admet-2551	299	7	dissolving	dissolve	VERB
admet-2551	299	8	capabilities	capability	NOUN
admet-2551	299	9	and	and	CCONJ
admet-2551	299	10	a	a	DET
admet-2551	299	11	low	low	ADJ
admet-2551	299	12	risk	risk	NOUN
admet-2551	299	13	of	of	ADP
admet-2551	299	14	bleeding	bleeding	NOUN
admet-2551	299	15	.	.	PUNCT
admet-2551	300	1	it	it	PRON
admet-2551	300	2	reduces	reduce	VERB
admet-2551	300	3	clot	clot	NOUN
admet-2551	300	4	lysis	lysis	NOUN
admet-2551	300	5	time	time	NOUN
admet-2551	300	6	and	and	CCONJ
admet-2551	300	7	lowers	lower	VERB
admet-2551	300	8	the	the	DET
admet-2551	300	9	indicators	indicator	NOUN
admet-2551	300	10	linked	link	VERB
admet-2551	300	11	to	to	ADP
admet-2551	300	12	cardiovascular	cardiovascular	ADJ
admet-2551	300	13	disease	disease	NOUN
admet-2551	300	14	[	[	X
admet-2551	300	15	119	119	NUM
admet-2551	300	16	]	]	PUNCT
admet-2551	300	17	.	.	PUNCT
admet-2551	301	1	the	the	DET
admet-2551	301	2	nk	nk	PROPN
admet-2551	301	3	extracted	extract	VERB
admet-2551	301	4	from	from	ADP
admet-2551	301	5	b.	b.	PROPN
admet-2551	301	6	subtilis	subtilis	PROPN
admet-2551	301	7	g8	g8	PROPN
admet-2551	301	8	has	have	AUX
admet-2551	301	9	shown	show	VERB
admet-2551	301	10	excellent	excellent	ADJ
admet-2551	301	11	fibrinolytic	fibrinolytic	ADJ
admet-2551	301	12	activity	activity	NOUN
admet-2551	301	13	[	[	X
admet-2551	301	14	120	120	NUM
admet-2551	301	15	]	]	PUNCT
admet-2551	301	16	.	.	PUNCT
admet-2551	302	1	kamiya	kamiya	PROPN
admet-2551	302	2	et	et	PROPN
admet-2551	302	3	al	al	PROPN
admet-2551	302	4	.	.	PROPN
admet-2551	302	5	found	find	VERB
admet-2551	302	6	that	that	SCONJ
admet-2551	302	7	the	the	DET
admet-2551	302	8	nk	nk	PROPN
admet-2551	302	9	enzyme	enzyme	NOUN
admet-2551	302	10	reduced	reduce	VERB
admet-2551	302	11	the	the	DET
admet-2551	302	12	length	length	NOUN
admet-2551	302	13	of	of	ADP
admet-2551	302	14	carrageenan	carrageenan	NOUN
admet-2551	302	15	-	-	PUNCT
admet-2551	302	16	induced	induce	VERB
admet-2551	302	17	rat	rat	NOUN
admet-2551	302	18	tail	tail	NOUN
admet-2551	302	19	and	and	CCONJ
admet-2551	302	20	the	the	DET
admet-2551	302	21	mass	mass	NOUN
admet-2551	302	22	of	of	ADP
admet-2551	302	23	ferric	ferric	ADJ
admet-2551	302	24	chloride	chloride	NOUN
admet-2551	302	25	-	-	PUNCT
admet-2551	302	26	induced	induce	VERB
admet-2551	302	27	carotid	carotid	NOUN
admet-2551	302	28	thrombus	thrombus	NOUN
admet-2551	302	29	[	[	X
admet-2551	302	30	121	121	NUM
admet-2551	302	31	]	]	PUNCT
admet-2551	302	32	.	.	PUNCT
admet-2551	303	1	the	the	DET
admet-2551	303	2	cationic	cationic	ADJ
admet-2551	303	3	peptide	peptide	NOUN
admet-2551	303	4	from	from	ADP
admet-2551	303	5	natto	natto	NOUN
admet-2551	303	6	extract	extract	NOUN
admet-2551	303	7	exhibited	exhibit	VERB
admet-2551	303	8	excellent	excellent	ADJ
admet-2551	303	9	angiogenic	angiogenic	ADJ
admet-2551	303	10	activity	activity	NOUN
admet-2551	303	11	in	in	ADP
admet-2551	303	12	human	human	ADJ
admet-2551	303	13	umbilical	umbilical	ADJ
admet-2551	303	14	vein	vein	ADJ
admet-2551	303	15	endothelial	endothelial	ADJ
admet-2551	303	16	cells	cell	NOUN
admet-2551	303	17	,	,	PUNCT
admet-2551	303	18	indicating	indicate	VERB
admet-2551	303	19	the	the	DET
admet-2551	303	20	potential	potential	NOUN
admet-2551	303	21	of	of	ADP
admet-2551	303	22	nk	nk	PROPN
admet-2551	303	23	as	as	ADP
admet-2551	303	24	an	an	DET
admet-2551	303	25	antithrombotic	antithrombotic	ADJ
admet-2551	303	26	agent	agent	NOUN
admet-2551	303	27	[	[	X
admet-2551	303	28	122	122	NUM
admet-2551	303	29	]	]	PUNCT
admet-2551	303	30	.	.	PUNCT
admet-2551	304	1	another	another	DET
admet-2551	304	2	study	study	NOUN
admet-2551	304	3	reported	report	VERB
admet-2551	304	4	that	that	SCONJ
admet-2551	304	5	sustained	sustain	VERB
admet-2551	304	6	release	release	NOUN
admet-2551	304	7	of	of	ADP
admet-2551	304	8	synthesized	synthesize	VERB
admet-2551	304	9	nk	nk	PROPN
admet-2551	304	10	-	-	PUNCT
admet-2551	304	11	conjugated	conjugate	VERB
admet-2551	304	12	magnetite	magnetite	NOUN
admet-2551	304	13	nanoparticles	nanoparticle	NOUN
admet-2551	304	14	was	be	AUX
admet-2551	304	15	identified	identify	VERB
admet-2551	304	16	as	as	ADP
admet-2551	304	17	a	a	DET
admet-2551	304	18	potential	potential	ADJ
admet-2551	304	19	candidate	candidate	NOUN
admet-2551	304	20	for	for	ADP
admet-2551	304	21	thrombolysis	thrombolysis	NOUN
admet-2551	304	22	[	[	X
admet-2551	304	23	123	123	NUM
admet-2551	304	24	]	]	PUNCT
admet-2551	304	25	.	.	PUNCT
admet-2551	305	1	a	a	DET
admet-2551	305	2	recent	recent	ADJ
admet-2551	305	3	study	study	NOUN
admet-2551	305	4	showed	show	VERB
admet-2551	305	5	the	the	DET
admet-2551	305	6	application	application	NOUN
admet-2551	305	7	of	of	ADP
admet-2551	305	8	nk	nk	PROPN
admet-2551	305	9	towards	towards	ADP
admet-2551	305	10	amyloid	amyloid	NOUN
admet-2551	305	11	degradation	degradation	NOUN
admet-2551	305	12	by	by	ADP
admet-2551	305	13	efficiently	efficiently	ADV
admet-2551	305	14	degrading	degrade	VERB
admet-2551	305	15	the	the	DET
admet-2551	305	16	three	three	NUM
admet-2551	305	17	types	type	NOUN
admet-2551	305	18	of	of	ADP
admet-2551	305	19	in	in	ADP
admet-2551	305	20	vitro	vitro	X
admet-2551	305	21	prepared	prepare	VERB
admet-2551	305	22	amyloid	amyloid	NOUN
admet-2551	305	23	fibrilsinsulin	fibrilsinsulin	NOUN
admet-2551	305	24	,	,	PUNCT
admet-2551	305	25	aβ1	aβ1	NOUN
admet-2551	305	26	-	-	PUNCT
admet-2551	305	27	40	40	NUM
admet-2551	305	28	,	,	PUNCT
admet-2551	305	29	and	and	CCONJ
admet-2551	305	30	huprp	huprp	NOUN
admet-2551	305	31	(	(	PUNCT
admet-2551	305	32	consisting	consist	VERB
admet-2551	305	33	of	of	ADP
admet-2551	305	34	prion	prion	NOUN
admet-2551	305	35	sequence	sequence	NOUN
admet-2551	305	36	108	108	NUM
admet-2551	305	37	-	-	SYM
admet-2551	305	38	144	144	NUM
admet-2551	305	39	)	)	PUNCT
admet-2551	305	40	.	.	PUNCT
admet-2551	306	1	the	the	DET
admet-2551	306	2	amyloids	amyloid	NOUN
admet-2551	306	3	were	be	AUX
admet-2551	306	4	generated	generate	VERB
admet-2551	306	5	using	use	VERB
admet-2551	306	6	these	these	DET
admet-2551	306	7	peptides	peptide	NOUN
admet-2551	306	8	in	in	ADP
admet-2551	306	9	appropriate	appropriate	ADJ
admet-2551	306	10	conditions	condition	NOUN
admet-2551	306	11	and	and	CCONJ
admet-2551	306	12	were	be	AUX
admet-2551	306	13	taken	take	VERB
admet-2551	306	14	to	to	PART
admet-2551	306	15	explore	explore	VERB
admet-2551	306	16	the	the	DET
admet-2551	306	17	degradation	degradation	NOUN
admet-2551	306	18	capacity	capacity	NOUN
admet-2551	306	19	of	of	ADP
admet-2551	306	20	nk	nk	PROPN
admet-2551	306	21	.	.	PUNCT
admet-2551	307	1	the	the	DET
admet-2551	307	2	results	result	NOUN
admet-2551	307	3	showed	show	VERB
admet-2551	307	4	a	a	DET
admet-2551	307	5	reduction	reduction	NOUN
admet-2551	307	6	in	in	ADP
admet-2551	307	7	fluorescence	fluorescence	ADJ
admet-2551	307	8	emission	emission	NOUN
admet-2551	307	9	at	at	ADP
admet-2551	307	10	487	487	NUM
admet-2551	307	11	nm	nm	NOUN
admet-2551	307	12	of	of	ADP
admet-2551	307	13	thioflavin	thioflavin	PROPN
admet-2551	307	14	-	-	PUNCT
admet-2551	307	15	t	t	PROPN
admet-2551	307	16	(	(	PUNCT
admet-2551	307	17	tht	tht	NOUN
admet-2551	307	18	)	)	PUNCT
admet-2551	307	19	dye	dye	NOUN
admet-2551	307	20	(	(	PUNCT
admet-2551	307	21	a	a	DET
admet-2551	307	22	dye	dye	NOUN
admet-2551	307	23	that	that	PRON
admet-2551	307	24	specifically	specifically	ADV
admet-2551	307	25	binds	bind	VERB
admet-2551	307	26	to	to	ADP
admet-2551	307	27	amyloids	amyloid	NOUN
admet-2551	307	28	)	)	PUNCT
admet-2551	307	29	,	,	PUNCT
admet-2551	307	30	negative	negative	ADJ
admet-2551	307	31	ellipticity	ellipticity	NOUN
admet-2551	307	32	at	at	ADP
admet-2551	307	33	218	218	NUM
admet-2551	307	34	nm	nm	NOUN
admet-2551	307	35	in	in	ADP
admet-2551	307	36	circular	circular	ADJ
admet-2551	307	37	dichroism	dichroism	NOUN
admet-2551	307	38	(	(	PUNCT
admet-2551	307	39	cd	cd	NOUN
admet-2551	307	40	)	)	PUNCT
admet-2551	307	41	spectrum	spectrum	NOUN
admet-2551	307	42	,	,	PUNCT
admet-2551	307	43	and	and	CCONJ
admet-2551	307	44	less	less	ADV
admet-2551	307	45	fibril	fibril	ADJ
admet-2551	307	46	morphology	morphology	NOUN
admet-2551	307	47	in	in	ADP
admet-2551	307	48	electron	electron	NOUN
admet-2551	307	49	microscopic	microscopic	ADJ
admet-2551	307	50	observation	observation	NOUN
admet-2551	307	51	.	.	PUNCT
admet-2551	308	1	overall	overall	ADV
admet-2551	308	2	,	,	PUNCT
admet-2551	308	3	this	this	DET
admet-2551	308	4	study	study	NOUN
admet-2551	308	5	explored	explore	VERB
admet-2551	308	6	the	the	DET
admet-2551	308	7	potential	potential	NOUN
admet-2551	308	8	of	of	ADP
admet-2551	308	9	nk	nk	PROPN
admet-2551	308	10	for	for	ADP
admet-2551	308	11	the	the	DET
admet-2551	308	12	degradation	degradation	NOUN
admet-2551	308	13	of	of	ADP
admet-2551	308	14	amyloid	amyloid	NOUN
admet-2551	308	15	at	at	ADP
admet-2551	308	16	a	a	DET
admet-2551	308	17	temperature	temperature	NOUN
admet-2551	308	18	of	of	ADP
admet-2551	308	19	40	40	NUM
admet-2551	308	20	°	°	NOUN
admet-2551	308	21	c	c	NOUN
admet-2551	308	22	and	and	CCONJ
admet-2551	308	23	ph	ph	X
admet-2551	308	24	7	7	NUM
admet-2551	308	25	[	[	X
admet-2551	308	26	12	12	NUM
admet-2551	308	27	]	]	PUNCT
admet-2551	308	28	.	.	PUNCT
admet-2551	309	1	nk	nk	PROPN
admet-2551	309	2	not	not	PART
admet-2551	309	3	only	only	ADV
admet-2551	309	4	plays	play	VERB
admet-2551	309	5	a	a	DET
admet-2551	309	6	role	role	NOUN
admet-2551	309	7	in	in	ADP
admet-2551	309	8	fibrin	fibrin	NOUN
admet-2551	309	9	degradation	degradation	NOUN
admet-2551	309	10	but	but	CCONJ
admet-2551	309	11	also	also	ADV
admet-2551	309	12	enhances	enhance	VERB
admet-2551	309	13	the	the	DET
admet-2551	309	14	release	release	NOUN
admet-2551	309	15	of	of	ADP
admet-2551	309	16	tissue	tissue	NOUN
admet-2551	309	17	plasminogen	plasminogen	NOUN
admet-2551	309	18	activators	activator	NOUN
admet-2551	309	19	from	from	ADP
admet-2551	309	20	cells	cell	NOUN
admet-2551	309	21	to	to	PART
admet-2551	309	22	break	break	VERB
admet-2551	309	23	down	down	ADP
admet-2551	309	24	the	the	DET
admet-2551	309	25	fibrin	fibrin	NOUN
admet-2551	310	1	[	[	X
admet-2551	310	2	124	124	NUM
admet-2551	310	3	]	]	PUNCT
admet-2551	310	4	.	.	PUNCT
admet-2551	311	1	anti	anti	ADJ
admet-2551	311	2	-	-	ADJ
admet-2551	311	3	inflammatory	inflammatory	ADJ
admet-2551	311	4	effect	effect	NOUN
admet-2551	311	5	in	in	ADP
admet-2551	311	6	recent	recent	ADJ
admet-2551	311	7	studies	study	NOUN
admet-2551	311	8	,	,	PUNCT
admet-2551	311	9	an	an	DET
admet-2551	311	10	anti	anti	ADJ
admet-2551	311	11	-	-	ADJ
admet-2551	311	12	inflammatory	inflammatory	ADJ
admet-2551	311	13	agent	agent	NOUN
admet-2551	311	14	,	,	PUNCT
admet-2551	311	15	like	like	ADP
admet-2551	311	16	nk	nk	PROPN
admet-2551	311	17	,	,	PUNCT
admet-2551	311	18	is	be	AUX
admet-2551	311	19	effective	effective	ADJ
admet-2551	311	20	in	in	ADP
admet-2551	311	21	suppressing	suppress	VERB
admet-2551	311	22	various	various	ADJ
admet-2551	311	23	inflammatory	inflammatory	ADJ
admet-2551	311	24	diseases	disease	NOUN
admet-2551	311	25	and	and	CCONJ
admet-2551	311	26	oxidative	oxidative	ADJ
admet-2551	311	27	stress	stress	NOUN
admet-2551	311	28	(	(	PUNCT
admet-2551	311	29	ros	ros	PROPN
admet-2551	311	30	)	)	PUNCT
admet-2551	311	31	.	.	PUNCT
admet-2551	312	1	wu	wu	PROPN
admet-2551	312	2	et	et	PROPN
admet-2551	312	3	al	al	PROPN
admet-2551	312	4	.	.	PROPN
admet-2551	312	5	demonstrated	demonstrate	VERB
admet-2551	312	6	that	that	SCONJ
admet-2551	312	7	nk	nk	PROPN
admet-2551	312	8	can	can	AUX
admet-2551	312	9	suppress	suppress	VERB
admet-2551	312	10	lps	lps	PROPN
admet-2551	312	11	-	-	PUNCT
admet-2551	312	12	induced	induce	VERB
admet-2551	312	13	nox2	nox2	ADJ
admet-2551	312	14	activation	activation	NOUN
admet-2551	312	15	and	and	CCONJ
admet-2551	312	16	the	the	DET
admet-2551	312	17	tlr4	tlr4	NOUN
admet-2551	312	18	pathway	pathway	NOUN
admet-2551	312	19	to	to	PART
admet-2551	312	20	reduce	reduce	VERB
admet-2551	312	21	ros	ro	NOUN
admet-2551	312	22	and	and	CCONJ
admet-2551	312	23	proinflammatory	proinflammatory	ADJ
admet-2551	312	24	mediators	mediator	NOUN
admet-2551	312	25	[	[	X
admet-2551	312	26	125	125	NUM
admet-2551	312	27	]	]	PUNCT
admet-2551	312	28	.	.	PUNCT
admet-2551	313	1	moreover	moreover	ADV
admet-2551	313	2	,	,	PUNCT
admet-2551	313	3	long	long	ADJ
admet-2551	313	4	-	-	PUNCT
admet-2551	313	5	term	term	NOUN
admet-2551	313	6	https://doi.org/10.5599/admet.2551	https://doi.org/10.5599/admet.2551	NOUN
admet-2551	313	7	s.	s.	PROPN
admet-2551	313	8	k.	k.	PROPN
admet-2551	314	1	metkar	metkar	PROPN
admet-2551	314	2	et	et	PROPN
admet-2551	314	3	al	al	PROPN
admet-2551	314	4	.	.	PROPN
admet-2551	314	5	admet	admet	PROPN
admet-2551	314	6	&	&	CCONJ
admet-2551	314	7	dmpk	dmpk	PROPN
admet-2551	314	8	12(6	12(6	NUM
admet-2551	314	9	)	)	PUNCT
admet-2551	314	10	(	(	PUNCT
admet-2551	314	11	2024	2024	NUM
admet-2551	314	12	)	)	PUNCT
admet-2551	314	13	797	797	NUM
admet-2551	314	14	-	-	SYM
admet-2551	314	15	820	820	NUM
admet-2551	314	16	808	808	NUM
admet-2551	314	17	use	use	NOUN
admet-2551	314	18	of	of	ADP
admet-2551	314	19	nk	nk	PROPN
admet-2551	314	20	has	have	AUX
admet-2551	314	21	shown	show	VERB
admet-2551	314	22	promising	promising	ADJ
admet-2551	314	23	results	result	NOUN
admet-2551	314	24	in	in	ADP
admet-2551	314	25	ameliorating	ameliorate	VERB
admet-2551	314	26	chronic	chronic	ADJ
admet-2551	314	27	colitis	colitis	NOUN
admet-2551	314	28	and	and	CCONJ
admet-2551	314	29	inhibiting	inhibit	VERB
admet-2551	314	30	colonic	colonic	ADJ
admet-2551	314	31	inflammation	inflammation	NOUN
admet-2551	314	32	by	by	ADP
admet-2551	314	33	regulating	regulate	VERB
admet-2551	314	34	gut	gut	NOUN
admet-2551	314	35	microbiota	microbiota	NOUN
admet-2551	314	36	and	and	CCONJ
admet-2551	314	37	suppressing	suppress	VERB
admet-2551	314	38	the	the	DET
admet-2551	314	39	trp	trp	PROPN
admet-2551	314	40	metabolism	metabolism	NOUN
admet-2551	314	41	[	[	X
admet-2551	314	42	126	126	NUM
admet-2551	314	43	]	]	PUNCT
admet-2551	314	44	.	.	PUNCT
admet-2551	315	1	additionally	additionally	ADV
admet-2551	315	2	,	,	PUNCT
admet-2551	315	3	nk	nk	PROPN
admet-2551	315	4	exhibits	exhibit	VERB
admet-2551	315	5	an	an	DET
admet-2551	315	6	inhibitory	inhibitory	ADJ
admet-2551	315	7	effect	effect	NOUN
admet-2551	315	8	against	against	ADP
admet-2551	315	9	retinal	retinal	ADJ
admet-2551	315	10	neovascularization	neovascularization	NOUN
admet-2551	315	11	and	and	CCONJ
admet-2551	315	12	can	can	AUX
admet-2551	315	13	alleviate	alleviate	VERB
admet-2551	315	14	neuroinflammation	neuroinflammation	NOUN
admet-2551	315	15	by	by	ADP
admet-2551	315	16	inducing	induce	VERB
admet-2551	315	17	proinflammatory	proinflammatory	ADJ
admet-2551	315	18	microglia	microglia	NOUN
admet-2551	315	19	into	into	ADP
admet-2551	315	20	an	an	DET
admet-2551	315	21	anti	anti	ADJ
admet-2551	315	22	-	-	ADJ
admet-2551	315	23	inflammatory	inflammatory	ADJ
admet-2551	315	24	phenotype	phenotype	NOUN
admet-2551	315	25	through	through	ADP
admet-2551	315	26	the	the	DET
admet-2551	315	27	nrf2	nrf2	NOUN
admet-2551	315	28	/	/	SYM
admet-2551	315	29	ho-1	ho-1	ADJ
admet-2551	315	30	pathway	pathway	NOUN
admet-2551	316	1	[	[	X
admet-2551	316	2	127	127	NUM
admet-2551	316	3	]	]	PUNCT
admet-2551	316	4	.	.	PUNCT
admet-2551	317	1	another	another	DET
admet-2551	317	2	study	study	NOUN
admet-2551	317	3	by	by	ADP
admet-2551	317	4	elbakry	elbakry	PROPN
admet-2551	317	5	et	et	PROPN
admet-2551	317	6	al	al	PROPN
admet-2551	317	7	.	.	PROPN
admet-2551	317	8	suggested	suggest	VERB
admet-2551	317	9	that	that	SCONJ
admet-2551	317	10	nk	nk	PROPN
admet-2551	317	11	can	can	AUX
admet-2551	317	12	protect	protect	VERB
admet-2551	317	13	against	against	ADP
admet-2551	317	14	neurotoxicity	neurotoxicity	NOUN
admet-2551	317	15	and	and	CCONJ
admet-2551	317	16	attenuate	attenuate	VERB
admet-2551	317	17	neuroinflammatory	neuroinflammatory	ADJ
admet-2551	317	18	activity	activity	NOUN
admet-2551	317	19	induced	induce	VERB
admet-2551	317	20	by	by	ADP
admet-2551	317	21	certain	certain	ADJ
admet-2551	317	22	substances	substance	NOUN
admet-2551	317	23	.	.	PUNCT
admet-2551	318	1	notably	notably	ADV
admet-2551	318	2	,	,	PUNCT
admet-2551	318	3	most	most	ADJ
admet-2551	318	4	clinical	clinical	ADJ
admet-2551	318	5	studies	study	NOUN
admet-2551	318	6	have	have	AUX
admet-2551	318	7	indicated	indicate	VERB
admet-2551	318	8	that	that	SCONJ
admet-2551	318	9	short	short	ADJ
admet-2551	318	10	-	-	PUNCT
admet-2551	318	11	term	term	NOUN
admet-2551	318	12	and	and	CCONJ
admet-2551	318	13	low	low	ADJ
admet-2551	318	14	-	-	PUNCT
admet-2551	318	15	dosage	dosage	NOUN
admet-2551	318	16	administration	administration	NOUN
admet-2551	318	17	of	of	ADP
admet-2551	318	18	nk	nk	PROPN
admet-2551	318	19	did	do	AUX
admet-2551	318	20	not	not	PART
admet-2551	318	21	induce	induce	VERB
admet-2551	318	22	toxicity	toxicity	NOUN
admet-2551	318	23	[	[	X
admet-2551	318	24	128	128	NUM
admet-2551	318	25	]	]	PUNCT
admet-2551	318	26	.	.	PUNCT
admet-2551	319	1	nattokinase	nattokinase	NOUN
admet-2551	319	2	’s	’s	PART
admet-2551	319	3	role	role	NOUN
admet-2551	319	4	in	in	ADP
admet-2551	319	5	other	other	ADJ
admet-2551	319	6	disease	disease	NOUN
admet-2551	319	7	research	research	NOUN
admet-2551	319	8	has	have	AUX
admet-2551	319	9	identified	identify	VERB
admet-2551	319	10	natural	natural	ADJ
admet-2551	319	11	anticancer	anticancer	NOUN
admet-2551	319	12	compounds	compound	NOUN
admet-2551	319	13	such	such	ADJ
admet-2551	319	14	as	as	ADP
admet-2551	319	15	phytoestroprotease	phytoestroprotease	ADJ
admet-2551	319	16	inhibitors	inhibitor	NOUN
admet-2551	319	17	,	,	PUNCT
admet-2551	319	18	flavonoids	flavonoid	NOUN
admet-2551	319	19	,	,	PUNCT
admet-2551	319	20	and	and	CCONJ
admet-2551	319	21	phytic	phytic	ADJ
admet-2551	319	22	acids	acid	NOUN
admet-2551	319	23	in	in	ADP
admet-2551	319	24	soybeans	soybean	NOUN
admet-2551	319	25	(	(	PUNCT
admet-2551	319	26	natto	natto	NOUN
admet-2551	319	27	)	)	PUNCT
admet-2551	319	28	.	.	PUNCT
admet-2551	320	1	furthermore	furthermore	ADV
admet-2551	320	2	,	,	PUNCT
admet-2551	320	3	studies	study	NOUN
admet-2551	320	4	have	have	AUX
admet-2551	320	5	shown	show	VERB
admet-2551	320	6	that	that	SCONJ
admet-2551	320	7	fermented	ferment	VERB
admet-2551	320	8	natto	natto	NOUN
admet-2551	320	9	contains	contain	VERB
admet-2551	320	10	higher	high	ADJ
admet-2551	320	11	levels	level	NOUN
admet-2551	320	12	of	of	ADP
admet-2551	320	13	anticancer	anticancer	NOUN
admet-2551	320	14	compounds	compound	NOUN
admet-2551	320	15	compared	compare	VERB
admet-2551	320	16	to	to	ADP
admet-2551	320	17	the	the	DET
admet-2551	320	18	raw	raw	ADJ
admet-2551	320	19	material	material	NOUN
admet-2551	320	20	.	.	PUNCT
admet-2551	321	1	according	accord	VERB
admet-2551	321	2	to	to	ADP
admet-2551	321	3	chou	chou	PROPN
admet-2551	321	4	et	et	PROPN
admet-2551	321	5	al	al	PROPN
admet-2551	321	6	.	.	PUNCT
admet-2551	322	1	[	[	X
admet-2551	322	2	129	129	NUM
admet-2551	322	3	]	]	PUNCT
admet-2551	322	4	,	,	PUNCT
admet-2551	322	5	both	both	DET
admet-2551	322	6	natto	natto	NOUN
admet-2551	322	7	freeze	freeze	NOUN
admet-2551	322	8	drying	dry	VERB
admet-2551	322	9	and	and	CCONJ
admet-2551	322	10	natto	natto	NOUN
admet-2551	322	11	water	water	NOUN
admet-2551	322	12	extract	extract	NOUN
admet-2551	322	13	have	have	AUX
admet-2551	322	14	been	be	AUX
admet-2551	322	15	found	find	VERB
admet-2551	322	16	to	to	PART
admet-2551	322	17	trigger	trigger	VERB
admet-2551	322	18	cell	cell	NOUN
admet-2551	322	19	autophagy	autophagy	NOUN
admet-2551	322	20	in	in	ADP
admet-2551	322	21	a	a	DET
admet-2551	322	22	dose	dose	NOUN
admet-2551	322	23	-	-	PUNCT
admet-2551	322	24	dependent	dependent	ADJ
admet-2551	322	25	manner	manner	NOUN
admet-2551	322	26	.	.	PUNCT
admet-2551	323	1	hypertension	hypertension	NOUN
admet-2551	323	2	stands	stand	VERB
admet-2551	323	3	as	as	ADP
admet-2551	323	4	the	the	DET
admet-2551	323	5	most	most	ADV
admet-2551	323	6	prevalent	prevalent	ADJ
admet-2551	323	7	chronic	chronic	ADJ
admet-2551	323	8	illness	illness	NOUN
admet-2551	323	9	and	and	CCONJ
admet-2551	323	10	a	a	DET
admet-2551	323	11	significant	significant	ADJ
admet-2551	323	12	risk	risk	NOUN
admet-2551	323	13	factor	factor	NOUN
admet-2551	323	14	for	for	ADP
admet-2551	323	15	cardiovascular	cardiovascular	ADJ
admet-2551	323	16	disease	disease	NOUN
admet-2551	323	17	.	.	PUNCT
admet-2551	324	1	nk	nk	PROPN
admet-2551	324	2	from	from	ADP
admet-2551	324	3	ruditapes	ruditapes	PROPN
admet-2551	324	4	philippinarum	philippinarum	PROPN
admet-2551	324	5	decreased	decrease	VERB
admet-2551	324	6	blood	blood	NOUN
admet-2551	324	7	pressure	pressure	NOUN
admet-2551	324	8	in	in	ADP
admet-2551	324	9	hypertensive	hypertensive	ADJ
admet-2551	324	10	rats	rat	NOUN
admet-2551	324	11	by	by	ADP
admet-2551	324	12	minimizing	minimize	VERB
admet-2551	324	13	intestinal	intestinal	ADJ
admet-2551	324	14	bacterial	bacterial	ADJ
admet-2551	324	15	diseases	disease	NOUN
admet-2551	324	16	,	,	PUNCT
admet-2551	324	17	providing	provide	VERB
admet-2551	324	18	an	an	DET
admet-2551	324	19	effective	effective	ADJ
admet-2551	324	20	defense	defense	NOUN
admet-2551	324	21	against	against	ADP
admet-2551	324	22	hypertension	hypertension	NOUN
admet-2551	324	23	-	-	PUNCT
admet-2551	324	24	induced	induce	VERB
admet-2551	324	25	vascular	vascular	ADJ
admet-2551	324	26	and	and	CCONJ
admet-2551	324	27	cardiac	cardiac	ADJ
admet-2551	324	28	damage	damage	NOUN
admet-2551	324	29	[	[	X
admet-2551	324	30	130	130	NUM
admet-2551	324	31	]	]	PUNCT
admet-2551	324	32	.	.	PUNCT
admet-2551	325	1	furthermore	furthermore	ADV
admet-2551	325	2	,	,	PUNCT
admet-2551	325	3	studies	study	NOUN
admet-2551	325	4	indicated	indicate	VERB
admet-2551	325	5	that	that	SCONJ
admet-2551	325	6	oral	oral	ADJ
admet-2551	325	7	administration	administration	NOUN
admet-2551	325	8	of	of	ADP
admet-2551	325	9	nk	nk	PROPN
admet-2551	325	10	has	have	AUX
admet-2551	325	11	decreased	decrease	VERB
admet-2551	325	12	systolic	systolic	ADJ
admet-2551	325	13	and	and	CCONJ
admet-2551	325	14	diastolic	diastolic	ADJ
admet-2551	325	15	blood	blood	NOUN
admet-2551	325	16	pressure	pressure	NOUN
admet-2551	325	17	by	by	ADP
admet-2551	325	18	cleaving	cleave	VERB
admet-2551	325	19	fibrinogen	fibrinogen	NOUN
admet-2551	325	20	in	in	ADP
admet-2551	325	21	plasma	plasma	NOUN
admet-2551	325	22	.	.	PUNCT
admet-2551	326	1	moreover	moreover	ADV
admet-2551	326	2	,	,	PUNCT
admet-2551	326	3	as	as	ADP
admet-2551	326	4	per	per	ADP
admet-2551	326	5	keziah	keziah	PROPN
admet-2551	326	6	,	,	PUNCT
admet-2551	326	7	nk	nk	PROPN
admet-2551	326	8	exhibited	exhibit	VERB
admet-2551	326	9	notable	notable	ADJ
admet-2551	326	10	angiotensin	angiotensin	NOUN
admet-2551	326	11	-	-	PUNCT
admet-2551	326	12	converting	convert	VERB
admet-2551	326	13	enzyme	enzyme	NOUN
admet-2551	326	14	inhibitor	inhibitor	NOUN
admet-2551	326	15	activity	activity	NOUN
admet-2551	326	16	,	,	PUNCT
admet-2551	326	17	achieving	achieve	VERB
admet-2551	326	18	87.45	87.45	NUM
admet-2551	326	19	%	%	NOUN
admet-2551	326	20	in	in	ADP
admet-2551	326	21	an	an	DET
admet-2551	326	22	in	in	X
admet-2551	326	23	vitro	vitro	X
admet-2551	326	24	coagulation	coagulation	NOUN
admet-2551	326	25	lysis	lysis	NOUN
admet-2551	326	26	assay	assay	NOUN
admet-2551	326	27	.	.	PUNCT
admet-2551	327	1	these	these	DET
admet-2551	327	2	findings	finding	NOUN
admet-2551	327	3	suggest	suggest	VERB
admet-2551	327	4	that	that	SCONJ
admet-2551	327	5	nk	nk	PROPN
admet-2551	327	6	plays	play	VERB
admet-2551	327	7	a	a	DET
admet-2551	327	8	significant	significant	ADJ
admet-2551	327	9	role	role	NOUN
admet-2551	327	10	in	in	ADP
admet-2551	327	11	preventing	prevent	VERB
admet-2551	327	12	and	and	CCONJ
admet-2551	327	13	treating	treat	VERB
admet-2551	327	14	hypertension	hypertension	NOUN
admet-2551	327	15	[	[	X
admet-2551	327	16	131	131	NUM
admet-2551	327	17	]	]	PUNCT
admet-2551	327	18	.	.	PUNCT
admet-2551	328	1	similar	similar	ADJ
admet-2551	328	2	findings	finding	NOUN
admet-2551	328	3	were	be	AUX
admet-2551	328	4	also	also	ADV
admet-2551	328	5	demonstrated	demonstrate	VERB
admet-2551	328	6	by	by	ADP
admet-2551	328	7	another	another	DET
admet-2551	328	8	enzyme	enzyme	NOUN
admet-2551	328	9	sp	sp	ADP
admet-2551	328	10	[	[	X
admet-2551	328	11	132	132	NUM
admet-2551	328	12	]	]	PUNCT
admet-2551	328	13	.	.	PUNCT
admet-2551	329	1	lumbrokinase	lumbrokinase	PROPN
admet-2551	329	2	and	and	CCONJ
admet-2551	329	3	serratiopeptidase	serratiopeptidase	VERB
admet-2551	329	4	in	in	ADP
admet-2551	329	5	amyloid	amyloid	NOUN
admet-2551	329	6	degradation	degradation	NOUN
admet-2551	329	7	prion	prion	NOUN
admet-2551	329	8	protein	protein	NOUN
admet-2551	329	9	prpc	prpc	NOUN
admet-2551	329	10	is	be	AUX
admet-2551	329	11	a	a	DET
admet-2551	329	12	cellular	cellular	ADJ
admet-2551	329	13	protein	protein	NOUN
admet-2551	329	14	post	post	ADJ
admet-2551	329	15	-	-	ADJ
admet-2551	329	16	translationally	translationally	ADV
admet-2551	329	17	modified	modify	VERB
admet-2551	329	18	into	into	ADP
admet-2551	329	19	a	a	DET
admet-2551	329	20	transmissible	transmissible	ADJ
admet-2551	329	21	,	,	PUNCT
admet-2551	329	22	prion	prion	NOUN
admet-2551	329	23	-	-	PUNCT
admet-2551	329	24	associated	associate	VERB
admet-2551	329	25	protein	protein	NOUN
admet-2551	329	26	known	know	VERB
admet-2551	329	27	as	as	ADP
admet-2551	329	28	prpsc	prpsc	NOUN
admet-2551	329	29	.	.	PUNCT
admet-2551	330	1	as	as	ADP
admet-2551	330	2	a	a	DET
admet-2551	330	3	result	result	NOUN
admet-2551	330	4	of	of	ADP
admet-2551	330	5	conformational	conformational	ADJ
admet-2551	330	6	changes	change	NOUN
admet-2551	330	7	in	in	ADP
admet-2551	330	8	the	the	DET
admet-2551	330	9	prp	prp	NOUN
admet-2551	330	10	106	106	NUM
admet-2551	330	11	-	-	SYM
admet-2551	330	12	126	126	NUM
admet-2551	330	13	region	region	NOUN
admet-2551	330	14	of	of	ADP
admet-2551	330	15	the	the	DET
admet-2551	330	16	prpsc	prpsc	NOUN
admet-2551	330	17	peptide	peptide	NOUN
admet-2551	330	18	,	,	PUNCT
admet-2551	330	19	fibrillation	fibrillation	NOUN
admet-2551	330	20	is	be	AUX
admet-2551	330	21	initiated	initiate	VERB
admet-2551	330	22	in	in	ADP
admet-2551	330	23	this	this	DET
admet-2551	330	24	protein	protein	NOUN
admet-2551	330	25	and	and	CCONJ
admet-2551	330	26	thus	thus	ADV
admet-2551	330	27	,	,	PUNCT
admet-2551	330	28	prp	prp	PROPN
admet-2551	330	29	106	106	NUM
admet-2551	330	30	-	-	SYM
admet-2551	330	31	126	126	NUM
admet-2551	330	32	can	can	AUX
admet-2551	330	33	be	be	AUX
admet-2551	330	34	used	use	VERB
admet-2551	330	35	for	for	ADP
admet-2551	330	36	studying	study	VERB
admet-2551	330	37	prion	prion	NOUN
admet-2551	330	38	peptide	peptide	NOUN
admet-2551	330	39	amyloidosis	amyloidosis	NOUN
admet-2551	330	40	.	.	PUNCT
admet-2551	331	1	there	there	PRON
admet-2551	331	2	is	be	VERB
admet-2551	331	3	a	a	DET
admet-2551	331	4	possibility	possibility	NOUN
admet-2551	331	5	that	that	SCONJ
admet-2551	331	6	any	any	DET
admet-2551	331	7	agent	agent	NOUN
admet-2551	331	8	capable	capable	ADJ
admet-2551	331	9	of	of	ADP
admet-2551	331	10	destabilizing	destabilize	VERB
admet-2551	331	11	or	or	CCONJ
admet-2551	331	12	disintegrating	disintegrate	VERB
admet-2551	331	13	such	such	ADJ
admet-2551	331	14	proteins	protein	NOUN
admet-2551	331	15	can	can	AUX
admet-2551	331	16	be	be	AUX
admet-2551	331	17	used	use	VERB
admet-2551	331	18	as	as	ADP
admet-2551	331	19	a	a	DET
admet-2551	331	20	potential	potential	ADJ
admet-2551	331	21	drug	drug	NOUN
admet-2551	331	22	candidate	candidate	NOUN
admet-2551	331	23	for	for	ADP
admet-2551	331	24	the	the	DET
admet-2551	331	25	treatment	treatment	NOUN
admet-2551	331	26	of	of	ADP
admet-2551	331	27	prion	prion	NOUN
admet-2551	331	28	diseases	disease	NOUN
admet-2551	331	29	.	.	PUNCT
admet-2551	332	1	the	the	DET
admet-2551	332	2	activity	activity	NOUN
admet-2551	332	3	of	of	ADP
admet-2551	332	4	lk	lk	NOUN
admet-2551	332	5	and	and	CCONJ
admet-2551	332	6	sp	sp	NOUN
admet-2551	332	7	was	be	AUX
admet-2551	332	8	in	in	ADP
admet-2551	332	9	vitro	vitro	X
admet-2551	332	10	tested	test	VERB
admet-2551	332	11	against	against	ADP
admet-2551	332	12	prp	prp	PROPN
admet-2551	332	13	106	106	NUM
admet-2551	332	14	-	-	SYM
admet-2551	332	15	126	126	NUM
admet-2551	332	16	amyloids	amyloid	NOUN
admet-2551	332	17	,	,	PUNCT
admet-2551	332	18	which	which	PRON
admet-2551	332	19	was	be	AUX
admet-2551	332	20	measured	measure	VERB
admet-2551	332	21	against	against	ADP
admet-2551	332	22	nk	nk	PROPN
admet-2551	332	23	,	,	PUNCT
admet-2551	332	24	the	the	DET
admet-2551	332	25	standard	standard	ADJ
admet-2551	332	26	amyloid	amyloid	NOUN
admet-2551	332	27	degrading	degrade	VERB
admet-2551	332	28	enzyme	enzyme	NOUN
admet-2551	332	29	.	.	PUNCT
admet-2551	333	1	based	base	VERB
admet-2551	333	2	on	on	ADP
admet-2551	333	3	tht	tht	PROPN
admet-2551	333	4	fluorescence	fluorescence	NOUN
admet-2551	333	5	assay	assay	PROPN
admet-2551	333	6	results	result	NOUN
admet-2551	333	7	,	,	PUNCT
admet-2551	333	8	both	both	CCONJ
admet-2551	333	9	lk	lk	NOUN
admet-2551	333	10	and	and	CCONJ
admet-2551	333	11	sp	sp	ADP
admet-2551	333	12	inhibited	inhibit	VERB
admet-2551	333	13	prp	prp	NOUN
admet-2551	333	14	106	106	NUM
admet-2551	333	15	-	-	SYM
admet-2551	333	16	126	126	NUM
admet-2551	333	17	amyloid	amyloid	NOUN
admet-2551	333	18	formation	formation	NOUN
admet-2551	333	19	.	.	PUNCT
admet-2551	334	1	furthermore	furthermore	ADV
admet-2551	334	2	,	,	PUNCT
admet-2551	334	3	after	after	ADP
admet-2551	334	4	incubation	incubation	NOUN
admet-2551	334	5	of	of	ADP
admet-2551	334	6	prion	prion	NOUN
admet-2551	334	7	amyloids	amyloid	NOUN
admet-2551	334	8	with	with	ADP
admet-2551	334	9	lk	lk	NOUN
admet-2551	334	10	and	and	CCONJ
admet-2551	334	11	sp	sp	NOUN
admet-2551	334	12	,	,	PUNCT
admet-2551	334	13	fibril	fibril	ADJ
admet-2551	334	14	sizes	size	NOUN
admet-2551	334	15	were	be	AUX
admet-2551	334	16	also	also	ADV
admet-2551	334	17	found	find	VERB
admet-2551	334	18	to	to	PART
admet-2551	334	19	be	be	AUX
admet-2551	334	20	smaller	small	ADJ
admet-2551	334	21	at	at	ADP
admet-2551	334	22	different	different	ADJ
admet-2551	334	23	time	time	NOUN
admet-2551	334	24	intervals	interval	NOUN
admet-2551	334	25	using	use	VERB
admet-2551	334	26	dynamic	dynamic	ADJ
admet-2551	334	27	light	light	ADJ
admet-2551	334	28	scattering	scattering	NOUN
admet-2551	334	29	.	.	PUNCT
admet-2551	335	1	furthermore	furthermore	ADV
admet-2551	335	2	,	,	PUNCT
admet-2551	335	3	the	the	DET
admet-2551	335	4	molecular	molecular	ADJ
admet-2551	335	5	dynamics	dynamic	NOUN
admet-2551	335	6	simulation	simulation	NOUN
admet-2551	335	7	revealed	reveal	VERB
admet-2551	335	8	that	that	SCONJ
admet-2551	335	9	prp	prp	PROPN
admet-2551	335	10	106	106	NUM
admet-2551	335	11	-	-	SYM
admet-2551	335	12	126	126	NUM
admet-2551	335	13	had	have	VERB
admet-2551	335	14	a	a	DET
admet-2551	335	15	high	high	ADJ
admet-2551	335	16	affinity	affinity	NOUN
admet-2551	335	17	for	for	ADP
admet-2551	335	18	lk	lk	NOUN
admet-2551	335	19	and	and	CCONJ
admet-2551	335	20	sp	sp	NOUN
admet-2551	335	21	.	.	PUNCT
admet-2551	336	1	according	accord	VERB
admet-2551	336	2	to	to	ADP
admet-2551	336	3	the	the	DET
admet-2551	336	4	study	study	NOUN
admet-2551	336	5	,	,	PUNCT
admet-2551	336	6	sp	sp	ADP
admet-2551	336	7	and	and	CCONJ
admet-2551	336	8	lk	lk	PROPN
admet-2551	336	9	have	have	VERB
admet-2551	336	10	the	the	DET
admet-2551	336	11	potential	potential	NOUN
admet-2551	336	12	to	to	PART
admet-2551	336	13	disintegrate	disintegrate	VERB
admet-2551	336	14	prp	prp	PROPN
admet-2551	336	15	106	106	NUM
admet-2551	336	16	-	-	SYM
admet-2551	336	17	126	126	NUM
admet-2551	336	18	amyloids	amyloid	NOUN
admet-2551	336	19	and	and	CCONJ
admet-2551	336	20	improve	improve	VERB
admet-2551	336	21	the	the	DET
admet-2551	336	22	viability	viability	NOUN
admet-2551	336	23	of	of	ADP
admet-2551	336	24	the	the	DET
admet-2551	336	25	pc12	pc12	PROPN
admet-2551	336	26	cells	cell	NOUN
admet-2551	336	27	[	[	X
admet-2551	336	28	133	133	NUM
admet-2551	336	29	]	]	PUNCT
admet-2551	336	30	.	.	PUNCT
admet-2551	337	1	a	a	DET
admet-2551	337	2	similar	similar	ADJ
admet-2551	337	3	result	result	NOUN
admet-2551	337	4	was	be	AUX
admet-2551	337	5	also	also	ADV
admet-2551	337	6	found	find	VERB
admet-2551	337	7	for	for	ADP
admet-2551	337	8	the	the	DET
admet-2551	337	9	amyloid	amyloid	NOUN
admet-2551	337	10	β	β	X
admet-2551	337	11	1	1	NUM
admet-2551	337	12	-	-	SYM
admet-2551	337	13	42	42	NUM
admet-2551	337	14	,	,	PUNCT
admet-2551	337	15	the	the	DET
admet-2551	337	16	protein	protein	NOUN
admet-2551	337	17	that	that	PRON
admet-2551	337	18	gets	get	AUX
admet-2551	337	19	misfolded	misfolde	VERB
admet-2551	337	20	and	and	CCONJ
admet-2551	337	21	deposited	deposit	VERB
admet-2551	337	22	in	in	ADP
admet-2551	337	23	the	the	DET
admet-2551	337	24	brain	brain	NOUN
admet-2551	337	25	in	in	ADP
admet-2551	337	26	case	case	NOUN
admet-2551	337	27	of	of	ADP
admet-2551	337	28	alzheimer	alzheimer	PROPN
admet-2551	337	29	’s	’s	PART
admet-2551	337	30	disease	disease	NOUN
admet-2551	337	31	[	[	X
admet-2551	337	32	134	134	NUM
admet-2551	337	33	]	]	PUNCT
admet-2551	337	34	.	.	PUNCT
admet-2551	338	1	in	in	ADP
admet-2551	338	2	vitro	vitro	X
admet-2551	338	3	studies	study	NOUN
admet-2551	338	4	of	of	ADP
admet-2551	338	5	the	the	DET
admet-2551	338	6	degradation	degradation	NOUN
admet-2551	338	7	of	of	ADP
admet-2551	338	8	insulin	insulin	NOUN
admet-2551	338	9	amyloid	amyloid	NOUN
admet-2551	338	10	using	use	VERB
admet-2551	338	11	lk	lk	NOUN
admet-2551	338	12	and	and	CCONJ
admet-2551	338	13	sp	sp	NOUN
admet-2551	338	14	and	and	CCONJ
admet-2551	338	15	the	the	DET
admet-2551	338	16	results	result	NOUN
admet-2551	338	17	were	be	AUX
admet-2551	338	18	promising	promise	VERB
admet-2551	338	19	[	[	X
admet-2551	338	20	132	132	NUM
admet-2551	338	21	,	,	PUNCT
admet-2551	338	22	135	135	NUM
admet-2551	338	23	]	]	PUNCT
admet-2551	338	24	.	.	PUNCT
admet-2551	339	1	when	when	SCONJ
admet-2551	339	2	the	the	DET
admet-2551	339	3	study	study	NOUN
admet-2551	339	4	was	be	AUX
admet-2551	339	5	extrapolated	extrapolate	VERB
admet-2551	339	6	in	in	ADP
admet-2551	339	7	an	an	DET
admet-2551	339	8	animal	animal	NOUN
admet-2551	339	9	model	model	NOUN
admet-2551	339	10	,	,	PUNCT
admet-2551	339	11	where	where	SCONJ
admet-2551	339	12	we	we	PRON
admet-2551	339	13	induced	induce	VERB
admet-2551	339	14	insulin	insulin	NOUN
admet-2551	339	15	amyloid	amyloid	NOUN
admet-2551	339	16	mass	mass	NOUN
admet-2551	339	17	,	,	PUNCT
admet-2551	339	18	after	after	ADP
admet-2551	339	19	repeated	repeat	VERB
admet-2551	339	20	subcutaneous	subcutaneous	ADJ
admet-2551	339	21	injection	injection	NOUN
admet-2551	339	22	of	of	ADP
admet-2551	339	23	insulin	insulin	NOUN
admet-2551	339	24	amyloids	amyloid	NOUN
admet-2551	339	25	,	,	PUNCT
admet-2551	339	26	we	we	PRON
admet-2551	339	27	could	could	AUX
admet-2551	339	28	observe	observe	VERB
admet-2551	339	29	that	that	SCONJ
admet-2551	339	30	the	the	DET
admet-2551	339	31	insulin	insulin	NOUN
admet-2551	339	32	amyloid	amyloid	NOUN
admet-2551	339	33	formation	formation	NOUN
admet-2551	339	34	was	be	AUX
admet-2551	339	35	retarded	retard	VERB
admet-2551	339	36	and	and	CCONJ
admet-2551	339	37	the	the	DET
admet-2551	339	38	amyloids	amyloid	NOUN
admet-2551	339	39	were	be	AUX
admet-2551	339	40	degraded	degrade	VERB
admet-2551	339	41	using	use	VERB
admet-2551	339	42	both	both	CCONJ
admet-2551	339	43	lk	lk	NOUN
admet-2551	339	44	and	and	CCONJ
admet-2551	339	45	sp	sp	ADP
admet-2551	339	46	[	[	X
admet-2551	339	47	136	136	NUM
admet-2551	339	48	]	]	PUNCT
admet-2551	339	49	.	.	PUNCT
admet-2551	340	1	other	other	ADJ
admet-2551	340	2	natural	natural	ADJ
admet-2551	340	3	compounds	compound	NOUN
admet-2551	340	4	reported	report	VERB
admet-2551	340	5	as	as	ADP
admet-2551	340	6	amyloid	amyloid	NOUN
admet-2551	340	7	inhibitors	inhibitor	NOUN
admet-2551	340	8	natural	natural	ADJ
admet-2551	340	9	compounds	compound	NOUN
admet-2551	340	10	with	with	ADP
admet-2551	340	11	anti	anti	ADJ
admet-2551	340	12	-	-	ADJ
admet-2551	340	13	amyloid	amyloid	ADJ
admet-2551	340	14	potential	potential	NOUN
admet-2551	340	15	are	be	AUX
admet-2551	340	16	always	always	ADV
admet-2551	340	17	more	more	ADV
admet-2551	340	18	beneficial	beneficial	ADJ
admet-2551	340	19	than	than	ADP
admet-2551	340	20	synthetic	synthetic	ADJ
admet-2551	340	21	ones	one	NOUN
admet-2551	340	22	as	as	SCONJ
admet-2551	340	23	they	they	PRON
admet-2551	340	24	are	be	AUX
admet-2551	340	25	routinely	routinely	ADV
admet-2551	340	26	consumed	consume	VERB
admet-2551	340	27	.	.	PUNCT
admet-2551	341	1	various	various	ADJ
admet-2551	341	2	polyphenols	polyphenol	NOUN
admet-2551	341	3	like	like	ADP
admet-2551	341	4	epigallocatechin-3	epigallocatechin-3	PROPN
admet-2551	341	5	-	-	NOUN
admet-2551	341	6	gallate	gallate	NOUN
admet-2551	341	7	(	(	PUNCT
admet-2551	341	8	egcg	egcg	NOUN
admet-2551	341	9	)	)	PUNCT
admet-2551	341	10	,	,	PUNCT
admet-2551	341	11	resveratrol	resveratrol	NOUN
admet-2551	341	12	and	and	CCONJ
admet-2551	341	13	curcumin	curcumin	NOUN
admet-2551	341	14	are	be	AUX
admet-2551	341	15	reported	report	VERB
admet-2551	341	16	for	for	ADP
admet-2551	341	17	anti	anti	ADJ
admet-2551	341	18	-	-	ADJ
admet-2551	341	19	amyloid	amyloid	ADJ
admet-2551	341	20	potential	potential	NOUN
admet-2551	341	21	and	and	CCONJ
admet-2551	341	22	progressed	progress	VERB
admet-2551	341	23	for	for	ADP
admet-2551	341	24	clinical	clinical	ADJ
admet-2551	341	25	trials	trial	NOUN
admet-2551	341	26	.	.	PUNCT
admet-2551	342	1	to	to	ADP
admet-2551	342	2	date	date	NOUN
admet-2551	342	3	,	,	PUNCT
admet-2551	342	4	72	72	NUM
admet-2551	342	5	natural	natural	ADJ
admet-2551	342	6	compounds	compound	NOUN
admet-2551	342	7	are	be	AUX
admet-2551	342	8	reported	report	VERB
admet-2551	342	9	for	for	ADP
admet-2551	342	10	the	the	DET
admet-2551	342	11	inhibition	inhibition	NOUN
admet-2551	342	12	of	of	ADP
admet-2551	342	13	amyloids	amyloid	NOUN
admet-2551	342	14	and	and	CCONJ
admet-2551	342	15	44	44	NUM
admet-2551	342	16	compounds	compound	NOUN
admet-2551	342	17	belong	belong	VERB
admet-2551	342	18	to	to	ADP
admet-2551	342	19	a	a	DET
admet-2551	342	20	phenolic	phenolic	ADJ
admet-2551	342	21	group	group	NOUN
admet-2551	342	22	,	,	PUNCT
admet-2551	342	23	4	4	NUM
admet-2551	342	24	anthraquinones	anthraquinone	NOUN
admet-2551	342	25	,	,	PUNCT
admet-2551	342	26	admet	admet	PROPN
admet-2551	342	27	&	&	CCONJ
admet-2551	342	28	dmpk	dmpk	PROPN
admet-2551	342	29	12(6	12(6	NUM
admet-2551	342	30	)	)	PUNCT
admet-2551	342	31	(	(	PUNCT
admet-2551	342	32	2024	2024	NUM
admet-2551	342	33	)	)	PUNCT
admet-2551	342	34	797	797	NUM
admet-2551	342	35	-	-	SYM
admet-2551	342	36	820	820	NUM
admet-2551	342	37	natural	natural	ADJ
admet-2551	342	38	serine	serine	NOUN
admet-2551	342	39	proteases	protease	NOUN
admet-2551	342	40	in	in	ADP
admet-2551	342	41	combating	combat	VERB
admet-2551	342	42	amyloid	amyloid	NOUN
admet-2551	342	43	formation	formation	NOUN
admet-2551	342	44	doi	doi	NOUN
admet-2551	342	45	:	:	PUNCT
admet-2551	342	46	https://doi.org/10.5599/admet.2551	https://doi.org/10.5599/admet.2551	NOUN
admet-2551	342	47	809	809	NUM
admet-2551	342	48	16	16	NUM
admet-2551	342	49	flavonoids	flavonoid	NOUN
admet-2551	342	50	,	,	PUNCT
admet-2551	342	51	13	13	NUM
admet-2551	342	52	alakoloids	alakoloid	NOUN
admet-2551	342	53	(	(	PUNCT
admet-2551	342	54	includes	include	VERB
admet-2551	342	55	3	3	NUM
admet-2551	342	56	pyridines	pyridine	NOUN
admet-2551	342	57	,	,	PUNCT
admet-2551	342	58	2	2	NUM
admet-2551	342	59	porphyrins	porphyrin	NOUN
admet-2551	342	60	,	,	PUNCT
admet-2551	342	61	and	and	CCONJ
admet-2551	342	62	3	3	NUM
admet-2551	342	63	indoles	indole	NOUN
admet-2551	342	64	)	)	PUNCT
admet-2551	342	65	,	,	PUNCT
admet-2551	342	66	terpenes	terpene	NOUN
admet-2551	342	67	,	,	PUNCT
admet-2551	342	68	and	and	CCONJ
admet-2551	342	69	steroids	steroid	NOUN
admet-2551	342	70	.	.	PUNCT
admet-2551	343	1	cyclodextrin	cyclodextrin	NOUN
admet-2551	343	2	,	,	PUNCT
admet-2551	343	3	squalamine	squalamine	NOUN
admet-2551	343	4	,	,	PUNCT
admet-2551	343	5	vitamin	vitamin	NOUN
admet-2551	343	6	a	a	NOUN
admet-2551	343	7	,	,	PUNCT
admet-2551	343	8	hematin	hematin	ADJ
admet-2551	343	9	,	,	PUNCT
admet-2551	343	10	rifampicin	rifampicin	VERB
admet-2551	343	11	,	,	PUNCT
admet-2551	343	12	and	and	CCONJ
admet-2551	343	13	scyllo	scyllo	NOUN
admet-2551	343	14	-	-	PUNCT
admet-2551	343	15	inositol	inositol	NOUN
admet-2551	343	16	have	have	VERB
admet-2551	343	17	anti	anti	ADJ
admet-2551	343	18	-	-	ADJ
admet-2551	343	19	amyloid	amyloid	ADJ
admet-2551	343	20	activity	activity	NOUN
admet-2551	343	21	shown	show	VERB
admet-2551	343	22	under	under	ADP
admet-2551	343	23	in	in	ADP
admet-2551	343	24	vitro	vitro	X
admet-2551	343	25	conditions	condition	NOUN
admet-2551	343	26	[	[	X
admet-2551	343	27	137,138	137,138	NUM
admet-2551	343	28	]	]	PUNCT
admet-2551	343	29	.	.	PUNCT
admet-2551	344	1	there	there	PRON
admet-2551	344	2	are	be	VERB
admet-2551	344	3	several	several	ADJ
admet-2551	344	4	agents	agent	NOUN
admet-2551	344	5	reported	report	VERB
admet-2551	344	6	as	as	ADP
admet-2551	344	7	amyloid	amyloid	NOUN
admet-2551	344	8	inhibitors	inhibitor	NOUN
admet-2551	344	9	,	,	PUNCT
admet-2551	344	10	some	some	PRON
admet-2551	344	11	of	of	ADP
admet-2551	344	12	them	they	PRON
admet-2551	344	13	are	be	AUX
admet-2551	344	14	in	in	ADP
admet-2551	344	15	clinical	clinical	ADJ
admet-2551	344	16	trials	trial	NOUN
admet-2551	344	17	,	,	PUNCT
admet-2551	344	18	as	as	SCONJ
admet-2551	344	19	shown	show	VERB
admet-2551	344	20	in	in	ADP
admet-2551	344	21	table	table	NOUN
admet-2551	344	22	2	2	NUM
admet-2551	344	23	[	[	X
admet-2551	344	24	139	139	NUM
admet-2551	344	25	]	]	PUNCT
admet-2551	344	26	.	.	PUNCT
admet-2551	345	1	table	table	NOUN
admet-2551	345	2	2	2	NUM
admet-2551	345	3	.	.	PUNCT
admet-2551	345	4	anti	anti	ADJ
admet-2551	345	5	-	-	ADJ
admet-2551	345	6	amyloid	amyloid	ADJ
admet-2551	345	7	drugs	drug	NOUN
admet-2551	345	8	in	in	ADP
admet-2551	345	9	the	the	DET
admet-2551	345	10	pipeline	pipeline	NOUN
admet-2551	345	11	for	for	ADP
admet-2551	345	12	clinical	clinical	ADJ
admet-2551	345	13	trials	trial	NOUN
admet-2551	345	14	.	.	PUNCT
admet-2551	346	1	stages	stage	NOUN
admet-2551	346	2	agent	agent	NOUN
admet-2551	346	3	agent	agent	NOUN
admet-2551	346	4	mechanism	mechanism	NOUN
admet-2551	346	5	class	class	NOUN
admet-2551	346	6	mechanism	mechanism	NOUN
admet-2551	346	7	of	of	ADP
admet-2551	346	8	action	action	NOUN
admet-2551	346	9	therapeutic	therapeutic	ADJ
admet-2551	346	10	purpose	purpose	NOUN
admet-2551	346	11	clinicaltrials.gov	clinicaltrials.gov	PUNCT
admet-2551	347	1	i	i	NOUN
admet-2551	347	2	d	d	PROPN
admet-2551	348	1	[	[	X
admet-2551	348	2	139	139	NUM
admet-2551	348	3	]	]	X
admet-2551	348	4	ref	ref	NOUN
admet-2551	348	5	.	.	PUNCT
admet-2551	348	6	phase	phase	NOUN
admet-2551	348	7	i	i	PRON
admet-2551	348	8	aducanumab	aducanumab	VERB
admet-2551	348	9	anti	anti	ADJ
admet-2551	348	10	-	-	ADJ
admet-2551	348	11	amyloid	amyloid	ADJ
admet-2551	348	12	monoclonal	monoclonal	NOUN
admet-2551	348	13	antibody	antibody	NOUN
admet-2551	348	14	remove	remove	VERB
admet-2551	348	15	amyloid	amyloid	NOUN
admet-2551	348	16	(	(	PUNCT
admet-2551	348	17	dmt	dmt	NOUN
admet-2551	348	18	)	)	PUNCT
admet-2551	348	19	nct01677572	nct01677572	ADV
admet-2551	349	1	[	[	X
admet-2551	349	2	140	140	NUM
admet-2551	349	3	]	]	X
admet-2551	349	4	crenezumab	crenezumab	NOUN
admet-2551	349	5	anti	anti	ADJ
admet-2551	349	6	-	-	ADJ
admet-2551	349	7	amyloid	amyloid	ADJ
admet-2551	349	8	monoclonal	monoclonal	NOUN
admet-2551	349	9	antibody	antibody	NOUN
admet-2551	349	10	remove	remove	VERB
admet-2551	349	11	amyloid	amyloid	NOUN
admet-2551	349	12	(	(	PUNCT
admet-2551	349	13	dmt	dmt	NOUN
admet-2551	349	14	)	)	PUNCT
admet-2551	349	15	nct02353598	nct02353598	NOUN
admet-2551	350	1	[	[	X
admet-2551	350	2	141	141	NUM
admet-2551	350	3	]	]	SYM
admet-2551	350	4	khk6640	khk6640	ADJ
admet-2551	350	5	anti	anti	ADJ
admet-2551	350	6	-	-	ADJ
admet-2551	350	7	amyloid	amyloid	ADJ
admet-2551	350	8	antiaβ	antiaβ	NOUN
admet-2551	350	9	peptide	peptide	NOUN
admet-2551	350	10	antibody	antibody	NOUN
admet-2551	350	11	remove	remove	VERB
admet-2551	350	12	amyloid	amyloid	NOUN
admet-2551	350	13	(	(	PUNCT
admet-2551	350	14	dmt	dmt	NOUN
admet-2551	350	15	)	)	PUNCT
admet-2551	350	16	nct03093519	nct03093519	NOUN
admet-2551	351	1	[	[	X
admet-2551	351	2	142	142	NUM
admet-2551	351	3	]	]	PUNCT
admet-2551	351	4	luaf20513	luaf20513	PROPN
admet-2551	351	5	anti	anti	ADJ
admet-2551	351	6	-	-	ADJ
admet-2551	351	7	amyloid	amyloid	ADJ
admet-2551	351	8	polyclonal	polyclonal	ADJ
admet-2551	351	9	antibody	antibody	NOUN
admet-2551	351	10	remove	remove	VERB
admet-2551	351	11	amyloid	amyloid	NOUN
admet-2551	351	12	(	(	PUNCT
admet-2551	351	13	dmt	dmt	NOUN
admet-2551	351	14	)	)	PUNCT
admet-2551	351	15	nct02388152	nct02388152	NOUN
admet-2551	352	1	[	[	X
admet-2551	352	2	143	143	NUM
admet-2551	352	3	]	]	X
admet-2551	352	4	ly3002813	ly3002813	ADJ
admet-2551	352	5	anti	anti	ADJ
admet-2551	352	6	-	-	ADJ
admet-2551	352	7	amyloid	amyloid	ADJ
admet-2551	352	8	monoclonal	monoclonal	NOUN
admet-2551	352	9	antibody	antibody	NOUN
admet-2551	352	10	remove	remove	VERB
admet-2551	352	11	amyloid	amyloid	NOUN
admet-2551	352	12	(	(	PUNCT
admet-2551	352	13	dmt	dmt	NOUN
admet-2551	352	14	)	)	PUNCT
admet-2551	352	15	nct02624778	nct02624778	NOUN
admet-2551	353	1	[	[	X
admet-2551	353	2	144	144	NUM
admet-2551	353	3	]	]	PUNCT
admet-2551	353	4	phase	phase	NOUN
admet-2551	353	5	ii	ii	PROPN
admet-2551	353	6	ban2401	ban2401	NOUN
admet-2551	353	7	anti	anti	ADJ
admet-2551	353	8	-	-	ADJ
admet-2551	353	9	amyloid	amyloid	ADJ
admet-2551	353	10	monoclonal	monoclonal	NOUN
admet-2551	353	11	antibody	antibody	NOUN
admet-2551	353	12	remove	remove	VERB
admet-2551	353	13	amyloid	amyloid	NOUN
admet-2551	353	14	(	(	PUNCT
admet-2551	353	15	dmt	dmt	NOUN
admet-2551	353	16	)	)	PUNCT
admet-2551	353	17	nct017673311	nct017673311	NOUN
admet-2551	354	1	[	[	X
admet-2551	354	2	145	145	NUM
admet-2551	354	3	]	]	PUNCT
admet-2551	354	4	e2609	e2609	VERB
admet-2551	354	5	anti	anti	ADJ
admet-2551	354	6	-	-	ADJ
admet-2551	354	7	amyloid	amyloid	ADJ
admet-2551	354	8	bace	bace	NOUN
admet-2551	354	9	inhibitor	inhibitor	NOUN
admet-2551	354	10	reduce	reduce	VERB
admet-2551	354	11	amyloid	amyloid	NOUN
admet-2551	354	12	production	production	NOUN
admet-2551	354	13	(	(	PUNCT
admet-2551	354	14	dmt	dmt	NOUN
admet-2551	354	15	)	)	PUNCT
admet-2551	354	16	nct02322021	nct02322021	NOUN
admet-2551	355	1	[	[	X
admet-2551	355	2	146	146	NUM
admet-2551	355	3	]	]	SYM
admet-2551	355	4	octagam	octagam	ADJ
admet-2551	355	5	10	10	NUM
admet-2551	355	6	%	%	NOUN
admet-2551	355	7	anti	anti	ADJ
admet-2551	355	8	-	-	NOUN
admet-2551	355	9	amyloid	amyloid	ADJ
admet-2551	355	10	10	10	NUM
admet-2551	355	11	%	%	NOUN
admet-2551	355	12	human	human	ADJ
admet-2551	355	13	normal	normal	ADJ
admet-2551	355	14	immunoglobulin	immunoglobulin	NOUN
admet-2551	355	15	remove	remove	VERB
admet-2551	355	16	amyloid	amyloid	NOUN
admet-2551	355	17	(	(	PUNCT
admet-2551	355	18	dmt	dmt	NOUN
admet-2551	355	19	)	)	PUNCT
admet-2551	355	20	nct03319810	nct03319810	NOUN
admet-2551	356	1	[	[	X
admet-2551	356	2	147	147	NUM
admet-2551	356	3	]	]	X
admet-2551	356	4	ub-311	ub-311	ADJ
admet-2551	356	5	anti	anti	ADJ
admet-2551	356	6	-	-	ADJ
admet-2551	356	7	amyloid	amyloid	ADJ
admet-2551	356	8	active	active	ADJ
admet-2551	356	9	immunotherapy	immunotherapy	NOUN
admet-2551	356	10	reduce	reduce	VERB
admet-2551	356	11	amyloid	amyloid	NOUN
admet-2551	356	12	(	(	PUNCT
admet-2551	356	13	dmt	dmt	NOUN
admet-2551	356	14	)	)	PUNCT
admet-2551	356	15	nct0255180	nct0255180	NOUN
admet-2551	357	1	[	[	X
admet-2551	357	2	148	148	NUM
admet-2551	357	3	]	]	SYM
admet-2551	357	4	phase	phase	NOUN
admet-2551	357	5	iii	iii	NUM
admet-2551	357	6	cnp520	cnp520	PROPN
admet-2551	357	7	anti	anti	ADJ
admet-2551	357	8	-	-	ADJ
admet-2551	357	9	amyloid	amyloid	ADJ
admet-2551	357	10	bace	bace	NOUN
admet-2551	357	11	inhibitor	inhibitor	NOUN
admet-2551	357	12	reduce	reduce	VERB
admet-2551	357	13	amyloid	amyloid	NOUN
admet-2551	357	14	production	production	NOUN
admet-2551	357	15	(	(	PUNCT
admet-2551	357	16	dmt	dmt	NOUN
admet-2551	357	17	)	)	PUNCT
admet-2551	357	18	nct03131453	nct03131453	NOUN
admet-2551	357	19	[	[	X
admet-2551	357	20	149	149	NUM
admet-2551	357	21	]	]	X
admet-2551	357	22	gantenerumab	gantenerumab	NOUN
admet-2551	357	23	anti	anti	ADJ
admet-2551	357	24	-	-	ADJ
admet-2551	357	25	amyloid	amyloid	ADJ
admet-2551	357	26	monoclonal	monoclonal	NOUN
admet-2551	357	27	antibody	antibody	NOUN
admet-2551	357	28	remove	remove	VERB
admet-2551	357	29	amyloid	amyloid	NOUN
admet-2551	357	30	(	(	PUNCT
admet-2551	357	31	dmt	dmt	NOUN
admet-2551	357	32	)	)	PUNCT
admet-2551	357	33	nct02051608	nct02051608	NOUN
admet-2551	358	1	[	[	X
admet-2551	358	2	150	150	NUM
admet-2551	358	3	]	]	X
admet-2551	358	4	mk-8931	mk-8931	NOUN
admet-2551	358	5	(	(	PUNCT
admet-2551	358	6	verubecestat	verubecestat	NOUN
admet-2551	358	7	)	)	PUNCT
admet-2551	358	8	anti	anti	ADJ
admet-2551	358	9	-	-	ADJ
admet-2551	358	10	amyloid	amyloid	ADJ
admet-2551	358	11	bace	bace	NOUN
admet-2551	358	12	inhibitor	inhibitor	NOUN
admet-2551	358	13	reduce	reduce	VERB
admet-2551	358	14	amyloid	amyloid	NOUN
admet-2551	358	15	production	production	NOUN
admet-2551	358	16	(	(	PUNCT
admet-2551	358	17	dmt	dmt	NOUN
admet-2551	358	18	)	)	PUNCT
admet-2551	358	19	nct01953601	nct01953601	NOUN
admet-2551	359	1	[	[	X
admet-2551	359	2	151	151	NUM
admet-2551	359	3	]	]	PUNCT
admet-2551	359	4	solanezumab	solanezumab	VERB
admet-2551	359	5	anti	anti	ADJ
admet-2551	359	6	-	-	ADJ
admet-2551	359	7	amyloid	amyloid	ADJ
admet-2551	359	8	monoclonal	monoclonal	NOUN
admet-2551	359	9	antibody	antibody	NOUN
admet-2551	359	10	remove	remove	VERB
admet-2551	359	11	amyloid	amyloid	NOUN
admet-2551	359	12	(	(	PUNCT
admet-2551	359	13	dmt	dmt	NOUN
admet-2551	359	14	)	)	PUNCT
admet-2551	359	15	nct02008357	nct02008357	NOUN
admet-2551	360	1	[	[	X
admet-2551	360	2	152	152	NUM
admet-2551	360	3	]	]	X
admet-2551	360	4	further	further	ADJ
admet-2551	360	5	research	research	NOUN
admet-2551	360	6	is	be	AUX
admet-2551	360	7	warranted	warrant	VERB
admet-2551	360	8	to	to	PART
admet-2551	360	9	determine	determine	VERB
admet-2551	360	10	many	many	ADJ
admet-2551	360	11	more	more	ADJ
admet-2551	360	12	drugs	drug	NOUN
admet-2551	360	13	that	that	PRON
admet-2551	360	14	can	can	AUX
admet-2551	360	15	cross	cross	VERB
admet-2551	360	16	the	the	DET
admet-2551	360	17	blood	blood	NOUN
admet-2551	360	18	-	-	PUNCT
admet-2551	360	19	brain	brain	NOUN
admet-2551	360	20	barrier	barrier	NOUN
admet-2551	360	21	and	and	CCONJ
admet-2551	360	22	effectively	effectively	ADV
admet-2551	360	23	degrade	degrade	VERB
admet-2551	360	24	the	the	DET
admet-2551	360	25	amyloids	amyloid	NOUN
admet-2551	360	26	responsible	responsible	ADJ
admet-2551	360	27	for	for	ADP
admet-2551	360	28	various	various	ADJ
admet-2551	360	29	neurodegenerative	neurodegenerative	ADJ
admet-2551	360	30	disorders	disorder	NOUN
admet-2551	360	31	.	.	PUNCT
admet-2551	361	1	conclusion	conclusion	NOUN
admet-2551	361	2	biotechnology	biotechnology	NOUN
admet-2551	361	3	has	have	AUX
admet-2551	361	4	become	become	VERB
admet-2551	361	5	highly	highly	ADV
admet-2551	361	6	versatile	versatile	ADJ
admet-2551	361	7	and	and	CCONJ
admet-2551	361	8	has	have	AUX
admet-2551	361	9	merged	merge	VERB
admet-2551	361	10	with	with	ADP
admet-2551	361	11	other	other	ADJ
admet-2551	361	12	technologies	technology	NOUN
admet-2551	361	13	to	to	PART
admet-2551	361	14	deliver	deliver	VERB
admet-2551	361	15	highthroughput	highthroughput	NOUN
admet-2551	361	16	products	product	NOUN
admet-2551	361	17	.	.	PUNCT
admet-2551	362	1	its	its	PRON
admet-2551	362	2	amalgamation	amalgamation	NOUN
admet-2551	362	3	with	with	ADP
admet-2551	362	4	bionanotechnology	bionanotechnology	NOUN
admet-2551	362	5	has	have	AUX
admet-2551	362	6	created	create	VERB
admet-2551	362	7	tremendous	tremendous	ADJ
admet-2551	362	8	demand	demand	NOUN
admet-2551	362	9	in	in	ADP
admet-2551	362	10	the	the	DET
admet-2551	362	11	biomedical	biomedical	ADJ
admet-2551	362	12	field	field	NOUN
admet-2551	362	13	.	.	PUNCT
admet-2551	363	1	enzymes	enzyme	NOUN
admet-2551	363	2	from	from	ADP
admet-2551	363	3	natural	natural	ADJ
admet-2551	363	4	sources	source	NOUN
admet-2551	363	5	have	have	AUX
admet-2551	363	6	been	be	AUX
admet-2551	363	7	consumed	consume	VERB
admet-2551	363	8	in	in	ADP
admet-2551	363	9	different	different	ADJ
admet-2551	363	10	forms	form	NOUN
admet-2551	363	11	worldwide	worldwide	ADV
admet-2551	363	12	for	for	ADP
admet-2551	363	13	a	a	DET
admet-2551	363	14	long	long	ADJ
admet-2551	363	15	time	time	NOUN
admet-2551	363	16	,	,	PUNCT
admet-2551	363	17	owing	owe	VERB
admet-2551	363	18	to	to	ADP
admet-2551	363	19	their	their	PRON
admet-2551	363	20	health	health	NOUN
admet-2551	363	21	benefits	benefit	NOUN
admet-2551	363	22	.	.	PUNCT
admet-2551	364	1	among	among	ADP
admet-2551	364	2	the	the	DET
admet-2551	364	3	various	various	ADJ
admet-2551	364	4	serine	serine	NOUN
admet-2551	364	5	proteases	protease	NOUN
admet-2551	364	6	,	,	PUNCT
admet-2551	364	7	sp	sp	NOUN
admet-2551	364	8	,	,	PUNCT
admet-2551	364	9	lk	lk	NOUN
admet-2551	364	10	,	,	PUNCT
admet-2551	364	11	ker	ker	NOUN
admet-2551	364	12	,	,	PUNCT
admet-2551	364	13	and	and	CCONJ
admet-2551	364	14	nk	nk	PROPN
admet-2551	364	15	have	have	AUX
admet-2551	364	16	shown	show	VERB
admet-2551	364	17	their	their	PRON
admet-2551	364	18	potential	potential	NOUN
admet-2551	364	19	in	in	ADP
admet-2551	364	20	inhibiting	inhibit	VERB
admet-2551	364	21	the	the	DET
admet-2551	364	22	amyloid	amyloid	NOUN
admet-2551	364	23	fibril	fibril	ADJ
admet-2551	364	24	formation	formation	NOUN
admet-2551	364	25	responsible	responsible	ADJ
admet-2551	364	26	for	for	ADP
admet-2551	364	27	different	different	ADJ
admet-2551	364	28	neurodegenerative	neurodegenerative	ADJ
admet-2551	364	29	disorders	disorder	NOUN
admet-2551	364	30	,	,	PUNCT
admet-2551	364	31	such	such	ADJ
admet-2551	364	32	as	as	ADP
admet-2551	364	33	alzheimer	alzheimer	PROPN
admet-2551	364	34	’s	’s	PART
admet-2551	364	35	disease	disease	NOUN
admet-2551	364	36	,	,	PUNCT
admet-2551	364	37	prion	prion	NOUN
admet-2551	364	38	disease	disease	NOUN
admet-2551	364	39	,	,	PUNCT
admet-2551	364	40	and	and	CCONJ
admet-2551	364	41	type	type	NOUN
admet-2551	364	42	ii	ii	NOUN
admet-2551	364	43	diabetes	diabetes	NOUN
admet-2551	364	44	.	.	PUNCT
admet-2551	365	1	early	early	ADJ
admet-2551	365	2	diagnosis	diagnosis	NOUN
admet-2551	365	3	of	of	ADP
admet-2551	365	4	amyloidosis	amyloidosis	NOUN
admet-2551	365	5	permits	permit	NOUN
admet-2551	365	6	for	for	ADP
admet-2551	365	7	effectively	effectively	ADV
admet-2551	365	8	improved	improve	VERB
admet-2551	365	9	organ	organ	NOUN
admet-2551	365	10	function	function	NOUN
admet-2551	365	11	.	.	PUNCT
admet-2551	366	1	moreover	moreover	ADV
admet-2551	366	2	,	,	PUNCT
admet-2551	366	3	if	if	SCONJ
admet-2551	366	4	these	these	DET
admet-2551	366	5	natural	natural	ADJ
admet-2551	366	6	inhibitors	inhibitor	NOUN
admet-2551	366	7	successfully	successfully	ADV
admet-2551	366	8	complete	complete	VERB
admet-2551	366	9	clinical	clinical	ADJ
admet-2551	366	10	trials	trial	NOUN
admet-2551	366	11	,	,	PUNCT
admet-2551	366	12	outcomes	outcome	NOUN
admet-2551	366	13	for	for	ADP
admet-2551	366	14	those	those	PRON
admet-2551	366	15	suffering	suffer	VERB
admet-2551	366	16	from	from	ADP
admet-2551	366	17	amyloidosis	amyloidosis	NOUN
admet-2551	366	18	can	can	AUX
admet-2551	366	19	be	be	AUX
admet-2551	366	20	improved	improve	VERB
admet-2551	366	21	,	,	PUNCT
admet-2551	366	22	and	and	CCONJ
admet-2551	366	23	serine	serine	NOUN
admet-2551	366	24	protease	protease	NOUN
admet-2551	366	25	enzymes	enzyme	NOUN
admet-2551	366	26	may	may	AUX
admet-2551	366	27	be	be	AUX
admet-2551	366	28	used	use	VERB
admet-2551	366	29	to	to	PART
admet-2551	366	30	improve	improve	VERB
admet-2551	366	31	quality	quality	NOUN
admet-2551	366	32	of	of	ADP
admet-2551	366	33	life	life	NOUN
admet-2551	366	34	in	in	ADP
admet-2551	366	35	the	the	DET
admet-2551	366	36	early	early	ADJ
admet-2551	366	37	stages	stage	NOUN
admet-2551	366	38	of	of	ADP
admet-2551	366	39	the	the	DET
admet-2551	366	40	disease	disease	NOUN
admet-2551	366	41	.	.	PUNCT
admet-2551	367	1	in	in	ADP
admet-2551	367	2	this	this	DET
admet-2551	367	3	mini	mini	ADJ
admet-2551	367	4	review	review	NOUN
admet-2551	367	5	,	,	PUNCT
admet-2551	367	6	we	we	PRON
admet-2551	367	7	have	have	AUX
admet-2551	367	8	discussed	discuss	VERB
admet-2551	367	9	these	these	DET
admet-2551	367	10	serine	serine	NOUN
admet-2551	367	11	proteases	protease	NOUN
admet-2551	367	12	and	and	CCONJ
admet-2551	367	13	other	other	ADJ
admet-2551	367	14	natural	natural	ADJ
admet-2551	367	15	compounds	compound	NOUN
admet-2551	367	16	that	that	PRON
admet-2551	367	17	can	can	AUX
admet-2551	367	18	be	be	AUX
admet-2551	367	19	used	use	VERB
admet-2551	367	20	to	to	PART
admet-2551	367	21	manage	manage	VERB
admet-2551	367	22	neurodegenerative	neurodegenerative	ADJ
admet-2551	367	23	diseases	disease	NOUN
admet-2551	367	24	.	.	PUNCT
admet-2551	368	1	these	these	DET
admet-2551	368	2	studies	study	NOUN
admet-2551	368	3	concluded	conclude	VERB
admet-2551	368	4	that	that	SCONJ
admet-2551	368	5	ker	ker	PROPN
admet-2551	368	6	can	can	AUX
admet-2551	368	7	be	be	AUX
admet-2551	368	8	used	use	VERB
admet-2551	368	9	to	to	PART
admet-2551	368	10	remove	remove	VERB
admet-2551	368	11	prion	prion	NOUN
admet-2551	368	12	infections	infection	NOUN
admet-2551	368	13	from	from	ADP
admet-2551	368	14	surgical	surgical	ADJ
admet-2551	368	15	instruments	instrument	NOUN
admet-2551	368	16	and	and	CCONJ
admet-2551	368	17	other	other	ADJ
admet-2551	368	18	surfaces	surface	NOUN
admet-2551	368	19	contaminated	contaminate	VERB
admet-2551	368	20	with	with	ADP
admet-2551	368	21	prions	prion	NOUN
admet-2551	368	22	because	because	SCONJ
admet-2551	368	23	ker	ker	NOUN
admet-2551	368	24	is	be	AUX
admet-2551	368	25	not	not	PART
admet-2551	368	26	consumable	consumable	ADJ
admet-2551	368	27	.	.	PUNCT
admet-2551	369	1	on	on	ADP
admet-2551	369	2	the	the	DET
admet-2551	369	3	other	other	ADJ
admet-2551	369	4	hand	hand	NOUN
admet-2551	369	5	,	,	PUNCT
admet-2551	369	6	lk	lk	NOUN
admet-2551	369	7	and	and	CCONJ
admet-2551	369	8	sp	sp	NOUN
admet-2551	369	9	can	can	AUX
admet-2551	369	10	be	be	AUX
admet-2551	369	11	used	use	VERB
admet-2551	369	12	to	to	PART
admet-2551	369	13	degrade	degrade	VERB
admet-2551	369	14	amyloids	amyloid	NOUN
admet-2551	369	15	.	.	PUNCT
admet-2551	370	1	since	since	SCONJ
admet-2551	370	2	they	they	PRON
admet-2551	370	3	possess	possess	VERB
admet-2551	370	4	fibrinolytic	fibrinolytic	ADJ
admet-2551	370	5	activity	activity	NOUN
admet-2551	370	6	,	,	PUNCT
admet-2551	370	7	they	they	PRON
admet-2551	370	8	can	can	AUX
admet-2551	370	9	be	be	AUX
admet-2551	370	10	used	use	VERB
admet-2551	370	11	as	as	ADP
admet-2551	370	12	coatings	coating	NOUN
admet-2551	370	13	above	above	ADP
admet-2551	370	14	https://doi.org/10.5599/admet.2551	https://doi.org/10.5599/admet.2551	NOUN
admet-2551	371	1	s.	s.	PROPN
admet-2551	371	2	k.	k.	PROPN
admet-2551	371	3	metkar	metkar	PROPN
admet-2551	371	4	et	et	PROPN
admet-2551	371	5	al	al	PROPN
admet-2551	371	6	.	.	PROPN
admet-2551	371	7	admet	admet	PROPN
admet-2551	371	8	&	&	CCONJ
admet-2551	371	9	dmpk	dmpk	PROPN
admet-2551	371	10	12(6	12(6	NUM
admet-2551	371	11	)	)	PUNCT
admet-2551	371	12	(	(	PUNCT
admet-2551	371	13	2024	2024	NUM
admet-2551	371	14	)	)	PUNCT
admet-2551	371	15	797	797	NUM
admet-2551	371	16	-	-	SYM
admet-2551	371	17	820	820	NUM
admet-2551	371	18	810	810	NUM
admet-2551	371	19	surgical	surgical	ADJ
admet-2551	371	20	implants	implant	NOUN
admet-2551	371	21	so	so	SCONJ
admet-2551	371	22	that	that	SCONJ
admet-2551	371	23	they	they	PRON
admet-2551	371	24	can	can	AUX
admet-2551	371	25	retard	retard	VERB
admet-2551	371	26	the	the	DET
admet-2551	371	27	clot	clot	NOUN
admet-2551	371	28	formation	formation	NOUN
admet-2551	371	29	at	at	ADP
admet-2551	371	30	the	the	DET
admet-2551	371	31	site	site	NOUN
admet-2551	371	32	of	of	ADP
admet-2551	371	33	implant	implant	ADJ
admet-2551	371	34	post	post	NOUN
admet-2551	371	35	-	-	NOUN
admet-2551	371	36	surgery	surgery	NOUN
admet-2551	371	37	.	.	PUNCT
admet-2551	372	1	future	future	ADJ
admet-2551	372	2	studies	study	NOUN
admet-2551	372	3	are	be	AUX
admet-2551	372	4	necessary	necessary	ADJ
admet-2551	372	5	to	to	AUX
admet-2551	372	6	nano	nano	NOUN
admet-2551	372	7	-	-	PUNCT
admet-2551	372	8	formulate	formulate	VERB
admet-2551	372	9	these	these	DET
admet-2551	372	10	enzymes	enzyme	NOUN
admet-2551	372	11	to	to	PART
admet-2551	372	12	effectively	effectively	ADV
admet-2551	372	13	cross	cross	VERB
admet-2551	372	14	the	the	DET
admet-2551	372	15	blood	blood	NOUN
admet-2551	372	16	-	-	PUNCT
admet-2551	372	17	brain	brain	NOUN
admet-2551	372	18	barrier	barrier	NOUN
admet-2551	372	19	and	and	CCONJ
admet-2551	372	20	get	get	AUX
admet-2551	372	21	delivered	deliver	VERB
admet-2551	372	22	to	to	ADP
admet-2551	372	23	the	the	DET
admet-2551	372	24	brain	brain	NOUN
admet-2551	372	25	for	for	ADP
admet-2551	372	26	exerting	exert	VERB
admet-2551	372	27	their	their	PRON
admet-2551	372	28	anti	anti	ADJ
admet-2551	372	29	-	-	ADJ
admet-2551	372	30	amyloid	amyloid	ADJ
admet-2551	372	31	activity	activity	NOUN
admet-2551	372	32	.	.	PUNCT
admet-2551	373	1	conflict	conflict	NOUN
admet-2551	373	2	of	of	ADP
admet-2551	373	3	interest	interest	NOUN
admet-2551	373	4	:	:	PUNCT
admet-2551	373	5	the	the	DET
admet-2551	373	6	authors	author	NOUN
admet-2551	373	7	declare	declare	VERB
admet-2551	373	8	no	no	DET
admet-2551	373	9	conflict	conflict	NOUN
admet-2551	373	10	of	of	ADP
admet-2551	373	11	interest	interest	NOUN
admet-2551	373	12	.	.	PUNCT
admet-2551	374	1	funding	funding	NOUN
admet-2551	374	2	:	:	PUNCT
admet-2551	374	3	no	no	DET
admet-2551	374	4	funding	funding	NOUN
admet-2551	374	5	was	be	AUX
admet-2551	374	6	received	receive	VERB
admet-2551	374	7	for	for	ADP
admet-2551	374	8	this	this	DET
admet-2551	374	9	research	research	NOUN
admet-2551	374	10	.	.	PUNCT
admet-2551	375	1	authors	author	NOUN
admet-2551	375	2	’	'	PUNCT
admet-2551	375	3	contributions	contribution	NOUN
admet-2551	375	4	:	:	PUNCT
admet-2551	376	1	s.	s.	PROPN
admet-2551	376	2	k.	k.	PROPN
admet-2551	376	3	metkar	metkar	PROPN
admet-2551	376	4	and	and	CCONJ
admet-2551	376	5	s.	s.	PROPN
admet-2551	376	6	udayakumar	udayakumar	PROPN
admet-2551	376	7	have	have	VERB
admet-2551	376	8	equal	equal	ADJ
admet-2551	376	9	contribution	contribution	NOUN
admet-2551	376	10	.	.	PUNCT
admet-2551	377	1	all	all	DET
admet-2551	377	2	authors	author	NOUN
admet-2551	377	3	contributed	contribute	VERB
admet-2551	377	4	equally	equally	ADV
admet-2551	377	5	to	to	ADP
admet-2551	377	6	the	the	DET
admet-2551	377	7	conception	conception	NOUN
admet-2551	377	8	and	and	CCONJ
admet-2551	377	9	preparation	preparation	NOUN
admet-2551	377	10	of	of	ADP
admet-2551	377	11	the	the	DET
admet-2551	377	12	manuscript	manuscript	NOUN
admet-2551	377	13	and	and	CCONJ
admet-2551	377	14	all	all	DET
admet-2551	377	15	authors	author	NOUN
admet-2551	377	16	read	read	VERB
admet-2551	377	17	and	and	CCONJ
admet-2551	377	18	approved	approve	VERB
admet-2551	377	19	the	the	DET
admet-2551	377	20	final	final	ADJ
admet-2551	377	21	manuscript	manuscript	NOUN
admet-2551	377	22	.	.	PUNCT
admet-2551	378	1	acknowledgement	acknowledgement	NOUN
admet-2551	378	2	:	:	PUNCT
admet-2551	378	3	the	the	DET
admet-2551	378	4	authors	author	NOUN
admet-2551	378	5	are	be	AUX
admet-2551	378	6	grateful	grateful	ADJ
admet-2551	378	7	to	to	ADP
admet-2551	378	8	chettinad	chettinad	PROPN
admet-2551	378	9	academy	academy	PROPN
admet-2551	378	10	of	of	ADP
admet-2551	378	11	research	research	NOUN
admet-2551	378	12	and	and	CCONJ
admet-2551	378	13	education	education	NOUN
admet-2551	378	14	for	for	ADP
admet-2551	378	15	the	the	DET
admet-2551	378	16	infrastructural	infrastructural	ADJ
admet-2551	378	17	support	support	NOUN
admet-2551	378	18	.	.	PUNCT
admet-2551	379	1	s.	s.	PROPN
admet-2551	379	2	udayakumar	udayakumar	PROPN
admet-2551	379	3	acknowledges	acknowledge	VERB
admet-2551	379	4	chettinad	chettinad	PROPN
admet-2551	379	5	academy	academy	PROPN
admet-2551	379	6	of	of	ADP
admet-2551	379	7	research	research	NOUN
admet-2551	379	8	and	and	CCONJ
admet-2551	379	9	education	education	NOUN
admet-2551	379	10	for	for	ADP
admet-2551	379	11	providing	provide	VERB
admet-2551	379	12	her	she	PRON
admet-2551	379	13	with	with	ADP
admet-2551	379	14	phd	phd	NOUN
admet-2551	379	15	fellowship	fellowship	NOUN
admet-2551	379	16	.	.	PUNCT
admet-2551	380	1	we	we	PRON
admet-2551	380	2	thank	thank	VERB
admet-2551	380	3	janani	janani	PROPN
admet-2551	380	4	g	g	PROPN
admet-2551	380	5	,	,	PUNCT
admet-2551	380	6	deepika	deepika	PROPN
admet-2551	380	7	b	b	PROPN
admet-2551	380	8	and	and	CCONJ
admet-2551	380	9	d.	d.	PROPN
admet-2551	380	10	jessy	jessy	PROPN
admet-2551	380	11	mercy	mercy	NOUN
admet-2551	380	12	for	for	ADP
admet-2551	380	13	their	their	PRON
admet-2551	380	14	extreme	extreme	ADJ
admet-2551	380	15	help	help	NOUN
admet-2551	380	16	while	while	SCONJ
admet-2551	380	17	preparing	prepare	VERB
admet-2551	380	18	the	the	DET
admet-2551	380	19	manuscript	manuscript	NOUN
admet-2551	380	20	.	.	PUNCT
admet-2551	381	1	references	reference	NOUN
admet-2551	381	2	[	[	X
admet-2551	381	3	1	1	X
admet-2551	381	4	]	]	X
admet-2551	381	5	s.k	s.k	PROPN
admet-2551	381	6	.	.	PROPN
admet-2551	381	7	metkar	metkar	PROPN
admet-2551	381	8	,	,	PUNCT
admet-2551	381	9	s.	s.	PROPN
admet-2551	381	10	udayakumar	udayakumar	PROPN
admet-2551	381	11	,	,	PUNCT
admet-2551	381	12	a.	a.	PROPN
admet-2551	381	13	girigoswami	girigoswami	PROPN
admet-2551	381	14	,	,	PUNCT
admet-2551	381	15	k.	k.	PROPN
admet-2551	381	16	girigoswami	girigoswami	PROPN
admet-2551	381	17	.	.	PUNCT
admet-2551	382	1	amyloidosis	amyloidosis	NOUN
admet-2551	382	2	-	-	PUNCT
admet-2551	382	3	history	history	NOUN
admet-2551	382	4	and	and	CCONJ
admet-2551	382	5	development	development	NOUN
admet-2551	382	6	,	,	PUNCT
admet-2551	382	7	emphasis	emphasis	NOUN
admet-2551	382	8	on	on	ADP
admet-2551	382	9	insulin	insulin	NOUN
admet-2551	382	10	and	and	CCONJ
admet-2551	382	11	prion	prion	NOUN
admet-2551	382	12	amyloids	amyloid	NOUN
admet-2551	382	13	.	.	PUNCT
admet-2551	383	1	brain	brain	NOUN
admet-2551	383	2	disorders	disorder	NOUN
admet-2551	383	3	13	13	NUM
admet-2551	383	4	(	(	PUNCT
admet-2551	383	5	2024	2024	NUM
admet-2551	383	6	)	)	PUNCT
admet-2551	383	7	100106	100106	NUM
admet-2551	383	8	.	.	PUNCT
admet-2551	384	1	https://doi.org/https://doi.org/10.1016/j.dscb.2023.100106	https://doi.org/https://doi.org/10.1016/j.dscb.2023.100106	X
admet-2551	384	2	.	.	PUNCT
admet-2551	385	1	[	[	X
admet-2551	385	2	2	2	NUM
admet-2551	385	3	]	]	PUNCT
admet-2551	385	4	a.	a.	NOUN
admet-2551	385	5	girigoswami	girigoswami	PROPN
admet-2551	385	6	,	,	PUNCT
admet-2551	385	7	m.	m.	NOUN
admet-2551	385	8	ramalakshmi	ramalakshmi	NOUN
admet-2551	385	9	,	,	PUNCT
admet-2551	385	10	n.	n.	NOUN
admet-2551	385	11	akhtar	akhtar	PROPN
admet-2551	385	12	,	,	PUNCT
admet-2551	385	13	s.k	s.k	PROPN
admet-2551	385	14	.	.	PROPN
admet-2551	385	15	metkar	metkar	PROPN
admet-2551	385	16	,	,	PUNCT
admet-2551	385	17	k.	k.	PROPN
admet-2551	385	18	girigoswami	girigoswami	PROPN
admet-2551	385	19	.	.	PUNCT
admet-2551	386	1	zno	zno	PROPN
admet-2551	386	2	nanoflower	nanoflower	PROPN
admet-2551	386	3	petals	petal	NOUN
admet-2551	386	4	mediated	mediate	VERB
admet-2551	386	5	amyloid	amyloid	NOUN
admet-2551	386	6	degradation	degradation	NOUN
admet-2551	386	7	-	-	PUNCT
admet-2551	386	8	an	an	NOUN
admet-2551	386	9	in	in	X
admet-2551	386	10	vitro	vitro	X
admet-2551	386	11	electrokinetic	electrokinetic	ADJ
admet-2551	386	12	potential	potential	ADJ
admet-2551	386	13	approach	approach	NOUN
admet-2551	386	14	.	.	PUNCT
admet-2551	387	1	materials	material	NOUN
admet-2551	387	2	science	science	NOUN
admet-2551	387	3	and	and	CCONJ
admet-2551	387	4	engineering	engineering	NOUN
admet-2551	387	5	c	c	PROPN
admet-2551	387	6	101	101	NUM
admet-2551	387	7	(	(	PUNCT
admet-2551	387	8	2019	2019	NUM
admet-2551	387	9	)	)	PUNCT
admet-2551	387	10	169	169	NUM
admet-2551	387	11	-	-	SYM
admet-2551	387	12	178	178	NUM
admet-2551	387	13	.	.	PUNCT
admet-2551	388	1	https://doi.org/10.1016/j.msec.2019.03.086	https://doi.org/10.1016/j.msec.2019.03.086	PROPN
admet-2551	388	2	.	.	PUNCT
admet-2551	389	1	[	[	X
admet-2551	389	2	3	3	X
admet-2551	389	3	]	]	PUNCT
admet-2551	389	4	s.	s.	PROPN
admet-2551	389	5	udayakumar	udayakumar	PROPN
admet-2551	389	6	,	,	PUNCT
admet-2551	389	7	s.k	s.k	PROPN
admet-2551	389	8	.	.	PROPN
admet-2551	389	9	metkar	metkar	PROPN
admet-2551	389	10	,	,	PUNCT
admet-2551	389	11	a.	a.	PROPN
admet-2551	389	12	girigoswami	girigoswami	PROPN
admet-2551	389	13	,	,	PUNCT
admet-2551	389	14	b.	b.	PROPN
admet-2551	389	15	deepika	deepika	PROPN
admet-2551	389	16	,	,	PUNCT
admet-2551	389	17	g.	g.	PROPN
admet-2551	389	18	janani	janani	PROPN
admet-2551	389	19	,	,	PUNCT
admet-2551	389	20	l.	l.	PROPN
admet-2551	389	21	kanakaraj	kanakaraj	PROPN
admet-2551	389	22	,	,	PUNCT
admet-2551	389	23	k.	k.	PROPN
admet-2551	389	24	girigoswami	girigoswami	PROPN
admet-2551	389	25	.	.	PUNCT
admet-2551	390	1	exploring	explore	VERB
admet-2551	390	2	the	the	DET
admet-2551	390	3	amyloid	amyloid	NOUN
admet-2551	390	4	degradation	degradation	NOUN
admet-2551	390	5	potential	potential	NOUN
admet-2551	390	6	of	of	ADP
admet-2551	390	7	nanoformulated	nanoformulate	VERB
admet-2551	390	8	carrageenan	carrageenan	NOUN
admet-2551	390	9	-	-	PUNCT
admet-2551	390	10	bridging	bridging	NOUN
admet-2551	390	11	in	in	ADP
admet-2551	390	12	vitro	vitro	X
admet-2551	390	13	and	and	CCONJ
admet-2551	390	14	in	in	ADP
admet-2551	390	15	vivo	vivo	ADJ
admet-2551	390	16	perspectives	perspective	NOUN
admet-2551	390	17	.	.	PUNCT
admet-2551	391	1	international	international	ADJ
admet-2551	391	2	journal	journal	NOUN
admet-2551	391	3	of	of	ADP
admet-2551	391	4	biological	biological	ADJ
admet-2551	391	5	macromolecules	macromolecule	NOUN
admet-2551	391	6	279	279	NUM
admet-2551	391	7	(	(	PUNCT
admet-2551	391	8	2024	2024	NUM
admet-2551	391	9	)	)	PUNCT
admet-2551	391	10	134814	134814	NUM
admet-2551	391	11	.	.	PUNCT
admet-2551	392	1	https://doi.org/https://doi.org/10.1016/j.ijbiomac.2024.134814	https://doi.org/https://doi.org/10.1016/j.ijbiomac.2024.134814	X
admet-2551	392	2	.	.	PUNCT
admet-2551	393	1	[	[	X
admet-2551	393	2	4	4	NUM
admet-2551	393	3	]	]	PUNCT
admet-2551	393	4	a.	a.	NOUN
admet-2551	393	5	jablaoui	jablaoui	PROPN
admet-2551	393	6	,	,	PUNCT
admet-2551	393	7	a.	a.	NOUN
admet-2551	393	8	kriaa	kriaa	PROPN
admet-2551	393	9	,	,	PUNCT
admet-2551	393	10	n.	n.	NOUN
admet-2551	393	11	akermi	akermi	NOUN
admet-2551	393	12	,	,	PUNCT
admet-2551	393	13	h.	h.	PROPN
admet-2551	393	14	mkaouar	mkaouar	PROPN
admet-2551	393	15	,	,	PUNCT
admet-2551	393	16	a.	a.	PROPN
admet-2551	393	17	gargouri	gargouri	PROPN
admet-2551	393	18	,	,	PUNCT
admet-2551	393	19	e.	e.	PROPN
admet-2551	393	20	maguin	maguin	PROPN
admet-2551	393	21	,	,	PUNCT
admet-2551	393	22	m.	m.	NOUN
admet-2551	393	23	rhimi	rhimi	PROPN
admet-2551	393	24	.	.	PUNCT
admet-2551	394	1	biotechnological	biotechnological	ADJ
admet-2551	394	2	applications	application	NOUN
admet-2551	394	3	of	of	ADP
admet-2551	394	4	serine	serine	ADJ
admet-2551	394	5	proteases	protease	NOUN
admet-2551	394	6	:	:	PUNCT
admet-2551	394	7	a	a	DET
admet-2551	394	8	patent	patent	NOUN
admet-2551	394	9	review	review	NOUN
admet-2551	394	10	.	.	PUNCT
admet-2551	395	1	recent	recent	ADJ
admet-2551	395	2	patents	patent	NOUN
admet-2551	395	3	on	on	ADP
admet-2551	395	4	biotechnology	biotechnology	NOUN
admet-2551	395	5	12	12	NUM
admet-2551	395	6	(	(	PUNCT
admet-2551	395	7	2018	2018	NUM
admet-2551	395	8	)	)	PUNCT
admet-2551	395	9	280287	280287	NUM
admet-2551	395	10	.	.	PUNCT
admet-2551	396	1	https://doi.org/10.2174/1872208312666180924112007	https://doi.org/10.2174/1872208312666180924112007	INTJ
admet-2551	396	2	.	.	PUNCT
admet-2551	397	1	[	[	X
admet-2551	397	2	5	5	X
admet-2551	397	3	]	]	PUNCT
admet-2551	397	4	s.	s.	PROPN
admet-2551	397	5	patel	patel	PROPN
admet-2551	397	6	.	.	PUNCT
admet-2551	398	1	a	a	DET
admet-2551	398	2	critical	critical	ADJ
admet-2551	398	3	review	review	NOUN
admet-2551	398	4	on	on	ADP
admet-2551	398	5	serine	serine	ADJ
admet-2551	398	6	protease	protease	NOUN
admet-2551	398	7	:	:	PUNCT
admet-2551	398	8	key	key	ADJ
admet-2551	398	9	immune	immune	ADJ
admet-2551	398	10	manipulator	manipulator	NOUN
admet-2551	398	11	and	and	CCONJ
admet-2551	398	12	pathology	pathology	NOUN
admet-2551	398	13	mediator	mediator	NOUN
admet-2551	398	14	.	.	PUNCT
admet-2551	399	1	allergologia	allergologia	PROPN
admet-2551	399	2	et	et	PROPN
admet-2551	399	3	immunopathologia	immunopathologia	PROPN
admet-2551	399	4	45	45	NUM
admet-2551	399	5	(	(	PUNCT
admet-2551	399	6	2017	2017	NUM
admet-2551	399	7	)	)	PUNCT
admet-2551	399	8	579	579	NUM
admet-2551	399	9	-	-	SYM
admet-2551	399	10	591	591	NUM
admet-2551	399	11	.	.	PUNCT
admet-2551	400	1	https://doi.org/10.1016/j.aller.2016.10.011	https://doi.org/10.1016/j.aller.2016.10.011	NUM
admet-2551	400	2	.	.	PUNCT
admet-2551	401	1	[	[	X
admet-2551	401	2	6	6	NUM
admet-2551	401	3	]	]	PUNCT
admet-2551	401	4	e.	e.	PROPN
admet-2551	401	5	di	di	PROPN
admet-2551	401	6	cera	cera	PROPN
admet-2551	401	7	.	.	PUNCT
admet-2551	401	8	serine	serine	ADJ
admet-2551	401	9	proteases	protease	NOUN
admet-2551	401	10	.	.	PUNCT
admet-2551	402	1	iubmb	iubmb	NOUN
admet-2551	402	2	life	life	NOUN
admet-2551	402	3	61	61	NUM
admet-2551	402	4	(	(	PUNCT
admet-2551	402	5	2009	2009	NUM
admet-2551	402	6	)	)	PUNCT
admet-2551	402	7	510	510	NUM
admet-2551	402	8	-	-	SYM
admet-2551	402	9	515	515	NUM
admet-2551	402	10	.	.	PUNCT
admet-2551	403	1	https://doi.org/10.1002/iub.186	https://doi.org/10.1002/iub.186	PROPN
admet-2551	403	2	.	.	PUNCT
admet-2551	404	1	[	[	X
admet-2551	404	2	7	7	X
admet-2551	404	3	]	]	X
admet-2551	404	4	l.	l.	PROPN
admet-2551	404	5	hedstrom	hedstrom	PROPN
admet-2551	404	6	.	.	PUNCT
admet-2551	404	7	serine	serine	ADJ
admet-2551	404	8	protease	protease	NOUN
admet-2551	404	9	mechanism	mechanism	NOUN
admet-2551	404	10	and	and	CCONJ
admet-2551	404	11	specificity	specificity	NOUN
admet-2551	404	12	.	.	PUNCT
admet-2551	405	1	chemical	chemical	ADJ
admet-2551	405	2	reviews	review	NOUN
admet-2551	405	3	102	102	NUM
admet-2551	405	4	(	(	PUNCT
admet-2551	405	5	2002	2002	NUM
admet-2551	405	6	)	)	PUNCT
admet-2551	405	7	4501	4501	NUM
admet-2551	405	8	-	-	SYM
admet-2551	405	9	4524	4524	NUM
admet-2551	405	10	.	.	PUNCT
admet-2551	406	1	https://doi.org/10.1021/cr000033x	https://doi.org/10.1021/cr000033x	PROPN
admet-2551	406	2	.	.	PUNCT
admet-2551	407	1	[	[	X
admet-2551	407	2	8	8	NUM
admet-2551	407	3	]	]	X
admet-2551	407	4	m.j	m.j	PROPN
admet-2551	407	5	.	.	PROPN
admet-2551	407	6	page	page	NOUN
admet-2551	407	7	,	,	PUNCT
admet-2551	407	8	e.	e.	PROPN
admet-2551	407	9	di	di	PROPN
admet-2551	407	10	cera	cera	PROPN
admet-2551	407	11	.	.	PUNCT
admet-2551	408	1	serine	serine	NOUN
admet-2551	408	2	peptidases	peptidase	NOUN
admet-2551	408	3	:	:	PUNCT
admet-2551	408	4	classification	classification	NOUN
admet-2551	408	5	,	,	PUNCT
admet-2551	408	6	structure	structure	NOUN
admet-2551	408	7	and	and	CCONJ
admet-2551	408	8	function	function	NOUN
admet-2551	408	9	.	.	PUNCT
admet-2551	409	1	cellular	cellular	ADJ
admet-2551	409	2	and	and	CCONJ
admet-2551	409	3	molecular	molecular	ADJ
admet-2551	409	4	life	life	NOUN
admet-2551	409	5	sciences	science	NOUN
admet-2551	409	6	65	65	NUM
admet-2551	409	7	(	(	PUNCT
admet-2551	409	8	2008	2008	NUM
admet-2551	409	9	)	)	PUNCT
admet-2551	409	10	1220	1220	NUM
admet-2551	409	11	-	-	SYM
admet-2551	409	12	1236	1236	NUM
admet-2551	409	13	.	.	PUNCT
admet-2551	410	1	https://doi.org/10.1007/s00018-008-7565-9	https://doi.org/10.1007/s00018-008-7565-9	NOUN
admet-2551	410	2	.	.	PUNCT
admet-2551	411	1	[	[	X
admet-2551	411	2	9	9	NUM
admet-2551	411	3	]	]	X
admet-2551	411	4	j.d	j.d	PROPN
admet-2551	411	5	.	.	PROPN
admet-2551	411	6	tyndall	tyndall	PROPN
admet-2551	411	7	,	,	PUNCT
admet-2551	411	8	t.	t.	NOUN
admet-2551	411	9	nall	nall	PROPN
admet-2551	411	10	,	,	PUNCT
admet-2551	411	11	d.p	d.p	PROPN
admet-2551	411	12	.	.	PROPN
admet-2551	411	13	fairlie	fairlie	PROPN
admet-2551	411	14	.	.	PUNCT
admet-2551	412	1	proteases	protease	NOUN
admet-2551	412	2	universally	universally	ADV
admet-2551	412	3	recognize	recognize	VERB
admet-2551	412	4	beta	beta	ADJ
admet-2551	412	5	strands	strand	NOUN
admet-2551	412	6	in	in	ADP
admet-2551	412	7	their	their	PRON
admet-2551	412	8	active	active	ADJ
admet-2551	412	9	sites	site	NOUN
admet-2551	412	10	.	.	PUNCT
admet-2551	413	1	chemical	chemical	ADJ
admet-2551	413	2	reviews	review	NOUN
admet-2551	413	3	105	105	NUM
admet-2551	413	4	(	(	PUNCT
admet-2551	413	5	2005	2005	NUM
admet-2551	413	6	)	)	PUNCT
admet-2551	413	7	973	973	NUM
admet-2551	413	8	-	-	SYM
admet-2551	413	9	1000	1000	NUM
admet-2551	413	10	.	.	PUNCT
admet-2551	414	1	https://doi.org/10.1021/cr040669e	https://doi.org/10.1021/cr040669e	PROPN
admet-2551	414	2	.	.	PUNCT
admet-2551	415	1	[	[	X
admet-2551	415	2	10	10	NUM
admet-2551	415	3	]	]	X
admet-2551	415	4	n.	n.	NOUN
admet-2551	415	5	barzkar	barzkar	NOUN
admet-2551	415	6	,	,	PUNCT
admet-2551	415	7	z.	z.	PROPN
admet-2551	415	8	khan	khan	PROPN
admet-2551	415	9	,	,	PUNCT
admet-2551	415	10	s.t	s.t	PROPN
admet-2551	415	11	.	.	PROPN
admet-2551	415	12	jahromi	jahromi	PROPN
admet-2551	415	13	,	,	PUNCT
admet-2551	415	14	s.	s.	PROPN
admet-2551	415	15	pourmozaffar	pourmozaffar	PROPN
admet-2551	415	16	,	,	PUNCT
admet-2551	415	17	m.	m.	NOUN
admet-2551	415	18	gozari	gozari	PROPN
admet-2551	415	19	,	,	PUNCT
admet-2551	415	20	r.	r.	PROPN
admet-2551	415	21	nahavandi	nahavandi	PROPN
admet-2551	415	22	.	.	PUNCT
admet-2551	416	1	a	a	DET
admet-2551	416	2	critical	critical	ADJ
admet-2551	416	3	review	review	NOUN
admet-2551	416	4	on	on	ADP
admet-2551	416	5	marine	marine	ADJ
admet-2551	416	6	serine	serine	NOUN
admet-2551	416	7	protease	protease	NOUN
admet-2551	416	8	and	and	CCONJ
admet-2551	416	9	its	its	PRON
admet-2551	416	10	inhibitors	inhibitor	NOUN
admet-2551	416	11	:	:	PUNCT
admet-2551	416	12	a	a	DET
admet-2551	416	13	new	new	ADJ
admet-2551	416	14	wave	wave	NOUN
admet-2551	416	15	of	of	ADP
admet-2551	416	16	drugs	drug	NOUN
admet-2551	416	17	?	?	PUNCT
admet-2551	417	1	international	international	ADJ
admet-2551	417	2	journal	journal	NOUN
admet-2551	417	3	of	of	ADP
admet-2551	417	4	biological	biological	ADJ
admet-2551	417	5	macromolecules	macromolecule	NOUN
admet-2551	417	6	170	170	NUM
admet-2551	417	7	(	(	PUNCT
admet-2551	417	8	2021	2021	NUM
admet-2551	417	9	)	)	PUNCT
admet-2551	417	10	674	674	NUM
admet-2551	417	11	-	-	SYM
admet-2551	417	12	687	687	NUM
admet-2551	417	13	.	.	PUNCT
admet-2551	418	1	https://doi.org/10.1016/j.ijbiomac.2020.12.134	https://doi.org/10.1016/j.ijbiomac.2020.12.134	NOUN
admet-2551	418	2	.	.	PUNCT
admet-2551	419	1	[	[	X
admet-2551	419	2	11	11	NUM
admet-2551	419	3	]	]	X
admet-2551	419	4	b.m	b.m	PROPN
admet-2551	419	5	.	.	PROPN
admet-2551	419	6	stojanovski	stojanovski	PROPN
admet-2551	419	7	,	,	PUNCT
admet-2551	419	8	l.a	l.a	PROPN
admet-2551	419	9	.	.	PROPN
admet-2551	419	10	pelc	pelc	PROPN
admet-2551	419	11	,	,	PUNCT
admet-2551	419	12	e.	e.	PROPN
admet-2551	419	13	di	di	PROPN
admet-2551	419	14	cera	cera	PROPN
admet-2551	419	15	.	.	PUNCT
admet-2551	420	1	thrombin	thrombin	PROPN
admet-2551	420	2	has	have	VERB
admet-2551	420	3	dual	dual	ADJ
admet-2551	420	4	trypsin	trypsin	NOUN
admet-2551	420	5	-	-	PUNCT
admet-2551	420	6	like	like	ADP
admet-2551	420	7	and	and	CCONJ
admet-2551	420	8	chymotrypsin	chymotrypsin	NOUN
admet-2551	420	9	-	-	PUNCT
admet-2551	420	10	like	like	ADJ
admet-2551	420	11	specificity	specificity	NOUN
admet-2551	420	12	.	.	PUNCT
admet-2551	421	1	journal	journal	NOUN
admet-2551	421	2	of	of	ADP
admet-2551	421	3	thrombosis	thrombosis	NOUN
admet-2551	421	4	and	and	CCONJ
admet-2551	421	5	haemostasis	haemostasis	NOUN
admet-2551	421	6	22	22	NUM
admet-2551	421	7	(	(	PUNCT
admet-2551	421	8	2024	2024	NUM
admet-2551	421	9	)	)	PUNCT
admet-2551	421	10	1009	1009	NUM
admet-2551	421	11	-	-	SYM
admet-2551	421	12	1015	1015	NUM
admet-2551	421	13	.	.	PUNCT
admet-2551	422	1	https://doi.org/10.1016/j.jtha.2023.12.026	https://doi.org/10.1016/j.jtha.2023.12.026	PROPN
admet-2551	422	2	.	.	PUNCT
admet-2551	423	1	[	[	X
admet-2551	423	2	12	12	NUM
admet-2551	423	3	]	]	PUNCT
admet-2551	423	4	r.-l	r.-l	NOUN
admet-2551	423	5	.	.	PUNCT
admet-2551	424	1	hsu	hsu	PROPN
admet-2551	424	2	,	,	PUNCT
admet-2551	424	3	k.-t	k.-t	PROPN
admet-2551	424	4	.	.	PUNCT
admet-2551	425	1	lee	lee	PROPN
admet-2551	425	2	,	,	PUNCT
admet-2551	425	3	j.-h	j.-h	PROPN
admet-2551	425	4	.	.	PUNCT
admet-2551	426	1	wang	wang	PROPN
admet-2551	426	2	,	,	PUNCT
admet-2551	426	3	l.y.-l	l.y.-l	PROPN
admet-2551	426	4	.	.	PUNCT
admet-2551	427	1	lee	lee	PROPN
admet-2551	427	2	,	,	PUNCT
admet-2551	427	3	r.p.-y	r.p.-y	PROPN
admet-2551	427	4	.	.	PUNCT
admet-2551	428	1	chen	chen	PROPN
admet-2551	428	2	.	.	PUNCT
admet-2551	429	1	amyloid	amyloid	NOUN
admet-2551	429	2	-	-	PUNCT
admet-2551	429	3	degrading	degrade	VERB
admet-2551	429	4	ability	ability	NOUN
admet-2551	429	5	of	of	ADP
admet-2551	429	6	nattokinase	nattokinase	NOUN
admet-2551	429	7	from	from	ADP
admet-2551	429	8	bacillus	bacillus	NOUN
admet-2551	429	9	subtilis	subtili	NOUN
admet-2551	429	10	natto	natto	NOUN
admet-2551	429	11	.	.	PUNCT
admet-2551	430	1	journal	journal	PROPN
admet-2551	430	2	of	of	ADP
admet-2551	430	3	agricultural	agricultural	ADJ
admet-2551	430	4	and	and	CCONJ
admet-2551	430	5	food	food	NOUN
admet-2551	430	6	chemistry	chemistry	NOUN
admet-2551	430	7	57	57	NUM
admet-2551	430	8	(	(	PUNCT
admet-2551	430	9	2009	2009	NUM
admet-2551	430	10	)	)	PUNCT
admet-2551	430	11	503	503	NUM
admet-2551	430	12	-	-	NUM
admet-2551	430	13	508	508	NUM
admet-2551	430	14	.	.	PUNCT
admet-2551	431	1	https://doi.org/10.1021/jf803072r	https://doi.org/10.1021/jf803072r	X
admet-2551	431	2	.	.	PUNCT
admet-2551	432	1	[	[	X
admet-2551	432	2	13	13	NUM
admet-2551	432	3	]	]	PUNCT
admet-2551	432	4	s.	s.	PROPN
admet-2551	432	5	mukherjee	mukherjee	PROPN
admet-2551	432	6	,	,	PUNCT
admet-2551	432	7	d.s	d.s	PROPN
admet-2551	432	8	.	.	PROPN
admet-2551	432	9	ningthoujam	ningthoujam	PROPN
admet-2551	432	10	,	,	PUNCT
admet-2551	432	11	l.	l.	PROPN
admet-2551	432	12	jaya	jaya	PROPN
admet-2551	432	13	devi	devi	PROPN
admet-2551	432	14	,	,	PUNCT
admet-2551	432	15	m.b.r	m.b.r	PROPN
admet-2551	432	16	.	.	PROPN
admet-2551	432	17	laboratory	laboratory	NOUN
admet-2551	432	18	.	.	PUNCT
admet-2551	433	1	p4‐033	p4‐033	PROPN
admet-2551	433	2	:	:	PUNCT
admet-2551	433	3	degradation	degradation	NOUN
admet-2551	433	4	of	of	ADP
admet-2551	433	5	amyloid‐	amyloid‐	ADJ
admet-2551	433	6	beta	beta	ADJ
admet-2551	433	7	aggregates	aggregate	NOUN
admet-2551	433	8	by	by	ADP
admet-2551	433	9	microbial	microbial	ADJ
admet-2551	433	10	keratinases	keratinase	NOUN
admet-2551	433	11	.	.	PUNCT
admet-2551	434	1	alzheimer	alzheimer	PROPN
admet-2551	434	2	's	's	PART
admet-2551	434	3	&	&	CCONJ
admet-2551	434	4	dementia	dementia	PROPN
admet-2551	434	5	11	11	NUM
admet-2551	434	6	(	(	PUNCT
admet-2551	434	7	2015	2015	NUM
admet-2551	434	8	)	)	PUNCT
admet-2551	434	9	p778	p778	PROPN
admet-2551	434	10	-	-	PUNCT
admet-2551	434	11	p778	p778	PROPN
admet-2551	434	12	.	.	PUNCT
admet-2551	434	13	https://doi.org/10.1016/j.jalz.2015.06.1737	https://doi.org/10.1016/j.jalz.2015.06.1737	PROPN
admet-2551	434	14	.	.	PUNCT
admet-2551	435	1	https://doi.org/https:/doi.org/10.1016/j.dscb.2023.100106	https://doi.org/https:/doi.org/10.1016/j.dscb.2023.100106	PROPN
admet-2551	435	2	https://doi.org/10.1016/j.msec.2019.03.086	https://doi.org/10.1016/j.msec.2019.03.086	PROPN
admet-2551	435	3	https://doi.org/https:/doi.org/10.1016/j.ijbiomac.2024.134814	https://doi.org/https:/doi.org/10.1016/j.ijbiomac.2024.134814	PROPN
admet-2551	435	4	https://doi.org/10.2174/1872208312666180924112007	https://doi.org/10.2174/1872208312666180924112007	VERB
admet-2551	435	5	https://doi.org/10.1016/j.aller.2016.10.011	https://doi.org/10.1016/j.aller.2016.10.011	NUM
admet-2551	435	6	https://doi.org/10.1002/iub.186	https://doi.org/10.1002/iub.186	PROPN
admet-2551	435	7	https://doi.org/10.1021/cr000033x	https://doi.org/10.1021/cr000033x	PROPN
admet-2551	435	8	https://doi.org/10.1007/s00018-008-7565-9	https://doi.org/10.1007/s00018-008-7565-9	NUM
admet-2551	435	9	https://doi.org/10.1021/cr040669e	https://doi.org/10.1021/cr040669e	PUNCT
admet-2551	436	1	https://doi.org/10.1016/j.ijbiomac.2020.12.134	https://doi.org/10.1016/j.ijbiomac.2020.12.134	PROPN
admet-2551	436	2	https://doi.org/10.1016/j.jtha.2023.12.026	https://doi.org/10.1016/j.jtha.2023.12.026	PROPN
admet-2551	436	3	https://doi.org/10.1021/jf803072r	https://doi.org/10.1021/jf803072r	PROPN
admet-2551	436	4	https://doi.org/10.1016/j.jalz.2015.06.1737	https://doi.org/10.1016/j.jalz.2015.06.1737	X
admet-2551	436	5	admet	admet	PROPN
admet-2551	436	6	&	&	CCONJ
admet-2551	436	7	dmpk	dmpk	PROPN
admet-2551	436	8	12(6	12(6	NUM
admet-2551	436	9	)	)	PUNCT
admet-2551	436	10	(	(	PUNCT
admet-2551	436	11	2024	2024	NUM
admet-2551	436	12	)	)	PUNCT
admet-2551	436	13	797	797	NUM
admet-2551	436	14	-	-	SYM
admet-2551	436	15	820	820	NUM
admet-2551	436	16	natural	natural	ADJ
admet-2551	436	17	serine	serine	NOUN
admet-2551	436	18	proteases	protease	NOUN
admet-2551	436	19	in	in	ADP
admet-2551	436	20	combating	combat	VERB
admet-2551	436	21	amyloid	amyloid	NOUN
admet-2551	436	22	formation	formation	NOUN
admet-2551	436	23	doi	doi	NOUN
admet-2551	436	24	:	:	PUNCT
admet-2551	436	25	https://doi.org/10.5599/admet.2551	https://doi.org/10.5599/admet.2551	NOUN
admet-2551	436	26	811	811	NUM
admet-2551	436	27	[	[	SYM
admet-2551	436	28	14	14	NUM
admet-2551	436	29	]	]	X
admet-2551	436	30	w.	w.	PROPN
admet-2551	436	31	yang	yang	PROPN
admet-2551	436	32	,	,	PUNCT
admet-2551	436	33	w.	w.	PROPN
admet-2551	436	34	wang	wang	PROPN
admet-2551	436	35	,	,	PUNCT
admet-2551	436	36	y.	y.	PROPN
admet-2551	436	37	ma	ma	PROPN
admet-2551	436	38	,	,	PUNCT
admet-2551	436	39	q.	q.	PROPN
admet-2551	436	40	yang	yang	PROPN
admet-2551	436	41	,	,	PUNCT
admet-2551	436	42	p.	p.	PROPN
admet-2551	436	43	li	li	PROPN
admet-2551	436	44	,	,	PUNCT
admet-2551	436	45	s.	s.	PROPN
admet-2551	436	46	du	du	PROPN
admet-2551	436	47	.	.	PROPN
admet-2551	436	48	bioevaluation	bioevaluation	NOUN
admet-2551	436	49	of	of	ADP
admet-2551	436	50	pheretima	pheretima	PROPN
admet-2551	436	51	vulgaris	vulgaris	PROPN
admet-2551	436	52	antithrombotic	antithrombotic	ADJ
admet-2551	436	53	extract	extract	NOUN
admet-2551	436	54	,	,	PUNCT
admet-2551	436	55	pvq	pvq	NOUN
admet-2551	436	56	,	,	PUNCT
admet-2551	436	57	and	and	CCONJ
admet-2551	436	58	isolation	isolation	NOUN
admet-2551	436	59	,	,	PUNCT
admet-2551	436	60	identification	identification	NOUN
admet-2551	436	61	of	of	ADP
admet-2551	436	62	six	six	NUM
admet-2551	436	63	novel	novel	ADJ
admet-2551	436	64	pvq	pvq	ADV
admet-2551	436	65	-	-	PUNCT
admet-2551	436	66	derived	derive	VERB
admet-2551	436	67	fibrinolytic	fibrinolytic	ADJ
admet-2551	436	68	proteases	protease	NOUN
admet-2551	436	69	.	.	PUNCT
admet-2551	437	1	molecules	molecule	NOUN
admet-2551	437	2	26	26	NUM
admet-2551	437	3	(	(	PUNCT
admet-2551	437	4	2021	2021	NUM
admet-2551	437	5	)	)	PUNCT
admet-2551	437	6	4946	4946	NUM
admet-2551	437	7	.	.	PUNCT
admet-2551	438	1	https://doi.org/10.3390/molecules26164946	https://doi.org/10.3390/molecules26164946	PROPN
admet-2551	438	2	.	.	PUNCT
admet-2551	439	1	[	[	X
admet-2551	439	2	15	15	NUM
admet-2551	439	3	]	]	X
admet-2551	439	4	r.	r.	PROPN
admet-2551	439	5	sinha	sinha	PROPN
admet-2551	439	6	,	,	PUNCT
admet-2551	439	7	s.	s.	PROPN
admet-2551	439	8	herat	herat	PROPN
admet-2551	439	9	,	,	PUNCT
admet-2551	439	10	k.	k.	PROPN
admet-2551	439	11	chauhan	chauhan	PROPN
admet-2551	439	12	,	,	PUNCT
admet-2551	439	13	d.	d.	PROPN
admet-2551	439	14	valani	valani	PROPN
admet-2551	439	15	.	.	PUNCT
admet-2551	440	1	earthworms	earthworm	NOUN
admet-2551	440	2	:	:	PUNCT
admet-2551	440	3	the'unheralded	the'unheralde	VERB
admet-2551	440	4	soldiers	soldier	NOUN
admet-2551	440	5	of	of	ADP
admet-2551	440	6	mankind'and'farmer	mankind'and'farmer	PRON
admet-2551	440	7	's	's	PART
admet-2551	440	8	friend'working	friend'working	ADJ
admet-2551	440	9	day	day	NOUN
admet-2551	440	10	and	and	CCONJ
admet-2551	440	11	night	night	NOUN
admet-2551	440	12	under	under	ADP
admet-2551	440	13	the	the	DET
admet-2551	440	14	soil	soil	NOUN
admet-2551	440	15	:	:	PUNCT
admet-2551	440	16	reviving	revive	VERB
admet-2551	440	17	the	the	DET
admet-2551	440	18	dreams	dream	NOUN
admet-2551	440	19	of	of	ADP
admet-2551	440	20	sir	sir	PROPN
admet-2551	440	21	charles	charles	PROPN
admet-2551	440	22	darwin	darwin	PROPN
admet-2551	440	23	for	for	ADP
admet-2551	440	24	promoting	promote	VERB
admet-2551	440	25	sustainable	sustainable	ADJ
admet-2551	440	26	agriculture	agriculture	NOUN
admet-2551	440	27	.	.	PUNCT
admet-2551	441	1	american	american	ADJ
admet-2551	441	2	-	-	PUNCT
admet-2551	441	3	eurasian	eurasian	ADJ
admet-2551	441	4	journal	journal	NOUN
admet-2551	441	5	of	of	ADP
admet-2551	441	6	agricultural	agricultural	ADJ
admet-2551	441	7	and	and	CCONJ
admet-2551	441	8	environmental	environmental	ADJ
admet-2551	441	9	science	science	NOUN
admet-2551	441	10	5	5	NUM
admet-2551	441	11	(	(	PUNCT
admet-2551	441	12	2009	2009	NUM
admet-2551	441	13	)	)	PUNCT
admet-2551	441	14	5	5	NUM
admet-2551	441	15	-	-	SYM
admet-2551	441	16	13	13	NUM
admet-2551	441	17	.	.	PUNCT
admet-2551	442	1	https://doi.org/hdl.handle.net/10072/30153	https://doi.org/hdl.handle.net/10072/30153	PROPN
admet-2551	442	2	.	.	PUNCT
admet-2551	443	1	[	[	X
admet-2551	443	2	16	16	NUM
admet-2551	443	3	]	]	X
admet-2551	443	4	m.j	m.j	PROPN
admet-2551	443	5	.	.	PROPN
admet-2551	443	6	shipitalo	shipitalo	NOUN
admet-2551	443	7	,	,	PUNCT
admet-2551	443	8	r.-c	r.-c	PROPN
admet-2551	443	9	.	.	PUNCT
admet-2551	443	10	le	le	PROPN
admet-2551	443	11	bayon	bayon	PROPN
admet-2551	443	12	.	.	PUNCT
admet-2551	444	1	quantifying	quantify	VERB
admet-2551	444	2	the	the	DET
admet-2551	444	3	effects	effect	NOUN
admet-2551	444	4	of	of	ADP
admet-2551	444	5	earthworms	earthworm	NOUN
admet-2551	444	6	on	on	ADP
admet-2551	444	7	soil	soil	NOUN
admet-2551	444	8	aggregation	aggregation	NOUN
admet-2551	444	9	and	and	CCONJ
admet-2551	444	10	porosity	porosity	NOUN
admet-2551	444	11	,	,	PUNCT
admet-2551	444	12	in	in	ADP
admet-2551	444	13	earthworm	earthworm	NOUN
admet-2551	444	14	ecology	ecology	NOUN
admet-2551	444	15	,	,	PUNCT
admet-2551	444	16	c.a	c.a	PROPN
admet-2551	444	17	.	.	PROPN
admet-2551	444	18	edwards	edwards	PROPN
admet-2551	444	19	(	(	PUNCT
admet-2551	444	20	ed	ed	NOUN
admet-2551	444	21	.	.	PUNCT
admet-2551	444	22	)	)	PUNCT
admet-2551	444	23	,	,	PUNCT
admet-2551	444	24	crc	crc	NOUN
admet-2551	444	25	press	press	PROPN
admet-2551	444	26	,	,	PUNCT
admet-2551	444	27	boca	boca	PROPN
admet-2551	444	28	raton	raton	PROPN
admet-2551	444	29	,	,	PUNCT
admet-2551	444	30	usa	usa	PROPN
admet-2551	444	31	,	,	PUNCT
admet-2551	444	32	2004	2004	NUM
admet-2551	444	33	,	,	PUNCT
admet-2551	444	34	183	183	NUM
admet-2551	444	35	-	-	SYM
admet-2551	444	36	200	200	NUM
admet-2551	444	37	.	.	PUNCT
admet-2551	445	1	https://doi.org/10.1201/9781420039719.pt5	https://doi.org/10.1201/9781420039719.pt5	NOUN
admet-2551	445	2	.	.	PUNCT
admet-2551	446	1	[	[	X
admet-2551	446	2	17	17	NUM
admet-2551	446	3	]	]	X
admet-2551	446	4	c.a	c.a	PROPN
admet-2551	446	5	.	.	PROPN
admet-2551	446	6	edwards	edwards	PROPN
admet-2551	446	7	,	,	PUNCT
admet-2551	446	8	n.q	n.q	PROPN
admet-2551	446	9	.	.	PROPN
admet-2551	446	10	arancon	arancon	PROPN
admet-2551	446	11	,	,	PUNCT
admet-2551	446	12	p.j	p.j	PROPN
admet-2551	446	13	.	.	PROPN
admet-2551	446	14	bohlen	bohlen	PROPN
admet-2551	446	15	,	,	PUNCT
admet-2551	446	16	p.	p.	PROPN
admet-2551	446	17	hendrix	hendrix	NOUN
admet-2551	446	18	,	,	PUNCT
admet-2551	446	19	biology	biology	NOUN
admet-2551	446	20	and	and	CCONJ
admet-2551	446	21	ecology	ecology	NOUN
admet-2551	446	22	of	of	ADP
admet-2551	446	23	earthworms	earthworm	NOUN
admet-2551	446	24	,	,	PUNCT
admet-2551	446	25	springer	springer	NOUN
admet-2551	446	26	new	new	PROPN
admet-2551	446	27	york	york	PROPN
admet-2551	446	28	,	,	PUNCT
admet-2551	446	29	ny	ny	PROPN
admet-2551	446	30	,	,	PUNCT
admet-2551	446	31	usa	usa	PROPN
admet-2551	446	32	,	,	PUNCT
admet-2551	446	33	2022	2022	NUM
admet-2551	446	34	,	,	PUNCT
admet-2551	446	35	isbn	isbn	ADJ
admet-2551	446	36	038774942x	038774942x	NOUN
admet-2551	446	37	.	.	PUNCT
admet-2551	447	1	https://doi.org/10.1007/978-0-387-74943-3	https://doi.org/10.1007/978-0-387-74943-3	NOUN
admet-2551	447	2	.	.	PUNCT
admet-2551	448	1	[	[	X
admet-2551	448	2	18	18	NUM
admet-2551	448	3	]	]	X
admet-2551	448	4	s.	s.	PROPN
admet-2551	448	5	afreen	afreen	PROPN
admet-2551	448	6	,	,	PUNCT
admet-2551	448	7	a.	a.	PROPN
admet-2551	448	8	shaikh	shaikh	PROPN
admet-2551	448	9	.	.	PUNCT
admet-2551	449	1	therapeutic	therapeutic	ADJ
admet-2551	449	2	uses	use	NOUN
admet-2551	449	3	of	of	ADP
admet-2551	449	4	earthworm	earthworm	NOUN
admet-2551	449	5	–	–	PUNCT
admet-2551	449	6	a	a	DET
admet-2551	449	7	review	review	NOUN
admet-2551	449	8	.	.	PUNCT
admet-2551	450	1	international	international	ADJ
admet-2551	450	2	journal	journal	NOUN
admet-2551	450	3	of	of	ADP
admet-2551	450	4	advanced	advanced	ADJ
admet-2551	450	5	ayurveda	ayurveda	NOUN
admet-2551	450	6	,	,	PUNCT
admet-2551	450	7	yoga	yoga	NOUN
admet-2551	450	8	,	,	PUNCT
admet-2551	450	9	unani	unani	NOUN
admet-2551	450	10	,	,	PUNCT
admet-2551	450	11	siddha	siddha	PROPN
admet-2551	450	12	homeopathy	homeopathy	ADJ
admet-2551	450	13	9	9	NUM
admet-2551	450	14	(	(	PUNCT
admet-2551	450	15	2020	2020	NUM
admet-2551	450	16	)	)	PUNCT
admet-2551	450	17	571	571	NUM
admet-2551	450	18	-	-	SYM
admet-2551	450	19	580	580	NUM
admet-2551	450	20	.	.	PUNCT
admet-2551	451	1	https://doi.org/10.23953/cloud.ijaayush.469	https://doi.org/10.23953/cloud.ijaayush.469	NOUN
admet-2551	451	2	.	.	PUNCT
admet-2551	452	1	[	[	X
admet-2551	452	2	19	19	NUM
admet-2551	452	3	]	]	X
admet-2551	452	4	h.	h.	PROPN
admet-2551	452	5	sumi	sumi	PROPN
admet-2551	452	6	,	,	PUNCT
admet-2551	452	7	n.	n.	PROPN
admet-2551	452	8	nakajima	nakajima	PROPN
admet-2551	452	9	,	,	PUNCT
admet-2551	452	10	h.	h.	PROPN
admet-2551	452	11	mihara	mihara	PROPN
admet-2551	452	12	.	.	PUNCT
admet-2551	453	1	a	a	DET
admet-2551	453	2	very	very	ADV
admet-2551	453	3	stable	stable	ADJ
admet-2551	453	4	and	and	CCONJ
admet-2551	453	5	potent	potent	ADJ
admet-2551	453	6	fibrinolytic	fibrinolytic	ADJ
admet-2551	453	7	enzyme	enzyme	NOUN
admet-2551	453	8	found	find	VERB
admet-2551	453	9	in	in	ADP
admet-2551	453	10	earthworm	earthworm	NOUN
admet-2551	453	11	lumbricus	lumbricus	NOUN
admet-2551	453	12	rubellus	rubellus	NOUN
admet-2551	453	13	autolysate	autolysate	NOUN
admet-2551	453	14	.	.	PUNCT
admet-2551	454	1	comparative	comparative	ADJ
admet-2551	454	2	biochemistry	biochemistry	NOUN
admet-2551	454	3	and	and	CCONJ
admet-2551	454	4	physiology	physiology	NOUN
admet-2551	454	5	part	part	NOUN
admet-2551	454	6	b	b	NOUN
admet-2551	454	7	:	:	PUNCT
admet-2551	454	8	comparative	comparative	ADJ
admet-2551	454	9	biochemistry	biochemistry	NOUN
admet-2551	454	10	106	106	NUM
admet-2551	454	11	(	(	PUNCT
admet-2551	454	12	1993	1993	NUM
admet-2551	454	13	)	)	PUNCT
admet-2551	454	14	763	763	NUM
admet-2551	454	15	-	-	SYM
admet-2551	454	16	766	766	NUM
admet-2551	454	17	.	.	PUNCT
admet-2551	454	18	https://doi.org/10.1016/0305-0491(93)90160-7	https://doi.org/10.1016/0305-0491(93)90160-7	NOUN
admet-2551	454	19	.	.	PUNCT
admet-2551	455	1	[	[	X
admet-2551	455	2	20	20	NUM
admet-2551	455	3	]	]	PUNCT
admet-2551	455	4	l.	l.	PROPN
admet-2551	455	5	stephani	stephani	PROPN
admet-2551	455	6	,	,	PUNCT
admet-2551	455	7	p.	p.	PROPN
admet-2551	455	8	rahayu	rahayu	PROPN
admet-2551	455	9	,	,	PUNCT
admet-2551	455	10	d.	d.	PROPN
admet-2551	455	11	retnoningrum	retnoningrum	PROPN
admet-2551	455	12	,	,	PUNCT
admet-2551	455	13	m.t	m.t	PROPN
admet-2551	455	14	.	.	PROPN
admet-2551	455	15	suhartono	suhartono	PROPN
admet-2551	455	16	,	,	PUNCT
admet-2551	455	17	h.	h.	PROPN
admet-2551	455	18	rachmawati	rachmawati	PROPN
admet-2551	455	19	,	,	PUNCT
admet-2551	455	20	r.r	r.r	PROPN
admet-2551	455	21	.	.	PROPN
admet-2551	455	22	tjandrawinata	tjandrawinata	PROPN
admet-2551	455	23	.	.	PUNCT
admet-2551	456	1	purification	purification	NOUN
admet-2551	456	2	and	and	CCONJ
admet-2551	456	3	proteomic	proteomic	ADJ
admet-2551	456	4	analysis	analysis	NOUN
admet-2551	456	5	of	of	ADP
admet-2551	456	6	potent	potent	ADJ
admet-2551	456	7	fibrinolytic	fibrinolytic	ADJ
admet-2551	456	8	enzymes	enzyme	NOUN
admet-2551	456	9	extracted	extract	VERB
admet-2551	456	10	from	from	ADP
admet-2551	456	11	lumbricus	lumbricus	NOUN
admet-2551	456	12	rubellus	rubellus	NOUN
admet-2551	456	13	.	.	PUNCT
admet-2551	457	1	proteome	proteome	PROPN
admet-2551	457	2	science	science	PROPN
admet-2551	457	3	21	21	NUM
admet-2551	457	4	(	(	PUNCT
admet-2551	457	5	2023	2023	NUM
admet-2551	457	6	)	)	PUNCT
admet-2551	457	7	8	8	NUM
admet-2551	457	8	.	.	PUNCT
admet-2551	457	9	https://doi.org/10.1186/s12953-023-00206-9	https://doi.org/10.1186/s12953-023-00206-9	NUM
admet-2551	457	10	.	.	PUNCT
admet-2551	458	1	[	[	X
admet-2551	458	2	21	21	NUM
admet-2551	458	3	]	]	X
admet-2551	458	4	f.	f.	PROPN
admet-2551	458	5	wang	wang	PROPN
admet-2551	458	6	,	,	PUNCT
admet-2551	458	7	c.	c.	PROPN
admet-2551	458	8	wang	wang	PROPN
admet-2551	458	9	,	,	PUNCT
admet-2551	458	10	m.	m.	PROPN
admet-2551	458	11	li	li	PROPN
admet-2551	458	12	,	,	PUNCT
admet-2551	458	13	l.	l.	PROPN
admet-2551	458	14	gui	gui	PROPN
admet-2551	458	15	,	,	PUNCT
admet-2551	458	16	j.	j.	PROPN
admet-2551	458	17	zhang	zhang	PROPN
admet-2551	458	18	,	,	PUNCT
admet-2551	458	19	w.	w.	PROPN
admet-2551	458	20	chang	chang	PROPN
admet-2551	458	21	.	.	PUNCT
admet-2551	459	1	purification	purification	NOUN
admet-2551	459	2	,	,	PUNCT
admet-2551	459	3	characterization	characterization	NOUN
admet-2551	459	4	and	and	CCONJ
admet-2551	459	5	crystallization	crystallization	NOUN
admet-2551	459	6	of	of	ADP
admet-2551	459	7	a	a	DET
admet-2551	459	8	group	group	NOUN
admet-2551	459	9	of	of	ADP
admet-2551	459	10	earthworm	earthworm	NOUN
admet-2551	459	11	fibrinolytic	fibrinolytic	ADJ
admet-2551	459	12	enzymes	enzyme	NOUN
admet-2551	459	13	from	from	ADP
admet-2551	459	14	eisenia	eisenia	NOUN
admet-2551	459	15	fetida	fetida	PROPN
admet-2551	459	16	.	.	PUNCT
admet-2551	460	1	biotechnology	biotechnology	NOUN
admet-2551	460	2	letters	letter	NOUN
admet-2551	460	3	25	25	NUM
admet-2551	460	4	(	(	PUNCT
admet-2551	460	5	2003	2003	NUM
admet-2551	460	6	)	)	PUNCT
admet-2551	460	7	1105	1105	NUM
admet-2551	460	8	-	-	SYM
admet-2551	460	9	1109	1109	NUM
admet-2551	460	10	.	.	PUNCT
admet-2551	461	1	https://doi.org/10.1023/a:1024196232252	https://doi.org/10.1023/a:1024196232252	PROPN
admet-2551	461	2	.	.	PUNCT
admet-2551	462	1	[	[	X
admet-2551	462	2	22	22	NUM
admet-2551	462	3	]	]	SYM
admet-2551	462	4	q.t.t	q.t.t	ADJ
admet-2551	462	5	.	.	PUNCT
admet-2551	462	6	nguyen	nguyen	PROPN
admet-2551	462	7	,	,	PUNCT
admet-2551	462	8	h.	h.	PROPN
admet-2551	462	9	rhee	rhee	PROPN
admet-2551	462	10	,	,	PUNCT
admet-2551	462	11	m.	m.	PROPN
admet-2551	462	12	kim	kim	PROPN
admet-2551	462	13	,	,	PUNCT
admet-2551	462	14	m.y	m.y	PROPN
admet-2551	462	15	.	.	PROPN
admet-2551	462	16	lee	lee	PROPN
admet-2551	462	17	,	,	PUNCT
admet-2551	462	18	e.-j	e.-j	PROPN
admet-2551	462	19	.	.	PROPN
admet-2551	462	20	lee	lee	PROPN
admet-2551	462	21	.	.	PROPN
admet-2551	462	22	lumbrokinase	lumbrokinase	PROPN
admet-2551	462	23	,	,	PUNCT
admet-2551	462	24	a	a	DET
admet-2551	462	25	fibrinolytic	fibrinolytic	ADJ
admet-2551	462	26	enzyme	enzyme	NOUN
admet-2551	462	27	,	,	PUNCT
admet-2551	462	28	prevents	prevent	VERB
admet-2551	462	29	intra	intra	ADJ
admet-2551	462	30	-	-	ADJ
admet-2551	462	31	abdominal	abdominal	ADJ
admet-2551	462	32	adhesion	adhesion	NOUN
admet-2551	462	33	by	by	ADP
admet-2551	462	34	inhibiting	inhibit	VERB
admet-2551	462	35	the	the	DET
admet-2551	462	36	migrative	migrative	ADJ
admet-2551	462	37	and	and	CCONJ
admet-2551	462	38	adhesive	adhesive	ADJ
admet-2551	462	39	activities	activity	NOUN
admet-2551	462	40	of	of	ADP
admet-2551	462	41	fibroblast	fibroblast	ADJ
admet-2551	462	42	via	via	ADP
admet-2551	462	43	attenuation	attenuation	NOUN
admet-2551	462	44	of	of	ADP
admet-2551	462	45	the	the	DET
admet-2551	462	46	ap-1	ap-1	NOUN
admet-2551	462	47	/	/	SYM
admet-2551	462	48	icam-1	icam-1	NUM
admet-2551	462	49	signaling	signal	VERB
admet-2551	462	50	pathway	pathway	NOUN
admet-2551	462	51	.	.	PUNCT
admet-2551	463	1	biomed	biome	VERB
admet-2551	463	2	research	research	NOUN
admet-2551	463	3	international	international	ADJ
admet-2551	463	4	2023	2023	NUM
admet-2551	463	5	(	(	PUNCT
admet-2551	463	6	2023	2023	NUM
admet-2551	463	7	)	)	PUNCT
admet-2551	463	8	.	.	PUNCT
admet-2551	464	1	https://doi.org/10.1155/2023/4050730	https://doi.org/10.1155/2023/4050730	PROPN
admet-2551	464	2	.	.	PUNCT
admet-2551	465	1	[	[	X
admet-2551	465	2	23	23	NUM
admet-2551	465	3	]	]	X
admet-2551	465	4	n.	n.	PROPN
admet-2551	465	5	nakajima	nakajima	PROPN
admet-2551	465	6	,	,	PUNCT
admet-2551	465	7	h.	h.	PROPN
admet-2551	465	8	mihara	mihara	PROPN
admet-2551	465	9	,	,	PUNCT
admet-2551	465	10	h.	h.	PROPN
admet-2551	465	11	sumi	sumi	PROPN
admet-2551	465	12	.	.	PUNCT
admet-2551	465	13	characterization	characterization	NOUN
admet-2551	465	14	of	of	ADP
admet-2551	465	15	potent	potent	ADJ
admet-2551	465	16	fibrinolytic	fibrinolytic	ADJ
admet-2551	465	17	enzymes	enzyme	NOUN
admet-2551	465	18	in	in	ADP
admet-2551	465	19	earthworm	earthworm	NOUN
admet-2551	465	20	,	,	PUNCT
admet-2551	465	21	lumbricus	lumbricus	NOUN
admet-2551	465	22	rubellus	rubellus	NOUN
admet-2551	465	23	.	.	PUNCT
admet-2551	466	1	bioscience	bioscience	NOUN
admet-2551	466	2	,	,	PUNCT
admet-2551	466	3	biotechnology	biotechnology	NOUN
admet-2551	466	4	,	,	PUNCT
admet-2551	466	5	and	and	CCONJ
admet-2551	466	6	biochemistry	biochemistry	NOUN
admet-2551	466	7	57	57	NUM
admet-2551	466	8	(	(	PUNCT
admet-2551	466	9	1993	1993	NUM
admet-2551	466	10	)	)	PUNCT
admet-2551	466	11	1726	1726	NUM
admet-2551	466	12	-	-	SYM
admet-2551	466	13	1730	1730	NUM
admet-2551	466	14	.	.	PUNCT
admet-2551	467	1	https://doi.org/10.1271/bbb.57.1726	https://doi.org/10.1271/bbb.57.1726	NOUN
admet-2551	467	2	.	.	PUNCT
admet-2551	468	1	[	[	X
admet-2551	468	2	24	24	NUM
admet-2551	468	3	]	]	PUNCT
admet-2551	468	4	t.	t.	PROPN
admet-2551	468	5	ge	ge	PROPN
admet-2551	468	6	,	,	PUNCT
admet-2551	468	7	z.-j	z.-j	PROPN
admet-2551	468	8	.	.	PUNCT
admet-2551	468	9	sun	sun	PROPN
admet-2551	468	10	,	,	PUNCT
admet-2551	468	11	s.-h	s.-h	NOUN
admet-2551	468	12	.	.	PUNCT
admet-2551	469	1	fu	fu	PROPN
admet-2551	469	2	,	,	PUNCT
admet-2551	469	3	g.-d	g.-d	PROPN
admet-2551	469	4	.	.	PUNCT
admet-2551	470	1	liang	liang	PROPN
admet-2551	470	2	.	.	PUNCT
admet-2551	471	1	cloning	cloning	NOUN
admet-2551	471	2	of	of	ADP
admet-2551	471	3	thrombolytic	thrombolytic	ADJ
admet-2551	471	4	enzyme	enzyme	NOUN
admet-2551	471	5	(	(	PUNCT
admet-2551	471	6	lumbrokinase	lumbrokinase	NOUN
admet-2551	471	7	)	)	PUNCT
admet-2551	471	8	from	from	ADP
admet-2551	471	9	earthworm	earthworm	NOUN
admet-2551	471	10	and	and	CCONJ
admet-2551	471	11	its	its	PRON
admet-2551	471	12	expression	expression	NOUN
admet-2551	471	13	in	in	ADP
admet-2551	471	14	the	the	DET
admet-2551	471	15	yeast	yeast	NOUN
admet-2551	471	16	pichia	pichia	NOUN
admet-2551	471	17	pastoris	pastoris	NOUN
admet-2551	471	18	.	.	PUNCT
admet-2551	472	1	protein	protein	NOUN
admet-2551	472	2	expression	expression	NOUN
admet-2551	472	3	and	and	CCONJ
admet-2551	472	4	purification	purification	NOUN
admet-2551	472	5	42	42	NUM
admet-2551	472	6	(	(	PUNCT
admet-2551	472	7	2005	2005	NUM
admet-2551	472	8	)	)	PUNCT
admet-2551	472	9	20	20	NUM
admet-2551	472	10	-	-	SYM
admet-2551	472	11	28	28	NUM
admet-2551	472	12	.	.	PUNCT
admet-2551	473	1	https://doi.org/10.1016/j.pep.2005.04.005	https://doi.org/10.1016/j.pep.2005.04.005	PROPN
admet-2551	473	2	.	.	PUNCT
admet-2551	474	1	[	[	X
admet-2551	474	2	25	25	NUM
admet-2551	474	3	]	]	X
admet-2551	474	4	m.k	m.k	PROPN
admet-2551	474	5	.	.	PROPN
admet-2551	474	6	verma	verma	PROPN
admet-2551	474	7	,	,	PUNCT
admet-2551	474	8	k.	k.	PROPN
admet-2551	474	9	pulicherla	pulicherla	PROPN
admet-2551	474	10	.	.	PUNCT
admet-2551	475	1	lumbrokinase	lumbrokinase	PROPN
admet-2551	475	2	-	-	PUNCT
admet-2551	475	3	a	a	DET
admet-2551	475	4	potent	potent	ADJ
admet-2551	475	5	and	and	CCONJ
admet-2551	475	6	stable	stable	ADJ
admet-2551	475	7	fibrin	fibrin	NOUN
admet-2551	475	8	-	-	PUNCT
admet-2551	475	9	specific	specific	ADJ
admet-2551	475	10	plasminogen	plasminogen	NOUN
admet-2551	475	11	activator	activator	NOUN
admet-2551	475	12	.	.	PUNCT
admet-2551	476	1	international	international	ADJ
admet-2551	476	2	journal	journal	PROPN
admet-2551	476	3	of	of	ADP
admet-2551	476	4	bio	bio	PROPN
admet-2551	476	5	-	-	NOUN
admet-2551	476	6	science	science	NOUN
admet-2551	476	7	and	and	CCONJ
admet-2551	476	8	bio	bio	NOUN
admet-2551	476	9	-	-	NOUN
admet-2551	476	10	technology	technology	NOUN
admet-2551	476	11	3(2	3(2	NUM
admet-2551	476	12	)	)	PUNCT
admet-2551	476	13	(	(	PUNCT
admet-2551	476	14	2011	2011	NUM
admet-2551	476	15	)	)	PUNCT
admet-2551	476	16	57	57	NUM
admet-2551	476	17	-	-	SYM
admet-2551	476	18	69	69	NUM
admet-2551	476	19	.	.	PUNCT
admet-2551	477	1	https://gvpress.com/journals/ijbsbt/vol3_no2/5.pdf	https://gvpress.com/journals/ijbsbt/vol3_no2/5.pdf	PUNCT
admet-2551	478	1	[	[	X
admet-2551	478	2	26	26	NUM
admet-2551	478	3	]	]	X
admet-2551	478	4	s.	s.	PROPN
admet-2551	478	5	munawar	munawar	PROPN
admet-2551	478	6	,	,	PUNCT
admet-2551	478	7	m.	m.	NOUN
admet-2551	478	8	sagir	sagir	PROPN
admet-2551	478	9	,	,	PUNCT
admet-2551	478	10	g.	g.	PROPN
admet-2551	478	11	mustafa	mustafa	PROPN
admet-2551	478	12	,	,	PUNCT
admet-2551	478	13	m.a	m.a	PROPN
admet-2551	478	14	.	.	PROPN
admet-2551	478	15	ali	ali	PROPN
admet-2551	478	16	,	,	PUNCT
admet-2551	478	17	a.k	a.k	PROPN
admet-2551	478	18	.	.	PROPN
admet-2551	478	19	niazi	niazi	PROPN
admet-2551	478	20	,	,	PUNCT
admet-2551	478	21	a.	a.	PROPN
admet-2551	478	22	parvaiz	parvaiz	PROPN
admet-2551	478	23	,	,	PUNCT
admet-2551	478	24	f.	f.	PROPN
admet-2551	478	25	yasmin	yasmin	PROPN
admet-2551	478	26	,	,	PUNCT
admet-2551	478	27	f.	f.	PROPN
admet-2551	478	28	mansoor	mansoor	PROPN
admet-2551	478	29	,	,	PUNCT
admet-2551	478	30	s.	s.	PROPN
admet-2551	478	31	kanwal	kanwal	PROPN
admet-2551	478	32	,	,	PUNCT
admet-2551	478	33	m.	m.	NOUN
admet-2551	478	34	rasheed	rasheed	NOUN
admet-2551	478	35	.	.	PUNCT
admet-2551	479	1	in	in	ADP
admet-2551	479	2	silico	silico	NOUN
admet-2551	479	3	analyses	analysis	NOUN
admet-2551	479	4	of	of	ADP
admet-2551	479	5	predicted	predict	VERB
admet-2551	479	6	substitutions	substitution	NOUN
admet-2551	479	7	in	in	ADP
admet-2551	479	8	fibrinolytic	fibrinolytic	ADJ
admet-2551	479	9	protein	protein	NOUN
admet-2551	479	10	‘	'	PUNCT
admet-2551	479	11	lumbrokinase6’suggest	lumbrokinase6’suggest	ADV
admet-2551	479	12	enhanced	enhance	VERB
admet-2551	479	13	activity	activity	NOUN
admet-2551	479	14	.	.	PUNCT
admet-2551	480	1	process	process	NOUN
admet-2551	480	2	biochemistry	biochemistry	NOUN
admet-2551	480	3	110	110	NUM
admet-2551	480	4	(	(	PUNCT
admet-2551	480	5	2021	2021	NUM
admet-2551	480	6	)	)	PUNCT
admet-2551	480	7	292	292	NUM
admet-2551	480	8	-	-	SYM
admet-2551	480	9	301	301	NUM
admet-2551	480	10	.	.	PUNCT
admet-2551	480	11	https://doi.org/10.1016/j.procbio.2021.08.022	https://doi.org/10.1016/j.procbio.2021.08.022	NOUN
admet-2551	480	12	.	.	PUNCT
admet-2551	481	1	[	[	X
admet-2551	481	2	27	27	NUM
admet-2551	481	3	]	]	X
admet-2551	481	4	g.-q	g.-q	PROPN
admet-2551	481	5	.	.	PUNCT
admet-2551	481	6	dong	dong	PROPN
admet-2551	481	7	,	,	PUNCT
admet-2551	481	8	x.-l	x.-l	PROPN
admet-2551	481	9	.	.	PUNCT
admet-2551	482	1	yuan	yuan	PROPN
admet-2551	482	2	,	,	PUNCT
admet-2551	482	3	y.-j	y.-j	PROPN
admet-2551	482	4	.	.	PROPN
admet-2551	482	5	shan	shan	PROPN
admet-2551	482	6	,	,	PUNCT
admet-2551	482	7	z.-h	z.-h	NOUN
admet-2551	482	8	.	.	PUNCT
admet-2551	483	1	zhao	zhao	NOUN
admet-2551	483	2	,	,	PUNCT
admet-2551	483	3	j.-p	j.-p	PROPN
admet-2551	483	4	.	.	PUNCT
admet-2551	484	1	chen	chen	PROPN
admet-2551	484	2	,	,	PUNCT
admet-2551	484	3	y.-w	y.-w	PROPN
admet-2551	484	4	.	.	PUNCT
admet-2551	485	1	cong	cong	PROPN
admet-2551	485	2	.	.	PUNCT
admet-2551	486	1	molecular	molecular	ADJ
admet-2551	486	2	cloning	cloning	NOUN
admet-2551	486	3	and	and	CCONJ
admet-2551	486	4	characterization	characterization	NOUN
admet-2551	486	5	of	of	ADP
admet-2551	486	6	cdna	cdna	PROPN
admet-2551	486	7	encoding	encode	VERB
admet-2551	486	8	fibrinolytic	fibrinolytic	NOUN
admet-2551	486	9	enzyme-3	enzyme-3	NUM
admet-2551	486	10	from	from	ADP
admet-2551	486	11	earthworm	earthworm	NOUN
admet-2551	486	12	eisenia	eisenia	NOUN
admet-2551	486	13	foetida	foetida	PROPN
admet-2551	486	14	.	.	PUNCT
admet-2551	487	1	acta	acta	PROPN
admet-2551	487	2	biochimica	biochimica	PROPN
admet-2551	487	3	et	et	PROPN
admet-2551	487	4	biophysica	biophysica	PROPN
admet-2551	487	5	sinica	sinica	PROPN
admet-2551	487	6	36	36	NUM
admet-2551	487	7	(	(	PUNCT
admet-2551	487	8	2004	2004	NUM
admet-2551	487	9	)	)	PUNCT
admet-2551	487	10	303	303	NUM
admet-2551	487	11	-	-	SYM
admet-2551	487	12	308	308	NUM
admet-2551	487	13	.	.	PUNCT
admet-2551	488	1	https://doi.org/10.1093/abbs/36.4.303	https://doi.org/10.1093/abbs/36.4.303	X
admet-2551	488	2	.	.	PUNCT
admet-2551	489	1	[	[	X
admet-2551	489	2	28	28	NUM
admet-2551	489	3	]	]	PUNCT
admet-2551	489	4	x.	x.	NOUN
admet-2551	489	5	yuan	yuan	PROPN
admet-2551	489	6	,	,	PUNCT
admet-2551	489	7	c.	c.	PROPN
admet-2551	489	8	cao	cao	PROPN
admet-2551	489	9	,	,	PUNCT
admet-2551	489	10	y.	y.	PROPN
admet-2551	489	11	shan	shan	PROPN
admet-2551	489	12	,	,	PUNCT
admet-2551	489	13	z.	z.	PROPN
admet-2551	489	14	zhao	zhao	PROPN
admet-2551	489	15	,	,	PUNCT
admet-2551	489	16	j.	j.	PROPN
admet-2551	489	17	chen	chen	PROPN
admet-2551	489	18	,	,	PUNCT
admet-2551	489	19	y.	y.	PROPN
admet-2551	489	20	cong	cong	PROPN
admet-2551	489	21	.	.	PUNCT
admet-2551	490	1	expression	expression	NOUN
admet-2551	490	2	and	and	CCONJ
admet-2551	490	3	characterization	characterization	NOUN
admet-2551	490	4	of	of	ADP
admet-2551	490	5	earthworm	earthworm	NOUN
admet-2551	490	6	eisenia	eisenia	NOUN
admet-2551	490	7	foetida	foetida	PROPN
admet-2551	490	8	lumbrokinase‐3	lumbrokinase‐3	PROPN
admet-2551	490	9	in	in	ADP
admet-2551	490	10	pichia	pichia	NOUN
admet-2551	490	11	pastoris	pastoris	PROPN
admet-2551	490	12	.	.	PUNCT
admet-2551	491	1	preparative	preparative	ADJ
admet-2551	491	2	biochemistry	biochemistry	PROPN
admet-2551	491	3	&	&	CCONJ
admet-2551	491	4	biotechnology	biotechnology	NOUN
admet-2551	491	5	36	36	NUM
admet-2551	491	6	(	(	PUNCT
admet-2551	491	7	2006	2006	NUM
admet-2551	491	8	)	)	PUNCT
admet-2551	491	9	273	273	NUM
admet-2551	491	10	-	-	SYM
admet-2551	491	11	279	279	NUM
admet-2551	491	12	.	.	PUNCT
admet-2551	492	1	https://doi.org/10.1080/10826060600716703	https://doi.org/10.1080/10826060600716703	NOUN
admet-2551	492	2	.	.	PUNCT
admet-2551	493	1	[	[	X
admet-2551	493	2	29	29	NUM
admet-2551	493	3	]	]	PUNCT
admet-2551	493	4	m.	m.	NOUN
admet-2551	493	5	sugimoto	sugimoto	PROPN
admet-2551	493	6	,	,	PUNCT
admet-2551	493	7	n.	n.	PROPN
admet-2551	493	8	nakajima	nakajima	PROPN
admet-2551	493	9	.	.	PUNCT
admet-2551	493	10	molecular	molecular	ADJ
admet-2551	493	11	cloning	cloning	NOUN
admet-2551	493	12	,	,	PUNCT
admet-2551	493	13	sequencing	sequencing	NOUN
admet-2551	493	14	,	,	PUNCT
admet-2551	493	15	and	and	CCONJ
admet-2551	493	16	expression	expression	NOUN
admet-2551	493	17	of	of	ADP
admet-2551	493	18	cdna	cdna	PROPN
admet-2551	493	19	encoding	encode	VERB
admet-2551	493	20	serine	serine	NOUN
admet-2551	493	21	protease	protease	NOUN
admet-2551	493	22	with	with	ADP
admet-2551	493	23	fibrinolytic	fibrinolytic	ADJ
admet-2551	493	24	activity	activity	NOUN
admet-2551	493	25	from	from	ADP
admet-2551	493	26	earthworm	earthworm	NOUN
admet-2551	493	27	.	.	PUNCT
admet-2551	494	1	bioscience	bioscience	NOUN
admet-2551	494	2	,	,	PUNCT
admet-2551	494	3	biotechnology	biotechnology	NOUN
admet-2551	494	4	,	,	PUNCT
admet-2551	494	5	and	and	CCONJ
admet-2551	494	6	biochemistry	biochemistry	NOUN
admet-2551	494	7	65	65	NUM
admet-2551	494	8	(	(	PUNCT
admet-2551	494	9	2001	2001	NUM
admet-2551	494	10	)	)	PUNCT
admet-2551	494	11	1575	1575	NUM
admet-2551	494	12	-	-	SYM
admet-2551	494	13	1580	1580	NUM
admet-2551	494	14	.	.	PUNCT
admet-2551	495	1	https://doi.org/doi.org/10.1271/bbb.65.1575	https://doi.org/doi.org/10.1271/bbb.65.1575	PROPN
admet-2551	495	2	.	.	PUNCT
admet-2551	495	3	https://doi.org/10.5599/admet.2551	https://doi.org/10.5599/admet.2551	NOUN
admet-2551	495	4	https://doi.org/10.3390/molecules26164946	https://doi.org/10.3390/molecules26164946	PROPN
admet-2551	495	5	https://doi.org/hdl.handle.net/10072/30153	https://doi.org/hdl.handle.net/10072/30153	VERB
admet-2551	496	1	https://doi.org/10.1201/9781420039719.pt5	https://doi.org/10.1201/9781420039719.pt5	PROPN
admet-2551	496	2	https://doi.org/10.1007/978-0-387-74943-3	https://doi.org/10.1007/978-0-387-74943-3	PROPN
admet-2551	496	3	https://doi.org/10.23953/cloud.ijaayush.469	https://doi.org/10.23953/cloud.ijaayush.469	PRON
admet-2551	496	4	https://doi.org/10.1016/0305-0491(93)90160-7	https://doi.org/10.1016/0305-0491(93)90160-7	X
admet-2551	496	5	https://doi.org/10.1186/s12953-023-00206-9	https://doi.org/10.1186/s12953-023-00206-9	NUM
admet-2551	496	6	https://doi.org/10.1023/a:1024196232252	https://doi.org/10.1023/a:1024196232252	PROPN
admet-2551	496	7	https://doi.org/10.1155/2023/4050730	https://doi.org/10.1155/2023/4050730	PROPN
admet-2551	496	8	https://doi.org/10.1271/bbb.57.1726	https://doi.org/10.1271/bbb.57.1726	PROPN
admet-2551	496	9	https://doi.org/10.1016/j.pep.2005.04.005	https://doi.org/10.1016/j.pep.2005.04.005	PROPN
admet-2551	496	10	https://gvpress.com/journals/ijbsbt/vol3_no2/5.pdf	https://gvpress.com/journals/ijbsbt/vol3_no2/5.pdf	PROPN
admet-2551	496	11	https://doi.org/10.1016/j.procbio.2021.08.022	https://doi.org/10.1016/j.procbio.2021.08.022	NOUN
admet-2551	496	12	https://doi.org/10.1093/abbs/36.4.303	https://doi.org/10.1093/abbs/36.4.303	PROPN
admet-2551	496	13	https://doi.org/10.1080/10826060600716703	https://doi.org/10.1080/10826060600716703	PROPN
admet-2551	497	1	https://doi.org/doi.org/10.1271/bbb.65.1575	https://doi.org/doi.org/10.1271/bbb.65.1575	PROPN
admet-2551	497	2	s.	s.	PROPN
admet-2551	497	3	k.	k.	PROPN
admet-2551	497	4	metkar	metkar	PROPN
admet-2551	497	5	et	et	PROPN
admet-2551	497	6	al	al	PROPN
admet-2551	497	7	.	.	PROPN
admet-2551	497	8	admet	admet	PROPN
admet-2551	497	9	&	&	CCONJ
admet-2551	497	10	dmpk	dmpk	PROPN
admet-2551	497	11	12(6	12(6	NUM
admet-2551	497	12	)	)	PUNCT
admet-2551	497	13	(	(	PUNCT
admet-2551	497	14	2024	2024	NUM
admet-2551	497	15	)	)	PUNCT
admet-2551	497	16	797	797	NUM
admet-2551	497	17	-	-	SYM
admet-2551	497	18	820	820	NUM
admet-2551	497	19	812	812	NUM
admet-2551	497	20	[	[	X
admet-2551	497	21	30	30	NUM
admet-2551	497	22	]	]	X
admet-2551	497	23	l.h	l.h	PROPN
admet-2551	497	24	.	.	PROPN
admet-2551	497	25	takahashi	takahashi	PROPN
admet-2551	497	26	,	,	PUNCT
admet-2551	497	27	r.	r.	PROPN
admet-2551	497	28	radhakrishnan	radhakrishnan	PROPN
admet-2551	497	29	,	,	PUNCT
admet-2551	497	30	r.e	r.e	PROPN
admet-2551	497	31	.	.	PROPN
admet-2551	497	32	rosenfield	rosenfield	PROPN
admet-2551	497	33	jr	jr	PROPN
admet-2551	497	34	,	,	PUNCT
admet-2551	497	35	e.f	e.f	PROPN
admet-2551	497	36	.	.	PROPN
admet-2551	497	37	meyer	meyer	PROPN
admet-2551	497	38	jr	jr	PROPN
admet-2551	497	39	,	,	PUNCT
admet-2551	497	40	d.a	d.a	PROPN
admet-2551	497	41	.	.	PROPN
admet-2551	497	42	trainor	trainor	PROPN
admet-2551	497	43	.	.	PUNCT
admet-2551	498	1	crystal	crystal	NOUN
admet-2551	498	2	structure	structure	NOUN
admet-2551	498	3	of	of	ADP
admet-2551	498	4	the	the	DET
admet-2551	498	5	covalent	covalent	ADJ
admet-2551	498	6	complex	complex	NOUN
admet-2551	498	7	formed	form	VERB
admet-2551	498	8	by	by	ADP
admet-2551	498	9	a	a	DET
admet-2551	498	10	peptidyl	peptidyl	NOUN
admet-2551	498	11	.	.	PUNCT
admet-2551	499	1	alpha	alpha	PROPN
admet-2551	499	2	.	.	PUNCT
admet-2551	499	3	,	,	PUNCT
admet-2551	499	4	.	.	PUNCT
admet-2551	500	1	alpha.-difluoro-	alpha.-difluoro-	PROPN
admet-2551	500	2	.	.	PUNCT
admet-2551	500	3	beta.-keto	beta.-keto	PROPN
admet-2551	500	4	amide	amide	NOUN
admet-2551	500	5	with	with	ADP
admet-2551	500	6	porcine	porcine	NOUN
admet-2551	500	7	pancreatic	pancreatic	ADJ
admet-2551	500	8	elastase	elastase	NOUN
admet-2551	500	9	at	at	ADP
admet-2551	500	10	1.78	1.78	NUM
admet-2551	500	11	.	.	PUNCT
admet-2551	501	1	ang	ang	PROPN
admet-2551	501	2	.	.	PUNCT
admet-2551	501	3	resolution	resolution	NOUN
admet-2551	501	4	.	.	PUNCT
admet-2551	502	1	journal	journal	PROPN
admet-2551	502	2	of	of	ADP
admet-2551	502	3	the	the	DET
admet-2551	502	4	american	american	PROPN
admet-2551	502	5	chemical	chemical	PROPN
admet-2551	502	6	society	society	PROPN
admet-2551	502	7	111	111	NUM
admet-2551	502	8	(	(	PUNCT
admet-2551	502	9	1989	1989	NUM
admet-2551	502	10	)	)	PUNCT
admet-2551	502	11	3368	3368	NUM
admet-2551	502	12	-	-	SYM
admet-2551	502	13	3374	3374	NUM
admet-2551	502	14	.	.	PUNCT
admet-2551	503	1	https://doi.org/10.1021/ja00191a039	https://doi.org/10.1021/ja00191a039	PROPN
admet-2551	503	2	.	.	PUNCT
admet-2551	504	1	[	[	X
admet-2551	504	2	31	31	NUM
admet-2551	504	3	]	]	PUNCT
admet-2551	504	4	m.	m.	NOUN
admet-2551	504	5	marquart	marquart	PROPN
admet-2551	504	6	,	,	PUNCT
admet-2551	504	7	j.	j.	PROPN
admet-2551	504	8	walter	walter	PROPN
admet-2551	504	9	,	,	PUNCT
admet-2551	504	10	j.	j.	PROPN
admet-2551	504	11	deisenhofer	deisenhofer	PROPN
admet-2551	504	12	,	,	PUNCT
admet-2551	504	13	w.	w.	PROPN
admet-2551	504	14	bode	bode	PROPN
admet-2551	504	15	,	,	PUNCT
admet-2551	504	16	r.	r.	PROPN
admet-2551	504	17	huber	huber	PROPN
admet-2551	504	18	.	.	PUNCT
admet-2551	505	1	the	the	DET
admet-2551	505	2	geometry	geometry	NOUN
admet-2551	505	3	of	of	ADP
admet-2551	505	4	the	the	DET
admet-2551	505	5	reactive	reactive	ADJ
admet-2551	505	6	site	site	NOUN
admet-2551	505	7	and	and	CCONJ
admet-2551	505	8	of	of	ADP
admet-2551	505	9	the	the	DET
admet-2551	505	10	peptide	peptide	NOUN
admet-2551	505	11	groups	group	NOUN
admet-2551	505	12	in	in	ADP
admet-2551	505	13	trypsin	trypsin	NOUN
admet-2551	505	14	,	,	PUNCT
admet-2551	505	15	trypsinogen	trypsinogen	NOUN
admet-2551	505	16	and	and	CCONJ
admet-2551	505	17	its	its	PRON
admet-2551	505	18	complexes	complex	NOUN
admet-2551	505	19	with	with	ADP
admet-2551	505	20	inhibitors	inhibitor	NOUN
admet-2551	505	21	.	.	PUNCT
admet-2551	506	1	acta	acta	PROPN
admet-2551	506	2	crystallographica	crystallographica	PROPN
admet-2551	506	3	section	section	PROPN
admet-2551	506	4	b	b	PROPN
admet-2551	506	5	:	:	PUNCT
admet-2551	506	6	structural	structural	ADJ
admet-2551	506	7	science	science	NOUN
admet-2551	506	8	39	39	NUM
admet-2551	506	9	(	(	PUNCT
admet-2551	506	10	1983	1983	NUM
admet-2551	506	11	)	)	PUNCT
admet-2551	506	12	480	480	NUM
admet-2551	506	13	-	-	SYM
admet-2551	506	14	490	490	NUM
admet-2551	506	15	.	.	PUNCT
admet-2551	507	1	https://doi.org/10.1107/s010876818300275x	https://doi.org/10.1107/s010876818300275x	NOUN
admet-2551	507	2	.	.	PUNCT
admet-2551	508	1	[	[	X
admet-2551	508	2	32	32	NUM
admet-2551	508	3	]	]	PUNCT
admet-2551	508	4	f.	f.	PROPN
admet-2551	508	5	wang	wang	PROPN
admet-2551	508	6	,	,	PUNCT
admet-2551	508	7	c.	c.	PROPN
admet-2551	508	8	wang	wang	PROPN
admet-2551	508	9	,	,	PUNCT
admet-2551	508	10	m.	m.	PROPN
admet-2551	508	11	li	li	PROPN
admet-2551	508	12	,	,	PUNCT
admet-2551	508	13	j.-p	j.-p	PROPN
admet-2551	508	14	.	.	PUNCT
admet-2551	509	1	zhang	zhang	PROPN
admet-2551	509	2	,	,	PUNCT
admet-2551	509	3	l.-l	l.-l	PROPN
admet-2551	509	4	.	.	PUNCT
admet-2551	510	1	gui	gui	PROPN
admet-2551	510	2	,	,	PUNCT
admet-2551	510	3	x.-m	x.-m	PROPN
admet-2551	510	4	.	.	PUNCT
admet-2551	511	1	an	an	PRON
admet-2551	511	2	,	,	PUNCT
admet-2551	511	3	w.-r	w.-r	PROPN
admet-2551	511	4	.	.	PUNCT
admet-2551	512	1	chang	chang	PROPN
admet-2551	512	2	.	.	PUNCT
admet-2551	513	1	crystal	crystal	NOUN
admet-2551	513	2	structure	structure	NOUN
admet-2551	513	3	of	of	ADP
admet-2551	513	4	earthworm	earthworm	NOUN
admet-2551	513	5	fibrinolytic	fibrinolytic	ADJ
admet-2551	513	6	enzyme	enzyme	NOUN
admet-2551	513	7	component	component	NOUN
admet-2551	513	8	b	b	NOUN
admet-2551	513	9	:	:	PUNCT
admet-2551	513	10	a	a	DET
admet-2551	513	11	novel	novel	NOUN
admet-2551	513	12	,	,	PUNCT
admet-2551	513	13	glycosylated	glycosylate	VERB
admet-2551	513	14	two	two	NUM
admet-2551	513	15	-	-	PUNCT
admet-2551	513	16	chained	chain	VERB
admet-2551	513	17	trypsin	trypsin	NOUN
admet-2551	513	18	.	.	PUNCT
admet-2551	514	1	journal	journal	NOUN
admet-2551	514	2	of	of	ADP
admet-2551	514	3	bolecular	bolecular	ADJ
admet-2551	514	4	biology	biology	NOUN
admet-2551	514	5	348	348	NUM
admet-2551	514	6	(	(	PUNCT
admet-2551	514	7	2005	2005	NUM
admet-2551	514	8	)	)	PUNCT
admet-2551	514	9	671	671	NUM
admet-2551	514	10	-	-	SYM
admet-2551	514	11	685	685	NUM
admet-2551	514	12	.	.	PUNCT
admet-2551	515	1	https://doi.org/10.1016/j.jmb.2005.02.055	https://doi.org/10.1016/j.jmb.2005.02.055	NOUN
admet-2551	515	2	.	.	PUNCT
admet-2551	516	1	[	[	X
admet-2551	516	2	33	33	NUM
admet-2551	516	3	]	]	PUNCT
admet-2551	516	4	f.	f.	PROPN
admet-2551	516	5	wang	wang	PROPN
admet-2551	516	6	,	,	PUNCT
admet-2551	516	7	c.	c.	PROPN
admet-2551	516	8	wang	wang	PROPN
admet-2551	516	9	,	,	PUNCT
admet-2551	516	10	m.	m.	PROPN
admet-2551	516	11	li	li	PROPN
admet-2551	516	12	,	,	PUNCT
admet-2551	516	13	l.	l.	PROPN
admet-2551	516	14	gui	gui	PROPN
admet-2551	516	15	,	,	PUNCT
admet-2551	516	16	j.	j.	PROPN
admet-2551	516	17	zhang	zhang	PROPN
admet-2551	516	18	,	,	PUNCT
admet-2551	516	19	w.	w.	PROPN
admet-2551	516	20	chang	chang	PROPN
admet-2551	516	21	.	.	PUNCT
admet-2551	517	1	crystallization	crystallization	NOUN
admet-2551	517	2	and	and	CCONJ
admet-2551	517	3	preliminary	preliminary	ADJ
admet-2551	517	4	crystallographic	crystallographic	ADJ
admet-2551	517	5	analysis	analysis	NOUN
admet-2551	517	6	of	of	ADP
admet-2551	517	7	earthworm	earthworm	NOUN
admet-2551	517	8	fibrinolytic	fibrinolytic	ADJ
admet-2551	517	9	enzyme	enzyme	NOUN
admet-2551	517	10	component	component	NOUN
admet-2551	517	11	b	b	NOUN
admet-2551	517	12	from	from	ADP
admet-2551	517	13	eisenia	eisenia	NOUN
admet-2551	517	14	fetida	fetida	PROPN
admet-2551	517	15	.	.	PUNCT
admet-2551	518	1	acta	acta	PROPN
admet-2551	518	2	crystallographica	crystallographica	PROPN
admet-2551	518	3	section	section	PROPN
admet-2551	519	1	d	d	NOUN
admet-2551	519	2	:	:	PUNCT
admet-2551	519	3	biological	biological	ADJ
admet-2551	519	4	crystallography	crystallography	NOUN
admet-2551	519	5	60	60	NUM
admet-2551	519	6	(	(	PUNCT
admet-2551	519	7	2004	2004	NUM
admet-2551	519	8	)	)	PUNCT
admet-2551	519	9	933	933	NUM
admet-2551	519	10	-	-	SYM
admet-2551	519	11	935	935	NUM
admet-2551	519	12	.	.	PUNCT
admet-2551	520	1	https://doi.org/10.1107/s0907444904004895	https://doi.org/10.1107/s0907444904004895	NUM
admet-2551	520	2	.	.	PUNCT
admet-2551	521	1	[	[	X
admet-2551	521	2	34	34	NUM
admet-2551	521	3	]	]	X
admet-2551	521	4	y.	y.	PROPN
admet-2551	521	5	tang	tang	PROPN
admet-2551	521	6	,	,	PUNCT
admet-2551	521	7	d.	d.	PROPN
admet-2551	521	8	liang	liang	PROPN
admet-2551	521	9	,	,	PUNCT
admet-2551	521	10	t.	t.	PROPN
admet-2551	521	11	jiang	jiang	PROPN
admet-2551	521	12	,	,	PUNCT
admet-2551	521	13	j.	j.	PROPN
admet-2551	521	14	zhang	zhang	PROPN
admet-2551	521	15	,	,	PUNCT
admet-2551	521	16	l.	l.	PROPN
admet-2551	521	17	gui	gui	PROPN
admet-2551	521	18	,	,	PUNCT
admet-2551	521	19	w.	w.	PROPN
admet-2551	521	20	chang	chang	PROPN
admet-2551	521	21	.	.	PUNCT
admet-2551	522	1	crystal	crystal	NOUN
admet-2551	522	2	structure	structure	NOUN
admet-2551	522	3	of	of	ADP
admet-2551	522	4	earthworm	earthworm	NOUN
admet-2551	522	5	fibrinolytic	fibrinolytic	ADJ
admet-2551	522	6	enzyme	enzyme	NOUN
admet-2551	522	7	component	component	NOUN
admet-2551	522	8	a	a	PRON
admet-2551	522	9	:	:	PUNCT
admet-2551	522	10	revealing	reveal	VERB
admet-2551	522	11	the	the	DET
admet-2551	522	12	structural	structural	ADJ
admet-2551	522	13	determinants	determinant	NOUN
admet-2551	522	14	of	of	ADP
admet-2551	522	15	its	its	PRON
admet-2551	522	16	dual	dual	ADJ
admet-2551	522	17	fibrinolytic	fibrinolytic	ADJ
admet-2551	522	18	activity	activity	NOUN
admet-2551	522	19	.	.	PUNCT
admet-2551	523	1	journal	journal	NOUN
admet-2551	523	2	of	of	ADP
admet-2551	523	3	molecular	molecular	ADJ
admet-2551	523	4	biology	biology	NOUN
admet-2551	523	5	321	321	NUM
admet-2551	523	6	(	(	PUNCT
admet-2551	523	7	2002	2002	NUM
admet-2551	523	8	)	)	PUNCT
admet-2551	523	9	57	57	NUM
admet-2551	523	10	-	-	SYM
admet-2551	523	11	68	68	NUM
admet-2551	523	12	.	.	PUNCT
admet-2551	524	1	https://doi.org/10.1016/s0022-2836(02)00559-4	https://doi.org/10.1016/s0022-2836(02)00559-4	PROPN
admet-2551	524	2	.	.	PUNCT
admet-2551	525	1	[	[	X
admet-2551	525	2	35	35	NUM
admet-2551	525	3	]	]	X
admet-2551	525	4	f.	f.	PROPN
admet-2551	525	5	blasi	blasi	PROPN
admet-2551	525	6	,	,	PUNCT
admet-2551	525	7	j.-d	j.-d	PROPN
admet-2551	525	8	.	.	PUNCT
admet-2551	526	1	vassalli	vassalli	PROPN
admet-2551	526	2	,	,	PUNCT
admet-2551	526	3	k.	k.	PROPN
admet-2551	526	4	danø	danø	PROPN
admet-2551	526	5	.	.	PUNCT
admet-2551	527	1	urokinase	urokinase	NOUN
admet-2551	527	2	-	-	PUNCT
admet-2551	527	3	type	type	NOUN
admet-2551	527	4	plasminogen	plasminogen	NOUN
admet-2551	527	5	activator	activator	NOUN
admet-2551	527	6	:	:	PUNCT
admet-2551	527	7	proenzyme	proenzyme	NOUN
admet-2551	527	8	,	,	PUNCT
admet-2551	527	9	receptor	receptor	NOUN
admet-2551	527	10	,	,	PUNCT
admet-2551	527	11	and	and	CCONJ
admet-2551	527	12	inhibitors	inhibitor	NOUN
admet-2551	527	13	.	.	PUNCT
admet-2551	528	1	the	the	DET
admet-2551	528	2	journal	journal	NOUN
admet-2551	528	3	of	of	ADP
admet-2551	528	4	cell	cell	NOUN
admet-2551	528	5	biology	biology	NOUN
admet-2551	528	6	104	104	NUM
admet-2551	528	7	(	(	PUNCT
admet-2551	528	8	1987	1987	NUM
admet-2551	528	9	)	)	PUNCT
admet-2551	528	10	801	801	NUM
admet-2551	528	11	-	-	SYM
admet-2551	528	12	804	804	NUM
admet-2551	528	13	.	.	PUNCT
admet-2551	528	14	https://doi.org/10.1083/jcb.104.4.801	https://doi.org/10.1083/jcb.104.4.801	PROPN
admet-2551	528	15	.	.	PUNCT
admet-2551	529	1	[	[	X
admet-2551	529	2	36	36	NUM
admet-2551	529	3	]	]	PUNCT
admet-2551	529	4	s.	s.	PROPN
admet-2551	529	5	kasai	kasai	PROPN
admet-2551	529	6	,	,	PUNCT
admet-2551	529	7	h.	h.	PROPN
admet-2551	529	8	arimura	arimura	PROPN
admet-2551	529	9	,	,	PUNCT
admet-2551	529	10	m.	m.	PROPN
admet-2551	529	11	nishida	nishida	PROPN
admet-2551	529	12	,	,	PUNCT
admet-2551	529	13	t.	t.	NOUN
admet-2551	529	14	suyama	suyama	NOUN
admet-2551	529	15	.	.	PUNCT
admet-2551	530	1	proteolytic	proteolytic	ADJ
admet-2551	530	2	cleavage	cleavage	NOUN
admet-2551	530	3	of	of	ADP
admet-2551	530	4	single	single	ADJ
admet-2551	530	5	-	-	PUNCT
admet-2551	530	6	chain	chain	NOUN
admet-2551	530	7	pro	pro	ADJ
admet-2551	530	8	-	-	ADJ
admet-2551	530	9	urokinase	urokinase	ADJ
admet-2551	530	10	induces	induce	VERB
admet-2551	530	11	conformational	conformational	ADJ
admet-2551	530	12	change	change	NOUN
admet-2551	530	13	which	which	PRON
admet-2551	530	14	follows	follow	VERB
admet-2551	530	15	activation	activation	NOUN
admet-2551	530	16	of	of	ADP
admet-2551	530	17	the	the	DET
admet-2551	530	18	zymogen	zymogen	NOUN
admet-2551	530	19	and	and	CCONJ
admet-2551	530	20	reduction	reduction	NOUN
admet-2551	530	21	of	of	ADP
admet-2551	530	22	its	its	PRON
admet-2551	530	23	high	high	ADJ
admet-2551	530	24	affinity	affinity	NOUN
admet-2551	530	25	for	for	ADP
admet-2551	530	26	fibrin	fibrin	NOUN
admet-2551	530	27	.	.	PUNCT
admet-2551	531	1	journal	journal	NOUN
admet-2551	531	2	of	of	ADP
admet-2551	531	3	biological	biological	ADJ
admet-2551	531	4	chemistry	chemistry	NOUN
admet-2551	531	5	260	260	NUM
admet-2551	531	6	(	(	PUNCT
admet-2551	531	7	1985	1985	NUM
admet-2551	531	8	)	)	PUNCT
admet-2551	531	9	12377	12377	NUM
admet-2551	531	10	-	-	SYM
admet-2551	531	11	12381	12381	NUM
admet-2551	531	12	.	.	PUNCT
admet-2551	532	1	https://doi.org/10.1016/s0021-9258(17)39035-x	https://doi.org/10.1016/s0021-9258(17)39035-x	NOUN
admet-2551	532	2	.	.	PUNCT
admet-2551	533	1	[	[	X
admet-2551	533	2	37	37	NUM
admet-2551	533	3	]	]	X
admet-2551	533	4	k.-c	k.-c	NOUN
admet-2551	533	5	.	.	PUNCT
admet-2551	533	6	young	young	ADJ
admet-2551	533	7	,	,	PUNCT
admet-2551	533	8	g.-y	g.-y	PROPN
admet-2551	533	9	.	.	PUNCT
admet-2551	534	1	shi	shi	PROPN
admet-2551	534	2	,	,	PUNCT
admet-2551	534	3	d.-h	d.-h	PROPN
admet-2551	534	4	.	.	PUNCT
admet-2551	535	1	wu	wu	PROPN
admet-2551	535	2	,	,	PUNCT
admet-2551	535	3	l.-c	l.-c	PROPN
admet-2551	535	4	.	.	PUNCT
admet-2551	536	1	chang	chang	PROPN
admet-2551	536	2	,	,	PUNCT
admet-2551	536	3	b.-i	b.-i	PROPN
admet-2551	536	4	.	.	PUNCT
admet-2551	537	1	chang	chang	PROPN
admet-2551	537	2	,	,	PUNCT
admet-2551	537	3	c.-p	c.-p	PROPN
admet-2551	537	4	.	.	PUNCT
admet-2551	538	1	ou	ou	PROPN
admet-2551	538	2	,	,	PUNCT
admet-2551	538	3	h.-l	h.-l	PROPN
admet-2551	538	4	.	.	PUNCT
admet-2551	539	1	wu	wu	PROPN
admet-2551	539	2	.	.	PUNCT
admet-2551	540	1	plasminogen	plasminogen	NOUN
admet-2551	540	2	activation	activation	NOUN
admet-2551	540	3	by	by	ADP
admet-2551	540	4	streptokinase	streptokinase	PROPN
admet-2551	540	5	via	via	ADP
admet-2551	540	6	a	a	DET
admet-2551	540	7	unique	unique	ADJ
admet-2551	540	8	mechanism	mechanism	NOUN
admet-2551	540	9	.	.	PUNCT
admet-2551	541	1	journal	journal	NOUN
admet-2551	541	2	of	of	ADP
admet-2551	541	3	biological	biological	ADJ
admet-2551	541	4	chemistry	chemistry	NOUN
admet-2551	541	5	273	273	NUM
admet-2551	541	6	(	(	PUNCT
admet-2551	541	7	1998	1998	NUM
admet-2551	541	8	)	)	PUNCT
admet-2551	541	9	3110	3110	NUM
admet-2551	541	10	-	-	SYM
admet-2551	541	11	3116	3116	NUM
admet-2551	541	12	.	.	PUNCT
admet-2551	542	1	https://doi.org/10.1074/jbc.273.5.3110	https://doi.org/10.1074/jbc.273.5.3110	NOUN
admet-2551	542	2	.	.	PUNCT
admet-2551	543	1	[	[	X
admet-2551	543	2	38	38	NUM
admet-2551	543	3	]	]	PUNCT
admet-2551	543	4	s.	s.	PROPN
admet-2551	543	5	szarka	szarka	PROPN
admet-2551	543	6	,	,	PUNCT
admet-2551	543	7	e.	e.	PROPN
admet-2551	543	8	sihota	sihota	PROPN
admet-2551	543	9	,	,	PUNCT
admet-2551	543	10	h.	h.	PROPN
admet-2551	543	11	habibi	habibi	PROPN
admet-2551	543	12	,	,	PUNCT
admet-2551	543	13	s.-l	s.-l	PROPN
admet-2551	543	14	.	.	PUNCT
admet-2551	544	1	wong	wong	PROPN
admet-2551	544	2	.	.	PROPN
admet-2551	544	3	staphylokinase	staphylokinase	PROPN
admet-2551	544	4	as	as	ADP
admet-2551	544	5	a	a	DET
admet-2551	544	6	plasminogen	plasminogen	NOUN
admet-2551	544	7	activator	activator	NOUN
admet-2551	544	8	component	component	NOUN
admet-2551	544	9	in	in	ADP
admet-2551	544	10	recombinant	recombinant	ADJ
admet-2551	544	11	fusion	fusion	NOUN
admet-2551	544	12	proteins	protein	NOUN
admet-2551	544	13	.	.	PUNCT
admet-2551	545	1	applied	apply	VERB
admet-2551	545	2	and	and	CCONJ
admet-2551	545	3	environmental	environmental	ADJ
admet-2551	545	4	microbiology	microbiology	NOUN
admet-2551	545	5	65	65	NUM
admet-2551	545	6	(	(	PUNCT
admet-2551	545	7	1999	1999	NUM
admet-2551	545	8	)	)	PUNCT
admet-2551	545	9	506	506	NUM
admet-2551	545	10	-	-	SYM
admet-2551	545	11	513	513	NUM
admet-2551	545	12	.	.	PUNCT
admet-2551	546	1	https://doi.org/10.1128/aem.65.2.506-513.1999	https://doi.org/10.1128/aem.65.2.506-513.1999	NOUN
admet-2551	546	2	.	.	PUNCT
admet-2551	547	1	[	[	X
admet-2551	547	2	39	39	NUM
admet-2551	547	3	]	]	PUNCT
admet-2551	547	4	m.	m.	PROPN
admet-2551	547	5	ali	ali	PROPN
admet-2551	547	6	,	,	PUNCT
admet-2551	547	7	m.	m.	PROPN
admet-2551	547	8	salim	salim	PROPN
admet-2551	547	9	hossain	hossain	PROPN
admet-2551	547	10	,	,	PUNCT
admet-2551	547	11	m.	m.	PROPN
admet-2551	547	12	islam	islam	PROPN
admet-2551	547	13	,	,	PUNCT
admet-2551	547	14	s.i	s.i	PROPN
admet-2551	547	15	.	.	PROPN
admet-2551	547	16	arman	arman	PROPN
admet-2551	547	17	,	,	PUNCT
admet-2551	547	18	g.	g.	PROPN
admet-2551	547	19	sarwar	sarwar	PROPN
admet-2551	547	20	raju	raju	PROPN
admet-2551	547	21	,	,	PUNCT
admet-2551	547	22	p.	p.	PROPN
admet-2551	547	23	dasgupta	dasgupta	PROPN
admet-2551	547	24	,	,	PUNCT
admet-2551	547	25	t.f	t.f	PROPN
admet-2551	547	26	.	.	PUNCT
admet-2551	547	27	noshin	noshin	PROPN
admet-2551	547	28	.	.	PUNCT
admet-2551	547	29	aspect	aspect	PROPN
admet-2551	547	30	of	of	ADP
admet-2551	547	31	thrombolytic	thrombolytic	ADJ
admet-2551	547	32	therapy	therapy	NOUN
admet-2551	547	33	:	:	PUNCT
admet-2551	547	34	a	a	DET
admet-2551	547	35	review	review	NOUN
admet-2551	547	36	.	.	PUNCT
admet-2551	548	1	the	the	DET
admet-2551	548	2	scientific	scientific	ADJ
admet-2551	548	3	world	world	NOUN
admet-2551	548	4	journal	journal	NOUN
admet-2551	548	5	2014	2014	NUM
admet-2551	548	6	(	(	PUNCT
admet-2551	548	7	2014	2014	NUM
admet-2551	548	8	)	)	PUNCT
admet-2551	548	9	.	.	PUNCT
admet-2551	549	1	https://doi.org/10.1155/2014/586510	https://doi.org/10.1155/2014/586510	PROPN
admet-2551	549	2	.	.	PUNCT
admet-2551	550	1	[	[	X
admet-2551	550	2	40	40	NUM
admet-2551	550	3	]	]	PUNCT
admet-2551	550	4	m.	m.	NOUN
admet-2551	550	5	verstraete	verstraete	NOUN
admet-2551	550	6	.	.	PUNCT
admet-2551	551	1	third	third	ADJ
admet-2551	551	2	-	-	PUNCT
admet-2551	551	3	generation	generation	NOUN
admet-2551	551	4	thrombolytic	thrombolytic	ADJ
admet-2551	551	5	drugs	drug	NOUN
admet-2551	551	6	.	.	PUNCT
admet-2551	552	1	the	the	DET
admet-2551	552	2	american	american	PROPN
admet-2551	552	3	journal	journal	PROPN
admet-2551	552	4	of	of	ADP
admet-2551	552	5	medicine	medicine	NOUN
admet-2551	552	6	109	109	NUM
admet-2551	552	7	(	(	PUNCT
admet-2551	552	8	2000	2000	NUM
admet-2551	552	9	)	)	PUNCT
admet-2551	552	10	52	52	NUM
admet-2551	552	11	-	-	SYM
admet-2551	552	12	58	58	NUM
admet-2551	552	13	.	.	PUNCT
admet-2551	553	1	https://doi.org/10.1016/s0002-9343(00)00380-6	https://doi.org/10.1016/s0002-9343(00)00380-6	PROPN
admet-2551	553	2	.	.	PUNCT
admet-2551	554	1	[	[	X
admet-2551	554	2	41	41	NUM
admet-2551	554	3	]	]	PUNCT
admet-2551	554	4	w.-l	w.-l	PROPN
admet-2551	554	5	.	.	PUNCT
admet-2551	555	1	wang	wang	PROPN
admet-2551	555	2	,	,	PUNCT
admet-2551	555	3	y.-m	y.-m	PROPN
admet-2551	555	4	.	.	PUNCT
admet-2551	556	1	hsu	hsu	PROPN
admet-2551	556	2	,	,	PUNCT
admet-2551	556	3	m.-l	m.-l	PROPN
admet-2551	556	4	.	.	PUNCT
admet-2551	557	1	lin	lin	PROPN
admet-2551	557	2	,	,	PUNCT
admet-2551	557	3	s.-s	s.-	NOUN
admet-2551	557	4	.	.	PUNCT
admet-2551	558	1	chen	chen	PROPN
admet-2551	558	2	,	,	PUNCT
admet-2551	558	3	y.-h	y.-h	PROPN
admet-2551	558	4	.	.	PUNCT
admet-2551	559	1	lai	lai	PROPN
admet-2551	559	2	,	,	PUNCT
admet-2551	559	3	c.-h	c.-h	PROPN
admet-2551	559	4	.	.	PUNCT
admet-2551	560	1	huang	huang	PROPN
admet-2551	560	2	,	,	PUNCT
admet-2551	560	3	c.-h	c.-h	PROPN
admet-2551	560	4	.	.	PUNCT
admet-2551	561	1	yao	yao	PROPN
admet-2551	561	2	.	.	PUNCT
admet-2551	562	1	ex	ex	PRON
admet-2551	562	2	vivo	vivo	ADJ
admet-2551	562	3	model	model	NOUN
admet-2551	562	4	to	to	PART
admet-2551	562	5	evaluate	evaluate	VERB
admet-2551	562	6	the	the	DET
admet-2551	562	7	antibacterial	antibacterial	ADJ
admet-2551	562	8	and	and	CCONJ
admet-2551	562	9	anti	anti	ADJ
admet-2551	562	10	-	-	ADJ
admet-2551	562	11	inflammatory	inflammatory	ADJ
admet-2551	562	12	effects	effect	NOUN
admet-2551	562	13	of	of	ADP
admet-2551	562	14	gelatin	gelatin	NOUN
admet-2551	562	15	–	–	PUNCT
admet-2551	562	16	tricalcium	tricalcium	NOUN
admet-2551	562	17	phosphate	phosphate	NOUN
admet-2551	562	18	composite	composite	NOUN
admet-2551	562	19	incorporated	incorporate	VERB
admet-2551	562	20	with	with	ADP
admet-2551	562	21	emodin	emodin	NOUN
admet-2551	562	22	and	and	CCONJ
admet-2551	562	23	lumbrokinase	lumbrokinase	NOUN
admet-2551	562	24	for	for	ADP
admet-2551	562	25	bone	bone	NOUN
admet-2551	562	26	regeneration	regeneration	NOUN
admet-2551	562	27	.	.	PUNCT
admet-2551	563	1	bioengineering	bioengineere	VERB
admet-2551	563	2	10	10	NUM
admet-2551	563	3	(	(	PUNCT
admet-2551	563	4	2023	2023	NUM
admet-2551	563	5	)	)	PUNCT
admet-2551	563	6	906	906	NUM
admet-2551	563	7	.	.	PUNCT
admet-2551	564	1	https://doi.org/10.3390/bioengineering10080906	https://doi.org/10.3390/bioengineering10080906	NOUN
admet-2551	564	2	.	.	PUNCT
admet-2551	565	1	[	[	X
admet-2551	565	2	42	42	NUM
admet-2551	565	3	]	]	PUNCT
admet-2551	565	4	l.	l.	PROPN
admet-2551	565	5	jin	jin	PROPN
admet-2551	565	6	,	,	PUNCT
admet-2551	565	7	h.	h.	PROPN
admet-2551	565	8	jin	jin	PROPN
admet-2551	565	9	,	,	PUNCT
admet-2551	565	10	g.	g.	PROPN
admet-2551	565	11	zhang	zhang	PROPN
admet-2551	565	12	,	,	PUNCT
admet-2551	565	13	g.	g.	PROPN
admet-2551	565	14	xu	xu	PROPN
admet-2551	565	15	.	.	PUNCT
admet-2551	566	1	changes	change	NOUN
admet-2551	566	2	in	in	ADP
admet-2551	566	3	coagulation	coagulation	NOUN
admet-2551	566	4	and	and	CCONJ
admet-2551	566	5	tissue	tissue	NOUN
admet-2551	566	6	plasminogen	plasminogen	NOUN
admet-2551	566	7	activator	activator	NOUN
admet-2551	566	8	after	after	ADP
admet-2551	566	9	the	the	DET
admet-2551	566	10	treatment	treatment	NOUN
admet-2551	566	11	of	of	ADP
admet-2551	566	12	cerebral	cerebral	ADJ
admet-2551	566	13	infarction	infarction	NOUN
admet-2551	566	14	with	with	ADP
admet-2551	566	15	lumbrokinase	lumbrokinase	NOUN
admet-2551	566	16	.	.	PUNCT
admet-2551	567	1	clinical	clinical	ADJ
admet-2551	567	2	hemorheology	hemorheology	NOUN
admet-2551	567	3	and	and	CCONJ
admet-2551	567	4	microcirculation	microcirculation	NOUN
admet-2551	567	5	23	23	NUM
admet-2551	567	6	(	(	PUNCT
admet-2551	567	7	2000	2000	NUM
admet-2551	567	8	)	)	PUNCT
admet-2551	567	9	213	213	NUM
admet-2551	567	10	-	-	SYM
admet-2551	567	11	218	218	NUM
admet-2551	567	12	.	.	PUNCT
admet-2551	568	1	https://content.iospress.com/articles/clinical-hemorheology-and-microcirculation/ch324	https://content.iospress.com/articles/clinical-hemorheology-and-microcirculation/ch324	PROPN
admet-2551	569	1	[	[	X
admet-2551	569	2	43	43	NUM
admet-2551	569	3	]	]	X
admet-2551	569	4	y.-g	y.-g	PROPN
admet-2551	569	5	.	.	PUNCT
admet-2551	570	1	zhao	zhao	PROPN
admet-2551	570	2	,	,	PUNCT
admet-2551	570	3	h.	h.	PROPN
admet-2551	570	4	li	li	PROPN
admet-2551	570	5	,	,	PUNCT
admet-2551	570	6	w.	w.	PROPN
admet-2551	570	7	xu	xu	PROPN
admet-2551	570	8	,	,	PUNCT
admet-2551	570	9	j.	j.	PROPN
admet-2551	570	10	luo	luo	PROPN
admet-2551	570	11	,	,	PUNCT
admet-2551	570	12	r.-a	r.-a	PROPN
admet-2551	570	13	.	.	PUNCT
admet-2551	571	1	xu	xu	INTJ
admet-2551	571	2	.	.	PUNCT
admet-2551	572	1	an	an	DET
admet-2551	572	2	overview	overview	NOUN
admet-2551	572	3	of	of	ADP
admet-2551	572	4	the	the	DET
admet-2551	572	5	fibrinolytic	fibrinolytic	ADJ
admet-2551	572	6	enzyme	enzyme	NOUN
admet-2551	572	7	from	from	ADP
admet-2551	572	8	earthworm	earthworm	NOUN
admet-2551	572	9	.	.	PUNCT
admet-2551	573	1	chinese	chinese	ADJ
admet-2551	573	2	journal	journal	PROPN
admet-2551	573	3	of	of	ADP
admet-2551	573	4	natural	natural	ADJ
admet-2551	573	5	medicines	medicine	NOUN
admet-2551	573	6	8	8	NUM
admet-2551	573	7	(	(	PUNCT
admet-2551	573	8	2010	2010	NUM
admet-2551	573	9	)	)	PUNCT
admet-2551	573	10	301	301	NUM
admet-2551	573	11	-	-	SYM
admet-2551	573	12	308	308	NUM
admet-2551	573	13	.	.	PUNCT
admet-2551	573	14	https://resource.iyp.tw/static.iyp.tw/916/files/51badbe435e29.pdf	https://resource.iyp.tw/static.iyp.tw/916/files/51badbe435e29.pdf	PUNCT
admet-2551	574	1	[	[	X
admet-2551	574	2	44	44	NUM
admet-2551	574	3	]	]	PUNCT
admet-2551	574	4	j.	j.	PROPN
admet-2551	574	5	liu	liu	PROPN
admet-2551	574	6	,	,	PUNCT
admet-2551	574	7	a.	a.	PROPN
admet-2551	574	8	solanki	solanki	PROPN
admet-2551	574	9	,	,	PUNCT
admet-2551	574	10	m.j	m.j	PROPN
admet-2551	574	11	.	.	PROPN
admet-2551	574	12	white	white	PROPN
admet-2551	574	13	,	,	PUNCT
admet-2551	574	14	j.a	j.a	PROPN
admet-2551	574	15	.	.	PROPN
admet-2551	574	16	hubbell	hubbell	PROPN
admet-2551	574	17	,	,	PUNCT
admet-2551	574	18	p.s	p.s	PROPN
admet-2551	574	19	.	.	PROPN
admet-2551	574	20	briquez	briquez	NOUN
admet-2551	574	21	.	.	PUNCT
admet-2551	575	1	therapeutic	therapeutic	ADJ
admet-2551	575	2	use	use	NOUN
admet-2551	575	3	of	of	ADP
admet-2551	575	4	α2	α2	NOUN
admet-2551	575	5	-	-	PUNCT
admet-2551	575	6	antiplasmin	antiplasmin	NOUN
admet-2551	575	7	as	as	ADP
admet-2551	575	8	an	an	DET
admet-2551	575	9	antifibrinolytic	antifibrinolytic	ADJ
admet-2551	575	10	and	and	CCONJ
admet-2551	575	11	hemostatic	hemostatic	ADJ
admet-2551	575	12	agent	agent	NOUN
admet-2551	575	13	in	in	ADP
admet-2551	575	14	surgery	surgery	NOUN
admet-2551	575	15	and	and	CCONJ
admet-2551	575	16	regenerative	regenerative	ADJ
admet-2551	575	17	medicine	medicine	NOUN
admet-2551	575	18	.	.	PUNCT
admet-2551	576	1	npj	npj	PROPN
admet-2551	576	2	regenerative	regenerative	ADJ
admet-2551	576	3	medicine	medicine	NOUN
admet-2551	576	4	7	7	NUM
admet-2551	576	5	(	(	PUNCT
admet-2551	576	6	2022	2022	NUM
admet-2551	576	7	)	)	PUNCT
admet-2551	576	8	34	34	NUM
admet-2551	576	9	.	.	PUNCT
admet-2551	577	1	https://doi.org/10.1038/s41536-022-00230-x	https://doi.org/10.1038/s41536-022-00230-x	NOUN
admet-2551	577	2	.	.	PUNCT
admet-2551	578	1	[	[	X
admet-2551	578	2	45	45	NUM
admet-2551	578	3	]	]	PUNCT
admet-2551	578	4	t.	t.	PROPN
admet-2551	578	5	li	li	PROPN
admet-2551	578	6	,	,	PUNCT
admet-2551	578	7	j.	j.	PROPN
admet-2551	578	8	ren	ren	PROPN
admet-2551	578	9	,	,	PUNCT
admet-2551	578	10	t.	t.	PROPN
admet-2551	578	11	li	li	PROPN
admet-2551	578	12	,	,	PUNCT
admet-2551	578	13	y.	y.	PROPN
admet-2551	578	14	wang	wang	PROPN
admet-2551	578	15	,	,	PUNCT
admet-2551	578	16	advances	advance	NOUN
admet-2551	578	17	in	in	ADP
admet-2551	578	18	applied	apply	VERB
admet-2551	578	19	biotechnology	biotechnology	NOUN
admet-2551	578	20	:	:	PUNCT
admet-2551	578	21	proceedings	proceeding	NOUN
admet-2551	578	22	of	of	ADP
admet-2551	578	23	the	the	DET
admet-2551	578	24	2nd	2nd	ADJ
admet-2551	578	25	international	international	ADJ
admet-2551	578	26	conference	conference	NOUN
admet-2551	578	27	on	on	ADP
admet-2551	578	28	applied	apply	VERB
admet-2551	578	29	biotechnology	biotechnology	NOUN
admet-2551	578	30	(	(	PUNCT
admet-2551	578	31	icab	icab	NOUN
admet-2551	578	32	2014)-volume	2014)-volume	NUM
admet-2551	579	1	i	i	PRON
admet-2551	579	2	,	,	PUNCT
admet-2551	579	3	2015	2015	NUM
admet-2551	579	4	,	,	PUNCT
admet-2551	579	5	pp	pp	ADJ
admet-2551	579	6	.	.	PUNCT
admet-2551	580	1	541	541	NUM
admet-2551	580	2	-	-	SYM
admet-2551	580	3	546	546	NUM
admet-2551	580	4	.	.	PUNCT
admet-2551	581	1	https://doi.org/10.1021/ja00191a039	https://doi.org/10.1021/ja00191a039	PROPN
admet-2551	581	2	https://doi.org/10.1107/s010876818300275x	https://doi.org/10.1107/s010876818300275x	NOUN
admet-2551	581	3	https://doi.org/10.1016/j.jmb.2005.02.055	https://doi.org/10.1016/j.jmb.2005.02.055	VERB
admet-2551	581	4	https://doi.org/10.1107/s0907444904004895	https://doi.org/10.1107/s0907444904004895	NUM
admet-2551	581	5	https://doi.org/10.1016/s0022-2836(02)00559-4	https://doi.org/10.1016/s0022-2836(02)00559-4	PROPN
admet-2551	581	6	https://doi.org/10.1083/jcb.104.4.801	https://doi.org/10.1083/jcb.104.4.801	PROPN
admet-2551	581	7	https://doi.org/10.1016/s0021-9258(17)39035-x	https://doi.org/10.1016/s0021-9258(17)39035-x	PROPN
admet-2551	581	8	https://doi.org/10.1074/jbc.273.5.3110	https://doi.org/10.1074/jbc.273.5.3110	PROPN
admet-2551	581	9	https://doi.org/10.1128/aem.65.2.506-513.1999	https://doi.org/10.1128/aem.65.2.506-513.1999	NOUN
admet-2551	581	10	https://doi.org/10.1155/2014/586510	https://doi.org/10.1155/2014/586510	VERB
admet-2551	581	11	https://doi.org/10.1016/s0002-9343(00)00380-6	https://doi.org/10.1016/s0002-9343(00)00380-6	PROPN
admet-2551	581	12	https://doi.org/10.3390/bioengineering10080906	https://doi.org/10.3390/bioengineering10080906	NOUN
admet-2551	581	13	https://content.iospress.com/articles/clinical-hemorheology-and-microcirculation/ch324	https://content.iospress.com/articles/clinical-hemorheology-and-microcirculation/ch324	NOUN
admet-2551	581	14	https://resource.iyp.tw/static.iyp.tw/916/files/51badbe435e29.pdf	https://resource.iyp.tw/static.iyp.tw/916/files/51badbe435e29.pdf	ADJ
admet-2551	581	15	https://doi.org/10.1038/s41536-022-00230-x	https://doi.org/10.1038/s41536-022-00230-x	PROPN
admet-2551	581	16	admet	admet	PROPN
admet-2551	581	17	&	&	CCONJ
admet-2551	581	18	dmpk	dmpk	PROPN
admet-2551	581	19	12(6	12(6	NUM
admet-2551	581	20	)	)	PUNCT
admet-2551	581	21	(	(	PUNCT
admet-2551	581	22	2024	2024	NUM
admet-2551	581	23	)	)	PUNCT
admet-2551	581	24	797	797	NUM
admet-2551	581	25	-	-	SYM
admet-2551	581	26	820	820	NUM
admet-2551	581	27	natural	natural	ADJ
admet-2551	581	28	serine	serine	NOUN
admet-2551	581	29	proteases	protease	NOUN
admet-2551	581	30	in	in	ADP
admet-2551	581	31	combating	combat	VERB
admet-2551	581	32	amyloid	amyloid	NOUN
admet-2551	581	33	formation	formation	NOUN
admet-2551	581	34	doi	doi	NOUN
admet-2551	581	35	:	:	PUNCT
admet-2551	581	36	https://doi.org/10.5599/admet.2551	https://doi.org/10.5599/admet.2551	NOUN
admet-2551	581	37	813	813	NUM
admet-2551	581	38	[	[	X
admet-2551	581	39	46	46	NUM
admet-2551	581	40	]	]	X
admet-2551	581	41	n.	n.	PROPN
admet-2551	581	42	iannucci	iannucci	PROPN
admet-2551	581	43	,	,	PUNCT
admet-2551	581	44	s.	s.	PROPN
admet-2551	581	45	camperi	camperi	PROPN
admet-2551	581	46	,	,	PUNCT
admet-2551	581	47	o.	o.	NOUN
admet-2551	581	48	cascone	cascone	NOUN
admet-2551	581	49	.	.	PUNCT
admet-2551	582	1	purification	purification	NOUN
admet-2551	582	2	of	of	ADP
admet-2551	582	3	lumbrokinase	lumbrokinase	NOUN
admet-2551	582	4	from	from	ADP
admet-2551	582	5	eisenia	eisenia	NOUN
admet-2551	582	6	fetida	fetida	PROPN
admet-2551	582	7	using	use	VERB
admet-2551	582	8	aqueous	aqueous	ADJ
admet-2551	582	9	two	two	NUM
admet-2551	582	10	-	-	PUNCT
admet-2551	582	11	phase	phase	NOUN
admet-2551	582	12	systems	system	NOUN
admet-2551	582	13	and	and	CCONJ
admet-2551	582	14	anion	anion	NOUN
admet-2551	582	15	-	-	PUNCT
admet-2551	582	16	exchange	exchange	NOUN
admet-2551	582	17	chromatography	chromatography	NOUN
admet-2551	582	18	.	.	PUNCT
admet-2551	583	1	separation	separation	NOUN
admet-2551	583	2	and	and	CCONJ
admet-2551	583	3	purification	purification	NOUN
admet-2551	583	4	technology	technology	NOUN
admet-2551	583	5	64	64	NUM
admet-2551	583	6	(	(	PUNCT
admet-2551	583	7	2008	2008	NUM
admet-2551	583	8	)	)	PUNCT
admet-2551	583	9	131	131	NUM
admet-2551	583	10	-	-	SYM
admet-2551	583	11	134	134	NUM
admet-2551	583	12	.	.	PUNCT
admet-2551	584	1	https://doi.org/10.1016/j.seppur.2008.08.014	https://doi.org/10.1016/j.seppur.2008.08.014	NOUN
admet-2551	584	2	.	.	PUNCT
admet-2551	585	1	[	[	X
admet-2551	585	2	47	47	NUM
admet-2551	585	3	]	]	X
admet-2551	585	4	t.t.b	t.t.b	NOUN
admet-2551	585	5	.	.	PUNCT
admet-2551	585	6	phan	phan	PROPN
admet-2551	585	7	,	,	PUNCT
admet-2551	585	8	t.d	t.d	PROPN
admet-2551	585	9	.	.	PROPN
admet-2551	585	10	ta	ta	PROPN
admet-2551	585	11	,	,	PUNCT
admet-2551	585	12	d.t.x	d.t.x	PROPN
admet-2551	585	13	.	.	PROPN
admet-2551	585	14	nguyen	nguyen	PROPN
admet-2551	585	15	,	,	PUNCT
admet-2551	585	16	l.a	l.a	PROPN
admet-2551	585	17	.	.	PROPN
admet-2551	585	18	van	van	PROPN
admet-2551	585	19	den	den	PROPN
admet-2551	585	20	broek	broek	PROPN
admet-2551	585	21	,	,	PUNCT
admet-2551	585	22	g.t.h	g.t.h	PROPN
admet-2551	585	23	.	.	PUNCT
admet-2551	586	1	duong	duong	PROPN
admet-2551	586	2	.	.	PUNCT
admet-2551	587	1	purification	purification	NOUN
admet-2551	587	2	and	and	CCONJ
admet-2551	587	3	characterization	characterization	NOUN
admet-2551	587	4	of	of	ADP
admet-2551	587	5	novel	novel	ADJ
admet-2551	587	6	fibrinolytic	fibrinolytic	ADJ
admet-2551	587	7	proteases	protease	NOUN
admet-2551	587	8	as	as	ADP
admet-2551	587	9	potential	potential	ADJ
admet-2551	587	10	antithrombotic	antithrombotic	ADJ
admet-2551	587	11	agents	agent	NOUN
admet-2551	587	12	from	from	ADP
admet-2551	587	13	earthworm	earthworm	NOUN
admet-2551	587	14	perionyx	perionyx	NOUN
admet-2551	587	15	excavatus	excavatus	NOUN
admet-2551	587	16	.	.	PUNCT
admet-2551	588	1	amb	amb	PROPN
admet-2551	588	2	express	express	VERB
admet-2551	588	3	1	1	NUM
admet-2551	588	4	(	(	PUNCT
admet-2551	588	5	2011	2011	NUM
admet-2551	588	6	)	)	PUNCT
admet-2551	588	7	26	26	NUM
admet-2551	588	8	.	.	PUNCT
admet-2551	589	1	https://doi.org/10.1186/2191-0855-1-26	https://doi.org/10.1186/2191-0855-1-26	X
admet-2551	589	2	.	.	PUNCT
admet-2551	590	1	[	[	X
admet-2551	590	2	48	48	NUM
admet-2551	590	3	]	]	X
admet-2551	590	4	j.x	j.x	PROPN
admet-2551	590	5	.	.	PROPN
admet-2551	590	6	wu	wu	PROPN
admet-2551	590	7	,	,	PUNCT
admet-2551	590	8	x.y	x.y	PROPN
admet-2551	590	9	.	.	PROPN
admet-2551	590	10	zhao	zhao	PROPN
admet-2551	590	11	,	,	PUNCT
admet-2551	590	12	r.	r.	PROPN
admet-2551	590	13	pan	pan	PROPN
admet-2551	590	14	,	,	PUNCT
admet-2551	590	15	r.q	r.q	PROPN
admet-2551	591	1	.	.	PUNCT
admet-2551	591	2	he	he	PRON
admet-2551	591	3	.	.	PUNCT
admet-2551	592	1	glycosylated	glycosylated	ADJ
admet-2551	592	2	trypsin	trypsin	NOUN
admet-2551	592	3	-	-	PUNCT
admet-2551	592	4	like	like	ADJ
admet-2551	592	5	proteases	protease	NOUN
admet-2551	592	6	from	from	ADP
admet-2551	592	7	earthworm	earthworm	NOUN
admet-2551	592	8	eisenia	eisenia	NOUN
admet-2551	592	9	fetida	fetida	PROPN
admet-2551	592	10	.	.	PUNCT
admet-2551	593	1	international	international	ADJ
admet-2551	593	2	journal	journal	PROPN
admet-2551	593	3	of	of	ADP
admet-2551	593	4	biological	biological	ADJ
admet-2551	593	5	macromolecules	macromolecule	NOUN
admet-2551	593	6	40	40	NUM
admet-2551	593	7	(	(	PUNCT
admet-2551	593	8	2007	2007	NUM
admet-2551	593	9	)	)	PUNCT
admet-2551	593	10	399	399	NUM
admet-2551	593	11	-	-	SYM
admet-2551	593	12	406	406	NUM
admet-2551	593	13	.	.	PUNCT
admet-2551	594	1	https://doi.org/10.1016/j.ijbiomac.2006.10.001	https://doi.org/10.1016/j.ijbiomac.2006.10.001	NOUN
admet-2551	594	2	.	.	PUNCT
admet-2551	595	1	[	[	X
admet-2551	595	2	49	49	NUM
admet-2551	595	3	]	]	X
admet-2551	595	4	k.s	k.s	PROPN
admet-2551	595	5	.	.	PROPN
admet-2551	595	6	katheem	katheem	PROPN
admet-2551	595	7	,	,	PUNCT
admet-2551	595	8	m.h	m.h	PROPN
admet-2551	595	9	.	.	PROPN
admet-2551	595	10	ibrahim	ibrahim	PROPN
admet-2551	595	11	,	,	PUNCT
admet-2551	595	12	s.	s.	PROPN
admet-2551	595	13	quaik	quaik	PROPN
admet-2551	595	14	,	,	PUNCT
admet-2551	595	15	s.	s.	PROPN
admet-2551	595	16	ahmed	ahmed	PROPN
admet-2551	595	17	ismail	ismail	PROPN
admet-2551	595	18	,	,	PUNCT
admet-2551	595	19	m.h	m.h	PROPN
admet-2551	595	20	.	.	PROPN
admet-2551	595	21	ibrahim	ibrahim	PROPN
admet-2551	595	22	,	,	PUNCT
admet-2551	595	23	s.	s.	PROPN
admet-2551	595	24	quaik	quaik	PROPN
admet-2551	595	25	,	,	PUNCT
admet-2551	595	26	s.a	s.a	PROPN
admet-2551	595	27	.	.	PROPN
admet-2551	595	28	ismail	ismail	PROPN
admet-2551	595	29	.	.	PUNCT
admet-2551	596	1	earthworm	earthworm	NOUN
admet-2551	596	2	based	base	VERB
admet-2551	596	3	products	product	NOUN
admet-2551	596	4	,	,	PUNCT
admet-2551	596	5	scope	scope	NOUN
admet-2551	596	6	and	and	CCONJ
admet-2551	596	7	future	future	ADJ
admet-2551	596	8	perspectives	perspective	NOUN
admet-2551	596	9	.	.	PUNCT
admet-2551	597	1	prospects	prospect	NOUN
admet-2551	597	2	of	of	ADP
admet-2551	597	3	organic	organic	ADJ
admet-2551	597	4	waste	waste	NOUN
admet-2551	597	5	management	management	NOUN
admet-2551	597	6	and	and	CCONJ
admet-2551	597	7	the	the	DET
admet-2551	597	8	significance	significance	NOUN
admet-2551	597	9	of	of	ADP
admet-2551	597	10	earthworms	earthworm	NOUN
admet-2551	597	11	(	(	PUNCT
admet-2551	597	12	2016	2016	NUM
admet-2551	597	13	)	)	PUNCT
admet-2551	597	14	231	231	NUM
admet-2551	597	15	-	-	SYM
admet-2551	597	16	243	243	NUM
admet-2551	597	17	.	.	PUNCT
admet-2551	597	18	https://doi.org/10.1007/978-3319-24708-3_10	https://doi.org/10.1007/978-3319-24708-3_10	NOUN
admet-2551	597	19	.	.	PUNCT
admet-2551	598	1	[	[	X
admet-2551	598	2	50	50	NUM
admet-2551	598	3	]	]	SYM
admet-2551	598	4	q.t.t	q.t.t	ADJ
admet-2551	598	5	.	.	PUNCT
admet-2551	598	6	nguyen	nguyen	PROPN
admet-2551	598	7	,	,	PUNCT
admet-2551	598	8	h.	h.	PROPN
admet-2551	598	9	rhee	rhee	PROPN
admet-2551	598	10	,	,	PUNCT
admet-2551	598	11	m.	m.	PROPN
admet-2551	598	12	kim	kim	PROPN
admet-2551	598	13	,	,	PUNCT
admet-2551	598	14	m.y	m.y	PROPN
admet-2551	598	15	.	.	PROPN
admet-2551	598	16	lee	lee	PROPN
admet-2551	598	17	,	,	PUNCT
admet-2551	598	18	e.-j	e.-j	PROPN
admet-2551	598	19	.	.	PROPN
admet-2551	598	20	lee	lee	PROPN
admet-2551	598	21	.	.	PROPN
admet-2551	598	22	lumbrokinase	lumbrokinase	PROPN
admet-2551	598	23	,	,	PUNCT
admet-2551	598	24	a	a	DET
admet-2551	598	25	fibrinolytic	fibrinolytic	ADJ
admet-2551	598	26	enzyme	enzyme	NOUN
admet-2551	598	27	,	,	PUNCT
admet-2551	598	28	prevents	prevent	VERB
admet-2551	598	29	intra‐abdominal	intra‐abdominal	ADJ
admet-2551	598	30	adhesion	adhesion	NOUN
admet-2551	598	31	by	by	ADP
admet-2551	598	32	inhibiting	inhibit	VERB
admet-2551	598	33	the	the	DET
admet-2551	598	34	migrative	migrative	ADJ
admet-2551	598	35	and	and	CCONJ
admet-2551	598	36	adhesive	adhesive	ADJ
admet-2551	598	37	activities	activity	NOUN
admet-2551	598	38	of	of	ADP
admet-2551	598	39	fibroblast	fibroblast	ADJ
admet-2551	598	40	via	via	ADP
admet-2551	598	41	attenuation	attenuation	NOUN
admet-2551	598	42	of	of	ADP
admet-2551	598	43	the	the	DET
admet-2551	598	44	ap‐1	ap‐1	NOUN
admet-2551	598	45	/	/	SYM
admet-2551	598	46	icam‐1	icam‐1	NOUN
admet-2551	598	47	signaling	signal	VERB
admet-2551	598	48	pathway	pathway	NOUN
admet-2551	598	49	.	.	PUNCT
admet-2551	599	1	biomed	biome	VERB
admet-2551	599	2	research	research	NOUN
admet-2551	599	3	international	international	ADJ
admet-2551	599	4	2023	2023	NUM
admet-2551	599	5	(	(	PUNCT
admet-2551	599	6	2023	2023	NUM
admet-2551	599	7	)	)	PUNCT
admet-2551	599	8	4050730	4050730	NUM
admet-2551	599	9	.	.	PUNCT
admet-2551	600	1	https://doi.org/10.1155/2023/4050730	https://doi.org/10.1155/2023/4050730	PROPN
admet-2551	600	2	.	.	PUNCT
admet-2551	601	1	[	[	X
admet-2551	601	2	51	51	NUM
admet-2551	601	3	]	]	X
admet-2551	601	4	h.	h.	PROPN
admet-2551	601	5	ji	ji	PROPN
admet-2551	601	6	,	,	PUNCT
admet-2551	601	7	l.	l.	PROPN
admet-2551	601	8	wang	wang	PROPN
admet-2551	601	9	,	,	PUNCT
admet-2551	601	10	h.	h.	PROPN
admet-2551	601	11	bi	bi	PROPN
admet-2551	601	12	,	,	PUNCT
admet-2551	601	13	l.	l.	PROPN
admet-2551	601	14	sun	sun	PROPN
admet-2551	601	15	,	,	PUNCT
admet-2551	601	16	b.	b.	PROPN
admet-2551	601	17	cai	cai	PROPN
admet-2551	601	18	,	,	PUNCT
admet-2551	601	19	y.	y.	PROPN
admet-2551	601	20	wang	wang	PROPN
admet-2551	601	21	,	,	PUNCT
admet-2551	601	22	j.	j.	PROPN
admet-2551	601	23	zhao	zhao	PROPN
admet-2551	601	24	,	,	PUNCT
admet-2551	601	25	z.	z.	PROPN
admet-2551	601	26	du	du	PROPN
admet-2551	601	27	.	.	PROPN
admet-2551	601	28	mechanisms	mechanism	NOUN
admet-2551	601	29	of	of	ADP
admet-2551	601	30	lumbrokinase	lumbrokinase	NOUN
admet-2551	601	31	in	in	ADP
admet-2551	601	32	protection	protection	NOUN
admet-2551	601	33	of	of	ADP
admet-2551	601	34	cerebral	cerebral	ADJ
admet-2551	601	35	ischemia	ischemia	NOUN
admet-2551	601	36	.	.	PUNCT
admet-2551	602	1	european	european	PROPN
admet-2551	602	2	journal	journal	PROPN
admet-2551	602	3	of	of	ADP
admet-2551	602	4	pharmacology	pharmacology	NOUN
admet-2551	602	5	590	590	NUM
admet-2551	602	6	(	(	PUNCT
admet-2551	602	7	2008	2008	NUM
admet-2551	602	8	)	)	PUNCT
admet-2551	602	9	281	281	NUM
admet-2551	602	10	-	-	SYM
admet-2551	602	11	289	289	NUM
admet-2551	602	12	.	.	PUNCT
admet-2551	603	1	https://doi.org/10.1016/j.ejphar.2008.05.037	https://doi.org/10.1016/j.ejphar.2008.05.037	NOUN
admet-2551	603	2	.	.	PUNCT
admet-2551	604	1	[	[	X
admet-2551	604	2	52	52	NUM
admet-2551	604	3	]	]	PUNCT
admet-2551	604	4	c.	c.	PROPN
admet-2551	604	5	hwang	hwang	PROPN
admet-2551	604	6	,	,	PUNCT
admet-2551	604	7	d.	d.	PROPN
admet-2551	604	8	kim	kim	PROPN
admet-2551	604	9	,	,	PUNCT
admet-2551	604	10	j.	j.	PROPN
admet-2551	604	11	kim	kim	PROPN
admet-2551	604	12	,	,	PUNCT
admet-2551	604	13	s.	s.	PROPN
admet-2551	604	14	huh	huh	PROPN
admet-2551	604	15	.	.	PUNCT
admet-2551	605	1	in	in	ADP
admet-2551	605	2	vivo	vivo	ADJ
admet-2551	605	3	evaluation	evaluation	NOUN
admet-2551	605	4	of	of	ADP
admet-2551	605	5	lumbrokinase	lumbrokinase	NOUN
admet-2551	605	6	,	,	PUNCT
admet-2551	605	7	a	a	DET
admet-2551	605	8	fibrinolytic	fibrinolytic	ADJ
admet-2551	605	9	enzyme	enzyme	NOUN
admet-2551	605	10	extracted	extract	VERB
admet-2551	605	11	from	from	ADP
admet-2551	605	12	lumbricus	lumbricus	NOUN
admet-2551	605	13	rubellus	rubellus	NOUN
admet-2551	605	14	,	,	PUNCT
admet-2551	605	15	in	in	ADP
admet-2551	605	16	a	a	DET
admet-2551	605	17	prosthetic	prosthetic	ADJ
admet-2551	605	18	vascular	vascular	ADJ
admet-2551	605	19	graft	graft	NOUN
admet-2551	605	20	.	.	PUNCT
admet-2551	606	1	journal	journal	NOUN
admet-2551	606	2	of	of	ADP
admet-2551	606	3	cardiovascular	cardiovascular	ADJ
admet-2551	606	4	surgery	surgery	NOUN
admet-2551	606	5	43	43	NUM
admet-2551	606	6	(	(	PUNCT
admet-2551	606	7	2002	2002	NUM
admet-2551	606	8	)	)	PUNCT
admet-2551	606	9	891	891	NUM
admet-2551	606	10	-	-	SYM
admet-2551	606	11	894	894	NUM
admet-2551	606	12	.	.	PUNCT
admet-2551	607	1	https://www.minervamedica.it/en/journals/cardiovascularsurgery/article.php?cod=r37y2002n06a0891	https://www.minervamedica.it/en/journals/cardiovascularsurgery/article.php?cod=r37y2002n06a0891	PROPN
admet-2551	607	2	[	[	X
admet-2551	607	3	53	53	NUM
admet-2551	607	4	]	]	PUNCT
admet-2551	607	5	y.-h	y.-h	PROPN
admet-2551	607	6	.	.	PUNCT
admet-2551	608	1	wang	wang	PROPN
admet-2551	608	2	,	,	PUNCT
admet-2551	608	3	s.-a	s.-a	PROPN
admet-2551	608	4	.	.	PUNCT
admet-2551	609	1	li	li	PROPN
admet-2551	609	2	,	,	PUNCT
admet-2551	609	3	c.-h	c.-h	PROPN
admet-2551	609	4	.	.	PUNCT
admet-2551	610	1	huang	huang	PROPN
admet-2551	610	2	,	,	PUNCT
admet-2551	610	3	h.-h	h.-h	PROPN
admet-2551	610	4	.	.	PUNCT
admet-2551	611	1	su	su	PROPN
admet-2551	611	2	,	,	PUNCT
admet-2551	611	3	y.-h	y.-h	PROPN
admet-2551	611	4	.	.	PUNCT
admet-2551	612	1	chen	chen	PROPN
admet-2551	612	2	,	,	PUNCT
admet-2551	612	3	j.t	j.t	PROPN
admet-2551	612	4	.	.	PROPN
admet-2551	612	5	chang	chang	PROPN
admet-2551	612	6	,	,	PUNCT
admet-2551	612	7	s.-s	s.-s	PROPN
admet-2551	612	8	.	.	PUNCT
admet-2551	613	1	huang	huang	PROPN
admet-2551	613	2	.	.	PUNCT
admet-2551	613	3	sirt1	sirt1	PROPN
admet-2551	613	4	activation	activation	NOUN
admet-2551	613	5	by	by	ADP
admet-2551	613	6	post	post	ADJ
admet-2551	613	7	-	-	ADJ
admet-2551	613	8	ischemic	ischemic	ADJ
admet-2551	613	9	treatment	treatment	NOUN
admet-2551	613	10	with	with	ADP
admet-2551	613	11	lumbrokinase	lumbrokinase	NOUN
admet-2551	613	12	protects	protect	VERB
admet-2551	613	13	against	against	ADP
admet-2551	613	14	myocardial	myocardial	ADJ
admet-2551	613	15	ischemia	ischemia	NOUN
admet-2551	613	16	-	-	PUNCT
admet-2551	613	17	reperfusion	reperfusion	NOUN
admet-2551	613	18	injury	injury	NOUN
admet-2551	613	19	.	.	PUNCT
admet-2551	614	1	frontiers	frontier	NOUN
admet-2551	614	2	in	in	ADP
admet-2551	614	3	pharmacology	pharmacology	NOUN
admet-2551	614	4	9	9	NUM
admet-2551	614	5	(	(	PUNCT
admet-2551	614	6	2018	2018	NUM
admet-2551	614	7	)	)	PUNCT
admet-2551	614	8	636	636	NUM
admet-2551	614	9	.	.	PUNCT
admet-2551	615	1	https://doi.org/10.3389/fphar.2018.00636	https://doi.org/10.3389/fphar.2018.00636	NOUN
admet-2551	615	2	.	.	PUNCT
admet-2551	616	1	[	[	X
admet-2551	616	2	54	54	NUM
admet-2551	616	3	]	]	PUNCT
admet-2551	616	4	y.-h	y.-h	PROPN
admet-2551	616	5	.	.	PUNCT
admet-2551	617	1	wang	wang	PROPN
admet-2551	617	2	,	,	PUNCT
admet-2551	617	3	k.-m	k.-m	PROPN
admet-2551	617	4	.	.	PUNCT
admet-2551	618	1	chen	chen	PROPN
admet-2551	618	2	,	,	PUNCT
admet-2551	618	3	p.-s	p.-s	PROPN
admet-2551	618	4	.	.	PUNCT
admet-2551	619	1	chiu	chiu	PROPN
admet-2551	619	2	,	,	PUNCT
admet-2551	619	3	s.-c	s.-c	PROPN
admet-2551	619	4	.	.	PUNCT
admet-2551	620	1	lai	lai	PROPN
admet-2551	620	2	,	,	PUNCT
admet-2551	620	3	h.-h	h.-h	PROPN
admet-2551	620	4	.	.	PUNCT
admet-2551	621	1	su	su	PROPN
admet-2551	621	2	,	,	PUNCT
admet-2551	621	3	m.-s	m.-s	PROPN
admet-2551	621	4	.	.	PUNCT
admet-2551	622	1	jan	jan	PROPN
admet-2551	622	2	,	,	PUNCT
admet-2551	622	3	c.-w	c.-w	PROPN
admet-2551	622	4	.	.	PUNCT
admet-2551	623	1	lin	lin	PROPN
admet-2551	623	2	,	,	PUNCT
admet-2551	623	3	d.-y	d.-y	PROPN
admet-2551	623	4	.	.	PUNCT
admet-2551	624	1	lu	lu	PROPN
admet-2551	624	2	,	,	PUNCT
admet-2551	624	3	y.-t	y.-t	NOUN
admet-2551	624	4	.	.	PUNCT
admet-2551	625	1	fu	fu	PROPN
admet-2551	625	2	,	,	PUNCT
admet-2551	625	3	j.-m	j.-m	PROPN
admet-2551	625	4	.	.	PUNCT
admet-2551	626	1	liao	liao	PROPN
admet-2551	626	2	.	.	PUNCT
admet-2551	627	1	lumbrokinase	lumbrokinase	PROPN
admet-2551	627	2	attenuates	attenuate	VERB
admet-2551	627	3	myocardial	myocardial	ADJ
admet-2551	627	4	ischemia	ischemia	NOUN
admet-2551	627	5	-	-	PUNCT
admet-2551	627	6	reperfusion	reperfusion	NOUN
admet-2551	627	7	injury	injury	NOUN
admet-2551	627	8	by	by	ADP
admet-2551	627	9	inhibiting	inhibit	VERB
admet-2551	627	10	tlr4	tlr4	NOUN
admet-2551	627	11	signaling	signal	VERB
admet-2551	627	12	.	.	PUNCT
admet-2551	628	1	journal	journal	NOUN
admet-2551	628	2	of	of	ADP
admet-2551	628	3	molecular	molecular	ADJ
admet-2551	628	4	and	and	CCONJ
admet-2551	628	5	cellular	cellular	ADJ
admet-2551	628	6	cardiology	cardiology	NOUN
admet-2551	628	7	99	99	NUM
admet-2551	628	8	(	(	PUNCT
admet-2551	628	9	2016	2016	NUM
admet-2551	628	10	)	)	PUNCT
admet-2551	628	11	113	113	NUM
admet-2551	628	12	-	-	SYM
admet-2551	628	13	122	122	NUM
admet-2551	628	14	.	.	PUNCT
admet-2551	629	1	https://doi.org/10.1016/j.yjmcc.2016.08.004	https://doi.org/10.1016/j.yjmcc.2016.08.004	NOUN
admet-2551	629	2	.	.	PUNCT
admet-2551	630	1	[	[	X
admet-2551	630	2	55	55	NUM
admet-2551	630	3	]	]	X
admet-2551	630	4	s.r	s.r	PROPN
admet-2551	630	5	.	.	PROPN
admet-2551	630	6	nair	nair	PROPN
admet-2551	630	7	.	.	PUNCT
admet-2551	631	1	serratiopeptidase	serratiopeptidase	PROPN
admet-2551	631	2	:	:	PUNCT
admet-2551	631	3	an	an	DET
admet-2551	631	4	integrated	integrated	ADJ
admet-2551	631	5	view	view	NOUN
admet-2551	631	6	of	of	ADP
admet-2551	631	7	multifaceted	multifaceted	ADJ
admet-2551	631	8	therapeutic	therapeutic	ADJ
admet-2551	631	9	enzyme	enzyme	NOUN
admet-2551	631	10	.	.	PUNCT
admet-2551	632	1	biomolecules	biomolecule	NOUN
admet-2551	632	2	12	12	NUM
admet-2551	632	3	(	(	PUNCT
admet-2551	632	4	2022	2022	NUM
admet-2551	632	5	)	)	PUNCT
admet-2551	632	6	1468	1468	NUM
admet-2551	632	7	.	.	PUNCT
admet-2551	633	1	https://doi.org/10.3390/biom12101468	https://doi.org/10.3390/biom12101468	NOUN
admet-2551	633	2	.	.	PUNCT
admet-2551	634	1	[	[	X
admet-2551	634	2	56	56	NUM
admet-2551	634	3	]	]	X
admet-2551	634	4	s.b	s.b	PROPN
admet-2551	634	5	.	.	PROPN
admet-2551	634	6	jadhav	jadhav	PROPN
admet-2551	634	7	,	,	PUNCT
admet-2551	634	8	n.	n.	PROPN
admet-2551	634	9	shah	shah	PROPN
admet-2551	634	10	,	,	PUNCT
admet-2551	634	11	a.	a.	NOUN
admet-2551	634	12	rathi	rathi	PROPN
admet-2551	634	13	,	,	PUNCT
admet-2551	634	14	v.	v.	PROPN
admet-2551	634	15	rathi	rathi	PROPN
admet-2551	634	16	,	,	PUNCT
admet-2551	634	17	a.	a.	NOUN
admet-2551	634	18	rathi	rathi	PROPN
admet-2551	634	19	.	.	PUNCT
admet-2551	635	1	serratiopeptidase	serratiopeptidase	PROPN
admet-2551	635	2	:	:	PUNCT
admet-2551	635	3	insights	insight	NOUN
admet-2551	635	4	into	into	ADP
admet-2551	635	5	the	the	DET
admet-2551	635	6	therapeutic	therapeutic	ADJ
admet-2551	635	7	applications	application	NOUN
admet-2551	635	8	.	.	PUNCT
admet-2551	636	1	biotechnology	biotechnology	NOUN
admet-2551	636	2	reports	report	VERB
admet-2551	636	3	28	28	NUM
admet-2551	636	4	(	(	PUNCT
admet-2551	636	5	2020	2020	NUM
admet-2551	636	6	)	)	PUNCT
admet-2551	637	1	e00544	e00544	PROPN
admet-2551	637	2	.	.	PUNCT
admet-2551	637	3	https://doi.org/https://doi.org/10.1016/j.btre.2020.e00544	https://doi.org/https://doi.org/10.1016/j.btre.2020.e00544	PROPN
admet-2551	637	4	.	.	PUNCT
admet-2551	638	1	[	[	X
admet-2551	638	2	57	57	NUM
admet-2551	638	3	]	]	X
admet-2551	638	4	p.r	p.r	PROPN
admet-2551	638	5	.	.	PROPN
admet-2551	638	6	salamone	salamone	PROPN
admet-2551	638	7	,	,	PUNCT
admet-2551	638	8	r.j	r.j	PROPN
admet-2551	638	9	.	.	PROPN
admet-2551	638	10	wodzinski	wodzinski	PROPN
admet-2551	638	11	.	.	PUNCT
admet-2551	639	1	production	production	NOUN
admet-2551	639	2	,	,	PUNCT
admet-2551	639	3	purification	purification	NOUN
admet-2551	639	4	and	and	CCONJ
admet-2551	639	5	characterization	characterization	NOUN
admet-2551	639	6	of	of	ADP
admet-2551	639	7	a	a	DET
admet-2551	639	8	50	50	NUM
admet-2551	639	9	-	-	PUNCT
admet-2551	639	10	kda	kda	NOUN
admet-2551	639	11	extracellular	extracellular	ADJ
admet-2551	639	12	metalloprotease	metalloprotease	NOUN
admet-2551	639	13	from	from	ADP
admet-2551	639	14	serratia	serratia	PROPN
admet-2551	639	15	marcescens	marcescens	PROPN
admet-2551	639	16	.	.	PUNCT
admet-2551	640	1	applied	apply	VERB
admet-2551	640	2	microbiology	microbiology	NOUN
admet-2551	640	3	and	and	CCONJ
admet-2551	640	4	biotechnology	biotechnology	NOUN
admet-2551	640	5	48	48	NUM
admet-2551	640	6	(	(	PUNCT
admet-2551	640	7	1997	1997	NUM
admet-2551	640	8	)	)	PUNCT
admet-2551	640	9	317	317	NUM
admet-2551	640	10	-	-	SYM
admet-2551	640	11	324	324	NUM
admet-2551	640	12	.	.	PUNCT
admet-2551	641	1	https://doi.org/10.1007/s002530051056	https://doi.org/10.1007/s002530051056	NUM
admet-2551	641	2	.	.	PUNCT
admet-2551	642	1	[	[	X
admet-2551	642	2	58	58	NUM
admet-2551	642	3	]	]	PUNCT
admet-2551	642	4	k.	k.	PROPN
admet-2551	642	5	miyata	miyata	PROPN
admet-2551	642	6	,	,	PUNCT
admet-2551	642	7	k.	k.	PROPN
admet-2551	642	8	maejima	maejima	PROPN
admet-2551	642	9	,	,	PUNCT
admet-2551	642	10	k.	k.	PROPN
admet-2551	642	11	tomoda	tomoda	PROPN
admet-2551	642	12	,	,	PUNCT
admet-2551	642	13	m.	m.	NOUN
admet-2551	642	14	isono	isono	NOUN
admet-2551	642	15	.	.	PUNCT
admet-2551	643	1	serratia	serratia	NOUN
admet-2551	643	2	protease	protease	NOUN
admet-2551	643	3	:	:	PUNCT
admet-2551	643	4	part	part	NOUN
admet-2551	643	5	i.	i.	PROPN
admet-2551	643	6	purification	purification	PROPN
admet-2551	643	7	and	and	CCONJ
admet-2551	643	8	general	general	ADJ
admet-2551	643	9	properties	property	NOUN
admet-2551	643	10	of	of	ADP
admet-2551	643	11	the	the	DET
admet-2551	643	12	enzyme	enzyme	NOUN
admet-2551	643	13	.	.	PUNCT
admet-2551	644	1	agricultural	agricultural	ADJ
admet-2551	644	2	and	and	CCONJ
admet-2551	644	3	biological	biological	ADJ
admet-2551	644	4	chemistry	chemistry	NOUN
admet-2551	644	5	34	34	NUM
admet-2551	644	6	(	(	PUNCT
admet-2551	644	7	1970	1970	NUM
admet-2551	644	8	)	)	PUNCT
admet-2551	644	9	310	310	NUM
admet-2551	644	10	-	-	SYM
admet-2551	644	11	318	318	NUM
admet-2551	644	12	.	.	PUNCT
admet-2551	645	1	https://doi.org/10.1080/00021369.1970.10859598	https://doi.org/10.1080/00021369.1970.10859598	PROPN
admet-2551	645	2	.	.	PUNCT
admet-2551	646	1	[	[	X
admet-2551	646	2	59	59	NUM
admet-2551	646	3	]	]	PUNCT
admet-2551	646	4	s.	s.	PROPN
admet-2551	646	5	ethiraj	ethiraj	PROPN
admet-2551	646	6	,	,	PUNCT
admet-2551	646	7	s.	s.	PROPN
admet-2551	646	8	gopinath	gopinath	PROPN
admet-2551	646	9	.	.	PUNCT
admet-2551	647	1	production	production	NOUN
admet-2551	647	2	,	,	PUNCT
admet-2551	647	3	purification	purification	NOUN
admet-2551	647	4	,	,	PUNCT
admet-2551	647	5	characterization	characterization	NOUN
admet-2551	647	6	,	,	PUNCT
admet-2551	647	7	immobilization	immobilization	NOUN
admet-2551	647	8	,	,	PUNCT
admet-2551	647	9	and	and	CCONJ
admet-2551	647	10	application	application	NOUN
admet-2551	647	11	of	of	ADP
admet-2551	647	12	serrapeptase	serrapeptase	NOUN
admet-2551	647	13	:	:	PUNCT
admet-2551	647	14	a	a	DET
admet-2551	647	15	review	review	NOUN
admet-2551	647	16	.	.	PUNCT
admet-2551	648	1	frontiers	frontier	NOUN
admet-2551	648	2	in	in	ADP
admet-2551	648	3	biology	biology	NOUN
admet-2551	648	4	12	12	NUM
admet-2551	648	5	(	(	PUNCT
admet-2551	648	6	2017	2017	NUM
admet-2551	648	7	)	)	PUNCT
admet-2551	648	8	333	333	NUM
admet-2551	648	9	-	-	SYM
admet-2551	648	10	348	348	NUM
admet-2551	648	11	.	.	PUNCT
admet-2551	649	1	https://doi.org/10.1007/s11515017-1461-3	https://doi.org/10.1007/s11515017-1461-3	PROPN
admet-2551	649	2	.	.	PUNCT
admet-2551	650	1	[	[	X
admet-2551	650	2	60	60	NUM
admet-2551	650	3	]	]	PUNCT
admet-2551	650	4	a.	a.	NOUN
admet-2551	650	5	raghvi	raghvi	PROPN
admet-2551	650	6	,	,	PUNCT
admet-2551	650	7	k.	k.	PROPN
admet-2551	650	8	priya	priya	PROPN
admet-2551	650	9	,	,	PUNCT
admet-2551	650	10	d.	d.	PROPN
admet-2551	650	11	balaji	balaji	PROPN
admet-2551	650	12	.	.	PUNCT
admet-2551	651	1	varied	vary	VERB
admet-2551	651	2	clinical	clinical	ADJ
admet-2551	651	3	presentations	presentation	NOUN
admet-2551	651	4	of	of	ADP
admet-2551	651	5	allergic	allergic	ADJ
admet-2551	651	6	fungal	fungal	ADJ
admet-2551	651	7	rhinosinusitis	rhinosinusitis	NOUN
admet-2551	651	8	-	-	PUNCT
admet-2551	651	9	a	a	DET
admet-2551	651	10	case	case	NOUN
admet-2551	651	11	series	series	NOUN
admet-2551	651	12	.	.	PUNCT
admet-2551	652	1	indian	indian	PROPN
admet-2551	652	2	journal	journal	PROPN
admet-2551	652	3	of	of	ADP
admet-2551	652	4	otolaryngology	otolaryngology	NOUN
admet-2551	652	5	and	and	CCONJ
admet-2551	652	6	head	head	NOUN
admet-2551	652	7	&	&	CCONJ
admet-2551	652	8	neck	neck	PROPN
admet-2551	652	9	surgery	surgery	NOUN
admet-2551	652	10	75	75	NUM
admet-2551	652	11	(	(	PUNCT
admet-2551	652	12	2023	2023	NUM
admet-2551	652	13	)	)	PUNCT
admet-2551	652	14	571	571	NUM
admet-2551	652	15	-	-	SYM
admet-2551	652	16	578	578	NUM
admet-2551	652	17	.	.	PUNCT
admet-2551	653	1	https://doi.org/10.1007/s12070-022-03338-0	https://doi.org/10.1007/s12070-022-03338-0	NOUN
admet-2551	653	2	.	.	PUNCT
admet-2551	654	1	[	[	X
admet-2551	654	2	61	61	NUM
admet-2551	654	3	]	]	PUNCT
admet-2551	654	4	r.	r.	PROPN
admet-2551	654	5	redfern	redfern	PROPN
admet-2551	654	6	.	.	PUNCT
admet-2551	655	1	the	the	DET
admet-2551	655	2	‘	'	PUNCT
admet-2551	655	3	miracle’enzyme	miracle’enzyme	NOUN
admet-2551	655	4	is	be	AUX
admet-2551	655	5	serrapeptase	serrapeptase	NOUN
admet-2551	655	6	,	,	PUNCT
admet-2551	655	7	the	the	DET
admet-2551	655	8	2nd	2nd	ADJ
admet-2551	655	9	gift	gift	NOUN
admet-2551	655	10	from	from	ADP
admet-2551	655	11	silkworms	silkworm	NOUN
admet-2551	655	12	giving	give	VERB
admet-2551	655	13	the	the	DET
admet-2551	655	14	answer	answer	NOUN
admet-2551	655	15	to	to	ADP
admet-2551	655	16	pain	pain	NOUN
admet-2551	655	17	,	,	PUNCT
admet-2551	655	18	inflammation	inflammation	NOUN
admet-2551	655	19	and	and	CCONJ
admet-2551	655	20	clear	clear	ADJ
admet-2551	655	21	arteries	artery	NOUN
admet-2551	655	22	.	.	PUNCT
admet-2551	656	1	naturally	naturally	ADV
admet-2551	656	2	healthy	healthy	ADJ
admet-2551	656	3	publications	publication	NOUN
admet-2551	656	4	,	,	PUNCT
admet-2551	656	5	2009	2009	NUM
admet-2551	656	6	,	,	PUNCT
admet-2551	656	7	isbn	isbn	ADJ
admet-2551	656	8	978	978	NUM
admet-2551	656	9	-	-	SYM
admet-2551	656	10	1910521007	1910521007	NUM
admet-2551	656	11	.	.	PUNCT
admet-2551	657	1	https://doi.org/10.5599/admet.2551	https://doi.org/10.5599/admet.2551	NOUN
admet-2551	657	2	https://doi.org/10.1016/j.seppur.2008.08.014	https://doi.org/10.1016/j.seppur.2008.08.014	PROPN
admet-2551	657	3	https://doi.org/10.1186/2191-0855-1-26	https://doi.org/10.1186/2191-0855-1-26	PROPN
admet-2551	657	4	https://doi.org/10.1016/j.ijbiomac.2006.10.001	https://doi.org/10.1016/j.ijbiomac.2006.10.001	PROPN
admet-2551	657	5	https://doi.org/10.1007/978-3-319-24708-3_10	https://doi.org/10.1007/978-3-319-24708-3_10	PROPN
admet-2551	657	6	https://doi.org/10.1007/978-3-319-24708-3_10	https://doi.org/10.1007/978-3-319-24708-3_10	PROPN
admet-2551	657	7	https://doi.org/10.1155/2023/4050730	https://doi.org/10.1155/2023/4050730	PROPN
admet-2551	657	8	https://doi.org/10.1016/j.ejphar.2008.05.037	https://doi.org/10.1016/j.ejphar.2008.05.037	VERB
admet-2551	657	9	https://www.minervamedica.it/en/journals/cardiovascular-surgery/article.php?cod=r37y2002n06a0891	https://www.minervamedica.it/en/journals/cardiovascular-surgery/article.php?cod=r37y2002n06a0891	NOUN
admet-2551	657	10	https://www.minervamedica.it/en/journals/cardiovascular-surgery/article.php?cod=r37y2002n06a0891	https://www.minervamedica.it/en/journals/cardiovascular-surgery/article.php?cod=r37y2002n06a0891	NOUN
admet-2551	657	11	https://doi.org/10.3389/fphar.2018.00636	https://doi.org/10.3389/fphar.2018.00636	NOUN
admet-2551	657	12	https://doi.org/10.1016/j.yjmcc.2016.08.004	https://doi.org/10.1016/j.yjmcc.2016.08.004	NOUN
admet-2551	657	13	https://doi.org/10.3390/biom12101468	https://doi.org/10.3390/biom12101468	NOUN
admet-2551	658	1	https://doi.org/https:/doi.org/10.1016/j.btre.2020.e00544	https://doi.org/https:/doi.org/10.1016/j.btre.2020.e00544	NOUN
admet-2551	658	2	https://doi.org/10.1007/s002530051056	https://doi.org/10.1007/s002530051056	NOUN
admet-2551	658	3	https://doi.org/10.1080/00021369.1970.10859598	https://doi.org/10.1080/00021369.1970.10859598	ADV
admet-2551	658	4	https://doi.org/10.1007/s11515-017-1461-3	https://doi.org/10.1007/s11515-017-1461-3	PROPN
admet-2551	658	5	https://doi.org/10.1007/s11515-017-1461-3	https://doi.org/10.1007/s11515-017-1461-3	PROPN
admet-2551	658	6	https://doi.org/10.1007/s12070-022-03338-0	https://doi.org/10.1007/s12070-022-03338-0	PROPN
admet-2551	658	7	s.	s.	PROPN
admet-2551	658	8	k.	k.	PROPN
admet-2551	659	1	metkar	metkar	PROPN
admet-2551	659	2	et	et	PROPN
admet-2551	659	3	al	al	PROPN
admet-2551	659	4	.	.	PROPN
admet-2551	659	5	admet	admet	PROPN
admet-2551	659	6	&	&	CCONJ
admet-2551	659	7	dmpk	dmpk	PROPN
admet-2551	659	8	12(6	12(6	NUM
admet-2551	659	9	)	)	PUNCT
admet-2551	659	10	(	(	PUNCT
admet-2551	659	11	2024	2024	NUM
admet-2551	659	12	)	)	PUNCT
admet-2551	659	13	797	797	NUM
admet-2551	659	14	-	-	SYM
admet-2551	659	15	820	820	NUM
admet-2551	659	16	814	814	NUM
admet-2551	659	17	https://www.amazon.com/miracle-enzyme-serrapeptase-silkwormsinflammation/dp/1910521000/ref=monarch_sidesheet_title	https://www.amazon.com/miracle-enzyme-serrapeptase-silkwormsinflammation/dp/1910521000/ref=monarch_sidesheet_title	NOUN
admet-2551	659	18	#	#	NOUN
admet-2551	659	19	[	[	X
admet-2551	659	20	62	62	NUM
admet-2551	659	21	]	]	PUNCT
admet-2551	659	22	k.	k.	PROPN
admet-2551	659	23	matsumoto	matsumoto	PROPN
admet-2551	659	24	,	,	PUNCT
admet-2551	659	25	h.	h.	PROPN
admet-2551	659	26	maeda	maeda	PROPN
admet-2551	659	27	,	,	PUNCT
admet-2551	659	28	k.	k.	PROPN
admet-2551	659	29	takata	takata	PROPN
admet-2551	659	30	,	,	PUNCT
admet-2551	659	31	r.	r.	PROPN
admet-2551	659	32	kamata	kamata	PROPN
admet-2551	659	33	,	,	PUNCT
admet-2551	659	34	r.	r.	PROPN
admet-2551	659	35	okamura	okamura	PROPN
admet-2551	659	36	.	.	PUNCT
admet-2551	660	1	purification	purification	NOUN
admet-2551	660	2	and	and	CCONJ
admet-2551	660	3	characterization	characterization	NOUN
admet-2551	660	4	of	of	ADP
admet-2551	660	5	four	four	NUM
admet-2551	660	6	proteases	protease	NOUN
admet-2551	660	7	from	from	ADP
admet-2551	660	8	a	a	DET
admet-2551	660	9	clinical	clinical	ADJ
admet-2551	660	10	isolate	isolate	NOUN
admet-2551	660	11	of	of	ADP
admet-2551	660	12	serratia	serratia	PROPN
admet-2551	660	13	marcescens	marcescens	PROPN
admet-2551	660	14	kums	kums	PROPN
admet-2551	660	15	3958	3958	NUM
admet-2551	660	16	.	.	PUNCT
admet-2551	661	1	journal	journal	NOUN
admet-2551	661	2	of	of	ADP
admet-2551	661	3	bacteriology	bacteriology	PROPN
admet-2551	661	4	157	157	NUM
admet-2551	661	5	(	(	PUNCT
admet-2551	661	6	1984	1984	NUM
admet-2551	661	7	)	)	PUNCT
admet-2551	661	8	225	225	NUM
admet-2551	661	9	-	-	SYM
admet-2551	661	10	232	232	NUM
admet-2551	661	11	.	.	PUNCT
admet-2551	662	1	https://doi.org/10.1128/jb.157.1.225-232.1984	https://doi.org/10.1128/jb.157.1.225-232.1984	PROPN
admet-2551	662	2	.	.	PUNCT
admet-2551	663	1	[	[	X
admet-2551	663	2	63	63	NUM
admet-2551	663	3	]	]	PUNCT
admet-2551	663	4	k.	k.	PROPN
admet-2551	663	5	nakahama	nakahama	PROPN
admet-2551	663	6	,	,	PUNCT
admet-2551	663	7	k.	k.	PROPN
admet-2551	663	8	yoshimura	yoshimura	PROPN
admet-2551	663	9	,	,	PUNCT
admet-2551	663	10	r.	r.	PROPN
admet-2551	663	11	marumoto	marumoto	PROPN
admet-2551	663	12	,	,	PUNCT
admet-2551	663	13	m.	m.	PROPN
admet-2551	663	14	kikuchi	kikuchi	PROPN
admet-2551	663	15	,	,	PUNCT
admet-2551	663	16	i.s	i.s	PROPN
admet-2551	663	17	.	.	PROPN
admet-2551	663	18	lee	lee	PROPN
admet-2551	663	19	,	,	PUNCT
admet-2551	663	20	t.	t.	PROPN
admet-2551	663	21	hase	hase	PROPN
admet-2551	663	22	,	,	PUNCT
admet-2551	663	23	h.	h.	PROPN
admet-2551	663	24	matsubara	matsubara	PROPN
admet-2551	663	25	.	.	PUNCT
admet-2551	664	1	cloning	cloning	NOUN
admet-2551	664	2	and	and	CCONJ
admet-2551	664	3	sequencing	sequencing	NOUN
admet-2551	664	4	of	of	ADP
admet-2551	664	5	serratia	serratia	NOUN
admet-2551	664	6	protease	protease	NOUN
admet-2551	664	7	gene	gene	NOUN
admet-2551	664	8	.	.	PUNCT
admet-2551	665	1	nucleic	nucleic	ADJ
admet-2551	665	2	acids	acid	NOUN
admet-2551	665	3	research	research	NOUN
admet-2551	665	4	14	14	NUM
admet-2551	665	5	(	(	PUNCT
admet-2551	665	6	1986	1986	NUM
admet-2551	665	7	)	)	PUNCT
admet-2551	665	8	5843	5843	NUM
admet-2551	665	9	-	-	SYM
admet-2551	665	10	5855	5855	NUM
admet-2551	665	11	.	.	PUNCT
admet-2551	666	1	https://doi.org/10.1093/nar/14.14.5843	https://doi.org/10.1093/nar/14.14.5843	NOUN
admet-2551	666	2	.	.	PUNCT
admet-2551	667	1	[	[	X
admet-2551	667	2	64	64	NUM
admet-2551	667	3	]	]	PUNCT
admet-2551	667	4	v.	v.	CCONJ
admet-2551	667	5	gupte	gupte	PROPN
admet-2551	667	6	,	,	PUNCT
admet-2551	667	7	u.	u.	PROPN
admet-2551	667	8	luthra	luthra	PROPN
admet-2551	667	9	.	.	PUNCT
admet-2551	668	1	analytical	analytical	ADJ
admet-2551	668	2	techniques	technique	NOUN
admet-2551	668	3	for	for	ADP
admet-2551	668	4	serratiopeptidase	serratiopeptidase	ADJ
admet-2551	668	5	:	:	PUNCT
admet-2551	668	6	a	a	DET
admet-2551	668	7	review	review	NOUN
admet-2551	668	8	.	.	PUNCT
admet-2551	669	1	journal	journal	NOUN
admet-2551	669	2	of	of	ADP
admet-2551	669	3	pharmaceutical	pharmaceutical	ADJ
admet-2551	669	4	analysis	analysis	NOUN
admet-2551	669	5	7	7	NUM
admet-2551	669	6	(	(	PUNCT
admet-2551	669	7	2017	2017	NUM
admet-2551	669	8	)	)	PUNCT
admet-2551	669	9	203	203	NUM
admet-2551	669	10	-	-	SYM
admet-2551	669	11	207	207	NUM
admet-2551	669	12	.	.	PUNCT
admet-2551	670	1	https://doi.org/10.1016/j.jpha.2017.03.005	https://doi.org/10.1016/j.jpha.2017.03.005	NUM
admet-2551	670	2	.	.	PUNCT
admet-2551	671	1	[	[	X
admet-2551	671	2	65	65	NUM
admet-2551	671	3	]	]	PUNCT
admet-2551	671	4	k.	k.	PROPN
admet-2551	671	5	tao	tao	PROPN
admet-2551	671	6	,	,	PUNCT
admet-2551	671	7	x.	x.	PROPN
admet-2551	671	8	yu	yu	PROPN
admet-2551	671	9	,	,	PUNCT
admet-2551	671	10	y.	y.	PROPN
admet-2551	671	11	liu	liu	PROPN
admet-2551	671	12	,	,	PUNCT
admet-2551	671	13	g.	g.	PROPN
admet-2551	671	14	shi	shi	PROPN
admet-2551	671	15	,	,	PUNCT
admet-2551	671	16	s.	s.	PROPN
admet-2551	671	17	liu	liu	PROPN
admet-2551	671	18	,	,	PUNCT
admet-2551	671	19	t.	t.	PROPN
admet-2551	671	20	hou	hou	PROPN
admet-2551	671	21	.	.	PUNCT
admet-2551	672	1	cloning	cloning	NOUN
admet-2551	672	2	,	,	PUNCT
admet-2551	672	3	expression	expression	NOUN
admet-2551	672	4	,	,	PUNCT
admet-2551	672	5	and	and	CCONJ
admet-2551	672	6	purification	purification	NOUN
admet-2551	672	7	of	of	ADP
admet-2551	672	8	insecticidal	insecticidal	NOUN
admet-2551	672	9	protein	protein	NOUN
admet-2551	672	10	pr596	pr596	PROPN
admet-2551	672	11	from	from	ADP
admet-2551	672	12	locust	locust	NOUN
admet-2551	672	13	pathogen	pathogen	NOUN
admet-2551	672	14	serratia	serratia	PROPN
admet-2551	672	15	marcescens	marcescens	PROPN
admet-2551	672	16	hr-3	hr-3	PROPN
admet-2551	672	17	.	.	PUNCT
admet-2551	673	1	current	current	ADJ
admet-2551	673	2	microbiology	microbiology	NOUN
admet-2551	673	3	55	55	NUM
admet-2551	673	4	(	(	PUNCT
admet-2551	673	5	2007	2007	NUM
admet-2551	673	6	)	)	PUNCT
admet-2551	673	7	228	228	NUM
admet-2551	673	8	-	-	SYM
admet-2551	673	9	233	233	NUM
admet-2551	673	10	.	.	PUNCT
admet-2551	674	1	https://doi.org/10.1007/s00284-007-0096-z	https://doi.org/10.1007/s00284-007-0096-z	NOUN
admet-2551	674	2	.	.	PUNCT
admet-2551	675	1	[	[	X
admet-2551	675	2	66	66	NUM
admet-2551	675	3	]	]	PUNCT
admet-2551	675	4	s.c	s.c	PROPN
admet-2551	675	5	.	.	PROPN
admet-2551	675	6	braunagel	braunagel	PROPN
admet-2551	675	7	,	,	PUNCT
admet-2551	675	8	m.j	m.j	PROPN
admet-2551	675	9	.	.	PROPN
admet-2551	675	10	benedik	benedik	PROPN
admet-2551	675	11	.	.	PUNCT
admet-2551	676	1	the	the	DET
admet-2551	676	2	metalloprotease	metalloprotease	ADJ
admet-2551	676	3	gene	gene	NOUN
admet-2551	676	4	of	of	ADP
admet-2551	676	5	serratia	serratia	PROPN
admet-2551	676	6	marcescens	marcescen	NOUN
admet-2551	676	7	strain	strain	VERB
admet-2551	676	8	sm6	sm6	ADV
admet-2551	676	9	.	.	PUNCT
admet-2551	677	1	molecular	molecular	ADJ
admet-2551	677	2	and	and	CCONJ
admet-2551	677	3	general	general	ADJ
admet-2551	677	4	genetics	genetic	NOUN
admet-2551	677	5	mgg	mgg	PROPN
admet-2551	677	6	222	222	NUM
admet-2551	677	7	(	(	PUNCT
admet-2551	677	8	1990	1990	NUM
admet-2551	677	9	)	)	PUNCT
admet-2551	677	10	446	446	NUM
admet-2551	677	11	-	-	SYM
admet-2551	677	12	451	451	NUM
admet-2551	677	13	.	.	PUNCT
admet-2551	678	1	https://doi.org/10.1007/bf00633854	https://doi.org/10.1007/bf00633854	X
admet-2551	678	2	.	.	PUNCT
admet-2551	679	1	[	[	X
admet-2551	679	2	67	67	NUM
admet-2551	679	3	]	]	PUNCT
admet-2551	679	4	s.	s.	PROPN
admet-2551	679	5	letoffe	letoffe	PROPN
admet-2551	679	6	,	,	PUNCT
admet-2551	679	7	p.	p.	NOUN
admet-2551	679	8	delepelaire	delepelaire	PROPN
admet-2551	679	9	,	,	PUNCT
admet-2551	679	10	c.	c.	PROPN
admet-2551	679	11	wandersman	wandersman	NOUN
admet-2551	679	12	.	.	PUNCT
admet-2551	680	1	cloning	cloning	NOUN
admet-2551	680	2	and	and	CCONJ
admet-2551	680	3	expression	expression	NOUN
admet-2551	680	4	in	in	ADP
admet-2551	680	5	escherichia	escherichia	NOUN
admet-2551	680	6	coli	coli	NOUN
admet-2551	680	7	of	of	ADP
admet-2551	680	8	the	the	DET
admet-2551	680	9	serratia	serratia	NOUN
admet-2551	680	10	marcescens	marcescens	PROPN
admet-2551	680	11	metalloprotease	metalloprotease	PROPN
admet-2551	680	12	gene	gene	NOUN
admet-2551	680	13	:	:	PUNCT
admet-2551	680	14	secretion	secretion	NOUN
admet-2551	680	15	of	of	ADP
admet-2551	680	16	the	the	DET
admet-2551	680	17	protease	protease	NOUN
admet-2551	680	18	from	from	ADP
admet-2551	680	19	e.	e.	PROPN
admet-2551	680	20	coli	coli	NOUN
admet-2551	680	21	in	in	ADP
admet-2551	680	22	the	the	DET
admet-2551	680	23	presence	presence	NOUN
admet-2551	680	24	of	of	ADP
admet-2551	680	25	the	the	DET
admet-2551	680	26	erwinia	erwinia	NOUN
admet-2551	680	27	chrysanthemi	chrysanthemi	NOUN
admet-2551	680	28	protease	protease	NOUN
admet-2551	680	29	secretion	secretion	NOUN
admet-2551	680	30	functions	function	NOUN
admet-2551	680	31	.	.	PUNCT
admet-2551	681	1	journal	journal	NOUN
admet-2551	681	2	of	of	ADP
admet-2551	681	3	bacteriology	bacteriology	NOUN
admet-2551	681	4	173	173	NUM
admet-2551	681	5	(	(	PUNCT
admet-2551	681	6	1991	1991	NUM
admet-2551	681	7	)	)	PUNCT
admet-2551	681	8	2160	2160	NUM
admet-2551	681	9	-	-	SYM
admet-2551	681	10	2166	2166	NUM
admet-2551	681	11	.	.	PUNCT
admet-2551	682	1	https://doi.org/10.1128/jb.173.7.2160-2166.1991	https://doi.org/10.1128/jb.173.7.2160-2166.1991	X
admet-2551	682	2	.	.	PUNCT
admet-2551	683	1	[	[	X
admet-2551	683	2	68	68	NUM
admet-2551	683	3	]	]	X
admet-2551	683	4	n.	n.	PROPN
admet-2551	683	5	moriya	moriya	PROPN
admet-2551	683	6	,	,	PUNCT
admet-2551	683	7	m.	m.	NOUN
admet-2551	683	8	nakata	nakata	PROPN
admet-2551	683	9	,	,	PUNCT
admet-2551	683	10	m.	m.	NOUN
admet-2551	683	11	nakamura	nakamura	PROPN
admet-2551	683	12	,	,	PUNCT
admet-2551	683	13	m.	m.	NOUN
admet-2551	683	14	takaoka	takaoka	PROPN
admet-2551	683	15	,	,	PUNCT
admet-2551	683	16	s.	s.	PROPN
admet-2551	683	17	iwasa	iwasa	PROPN
admet-2551	683	18	,	,	PUNCT
admet-2551	683	19	k.	k.	PROPN
admet-2551	683	20	kato	kato	PROPN
admet-2551	683	21	,	,	PUNCT
admet-2551	683	22	a.	a.	PROPN
admet-2551	683	23	kakinuma	kakinuma	PROPN
admet-2551	683	24	.	.	PUNCT
admet-2551	684	1	intestinal	intestinal	ADJ
admet-2551	684	2	absorption	absorption	NOUN
admet-2551	684	3	of	of	ADP
admet-2551	684	4	serrapeptase	serrapeptase	NOUN
admet-2551	684	5	(	(	PUNCT
admet-2551	684	6	tsp	tsp	NOUN
admet-2551	684	7	)	)	PUNCT
admet-2551	684	8	in	in	ADP
admet-2551	684	9	rats	rat	NOUN
admet-2551	684	10	.	.	PUNCT
admet-2551	685	1	biotechnology	biotechnology	NOUN
admet-2551	685	2	and	and	CCONJ
admet-2551	685	3	applied	apply	VERB
admet-2551	685	4	biochemistry	biochemistry	NOUN
admet-2551	685	5	20	20	NUM
admet-2551	685	6	(	(	PUNCT
admet-2551	685	7	1994	1994	NUM
admet-2551	685	8	)	)	PUNCT
admet-2551	685	9	101	101	NUM
admet-2551	685	10	-	-	SYM
admet-2551	685	11	108	108	NUM
admet-2551	685	12	.	.	PUNCT
admet-2551	686	1	https://doi.org/10.1111/j.1470-8744.1994.tb00308.x	https://doi.org/10.1111/j.1470-8744.1994.tb00308.x	PROPN
admet-2551	686	2	.	.	PUNCT
admet-2551	687	1	[	[	X
admet-2551	687	2	69	69	NUM
admet-2551	687	3	]	]	PUNCT
admet-2551	687	4	s.	s.	PROPN
admet-2551	687	5	bhagat	bhagat	PROPN
admet-2551	687	6	,	,	PUNCT
admet-2551	687	7	m.	m.	NOUN
admet-2551	687	8	agarwal	agarwal	PROPN
admet-2551	687	9	,	,	PUNCT
admet-2551	687	10	v.	v.	PROPN
admet-2551	687	11	roy	roy	PROPN
admet-2551	687	12	.	.	PROPN
admet-2551	687	13	serratiopeptidase	serratiopeptidase	PROPN
admet-2551	687	14	:	:	PUNCT
admet-2551	687	15	a	a	DET
admet-2551	687	16	systematic	systematic	ADJ
admet-2551	687	17	review	review	NOUN
admet-2551	687	18	of	of	ADP
admet-2551	687	19	the	the	DET
admet-2551	687	20	existing	exist	VERB
admet-2551	687	21	evidence	evidence	NOUN
admet-2551	687	22	.	.	PUNCT
admet-2551	688	1	international	international	ADJ
admet-2551	688	2	journal	journal	NOUN
admet-2551	688	3	of	of	ADP
admet-2551	688	4	surgery	surgery	NOUN
admet-2551	688	5	11	11	NUM
admet-2551	688	6	(	(	PUNCT
admet-2551	688	7	2013	2013	NUM
admet-2551	688	8	)	)	PUNCT
admet-2551	688	9	209	209	NUM
admet-2551	688	10	-	-	SYM
admet-2551	688	11	217	217	NUM
admet-2551	688	12	.	.	PUNCT
admet-2551	689	1	https://doi.org/10.1016/j.ijsu.2013.01.010	https://doi.org/10.1016/j.ijsu.2013.01.010	NOUN
admet-2551	689	2	.	.	PUNCT
admet-2551	690	1	[	[	X
admet-2551	690	2	70	70	NUM
admet-2551	690	3	]	]	X
admet-2551	690	4	g.c	g.c	PROPN
admet-2551	690	5	.	.	PROPN
admet-2551	690	6	jickling	jickling	PROPN
admet-2551	690	7	,	,	PUNCT
admet-2551	690	8	x.	x.	PROPN
admet-2551	690	9	zhan	zhan	PROPN
admet-2551	690	10	,	,	PUNCT
admet-2551	690	11	b.p	b.p	PROPN
admet-2551	690	12	.	.	PROPN
admet-2551	690	13	ander	ander	PROPN
admet-2551	690	14	,	,	PUNCT
admet-2551	690	15	r.j	r.j	PROPN
admet-2551	690	16	.	.	PROPN
admet-2551	690	17	turner	turner	PROPN
admet-2551	690	18	,	,	PUNCT
admet-2551	690	19	b.	b.	PROPN
admet-2551	690	20	stamova	stamova	PROPN
admet-2551	690	21	,	,	PUNCT
admet-2551	690	22	h.	h.	PROPN
admet-2551	690	23	xu	xu	PROPN
admet-2551	690	24	,	,	PUNCT
admet-2551	690	25	y.	y.	PROPN
admet-2551	690	26	tian	tian	PROPN
admet-2551	690	27	,	,	PUNCT
admet-2551	690	28	d.	d.	PROPN
admet-2551	690	29	liu	liu	PROPN
admet-2551	690	30	,	,	PUNCT
admet-2551	690	31	r.r	r.r	PROPN
admet-2551	690	32	.	.	PROPN
admet-2551	690	33	davis	davis	PROPN
admet-2551	690	34	,	,	PUNCT
admet-2551	690	35	p.a	p.a	PROPN
admet-2551	690	36	.	.	PROPN
admet-2551	690	37	lapchak	lapchak	PROPN
admet-2551	690	38	.	.	PUNCT
admet-2551	691	1	genome	genome	NOUN
admet-2551	691	2	response	response	NOUN
admet-2551	691	3	to	to	ADP
admet-2551	691	4	tissue	tissue	NOUN
admet-2551	691	5	plasminogen	plasminogen	NOUN
admet-2551	691	6	activator	activator	NOUN
admet-2551	691	7	in	in	ADP
admet-2551	691	8	experimental	experimental	ADJ
admet-2551	691	9	ischemic	ischemic	ADJ
admet-2551	691	10	stroke	stroke	NOUN
admet-2551	691	11	.	.	PUNCT
admet-2551	692	1	bmc	bmc	ADJ
admet-2551	692	2	genomics	genomic	NOUN
admet-2551	692	3	11	11	NUM
admet-2551	692	4	(	(	PUNCT
admet-2551	692	5	2010	2010	NUM
admet-2551	692	6	)	)	PUNCT
admet-2551	692	7	254	254	NUM
admet-2551	692	8	.	.	PUNCT
admet-2551	693	1	https://doi.org/10.1186/1471-2164-11-254	https://doi.org/10.1186/1471-2164-11-254	X
admet-2551	693	2	.	.	PUNCT
admet-2551	694	1	[	[	X
admet-2551	694	2	71	71	NUM
admet-2551	694	3	]	]	X
admet-2551	694	4	j.f	j.f	PROPN
admet-2551	694	5	.	.	PROPN
admet-2551	694	6	mei	mei	PROPN
admet-2551	694	7	,	,	PUNCT
admet-2551	694	8	s.f	s.f	PROPN
admet-2551	694	9	.	.	PROPN
admet-2551	694	10	cai	cai	PROPN
admet-2551	694	11	,	,	PUNCT
admet-2551	694	12	y.	y.	PROPN
admet-2551	694	13	yi	yi	PROPN
admet-2551	694	14	,	,	PUNCT
admet-2551	694	15	x.d	x.d	PROPN
admet-2551	694	16	.	.	PROPN
admet-2551	694	17	wang	wang	PROPN
admet-2551	694	18	,	,	PUNCT
admet-2551	694	19	g.q	g.q	PROPN
admet-2551	694	20	.	.	PROPN
admet-2551	694	21	ying	ying	PROPN
admet-2551	694	22	.	.	PUNCT
admet-2551	695	1	study	study	NOUN
admet-2551	695	2	of	of	ADP
admet-2551	695	3	the	the	DET
admet-2551	695	4	fibrinolytic	fibrinolytic	ADJ
admet-2551	695	5	activity	activity	NOUN
admet-2551	695	6	of	of	ADP
admet-2551	695	7	serrapeptase	serrapeptase	NOUN
admet-2551	695	8	and	and	CCONJ
admet-2551	695	9	its	its	PRON
admet-2551	695	10	in	in	X
admet-2551	695	11	vitro	vitro	X
admet-2551	695	12	thrombolytic	thrombolytic	ADJ
admet-2551	695	13	effects	effect	NOUN
admet-2551	695	14	.	.	PUNCT
admet-2551	696	1	brazilian	brazilian	ADJ
admet-2551	696	2	journal	journal	PROPN
admet-2551	696	3	of	of	ADP
admet-2551	696	4	pharmaceutical	pharmaceutical	PROPN
admet-2551	696	5	sciences	science	NOUN
admet-2551	696	6	58	58	NUM
admet-2551	696	7	(	(	PUNCT
admet-2551	696	8	2022	2022	NUM
admet-2551	696	9	)	)	PUNCT
admet-2551	696	10	e201004	e201004	NOUN
admet-2551	696	11	.	.	PUNCT
admet-2551	696	12	https://doi.org/10.1590/s2175-97902022e201004	https://doi.org/10.1590/s2175-97902022e201004	PROPN
admet-2551	696	13	.	.	PUNCT
admet-2551	697	1	[	[	X
admet-2551	697	2	72	72	NUM
admet-2551	697	3	]	]	PUNCT
admet-2551	697	4	t.	t.	PROPN
admet-2551	697	5	al	al	PROPN
admet-2551	697	6	-	-	PUNCT
admet-2551	697	7	khateeb	khateeb	PROPN
admet-2551	697	8	,	,	PUNCT
admet-2551	697	9	y.	y.	NOUN
admet-2551	697	10	nusair	nusair	NOUN
admet-2551	697	11	.	.	PUNCT
admet-2551	698	1	effect	effect	NOUN
admet-2551	698	2	of	of	ADP
admet-2551	698	3	the	the	DET
admet-2551	698	4	proteolytic	proteolytic	ADJ
admet-2551	698	5	enzyme	enzyme	NOUN
admet-2551	698	6	serrapeptase	serrapeptase	NOUN
admet-2551	698	7	on	on	ADP
admet-2551	698	8	swelling	swelling	NOUN
admet-2551	698	9	,	,	PUNCT
admet-2551	698	10	pain	pain	NOUN
admet-2551	698	11	and	and	CCONJ
admet-2551	698	12	trismus	trismus	NOUN
admet-2551	698	13	after	after	ADP
admet-2551	698	14	surgical	surgical	ADJ
admet-2551	698	15	extraction	extraction	NOUN
admet-2551	698	16	of	of	ADP
admet-2551	698	17	mandibular	mandibular	ADJ
admet-2551	698	18	third	third	ADJ
admet-2551	698	19	molars	molar	NOUN
admet-2551	698	20	.	.	PUNCT
admet-2551	699	1	international	international	ADJ
admet-2551	699	2	journal	journal	NOUN
admet-2551	699	3	of	of	ADP
admet-2551	699	4	oral	oral	ADJ
admet-2551	699	5	and	and	CCONJ
admet-2551	699	6	maxillofacial	maxillofacial	ADJ
admet-2551	699	7	surgery	surgery	NOUN
admet-2551	699	8	37	37	NUM
admet-2551	699	9	(	(	PUNCT
admet-2551	699	10	2008	2008	NUM
admet-2551	699	11	)	)	PUNCT
admet-2551	699	12	264	264	NUM
admet-2551	699	13	-	-	SYM
admet-2551	699	14	268	268	NUM
admet-2551	699	15	.	.	PUNCT
admet-2551	700	1	https://doi.org/10.1016/j.ijom.2007.11.011	https://doi.org/10.1016/j.ijom.2007.11.011	NOUN
admet-2551	700	2	.	.	PUNCT
admet-2551	701	1	[	[	X
admet-2551	701	2	73	73	NUM
admet-2551	701	3	]	]	SYM
admet-2551	701	4	s.p	s.p	PROPN
admet-2551	701	5	.	.	PROPN
admet-2551	701	6	jadav	jadav	PROPN
admet-2551	701	7	,	,	PUNCT
admet-2551	701	8	n.h	n.h	PROPN
admet-2551	701	9	.	.	PROPN
admet-2551	701	10	patel	patel	PROPN
admet-2551	701	11	,	,	PUNCT
admet-2551	701	12	t.g	t.g	PROPN
admet-2551	701	13	.	.	PROPN
admet-2551	701	14	shah	shah	PROPN
admet-2551	701	15	,	,	PUNCT
admet-2551	701	16	m.v	m.v	PROPN
admet-2551	701	17	.	.	PROPN
admet-2551	701	18	gajera	gajera	PROPN
admet-2551	701	19	,	,	PUNCT
admet-2551	701	20	h.r	h.r	PROPN
admet-2551	701	21	.	.	PROPN
admet-2551	701	22	trivedi	trivedi	PROPN
admet-2551	701	23	,	,	PUNCT
admet-2551	701	24	b.k	b.k	PROPN
admet-2551	701	25	.	.	PROPN
admet-2551	701	26	shah	shah	PROPN
admet-2551	701	27	.	.	PUNCT
admet-2551	702	1	comparison	comparison	NOUN
admet-2551	702	2	of	of	ADP
admet-2551	702	3	antiinflammatory	antiinflammatory	NOUN
admet-2551	702	4	activity	activity	NOUN
admet-2551	702	5	of	of	ADP
admet-2551	702	6	serratiopeptidase	serratiopeptidase	NOUN
admet-2551	702	7	and	and	CCONJ
admet-2551	702	8	diclofenac	diclofenac	NOUN
admet-2551	702	9	in	in	ADP
admet-2551	702	10	albino	albino	NOUN
admet-2551	702	11	rats	rat	NOUN
admet-2551	702	12	.	.	PUNCT
admet-2551	703	1	journal	journal	NOUN
admet-2551	703	2	of	of	ADP
admet-2551	703	3	pharmacology	pharmacology	NOUN
admet-2551	703	4	and	and	CCONJ
admet-2551	703	5	pharmacotherapeutics	pharmacotherapeutic	NOUN
admet-2551	703	6	1	1	NUM
admet-2551	703	7	(	(	PUNCT
admet-2551	703	8	2010	2010	NUM
admet-2551	703	9	)	)	PUNCT
admet-2551	703	10	116	116	NUM
admet-2551	703	11	-	-	SYM
admet-2551	703	12	117	117	NUM
admet-2551	703	13	.	.	PUNCT
admet-2551	704	1	https://doi.org/10.4103/0976500x.72362	https://doi.org/10.4103/0976500x.72362	PROPN
admet-2551	704	2	.	.	PUNCT
admet-2551	705	1	[	[	X
admet-2551	705	2	74	74	NUM
admet-2551	705	3	]	]	PUNCT
admet-2551	705	4	k.	k.	PROPN
admet-2551	705	5	suma	suma	PROPN
admet-2551	705	6	,	,	PUNCT
admet-2551	705	7	h.	h.	PROPN
admet-2551	705	8	manasa	manasa	PROPN
admet-2551	705	9	,	,	PUNCT
admet-2551	705	10	a.	a.	PROPN
admet-2551	705	11	likhitha	likhitha	PROPN
admet-2551	705	12	,	,	PUNCT
admet-2551	705	13	t.	t.	PROPN
admet-2551	705	14	nagamani	nagamani	PROPN
admet-2551	705	15	.	.	PUNCT
admet-2551	706	1	isolation	isolation	NOUN
admet-2551	706	2	,	,	PUNCT
admet-2551	706	3	purification	purification	NOUN
admet-2551	706	4	,	,	PUNCT
admet-2551	706	5	and	and	CCONJ
admet-2551	706	6	characterization	characterization	NOUN
admet-2551	706	7	of	of	ADP
admet-2551	706	8	serratiopeptidase	serratiopeptidase	ADJ
admet-2551	706	9	enzyme	enzyme	NOUN
admet-2551	706	10	from	from	ADP
admet-2551	706	11	serratia	serratia	PROPN
admet-2551	706	12	marcescens	marcescens	PROPN
admet-2551	706	13	.	.	PUNCT
admet-2551	707	1	int	int	NOUN
admet-2551	707	2	.	.	PUNCT
admet-2551	708	1	j.	j.	PROPN
admet-2551	708	2	innov	innov	PROPN
admet-2551	708	3	.	.	PUNCT
admet-2551	709	1	sci	sci	PROPN
admet-2551	709	2	.	.	PUNCT
admet-2551	709	3	res	res	PROPN
admet-2551	709	4	.	.	PUNCT
admet-2551	710	1	technol	technol	NOUN
admet-2551	710	2	5	5	NUM
admet-2551	710	3	(	(	PUNCT
admet-2551	710	4	2020	2020	NUM
admet-2551	710	5	)	)	PUNCT
admet-2551	710	6	156161	156161	NUM
admet-2551	710	7	.	.	PUNCT
admet-2551	711	1	https://doi.org/10.38124/ijisrt20jul135	https://doi.org/10.38124/ijisrt20jul135	X
admet-2551	711	2	.	.	PUNCT
admet-2551	712	1	[	[	X
admet-2551	712	2	75	75	NUM
admet-2551	712	3	]	]	PUNCT
admet-2551	712	4	d.	d.	PROPN
admet-2551	712	5	kumar	kumar	PROPN
admet-2551	712	6	,	,	PUNCT
admet-2551	712	7	d.	d.	PROPN
admet-2551	712	8	verma	verma	PROPN
admet-2551	712	9	,	,	PUNCT
admet-2551	712	10	v.	v.	ADP
admet-2551	712	11	abbot	abbot	NOUN
admet-2551	712	12	.	.	PUNCT
admet-2551	713	1	a	a	DET
admet-2551	713	2	review	review	NOUN
admet-2551	713	3	on	on	ADP
admet-2551	713	4	pharmaceutical	pharmaceutical	NOUN
admet-2551	713	5	,	,	PUNCT
admet-2551	713	6	pharmacological	pharmacological	NOUN
admet-2551	713	7	and	and	CCONJ
admet-2551	713	8	chemical	chemical	NOUN
admet-2551	713	9	aspects	aspect	NOUN
admet-2551	713	10	of	of	ADP
admet-2551	713	11	serratiopeptidase	serratiopeptidase	PROPN
admet-2551	713	12	as	as	ADP
admet-2551	713	13	anti	anti	ADJ
admet-2551	713	14	-	-	ADJ
admet-2551	713	15	inflammatory	inflammatory	ADJ
admet-2551	713	16	agent	agent	NOUN
admet-2551	713	17	.	.	PUNCT
admet-2551	714	1	materials	material	NOUN
admet-2551	714	2	today	today	NOUN
admet-2551	714	3	:	:	PUNCT
admet-2551	714	4	proceedings	proceeding	NOUN
admet-2551	714	5	(	(	PUNCT
admet-2551	714	6	2023	2023	NUM
admet-2551	714	7	)	)	PUNCT
admet-2551	714	8	.	.	PUNCT
admet-2551	715	1	https://doi.org/10.1016/j.matpr.2023.01.256	https://doi.org/10.1016/j.matpr.2023.01.256	PROPN
admet-2551	715	2	.	.	PUNCT
admet-2551	716	1	[	[	X
admet-2551	716	2	76	76	NUM
admet-2551	716	3	]	]	X
admet-2551	716	4	b.p	b.p	PROPN
admet-2551	716	5	.	.	PROPN
admet-2551	716	6	krishna	krishna	PROPN
admet-2551	716	7	,	,	PUNCT
admet-2551	716	8	b.p	b.p	PROPN
admet-2551	716	9	.	.	PROPN
admet-2551	716	10	reddy	reddy	PROPN
admet-2551	716	11	,	,	PUNCT
admet-2551	716	12	d.y	d.y	PROPN
admet-2551	716	13	.	.	PROPN
admet-2551	716	14	kumar	kumar	PROPN
admet-2551	716	15	,	,	PUNCT
admet-2551	716	16	m.	m.	PROPN
admet-2551	716	17	ummar	ummar	PROPN
admet-2551	716	18	,	,	PUNCT
admet-2551	716	19	v.	v.	CCONJ
admet-2551	716	20	shekhar	shekhar	PROPN
admet-2551	716	21	,	,	PUNCT
admet-2551	716	22	r.v.c	r.v.c	PROPN
admet-2551	716	23	.	.	PROPN
admet-2551	716	24	tiwari	tiwari	PROPN
admet-2551	716	25	.	.	PUNCT
admet-2551	717	1	role	role	NOUN
admet-2551	717	2	of	of	ADP
admet-2551	717	3	serratiopeptidase	serratiopeptidase	PROPN
admet-2551	717	4	and	and	CCONJ
admet-2551	717	5	dexamethasone	dexamethasone	NOUN
admet-2551	717	6	in	in	ADP
admet-2551	717	7	the	the	DET
admet-2551	717	8	control	control	NOUN
admet-2551	717	9	of	of	ADP
admet-2551	717	10	postoperative	postoperative	ADJ
admet-2551	717	11	swelling	swelling	NOUN
admet-2551	717	12	.	.	PUNCT
admet-2551	718	1	annals	annal	NOUN
admet-2551	718	2	of	of	ADP
admet-2551	718	3	maxillofacial	maxillofacial	ADJ
admet-2551	718	4	surgery	surgery	NOUN
admet-2551	718	5	10	10	NUM
admet-2551	718	6	(	(	PUNCT
admet-2551	718	7	2020	2020	NUM
admet-2551	718	8	)	)	PUNCT
admet-2551	718	9	108	108	NUM
admet-2551	718	10	-	-	SYM
admet-2551	718	11	113	113	NUM
admet-2551	718	12	.	.	PUNCT
admet-2551	719	1	https://doi.org/10.4103/ams.ams_249_19	https://doi.org/10.4103/ams.ams_249_19	NOUN
admet-2551	719	2	.	.	PUNCT
admet-2551	720	1	[	[	X
admet-2551	720	2	77	77	X
admet-2551	720	3	]	]	X
admet-2551	720	4	v.	v.	CCONJ
admet-2551	720	5	yadav	yadav	PROPN
admet-2551	720	6	,	,	PUNCT
admet-2551	720	7	s.	s.	PROPN
admet-2551	720	8	sharma	sharma	PROPN
admet-2551	720	9	,	,	PUNCT
admet-2551	720	10	a.	a.	PROPN
admet-2551	720	11	kumar	kumar	PROPN
admet-2551	720	12	,	,	PUNCT
admet-2551	720	13	s.	s.	PROPN
admet-2551	720	14	singh	singh	PROPN
admet-2551	720	15	,	,	PUNCT
admet-2551	720	16	v.	v.	ADP
admet-2551	720	17	ravichandiran	ravichandiran	ADJ
admet-2551	720	18	.	.	PUNCT
admet-2551	721	1	serratiopeptidase	serratiopeptidase	PROPN
admet-2551	721	2	attenuates	attenuate	VERB
admet-2551	721	3	lipopolysaccharide	lipopolysaccharide	ADV
admet-2551	721	4	-	-	PUNCT
admet-2551	721	5	induced	induce	VERB
admet-2551	721	6	vascular	vascular	ADJ
admet-2551	721	7	inflammation	inflammation	NOUN
admet-2551	721	8	by	by	ADP
admet-2551	721	9	inhibiting	inhibit	VERB
admet-2551	721	10	the	the	DET
admet-2551	721	11	expression	expression	NOUN
admet-2551	721	12	of	of	ADP
admet-2551	721	13	monocyte	monocyte	PROPN
admet-2551	721	14	chemoattractant	chemoattractant	PROPN
admet-2551	721	15	protein-1	protein-1	PROPN
admet-2551	721	16	.	.	PUNCT
admet-2551	722	1	current	current	ADJ
admet-2551	722	2	issues	issue	NOUN
admet-2551	722	3	in	in	ADP
admet-2551	722	4	molecular	molecular	ADJ
admet-2551	722	5	biology	biology	NOUN
admet-2551	722	6	45	45	NUM
admet-2551	722	7	(	(	PUNCT
admet-2551	722	8	2023	2023	NUM
admet-2551	722	9	)	)	PUNCT
admet-2551	722	10	2201	2201	NUM
admet-2551	722	11	-	-	SYM
admet-2551	722	12	2212	2212	NUM
admet-2551	722	13	.	.	PUNCT
admet-2551	723	1	https://doi.org/10.3390/cimb45030142	https://doi.org/10.3390/cimb45030142	PROPN
admet-2551	723	2	.	.	PUNCT
admet-2551	724	1	https://www.amazon.com/miracle-enzyme-serrapeptase-silkworms-inflammation/dp/1910521000/ref=monarch_sidesheet_title%23	https://www.amazon.com/miracle-enzyme-serrapeptase-silkworms-inflammation/dp/1910521000/ref=monarch_sidesheet_title%23	NOUN
admet-2551	724	2	https://www.amazon.com/miracle-enzyme-serrapeptase-silkworms-inflammation/dp/1910521000/ref=monarch_sidesheet_title%23	https://www.amazon.com/miracle-enzyme-serrapeptase-silkworms-inflammation/dp/1910521000/ref=monarch_sidesheet_title%23	X
admet-2551	724	3	https://doi.org/10.1128/jb.157.1.225-232.1984	https://doi.org/10.1128/jb.157.1.225-232.1984	PROPN
admet-2551	724	4	https://doi.org/10.1093/nar/14.14.5843	https://doi.org/10.1093/nar/14.14.5843	PROPN
admet-2551	724	5	https://doi.org/10.1016/j.jpha.2017.03.005	https://doi.org/10.1016/j.jpha.2017.03.005	NUM
admet-2551	724	6	https://doi.org/10.1007/s00284-007-0096-z	https://doi.org/10.1007/s00284-007-0096-z	PROPN
admet-2551	725	1	https://doi.org/10.1007/bf00633854	https://doi.org/10.1007/bf00633854	ADJ
admet-2551	725	2	https://doi.org/10.1128/jb.173.7.2160-2166.1991	https://doi.org/10.1128/jb.173.7.2160-2166.1991	PRON
admet-2551	725	3	https://doi.org/10.1111/j.1470-8744.1994.tb00308.x	https://doi.org/10.1111/j.1470-8744.1994.tb00308.x	PROPN
admet-2551	725	4	https://doi.org/10.1016/j.ijsu.2013.01.010	https://doi.org/10.1016/j.ijsu.2013.01.010	PROPN
admet-2551	725	5	https://doi.org/10.1186/1471-2164-11-254	https://doi.org/10.1186/1471-2164-11-254	PROPN
admet-2551	725	6	https://doi.org/10.1590/s2175-97902022e201004	https://doi.org/10.1590/s2175-97902022e201004	PROPN
admet-2551	725	7	https://doi.org/10.1016/j.ijom.2007.11.011	https://doi.org/10.1016/j.ijom.2007.11.011	NUM
admet-2551	725	8	https://doi.org/10.4103/0976-500x.72362	https://doi.org/10.4103/0976-500x.72362	PROPN
admet-2551	725	9	https://doi.org/10.4103/0976-500x.72362	https://doi.org/10.4103/0976-500x.72362	PROPN
admet-2551	725	10	https://doi.org/10.38124/ijisrt20jul135	https://doi.org/10.38124/ijisrt20jul135	NUM
admet-2551	725	11	https://doi.org/10.1016/j.matpr.2023.01.256	https://doi.org/10.1016/j.matpr.2023.01.256	PROPN
admet-2551	725	12	https://doi.org/10.4103/ams.ams_249_19	https://doi.org/10.4103/ams.ams_249_19	PROPN
admet-2551	725	13	https://doi.org/10.3390/cimb45030142	https://doi.org/10.3390/cimb45030142	PROPN
admet-2551	725	14	admet	admet	PROPN
admet-2551	725	15	&	&	CCONJ
admet-2551	725	16	dmpk	dmpk	PROPN
admet-2551	725	17	12(6	12(6	NUM
admet-2551	725	18	)	)	PUNCT
admet-2551	725	19	(	(	PUNCT
admet-2551	725	20	2024	2024	NUM
admet-2551	725	21	)	)	PUNCT
admet-2551	725	22	797	797	NUM
admet-2551	725	23	-	-	SYM
admet-2551	725	24	820	820	NUM
admet-2551	725	25	natural	natural	ADJ
admet-2551	725	26	serine	serine	NOUN
admet-2551	725	27	proteases	protease	NOUN
admet-2551	725	28	in	in	ADP
admet-2551	725	29	combating	combat	VERB
admet-2551	725	30	amyloid	amyloid	NOUN
admet-2551	725	31	formation	formation	NOUN
admet-2551	725	32	doi	doi	NOUN
admet-2551	725	33	:	:	PUNCT
admet-2551	725	34	https://doi.org/10.5599/admet.2551	https://doi.org/10.5599/admet.2551	NOUN
admet-2551	725	35	815	815	NUM
admet-2551	726	1	[	[	X
admet-2551	726	2	78	78	NUM
admet-2551	726	3	]	]	X
admet-2551	726	4	v.d	v.d	PROPN
admet-2551	726	5	.	.	PROPN
admet-2551	726	6	menon	menon	PROPN
admet-2551	726	7	,	,	PUNCT
admet-2551	726	8	m.	m.	NOUN
admet-2551	726	9	muthusekhar	muthusekhar	PROPN
admet-2551	726	10	.	.	PROPN
admet-2551	726	11	effectiveness	effectiveness	NOUN
admet-2551	726	12	of	of	ADP
admet-2551	726	13	anti	anti	ADJ
admet-2551	726	14	-	-	ADJ
admet-2551	726	15	inflammatory	inflammatory	ADJ
admet-2551	726	16	properties	property	NOUN
admet-2551	726	17	of	of	ADP
admet-2551	726	18	combination	combination	NOUN
admet-2551	726	19	of	of	ADP
admet-2551	726	20	bromelain	bromelain	NOUN
admet-2551	726	21	,	,	PUNCT
admet-2551	726	22	trypsin	trypsin	NOUN
admet-2551	726	23	and	and	CCONJ
admet-2551	726	24	rutoside	rutoside	NOUN
admet-2551	726	25	with	with	ADP
admet-2551	726	26	combination	combination	NOUN
admet-2551	726	27	of	of	ADP
admet-2551	726	28	diclofenac	diclofenac	NOUN
admet-2551	726	29	and	and	CCONJ
admet-2551	726	30	serratiopeptidase	serratiopeptidase	VERB
admet-2551	726	31	following	follow	VERB
admet-2551	726	32	surgical	surgical	ADJ
admet-2551	726	33	removal	removal	NOUN
admet-2551	726	34	of	of	ADP
admet-2551	726	35	impacted	impact	VERB
admet-2551	726	36	mandibular	mandibular	ADJ
admet-2551	726	37	third	third	ADJ
admet-2551	726	38	molar	molar	NOUN
admet-2551	726	39	-	-	PUNCT
admet-2551	726	40	a	a	DET
admet-2551	726	41	randomised	randomised	ADJ
admet-2551	726	42	double	double	ADJ
admet-2551	726	43	blinded	blind	VERB
admet-2551	726	44	clinical	clinical	ADJ
admet-2551	726	45	trial	trial	NOUN
admet-2551	726	46	.	.	PUNCT
admet-2551	727	1	int	int	NOUN
admet-2551	727	2	j	j	PROPN
admet-2551	727	3	dentistry	dentistry	PROPN
admet-2551	727	4	oral	oral	ADJ
admet-2551	727	5	sci	sci	PROPN
admet-2551	727	6	8	8	NUM
admet-2551	727	7	(	(	PUNCT
admet-2551	727	8	2021	2021	NUM
admet-2551	727	9	)	)	PUNCT
admet-2551	727	10	4217	4217	NUM
admet-2551	727	11	-	-	SYM
admet-2551	727	12	4221	4221	NUM
admet-2551	727	13	.	.	PUNCT
admet-2551	728	1	https://doi.org/dx.doi.org/10.19070/2377-8075-21000859	https://doi.org/dx.doi.org/10.19070/2377-8075-21000859	X
admet-2551	728	2	.	.	PUNCT
admet-2551	729	1	[	[	X
admet-2551	729	2	79	79	NUM
admet-2551	729	3	]	]	X
admet-2551	729	4	j.k	j.k	PROPN
admet-2551	729	5	.	.	PROPN
admet-2551	729	6	mammdoh	mammdoh	PROPN
admet-2551	729	7	,	,	PUNCT
admet-2551	729	8	l.h	l.h	PROPN
admet-2551	729	9	.	.	PROPN
admet-2551	729	10	al	al	PROPN
admet-2551	729	11	-	-	PUNCT
admet-2551	729	12	alsadoon	alsadoon	PROPN
admet-2551	729	13	,	,	PUNCT
admet-2551	729	14	g.a	g.a	PROPN
admet-2551	729	15	.	.	PROPN
admet-2551	729	16	taqa	taqa	PROPN
admet-2551	729	17	,	,	PUNCT
admet-2551	729	18	a.a	a.a	PROPN
admet-2551	729	19	.	.	PROPN
admet-2551	729	20	taqa	taqa	PROPN
admet-2551	729	21	.	.	PUNCT
admet-2551	730	1	evaluation	evaluation	NOUN
admet-2551	730	2	of	of	ADP
admet-2551	730	3	anti	anti	ADJ
admet-2551	730	4	-	-	ADJ
admet-2551	730	5	inflammatory	inflammatory	ADJ
admet-2551	730	6	effect	effect	NOUN
admet-2551	730	7	of	of	ADP
admet-2551	730	8	topical	topical	ADJ
admet-2551	730	9	serratiopeptidase	serratiopeptidase	NOUN
admet-2551	730	10	in	in	ADP
admet-2551	730	11	mice	mouse	NOUN
admet-2551	730	12	.	.	PUNCT
admet-2551	731	1	inflammation	inflammation	NOUN
admet-2551	731	2	12	12	NUM
admet-2551	731	3	(	(	PUNCT
admet-2551	731	4	2022	2022	NUM
admet-2551	731	5	)	)	PUNCT
admet-2551	731	6	13	13	NUM
admet-2551	731	7	.	.	PUNCT
admet-2551	732	1	https://doi.org/10.25258/ijddt.12.1.29	https://doi.org/10.25258/ijddt.12.1.29	NOUN
admet-2551	732	2	.	.	PUNCT
admet-2551	733	1	[	[	X
admet-2551	733	2	80	80	NUM
admet-2551	733	3	]	]	PUNCT
admet-2551	733	4	a.	a.	NOUN
admet-2551	733	5	mazzone	mazzone	NOUN
admet-2551	733	6	,	,	PUNCT
admet-2551	733	7	m.	m.	NOUN
admet-2551	733	8	catalani	catalani	PROPN
admet-2551	733	9	,	,	PUNCT
admet-2551	733	10	m.	m.	NOUN
admet-2551	733	11	costanzo	costanzo	PROPN
admet-2551	733	12	,	,	PUNCT
admet-2551	733	13	a.	a.	PROPN
admet-2551	733	14	drusian	drusian	PROPN
admet-2551	733	15	,	,	PUNCT
admet-2551	733	16	a.	a.	NOUN
admet-2551	733	17	mandoli	mandoli	PROPN
admet-2551	733	18	,	,	PUNCT
admet-2551	733	19	s.	s.	PROPN
admet-2551	733	20	russo	russo	PROPN
admet-2551	733	21	,	,	PUNCT
admet-2551	733	22	e.	e.	PROPN
admet-2551	733	23	guarini	guarini	PROPN
admet-2551	733	24	,	,	PUNCT
admet-2551	733	25	g.	g.	PROPN
admet-2551	733	26	vesperini	vesperini	PROPN
admet-2551	733	27	.	.	PUNCT
admet-2551	734	1	evaluation	evaluation	NOUN
admet-2551	734	2	of	of	ADP
admet-2551	734	3	serratia	serratia	NOUN
admet-2551	734	4	peptidase	peptidase	NOUN
admet-2551	734	5	in	in	ADP
admet-2551	734	6	acute	acute	ADJ
admet-2551	734	7	or	or	CCONJ
admet-2551	734	8	chronic	chronic	ADJ
admet-2551	734	9	inflammation	inflammation	NOUN
admet-2551	734	10	of	of	ADP
admet-2551	734	11	otorhinolaryngology	otorhinolaryngology	NOUN
admet-2551	734	12	pathology	pathology	NOUN
admet-2551	734	13	:	:	PUNCT
admet-2551	734	14	a	a	DET
admet-2551	734	15	multicentre	multicentre	NOUN
admet-2551	734	16	,	,	PUNCT
admet-2551	734	17	double	double	ADJ
admet-2551	734	18	-	-	PUNCT
admet-2551	734	19	blind	blind	ADJ
admet-2551	734	20	,	,	PUNCT
admet-2551	734	21	randomized	randomize	VERB
admet-2551	734	22	trial	trial	NOUN
admet-2551	734	23	versus	versus	ADP
admet-2551	734	24	placebo	placebo	NOUN
admet-2551	734	25	.	.	PUNCT
admet-2551	735	1	journal	journal	PROPN
admet-2551	735	2	of	of	ADP
admet-2551	735	3	international	international	PROPN
admet-2551	735	4	medical	medical	ADJ
admet-2551	735	5	research	research	NOUN
admet-2551	735	6	18	18	NUM
admet-2551	735	7	(	(	PUNCT
admet-2551	735	8	1990	1990	NUM
admet-2551	735	9	)	)	PUNCT
admet-2551	735	10	379	379	NUM
admet-2551	735	11	-	-	SYM
admet-2551	735	12	388	388	NUM
admet-2551	735	13	.	.	PUNCT
admet-2551	736	1	https://doi.org/10.1177/0300060590018005	https://doi.org/10.1177/0300060590018005	NOUN
admet-2551	736	2	.	.	PUNCT
admet-2551	737	1	[	[	X
admet-2551	737	2	81	81	NUM
admet-2551	737	3	]	]	PUNCT
admet-2551	737	4	a.	a.	NOUN
admet-2551	737	5	dhiman	dhiman	NOUN
admet-2551	737	6	,	,	PUNCT
admet-2551	737	7	r.	r.	PROPN
admet-2551	737	8	purohit	purohit	PROPN
admet-2551	737	9	.	.	PUNCT
admet-2551	738	1	identification	identification	NOUN
admet-2551	738	2	of	of	ADP
admet-2551	738	3	potential	potential	ADJ
admet-2551	738	4	mutational	mutational	ADJ
admet-2551	738	5	hotspots	hotspot	NOUN
admet-2551	738	6	in	in	ADP
admet-2551	738	7	serratiopeptidase	serratiopeptidase	PROPN
admet-2551	738	8	to	to	PART
admet-2551	738	9	address	address	VERB
admet-2551	738	10	its	its	PRON
admet-2551	738	11	poor	poor	ADJ
admet-2551	738	12	ph	ph	ADJ
admet-2551	738	13	tolerance	tolerance	NOUN
admet-2551	738	14	issue	issue	NOUN
admet-2551	738	15	.	.	PUNCT
admet-2551	739	1	journal	journal	NOUN
admet-2551	739	2	of	of	ADP
admet-2551	739	3	biomolecular	biomolecular	ADJ
admet-2551	739	4	structure	structure	NOUN
admet-2551	739	5	and	and	CCONJ
admet-2551	739	6	dynamics	dynamic	NOUN
admet-2551	739	7	41	41	NUM
admet-2551	739	8	(	(	PUNCT
admet-2551	739	9	2023	2023	NUM
admet-2551	739	10	)	)	PUNCT
admet-2551	739	11	8831	8831	NUM
admet-2551	739	12	-	-	SYM
admet-2551	739	13	8843	8843	NUM
admet-2551	739	14	.	.	PUNCT
admet-2551	740	1	https://doi.org/10.1080/07391102.2022.2137699	https://doi.org/10.1080/07391102.2022.2137699	NOUN
admet-2551	740	2	.	.	PUNCT
admet-2551	741	1	[	[	X
admet-2551	741	2	82	82	NUM
admet-2551	741	3	]	]	PUNCT
admet-2551	741	4	a.	a.	NOUN
admet-2551	741	5	dhiman	dhiman	NOUN
admet-2551	741	6	,	,	PUNCT
admet-2551	741	7	r.	r.	PROPN
admet-2551	741	8	purohit	purohit	PROPN
admet-2551	741	9	.	.	PUNCT
admet-2551	742	1	targeting	target	VERB
admet-2551	742	2	tachykinin	tachykinin	NOUN
admet-2551	742	3	peptides	peptide	NOUN
admet-2551	742	4	involved	involve	VERB
admet-2551	742	5	in	in	ADP
admet-2551	742	6	viral	viral	ADJ
admet-2551	742	7	infections	infection	NOUN
admet-2551	742	8	through	through	ADP
admet-2551	742	9	in	in	ADP
admet-2551	742	10	silico	silico	NOUN
admet-2551	742	11	approach	approach	NOUN
admet-2551	742	12	:	:	PUNCT
admet-2551	742	13	screening	screen	VERB
admet-2551	742	14	the	the	DET
admet-2551	742	15	unforeseen	unforeseen	ADJ
admet-2551	742	16	potency	potency	NOUN
admet-2551	742	17	of	of	ADP
admet-2551	742	18	serratiopeptidase	serratiopeptidase	PROPN
admet-2551	742	19	.	.	PUNCT
admet-2551	743	1	journal	journal	PROPN
admet-2551	743	2	of	of	ADP
admet-2551	743	3	molecular	molecular	ADJ
admet-2551	743	4	liquids	liquid	NOUN
admet-2551	743	5	392	392	NUM
admet-2551	743	6	(	(	PUNCT
admet-2551	743	7	2023	2023	NUM
admet-2551	743	8	)	)	PUNCT
admet-2551	743	9	123504	123504	NUM
admet-2551	743	10	.	.	PUNCT
admet-2551	744	1	https://doi.org/10.1016/j.molliq.2023.123504	https://doi.org/10.1016/j.molliq.2023.123504	PROPN
admet-2551	744	2	.	.	PUNCT
admet-2551	745	1	[	[	X
admet-2551	745	2	83	83	NUM
admet-2551	745	3	]	]	X
admet-2551	745	4	k.k	k.k	PROPN
admet-2551	745	5	.	.	PROPN
admet-2551	745	6	gupta	gupta	PROPN
admet-2551	745	7	,	,	PUNCT
admet-2551	745	8	a.	a.	PROPN
admet-2551	745	9	rahman	rahman	PROPN
admet-2551	745	10	,	,	PUNCT
admet-2551	745	11	a.	a.	PROPN
admet-2551	745	12	kumar	kumar	PROPN
admet-2551	745	13	,	,	PUNCT
admet-2551	745	14	p.	p.	PROPN
admet-2551	745	15	gavel	gavel	NOUN
admet-2551	745	16	,	,	PUNCT
admet-2551	745	17	p.	p.	PROPN
admet-2551	745	18	asia	asia	PROPN
admet-2551	745	19	.	.	PUNCT
admet-2551	746	1	adjuvant	adjuvant	ADJ
admet-2551	746	2	therapy	therapy	NOUN
admet-2551	746	3	with	with	ADP
admet-2551	746	4	serratiopeptidase	serratiopeptidase	PROPN
admet-2551	746	5	and	and	CCONJ
admet-2551	746	6	vitamin	vitamin	NOUN
admet-2551	746	7	d	d	NOUN
admet-2551	746	8	for	for	ADP
admet-2551	746	9	covid-19	covid-19	PROPN
admet-2551	746	10	patients	patient	NOUN
admet-2551	746	11	:	:	PUNCT
admet-2551	746	12	a	a	DET
admet-2551	746	13	new	new	ADJ
admet-2551	746	14	perspective	perspective	NOUN
admet-2551	746	15	.	.	PUNCT
admet-2551	747	1	int	int	NOUN
admet-2551	747	2	.	.	PUNCT
admet-2551	748	1	j.	j.	PROPN
admet-2551	748	2	med	med	PROPN
admet-2551	748	3	.	.	PUNCT
admet-2551	749	1	sci	sci	PROPN
admet-2551	749	2	4	4	NUM
admet-2551	749	3	(	(	PUNCT
admet-2551	749	4	2021	2021	NUM
admet-2551	749	5	)	)	PUNCT
admet-2551	749	6	282	282	NUM
admet-2551	749	7	-	-	SYM
admet-2551	749	8	287	287	NUM
admet-2551	749	9	.	.	PUNCT
admet-2551	750	1	https://www.researchgate.net/publication/352282548_adjuvant_therapy_with_serratiopeptidase	https://www.researchgate.net/publication/352282548_adjuvant_therapy_with_serratiopeptidase	VERB
admet-2551	751	1	_	_	PRON
admet-2551	752	1	and_vitamin_d_for_covid-19_patients_a_new_perspective	and_vitamin_d_for_covid-19_patients_a_new_perspective	NOUN
admet-2551	752	2	[	[	X
admet-2551	752	3	84	84	NUM
admet-2551	752	4	]	]	X
admet-2551	752	5	y.	y.	PROPN
admet-2551	752	6	kase	kase	PROPN
admet-2551	752	7	,	,	PUNCT
admet-2551	752	8	h.	h.	PROPN
admet-2551	752	9	seo	seo	PROPN
admet-2551	752	10	,	,	PUNCT
admet-2551	752	11	y.	y.	PROPN
admet-2551	752	12	oyama	oyama	PROPN
admet-2551	752	13	,	,	PUNCT
admet-2551	752	14	m.	m.	NOUN
admet-2551	752	15	sakata	sakata	PROPN
admet-2551	752	16	,	,	PUNCT
admet-2551	752	17	k.	k.	PROPN
admet-2551	752	18	tomoda	tomoda	PROPN
admet-2551	752	19	,	,	PUNCT
admet-2551	752	20	k.	k.	PROPN
admet-2551	752	21	takahama	takahama	PROPN
admet-2551	752	22	,	,	PUNCT
admet-2551	752	23	t.	t.	PROPN
admet-2551	752	24	hitoshi	hitoshi	PROPN
admet-2551	752	25	,	,	PUNCT
admet-2551	752	26	y.	y.	PROPN
admet-2551	752	27	okano	okano	PROPN
admet-2551	752	28	,	,	PUNCT
admet-2551	752	29	t.	t.	PROPN
admet-2551	752	30	miyata	miyata	PROPN
admet-2551	752	31	.	.	PUNCT
admet-2551	753	1	a	a	DET
admet-2551	753	2	new	new	ADJ
admet-2551	753	3	method	method	NOUN
admet-2551	753	4	for	for	ADP
admet-2551	753	5	evaluating	evaluate	VERB
admet-2551	753	6	mucolytic	mucolytic	ADJ
admet-2551	753	7	expectorant	expectorant	NOUN
admet-2551	753	8	activity	activity	NOUN
admet-2551	753	9	and	and	CCONJ
admet-2551	753	10	its	its	PRON
admet-2551	753	11	application	application	NOUN
admet-2551	753	12	.	.	PUNCT
admet-2551	754	1	ii	ii	PROPN
admet-2551	754	2	.	.	PUNCT
admet-2551	754	3	application	application	NOUN
admet-2551	754	4	to	to	ADP
admet-2551	754	5	two	two	NUM
admet-2551	754	6	proteolytic	proteolytic	ADJ
admet-2551	754	7	enzymes	enzyme	NOUN
admet-2551	754	8	,	,	PUNCT
admet-2551	754	9	serratiopeptidase	serratiopeptidase	VERB
admet-2551	754	10	and	and	CCONJ
admet-2551	754	11	seaprose	seaprose	VERB
admet-2551	754	12	.	.	PUNCT
admet-2551	755	1	arzneimittel	arzneimittel	NOUN
admet-2551	755	2	-	-	PUNCT
admet-2551	755	3	forschung	forschung	VERB
admet-2551	755	4	32	32	NUM
admet-2551	755	5	(	(	PUNCT
admet-2551	755	6	1982	1982	NUM
admet-2551	755	7	)	)	PUNCT
admet-2551	755	8	374	374	NUM
admet-2551	755	9	-	-	SYM
admet-2551	755	10	378	378	NUM
admet-2551	755	11	.	.	PUNCT
admet-2551	756	1	https://europepmc.org/article/med/7049188	https://europepmc.org/article/med/7049188	NOUN
admet-2551	756	2	[	[	X
admet-2551	756	3	85	85	NUM
admet-2551	756	4	]	]	PUNCT
admet-2551	756	5	m.	m.	NOUN
admet-2551	756	6	gioia	gioia	PROPN
admet-2551	756	7	,	,	PUNCT
admet-2551	756	8	c.	c.	PROPN
admet-2551	756	9	ciaccio	ciaccio	PROPN
admet-2551	756	10	,	,	PUNCT
admet-2551	756	11	p.	p.	NOUN
admet-2551	756	12	calligari	calligari	PROPN
admet-2551	756	13	,	,	PUNCT
admet-2551	756	14	g.	g.	PROPN
admet-2551	756	15	de	de	X
admet-2551	756	16	simone	simone	PROPN
admet-2551	756	17	,	,	PUNCT
admet-2551	756	18	d.	d.	NOUN
admet-2551	756	19	sbardella	sbardella	PROPN
admet-2551	756	20	,	,	PUNCT
admet-2551	756	21	g.	g.	PROPN
admet-2551	756	22	tundo	tundo	PROPN
admet-2551	756	23	,	,	PUNCT
admet-2551	756	24	g.f	g.f	PROPN
admet-2551	756	25	.	.	PROPN
admet-2551	756	26	fasciglione	fasciglione	PROPN
admet-2551	756	27	,	,	PUNCT
admet-2551	756	28	a.	a.	PROPN
admet-2551	756	29	di	di	PROPN
admet-2551	756	30	masi	masi	PROPN
admet-2551	756	31	,	,	PUNCT
admet-2551	756	32	d.	d.	PROPN
admet-2551	756	33	di	di	PROPN
admet-2551	756	34	pierro	pierro	PROPN
admet-2551	756	35	,	,	PUNCT
admet-2551	756	36	a.	a.	PROPN
admet-2551	756	37	bocedi	bocedi	PROPN
admet-2551	756	38	.	.	PUNCT
admet-2551	757	1	role	role	NOUN
admet-2551	757	2	of	of	ADP
admet-2551	757	3	proteolytic	proteolytic	ADJ
admet-2551	757	4	enzymes	enzyme	NOUN
admet-2551	757	5	in	in	ADP
admet-2551	757	6	the	the	DET
admet-2551	757	7	covid-19	covid-19	PROPN
admet-2551	757	8	infection	infection	NOUN
admet-2551	757	9	and	and	CCONJ
admet-2551	757	10	promising	promise	VERB
admet-2551	757	11	therapeutic	therapeutic	ADJ
admet-2551	757	12	approaches	approach	NOUN
admet-2551	757	13	.	.	PUNCT
admet-2551	758	1	biochemical	biochemical	ADJ
admet-2551	758	2	pharmacology	pharmacology	NOUN
admet-2551	758	3	182	182	NUM
admet-2551	758	4	(	(	PUNCT
admet-2551	758	5	2020	2020	NUM
admet-2551	758	6	)	)	PUNCT
admet-2551	758	7	114225	114225	NUM
admet-2551	758	8	.	.	PUNCT
admet-2551	759	1	https://doi.org/10.1016/j.bcp.2020.114225	https://doi.org/10.1016/j.bcp.2020.114225	X
admet-2551	759	2	.	.	PUNCT
admet-2551	760	1	[	[	X
admet-2551	760	2	86	86	NUM
admet-2551	760	3	]	]	X
admet-2551	760	4	v.	v.	ADP
admet-2551	760	5	gomathy	gomathy	NOUN
admet-2551	760	6	,	,	PUNCT
admet-2551	760	7	v.	v.	ADP
admet-2551	760	8	manigandan	manigandan	PROPN
admet-2551	760	9	,	,	PUNCT
admet-2551	760	10	n.	n.	PROPN
admet-2551	760	11	vignesh	vignesh	PROPN
admet-2551	760	12	,	,	PUNCT
admet-2551	760	13	a.	a.	NOUN
admet-2551	760	14	thabitha	thabitha	PROPN
admet-2551	760	15	,	,	PUNCT
admet-2551	760	16	r.	r.	PROPN
admet-2551	760	17	saravanan	saravanan	PROPN
admet-2551	760	18	.	.	PUNCT
admet-2551	761	1	evaluation	evaluation	NOUN
admet-2551	761	2	of	of	ADP
admet-2551	761	3	antibacterial	antibacterial	ADJ
admet-2551	761	4	,	,	PUNCT
admet-2551	761	5	teratogenicity	teratogenicity	NOUN
admet-2551	761	6	and	and	CCONJ
admet-2551	761	7	antibiofilm	antibiofilm	VERB
admet-2551	761	8	effect	effect	NOUN
admet-2551	761	9	of	of	ADP
admet-2551	761	10	sulfated	sulfated	ADJ
admet-2551	761	11	chitosans	chitosan	NOUN
admet-2551	761	12	extracted	extract	VERB
admet-2551	761	13	from	from	ADP
admet-2551	761	14	marine	marine	ADJ
admet-2551	761	15	waste	waste	NOUN
admet-2551	761	16	against	against	ADP
admet-2551	761	17	microorganism	microorganism	NOUN
admet-2551	761	18	.	.	PUNCT
admet-2551	762	1	journal	journal	PROPN
admet-2551	762	2	of	of	ADP
admet-2551	762	3	bioactive	bioactive	PROPN
admet-2551	762	4	and	and	CCONJ
admet-2551	762	5	compatible	compatible	ADJ
admet-2551	762	6	polymers	polymer	NOUN
admet-2551	762	7	36	36	NUM
admet-2551	762	8	(	(	PUNCT
admet-2551	762	9	2021	2021	NUM
admet-2551	762	10	)	)	PUNCT
admet-2551	762	11	249	249	NUM
admet-2551	762	12	-	-	SYM
admet-2551	762	13	258	258	NUM
admet-2551	762	14	.	.	PUNCT
admet-2551	763	1	https://doi.org/10.1177/08839115211014225	https://doi.org/10.1177/08839115211014225	X
admet-2551	763	2	.	.	PUNCT
admet-2551	764	1	[	[	X
admet-2551	764	2	87	87	NUM
admet-2551	764	3	]	]	PUNCT
admet-2551	764	4	l.	l.	PROPN
admet-2551	764	5	selan	selan	PROPN
admet-2551	764	6	,	,	PUNCT
admet-2551	764	7	r.	r.	PROPN
admet-2551	764	8	papa	papa	PROPN
admet-2551	764	9	,	,	PUNCT
admet-2551	764	10	m.	m.	NOUN
admet-2551	764	11	tilotta	tilotta	NOUN
admet-2551	764	12	,	,	PUNCT
admet-2551	764	13	g.	g.	PROPN
admet-2551	764	14	vrenna	vrenna	PROPN
admet-2551	764	15	,	,	PUNCT
admet-2551	764	16	a.	a.	PROPN
admet-2551	764	17	carpentieri	carpentieri	PROPN
admet-2551	764	18	,	,	PUNCT
admet-2551	764	19	a.	a.	PROPN
admet-2551	764	20	amoresano	amoresano	PROPN
admet-2551	764	21	,	,	PUNCT
admet-2551	764	22	p.	p.	PROPN
admet-2551	764	23	pucci	pucci	PROPN
admet-2551	764	24	,	,	PUNCT
admet-2551	764	25	m.	m.	NOUN
admet-2551	764	26	artini	artini	PROPN
admet-2551	764	27	.	.	PUNCT
admet-2551	765	1	serratiopeptidase	serratiopeptidase	PROPN
admet-2551	765	2	:	:	PUNCT
admet-2551	765	3	a	a	DET
admet-2551	765	4	well	well	ADV
admet-2551	765	5	-	-	PUNCT
admet-2551	765	6	known	know	VERB
admet-2551	765	7	metalloprotease	metalloprotease	NOUN
admet-2551	765	8	with	with	ADP
admet-2551	765	9	a	a	DET
admet-2551	765	10	new	new	ADJ
admet-2551	765	11	non	non	ADJ
admet-2551	765	12	-	-	ADJ
admet-2551	765	13	proteolytic	proteolytic	ADJ
admet-2551	765	14	activity	activity	NOUN
admet-2551	765	15	against	against	ADP
admet-2551	765	16	s.	s.	PROPN
admet-2551	765	17	aureus	aureus	PROPN
admet-2551	765	18	biofilm	biofilm	NOUN
admet-2551	765	19	.	.	PUNCT
admet-2551	766	1	bmc	bmc	PROPN
admet-2551	766	2	microbiology	microbiology	NOUN
admet-2551	766	3	15	15	NUM
admet-2551	766	4	(	(	PUNCT
admet-2551	766	5	2015	2015	NUM
admet-2551	766	6	)	)	PUNCT
admet-2551	766	7	207	207	NUM
admet-2551	766	8	.	.	PUNCT
admet-2551	767	1	https://doi.org/10.1186/s12866-015-0548-8	https://doi.org/10.1186/s12866-015-0548-8	NUM
admet-2551	767	2	.	.	PUNCT
admet-2551	768	1	[	[	X
admet-2551	768	2	88	88	NUM
admet-2551	768	3	]	]	X
admet-2551	768	4	c.s	c.s	PROPN
admet-2551	768	5	.	.	PROPN
admet-2551	768	6	devi	devi	PROPN
admet-2551	768	7	,	,	PUNCT
admet-2551	768	8	r.	r.	PROPN
admet-2551	768	9	elizabeth	elizabeth	PROPN
admet-2551	768	10	joseph	joseph	PROPN
admet-2551	768	11	,	,	PUNCT
admet-2551	768	12	h.	h.	PROPN
admet-2551	768	13	saravanan	saravanan	PROPN
admet-2551	768	14	,	,	PUNCT
admet-2551	768	15	s.j	s.j	PROPN
admet-2551	768	16	.	.	PROPN
admet-2551	768	17	naine	naine	PROPN
admet-2551	768	18	,	,	PUNCT
admet-2551	768	19	v.m	v.m	PROPN
admet-2551	768	20	.	.	PROPN
admet-2551	768	21	srinivansan	srinivansan	PROPN
admet-2551	768	22	.	.	PUNCT
admet-2551	769	1	screening	screening	NOUN
admet-2551	769	2	and	and	CCONJ
admet-2551	769	3	molecular	molecular	ADJ
admet-2551	769	4	characterization	characterization	NOUN
admet-2551	769	5	of	of	ADP
admet-2551	769	6	serratia	serratia	PROPN
admet-2551	769	7	marcescens	marcescen	NOUN
admet-2551	769	8	vitsd2	vitsd2	PROPN
admet-2551	769	9	:	:	PUNCT
admet-2551	769	10	a	a	DET
admet-2551	769	11	strain	strain	NOUN
admet-2551	769	12	producing	produce	VERB
admet-2551	769	13	optimum	optimum	ADJ
admet-2551	769	14	serratiopeptidase	serratiopeptidase	ADJ
admet-2551	769	15	.	.	PUNCT
admet-2551	770	1	frontiers	frontier	NOUN
admet-2551	770	2	in	in	ADP
admet-2551	770	3	biology	biology	NOUN
admet-2551	770	4	8	8	NUM
admet-2551	770	5	(	(	PUNCT
admet-2551	770	6	2013	2013	NUM
admet-2551	770	7	)	)	PUNCT
admet-2551	770	8	632	632	NUM
admet-2551	770	9	-	-	SYM
admet-2551	770	10	639	639	NUM
admet-2551	770	11	.	.	PUNCT
admet-2551	771	1	https://doi.org/10.1007/s11515-013-1284-9	https://doi.org/10.1007/s11515-013-1284-9	NUM
admet-2551	771	2	.	.	PUNCT
admet-2551	772	1	[	[	X
admet-2551	772	2	89	89	NUM
admet-2551	772	3	]	]	PUNCT
admet-2551	772	4	m.	m.	NOUN
admet-2551	772	5	mecikoglu	mecikoglu	PROPN
admet-2551	772	6	,	,	PUNCT
admet-2551	772	7	b.	b.	PROPN
admet-2551	772	8	saygi	saygi	PROPN
admet-2551	772	9	,	,	PUNCT
admet-2551	772	10	y.	y.	PROPN
admet-2551	772	11	yildirim	yildirim	PROPN
admet-2551	772	12	,	,	PUNCT
admet-2551	772	13	e.	e.	PROPN
admet-2551	772	14	karadag	karadag	PROPN
admet-2551	772	15	-	-	PUNCT
admet-2551	772	16	saygi	saygi	PROPN
admet-2551	772	17	,	,	PUNCT
admet-2551	772	18	s.s	s.s	PROPN
admet-2551	772	19	.	.	PROPN
admet-2551	772	20	ramadan	ramadan	PROPN
admet-2551	772	21	,	,	PUNCT
admet-2551	772	22	t.	t.	PROPN
admet-2551	772	23	esemenli	esemenli	PROPN
admet-2551	772	24	.	.	PUNCT
admet-2551	773	1	the	the	DET
admet-2551	773	2	effect	effect	NOUN
admet-2551	773	3	of	of	ADP
admet-2551	773	4	proteolytic	proteolytic	ADJ
admet-2551	773	5	enzyme	enzyme	NOUN
admet-2551	773	6	serratiopeptidase	serratiopeptidase	VERB
admet-2551	773	7	in	in	ADP
admet-2551	773	8	the	the	DET
admet-2551	773	9	treatment	treatment	NOUN
admet-2551	773	10	of	of	ADP
admet-2551	773	11	experimental	experimental	ADJ
admet-2551	773	12	implant	implant	ADJ
admet-2551	773	13	-	-	PUNCT
admet-2551	773	14	related	relate	VERB
admet-2551	773	15	infection	infection	NOUN
admet-2551	773	16	.	.	PUNCT
admet-2551	774	1	jbjs	jbjs	PROPN
admet-2551	774	2	88	88	NUM
admet-2551	774	3	(	(	PUNCT
admet-2551	774	4	2006	2006	NUM
admet-2551	774	5	)	)	PUNCT
admet-2551	774	6	1208	1208	NUM
admet-2551	774	7	-	-	SYM
admet-2551	774	8	1214	1214	NUM
admet-2551	774	9	.	.	PUNCT
admet-2551	775	1	https://doi.org/10.2106/jbjs.e.00007	https://doi.org/10.2106/jbjs.e.00007	X
admet-2551	775	2	.	.	PUNCT
admet-2551	776	1	[	[	X
admet-2551	776	2	90	90	NUM
admet-2551	776	3	]	]	PUNCT
admet-2551	776	4	b.	b.	PROPN
admet-2551	776	5	vidmar	vidmar	PROPN
admet-2551	776	6	,	,	PUNCT
admet-2551	776	7	m.	m.	NOUN
admet-2551	776	8	vodovnik	vodovnik	PROPN
admet-2551	776	9	.	.	PUNCT
admet-2551	777	1	microbial	microbial	ADJ
admet-2551	777	2	keratinases	keratinase	NOUN
admet-2551	777	3	:	:	PUNCT
admet-2551	777	4	enzymes	enzyme	NOUN
admet-2551	777	5	with	with	ADP
admet-2551	777	6	promising	promise	VERB
admet-2551	777	7	biotechnological	biotechnological	ADJ
admet-2551	777	8	applications	application	NOUN
admet-2551	777	9	.	.	PUNCT
admet-2551	778	1	food	food	NOUN
admet-2551	778	2	technology	technology	NOUN
admet-2551	778	3	and	and	CCONJ
admet-2551	778	4	biotechnology	biotechnology	NOUN
admet-2551	778	5	56	56	NUM
admet-2551	778	6	(	(	PUNCT
admet-2551	778	7	2018	2018	NUM
admet-2551	778	8	)	)	PUNCT
admet-2551	778	9	312	312	NUM
admet-2551	778	10	-	-	SYM
admet-2551	778	11	328	328	NUM
admet-2551	778	12	.	.	PUNCT
admet-2551	779	1	https://doi.org/10.17113/ftb.56.03.18.5658	https://doi.org/10.17113/ftb.56.03.18.5658	PROPN
admet-2551	779	2	.	.	PUNCT
admet-2551	780	1	[	[	X
admet-2551	780	2	91	91	NUM
admet-2551	780	3	]	]	X
admet-2551	780	4	n.e	n.e	PROPN
admet-2551	780	5	.	.	PROPN
admet-2551	780	6	nnolim	nnolim	PROPN
admet-2551	780	7	,	,	PUNCT
admet-2551	780	8	c.c	c.c	PROPN
admet-2551	780	9	.	.	PROPN
admet-2551	780	10	udenigwe	udenigwe	PROPN
admet-2551	780	11	,	,	PUNCT
admet-2551	780	12	a.i	a.i	PROPN
admet-2551	780	13	.	.	PROPN
admet-2551	780	14	okoh	okoh	PROPN
admet-2551	780	15	,	,	PUNCT
admet-2551	780	16	u.u	u.u	PROPN
admet-2551	780	17	.	.	PROPN
admet-2551	780	18	nwodo	nwodo	PROPN
admet-2551	780	19	.	.	PUNCT
admet-2551	781	1	microbial	microbial	ADJ
admet-2551	781	2	keratinase	keratinase	NOUN
admet-2551	781	3	:	:	PUNCT
admet-2551	781	4	next	next	ADJ
admet-2551	781	5	generation	generation	NOUN
admet-2551	781	6	green	green	ADJ
admet-2551	781	7	catalyst	catalyst	NOUN
admet-2551	781	8	and	and	CCONJ
admet-2551	781	9	prospective	prospective	ADJ
admet-2551	781	10	applications	application	NOUN
admet-2551	781	11	.	.	PUNCT
admet-2551	782	1	frontiers	frontier	NOUN
admet-2551	782	2	in	in	ADP
admet-2551	782	3	microbiology	microbiology	NOUN
admet-2551	782	4	11	11	NUM
admet-2551	782	5	(	(	PUNCT
admet-2551	782	6	2020	2020	NUM
admet-2551	782	7	)	)	PUNCT
admet-2551	782	8	580164	580164	NUM
admet-2551	782	9	.	.	PUNCT
admet-2551	783	1	https://doi.org/10.3389/fmicb.2020.580164	https://doi.org/10.3389/fmicb.2020.580164	PROPN
admet-2551	783	2	.	.	PUNCT
admet-2551	784	1	[	[	X
admet-2551	784	2	92	92	NUM
admet-2551	784	3	]	]	X
admet-2551	784	4	s.b	s.b	PROPN
admet-2551	784	5	.	.	PROPN
admet-2551	784	6	prusiner	prusiner	NOUN
admet-2551	784	7	.	.	PUNCT
admet-2551	785	1	prions	prion	NOUN
admet-2551	785	2	.	.	PUNCT
admet-2551	786	1	proceedings	proceeding	NOUN
admet-2551	786	2	of	of	ADP
admet-2551	786	3	the	the	DET
admet-2551	786	4	national	national	PROPN
admet-2551	786	5	academy	academy	PROPN
admet-2551	786	6	of	of	ADP
admet-2551	786	7	sciences	sciences	PROPN
admet-2551	786	8	95	95	NUM
admet-2551	786	9	(	(	PUNCT
admet-2551	786	10	1998	1998	NUM
admet-2551	786	11	)	)	PUNCT
admet-2551	786	12	13363	13363	NUM
admet-2551	786	13	-	-	SYM
admet-2551	786	14	13383	13383	NUM
admet-2551	786	15	.	.	PUNCT
admet-2551	787	1	https://doi.org/10.1073/pnas.95.23.13363	https://doi.org/10.1073/pnas.95.23.13363	PROPN
admet-2551	787	2	.	.	PUNCT
admet-2551	788	1	https://doi.org/10.5599/admet.2551	https://doi.org/10.5599/admet.2551	NOUN
admet-2551	788	2	https://doi.org/dx.doi.org/10.19070/2377-8075-21000859	https://doi.org/dx.doi.org/10.19070/2377-8075-21000859	PUNCT
admet-2551	789	1	https://doi.org/10.25258/ijddt.12.1.29	https://doi.org/10.25258/ijddt.12.1.29	PROPN
admet-2551	789	2	https://doi.org/10.1177/0300060590018005	https://doi.org/10.1177/0300060590018005	PROPN
admet-2551	789	3	https://doi.org/10.1080/07391102.2022.2137699	https://doi.org/10.1080/07391102.2022.2137699	PROPN
admet-2551	789	4	https://doi.org/10.1016/j.molliq.2023.123504	https://doi.org/10.1016/j.molliq.2023.123504	PROPN
admet-2551	789	5	https://www.researchgate.net/publication/352282548_adjuvant_therapy_with_serratiopeptidase_and_vitamin_d_for_covid-19_patients_a_new_perspective	https://www.researchgate.net/publication/352282548_adjuvant_therapy_with_serratiopeptidase_and_vitamin_d_for_covid-19_patients_a_new_perspective	PROPN
admet-2551	790	1	https://www.researchgate.net/publication/352282548_adjuvant_therapy_with_serratiopeptidase_and_vitamin_d_for_covid-19_patients_a_new_perspective	https://www.researchgate.net/publication/352282548_adjuvant_therapy_with_serratiopeptidase_and_vitamin_d_for_covid-19_patients_a_new_perspective	ADJ
admet-2551	790	2	https://europepmc.org/article/med/7049188	https://europepmc.org/article/med/7049188	NOUN
admet-2551	790	3	https://doi.org/10.1016/j.bcp.2020.114225	https://doi.org/10.1016/j.bcp.2020.114225	X
admet-2551	791	1	https://doi.org/10.1177/08839115211014225	https://doi.org/10.1177/08839115211014225	X
admet-2551	791	2	https://doi.org/10.1186/s12866-015-0548-8	https://doi.org/10.1186/s12866-015-0548-8	NUM
admet-2551	791	3	https://doi.org/10.1007/s11515-013-1284-9	https://doi.org/10.1007/s11515-013-1284-9	PROPN
admet-2551	791	4	https://doi.org/10.2106/jbjs.e.00007	https://doi.org/10.2106/jbjs.e.00007	X
admet-2551	791	5	https://doi.org/10.17113/ftb.56.03.18.5658	https://doi.org/10.17113/ftb.56.03.18.5658	NOUN
admet-2551	791	6	https://doi.org/10.3389/fmicb.2020.580164	https://doi.org/10.3389/fmicb.2020.580164	PROPN
admet-2551	791	7	https://doi.org/10.1073/pnas.95.23.13363	https://doi.org/10.1073/pnas.95.23.13363	NUM
admet-2551	792	1	s.	s.	PROPN
admet-2551	792	2	k.	k.	PROPN
admet-2551	792	3	metkar	metkar	PROPN
admet-2551	792	4	et	et	PROPN
admet-2551	792	5	al	al	PROPN
admet-2551	792	6	.	.	PROPN
admet-2551	792	7	admet	admet	PROPN
admet-2551	792	8	&	&	CCONJ
admet-2551	792	9	dmpk	dmpk	PROPN
admet-2551	792	10	12(6	12(6	NUM
admet-2551	792	11	)	)	PUNCT
admet-2551	792	12	(	(	PUNCT
admet-2551	792	13	2024	2024	NUM
admet-2551	792	14	)	)	PUNCT
admet-2551	792	15	797	797	NUM
admet-2551	792	16	-	-	SYM
admet-2551	792	17	820	820	NUM
admet-2551	792	18	816	816	NUM
admet-2551	793	1	[	[	X
admet-2551	793	2	93	93	NUM
admet-2551	793	3	]	]	X
admet-2551	793	4	s.b	s.b	PROPN
admet-2551	793	5	.	.	PROPN
admet-2551	793	6	prusiner	prusiner	NOUN
admet-2551	793	7	.	.	PUNCT
admet-2551	794	1	novel	novel	ADJ
admet-2551	794	2	proteinaceous	proteinaceous	ADJ
admet-2551	794	3	infectious	infectious	ADJ
admet-2551	794	4	particles	particle	NOUN
admet-2551	794	5	cause	cause	VERB
admet-2551	794	6	scrapie	scrapie	NOUN
admet-2551	794	7	.	.	PUNCT
admet-2551	795	1	science	science	NOUN
admet-2551	795	2	216	216	NUM
admet-2551	795	3	(	(	PUNCT
admet-2551	795	4	1982	1982	NUM
admet-2551	795	5	)	)	PUNCT
admet-2551	795	6	136	136	NUM
admet-2551	795	7	-	-	SYM
admet-2551	795	8	144	144	NUM
admet-2551	795	9	.	.	PUNCT
admet-2551	795	10	https://doi.org/10.1126/science.6801762	https://doi.org/10.1126/science.6801762	NOUN
admet-2551	795	11	.	.	PUNCT
admet-2551	796	1	[	[	X
admet-2551	796	2	94	94	NUM
admet-2551	796	3	]	]	X
admet-2551	796	4	l.m	l.m	PROPN
admet-2551	796	5	.	.	PROPN
admet-2551	796	6	ascari	ascari	PROPN
admet-2551	796	7	,	,	PUNCT
admet-2551	796	8	s.c	s.c	PROPN
admet-2551	796	9	.	.	PROPN
admet-2551	796	10	rocha	rocha	PROPN
admet-2551	796	11	,	,	PUNCT
admet-2551	796	12	p.b	p.b	PROPN
admet-2551	796	13	.	.	PROPN
admet-2551	796	14	gonçalves	gonçalves	PROPN
admet-2551	796	15	,	,	PUNCT
admet-2551	796	16	t.c	t.c	PROPN
admet-2551	796	17	.	.	PROPN
admet-2551	796	18	vieira	vieira	PROPN
admet-2551	796	19	,	,	PUNCT
admet-2551	796	20	y.	y.	PROPN
admet-2551	796	21	cordeiro	cordeiro	PROPN
admet-2551	796	22	.	.	PUNCT
admet-2551	797	1	challenges	challenge	NOUN
admet-2551	797	2	and	and	CCONJ
admet-2551	797	3	advances	advance	NOUN
admet-2551	797	4	in	in	ADP
admet-2551	797	5	antemortem	antemortem	NOUN
admet-2551	797	6	diagnosis	diagnosis	NOUN
admet-2551	797	7	of	of	ADP
admet-2551	797	8	human	human	ADJ
admet-2551	797	9	transmissible	transmissible	ADJ
admet-2551	797	10	spongiform	spongiform	NOUN
admet-2551	797	11	encephalopathies	encephalopathy	NOUN
admet-2551	797	12	.	.	PUNCT
admet-2551	798	1	frontiers	frontier	NOUN
admet-2551	798	2	in	in	ADP
admet-2551	798	3	bioengineering	bioengineering	NOUN
admet-2551	798	4	and	and	CCONJ
admet-2551	798	5	biotechnology	biotechnology	NOUN
admet-2551	798	6	8	8	NUM
admet-2551	798	7	(	(	PUNCT
admet-2551	798	8	2020	2020	NUM
admet-2551	798	9	)	)	PUNCT
admet-2551	798	10	585896	585896	NUM
admet-2551	798	11	.	.	PUNCT
admet-2551	799	1	https://doi.org/10.3389/fbioe.2020.585896	https://doi.org/10.3389/fbioe.2020.585896	PROPN
admet-2551	799	2	.	.	PUNCT
admet-2551	800	1	[	[	X
admet-2551	800	2	95	95	NUM
admet-2551	800	3	]	]	X
admet-2551	800	4	w.a	w.a	PROPN
admet-2551	800	5	.	.	PROPN
admet-2551	800	6	rutala	rutala	PROPN
admet-2551	800	7	,	,	PUNCT
admet-2551	800	8	d.j	d.j	PROPN
admet-2551	800	9	.	.	PROPN
admet-2551	800	10	weber	weber	PROPN
admet-2551	800	11	.	.	PUNCT
admet-2551	800	12	guideline	guideline	NOUN
admet-2551	800	13	for	for	ADP
admet-2551	800	14	disinfection	disinfection	NOUN
admet-2551	800	15	and	and	CCONJ
admet-2551	800	16	sterilization	sterilization	NOUN
admet-2551	800	17	of	of	ADP
admet-2551	800	18	prion	prion	NOUN
admet-2551	800	19	-	-	PUNCT
admet-2551	800	20	contaminated	contaminate	VERB
admet-2551	800	21	medical	medical	ADJ
admet-2551	800	22	instruments	instrument	NOUN
admet-2551	800	23	.	.	PUNCT
admet-2551	801	1	infection	infection	NOUN
admet-2551	801	2	control	control	PROPN
admet-2551	801	3	&	&	CCONJ
admet-2551	801	4	hospital	hospital	PROPN
admet-2551	801	5	epidemiology	epidemiology	NOUN
admet-2551	801	6	31	31	NUM
admet-2551	801	7	(	(	PUNCT
admet-2551	801	8	2010	2010	NUM
admet-2551	801	9	)	)	PUNCT
admet-2551	801	10	107	107	NUM
admet-2551	801	11	-	-	SYM
admet-2551	801	12	117	117	NUM
admet-2551	801	13	.	.	PUNCT
admet-2551	802	1	https://doi.org/10.1086/650197	https://doi.org/10.1086/650197	NOUN
admet-2551	802	2	.	.	PUNCT
admet-2551	803	1	[	[	X
admet-2551	803	2	96	96	NUM
admet-2551	803	3	]	]	X
admet-2551	803	4	d.	d.	PROPN
admet-2551	803	5	taylor	taylor	PROPN
admet-2551	803	6	.	.	PUNCT
admet-2551	804	1	inactivation	inactivation	NOUN
admet-2551	804	2	of	of	ADP
admet-2551	804	3	transmissible	transmissible	ADJ
admet-2551	804	4	degenerative	degenerative	ADJ
admet-2551	804	5	encephalopathy	encephalopathy	ADJ
admet-2551	804	6	agents	agent	NOUN
admet-2551	804	7	:	:	PUNCT
admet-2551	804	8	a	a	DET
admet-2551	804	9	review	review	NOUN
admet-2551	804	10	.	.	PUNCT
admet-2551	805	1	the	the	DET
admet-2551	805	2	veterinary	veterinary	ADJ
admet-2551	805	3	journal	journal	NOUN
admet-2551	805	4	159	159	NUM
admet-2551	805	5	(	(	PUNCT
admet-2551	805	6	2000	2000	NUM
admet-2551	805	7	)	)	PUNCT
admet-2551	805	8	10	10	NUM
admet-2551	805	9	-	-	SYM
admet-2551	805	10	17	17	NUM
admet-2551	805	11	.	.	PUNCT
admet-2551	806	1	https://doi.org/10.1053/tvjl.1999.0406	https://doi.org/10.1053/tvjl.1999.0406	X
admet-2551	806	2	.	.	PUNCT
admet-2551	807	1	[	[	X
admet-2551	807	2	97	97	NUM
admet-2551	807	3	]	]	X
admet-2551	807	4	r.	r.	PROPN
admet-2551	807	5	gupta	gupta	PROPN
admet-2551	807	6	,	,	PUNCT
admet-2551	807	7	r.	r.	PROPN
admet-2551	807	8	sharma	sharma	PROPN
admet-2551	807	9	,	,	PUNCT
admet-2551	807	10	q.k	q.k	PROPN
admet-2551	807	11	.	.	PUNCT
admet-2551	808	1	beg	beg	VERB
admet-2551	808	2	.	.	PUNCT
admet-2551	809	1	revisiting	revisit	VERB
admet-2551	809	2	microbial	microbial	ADJ
admet-2551	809	3	keratinases	keratinase	NOUN
admet-2551	809	4	:	:	PUNCT
admet-2551	809	5	next	next	ADJ
admet-2551	809	6	generation	generation	NOUN
admet-2551	809	7	proteases	protease	NOUN
admet-2551	809	8	for	for	ADP
admet-2551	809	9	sustainable	sustainable	ADJ
admet-2551	809	10	biotechnology	biotechnology	NOUN
admet-2551	809	11	.	.	PUNCT
admet-2551	810	1	critical	critical	ADJ
admet-2551	810	2	reviews	review	NOUN
admet-2551	810	3	in	in	ADP
admet-2551	810	4	biotechnology	biotechnology	NOUN
admet-2551	810	5	33	33	NUM
admet-2551	810	6	(	(	PUNCT
admet-2551	810	7	2013	2013	NUM
admet-2551	810	8	)	)	PUNCT
admet-2551	810	9	216	216	NUM
admet-2551	810	10	-	-	SYM
admet-2551	810	11	228	228	NUM
admet-2551	810	12	.	.	PUNCT
admet-2551	810	13	https://doi.org/10.3109/07388551.2012.685051	https://doi.org/10.3109/07388551.2012.685051	PROPN
admet-2551	810	14	.	.	PUNCT
admet-2551	811	1	[	[	X
admet-2551	811	2	98	98	NUM
admet-2551	811	3	]	]	X
admet-2551	811	4	s.	s.	PROPN
admet-2551	811	5	kamaraj	kamaraj	PROPN
admet-2551	811	6	,	,	PUNCT
admet-2551	811	7	s.	s.	PROPN
admet-2551	811	8	vuppu	vuppu	PROPN
admet-2551	811	9	.	.	PUNCT
admet-2551	812	1	in	in	ADP
admet-2551	812	2	-	-	PUNCT
admet-2551	812	3	silico	silico	NOUN
admet-2551	812	4	study	study	NOUN
admet-2551	812	5	of	of	ADP
admet-2551	812	6	bacterial	bacterial	ADJ
admet-2551	812	7	keratinase	keratinase	NOUN
admet-2551	812	8	and	and	CCONJ
admet-2551	812	9	optimization	optimization	NOUN
admet-2551	812	10	of	of	ADP
admet-2551	812	11	extraction	extraction	NOUN
admet-2551	812	12	procedure	procedure	NOUN
admet-2551	812	13	for	for	ADP
admet-2551	812	14	keratin	keratin	NOUN
admet-2551	812	15	from	from	ADP
admet-2551	812	16	country	country	NOUN
admet-2551	812	17	chicken	chicken	NOUN
admet-2551	812	18	and	and	CCONJ
admet-2551	812	19	indian	indian	ADJ
admet-2551	812	20	blue	blue	ADJ
admet-2551	812	21	rock	rock	NOUN
admet-2551	812	22	pigeon	pigeon	NOUN
admet-2551	812	23	feathers	feather	NOUN
admet-2551	812	24	.	.	PUNCT
admet-2551	813	1	kuwait	kuwait	PROPN
admet-2551	813	2	journal	journal	PROPN
admet-2551	813	3	of	of	ADP
admet-2551	813	4	science	science	PROPN
admet-2551	813	5	51	51	NUM
admet-2551	813	6	(	(	PUNCT
admet-2551	813	7	2024	2024	NUM
admet-2551	813	8	)	)	PUNCT
admet-2551	813	9	100149	100149	NUM
admet-2551	813	10	.	.	PUNCT
admet-2551	814	1	https://doi.org/10.1016/j.kjs.2023.10.016	https://doi.org/10.1016/j.kjs.2023.10.016	PROPN
admet-2551	814	2	.	.	PUNCT
admet-2551	815	1	[	[	X
admet-2551	815	2	99	99	NUM
admet-2551	815	3	]	]	X
admet-2551	815	4	d.s	d.s	PROPN
admet-2551	815	5	.	.	PROPN
admet-2551	815	6	ningthoujam	ningthoujam	PROPN
admet-2551	815	7	,	,	PUNCT
admet-2551	815	8	s.	s.	PROPN
admet-2551	815	9	mukherjee	mukherjee	PROPN
admet-2551	815	10	,	,	PUNCT
admet-2551	815	11	l.j	l.j	PROPN
admet-2551	815	12	.	.	PROPN
admet-2551	815	13	devi	devi	PROPN
admet-2551	815	14	,	,	PUNCT
admet-2551	815	15	e.s	e.s	PROPN
admet-2551	815	16	.	.	PROPN
admet-2551	815	17	singh	singh	PROPN
admet-2551	815	18	,	,	PUNCT
admet-2551	815	19	k.	k.	PROPN
admet-2551	815	20	tamreihao	tamreihao	PROPN
admet-2551	815	21	,	,	PUNCT
admet-2551	815	22	r.	r.	PROPN
admet-2551	815	23	khunjamayum	khunjamayum	PROPN
admet-2551	815	24	,	,	PUNCT
admet-2551	815	25	s.	s.	PROPN
admet-2551	815	26	banerjee	banerjee	PROPN
admet-2551	815	27	,	,	PUNCT
admet-2551	815	28	d.	d.	PROPN
admet-2551	815	29	mukhopadhyay	mukhopadhyay	PROPN
admet-2551	815	30	.	.	PUNCT
admet-2551	816	1	in	in	ADP
admet-2551	816	2	vitro	vitro	X
admet-2551	816	3	degradation	degradation	NOUN
admet-2551	816	4	of	of	ADP
admet-2551	816	5	β	β	NOUN
admet-2551	816	6	-	-	NOUN
admet-2551	816	7	amyloid	amyloid	NOUN
admet-2551	816	8	fibrils	fibril	NOUN
admet-2551	816	9	by	by	ADP
admet-2551	816	10	microbial	microbial	ADJ
admet-2551	816	11	keratinase	keratinase	NOUN
admet-2551	816	12	.	.	PUNCT
admet-2551	817	1	alzheimer	alzheimer	PROPN
admet-2551	817	2	's	's	PART
admet-2551	817	3	&	&	CCONJ
admet-2551	817	4	dementia	dementia	PROPN
admet-2551	817	5	:	:	PUNCT
admet-2551	817	6	translational	translational	ADJ
admet-2551	817	7	research	research	PROPN
admet-2551	817	8	&	&	CCONJ
admet-2551	817	9	clinical	clinical	ADJ
admet-2551	817	10	interventions	intervention	NOUN
admet-2551	817	11	5	5	NUM
admet-2551	817	12	(	(	PUNCT
admet-2551	817	13	2019	2019	NUM
admet-2551	817	14	)	)	PUNCT
admet-2551	817	15	154	154	NUM
admet-2551	817	16	-	-	SYM
admet-2551	817	17	163	163	NUM
admet-2551	817	18	.	.	PUNCT
admet-2551	818	1	https://doi.org/10.1016/j.trci.2019.03.003	https://doi.org/10.1016/j.trci.2019.03.003	NUM
admet-2551	818	2	.	.	PUNCT
admet-2551	819	1	[	[	X
admet-2551	819	2	100	100	NUM
admet-2551	819	3	]	]	PUNCT
admet-2551	819	4	m.	m.	NOUN
admet-2551	819	5	yoshioka	yoshioka	PROPN
admet-2551	819	6	,	,	PUNCT
admet-2551	819	7	t.	t.	PROPN
admet-2551	819	8	miwa	miwa	PROPN
admet-2551	819	9	,	,	PUNCT
admet-2551	819	10	h.	h.	PROPN
admet-2551	819	11	horii	horii	PROPN
admet-2551	819	12	,	,	PUNCT
admet-2551	819	13	m.	m.	NOUN
admet-2551	819	14	takata	takata	NOUN
admet-2551	819	15	,	,	PUNCT
admet-2551	819	16	t.	t.	PROPN
admet-2551	819	17	yokoyama	yokoyama	PROPN
admet-2551	819	18	,	,	PUNCT
admet-2551	819	19	k.	k.	PROPN
admet-2551	819	20	nishizawa	nishizawa	PROPN
admet-2551	819	21	,	,	PUNCT
admet-2551	819	22	m.	m.	PROPN
admet-2551	819	23	watanabe	watanabe	PROPN
admet-2551	819	24	,	,	PUNCT
admet-2551	819	25	m.	m.	NOUN
admet-2551	819	26	shinagawa	shinagawa	PROPN
admet-2551	819	27	,	,	PUNCT
admet-2551	819	28	y.	y.	PROPN
admet-2551	819	29	murayama	murayama	PROPN
admet-2551	819	30	.	.	PUNCT
admet-2551	820	1	characterization	characterization	NOUN
admet-2551	820	2	of	of	ADP
admet-2551	820	3	a	a	DET
admet-2551	820	4	proteolytic	proteolytic	ADJ
admet-2551	820	5	enzyme	enzyme	NOUN
admet-2551	820	6	derived	derive	VERB
admet-2551	820	7	from	from	ADP
admet-2551	820	8	a	a	DET
admet-2551	820	9	bacillus	bacillus	NOUN
admet-2551	820	10	strain	strain	NOUN
admet-2551	820	11	that	that	PRON
admet-2551	820	12	effectively	effectively	ADV
admet-2551	820	13	degrades	degrade	VERB
admet-2551	820	14	prion	prion	NOUN
admet-2551	820	15	protein	protein	NOUN
admet-2551	820	16	.	.	PUNCT
admet-2551	821	1	journal	journal	PROPN
admet-2551	821	2	of	of	ADP
admet-2551	821	3	applied	apply	VERB
admet-2551	821	4	microbiology	microbiology	NOUN
admet-2551	821	5	102	102	NUM
admet-2551	821	6	(	(	PUNCT
admet-2551	821	7	2007	2007	NUM
admet-2551	821	8	)	)	PUNCT
admet-2551	821	9	509	509	NUM
admet-2551	821	10	-	-	SYM
admet-2551	821	11	515	515	NUM
admet-2551	821	12	.	.	PUNCT
admet-2551	821	13	https://doi.org/10.1111/j.1365-2672.2006.03080.x	https://doi.org/10.1111/j.1365-2672.2006.03080.x	NOUN
admet-2551	821	14	.	.	PUNCT
admet-2551	822	1	[	[	X
admet-2551	822	2	101	101	NUM
admet-2551	822	3	]	]	X
admet-2551	822	4	e.a	e.a	PROPN
admet-2551	822	5	.	.	PROPN
admet-2551	822	6	okoroma	okoroma	PROPN
admet-2551	822	7	,	,	PUNCT
admet-2551	822	8	d.	d.	PROPN
admet-2551	822	9	purchase	purchase	PROPN
admet-2551	822	10	,	,	PUNCT
admet-2551	822	11	h.	h.	PROPN
admet-2551	822	12	garelick	garelick	PROPN
admet-2551	822	13	,	,	PUNCT
admet-2551	822	14	r.	r.	PROPN
admet-2551	822	15	morris	morris	PROPN
admet-2551	822	16	,	,	PUNCT
admet-2551	822	17	m.h	m.h	PROPN
admet-2551	822	18	.	.	PROPN
admet-2551	822	19	neale	neale	PROPN
admet-2551	822	20	,	,	PUNCT
admet-2551	822	21	o.	o.	PROPN
admet-2551	822	22	windl	windl	PROPN
admet-2551	822	23	,	,	PUNCT
admet-2551	822	24	o.o	o.o	PROPN
admet-2551	822	25	.	.	PROPN
admet-2551	822	26	abiola	abiola	PROPN
admet-2551	822	27	.	.	PUNCT
admet-2551	823	1	enzymatic	enzymatic	ADJ
admet-2551	823	2	formulation	formulation	NOUN
admet-2551	823	3	capable	capable	ADJ
admet-2551	823	4	of	of	ADP
admet-2551	823	5	degrading	degrade	VERB
admet-2551	823	6	scrapie	scrapie	NOUN
admet-2551	823	7	prion	prion	NOUN
admet-2551	823	8	under	under	ADP
admet-2551	823	9	mild	mild	ADJ
admet-2551	823	10	digestion	digestion	NOUN
admet-2551	823	11	conditions	condition	NOUN
admet-2551	823	12	.	.	PUNCT
admet-2551	824	1	plos	plos	PROPN
admet-2551	824	2	one	one	NUM
admet-2551	824	3	8	8	NUM
admet-2551	824	4	(	(	PUNCT
admet-2551	824	5	2013	2013	NUM
admet-2551	824	6	)	)	PUNCT
admet-2551	825	1	e68099	e68099	NOUN
admet-2551	825	2	.	.	PUNCT
admet-2551	825	3	https://doi.org/10.1371/journal.pone.0068099	https://doi.org/10.1371/journal.pone.0068099	NOUN
admet-2551	825	4	.	.	PUNCT
admet-2551	826	1	[	[	X
admet-2551	826	2	102	102	NUM
admet-2551	826	3	]	]	X
admet-2551	826	4	j.p	j.p	PROPN
admet-2551	826	5	.	.	PROPN
admet-2551	826	6	langeveld	langeveld	PROPN
admet-2551	826	7	,	,	PUNCT
admet-2551	826	8	j.-j	j.-j	PROPN
admet-2551	826	9	.	.	PUNCT
admet-2551	827	1	wang	wang	PROPN
admet-2551	827	2	,	,	PUNCT
admet-2551	827	3	d.f	d.f	PROPN
admet-2551	827	4	.	.	PROPN
admet-2551	827	5	van	van	PROPN
admet-2551	827	6	de	de	X
admet-2551	827	7	wiel	wiel	PROPN
admet-2551	827	8	,	,	PUNCT
admet-2551	827	9	g.c	g.c	PROPN
admet-2551	827	10	.	.	PROPN
admet-2551	827	11	shih	shih	PROPN
admet-2551	827	12	,	,	PUNCT
admet-2551	827	13	g.j	g.j	PROPN
admet-2551	827	14	.	.	PROPN
admet-2551	827	15	garssen	garssen	PROPN
admet-2551	827	16	,	,	PUNCT
admet-2551	827	17	a.	a.	NOUN
admet-2551	827	18	bossers	bosser	NOUN
admet-2551	827	19	,	,	PUNCT
admet-2551	827	20	j.c	j.c	PROPN
admet-2551	827	21	.	.	PROPN
admet-2551	827	22	shih	shih	PROPN
admet-2551	827	23	.	.	PUNCT
admet-2551	828	1	enzymatic	enzymatic	ADJ
admet-2551	828	2	degradation	degradation	NOUN
admet-2551	828	3	of	of	ADP
admet-2551	828	4	prion	prion	NOUN
admet-2551	828	5	protein	protein	NOUN
admet-2551	828	6	in	in	ADP
admet-2551	828	7	brain	brain	NOUN
admet-2551	828	8	stem	stem	NOUN
admet-2551	828	9	from	from	ADP
admet-2551	828	10	infected	infected	ADJ
admet-2551	828	11	cattle	cattle	NOUN
admet-2551	828	12	and	and	CCONJ
admet-2551	828	13	sheep	sheep	NOUN
admet-2551	828	14	.	.	PUNCT
admet-2551	829	1	the	the	DET
admet-2551	829	2	journal	journal	NOUN
admet-2551	829	3	of	of	ADP
admet-2551	829	4	iinfectious	iinfectious	ADJ
admet-2551	829	5	diseases	disease	NOUN
admet-2551	829	6	188	188	NUM
admet-2551	829	7	(	(	PUNCT
admet-2551	829	8	2003	2003	NUM
admet-2551	829	9	)	)	PUNCT
admet-2551	829	10	1782	1782	NUM
admet-2551	829	11	-	-	SYM
admet-2551	829	12	1789	1789	NUM
admet-2551	829	13	.	.	PUNCT
admet-2551	830	1	https://doi.org/10.1086/379664	https://doi.org/10.1086/379664	X
admet-2551	830	2	.	.	PUNCT
admet-2551	831	1	[	[	X
admet-2551	831	2	103	103	NUM
admet-2551	831	3	]	]	X
admet-2551	831	4	d.	d.	NOUN
admet-2551	831	5	purchase	purchase	NOUN
admet-2551	831	6	.	.	PUNCT
admet-2551	832	1	microbial	microbial	ADJ
admet-2551	832	2	keratinases	keratinase	NOUN
admet-2551	832	3	:	:	PUNCT
admet-2551	832	4	characteristics	characteristic	NOUN
admet-2551	832	5	,	,	PUNCT
admet-2551	832	6	biotechnological	biotechnological	ADJ
admet-2551	832	7	applications	application	NOUN
admet-2551	832	8	and	and	CCONJ
admet-2551	832	9	potential	potential	NOUN
admet-2551	832	10	.	.	PUNCT
admet-2551	833	1	the	the	DET
admet-2551	833	2	handbook	handbook	NOUN
admet-2551	833	3	of	of	ADP
admet-2551	833	4	microbial	microbial	ADJ
admet-2551	833	5	bioresources	bioresource	NOUN
admet-2551	833	6	.	.	PUNCT
admet-2551	834	1	wallingford	wallingford	PROPN
admet-2551	834	2	:	:	PUNCT
admet-2551	834	3	cab	cab	NOUN
admet-2551	834	4	international	international	ADJ
admet-2551	834	5	publishing	publishing	NOUN
admet-2551	834	6	(	(	PUNCT
admet-2551	834	7	2016	2016	NUM
admet-2551	834	8	)	)	PUNCT
admet-2551	834	9	634	634	NUM
admet-2551	834	10	-	-	SYM
admet-2551	834	11	674	674	NUM
admet-2551	834	12	.	.	PUNCT
admet-2551	834	13	https://doi.org/10.1079/9781780645216.0634	https://doi.org/10.1079/9781780645216.0634	NOUN
admet-2551	834	14	.	.	PUNCT
admet-2551	835	1	[	[	X
admet-2551	835	2	104	104	X
admet-2551	835	3	]	]	PUNCT
admet-2551	835	4	z.	z.	PROPN
admet-2551	835	5	hui	hui	PROPN
admet-2551	835	6	,	,	PUNCT
admet-2551	835	7	h.	h.	PROPN
admet-2551	835	8	doi	doi	PROPN
admet-2551	835	9	,	,	PUNCT
admet-2551	835	10	h.	h.	PROPN
admet-2551	835	11	kanouchi	kanouchi	PROPN
admet-2551	835	12	,	,	PUNCT
admet-2551	835	13	y.	y.	PROPN
admet-2551	835	14	matsuura	matsuura	PROPN
admet-2551	835	15	,	,	PUNCT
admet-2551	835	16	s.	s.	PROPN
admet-2551	835	17	mohri	mohri	PROPN
admet-2551	835	18	,	,	PUNCT
admet-2551	835	19	y.	y.	PROPN
admet-2551	835	20	nonomura	nonomura	PROPN
admet-2551	835	21	,	,	PUNCT
admet-2551	835	22	t.	t.	PROPN
admet-2551	835	23	oka	oka	PROPN
admet-2551	835	24	.	.	PUNCT
admet-2551	835	25	alkaline	alkaline	NOUN
admet-2551	835	26	serine	serine	NOUN
admet-2551	835	27	protease	protease	NOUN
admet-2551	835	28	produced	produce	VERB
admet-2551	835	29	by	by	ADP
admet-2551	835	30	streptomyces	streptomyce	NOUN
admet-2551	835	31	sp	sp	NOUN
admet-2551	835	32	.	.	PROPN
admet-2551	835	33	degrades	degrade	VERB
admet-2551	835	34	prpsc	prpsc	NOUN
admet-2551	835	35	.	.	PUNCT
admet-2551	836	1	biochemical	biochemical	ADJ
admet-2551	836	2	and	and	CCONJ
admet-2551	836	3	biophysical	biophysical	ADJ
admet-2551	836	4	research	research	NOUN
admet-2551	836	5	communications	communication	NOUN
admet-2551	836	6	321	321	NUM
admet-2551	836	7	(	(	PUNCT
admet-2551	836	8	2004	2004	NUM
admet-2551	836	9	)	)	PUNCT
admet-2551	836	10	45	45	NUM
admet-2551	836	11	-	-	SYM
admet-2551	836	12	50	50	NUM
admet-2551	836	13	.	.	PUNCT
admet-2551	836	14	https://doi.org/10.1016/j.bbrc.2004.06.100	https://doi.org/10.1016/j.bbrc.2004.06.100	PROPN
admet-2551	836	15	.	.	PUNCT
admet-2551	837	1	[	[	X
admet-2551	837	2	105	105	NUM
admet-2551	837	3	]	]	X
admet-2551	837	4	r.	r.	PROPN
admet-2551	837	5	sharma	sharma	PROPN
admet-2551	837	6	,	,	PUNCT
admet-2551	837	7	r.	r.	PROPN
admet-2551	837	8	gupta	gupta	PROPN
admet-2551	837	9	.	.	PUNCT
admet-2551	837	10	coupled	couple	VERB
admet-2551	837	11	action	action	NOUN
admet-2551	837	12	of	of	ADP
admet-2551	837	13	γ	γ	X
admet-2551	837	14	-	-	ADJ
admet-2551	837	15	glutamyl	glutamyl	VERB
admet-2551	837	16	transpeptidase	transpeptidase	NOUN
admet-2551	837	17	-	-	PUNCT
admet-2551	837	18	glutathione	glutathione	NOUN
admet-2551	837	19	and	and	CCONJ
admet-2551	837	20	keratinase	keratinase	NOUN
admet-2551	837	21	effectively	effectively	ADV
admet-2551	837	22	degrades	degrade	VERB
admet-2551	837	23	feather	feather	NOUN
admet-2551	837	24	keratin	keratin	NOUN
admet-2551	837	25	and	and	CCONJ
admet-2551	837	26	surrogate	surrogate	ADJ
admet-2551	837	27	prion	prion	NOUN
admet-2551	837	28	protein	protein	NOUN
admet-2551	837	29	,	,	PUNCT
admet-2551	837	30	sup	sup	NOUN
admet-2551	837	31	35	35	NUM
admet-2551	837	32	nm	nm	NOUN
admet-2551	837	33	.	.	PUNCT
admet-2551	838	1	bioresource	bioresource	PROPN
admet-2551	838	2	technology	technology	NOUN
admet-2551	838	3	120	120	NUM
admet-2551	838	4	(	(	PUNCT
admet-2551	838	5	2012	2012	NUM
admet-2551	838	6	)	)	PUNCT
admet-2551	838	7	314	314	NUM
admet-2551	838	8	-	-	SYM
admet-2551	838	9	317	317	NUM
admet-2551	838	10	.	.	PUNCT
admet-2551	839	1	https://doi.org/10.1016/j.biortech.2012.06.038	https://doi.org/10.1016/j.biortech.2012.06.038	NOUN
admet-2551	840	1	[	[	X
admet-2551	840	2	106	106	NUM
admet-2551	840	3	]	]	PUNCT
admet-2551	840	4	k.	k.	PROPN
admet-2551	840	5	nishinari	nishinari	PROPN
admet-2551	840	6	,	,	PUNCT
admet-2551	840	7	y.	y.	PROPN
admet-2551	840	8	fang	fang	PROPN
admet-2551	840	9	,	,	PUNCT
admet-2551	840	10	t.	t.	PROPN
admet-2551	840	11	nagano	nagano	PROPN
admet-2551	840	12	,	,	PUNCT
admet-2551	840	13	s.	s.	PROPN
admet-2551	840	14	guo	guo	PROPN
admet-2551	840	15	,	,	PUNCT
admet-2551	840	16	r.	r.	PROPN
admet-2551	840	17	wang	wang	PROPN
admet-2551	840	18	,	,	PUNCT
admet-2551	840	19	soy	soy	NOUN
admet-2551	840	20	as	as	ADP
admet-2551	840	21	a	a	DET
admet-2551	840	22	food	food	NOUN
admet-2551	840	23	ingredient	ingredient	NOUN
admet-2551	840	24	,	,	PUNCT
admet-2551	840	25	in	in	ADP
admet-2551	840	26	proteins	protein	NOUN
admet-2551	840	27	in	in	ADP
admet-2551	840	28	food	food	NOUN
admet-2551	840	29	processing	processing	NOUN
admet-2551	840	30	,	,	PUNCT
admet-2551	840	31	r.y	r.y	PROPN
admet-2551	840	32	.	.	PROPN
admet-2551	840	33	yada	yada	NOUN
admet-2551	840	34	(	(	PUNCT
admet-2551	840	35	ed	ed	NOUN
admet-2551	840	36	.	.	PUNCT
admet-2551	840	37	)	)	PUNCT
admet-2551	840	38	,	,	PUNCT
admet-2551	840	39	elsevier	elsevier	NOUN
admet-2551	840	40	,	,	PUNCT
admet-2551	840	41	2018	2018	NUM
admet-2551	840	42	,	,	PUNCT
admet-2551	840	43	p.	p.	NOUN
admet-2551	840	44	149	149	NUM
admet-2551	840	45	-	-	SYM
admet-2551	840	46	186	186	NUM
admet-2551	840	47	.	.	PUNCT
admet-2551	841	1	https://doi.org/10.1016/b978-0-08-100722-8.00007-3	https://doi.org/10.1016/b978-0-08-100722-8.00007-3	NOUN
admet-2551	841	2	.	.	PUNCT
admet-2551	842	1	[	[	X
admet-2551	842	2	107	107	NUM
admet-2551	842	3	]	]	X
admet-2551	842	4	g.	g.	PROPN
admet-2551	842	5	gallelli	gallelli	PROPN
admet-2551	842	6	,	,	PUNCT
admet-2551	842	7	g.	g.	PROPN
admet-2551	842	8	di	di	PROPN
admet-2551	842	9	mizio	mizio	PROPN
admet-2551	842	10	,	,	PUNCT
admet-2551	842	11	c.	c.	PROPN
admet-2551	842	12	palleria	palleria	PROPN
admet-2551	842	13	,	,	PUNCT
admet-2551	842	14	a.	a.	NOUN
admet-2551	842	15	siniscalchi	siniscalchi	PROPN
admet-2551	842	16	,	,	PUNCT
admet-2551	842	17	p.	p.	NOUN
admet-2551	842	18	rubino	rubino	PROPN
admet-2551	842	19	,	,	PUNCT
admet-2551	842	20	l.	l.	PROPN
admet-2551	842	21	muraca	muraca	PROPN
admet-2551	842	22	,	,	PUNCT
admet-2551	842	23	e.	e.	PROPN
admet-2551	842	24	cione	cione	PROPN
admet-2551	842	25	,	,	PUNCT
admet-2551	842	26	m.	m.	NOUN
admet-2551	842	27	salerno	salerno	PROPN
admet-2551	842	28	,	,	PUNCT
admet-2551	842	29	g.	g.	PROPN
admet-2551	842	30	de	de	PROPN
admet-2551	842	31	sarro	sarro	PROPN
admet-2551	842	32	,	,	PUNCT
admet-2551	842	33	l.	l.	PROPN
admet-2551	842	34	gallelli	gallelli	PROPN
admet-2551	842	35	.	.	PUNCT
admet-2551	843	1	data	datum	NOUN
admet-2551	843	2	recorded	record	VERB
admet-2551	843	3	in	in	ADP
admet-2551	843	4	real	real	ADJ
admet-2551	843	5	life	life	NOUN
admet-2551	843	6	support	support	VERB
admet-2551	843	7	the	the	DET
admet-2551	843	8	safety	safety	NOUN
admet-2551	843	9	of	of	ADP
admet-2551	843	10	nattokinase	nattokinase	NOUN
admet-2551	843	11	in	in	ADP
admet-2551	843	12	patients	patient	NOUN
admet-2551	843	13	with	with	ADP
admet-2551	843	14	vascular	vascular	ADJ
admet-2551	843	15	diseases	disease	NOUN
admet-2551	843	16	.	.	PUNCT
admet-2551	844	1	nutrients	nutrient	NOUN
admet-2551	844	2	13	13	NUM
admet-2551	844	3	(	(	PUNCT
admet-2551	844	4	2021	2021	NUM
admet-2551	844	5	)	)	PUNCT
admet-2551	844	6	2031	2031	NUM
admet-2551	844	7	.	.	PUNCT
admet-2551	845	1	https://doi.org/10.3390/nu13062031	https://doi.org/10.3390/nu13062031	VERB
admet-2551	845	2	.	.	PUNCT
admet-2551	846	1	[	[	X
admet-2551	846	2	108	108	NUM
admet-2551	846	3	]	]	PUNCT
admet-2551	846	4	t.	t.	NOUN
admet-2551	846	5	yokoyama	yokoyama	PROPN
admet-2551	846	6	,	,	PUNCT
admet-2551	846	7	t.	t.	PROPN
admet-2551	846	8	nakamura	nakamura	PROPN
admet-2551	846	9	,	,	PUNCT
admet-2551	846	10	m.	m.	NOUN
admet-2551	846	11	kimijima	kimijima	PROPN
admet-2551	846	12	,	,	PUNCT
admet-2551	846	13	k.	k.	PROPN
admet-2551	846	14	mandokoro	mandokoro	PROPN
admet-2551	846	15	,	,	PUNCT
admet-2551	846	16	m.	m.	NOUN
admet-2551	846	17	tokumaru	tokumaru	PROPN
admet-2551	846	18	,	,	PUNCT
admet-2551	846	19	a.	a.	NOUN
admet-2551	846	20	takatsuka	takatsuka	PROPN
admet-2551	846	21	,	,	PUNCT
admet-2551	846	22	n.	n.	PROPN
admet-2551	846	23	narisawa	narisawa	PROPN
admet-2551	846	24	,	,	PUNCT
admet-2551	846	25	r.	r.	PROPN
admet-2551	846	26	kobayashi	kobayashi	PROPN
admet-2551	846	27	,	,	PUNCT
admet-2551	846	28	f.	f.	PROPN
admet-2551	846	29	takenaga	takenaga	PROPN
admet-2551	846	30	.	.	PUNCT
admet-2551	847	1	subtilisin	subtilisin	PROPN
admet-2551	847	2	nat	nat	PROPN
admet-2551	847	3	,	,	PUNCT
admet-2551	847	4	a	a	DET
admet-2551	847	5	subtilisin	subtilisin	NOUN
admet-2551	847	6	-	-	PUNCT
admet-2551	847	7	like	like	ADJ
admet-2551	847	8	serine	serine	NOUN
admet-2551	847	9	protease	protease	NOUN
admet-2551	847	10	present	present	ADJ
admet-2551	847	11	in	in	ADP
admet-2551	847	12	fermented	fermented	ADJ
admet-2551	847	13	soybean	soybean	NOUN
admet-2551	847	14	“	"	PUNCT
admet-2551	847	15	natto	natto	NOUN
admet-2551	847	16	”	"	PUNCT
admet-2551	847	17	extract	extract	NOUN
admet-2551	847	18	,	,	PUNCT
admet-2551	847	19	inhibits	inhibit	VERB
admet-2551	847	20	streptococcus	streptococcus	NOUN
admet-2551	847	21	mutans	mutan	NOUN
admet-2551	847	22	biofilm	biofilm	NOUN
admet-2551	847	23	formation	formation	NOUN
admet-2551	847	24	.	.	PUNCT
admet-2551	848	1	food	food	NOUN
admet-2551	848	2	science	science	NOUN
admet-2551	848	3	and	and	CCONJ
admet-2551	848	4	technology	technology	NOUN
admet-2551	848	5	research	research	NOUN
admet-2551	848	6	27	27	NUM
admet-2551	848	7	(	(	PUNCT
admet-2551	848	8	2021	2021	NUM
admet-2551	848	9	)	)	PUNCT
admet-2551	848	10	537	537	NUM
admet-2551	848	11	-	-	SYM
admet-2551	848	12	542	542	NUM
admet-2551	848	13	.	.	PUNCT
admet-2551	849	1	https://doi.org/10.3136/fstr.27.537	https://doi.org/10.3136/fstr.27.537	PROPN
admet-2551	849	2	.	.	PUNCT
admet-2551	850	1	https://doi.org/10.1126/science.6801762	https://doi.org/10.1126/science.6801762	PROPN
admet-2551	851	1	https://doi.org/10.3389/fbioe.2020.585896	https://doi.org/10.3389/fbioe.2020.585896	PROPN
admet-2551	851	2	https://doi.org/10.1086/650197	https://doi.org/10.1086/650197	NOUN
admet-2551	851	3	https://doi.org/10.1053/tvjl.1999.0406	https://doi.org/10.1053/tvjl.1999.0406	ADJ
admet-2551	851	4	https://doi.org/10.3109/07388551.2012.685051	https://doi.org/10.3109/07388551.2012.685051	PROPN
admet-2551	852	1	https://doi.org/10.1016/j.kjs.2023.10.016	https://doi.org/10.1016/j.kjs.2023.10.016	PROPN
admet-2551	852	2	https://doi.org/10.1016/j.trci.2019.03.003	https://doi.org/10.1016/j.trci.2019.03.003	NUM
admet-2551	852	3	https://doi.org/10.1111/j.1365-2672.2006.03080.x	https://doi.org/10.1111/j.1365-2672.2006.03080.x	NOUN
admet-2551	852	4	https://doi.org/10.1371/journal.pone.0068099	https://doi.org/10.1371/journal.pone.0068099	NOUN
admet-2551	852	5	https://doi.org/10.1086/379664	https://doi.org/10.1086/379664	PART
admet-2551	852	6	https://doi.org/10.1079/9781780645216.0634	https://doi.org/10.1079/9781780645216.0634	NOUN
admet-2551	852	7	https://doi.org/10.1016/j.bbrc.2004.06.100	https://doi.org/10.1016/j.bbrc.2004.06.100	X
admet-2551	852	8	https://doi.org/10.1016/j.biortech.2012.06.038	https://doi.org/10.1016/j.biortech.2012.06.038	NOUN
admet-2551	852	9	https://doi.org/10.1016/b978-0-08-100722-8.00007-3	https://doi.org/10.1016/b978-0-08-100722-8.00007-3	PROPN
admet-2551	852	10	https://doi.org/10.3390/nu13062031	https://doi.org/10.3390/nu13062031	NOUN
admet-2551	852	11	https://doi.org/10.3136/fstr.27.537	https://doi.org/10.3136/fstr.27.537	PROPN
admet-2551	852	12	admet	admet	PROPN
admet-2551	852	13	&	&	CCONJ
admet-2551	852	14	dmpk	dmpk	PROPN
admet-2551	852	15	12(6	12(6	NUM
admet-2551	852	16	)	)	PUNCT
admet-2551	852	17	(	(	PUNCT
admet-2551	852	18	2024	2024	NUM
admet-2551	852	19	)	)	PUNCT
admet-2551	852	20	797	797	NUM
admet-2551	852	21	-	-	SYM
admet-2551	852	22	820	820	NUM
admet-2551	852	23	natural	natural	ADJ
admet-2551	852	24	serine	serine	NOUN
admet-2551	852	25	proteases	protease	NOUN
admet-2551	852	26	in	in	ADP
admet-2551	852	27	combating	combat	VERB
admet-2551	852	28	amyloid	amyloid	NOUN
admet-2551	852	29	formation	formation	NOUN
admet-2551	852	30	doi	doi	NOUN
admet-2551	852	31	:	:	PUNCT
admet-2551	852	32	https://doi.org/10.5599/admet.2551	https://doi.org/10.5599/admet.2551	NOUN
admet-2551	852	33	817	817	NUM
admet-2551	853	1	[	[	X
admet-2551	853	2	109	109	NUM
admet-2551	853	3	]	]	PUNCT
admet-2551	853	4	h.	h.	PROPN
admet-2551	853	5	kamata	kamata	PROPN
admet-2551	853	6	,	,	PUNCT
admet-2551	853	7	y.	y.	PROPN
admet-2551	853	8	yamagata	yamagata	PROPN
admet-2551	853	9	,	,	PUNCT
admet-2551	853	10	t.	t.	PROPN
admet-2551	853	11	nakamura	nakamura	PROPN
admet-2551	853	12	,	,	PUNCT
admet-2551	853	13	t.	t.	PROPN
admet-2551	853	14	nakajima	nakajima	PROPN
admet-2551	853	15	,	,	PUNCT
admet-2551	853	16	k.	k.	PROPN
admet-2551	853	17	oda	oda	PROPN
admet-2551	853	18	,	,	PUNCT
admet-2551	853	19	s.	s.	PROPN
admet-2551	853	20	murao	murao	PROPN
admet-2551	853	21	,	,	PUNCT
admet-2551	853	22	e.	e.	PROPN
admet-2551	853	23	ichishima	ichishima	PROPN
admet-2551	853	24	.	.	PUNCT
admet-2551	854	1	characterization	characterization	NOUN
admet-2551	854	2	of	of	ADP
admet-2551	854	3	the	the	DET
admet-2551	854	4	complex	complex	NOUN
admet-2551	854	5	between	between	ADP
admet-2551	854	6	α2	α2	NOUN
admet-2551	854	7	-	-	PUNCT
admet-2551	854	8	macroglobulin	macroglobulin	PROPN
admet-2551	854	9	and	and	CCONJ
admet-2551	854	10	a	a	DET
admet-2551	854	11	serine	serine	NOUN
admet-2551	854	12	proteinase	proteinase	NOUN
admet-2551	854	13	from	from	ADP
admet-2551	854	14	bacillus	bacillus	NOUN
admet-2551	854	15	natto	natto	NOUN
admet-2551	854	16	.	.	PUNCT
admet-2551	855	1	agricultural	agricultural	ADJ
admet-2551	855	2	and	and	CCONJ
admet-2551	855	3	biological	biological	ADJ
admet-2551	855	4	chemistry	chemistry	NOUN
admet-2551	855	5	53	53	NUM
admet-2551	855	6	(	(	PUNCT
admet-2551	855	7	1989	1989	NUM
admet-2551	855	8	)	)	PUNCT
admet-2551	855	9	2695	2695	NUM
admet-2551	855	10	-	-	SYM
admet-2551	855	11	2702	2702	NUM
admet-2551	855	12	.	.	PUNCT
admet-2551	856	1	https://doi.org/10.1080/00021369.1989.10869721	https://doi.org/10.1080/00021369.1989.10869721	PROPN
admet-2551	856	2	.	.	PUNCT
admet-2551	857	1	[	[	X
admet-2551	857	2	110	110	NUM
admet-2551	857	3	]	]	X
admet-2551	857	4	m.	m.	NOUN
admet-2551	857	5	fujita	fujita	PROPN
admet-2551	857	6	,	,	PUNCT
admet-2551	857	7	k.	k.	PROPN
admet-2551	857	8	nomura	nomura	PROPN
admet-2551	857	9	,	,	PUNCT
admet-2551	857	10	k.	k.	PROPN
admet-2551	857	11	hong	hong	PROPN
admet-2551	857	12	,	,	PUNCT
admet-2551	857	13	y.	y.	PROPN
admet-2551	857	14	ito	ito	PROPN
admet-2551	857	15	,	,	PUNCT
admet-2551	857	16	a.	a.	PROPN
admet-2551	857	17	asada	asada	PROPN
admet-2551	857	18	,	,	PUNCT
admet-2551	857	19	s.	s.	PROPN
admet-2551	857	20	nishimuro	nishimuro	PROPN
admet-2551	857	21	.	.	PUNCT
admet-2551	858	1	purification	purification	NOUN
admet-2551	858	2	and	and	CCONJ
admet-2551	858	3	characterization	characterization	NOUN
admet-2551	858	4	of	of	ADP
admet-2551	858	5	a	a	DET
admet-2551	858	6	strong	strong	ADJ
admet-2551	858	7	fibrinolytic	fibrinolytic	ADJ
admet-2551	858	8	enzyme	enzyme	NOUN
admet-2551	858	9	(	(	PUNCT
admet-2551	858	10	nattokinase	nattokinase	NOUN
admet-2551	858	11	)	)	PUNCT
admet-2551	858	12	in	in	ADP
admet-2551	858	13	the	the	DET
admet-2551	858	14	vegetable	vegetable	ADJ
admet-2551	858	15	cheese	cheese	NOUN
admet-2551	858	16	natto	natto	NOUN
admet-2551	858	17	,	,	PUNCT
admet-2551	858	18	a	a	DET
admet-2551	858	19	popular	popular	ADJ
admet-2551	858	20	soybean	soybean	NOUN
admet-2551	858	21	fermented	ferment	VERB
admet-2551	858	22	food	food	NOUN
admet-2551	858	23	in	in	ADP
admet-2551	858	24	japan	japan	PROPN
admet-2551	858	25	.	.	PUNCT
admet-2551	859	1	biochemical	biochemical	ADJ
admet-2551	859	2	and	and	CCONJ
admet-2551	859	3	bbiophysical	bbiophysical	ADJ
admet-2551	859	4	research	research	NOUN
admet-2551	859	5	communications	communication	NOUN
admet-2551	859	6	197	197	NUM
admet-2551	859	7	(	(	PUNCT
admet-2551	859	8	1993	1993	NUM
admet-2551	859	9	)	)	PUNCT
admet-2551	859	10	13401347	13401347	NUM
admet-2551	859	11	.	.	PUNCT
admet-2551	860	1	https://doi.org/10.1006/bbrc.1993.2624	https://doi.org/10.1006/bbrc.1993.2624	PROPN
admet-2551	860	2	.	.	PUNCT
admet-2551	861	1	[	[	X
admet-2551	861	2	111	111	NUM
admet-2551	861	3	]	]	PUNCT
admet-2551	861	4	d.	d.	PROPN
admet-2551	861	5	cai	cai	PROPN
admet-2551	861	6	,	,	PUNCT
admet-2551	861	7	c.	c.	PROPN
admet-2551	861	8	zhu	zhu	PROPN
admet-2551	861	9	,	,	PUNCT
admet-2551	861	10	s.	s.	PROPN
admet-2551	861	11	chen	chen	PROPN
admet-2551	861	12	.	.	PUNCT
admet-2551	861	13	microbial	microbial	ADJ
admet-2551	861	14	production	production	NOUN
admet-2551	861	15	of	of	ADP
admet-2551	861	16	nattokinase	nattokinase	NOUN
admet-2551	861	17	:	:	PUNCT
admet-2551	861	18	current	current	ADJ
admet-2551	861	19	progress	progress	NOUN
admet-2551	861	20	,	,	PUNCT
admet-2551	861	21	challenge	challenge	NOUN
admet-2551	861	22	and	and	CCONJ
admet-2551	861	23	prospect	prospect	NOUN
admet-2551	861	24	.	.	PUNCT
admet-2551	862	1	world	world	PROPN
admet-2551	862	2	journal	journal	PROPN
admet-2551	862	3	of	of	ADP
admet-2551	862	4	microbiology	microbiology	NOUN
admet-2551	862	5	and	and	CCONJ
admet-2551	862	6	biotechnology	biotechnology	NOUN
admet-2551	862	7	33	33	NUM
admet-2551	862	8	(	(	PUNCT
admet-2551	862	9	2017	2017	NUM
admet-2551	862	10	)	)	PUNCT
admet-2551	862	11	84	84	NUM
admet-2551	862	12	.	.	PUNCT
admet-2551	863	1	https://doi.org/10.1007/s11274-017-2253-2	https://doi.org/10.1007/s11274-017-2253-2	NUM
admet-2551	863	2	.	.	PUNCT
admet-2551	864	1	[	[	X
admet-2551	864	2	112	112	NUM
admet-2551	864	3	]	]	PUNCT
admet-2551	864	4	e.	e.	PROPN
admet-2551	864	5	selvarajan	selvarajan	PROPN
admet-2551	864	6	,	,	PUNCT
admet-2551	864	7	n.	n.	PROPN
admet-2551	864	8	bhatnagar	bhatnagar	PROPN
admet-2551	864	9	.	.	PUNCT
admet-2551	864	10	nattokinase	nattokinase	NOUN
admet-2551	864	11	:	:	PUNCT
admet-2551	864	12	an	an	DET
admet-2551	864	13	updated	update	VERB
admet-2551	864	14	critical	critical	ADJ
admet-2551	864	15	review	review	NOUN
admet-2551	864	16	on	on	ADP
admet-2551	864	17	challenges	challenge	NOUN
admet-2551	864	18	and	and	CCONJ
admet-2551	864	19	perspectives	perspective	NOUN
admet-2551	864	20	.	.	PUNCT
admet-2551	865	1	cardiovascular	cardiovascular	ADJ
admet-2551	865	2	&	&	CCONJ
admet-2551	865	3	hematological	hematological	ADJ
admet-2551	865	4	agents	agent	NOUN
admet-2551	865	5	in	in	ADP
admet-2551	865	6	medicinal	medicinal	ADJ
admet-2551	865	7	chemistry	chemistry	NOUN
admet-2551	865	8	(	(	PUNCT
admet-2551	865	9	formerly	formerly	ADV
admet-2551	865	10	current	current	ADJ
admet-2551	865	11	medicinal	medicinal	ADJ
admet-2551	865	12	chemistry	chemistry	NOUN
admet-2551	865	13	-	-	PUNCT
admet-2551	865	14	cardiovascular	cardiovascular	ADJ
admet-2551	865	15	&	&	CCONJ
admet-2551	865	16	hematological	hematological	ADJ
admet-2551	865	17	agents	agent	NOUN
admet-2551	865	18	)	)	PUNCT
admet-2551	865	19	15	15	NUM
admet-2551	865	20	(	(	PUNCT
admet-2551	865	21	2017	2017	NUM
admet-2551	865	22	)	)	PUNCT
admet-2551	865	23	128	128	NUM
admet-2551	865	24	-	-	SYM
admet-2551	865	25	135	135	NUM
admet-2551	865	26	.	.	PUNCT
admet-2551	866	1	https://doi.org/10.2174/1871525716666171207153332	https://doi.org/10.2174/1871525716666171207153332	NOUN
admet-2551	866	2	.	.	PUNCT
admet-2551	867	1	[	[	X
admet-2551	867	2	113	113	NUM
admet-2551	867	3	]	]	PUNCT
admet-2551	867	4	m.	m.	NOUN
admet-2551	867	5	fujita	fujita	PROPN
admet-2551	867	6	,	,	PUNCT
admet-2551	867	7	k.	k.	PROPN
admet-2551	867	8	hong	hong	PROPN
admet-2551	867	9	,	,	PUNCT
admet-2551	867	10	y.	y.	PROPN
admet-2551	867	11	ito	ito	PROPN
admet-2551	867	12	,	,	PUNCT
admet-2551	867	13	r.	r.	PROPN
admet-2551	867	14	fujii	fujii	PROPN
admet-2551	867	15	,	,	PUNCT
admet-2551	867	16	k.	k.	PROPN
admet-2551	867	17	kariya	kariya	PROPN
admet-2551	867	18	,	,	PUNCT
admet-2551	867	19	s.	s.	PROPN
admet-2551	867	20	nishimuro	nishimuro	PROPN
admet-2551	867	21	.	.	PUNCT
admet-2551	868	1	thrombolytic	thrombolytic	ADJ
admet-2551	868	2	effect	effect	NOUN
admet-2551	868	3	of	of	ADP
admet-2551	868	4	nattokinase	nattokinase	NOUN
admet-2551	868	5	on	on	ADP
admet-2551	868	6	a	a	DET
admet-2551	868	7	chemically	chemically	ADV
admet-2551	868	8	induced	induce	VERB
admet-2551	868	9	thrombosis	thrombosis	NOUN
admet-2551	868	10	model	model	NOUN
admet-2551	868	11	in	in	ADP
admet-2551	868	12	rat	rat	PROPN
admet-2551	868	13	.	.	PROPN
admet-2551	868	14	biological	biological	ADJ
admet-2551	868	15	and	and	CCONJ
admet-2551	868	16	pharmaceutical	pharmaceutical	ADJ
admet-2551	868	17	bulletin	bulletin	NOUN
admet-2551	868	18	18	18	NUM
admet-2551	868	19	(	(	PUNCT
admet-2551	868	20	1995	1995	NUM
admet-2551	868	21	)	)	PUNCT
admet-2551	868	22	13871391	13871391	NUM
admet-2551	868	23	.	.	PUNCT
admet-2551	869	1	https://doi.org/10.1248/bpb.18.1387	https://doi.org/10.1248/bpb.18.1387	NOUN
admet-2551	869	2	.	.	PUNCT
admet-2551	870	1	[	[	X
admet-2551	870	2	114	114	NUM
admet-2551	870	3	]	]	PUNCT
admet-2551	870	4	l.	l.	PROPN
admet-2551	870	5	wang	wang	PROPN
admet-2551	870	6	,	,	PUNCT
admet-2551	870	7	j.	j.	PROPN
admet-2551	870	8	meng	meng	PROPN
admet-2551	870	9	,	,	PUNCT
admet-2551	870	10	x.	x.	PROPN
admet-2551	870	11	yu	yu	PROPN
admet-2551	870	12	,	,	PUNCT
admet-2551	870	13	j.	j.	PROPN
admet-2551	870	14	wang	wang	PROPN
admet-2551	870	15	,	,	PUNCT
admet-2551	870	16	y.	y.	PROPN
admet-2551	870	17	zhang	zhang	PROPN
admet-2551	870	18	,	,	PUNCT
admet-2551	870	19	m.	m.	PROPN
admet-2551	870	20	zhang	zhang	PROPN
admet-2551	870	21	,	,	PUNCT
admet-2551	870	22	y.	y.	PROPN
admet-2551	870	23	zhang	zhang	PROPN
admet-2551	870	24	,	,	PUNCT
admet-2551	870	25	h.	h.	PROPN
admet-2551	870	26	wang	wang	PROPN
admet-2551	870	27	,	,	PUNCT
admet-2551	870	28	h.	h.	PROPN
admet-2551	870	29	feng	feng	PROPN
admet-2551	870	30	,	,	PUNCT
admet-2551	870	31	q.	q.	PROPN
admet-2551	870	32	tian	tian	PROPN
admet-2551	870	33	.	.	PUNCT
admet-2551	871	1	construction	construction	NOUN
admet-2551	871	2	of	of	ADP
admet-2551	871	3	highly	highly	ADV
admet-2551	871	4	active	active	ADJ
admet-2551	871	5	and	and	CCONJ
admet-2551	871	6	stable	stable	ADJ
admet-2551	871	7	recombinant	recombinant	ADJ
admet-2551	871	8	nattokinase	nattokinase	NOUN
admet-2551	871	9	by	by	ADP
admet-2551	871	10	engineered	engineer	VERB
admet-2551	871	11	bacteria	bacteria	NOUN
admet-2551	871	12	and	and	CCONJ
admet-2551	871	13	computational	computational	ADJ
admet-2551	871	14	design	design	NOUN
admet-2551	871	15	.	.	PUNCT
admet-2551	872	1	archives	archive	NOUN
admet-2551	872	2	of	of	ADP
admet-2551	872	3	biochemistry	biochemistry	NOUN
admet-2551	872	4	and	and	CCONJ
admet-2551	872	5	biophysics	biophysic	NOUN
admet-2551	872	6	760	760	NUM
admet-2551	872	7	(	(	PUNCT
admet-2551	872	8	2024	2024	NUM
admet-2551	872	9	)	)	PUNCT
admet-2551	872	10	110126	110126	NUM
admet-2551	872	11	.	.	PUNCT
admet-2551	873	1	https://doi.org/10.1016/j.abb.2024.110126	https://doi.org/10.1016/j.abb.2024.110126	X
admet-2551	873	2	.	.	PUNCT
admet-2551	874	1	[	[	X
admet-2551	874	2	115	115	NUM
admet-2551	874	3	]	]	X
admet-2551	874	4	c.	c.	PROPN
admet-2551	874	5	chen	chen	PROPN
admet-2551	874	6	,	,	PUNCT
admet-2551	874	7	q.-d	q.-d	PROPN
admet-2551	874	8	.	.	PUNCT
admet-2551	875	1	ai	ai	VERB
admet-2551	875	2	,	,	PUNCT
admet-2551	875	3	s.-f	s.-f	PROPN
admet-2551	875	4	.	.	PUNCT
admet-2551	876	1	chu	chu	PROPN
admet-2551	876	2	,	,	PUNCT
admet-2551	876	3	z.	z.	PROPN
admet-2551	876	4	zhang	zhang	PROPN
admet-2551	876	5	,	,	PUNCT
admet-2551	876	6	n.-h	n.-h	PROPN
admet-2551	876	7	.	.	PUNCT
admet-2551	877	1	chen	chen	PROPN
admet-2551	877	2	.	.	PUNCT
admet-2551	878	1	nk	nk	PROPN
admet-2551	878	2	cells	cell	NOUN
admet-2551	878	3	in	in	ADP
admet-2551	878	4	cerebral	cerebral	ADJ
admet-2551	878	5	ischemia	ischemia	NOUN
admet-2551	878	6	.	.	PUNCT
admet-2551	879	1	biomedicine	biomedicine	NOUN
admet-2551	879	2	&	&	CCONJ
admet-2551	879	3	pharmacotherapy	pharmacotherapy	NOUN
admet-2551	879	4	109	109	NUM
admet-2551	879	5	(	(	PUNCT
admet-2551	879	6	2019	2019	NUM
admet-2551	879	7	)	)	PUNCT
admet-2551	879	8	547	547	NUM
admet-2551	879	9	-	-	SYM
admet-2551	879	10	554	554	NUM
admet-2551	879	11	.	.	PUNCT
admet-2551	879	12	https://doi.org/10.1016/j.biopha.2018.10.103	https://doi.org/10.1016/j.biopha.2018.10.103	NOUN
admet-2551	879	13	.	.	PUNCT
admet-2551	880	1	[	[	X
admet-2551	880	2	116	116	NUM
admet-2551	880	3	]	]	X
admet-2551	880	4	j.-m	j.-m	NOUN
admet-2551	880	5	.	.	PUNCT
admet-2551	881	1	wang	wang	PROPN
admet-2551	881	2	,	,	PUNCT
admet-2551	881	3	h.-y	h.-y	NOUN
admet-2551	881	4	.	.	PUNCT
admet-2551	882	1	chen	chen	PROPN
admet-2551	882	2	,	,	PUNCT
admet-2551	882	3	s.-m	s.-m	PROPN
admet-2551	882	4	.	.	PUNCT
admet-2551	883	1	cheng	cheng	PROPN
admet-2551	883	2	,	,	PUNCT
admet-2551	883	3	s.-h	s.-h	PROPN
admet-2551	883	4	.	.	PUNCT
admet-2551	884	1	chen	chen	PROPN
admet-2551	884	2	,	,	PUNCT
admet-2551	884	3	l.-l	l.-l	PROPN
admet-2551	884	4	.	.	PUNCT
admet-2551	885	1	yang	yang	PROPN
admet-2551	885	2	,	,	PUNCT
admet-2551	885	3	f.-c	f.-c	PROPN
admet-2551	885	4	.	.	PUNCT
admet-2551	886	1	cheng	cheng	PROPN
admet-2551	886	2	.	.	PUNCT
admet-2551	886	3	nattokinase	nattokinase	NOUN
admet-2551	886	4	reduces	reduce	VERB
admet-2551	886	5	brain	brain	NOUN
admet-2551	886	6	infarction	infarction	NOUN
admet-2551	886	7	,	,	PUNCT
admet-2551	886	8	fibrinogen	fibrinogen	NOUN
admet-2551	886	9	and	and	CCONJ
admet-2551	886	10	activated	activate	VERB
admet-2551	886	11	partial	partial	ADJ
admet-2551	886	12	thromboplastin	thromboplastin	NOUN
admet-2551	886	13	time	time	NOUN
admet-2551	886	14	against	against	ADP
admet-2551	886	15	cerebral	cerebral	ADJ
admet-2551	886	16	ischemiareperfusion	ischemiareperfusion	NOUN
admet-2551	886	17	injury	injury	NOUN
admet-2551	886	18	.	.	PUNCT
admet-2551	887	1	journal	journal	NOUN
admet-2551	887	2	of	of	ADP
admet-2551	887	3	food	food	NOUN
admet-2551	887	4	and	and	CCONJ
admet-2551	887	5	drug	drug	NOUN
admet-2551	887	6	analysis	analysis	NOUN
admet-2551	887	7	20	20	NUM
admet-2551	887	8	(	(	PUNCT
admet-2551	887	9	2012	2012	NUM
admet-2551	887	10	)	)	PUNCT
admet-2551	887	11	1	1	NUM
admet-2551	887	12	.	.	PUNCT
admet-2551	888	1	https://doi.org/10.6227/jfda.2012200317	https://doi.org/10.6227/jfda.2012200317	ADJ
admet-2551	888	2	[	[	X
admet-2551	888	3	117	117	NUM
admet-2551	888	4	]	]	PUNCT
admet-2551	888	5	c.-h	c.-h	NOUN
admet-2551	888	6	.	.	PUNCT
admet-2551	889	1	hsia	hsia	PROPN
admet-2551	889	2	,	,	PUNCT
admet-2551	889	3	m.-c	m.-c	PROPN
admet-2551	889	4	.	.	PUNCT
admet-2551	890	1	shen	shen	PROPN
admet-2551	890	2	,	,	PUNCT
admet-2551	890	3	j.-s	j.-s	PROPN
admet-2551	890	4	.	.	PUNCT
admet-2551	891	1	lin	lin	PROPN
admet-2551	891	2	,	,	PUNCT
admet-2551	891	3	y.-k	y.-k	PROPN
admet-2551	891	4	.	.	PUNCT
admet-2551	892	1	wen	wen	PROPN
admet-2551	892	2	,	,	PUNCT
admet-2551	892	3	k.-l	k.-l	PROPN
admet-2551	892	4	.	.	PUNCT
admet-2551	893	1	hwang	hwang	PROPN
admet-2551	893	2	,	,	PUNCT
admet-2551	893	3	t.-m	t.-m	PROPN
admet-2551	893	4	.	.	PUNCT
admet-2551	894	1	cham	cham	PROPN
admet-2551	894	2	,	,	PUNCT
admet-2551	894	3	n.-c	n.-c	PROPN
admet-2551	894	4	.	.	PUNCT
admet-2551	895	1	yang	yang	PROPN
admet-2551	895	2	.	.	PUNCT
admet-2551	896	1	nattokinase	nattokinase	PROPN
admet-2551	896	2	decreases	decrease	VERB
admet-2551	896	3	plasma	plasma	NOUN
admet-2551	896	4	levels	level	NOUN
admet-2551	896	5	of	of	ADP
admet-2551	896	6	fibrinogen	fibrinogen	NOUN
admet-2551	896	7	,	,	PUNCT
admet-2551	896	8	factor	factor	NOUN
admet-2551	896	9	vii	vii	PROPN
admet-2551	896	10	,	,	PUNCT
admet-2551	896	11	and	and	CCONJ
admet-2551	896	12	factor	factor	NOUN
admet-2551	896	13	viii	viii	NOUN
admet-2551	896	14	in	in	ADP
admet-2551	896	15	human	human	ADJ
admet-2551	896	16	subjects	subject	NOUN
admet-2551	896	17	.	.	PUNCT
admet-2551	897	1	nutrition	nutrition	NOUN
admet-2551	897	2	research	research	NOUN
admet-2551	897	3	29	29	NUM
admet-2551	897	4	(	(	PUNCT
admet-2551	897	5	2009	2009	NUM
admet-2551	897	6	)	)	PUNCT
admet-2551	897	7	190	190	NUM
admet-2551	897	8	-	-	SYM
admet-2551	897	9	196	196	NUM
admet-2551	897	10	.	.	PUNCT
admet-2551	898	1	https://doi.org/10.1016/j.nutres.2009.01.009	https://doi.org/10.1016/j.nutres.2009.01.009	NUM
admet-2551	898	2	.	.	PUNCT
admet-2551	899	1	[	[	X
admet-2551	899	2	118	118	NUM
admet-2551	899	3	]	]	X
admet-2551	899	4	y.	y.	PROPN
admet-2551	899	5	guangbo	guangbo	PROPN
admet-2551	899	6	,	,	PUNCT
admet-2551	899	7	s.	s.	PROPN
admet-2551	899	8	min	min	PROPN
admet-2551	899	9	,	,	PUNCT
admet-2551	899	10	s.	s.	PROPN
admet-2551	899	11	wei	wei	PROPN
admet-2551	899	12	,	,	PUNCT
admet-2551	899	13	m.	m.	NOUN
admet-2551	899	14	lixin	lixin	PROPN
admet-2551	899	15	,	,	PUNCT
admet-2551	899	16	z.	z.	PROPN
admet-2551	899	17	chao	chao	PROPN
admet-2551	899	18	,	,	PUNCT
admet-2551	899	19	w.	w.	PROPN
admet-2551	899	20	yaping	yaping	PROPN
admet-2551	899	21	,	,	PUNCT
admet-2551	899	22	h.	h.	PROPN
admet-2551	899	23	zunxi	zunxi	PROPN
admet-2551	899	24	.	.	PUNCT
admet-2551	900	1	heterologous	heterologous	ADJ
admet-2551	900	2	expression	expression	NOUN
admet-2551	900	3	of	of	ADP
admet-2551	900	4	nattokinase	nattokinase	NOUN
admet-2551	900	5	from	from	ADP
admet-2551	900	6	b.	b.	PROPN
admet-2551	900	7	subtilis	subtilis	PROPN
admet-2551	900	8	natto	natto	NOUN
admet-2551	900	9	using	use	VERB
admet-2551	900	10	pichia	pichia	NOUN
admet-2551	900	11	pastoris	pastoris	PROPN
admet-2551	900	12	gs115	gs115	PROPN
admet-2551	900	13	and	and	CCONJ
admet-2551	900	14	assessment	assessment	NOUN
admet-2551	900	15	of	of	ADP
admet-2551	900	16	its	its	PRON
admet-2551	900	17	thrombolytic	thrombolytic	ADJ
admet-2551	900	18	activity	activity	NOUN
admet-2551	900	19	.	.	PUNCT
admet-2551	901	1	bmc	bmc	PROPN
admet-2551	901	2	biotechnology	biotechnology	NOUN
admet-2551	901	3	21	21	NUM
admet-2551	901	4	(	(	PUNCT
admet-2551	901	5	2021	2021	NUM
admet-2551	901	6	)	)	PUNCT
admet-2551	901	7	49	49	NUM
admet-2551	901	8	.	.	PUNCT
admet-2551	902	1	https://doi.org/10.1186/s12896-021-00708-4	https://doi.org/10.1186/s12896-021-00708-4	NUM
admet-2551	902	2	.	.	PUNCT
admet-2551	903	1	[	[	X
admet-2551	903	2	119	119	NUM
admet-2551	903	3	]	]	PUNCT
admet-2551	903	4	a.	a.	NOUN
admet-2551	903	5	krishnamurthy	krishnamurthy	PROPN
admet-2551	903	6	,	,	PUNCT
admet-2551	903	7	p.d	p.d	PROPN
admet-2551	903	8	.	.	PROPN
admet-2551	903	9	belur	belur	PROPN
admet-2551	903	10	,	,	PUNCT
admet-2551	903	11	s.b	s.b	PROPN
admet-2551	903	12	.	.	PROPN
admet-2551	903	13	subramanya	subramanya	PROPN
admet-2551	903	14	.	.	PUNCT
admet-2551	904	1	methods	method	NOUN
admet-2551	904	2	available	available	ADJ
admet-2551	904	3	to	to	PART
admet-2551	904	4	assess	assess	VERB
admet-2551	904	5	therapeutic	therapeutic	ADJ
admet-2551	904	6	potential	potential	NOUN
admet-2551	904	7	of	of	ADP
admet-2551	904	8	fibrinolytic	fibrinolytic	ADJ
admet-2551	904	9	enzymes	enzyme	NOUN
admet-2551	904	10	of	of	ADP
admet-2551	904	11	microbial	microbial	ADJ
admet-2551	904	12	origin	origin	NOUN
admet-2551	904	13	:	:	PUNCT
admet-2551	904	14	a	a	DET
admet-2551	904	15	review	review	NOUN
admet-2551	904	16	.	.	PUNCT
admet-2551	905	1	journal	journal	NOUN
admet-2551	905	2	of	of	ADP
admet-2551	905	3	analytical	analytical	ADJ
admet-2551	905	4	science	science	NOUN
admet-2551	905	5	and	and	CCONJ
admet-2551	905	6	technology	technology	NOUN
admet-2551	905	7	9	9	NUM
admet-2551	905	8	(	(	PUNCT
admet-2551	905	9	2018	2018	NUM
admet-2551	905	10	)	)	PUNCT
admet-2551	905	11	10	10	NUM
admet-2551	905	12	.	.	PUNCT
admet-2551	906	1	https://doi.org/10.1186/s40543-018-0143-3	https://doi.org/10.1186/s40543-018-0143-3	NUM
admet-2551	906	2	.	.	PUNCT
admet-2551	907	1	[	[	X
admet-2551	907	2	120	120	NUM
admet-2551	907	3	]	]	X
admet-2551	907	4	r.	r.	PROPN
admet-2551	907	5	pinontoan	pinontoan	PROPN
admet-2551	907	6	,	,	PUNCT
admet-2551	907	7	a.	a.	PROPN
admet-2551	907	8	sanjaya	sanjaya	PROPN
admet-2551	907	9	,	,	PUNCT
admet-2551	907	10	j.	j.	PROPN
admet-2551	907	11	jo	jo	PROPN
admet-2551	907	12	.	.	PUNCT
admet-2551	908	1	fibrinolytic	fibrinolytic	ADJ
admet-2551	908	2	characteristics	characteristic	NOUN
admet-2551	908	3	of	of	ADP
admet-2551	908	4	bacillus	bacillus	NOUN
admet-2551	908	5	subtilis	subtili	NOUN
admet-2551	908	6	g8	g8	PROPN
admet-2551	908	7	isolated	isolate	VERB
admet-2551	908	8	from	from	ADP
admet-2551	908	9	natto	natto	NOUN
admet-2551	908	10	.	.	PUNCT
admet-2551	909	1	bioscience	bioscience	NOUN
admet-2551	909	2	of	of	ADP
admet-2551	909	3	microbiota	microbiota	NOUN
admet-2551	909	4	,	,	PUNCT
admet-2551	909	5	food	food	NOUN
admet-2551	909	6	and	and	CCONJ
admet-2551	909	7	health	health	NOUN
admet-2551	909	8	40	40	NUM
admet-2551	909	9	(	(	PUNCT
admet-2551	909	10	2021	2021	NUM
admet-2551	909	11	)	)	PUNCT
admet-2551	909	12	144	144	NUM
admet-2551	909	13	-	-	SYM
admet-2551	909	14	149	149	NUM
admet-2551	909	15	.	.	PUNCT
admet-2551	910	1	https://doi.org/10.12938/bmfh.2020-071	https://doi.org/10.12938/bmfh.2020-071	ADJ
admet-2551	910	2	.	.	PUNCT
admet-2551	911	1	[	[	X
admet-2551	911	2	121	121	NUM
admet-2551	911	3	]	]	PUNCT
admet-2551	911	4	s.	s.	PROPN
admet-2551	911	5	kamiya	kamiya	PROPN
admet-2551	911	6	,	,	PUNCT
admet-2551	911	7	m.	m.	NOUN
admet-2551	911	8	hagimori	hagimori	PROPN
admet-2551	911	9	,	,	PUNCT
admet-2551	911	10	m.	m.	NOUN
admet-2551	911	11	ogasawara	ogasawara	PROPN
admet-2551	911	12	,	,	PUNCT
admet-2551	911	13	m.	m.	NOUN
admet-2551	911	14	arakawa	arakawa	PROPN
admet-2551	911	15	.	.	PUNCT
admet-2551	912	1	in	in	ADP
admet-2551	912	2	vivo	vivo	ADJ
admet-2551	912	3	evaluation	evaluation	NOUN
admet-2551	912	4	method	method	NOUN
admet-2551	912	5	of	of	ADP
admet-2551	912	6	the	the	DET
admet-2551	912	7	effect	effect	NOUN
admet-2551	912	8	of	of	ADP
admet-2551	912	9	nattokinase	nattokinase	NOUN
admet-2551	912	10	on	on	ADP
admet-2551	912	11	carrageenan	carrageenan	NOUN
admet-2551	912	12	-	-	PUNCT
admet-2551	912	13	induced	induce	VERB
admet-2551	912	14	tail	tail	NOUN
admet-2551	912	15	thrombosis	thrombosis	NOUN
admet-2551	912	16	in	in	ADP
admet-2551	912	17	a	a	DET
admet-2551	912	18	rat	rat	NOUN
admet-2551	912	19	model	model	NOUN
admet-2551	912	20	.	.	PUNCT
admet-2551	913	1	acta	acta	PROPN
admet-2551	913	2	haematologica	haematologica	PROPN
admet-2551	913	3	124	124	NUM
admet-2551	913	4	(	(	PUNCT
admet-2551	913	5	2010	2010	NUM
admet-2551	913	6	)	)	PUNCT
admet-2551	913	7	218	218	NUM
admet-2551	913	8	-	-	SYM
admet-2551	913	9	224	224	NUM
admet-2551	913	10	.	.	PUNCT
admet-2551	914	1	https://doi.org/10.1007/s10930-021-10023-8	https://doi.org/10.1007/s10930-021-10023-8	NUM
admet-2551	914	2	.	.	PUNCT
admet-2551	915	1	[	[	X
admet-2551	915	2	122	122	NUM
admet-2551	915	3	]	]	X
admet-2551	915	4	m.	m.	NOUN
admet-2551	915	5	taniguchi	taniguchi	PROPN
admet-2551	915	6	,	,	PUNCT
admet-2551	915	7	r.	r.	PROPN
admet-2551	915	8	aida	aida	PROPN
admet-2551	915	9	,	,	PUNCT
admet-2551	915	10	k.	k.	PROPN
admet-2551	915	11	saito	saito	PROPN
admet-2551	915	12	,	,	PUNCT
admet-2551	915	13	t.	t.	PROPN
admet-2551	915	14	kikura	kikura	PROPN
admet-2551	915	15	,	,	PUNCT
admet-2551	915	16	a.	a.	NOUN
admet-2551	915	17	ochiai	ochiai	PROPN
admet-2551	915	18	,	,	PUNCT
admet-2551	915	19	e.	e.	PROPN
admet-2551	915	20	saitoh	saitoh	PROPN
admet-2551	915	21	,	,	PUNCT
admet-2551	915	22	t.	t.	PROPN
admet-2551	915	23	tanaka	tanaka	PROPN
admet-2551	915	24	.	.	PUNCT
admet-2551	916	1	identification	identification	NOUN
admet-2551	916	2	and	and	CCONJ
admet-2551	916	3	characterization	characterization	NOUN
admet-2551	916	4	of	of	ADP
admet-2551	916	5	multifunctional	multifunctional	ADJ
admet-2551	916	6	cationic	cationic	ADJ
admet-2551	916	7	peptides	peptide	NOUN
admet-2551	916	8	from	from	ADP
admet-2551	916	9	enzymatic	enzymatic	ADJ
admet-2551	916	10	hydrolysates	hydrolysate	NOUN
admet-2551	916	11	of	of	ADP
admet-2551	916	12	soybean	soybean	NOUN
admet-2551	916	13	proteins	protein	NOUN
admet-2551	916	14	.	.	PUNCT
admet-2551	917	1	journal	journal	NOUN
admet-2551	917	2	of	of	ADP
admet-2551	917	3	bioscience	bioscience	NOUN
admet-2551	917	4	and	and	CCONJ
admet-2551	917	5	bioengineering	bioengineere	VERB
admet-2551	917	6	129	129	NUM
admet-2551	917	7	(	(	PUNCT
admet-2551	917	8	2020	2020	NUM
admet-2551	917	9	)	)	PUNCT
admet-2551	917	10	59	59	NUM
admet-2551	917	11	-	-	SYM
admet-2551	917	12	66	66	NUM
admet-2551	917	13	.	.	PUNCT
admet-2551	918	1	https://doi.org/10.1016/j.jbiosc.2019.06.016	https://doi.org/10.1016/j.jbiosc.2019.06.016	PROPN
admet-2551	918	2	.	.	PUNCT
admet-2551	919	1	[	[	X
admet-2551	919	2	123	123	NUM
admet-2551	919	3	]	]	PUNCT
admet-2551	919	4	s.	s.	PROPN
admet-2551	919	5	liu	liu	PROPN
admet-2551	919	6	,	,	PUNCT
admet-2551	919	7	j.	j.	PROPN
admet-2551	919	8	zhu	zhu	PROPN
admet-2551	919	9	,	,	PUNCT
admet-2551	919	10	c.	c.	PROPN
admet-2551	919	11	liu	liu	PROPN
admet-2551	919	12	,	,	PUNCT
admet-2551	919	13	j.	j.	PROPN
admet-2551	919	14	li	li	PROPN
admet-2551	919	15	,	,	PUNCT
admet-2551	919	16	z.	z.	PROPN
admet-2551	919	17	li	li	PROPN
admet-2551	919	18	,	,	PUNCT
admet-2551	919	19	j.	j.	PROPN
admet-2551	919	20	zhao	zhao	PROPN
admet-2551	919	21	,	,	PUNCT
admet-2551	919	22	h.	h.	PROPN
admet-2551	919	23	liu	liu	PROPN
admet-2551	919	24	.	.	PUNCT
admet-2551	920	1	synthesis	synthesis	NOUN
admet-2551	920	2	of	of	ADP
admet-2551	920	3	sustained	sustained	ADJ
admet-2551	920	4	release	release	NOUN
admet-2551	920	5	/	/	SYM
admet-2551	920	6	controlled	control	VERB
admet-2551	920	7	release	release	NOUN
admet-2551	920	8	nanoparticles	nanoparticle	NOUN
admet-2551	920	9	carrying	carry	VERB
admet-2551	920	10	nattokinase	nattokinase	NOUN
admet-2551	920	11	and	and	CCONJ
admet-2551	920	12	their	their	PRON
admet-2551	920	13	application	application	NOUN
admet-2551	920	14	in	in	ADP
admet-2551	920	15	thrombolysis	thrombolysis	NOUN
admet-2551	920	16	.	.	PUNCT
admet-2551	921	1	die	die	VERB
admet-2551	921	2	pharmazie	pharmazie	PROPN
admet-2551	921	3	-	-	PUNCT
admet-2551	921	4	an	an	DET
admet-2551	921	5	international	international	ADJ
admet-2551	921	6	journal	journal	NOUN
admet-2551	921	7	of	of	ADP
admet-2551	921	8	pharmaceutical	pharmaceutical	ADJ
admet-2551	921	9	sciences	science	NOUN
admet-2551	921	10	76	76	NUM
admet-2551	921	11	(	(	PUNCT
admet-2551	921	12	2021	2021	NUM
admet-2551	921	13	)	)	PUNCT
admet-2551	921	14	145	145	NUM
admet-2551	921	15	-	-	SYM
admet-2551	921	16	149	149	NUM
admet-2551	921	17	.	.	PUNCT
admet-2551	922	1	https://doi.org/10.1691/ph.2021.0155	https://doi.org/10.1691/ph.2021.0155	PROPN
admet-2551	922	2	.	.	PROPN
admet-2551	922	3	https://doi.org/10.5599/admet.2551	https://doi.org/10.5599/admet.2551	NOUN
admet-2551	922	4	https://doi.org/10.1080/00021369.1989.10869721	https://doi.org/10.1080/00021369.1989.10869721	PROPN
admet-2551	923	1	https://doi.org/10.1006/bbrc.1993.2624	https://doi.org/10.1006/bbrc.1993.2624	NOUN
admet-2551	923	2	https://doi.org/10.1007/s11274-017-2253-2	https://doi.org/10.1007/s11274-017-2253-2	NUM
admet-2551	923	3	https://doi.org/10.2174/1871525716666171207153332	https://doi.org/10.2174/1871525716666171207153332	NOUN
admet-2551	923	4	https://doi.org/10.1248/bpb.18.1387	https://doi.org/10.1248/bpb.18.1387	PROPN
admet-2551	923	5	https://doi.org/10.1016/j.abb.2024.110126	https://doi.org/10.1016/j.abb.2024.110126	PROPN
admet-2551	923	6	https://doi.org/10.1016/j.biopha.2018.10.103	https://doi.org/10.1016/j.biopha.2018.10.103	NOUN
admet-2551	923	7	https://doi.org/10.6227/jfda.2012200317	https://doi.org/10.6227/jfda.2012200317	ADJ
admet-2551	923	8	https://doi.org/10.1016/j.nutres.2009.01.009	https://doi.org/10.1016/j.nutres.2009.01.009	NUM
admet-2551	923	9	https://doi.org/10.1186/s12896-021-00708-4	https://doi.org/10.1186/s12896-021-00708-4	NUM
admet-2551	923	10	https://doi.org/10.1186/s40543-018-0143-3	https://doi.org/10.1186/s40543-018-0143-3	NUM
admet-2551	923	11	https://doi.org/10.12938/bmfh.2020-071	https://doi.org/10.12938/bmfh.2020-071	PROPN
admet-2551	923	12	https://doi.org/10.1007/s10930-021-10023-8	https://doi.org/10.1007/s10930-021-10023-8	NUM
admet-2551	923	13	https://doi.org/10.1016/j.jbiosc.2019.06.016	https://doi.org/10.1016/j.jbiosc.2019.06.016	PROPN
admet-2551	923	14	https://doi.org/10.1691/ph.2021.0155	https://doi.org/10.1691/ph.2021.0155	PROPN
admet-2551	923	15	s.	s.	PROPN
admet-2551	923	16	k.	k.	PROPN
admet-2551	923	17	metkar	metkar	PROPN
admet-2551	923	18	et	et	PROPN
admet-2551	923	19	al	al	PROPN
admet-2551	923	20	.	.	PROPN
admet-2551	923	21	admet	admet	PROPN
admet-2551	923	22	&	&	CCONJ
admet-2551	923	23	dmpk	dmpk	PROPN
admet-2551	923	24	12(6	12(6	NUM
admet-2551	923	25	)	)	PUNCT
admet-2551	923	26	(	(	PUNCT
admet-2551	923	27	2024	2024	NUM
admet-2551	923	28	)	)	PUNCT
admet-2551	923	29	797	797	NUM
admet-2551	923	30	-	-	SYM
admet-2551	923	31	820	820	NUM
admet-2551	923	32	818	818	NUM
admet-2551	923	33	[	[	X
admet-2551	923	34	124	124	NUM
admet-2551	923	35	]	]	X
admet-2551	923	36	c.	c.	PROPN
admet-2551	923	37	yatagai	yatagai	PROPN
admet-2551	923	38	,	,	PUNCT
admet-2551	923	39	m.	m.	NOUN
admet-2551	923	40	maruyama	maruyama	PROPN
admet-2551	923	41	,	,	PUNCT
admet-2551	923	42	t.	t.	PROPN
admet-2551	923	43	kawahara	kawahara	PROPN
admet-2551	923	44	,	,	PUNCT
admet-2551	923	45	h.	h.	PROPN
admet-2551	923	46	sumi	sumi	PROPN
admet-2551	923	47	.	.	PUNCT
admet-2551	923	48	nattokinase	nattokinase	NOUN
admet-2551	923	49	-	-	PUNCT
admet-2551	923	50	promoted	promote	VERB
admet-2551	923	51	tissue	tissue	NOUN
admet-2551	923	52	plasminogen	plasminogen	NOUN
admet-2551	923	53	activator	activator	NOUN
admet-2551	923	54	release	release	NOUN
admet-2551	923	55	from	from	ADP
admet-2551	923	56	human	human	ADJ
admet-2551	923	57	cells	cell	NOUN
admet-2551	923	58	.	.	PUNCT
admet-2551	924	1	pathophysiology	pathophysiology	NOUN
admet-2551	924	2	of	of	ADP
admet-2551	924	3	haemostasis	haemostasis	NOUN
admet-2551	924	4	and	and	CCONJ
admet-2551	924	5	thrombosis	thrombosis	NOUN
admet-2551	924	6	36	36	NUM
admet-2551	924	7	(	(	PUNCT
admet-2551	924	8	2007	2007	NUM
admet-2551	924	9	)	)	PUNCT
admet-2551	924	10	227232	227232	NUM
admet-2551	924	11	.	.	PUNCT
admet-2551	925	1	https://doi.org/10.1159/000252817	https://doi.org/10.1159/000252817	NOUN
admet-2551	925	2	.	.	PUNCT
admet-2551	926	1	[	[	X
admet-2551	926	2	125	125	NUM
admet-2551	926	3	]	]	PUNCT
admet-2551	926	4	h.	h.	PROPN
admet-2551	926	5	wu	wu	PROPN
admet-2551	926	6	,	,	PUNCT
admet-2551	926	7	y.	y.	PROPN
admet-2551	926	8	wang	wang	PROPN
admet-2551	926	9	,	,	PUNCT
admet-2551	926	10	y.	y.	PROPN
admet-2551	926	11	zhang	zhang	PROPN
admet-2551	926	12	,	,	PUNCT
admet-2551	926	13	f.	f.	PROPN
admet-2551	926	14	xu	xu	PROPN
admet-2551	926	15	,	,	PUNCT
admet-2551	926	16	j.	j.	PROPN
admet-2551	926	17	chen	chen	PROPN
admet-2551	926	18	,	,	PUNCT
admet-2551	926	19	l.	l.	PROPN
admet-2551	926	20	duan	duan	PROPN
admet-2551	926	21	,	,	PUNCT
admet-2551	926	22	t.	t.	PROPN
admet-2551	926	23	zhang	zhang	PROPN
admet-2551	926	24	,	,	PUNCT
admet-2551	926	25	j.	j.	PROPN
admet-2551	926	26	wang	wang	PROPN
admet-2551	926	27	,	,	PUNCT
admet-2551	926	28	f.	f.	PROPN
admet-2551	926	29	zhang	zhang	PROPN
admet-2551	926	30	.	.	PUNCT
admet-2551	927	1	breaking	break	VERB
admet-2551	927	2	the	the	DET
admet-2551	927	3	vicious	vicious	ADJ
admet-2551	927	4	loop	loop	NOUN
admet-2551	927	5	between	between	ADP
admet-2551	927	6	inflammation	inflammation	NOUN
admet-2551	927	7	,	,	PUNCT
admet-2551	927	8	oxidative	oxidative	ADJ
admet-2551	927	9	stress	stress	NOUN
admet-2551	927	10	and	and	CCONJ
admet-2551	927	11	coagulation	coagulation	NOUN
admet-2551	927	12	,	,	PUNCT
admet-2551	927	13	a	a	DET
admet-2551	927	14	novel	novel	ADJ
admet-2551	927	15	anti	anti	ADJ
admet-2551	927	16	-	-	ADJ
admet-2551	927	17	thrombus	thrombus	ADJ
admet-2551	927	18	insight	insight	NOUN
admet-2551	927	19	of	of	ADP
admet-2551	927	20	nattokinase	nattokinase	NOUN
admet-2551	927	21	by	by	ADP
admet-2551	927	22	inhibiting	inhibit	VERB
admet-2551	927	23	lps	lps	PROPN
admet-2551	927	24	-	-	PUNCT
admet-2551	927	25	induced	induce	VERB
admet-2551	927	26	inflammation	inflammation	NOUN
admet-2551	927	27	and	and	CCONJ
admet-2551	927	28	oxidative	oxidative	ADJ
admet-2551	927	29	stress	stress	NOUN
admet-2551	927	30	.	.	PUNCT
admet-2551	928	1	redox	redox	ADJ
admet-2551	928	2	biology	biology	NOUN
admet-2551	928	3	32	32	NUM
admet-2551	928	4	(	(	PUNCT
admet-2551	928	5	2020	2020	NUM
admet-2551	928	6	)	)	PUNCT
admet-2551	928	7	101500	101500	NUM
admet-2551	928	8	.	.	PUNCT
admet-2551	929	1	https://doi.org/10.1016/j.redox.2020.101500	https://doi.org/10.1016/j.redox.2020.101500	NOUN
admet-2551	929	2	.	.	PUNCT
admet-2551	930	1	[	[	X
admet-2551	930	2	126	126	NUM
admet-2551	930	3	]	]	PUNCT
admet-2551	930	4	l.	l.	PROPN
admet-2551	930	5	zhou	zhou	PROPN
admet-2551	930	6	,	,	PUNCT
admet-2551	930	7	n.	n.	PROPN
admet-2551	930	8	hao	hao	PROPN
admet-2551	930	9	,	,	PUNCT
admet-2551	930	10	x.	x.	PROPN
admet-2551	930	11	li	li	PROPN
admet-2551	930	12	,	,	PUNCT
admet-2551	930	13	j.	j.	PROPN
admet-2551	930	14	chen	chen	PROPN
admet-2551	930	15	,	,	PUNCT
admet-2551	930	16	r.	r.	PROPN
admet-2551	930	17	yang	yang	PROPN
admet-2551	930	18	,	,	PUNCT
admet-2551	930	19	c.	c.	PROPN
admet-2551	930	20	song	song	PROPN
admet-2551	930	21	,	,	PUNCT
admet-2551	930	22	y.	y.	PROPN
admet-2551	930	23	sun	sun	PROPN
admet-2551	930	24	,	,	PUNCT
admet-2551	930	25	q.	q.	PROPN
admet-2551	930	26	zhang	zhang	PROPN
admet-2551	930	27	.	.	PUNCT
admet-2551	930	28	nattokinase	nattokinase	PROPN
admet-2551	930	29	mitigated	mitigate	VERB
admet-2551	930	30	dextran	dextran	NOUN
admet-2551	930	31	sulfate	sulfate	NOUN
admet-2551	930	32	sodium	sodium	NOUN
admet-2551	930	33	-	-	PUNCT
admet-2551	930	34	induced	induce	VERB
admet-2551	930	35	chronic	chronic	ADJ
admet-2551	930	36	colitis	colitis	NOUN
admet-2551	930	37	by	by	ADP
admet-2551	930	38	regulating	regulate	VERB
admet-2551	930	39	microbiota	microbiota	NOUN
admet-2551	930	40	and	and	CCONJ
admet-2551	930	41	suppressing	suppress	VERB
admet-2551	930	42	tryptophan	tryptophan	NOUN
admet-2551	930	43	metabolism	metabolism	NOUN
admet-2551	930	44	via	via	ADP
admet-2551	930	45	inhibiting	inhibit	VERB
admet-2551	930	46	ido-1	ido-1	NOUN
admet-2551	930	47	.	.	PUNCT
admet-2551	931	1	journal	journal	NOUN
admet-2551	931	2	of	of	ADP
admet-2551	931	3	functional	functional	ADJ
admet-2551	931	4	foods	food	NOUN
admet-2551	931	5	75	75	NUM
admet-2551	931	6	(	(	PUNCT
admet-2551	931	7	2020	2020	NUM
admet-2551	931	8	)	)	PUNCT
admet-2551	931	9	104251	104251	NUM
admet-2551	931	10	.	.	PUNCT
admet-2551	932	1	https://doi.org/10.1016/j.jff.2020.104251	https://doi.org/10.1016/j.jff.2020.104251	X
admet-2551	932	2	.	.	PUNCT
admet-2551	933	1	[	[	X
admet-2551	933	2	127	127	NUM
admet-2551	933	3	]	]	X
admet-2551	933	4	z.	z.	PROPN
admet-2551	933	5	huang	huang	PROPN
admet-2551	933	6	,	,	PUNCT
admet-2551	933	7	t.k	t.k	PROPN
admet-2551	933	8	.	.	PROPN
admet-2551	933	9	ng	ng	PROPN
admet-2551	933	10	,	,	PUNCT
admet-2551	933	11	w.	w.	PROPN
admet-2551	933	12	chen	chen	PROPN
admet-2551	933	13	,	,	PUNCT
admet-2551	933	14	x.	x.	PROPN
admet-2551	933	15	sun	sun	PROPN
admet-2551	933	16	,	,	PUNCT
admet-2551	933	17	d.	d.	PROPN
admet-2551	933	18	huang	huang	PROPN
admet-2551	933	19	,	,	PUNCT
admet-2551	933	20	d.	d.	PROPN
admet-2551	933	21	zheng	zheng	PROPN
admet-2551	933	22	,	,	PUNCT
admet-2551	933	23	j.	j.	PROPN
admet-2551	933	24	yi	yi	PROPN
admet-2551	933	25	,	,	PUNCT
admet-2551	933	26	y.	y.	PROPN
admet-2551	933	27	xu	xu	PROPN
admet-2551	933	28	,	,	PUNCT
admet-2551	933	29	x.	x.	PROPN
admet-2551	933	30	zhuang	zhuang	PROPN
admet-2551	933	31	,	,	PUNCT
admet-2551	933	32	s.	s.	PROPN
admet-2551	933	33	chen	chen	PROPN
admet-2551	933	34	.	.	PUNCT
admet-2551	934	1	nattokinase	nattokinase	NOUN
admet-2551	934	2	attenuates	attenuate	VERB
admet-2551	934	3	retinal	retinal	ADJ
admet-2551	934	4	neovascularization	neovascularization	NOUN
admet-2551	934	5	via	via	ADP
admet-2551	934	6	modulation	modulation	NOUN
admet-2551	934	7	of	of	ADP
admet-2551	934	8	nrf2	nrf2	PROPN
admet-2551	934	9	/	/	SYM
admet-2551	934	10	ho-1	ho-1	NOUN
admet-2551	934	11	and	and	CCONJ
admet-2551	934	12	glial	glial	ADJ
admet-2551	934	13	activation	activation	NOUN
admet-2551	934	14	.	.	PUNCT
admet-2551	935	1	investigative	investigative	ADJ
admet-2551	935	2	ophthalmology	ophthalmology	NOUN
admet-2551	935	3	&	&	CCONJ
admet-2551	935	4	visual	visual	ADJ
admet-2551	935	5	science	science	PROPN
admet-2551	935	6	62	62	NUM
admet-2551	935	7	(	(	PUNCT
admet-2551	935	8	2021	2021	NUM
admet-2551	935	9	)	)	PUNCT
admet-2551	935	10	25	25	NUM
admet-2551	935	11	-	-	SYM
admet-2551	935	12	25	25	NUM
admet-2551	935	13	.	.	PUNCT
admet-2551	936	1	https://doi.org/10.1167/iovs.62.6.25	https://doi.org/10.1167/iovs.62.6.25	NOUN
admet-2551	936	2	.	.	PUNCT
admet-2551	937	1	[	[	X
admet-2551	937	2	128	128	NUM
admet-2551	937	3	]	]	X
admet-2551	937	4	m.m	m.m	PROPN
admet-2551	937	5	.	.	PROPN
admet-2551	937	6	elbakry	elbakry	PROPN
admet-2551	937	7	,	,	PUNCT
admet-2551	937	8	s.z	s.z	PROPN
admet-2551	937	9	.	.	PROPN
admet-2551	937	10	mansour	mansour	PROPN
admet-2551	937	11	,	,	PUNCT
admet-2551	937	12	h.	h.	PROPN
admet-2551	937	13	helal	helal	PROPN
admet-2551	937	14	,	,	PUNCT
admet-2551	937	15	e.s	e.s	PROPN
admet-2551	937	16	.	.	PROPN
admet-2551	937	17	ahmed	ahmed	PROPN
admet-2551	937	18	.	.	PUNCT
admet-2551	937	19	nattokinase	nattokinase	NOUN
admet-2551	937	20	attenuates	attenuate	VERB
admet-2551	937	21	bisphenol	bisphenol	NOUN
admet-2551	937	22	a	a	DET
admet-2551	937	23	or	or	CCONJ
admet-2551	937	24	gamma	gamma	NOUN
admet-2551	937	25	irradiation	irradiation	NOUN
admet-2551	937	26	-	-	PUNCT
admet-2551	937	27	mediated	mediate	VERB
admet-2551	937	28	hepatic	hepatic	ADJ
admet-2551	937	29	and	and	CCONJ
admet-2551	937	30	neural	neural	ADJ
admet-2551	937	31	toxicity	toxicity	NOUN
admet-2551	937	32	by	by	ADP
admet-2551	937	33	activation	activation	NOUN
admet-2551	937	34	of	of	ADP
admet-2551	937	35	nrf2	nrf2	NOUN
admet-2551	937	36	and	and	CCONJ
admet-2551	937	37	suppression	suppression	NOUN
admet-2551	937	38	of	of	ADP
admet-2551	937	39	inflammatory	inflammatory	ADJ
admet-2551	937	40	mediators	mediator	NOUN
admet-2551	937	41	in	in	ADP
admet-2551	937	42	rats	rat	NOUN
admet-2551	937	43	.	.	PUNCT
admet-2551	938	1	environmental	environmental	ADJ
admet-2551	938	2	science	science	NOUN
admet-2551	938	3	and	and	CCONJ
admet-2551	938	4	pollution	pollution	NOUN
admet-2551	938	5	research	research	NOUN
admet-2551	938	6	29	29	NUM
admet-2551	938	7	(	(	PUNCT
admet-2551	938	8	2022	2022	NUM
admet-2551	938	9	)	)	PUNCT
admet-2551	938	10	75086	75086	NUM
admet-2551	938	11	-	-	SYM
admet-2551	938	12	75100	75100	NUM
admet-2551	938	13	.	.	PUNCT
admet-2551	939	1	https://doi.org/10.1007/s11356-022-21126-9	https://doi.org/10.1007/s11356-022-21126-9	NOUN
admet-2551	939	2	.	.	PUNCT
admet-2551	940	1	[	[	X
admet-2551	940	2	129	129	NUM
admet-2551	940	3	]	]	PUNCT
admet-2551	940	4	h.-y	h.-y	NOUN
admet-2551	940	5	.	.	PUNCT
admet-2551	941	1	chou	chou	NOUN
admet-2551	941	2	,	,	PUNCT
admet-2551	941	3	l.-h	l.-h	PROPN
admet-2551	941	4	.	.	PUNCT
admet-2551	942	1	liu	liu	PROPN
admet-2551	942	2	,	,	PUNCT
admet-2551	942	3	c.-y	c.-y	NOUN
admet-2551	942	4	.	.	PUNCT
admet-2551	943	1	chen	chen	PROPN
admet-2551	943	2	,	,	PUNCT
admet-2551	943	3	i.-f	i.-f	PROPN
admet-2551	943	4	.	.	PUNCT
admet-2551	944	1	lin	lin	PROPN
admet-2551	944	2	,	,	PUNCT
admet-2551	944	3	d.	d.	PROPN
admet-2551	944	4	ali	ali	PROPN
admet-2551	944	5	,	,	PUNCT
admet-2551	944	6	a.y.-l	a.y.-l	PROPN
admet-2551	944	7	.	.	PUNCT
admet-2551	945	1	lee	lee	PROPN
admet-2551	945	2	,	,	PUNCT
admet-2551	945	3	h.-m.d	h.-m.d	PROPN
admet-2551	945	4	.	.	PUNCT
admet-2551	946	1	wang	wang	PROPN
admet-2551	946	2	.	.	PUNCT
admet-2551	946	3	bifunctional	bifunctional	ADJ
admet-2551	946	4	mechanisms	mechanism	NOUN
admet-2551	946	5	of	of	ADP
admet-2551	946	6	autophagy	autophagy	ADJ
admet-2551	946	7	and	and	CCONJ
admet-2551	946	8	apoptosis	apoptosis	NOUN
admet-2551	946	9	regulations	regulation	NOUN
admet-2551	946	10	in	in	ADP
admet-2551	946	11	melanoma	melanoma	NOUN
admet-2551	946	12	from	from	ADP
admet-2551	946	13	bacillus	bacillus	NOUN
admet-2551	946	14	subtilis	subtili	NOUN
admet-2551	946	15	natto	natto	NOUN
admet-2551	946	16	fermentation	fermentation	NOUN
admet-2551	946	17	extract	extract	NOUN
admet-2551	946	18	.	.	PUNCT
admet-2551	947	1	food	food	NOUN
admet-2551	947	2	and	and	CCONJ
admet-2551	947	3	chemical	chemical	NOUN
admet-2551	947	4	toxicology	toxicology	NOUN
admet-2551	947	5	150	150	NUM
admet-2551	947	6	(	(	PUNCT
admet-2551	947	7	2021	2021	NUM
admet-2551	947	8	)	)	PUNCT
admet-2551	947	9	112020	112020	NUM
admet-2551	947	10	.	.	PUNCT
admet-2551	948	1	https://doi.org/10.1016/j.fct.2021.112020	https://doi.org/10.1016/j.fct.2021.112020	PROPN
admet-2551	948	2	.	.	PUNCT
admet-2551	949	1	[	[	X
admet-2551	949	2	130	130	NUM
admet-2551	949	3	]	]	X
admet-2551	949	4	y.	y.	NOUN
admet-2551	949	5	song	song	PROPN
admet-2551	949	6	,	,	PUNCT
admet-2551	949	7	j.	j.	PROPN
admet-2551	949	8	yu	yu	PROPN
admet-2551	949	9	,	,	PUNCT
admet-2551	949	10	j.	j.	PROPN
admet-2551	949	11	song	song	PROPN
admet-2551	949	12	,	,	PUNCT
admet-2551	949	13	s.	s.	PROPN
admet-2551	949	14	wang	wang	PROPN
admet-2551	949	15	,	,	PUNCT
admet-2551	949	16	t.	t.	PROPN
admet-2551	949	17	cao	cao	PROPN
admet-2551	949	18	,	,	PUNCT
admet-2551	949	19	z.	z.	PROPN
admet-2551	949	20	liu	liu	PROPN
admet-2551	949	21	,	,	PUNCT
admet-2551	949	22	x.	x.	PROPN
admet-2551	949	23	gao	gao	PROPN
admet-2551	949	24	,	,	PUNCT
admet-2551	949	25	y.	y.	PROPN
admet-2551	949	26	wei	wei	PROPN
admet-2551	949	27	.	.	PUNCT
admet-2551	950	1	the	the	DET
admet-2551	950	2	antihypertensive	antihypertensive	ADJ
admet-2551	950	3	effect	effect	NOUN
admet-2551	950	4	and	and	CCONJ
admet-2551	950	5	mechanisms	mechanism	NOUN
admet-2551	950	6	of	of	ADP
admet-2551	950	7	bioactive	bioactive	ADJ
admet-2551	950	8	peptides	peptide	NOUN
admet-2551	950	9	from	from	ADP
admet-2551	950	10	ruditapes	ruditape	NOUN
admet-2551	950	11	philippinarum	philippinarum	PROPN
admet-2551	950	12	fermented	ferment	VERB
admet-2551	950	13	with	with	ADP
admet-2551	950	14	bacillus	bacillus	NOUN
admet-2551	950	15	natto	natto	NOUN
admet-2551	950	16	in	in	ADP
admet-2551	950	17	spontaneously	spontaneously	ADV
admet-2551	950	18	hypertensive	hypertensive	ADJ
admet-2551	950	19	rats	rat	NOUN
admet-2551	950	20	.	.	PUNCT
admet-2551	951	1	journal	journal	NOUN
admet-2551	951	2	of	of	ADP
admet-2551	951	3	functional	functional	ADJ
admet-2551	951	4	foods	food	NOUN
admet-2551	951	5	79	79	NUM
admet-2551	951	6	(	(	PUNCT
admet-2551	951	7	2021	2021	NUM
admet-2551	951	8	)	)	PUNCT
admet-2551	951	9	104411	104411	NUM
admet-2551	951	10	.	.	PUNCT
admet-2551	952	1	https://doi.org/10.1016/j.jff.2021.104411	https://doi.org/10.1016/j.jff.2021.104411	PROPN
admet-2551	952	2	.	.	PUNCT
admet-2551	953	1	[	[	X
admet-2551	953	2	131	131	NUM
admet-2551	953	3	]	]	X
admet-2551	953	4	s.m	s.m	PROPN
admet-2551	953	5	.	.	PUNCT
admet-2551	953	6	keziah	keziah	PROPN
admet-2551	953	7	,	,	PUNCT
admet-2551	953	8	c.s	c.s	PROPN
admet-2551	953	9	.	.	PROPN
admet-2551	953	10	devi	devi	PROPN
admet-2551	953	11	.	.	PROPN
admet-2551	954	1	fibrinolytic	fibrinolytic	PROPN
admet-2551	954	2	and	and	CCONJ
admet-2551	954	3	ace	ace	VERB
admet-2551	954	4	inhibitory	inhibitory	ADJ
admet-2551	954	5	activity	activity	NOUN
admet-2551	954	6	of	of	ADP
admet-2551	954	7	nattokinase	nattokinase	NOUN
admet-2551	954	8	extracted	extract	VERB
admet-2551	954	9	from	from	ADP
admet-2551	954	10	bacillus	bacillus	NOUN
admet-2551	954	11	subtilis	subtili	NOUN
admet-2551	954	12	vitms	vitms	NOUN
admet-2551	954	13	2	2	NUM
admet-2551	954	14	:	:	PUNCT
admet-2551	954	15	a	a	DET
admet-2551	954	16	strain	strain	NOUN
admet-2551	954	17	isolated	isolate	VERB
admet-2551	954	18	from	from	ADP
admet-2551	954	19	fermented	ferment	VERB
admet-2551	954	20	milk	milk	NOUN
admet-2551	954	21	of	of	ADP
admet-2551	954	22	vigna	vigna	PROPN
admet-2551	954	23	unguiculata	unguiculata	PROPN
admet-2551	954	24	.	.	PUNCT
admet-2551	955	1	the	the	DET
admet-2551	955	2	protein	protein	NOUN
admet-2551	955	3	journal	journal	NOUN
admet-2551	955	4	40	40	NUM
admet-2551	955	5	(	(	PUNCT
admet-2551	955	6	2021	2021	NUM
admet-2551	955	7	)	)	PUNCT
admet-2551	955	8	876	876	NUM
admet-2551	955	9	-	-	SYM
admet-2551	955	10	890	890	NUM
admet-2551	955	11	.	.	PUNCT
admet-2551	955	12	https://doi.org/10.1007/s10930-021-10023-8	https://doi.org/10.1007/s10930-021-10023-8	NUM
admet-2551	955	13	.	.	PUNCT
admet-2551	956	1	[	[	X
admet-2551	956	2	132	132	NUM
admet-2551	956	3	]	]	X
admet-2551	956	4	s.k	s.k	PROPN
admet-2551	956	5	.	.	PROPN
admet-2551	956	6	metkar	metkar	PROPN
admet-2551	956	7	,	,	PUNCT
admet-2551	956	8	a.	a.	PROPN
admet-2551	956	9	girigoswami	girigoswami	PROPN
admet-2551	956	10	,	,	PUNCT
admet-2551	956	11	r.	r.	PROPN
admet-2551	956	12	murugesan	murugesan	PROPN
admet-2551	956	13	,	,	PUNCT
admet-2551	956	14	k.	k.	PROPN
admet-2551	956	15	girigoswami	girigoswami	PROPN
admet-2551	956	16	.	.	PUNCT
admet-2551	957	1	in	in	ADP
admet-2551	957	2	vitro	vitro	X
admet-2551	957	3	and	and	CCONJ
admet-2551	957	4	in	in	ADP
admet-2551	957	5	vivo	vivo	ADJ
admet-2551	957	6	insulin	insulin	NOUN
admet-2551	957	7	amyloid	amyloid	NOUN
admet-2551	957	8	degradation	degradation	NOUN
admet-2551	957	9	mediated	mediate	VERB
admet-2551	957	10	by	by	ADP
admet-2551	957	11	serratiopeptidase	serratiopeptidase	PROPN
admet-2551	957	12	.	.	PUNCT
admet-2551	958	1	materials	material	NOUN
admet-2551	958	2	science	science	NOUN
admet-2551	958	3	and	and	CCONJ
admet-2551	958	4	engineering	engineering	NOUN
admet-2551	958	5	:	:	PUNCT
admet-2551	958	6	c	c	NOUN
admet-2551	958	7	70	70	NUM
admet-2551	958	8	(	(	PUNCT
admet-2551	958	9	2017	2017	NUM
admet-2551	958	10	)	)	PUNCT
admet-2551	958	11	728	728	NUM
admet-2551	958	12	-	-	SYM
admet-2551	958	13	735	735	NUM
admet-2551	958	14	.	.	PUNCT
admet-2551	958	15	https://doi.org/10.1016/j.msec.2016.09.049	https://doi.org/10.1016/j.msec.2016.09.049	PROPN
admet-2551	958	16	.	.	PUNCT
admet-2551	959	1	[	[	X
admet-2551	959	2	133	133	NUM
admet-2551	959	3	]	]	X
admet-2551	959	4	s.k	s.k	PROPN
admet-2551	959	5	.	.	PROPN
admet-2551	959	6	metkar	metkar	PROPN
admet-2551	959	7	,	,	PUNCT
admet-2551	959	8	s.	s.	PROPN
admet-2551	959	9	ghosh	ghosh	PROPN
admet-2551	959	10	,	,	PUNCT
admet-2551	959	11	a.	a.	PROPN
admet-2551	959	12	girigoswami	girigoswami	PROPN
admet-2551	959	13	,	,	PUNCT
admet-2551	959	14	k.	k.	PROPN
admet-2551	959	15	girigoswami	girigoswami	PROPN
admet-2551	959	16	.	.	PUNCT
admet-2551	960	1	prion	prion	NOUN
admet-2551	960	2	peptide	peptide	PROPN
admet-2551	960	3	106	106	NUM
admet-2551	960	4	-	-	SYM
admet-2551	960	5	126	126	NUM
admet-2551	960	6	degradation	degradation	NOUN
admet-2551	960	7	potential	potential	NOUN
admet-2551	960	8	of	of	ADP
admet-2551	960	9	serratiopetidase	serratiopetidase	NOUN
admet-2551	960	10	and	and	CCONJ
admet-2551	960	11	lumbrokinase	lumbrokinase	NOUN
admet-2551	960	12	-	-	PUNCT
admet-2551	960	13	an	an	NOUN
admet-2551	960	14	in	in	ADP
admet-2551	960	15	vitro	vitro	X
admet-2551	960	16	and	and	CCONJ
admet-2551	960	17	in	in	ADP
admet-2551	960	18	silico	silico	NOUN
admet-2551	960	19	perspective	perspective	NOUN
admet-2551	960	20	.	.	PUNCT
admet-2551	961	1	cns	cns	PROPN
admet-2551	961	2	&	&	CCONJ
admet-2551	961	3	neurological	neurological	ADJ
admet-2551	961	4	disorders	disorder	NOUN
admet-2551	961	5	-	-	PUNCT
admet-2551	961	6	drug	drug	NOUN
admet-2551	961	7	targets	target	NOUN
admet-2551	961	8	(	(	PUNCT
admet-2551	961	9	formerly	formerly	ADV
admet-2551	961	10	current	current	ADJ
admet-2551	961	11	drug	drug	NOUN
admet-2551	961	12	targets	target	NOUN
admet-2551	961	13	-	-	PUNCT
admet-2551	961	14	cns	cns	NOUN
admet-2551	961	15	&	&	CCONJ
admet-2551	961	16	neurological	neurological	ADJ
admet-2551	961	17	disorders	disorder	NOUN
admet-2551	961	18	)	)	PUNCT
admet-2551	961	19	18	18	NUM
admet-2551	961	20	(	(	PUNCT
admet-2551	961	21	2019	2019	NUM
admet-2551	961	22	)	)	PUNCT
admet-2551	961	23	723	723	NUM
admet-2551	961	24	-	-	SYM
admet-2551	961	25	731	731	NUM
admet-2551	961	26	.	.	PUNCT
admet-2551	962	1	https://doi.org/10.2174/1871527318666191021150002	https://doi.org/10.2174/1871527318666191021150002	NOUN
admet-2551	962	2	.	.	PUNCT
admet-2551	963	1	[	[	X
admet-2551	963	2	134	134	NUM
admet-2551	963	3	]	]	X
admet-2551	963	4	s.k	s.k	PROPN
admet-2551	963	5	.	.	PROPN
admet-2551	963	6	metkar	metkar	PROPN
admet-2551	963	7	,	,	PUNCT
admet-2551	963	8	a.	a.	PROPN
admet-2551	963	9	girigoswami	girigoswami	PROPN
admet-2551	963	10	,	,	PUNCT
admet-2551	963	11	d.d	d.d	PROPN
admet-2551	963	12	.	.	PROPN
admet-2551	963	13	bondage	bondage	PROPN
admet-2551	963	14	,	,	PUNCT
admet-2551	963	15	u.g	u.g	PROPN
admet-2551	963	16	.	.	PROPN
admet-2551	963	17	shinde	shinde	PROPN
admet-2551	963	18	,	,	PUNCT
admet-2551	963	19	k.	k.	PROPN
admet-2551	963	20	girigoswami	girigoswami	PROPN
admet-2551	963	21	.	.	PUNCT
admet-2551	964	1	the	the	DET
admet-2551	964	2	potential	potential	NOUN
admet-2551	964	3	of	of	ADP
admet-2551	964	4	lumbrokinase	lumbrokinase	NOUN
admet-2551	964	5	and	and	CCONJ
admet-2551	964	6	serratiopeptidase	serratiopeptidase	VERB
admet-2551	964	7	for	for	ADP
admet-2551	964	8	the	the	DET
admet-2551	964	9	degradation	degradation	NOUN
admet-2551	964	10	of	of	ADP
admet-2551	964	11	aβ	aβ	DET
admet-2551	964	12	1–42	1–42	PROPN
admet-2551	964	13	peptide	peptide	NOUN
admet-2551	964	14	–	–	PUNCT
admet-2551	964	15	an	an	PRON
admet-2551	964	16	in	in	ADP
admet-2551	964	17	vitro	vitro	X
admet-2551	964	18	and	and	CCONJ
admet-2551	964	19	in	in	ADP
admet-2551	964	20	silico	silico	NOUN
admet-2551	964	21	approach	approach	NOUN
admet-2551	964	22	.	.	PUNCT
admet-2551	965	1	international	international	ADJ
admet-2551	965	2	journal	journal	PROPN
admet-2551	965	3	of	of	ADP
admet-2551	965	4	neuroscience	neuroscience	NOUN
admet-2551	965	5	134	134	NUM
admet-2551	965	6	(	(	PUNCT
admet-2551	965	7	2022	2022	NUM
admet-2551	965	8	)	)	PUNCT
admet-2551	965	9	112	112	NUM
admet-2551	965	10	-	-	SYM
admet-2551	965	11	123	123	NUM
admet-2551	965	12	.	.	PUNCT
admet-2551	966	1	https://doi.org/10.1080/00207454.2022.2089137	https://doi.org/10.1080/00207454.2022.2089137	X
admet-2551	966	2	.	.	PUNCT
admet-2551	967	1	[	[	X
admet-2551	967	2	135	135	NUM
admet-2551	967	3	]	]	X
admet-2551	967	4	s.k	s.k	PROPN
admet-2551	967	5	.	.	PROPN
admet-2551	967	6	metkar	metkar	PROPN
admet-2551	967	7	,	,	PUNCT
admet-2551	967	8	a.	a.	PROPN
admet-2551	967	9	girigoswami	girigoswami	PROPN
admet-2551	967	10	,	,	PUNCT
admet-2551	967	11	r.	r.	PROPN
admet-2551	967	12	murugesan	murugesan	PROPN
admet-2551	967	13	,	,	PUNCT
admet-2551	967	14	k.	k.	PROPN
admet-2551	967	15	girigoswami	girigoswami	PROPN
admet-2551	967	16	.	.	PUNCT
admet-2551	968	1	lumbrokinase	lumbrokinase	PROPN
admet-2551	968	2	for	for	ADP
admet-2551	968	3	degradation	degradation	NOUN
admet-2551	968	4	and	and	CCONJ
admet-2551	968	5	reduction	reduction	NOUN
admet-2551	968	6	of	of	ADP
admet-2551	968	7	amyloid	amyloid	NOUN
admet-2551	968	8	fibrils	fibril	NOUN
admet-2551	968	9	associated	associate	VERB
admet-2551	968	10	with	with	ADP
admet-2551	968	11	amyloidosis	amyloidosis	NOUN
admet-2551	968	12	.	.	PUNCT
admet-2551	969	1	journal	journal	NOUN
admet-2551	969	2	of	of	ADP
admet-2551	969	3	applied	apply	VERB
admet-2551	969	4	biomedicine	biomedicine	NOUN
admet-2551	969	5	15	15	NUM
admet-2551	969	6	(	(	PUNCT
admet-2551	969	7	2017	2017	NUM
admet-2551	969	8	)	)	PUNCT
admet-2551	969	9	96	96	NUM
admet-2551	969	10	-	-	SYM
admet-2551	969	11	104	104	NUM
admet-2551	969	12	.	.	PUNCT
admet-2551	970	1	https://doi.org/10.1016/j.jab.2017.01.003	https://doi.org/10.1016/j.jab.2017.01.003	NOUN
admet-2551	970	2	.	.	PUNCT
admet-2551	971	1	[	[	X
admet-2551	971	2	136	136	NUM
admet-2551	971	3	]	]	X
admet-2551	971	4	s.k	s.k	PROPN
admet-2551	971	5	.	.	PROPN
admet-2551	971	6	metkar	metkar	PROPN
admet-2551	971	7	,	,	PUNCT
admet-2551	971	8	a.	a.	PROPN
admet-2551	971	9	girigoswami	girigoswami	PROPN
admet-2551	971	10	,	,	PUNCT
admet-2551	971	11	r.	r.	PROPN
admet-2551	971	12	vijayashree	vijayashree	PROPN
admet-2551	971	13	,	,	PUNCT
admet-2551	971	14	k.	k.	PROPN
admet-2551	971	15	girigoswami	girigoswami	PROPN
admet-2551	971	16	.	.	PUNCT
admet-2551	972	1	attenuation	attenuation	NOUN
admet-2551	972	2	of	of	ADP
admet-2551	972	3	subcutaneous	subcutaneous	ADJ
admet-2551	972	4	insulin	insulin	NOUN
admet-2551	972	5	induced	induce	VERB
admet-2551	972	6	amyloid	amyloid	NOUN
admet-2551	972	7	mass	mass	NOUN
admet-2551	972	8	in	in	ADP
admet-2551	972	9	vivo	vivo	NOUN
admet-2551	972	10	using	use	VERB
admet-2551	972	11	lumbrokinase	lumbrokinase	NOUN
admet-2551	972	12	and	and	CCONJ
admet-2551	972	13	serratiopeptidase	serratiopeptidase	VERB
admet-2551	972	14	.	.	PUNCT
admet-2551	973	1	international	international	ADJ
admet-2551	973	2	journal	journal	PROPN
admet-2551	973	3	of	of	ADP
admet-2551	973	4	biological	biological	ADJ
admet-2551	973	5	macromolecules	macromolecule	NOUN
admet-2551	973	6	163	163	NUM
admet-2551	973	7	(	(	PUNCT
admet-2551	973	8	2020	2020	NUM
admet-2551	973	9	)	)	PUNCT
admet-2551	973	10	128	128	NUM
admet-2551	973	11	-	-	SYM
admet-2551	973	12	134	134	NUM
admet-2551	973	13	.	.	PUNCT
admet-2551	974	1	https://doi.org/10.1016/j.ijbiomac.2020.06.256	https://doi.org/10.1016/j.ijbiomac.2020.06.256	PROPN
admet-2551	974	2	.	.	PUNCT
admet-2551	975	1	[	[	X
admet-2551	975	2	137	137	NUM
admet-2551	975	3	]	]	PUNCT
admet-2551	975	4	p.	p.	NOUN
admet-2551	975	5	velander	velander	PROPN
admet-2551	975	6	,	,	PUNCT
admet-2551	975	7	l.	l.	PROPN
admet-2551	975	8	wu	wu	PROPN
admet-2551	975	9	,	,	PUNCT
admet-2551	975	10	f.	f.	PROPN
admet-2551	975	11	henderson	henderson	PROPN
admet-2551	975	12	,	,	PUNCT
admet-2551	975	13	s.	s.	PROPN
admet-2551	975	14	zhang	zhang	PROPN
admet-2551	975	15	,	,	PUNCT
admet-2551	975	16	d.r	d.r	PROPN
admet-2551	975	17	.	.	PROPN
admet-2551	975	18	bevan	bevan	PROPN
admet-2551	975	19	,	,	PUNCT
admet-2551	975	20	b.	b.	PROPN
admet-2551	975	21	xu	xu	PROPN
admet-2551	975	22	.	.	PUNCT
admet-2551	976	1	natural	natural	ADJ
admet-2551	976	2	product	product	NOUN
admet-2551	976	3	-	-	PUNCT
admet-2551	976	4	based	base	VERB
admet-2551	976	5	amyloid	amyloid	NOUN
admet-2551	976	6	inhibitors	inhibitor	NOUN
admet-2551	976	7	.	.	PUNCT
admet-2551	977	1	biochemical	biochemical	ADJ
admet-2551	977	2	pharmacology	pharmacology	NOUN
admet-2551	977	3	139	139	NUM
admet-2551	977	4	(	(	PUNCT
admet-2551	977	5	2017	2017	NUM
admet-2551	977	6	)	)	PUNCT
admet-2551	977	7	40	40	NUM
admet-2551	977	8	-	-	SYM
admet-2551	977	9	55	55	NUM
admet-2551	977	10	.	.	PUNCT
admet-2551	978	1	https://doi.org/10.1016/j.bcp.2017.04.004	https://doi.org/10.1016/j.bcp.2017.04.004	VERB
admet-2551	978	2	.	.	PUNCT
admet-2551	979	1	[	[	X
admet-2551	979	2	138	138	NUM
admet-2551	979	3	]	]	X
admet-2551	979	4	l.	l.	PROPN
admet-2551	979	5	ciccone	ciccone	PROPN
admet-2551	979	6	,	,	PUNCT
admet-2551	979	7	n.	n.	PROPN
admet-2551	979	8	tonali	tonali	PROPN
admet-2551	979	9	,	,	PUNCT
admet-2551	979	10	s.	s.	PROPN
admet-2551	979	11	nencetti	nencetti	PROPN
admet-2551	979	12	,	,	PUNCT
admet-2551	979	13	e.	e.	PROPN
admet-2551	979	14	orlandini	orlandini	PROPN
admet-2551	979	15	.	.	PUNCT
admet-2551	980	1	natural	natural	ADJ
admet-2551	980	2	compounds	compound	NOUN
admet-2551	980	3	as	as	ADP
admet-2551	980	4	inhibitors	inhibitor	NOUN
admet-2551	980	5	of	of	ADP
admet-2551	980	6	transthyretin	transthyretin	PRON
admet-2551	980	7	amyloidosis	amyloidosis	NOUN
admet-2551	980	8	and	and	CCONJ
admet-2551	980	9	neuroprotective	neuroprotective	ADJ
admet-2551	980	10	agents	agent	NOUN
admet-2551	980	11	:	:	PUNCT
admet-2551	980	12	analysis	analysis	NOUN
admet-2551	980	13	of	of	ADP
admet-2551	980	14	structural	structural	ADJ
admet-2551	980	15	data	datum	NOUN
admet-2551	980	16	for	for	ADP
admet-2551	980	17	future	future	ADJ
admet-2551	980	18	drug	drug	NOUN
admet-2551	980	19	design	design	NOUN
admet-2551	980	20	.	.	PUNCT
admet-2551	981	1	journal	journal	PROPN
admet-2551	981	2	https://doi.org/10.1159/000252817	https://doi.org/10.1159/000252817	PROPN
admet-2551	981	3	https://doi.org/10.1016/j.redox.2020.101500	https://doi.org/10.1016/j.redox.2020.101500	PROPN
admet-2551	981	4	https://doi.org/10.1016/j.jff.2020.104251	https://doi.org/10.1016/j.jff.2020.104251	PROPN
admet-2551	981	5	https://doi.org/10.1167/iovs.62.6.25	https://doi.org/10.1167/iovs.62.6.25	PROPN
admet-2551	981	6	https://doi.org/10.1007/s11356-022-21126-9	https://doi.org/10.1007/s11356-022-21126-9	NOUN
admet-2551	981	7	https://doi.org/10.1016/j.fct.2021.112020	https://doi.org/10.1016/j.fct.2021.112020	PROPN
admet-2551	981	8	https://doi.org/10.1016/j.jff.2021.104411	https://doi.org/10.1016/j.jff.2021.104411	PROPN
admet-2551	981	9	https://doi.org/10.1007/s10930-021-10023-8	https://doi.org/10.1007/s10930-021-10023-8	NUM
admet-2551	982	1	https://doi.org/10.1016/j.msec.2016.09.049	https://doi.org/10.1016/j.msec.2016.09.049	INTJ
admet-2551	982	2	https://doi.org/10.2174/1871527318666191021150002	https://doi.org/10.2174/1871527318666191021150002	NOUN
admet-2551	982	3	https://doi.org/10.1080/00207454.2022.2089137	https://doi.org/10.1080/00207454.2022.2089137	PROPN
admet-2551	983	1	https://doi.org/10.1016/j.jab.2017.01.003	https://doi.org/10.1016/j.jab.2017.01.003	PROPN
admet-2551	983	2	https://doi.org/10.1016/j.ijbiomac.2020.06.256	https://doi.org/10.1016/j.ijbiomac.2020.06.256	PROPN
admet-2551	983	3	https://doi.org/10.1016/j.bcp.2017.04.004	https://doi.org/10.1016/j.bcp.2017.04.004	NOUN
admet-2551	983	4	admet	admet	X
admet-2551	983	5	&	&	CCONJ
admet-2551	983	6	dmpk	dmpk	PROPN
admet-2551	983	7	12(6	12(6	NUM
admet-2551	983	8	)	)	PUNCT
admet-2551	983	9	(	(	PUNCT
admet-2551	983	10	2024	2024	NUM
admet-2551	983	11	)	)	PUNCT
admet-2551	983	12	797	797	NUM
admet-2551	983	13	-	-	SYM
admet-2551	983	14	820	820	NUM
admet-2551	983	15	natural	natural	ADJ
admet-2551	983	16	serine	serine	NOUN
admet-2551	983	17	proteases	protease	NOUN
admet-2551	983	18	in	in	ADP
admet-2551	983	19	combating	combat	VERB
admet-2551	983	20	amyloid	amyloid	NOUN
admet-2551	983	21	formation	formation	NOUN
admet-2551	983	22	doi	doi	NOUN
admet-2551	983	23	:	:	PUNCT
admet-2551	983	24	https://doi.org/10.5599/admet.2551	https://doi.org/10.5599/admet.2551	NOUN
admet-2551	983	25	819	819	NUM
admet-2551	983	26	of	of	ADP
admet-2551	983	27	enzyme	enzyme	NOUN
admet-2551	983	28	inhibition	inhibition	NOUN
admet-2551	983	29	and	and	CCONJ
admet-2551	983	30	medicinal	medicinal	ADJ
admet-2551	983	31	chemistry	chemistry	NOUN
admet-2551	983	32	35	35	NUM
admet-2551	983	33	(	(	PUNCT
admet-2551	983	34	2020	2020	NUM
admet-2551	983	35	)	)	PUNCT
admet-2551	983	36	1145	1145	NUM
admet-2551	983	37	-	-	SYM
admet-2551	983	38	1162	1162	NUM
admet-2551	983	39	.	.	PUNCT
admet-2551	984	1	https://doi.org/10.1080/14756366.2020.1760262	https://doi.org/10.1080/14756366.2020.1760262	X
admet-2551	984	2	.	.	PUNCT
admet-2551	985	1	[	[	X
admet-2551	985	2	139	139	NUM
admet-2551	985	3	]	]	X
admet-2551	985	4	j.	j.	PROPN
admet-2551	985	5	cummings	cummings	PROPN
admet-2551	985	6	,	,	PUNCT
admet-2551	985	7	g.	g.	PROPN
admet-2551	985	8	lee	lee	PROPN
admet-2551	985	9	,	,	PUNCT
admet-2551	985	10	a.	a.	PROPN
admet-2551	985	11	ritter	ritter	PROPN
admet-2551	985	12	,	,	PUNCT
admet-2551	985	13	k.	k.	PROPN
admet-2551	985	14	zhong	zhong	PROPN
admet-2551	985	15	.	.	PUNCT
admet-2551	986	1	alzheimer	alzheimer	PROPN
admet-2551	986	2	's	's	PART
admet-2551	986	3	disease	disease	NOUN
admet-2551	986	4	drug	drug	NOUN
admet-2551	986	5	development	development	NOUN
admet-2551	986	6	pipeline	pipeline	NOUN
admet-2551	986	7	:	:	PUNCT
admet-2551	986	8	2018	2018	NUM
admet-2551	986	9	.	.	PUNCT
admet-2551	987	1	alzheimer	alzheimer	PROPN
admet-2551	987	2	's	's	PART
admet-2551	987	3	&	&	CCONJ
admet-2551	987	4	dementia	dementia	PROPN
admet-2551	987	5	:	:	PUNCT
admet-2551	987	6	translational	translational	ADJ
admet-2551	987	7	research	research	PROPN
admet-2551	987	8	&	&	CCONJ
admet-2551	987	9	clinical	clinical	ADJ
admet-2551	987	10	interventions	intervention	NOUN
admet-2551	987	11	4	4	NUM
admet-2551	987	12	(	(	PUNCT
admet-2551	987	13	2018	2018	NUM
admet-2551	987	14	)	)	PUNCT
admet-2551	987	15	195	195	NUM
admet-2551	987	16	-	-	SYM
admet-2551	987	17	214	214	NUM
admet-2551	987	18	.	.	PUNCT
admet-2551	987	19	https://doi.org/10.1016/j.trci.2018.03.009	https://doi.org/10.1016/j.trci.2018.03.009	NUM
admet-2551	987	20	.	.	PUNCT
admet-2551	988	1	[	[	X
admet-2551	988	2	140	140	NUM
admet-2551	988	3	]	]	X
admet-2551	988	4	j.	j.	PROPN
admet-2551	988	5	sevigny	sevigny	PROPN
admet-2551	988	6	,	,	PUNCT
admet-2551	988	7	p.	p.	PROPN
admet-2551	988	8	chiao	chiao	PROPN
admet-2551	988	9	,	,	PUNCT
admet-2551	988	10	t.	t.	NOUN
admet-2551	988	11	bussière	bussière	PROPN
admet-2551	988	12	,	,	PUNCT
admet-2551	988	13	p.h	p.h	PROPN
admet-2551	988	14	.	.	PROPN
admet-2551	988	15	weinreb	weinreb	PROPN
admet-2551	988	16	,	,	PUNCT
admet-2551	988	17	l.	l.	PROPN
admet-2551	988	18	williams	williams	PROPN
admet-2551	988	19	,	,	PUNCT
admet-2551	988	20	m.	m.	PROPN
admet-2551	988	21	maier	maier	PROPN
admet-2551	988	22	,	,	PUNCT
admet-2551	988	23	r.	r.	PROPN
admet-2551	988	24	dunstan	dunstan	PROPN
admet-2551	988	25	,	,	PUNCT
admet-2551	988	26	s.	s.	PROPN
admet-2551	988	27	salloway	salloway	PROPN
admet-2551	988	28	,	,	PUNCT
admet-2551	988	29	t.	t.	PROPN
admet-2551	988	30	chen	chen	PROPN
admet-2551	988	31	,	,	PUNCT
admet-2551	988	32	y.	y.	PROPN
admet-2551	988	33	ling	ling	PROPN
admet-2551	988	34	.	.	PUNCT
admet-2551	989	1	the	the	DET
admet-2551	989	2	antibody	antibody	NOUN
admet-2551	989	3	aducanumab	aducanumab	NOUN
admet-2551	989	4	reduces	reduce	VERB
admet-2551	989	5	aβ	aβ	PRON
admet-2551	989	6	plaques	plaque	NOUN
admet-2551	989	7	in	in	ADP
admet-2551	989	8	alzheimer	alzheimer	PROPN
admet-2551	989	9	’s	’s	PART
admet-2551	989	10	disease	disease	NOUN
admet-2551	989	11	.	.	PUNCT
admet-2551	990	1	nature	nature	NOUN
admet-2551	990	2	537	537	NUM
admet-2551	990	3	(	(	PUNCT
admet-2551	990	4	2016	2016	NUM
admet-2551	990	5	)	)	PUNCT
admet-2551	990	6	50	50	NUM
admet-2551	990	7	-	-	SYM
admet-2551	990	8	56	56	NUM
admet-2551	990	9	.	.	PUNCT
admet-2551	991	1	https://doi.org/10.1038/nature19323	https://doi.org/10.1038/nature19323	PROPN
admet-2551	991	2	.	.	PUNCT
admet-2551	992	1	[	[	X
admet-2551	992	2	141	141	NUM
admet-2551	992	3	]	]	PUNCT
admet-2551	992	4	h.	h.	PROPN
admet-2551	992	5	guthrie	guthrie	PROPN
admet-2551	992	6	,	,	PUNCT
admet-2551	992	7	l.s	l.s	PROPN
admet-2551	992	8	.	.	PROPN
admet-2551	992	9	honig	honig	PROPN
admet-2551	992	10	,	,	PUNCT
admet-2551	992	11	h.	h.	PROPN
admet-2551	992	12	lin	lin	PROPN
admet-2551	992	13	,	,	PUNCT
admet-2551	992	14	k.m	k.m	PROPN
admet-2551	992	15	.	.	PROPN
admet-2551	992	16	sink	sink	PROPN
admet-2551	992	17	,	,	PUNCT
admet-2551	992	18	k.	k.	PROPN
admet-2551	992	19	blondeau	blondeau	PROPN
admet-2551	992	20	,	,	PUNCT
admet-2551	992	21	a.	a.	NOUN
admet-2551	992	22	quartino	quartino	PROPN
admet-2551	992	23	,	,	PUNCT
admet-2551	992	24	m.	m.	NOUN
admet-2551	992	25	dolton	dolton	PROPN
admet-2551	992	26	,	,	PUNCT
admet-2551	992	27	m.	m.	PROPN
admet-2551	992	28	carrasco	carrasco	PROPN
admet-2551	992	29	-	-	PUNCT
admet-2551	992	30	triguero	triguero	PROPN
admet-2551	992	31	,	,	PUNCT
admet-2551	992	32	q.	q.	PROPN
admet-2551	992	33	lian	lian	PROPN
admet-2551	992	34	,	,	PUNCT
admet-2551	992	35	t.	t.	PROPN
admet-2551	992	36	bittner	bittner	PROPN
admet-2551	992	37	.	.	PUNCT
admet-2551	993	1	safety	safety	NOUN
admet-2551	993	2	,	,	PUNCT
admet-2551	993	3	tolerability	tolerability	NOUN
admet-2551	993	4	,	,	PUNCT
admet-2551	993	5	and	and	CCONJ
admet-2551	993	6	pharmacokinetics	pharmacokinetic	NOUN
admet-2551	993	7	of	of	ADP
admet-2551	993	8	crenezumab	crenezumab	NOUN
admet-2551	993	9	in	in	ADP
admet-2551	993	10	patients	patient	NOUN
admet-2551	993	11	with	with	ADP
admet-2551	993	12	mildto	mildto	PROPN
admet-2551	993	13	-	-	PUNCT
admet-2551	993	14	moderate	moderate	ADJ
admet-2551	993	15	alzheimer	alzheimer	PROPN
admet-2551	993	16	’s	’s	PART
admet-2551	993	17	disease	disease	NOUN
admet-2551	993	18	treated	treat	VERB
admet-2551	993	19	with	with	ADP
admet-2551	993	20	escalating	escalate	VERB
admet-2551	993	21	doses	dose	NOUN
admet-2551	993	22	for	for	ADP
admet-2551	993	23	up	up	ADP
admet-2551	993	24	to	to	PART
admet-2551	993	25	133	133	NUM
admet-2551	993	26	weeks	week	NOUN
admet-2551	993	27	.	.	PUNCT
admet-2551	994	1	journal	journal	PROPN
admet-2551	994	2	of	of	ADP
admet-2551	994	3	alzheimer	alzheimer	PROPN
admet-2551	994	4	's	's	PART
admet-2551	994	5	disease	disease	NOUN
admet-2551	994	6	76	76	NUM
admet-2551	994	7	(	(	PUNCT
admet-2551	994	8	2020	2020	NUM
admet-2551	994	9	)	)	PUNCT
admet-2551	994	10	967	967	NUM
admet-2551	994	11	-	-	SYM
admet-2551	994	12	979	979	NUM
admet-2551	994	13	.	.	PUNCT
admet-2551	995	1	https://doi.org/10.3233/jad-200134	https://doi.org/10.3233/jad-200134	PROPN
admet-2551	995	2	.	.	PUNCT
admet-2551	996	1	[	[	X
admet-2551	996	2	142	142	NUM
admet-2551	996	3	]	]	PUNCT
admet-2551	996	4	m.	m.	NOUN
admet-2551	996	5	cantillon	cantillon	PROPN
admet-2551	996	6	,	,	PUNCT
admet-2551	996	7	n.	n.	NOUN
admet-2551	996	8	andreasen	andreasen	PROPN
admet-2551	996	9	,	,	PUNCT
admet-2551	996	10	n.	n.	PROPN
admet-2551	996	11	prins	prin	NOUN
admet-2551	996	12	.	.	PUNCT
admet-2551	997	1	phase	phase	NOUN
admet-2551	997	2	1/2a	1/2a	NUM
admet-2551	997	3	intravenous	intravenous	ADJ
admet-2551	997	4	and	and	CCONJ
admet-2551	997	5	subcutaneous	subcutaneous	ADJ
admet-2551	997	6	oligomer	oligomer	ADJ
admet-2551	997	7	-	-	PUNCT
admet-2551	997	8	specific	specific	ADJ
admet-2551	997	9	antibody	antibody	NOUN
admet-2551	997	10	khk6640	khk6640	VERB
admet-2551	997	11	in	in	ADP
admet-2551	997	12	mild	mild	ADJ
admet-2551	997	13	to	to	ADP
admet-2551	997	14	moderate	moderate	ADJ
admet-2551	997	15	alzheimer	alzheimer	PROPN
admet-2551	997	16	’s	’s	PART
admet-2551	997	17	disease	disease	NOUN
admet-2551	997	18	.	.	PUNCT
admet-2551	998	1	the	the	DET
admet-2551	998	2	journal	journal	NOUN
admet-2551	998	3	of	of	ADP
admet-2551	998	4	prevention	prevention	NOUN
admet-2551	998	5	of	of	ADP
admet-2551	998	6	alzheimer	alzheimer	PROPN
admet-2551	998	7	's	's	PART
admet-2551	998	8	disease	disease	NOUN
admet-2551	998	9	11	11	NUM
admet-2551	998	10	(	(	PUNCT
admet-2551	998	11	2024	2024	NUM
admet-2551	998	12	)	)	PUNCT
admet-2551	998	13	65	65	NUM
admet-2551	998	14	-	-	SYM
admet-2551	998	15	70	70	NUM
admet-2551	998	16	.	.	PUNCT
admet-2551	998	17	https://doi.org/10.14283/jpad.2024.2	https://doi.org/10.14283/jpad.2024.2	NOUN
admet-2551	998	18	.	.	PUNCT
admet-2551	999	1	[	[	X
admet-2551	999	2	143	143	X
admet-2551	999	3	]	]	X
admet-2551	999	4	h.	h.	PROPN
admet-2551	999	5	davtyan	davtyan	PROPN
admet-2551	999	6	,	,	PUNCT
admet-2551	999	7	a.	a.	PROPN
admet-2551	999	8	ghochikyan	ghochikyan	PROPN
admet-2551	999	9	,	,	PUNCT
admet-2551	999	10	i.	i.	PROPN
admet-2551	999	11	petrushina	petrushina	PROPN
admet-2551	999	12	,	,	PUNCT
admet-2551	999	13	a.	a.	PROPN
admet-2551	999	14	hovakimyan	hovakimyan	PROPN
admet-2551	999	15	,	,	PUNCT
admet-2551	999	16	a.	a.	NOUN
admet-2551	999	17	davtyan	davtyan	NOUN
admet-2551	999	18	,	,	PUNCT
admet-2551	999	19	a.	a.	PROPN
admet-2551	999	20	poghosyan	poghosyan	PROPN
admet-2551	999	21	,	,	PUNCT
admet-2551	999	22	a.m.	a.m.	PROPN
admet-2551	999	23	marleau	marleau	PROPN
admet-2551	999	24	,	,	PUNCT
admet-2551	999	25	n.	n.	PROPN
admet-2551	999	26	movsesyan	movsesyan	PROPN
admet-2551	999	27	,	,	PUNCT
admet-2551	999	28	a.	a.	PROPN
admet-2551	999	29	kiyatkin	kiyatkin	PROPN
admet-2551	999	30	,	,	PUNCT
admet-2551	999	31	s.	s.	PROPN
admet-2551	999	32	rasool	rasool	PROPN
admet-2551	999	33	.	.	PUNCT
admet-2551	1000	1	immunogenicity	immunogenicity	NOUN
admet-2551	1000	2	,	,	PUNCT
admet-2551	1000	3	efficacy	efficacy	NOUN
admet-2551	1000	4	,	,	PUNCT
admet-2551	1000	5	safety	safety	NOUN
admet-2551	1000	6	,	,	PUNCT
admet-2551	1000	7	and	and	CCONJ
admet-2551	1000	8	mechanism	mechanism	NOUN
admet-2551	1000	9	of	of	ADP
admet-2551	1000	10	action	action	NOUN
admet-2551	1000	11	of	of	ADP
admet-2551	1000	12	epitope	epitope	NOUN
admet-2551	1000	13	vaccine	vaccine	NOUN
admet-2551	1000	14	(	(	PUNCT
admet-2551	1000	15	lu	lu	PROPN
admet-2551	1000	16	af20513	af20513	PROPN
admet-2551	1000	17	)	)	PUNCT
admet-2551	1000	18	for	for	ADP
admet-2551	1000	19	alzheimer	alzheimer	PROPN
admet-2551	1000	20	's	's	PART
admet-2551	1000	21	disease	disease	NOUN
admet-2551	1000	22	:	:	PUNCT
admet-2551	1000	23	prelude	prelude	VERB
admet-2551	1000	24	to	to	ADP
admet-2551	1000	25	a	a	DET
admet-2551	1000	26	clinical	clinical	ADJ
admet-2551	1000	27	trial	trial	NOUN
admet-2551	1000	28	.	.	PUNCT
admet-2551	1001	1	journal	journal	NOUN
admet-2551	1001	2	of	of	ADP
admet-2551	1001	3	neuroscience	neuroscience	NOUN
admet-2551	1001	4	33	33	NUM
admet-2551	1001	5	(	(	PUNCT
admet-2551	1001	6	2013	2013	NUM
admet-2551	1001	7	)	)	PUNCT
admet-2551	1001	8	4923	4923	NUM
admet-2551	1001	9	-	-	SYM
admet-2551	1001	10	4934	4934	NUM
admet-2551	1001	11	.	.	PUNCT
admet-2551	1002	1	https://doi.org/10.1523/jneurosci.4672-12.2013	https://doi.org/10.1523/jneurosci.4672-12.2013	PROPN
admet-2551	1002	2	.	.	PUNCT
admet-2551	1003	1	[	[	X
admet-2551	1003	2	144	144	NUM
admet-2551	1003	3	]	]	X
admet-2551	1003	4	s.l	s.l	PROPN
admet-2551	1003	5	.	.	PROPN
admet-2551	1003	6	lowe	lowe	PROPN
admet-2551	1003	7	,	,	PUNCT
admet-2551	1003	8	b.a	b.a	PROPN
admet-2551	1003	9	.	.	PROPN
admet-2551	1003	10	willis	willis	PROPN
admet-2551	1003	11	,	,	PUNCT
admet-2551	1003	12	a.	a.	PROPN
admet-2551	1003	13	hawdon	hawdon	PROPN
admet-2551	1003	14	,	,	PUNCT
admet-2551	1003	15	f.	f.	PROPN
admet-2551	1003	16	natanegara	natanegara	PROPN
admet-2551	1003	17	,	,	PUNCT
admet-2551	1003	18	l.	l.	PROPN
admet-2551	1003	19	chua	chua	PROPN
admet-2551	1003	20	,	,	PUNCT
admet-2551	1003	21	j.	j.	PROPN
admet-2551	1003	22	foster	foster	PROPN
admet-2551	1003	23	,	,	PUNCT
admet-2551	1003	24	s.	s.	PROPN
admet-2551	1003	25	shcherbinin	shcherbinin	PROPN
admet-2551	1003	26	,	,	PUNCT
admet-2551	1003	27	p.	p.	PROPN
admet-2551	1003	28	ardayfio	ardayfio	PROPN
admet-2551	1003	29	,	,	PUNCT
admet-2551	1003	30	j.r	j.r	PROPN
admet-2551	1003	31	.	.	PROPN
admet-2551	1003	32	sims	sim	NOUN
admet-2551	1003	33	.	.	PUNCT
admet-2551	1004	1	donanemab	donanemab	NOUN
admet-2551	1004	2	(	(	PUNCT
admet-2551	1004	3	ly3002813	ly3002813	ADJ
admet-2551	1004	4	)	)	PUNCT
admet-2551	1004	5	dose‐escalation	dose‐escalation	NOUN
admet-2551	1004	6	study	study	NOUN
admet-2551	1004	7	in	in	ADP
admet-2551	1004	8	alzheimer	alzheimer	PROPN
admet-2551	1004	9	's	's	PART
admet-2551	1004	10	disease	disease	NOUN
admet-2551	1004	11	.	.	PUNCT
admet-2551	1005	1	alzheimer	alzheimer	PROPN
admet-2551	1005	2	's	's	PART
admet-2551	1005	3	&	&	CCONJ
admet-2551	1005	4	dementia	dementia	PROPN
admet-2551	1005	5	:	:	PUNCT
admet-2551	1005	6	translational	translational	ADJ
admet-2551	1005	7	research	research	PROPN
admet-2551	1005	8	&	&	CCONJ
admet-2551	1005	9	clinical	clinical	ADJ
admet-2551	1005	10	interventions	intervention	NOUN
admet-2551	1005	11	7	7	NUM
admet-2551	1005	12	(	(	PUNCT
admet-2551	1005	13	2021	2021	NUM
admet-2551	1005	14	)	)	PUNCT
admet-2551	1005	15	e12112	e12112	PROPN
admet-2551	1005	16	.	.	PUNCT
admet-2551	1006	1	https://doi.org/10.1002/trc2.12112	https://doi.org/10.1002/trc2.12112	PROPN
admet-2551	1006	2	.	.	PUNCT
admet-2551	1007	1	[	[	X
admet-2551	1007	2	145	145	NUM
admet-2551	1007	3	]	]	X
admet-2551	1007	4	c.j	c.j	PROPN
admet-2551	1007	5	.	.	PROPN
admet-2551	1007	6	swanson	swanson	PROPN
admet-2551	1007	7	,	,	PUNCT
admet-2551	1007	8	y.	y.	PROPN
admet-2551	1007	9	zhang	zhang	PROPN
admet-2551	1007	10	,	,	PUNCT
admet-2551	1007	11	s.	s.	PROPN
admet-2551	1007	12	dhadda	dhadda	PROPN
admet-2551	1007	13	,	,	PUNCT
admet-2551	1007	14	j.	j.	PROPN
admet-2551	1007	15	wang	wang	PROPN
admet-2551	1007	16	,	,	PUNCT
admet-2551	1007	17	j.	j.	PROPN
admet-2551	1007	18	kaplow	kaplow	PROPN
admet-2551	1007	19	,	,	PUNCT
admet-2551	1007	20	r.y	r.y	PROPN
admet-2551	1007	21	.	.	PROPN
admet-2551	1007	22	lai	lai	PROPN
admet-2551	1007	23	,	,	PUNCT
admet-2551	1007	24	l.	l.	PROPN
admet-2551	1007	25	lannfelt	lannfelt	PROPN
admet-2551	1007	26	,	,	PUNCT
admet-2551	1007	27	h.	h.	PROPN
admet-2551	1007	28	bradley	bradley	PROPN
admet-2551	1007	29	,	,	PUNCT
admet-2551	1007	30	m.	m.	NOUN
admet-2551	1007	31	rabe	rabe	NOUN
admet-2551	1007	32	,	,	PUNCT
admet-2551	1007	33	a.	a.	NOUN
admet-2551	1007	34	koyama	koyama	PROPN
admet-2551	1007	35	.	.	PUNCT
admet-2551	1008	1	a	a	DET
admet-2551	1008	2	randomized	randomized	ADJ
admet-2551	1008	3	,	,	PUNCT
admet-2551	1008	4	double	double	ADJ
admet-2551	1008	5	-	-	PUNCT
admet-2551	1008	6	blind	blind	ADJ
admet-2551	1008	7	,	,	PUNCT
admet-2551	1008	8	phase	phase	NOUN
admet-2551	1008	9	2b	2b	NUM
admet-2551	1008	10	proof	proof	NOUN
admet-2551	1008	11	-	-	PUNCT
admet-2551	1008	12	of	of	ADP
admet-2551	1008	13	-	-	PUNCT
admet-2551	1008	14	concept	concept	NOUN
admet-2551	1008	15	clinical	clinical	ADJ
admet-2551	1008	16	trial	trial	NOUN
admet-2551	1008	17	in	in	ADP
admet-2551	1008	18	early	early	PROPN
admet-2551	1008	19	alzheimer	alzheimer	PROPN
admet-2551	1008	20	’s	’s	PART
admet-2551	1008	21	disease	disease	NOUN
admet-2551	1008	22	with	with	ADP
admet-2551	1008	23	lecanemab	lecanemab	NOUN
admet-2551	1008	24	,	,	PUNCT
admet-2551	1008	25	an	an	DET
admet-2551	1008	26	anti	anti	ADJ
admet-2551	1008	27	-	-	ADJ
admet-2551	1008	28	aβ	aβ	ADJ
admet-2551	1008	29	protofibril	protofibril	ADJ
admet-2551	1008	30	antibody	antibody	NOUN
admet-2551	1008	31	.	.	PUNCT
admet-2551	1009	1	alzheimer	alzheimer	PROPN
admet-2551	1009	2	's	's	PART
admet-2551	1009	3	research	research	NOUN
admet-2551	1009	4	&	&	CCONJ
admet-2551	1009	5	therapy	therapy	NOUN
admet-2551	1009	6	13	13	NUM
admet-2551	1009	7	(	(	PUNCT
admet-2551	1009	8	2021	2021	NUM
admet-2551	1009	9	)	)	PUNCT
admet-2551	1009	10	80	80	NUM
admet-2551	1009	11	.	.	PUNCT
admet-2551	1009	12	https://doi.org/10.1186/s13195-021-00813-8	https://doi.org/10.1186/s13195-021-00813-8	NUM
admet-2551	1009	13	.	.	PUNCT
admet-2551	1010	1	[	[	X
admet-2551	1010	2	146	146	NUM
admet-2551	1010	3	]	]	PUNCT
admet-2551	1010	4	m.	m.	NOUN
admet-2551	1010	5	matijevic	matijevic	PROPN
admet-2551	1010	6	,	,	PUNCT
admet-2551	1010	7	h.	h.	PROPN
admet-2551	1010	8	watanabe	watanabe	PROPN
admet-2551	1010	9	,	,	PUNCT
admet-2551	1010	10	y.	y.	PROPN
admet-2551	1010	11	sato	sato	PROPN
admet-2551	1010	12	,	,	PUNCT
admet-2551	1010	13	f.	f.	NOUN
admet-2551	1010	14	bernier	bernier	PROPN
admet-2551	1010	15	,	,	PUNCT
admet-2551	1010	16	s.	s.	PROPN
admet-2551	1010	17	mcgrath	mcgrath	PROPN
admet-2551	1010	18	,	,	PUNCT
admet-2551	1010	19	l.	l.	PROPN
admet-2551	1010	20	burns	burns	PROPN
admet-2551	1010	21	,	,	PUNCT
admet-2551	1010	22	n.	n.	PROPN
admet-2551	1010	23	yamamoto	yamamoto	PROPN
admet-2551	1010	24	,	,	PUNCT
admet-2551	1010	25	m.	m.	PROPN
admet-2551	1010	26	ogo	ogo	PROPN
admet-2551	1010	27	,	,	PUNCT
admet-2551	1010	28	z.	z.	PROPN
admet-2551	1010	29	dezso	dezso	PROPN
admet-2551	1010	30	,	,	PUNCT
admet-2551	1010	31	j.	j.	PROPN
admet-2551	1010	32	chow	chow	PROPN
admet-2551	1010	33	.	.	PUNCT
admet-2551	1011	1	p4–163	p4–163	NUM
admet-2551	1011	2	:	:	PUNCT
admet-2551	1011	3	a	a	DET
admet-2551	1011	4	single	single	ADJ
admet-2551	1011	5	dose	dose	NOUN
admet-2551	1011	6	of	of	ADP
admet-2551	1011	7	the	the	DET
admet-2551	1011	8	beta	beta	NOUN
admet-2551	1011	9	-	-	PUNCT
admet-2551	1011	10	secretase	secretase	NOUN
admet-2551	1011	11	inhibitor	inhibitor	NOUN
admet-2551	1011	12	,	,	PUNCT
admet-2551	1011	13	e2609	e2609	PROPN
admet-2551	1011	14	,	,	PUNCT
admet-2551	1011	15	decreases	decrease	VERB
admet-2551	1011	16	csf	csf	ADJ
admet-2551	1011	17	bace1	bace1	NOUN
admet-2551	1011	18	enzymatic	enzymatic	ADJ
admet-2551	1011	19	activity	activity	NOUN
admet-2551	1011	20	in	in	ADP
admet-2551	1011	21	cynomolgus	cynomolgus	ADJ
admet-2551	1011	22	monkeys	monkey	NOUN
admet-2551	1011	23	.	.	PUNCT
admet-2551	1012	1	alzheimer	alzheimer	PROPN
admet-2551	1012	2	's	's	PART
admet-2551	1012	3	&	&	CCONJ
admet-2551	1012	4	dementia	dementia	PROPN
admet-2551	1012	5	11	11	NUM
admet-2551	1012	6	(	(	PUNCT
admet-2551	1012	7	2015	2015	NUM
admet-2551	1012	8	)	)	PUNCT
admet-2551	1012	9	p841	p841	PROPN
admet-2551	1012	10	.	.	PUNCT
admet-2551	1012	11	https://doi.org/10.1016/j.jalz.2015.06.1870	https://doi.org/10.1016/j.jalz.2015.06.1870	NOUN
admet-2551	1012	12	.	.	PUNCT
admet-2551	1013	1	[	[	X
admet-2551	1013	2	147	147	NUM
admet-2551	1013	3	]	]	X
admet-2551	1013	4	r.	r.	PROPN
admet-2551	1013	5	dodel	dodel	PROPN
admet-2551	1013	6	,	,	PUNCT
admet-2551	1013	7	a.	a.	NOUN
admet-2551	1013	8	rominger	rominger	NOUN
admet-2551	1013	9	,	,	PUNCT
admet-2551	1013	10	k.	k.	PROPN
admet-2551	1013	11	blennow	blennow	PROPN
admet-2551	1013	12	,	,	PUNCT
admet-2551	1013	13	f.	f.	PROPN
admet-2551	1013	14	barkhof	barkhof	PROPN
admet-2551	1013	15	,	,	PUNCT
admet-2551	1013	16	s.	s.	PROPN
admet-2551	1013	17	wietek	wietek	PROPN
admet-2551	1013	18	,	,	PUNCT
admet-2551	1013	19	s.	s.	PROPN
admet-2551	1013	20	haag	haag	PROPN
admet-2551	1013	21	,	,	PUNCT
admet-2551	1013	22	p.	p.	PROPN
admet-2551	1013	23	bartenstein	bartenstein	PROPN
admet-2551	1013	24	,	,	PUNCT
admet-2551	1013	25	m.	m.	NOUN
admet-2551	1013	26	farlow	farlow	NOUN
admet-2551	1013	27	,	,	PUNCT
admet-2551	1013	28	f.	f.	PROPN
admet-2551	1013	29	jessen	jessen	PROPN
admet-2551	1013	30	.	.	PUNCT
admet-2551	1014	1	p4‐411	p4‐411	ADV
admet-2551	1014	2	:	:	PUNCT
admet-2551	1014	3	a	a	DET
admet-2551	1014	4	randomized	randomized	ADJ
admet-2551	1014	5	,	,	PUNCT
admet-2551	1014	6	double‐blind	double‐blind	ADJ
admet-2551	1014	7	,	,	PUNCT
admet-2551	1014	8	placebo‐controlled	placebo‐controlle	VERB
admet-2551	1014	9	dose‐finding	dose‐finding	NOUN
admet-2551	1014	10	trial	trial	NOUN
admet-2551	1014	11	of	of	ADP
admet-2551	1014	12	intravenous	intravenous	ADJ
admet-2551	1014	13	immunoglobulin	immunoglobulin	NOUN
admet-2551	1014	14	(	(	PUNCT
admet-2551	1014	15	ivig	ivig	NOUN
admet-2551	1014	16	;	;	PUNCT
admet-2551	1014	17	octagam	octagam	NUM
admet-2551	1014	18	®	®	NOUN
admet-2551	1014	19	10	10	NUM
admet-2551	1014	20	%	%	NOUN
admet-2551	1014	21	,	,	PUNCT
admet-2551	1014	22	octapharma	octapharma	NOUN
admet-2551	1014	23	ag	ag	PROPN
admet-2551	1014	24	)	)	PUNCT
admet-2551	1014	25	in	in	ADP
admet-2551	1014	26	patients	patient	NOUN
admet-2551	1014	27	with	with	ADP
admet-2551	1014	28	mild	mild	ADJ
admet-2551	1014	29	to	to	ADP
admet-2551	1014	30	moderate	moderate	ADJ
admet-2551	1014	31	alzheimer	alzheimer	PROPN
admet-2551	1014	32	's	's	PART
admet-2551	1014	33	disease	disease	NOUN
admet-2551	1014	34	(	(	PUNCT
admet-2551	1014	35	gam10‐04	gam10‐04	PROPN
admet-2551	1014	36	)	)	PUNCT
admet-2551	1014	37	.	.	PUNCT
admet-2551	1015	1	alzheimer	alzheimer	PROPN
admet-2551	1015	2	's	's	PART
admet-2551	1015	3	&	&	CCONJ
admet-2551	1015	4	dementia	dementia	PROPN
admet-2551	1015	5	7	7	NUM
admet-2551	1015	6	(	(	PUNCT
admet-2551	1015	7	2011	2011	NUM
admet-2551	1015	8	)	)	PUNCT
admet-2551	1015	9	e55	e55	NOUN
admet-2551	1015	10	-	-	PUNCT
admet-2551	1015	11	e56	e56	PROPN
admet-2551	1015	12	.	.	PUNCT
admet-2551	1015	13	https://doi.org/10.1016/j.jalz.2011.09.107	https://doi.org/10.1016/j.jalz.2011.09.107	PROPN
admet-2551	1015	14	.	.	PUNCT
admet-2551	1016	1	[	[	X
admet-2551	1016	2	148	148	NUM
admet-2551	1016	3	]	]	X
admet-2551	1016	4	h.j	h.j	PROPN
admet-2551	1016	5	.	.	PROPN
admet-2551	1016	6	yu	yu	PROPN
admet-2551	1016	7	,	,	PUNCT
admet-2551	1016	8	s.p	s.p	PROPN
admet-2551	1016	9	.	.	PUNCT
admet-2551	1016	10	dickson	dickson	PROPN
admet-2551	1016	11	,	,	PUNCT
admet-2551	1016	12	p.-n	p.-n	PROPN
admet-2551	1016	13	.	.	PUNCT
admet-2551	1017	1	wang	wang	PROPN
admet-2551	1017	2	,	,	PUNCT
admet-2551	1017	3	m.-j	m.-j	PROPN
admet-2551	1017	4	.	.	PUNCT
admet-2551	1018	1	chiu	chiu	PROPN
admet-2551	1018	2	,	,	PUNCT
admet-2551	1018	3	c.-c	c.-c	PROPN
admet-2551	1018	4	.	.	PUNCT
admet-2551	1019	1	huang	huang	PROPN
admet-2551	1019	2	,	,	PUNCT
admet-2551	1019	3	c.-c	c.-c	PROPN
admet-2551	1019	4	.	.	PUNCT
admet-2551	1020	1	chang	chang	PROPN
admet-2551	1020	2	,	,	PUNCT
admet-2551	1020	3	h.	h.	PROPN
admet-2551	1020	4	liu	liu	PROPN
admet-2551	1020	5	,	,	PUNCT
admet-2551	1020	6	s.b	s.b	PROPN
admet-2551	1020	7	.	.	PROPN
admet-2551	1020	8	hendrix	hendrix	NOUN
admet-2551	1020	9	,	,	PUNCT
admet-2551	1020	10	j.-c	j.-c	PROPN
admet-2551	1020	11	.	.	PUNCT
admet-2551	1021	1	dodart	dodart	PROPN
admet-2551	1021	2	,	,	PUNCT
admet-2551	1021	3	a.	a.	PROPN
admet-2551	1021	4	verma	verma	PROPN
admet-2551	1021	5	.	.	PUNCT
admet-2551	1022	1	safety	safety	NOUN
admet-2551	1022	2	,	,	PUNCT
admet-2551	1022	3	tolerability	tolerability	NOUN
admet-2551	1022	4	,	,	PUNCT
admet-2551	1022	5	immunogenicity	immunogenicity	NOUN
admet-2551	1022	6	,	,	PUNCT
admet-2551	1022	7	and	and	CCONJ
admet-2551	1022	8	efficacy	efficacy	NOUN
admet-2551	1022	9	of	of	ADP
admet-2551	1022	10	ub-311	ub-311	PROPN
admet-2551	1022	11	in	in	ADP
admet-2551	1022	12	participants	participant	NOUN
admet-2551	1022	13	with	with	ADP
admet-2551	1022	14	mild	mild	ADJ
admet-2551	1022	15	alzheimer	alzheimer	NOUN
admet-2551	1022	16	's	's	PART
admet-2551	1022	17	disease	disease	NOUN
admet-2551	1022	18	:	:	PUNCT
admet-2551	1022	19	a	a	DET
admet-2551	1022	20	randomised	randomised	ADJ
admet-2551	1022	21	,	,	PUNCT
admet-2551	1022	22	double	double	ADJ
admet-2551	1022	23	-	-	PUNCT
admet-2551	1022	24	blind	blind	ADJ
admet-2551	1022	25	,	,	PUNCT
admet-2551	1022	26	placebo	placebo	NOUN
admet-2551	1022	27	-	-	PUNCT
admet-2551	1022	28	controlled	control	VERB
admet-2551	1022	29	,	,	PUNCT
admet-2551	1022	30	phase	phase	NOUN
admet-2551	1022	31	2a	2a	NUM
admet-2551	1022	32	study	study	NOUN
admet-2551	1022	33	.	.	PUNCT
admet-2551	1023	1	ebiomedicine	ebiomedicine	PROPN
admet-2551	1023	2	94	94	NUM
admet-2551	1023	3	(	(	PUNCT
admet-2551	1023	4	2023	2023	NUM
admet-2551	1023	5	)	)	PUNCT
admet-2551	1023	6	104665	104665	NUM
admet-2551	1023	7	.	.	PUNCT
admet-2551	1024	1	https://doi.org/10.1016/j.ebiom.2023.104665	https://doi.org/10.1016/j.ebiom.2023.104665	ADJ
admet-2551	1024	2	.	.	PUNCT
admet-2551	1025	1	[	[	X
admet-2551	1025	2	149	149	NUM
admet-2551	1025	3	]	]	X
admet-2551	1025	4	u.	u.	PROPN
admet-2551	1025	5	neumann	neumann	PROPN
admet-2551	1025	6	,	,	PUNCT
admet-2551	1025	7	m.	m.	PROPN
admet-2551	1025	8	ufer	ufer	PROPN
admet-2551	1025	9	,	,	PUNCT
admet-2551	1025	10	l.h	l.h	PROPN
admet-2551	1025	11	.	.	PROPN
admet-2551	1025	12	jacobson	jacobson	PROPN
admet-2551	1025	13	,	,	PUNCT
admet-2551	1025	14	m.l	m.l	PROPN
admet-2551	1025	15	.	.	PROPN
admet-2551	1025	16	rouzade‐dominguez	rouzade‐dominguez	PROPN
admet-2551	1025	17	,	,	PUNCT
admet-2551	1025	18	g.	g.	PROPN
admet-2551	1025	19	huledal	huledal	PROPN
admet-2551	1025	20	,	,	PUNCT
admet-2551	1025	21	c.	c.	PROPN
admet-2551	1025	22	kolly	kolly	PROPN
admet-2551	1025	23	,	,	PUNCT
admet-2551	1025	24	r.m	r.m	PROPN
admet-2551	1025	25	.	.	PROPN
admet-2551	1025	26	lüönd	lüönd	PROPN
admet-2551	1025	27	,	,	PUNCT
admet-2551	1025	28	r.	r.	PROPN
admet-2551	1025	29	machauer	machauer	PROPN
admet-2551	1025	30	,	,	PUNCT
admet-2551	1025	31	s.j	s.j	PROPN
admet-2551	1025	32	.	.	PROPN
admet-2551	1025	33	veenstra	veenstra	PROPN
admet-2551	1025	34	,	,	PUNCT
admet-2551	1025	35	k.	k.	PROPN
admet-2551	1025	36	hurth	hurth	PROPN
admet-2551	1025	37	.	.	PUNCT
admet-2551	1026	1	the	the	DET
admet-2551	1026	2	bace‐1	bace‐1	PROPN
admet-2551	1026	3	inhibitor	inhibitor	NOUN
admet-2551	1026	4	cnp	cnp	PROPN
admet-2551	1026	5	520	520	NUM
admet-2551	1026	6	for	for	ADP
admet-2551	1026	7	prevention	prevention	NOUN
admet-2551	1026	8	trials	trial	NOUN
admet-2551	1026	9	in	in	ADP
admet-2551	1026	10	alzheimer	alzheimer	PROPN
admet-2551	1026	11	's	's	PART
admet-2551	1026	12	disease	disease	NOUN
admet-2551	1026	13	.	.	PUNCT
admet-2551	1027	1	embo	embo	NOUN
admet-2551	1027	2	molecular	molecular	ADJ
admet-2551	1027	3	medicine	medicine	NOUN
admet-2551	1027	4	10	10	NUM
admet-2551	1027	5	(	(	PUNCT
admet-2551	1027	6	2018	2018	NUM
admet-2551	1027	7	)	)	PUNCT
admet-2551	1027	8	e9316	e9316	PROPN
admet-2551	1027	9	.	.	PUNCT
admet-2551	1027	10	https://doi.org/10.15252/emmm.201809316	https://doi.org/10.15252/emmm.201809316	X
admet-2551	1027	11	.	.	PUNCT
admet-2551	1028	1	[	[	X
admet-2551	1028	2	150	150	NUM
admet-2551	1028	3	]	]	PUNCT
admet-2551	1028	4	h.	h.	PROPN
admet-2551	1028	5	jacobsen	jacobsen	PROPN
admet-2551	1028	6	,	,	PUNCT
admet-2551	1028	7	l.	l.	PROPN
admet-2551	1028	8	ozmen	ozmen	PROPN
admet-2551	1028	9	,	,	PUNCT
admet-2551	1028	10	a.	a.	PROPN
admet-2551	1028	11	caruso	caruso	PROPN
admet-2551	1028	12	,	,	PUNCT
admet-2551	1028	13	r.	r.	PROPN
admet-2551	1028	14	narquizian	narquizian	PROPN
admet-2551	1028	15	,	,	PUNCT
admet-2551	1028	16	h.	h.	PROPN
admet-2551	1028	17	hilpert	hilpert	PROPN
admet-2551	1028	18	,	,	PUNCT
admet-2551	1028	19	b.	b.	PROPN
admet-2551	1028	20	jacobsen	jacobsen	PROPN
admet-2551	1028	21	,	,	PUNCT
admet-2551	1028	22	d.	d.	PROPN
admet-2551	1028	23	terwel	terwel	PROPN
admet-2551	1028	24	,	,	PUNCT
admet-2551	1028	25	a.	a.	NOUN
admet-2551	1028	26	tanghe	tanghe	PROPN
admet-2551	1028	27	,	,	PUNCT
admet-2551	1028	28	b.	b.	PROPN
admet-2551	1028	29	bohrmann	bohrmann	PROPN
admet-2551	1028	30	.	.	PUNCT
admet-2551	1029	1	combined	combine	VERB
admet-2551	1029	2	treatment	treatment	NOUN
admet-2551	1029	3	with	with	ADP
admet-2551	1029	4	a	a	DET
admet-2551	1029	5	bace	bace	NOUN
admet-2551	1029	6	inhibitor	inhibitor	NOUN
admet-2551	1029	7	and	and	CCONJ
admet-2551	1029	8	anti	anti	ADJ
admet-2551	1029	9	-	-	ADJ
admet-2551	1029	10	aβ	aβ	ADJ
admet-2551	1029	11	antibody	antibody	NOUN
admet-2551	1029	12	gantenerumab	gantenerumab	NOUN
admet-2551	1029	13	enhances	enhance	VERB
admet-2551	1029	14	amyloid	amyloid	NOUN
admet-2551	1029	15	reduction	reduction	NOUN
admet-2551	1029	16	in	in	ADP
admet-2551	1029	17	applondon	applondon	ADJ
admet-2551	1029	18	mice	mouse	NOUN
admet-2551	1029	19	.	.	PUNCT
admet-2551	1030	1	journal	journal	NOUN
admet-2551	1030	2	of	of	ADP
admet-2551	1030	3	neuroscience	neuroscience	NOUN
admet-2551	1030	4	34	34	NUM
admet-2551	1030	5	(	(	PUNCT
admet-2551	1030	6	2014	2014	NUM
admet-2551	1030	7	)	)	PUNCT
admet-2551	1030	8	11621	11621	NUM
admet-2551	1030	9	-	-	SYM
admet-2551	1030	10	11630	11630	NUM
admet-2551	1030	11	.	.	PUNCT
admet-2551	1031	1	https://doi.org/10.1523/jneurosci.1405-14.2014	https://doi.org/10.1523/jneurosci.1405-14.2014	PROPN
admet-2551	1031	2	.	.	PUNCT
admet-2551	1032	1	[	[	X
admet-2551	1032	2	151	151	NUM
admet-2551	1032	3	]	]	X
admet-2551	1032	4	c.e	c.e	PROPN
admet-2551	1032	5	.	.	PROPN
admet-2551	1032	6	moussa	moussa	PROPN
admet-2551	1032	7	.	.	PUNCT
admet-2551	1033	1	beta	beta	NOUN
admet-2551	1033	2	-	-	PUNCT
admet-2551	1033	3	secretase	secretase	NOUN
admet-2551	1033	4	inhibitors	inhibitor	NOUN
admet-2551	1033	5	in	in	ADP
admet-2551	1033	6	phase	phase	NOUN
admet-2551	1033	7	i	i	PRON
admet-2551	1033	8	and	and	CCONJ
admet-2551	1033	9	phase	phase	NOUN
admet-2551	1033	10	ii	ii	NOUN
admet-2551	1033	11	clinical	clinical	ADJ
admet-2551	1033	12	trials	trial	NOUN
admet-2551	1033	13	for	for	ADP
admet-2551	1033	14	alzheimer	alzheimer	PROPN
admet-2551	1033	15	’s	’s	PART
admet-2551	1033	16	disease	disease	NOUN
admet-2551	1033	17	.	.	PUNCT
admet-2551	1034	1	expert	expert	ADJ
admet-2551	1034	2	opinion	opinion	NOUN
admet-2551	1034	3	on	on	ADP
admet-2551	1034	4	investigational	investigational	ADJ
admet-2551	1034	5	drugs	drug	NOUN
admet-2551	1034	6	26	26	NUM
admet-2551	1034	7	(	(	PUNCT
admet-2551	1034	8	2017	2017	NUM
admet-2551	1034	9	)	)	PUNCT
admet-2551	1034	10	1131	1131	NUM
admet-2551	1034	11	-	-	SYM
admet-2551	1034	12	1136	1136	NUM
admet-2551	1034	13	.	.	PUNCT
admet-2551	1035	1	https://doi.org/10.1080/13543784.2017.1369527	https://doi.org/10.1080/13543784.2017.1369527	PROPN
admet-2551	1035	2	.	.	PUNCT
admet-2551	1035	3	https://doi.org/10.5599/admet.2551	https://doi.org/10.5599/admet.2551	PROPN
admet-2551	1035	4	https://doi.org/10.1080/14756366.2020.1760262	https://doi.org/10.1080/14756366.2020.1760262	X
admet-2551	1035	5	https://doi.org/10.1016/j.trci.2018.03.009	https://doi.org/10.1016/j.trci.2018.03.009	NUM
admet-2551	1035	6	https://doi.org/10.1038/nature19323	https://doi.org/10.1038/nature19323	PROPN
admet-2551	1035	7	https://doi.org/10.3233/jad-200134	https://doi.org/10.3233/jad-200134	PROPN
admet-2551	1035	8	https://doi.org/10.14283/jpad.2024.2	https://doi.org/10.14283/jpad.2024.2	NOUN
admet-2551	1035	9	https://doi.org/10.1523/jneurosci.4672-12.2013	https://doi.org/10.1523/jneurosci.4672-12.2013	NOUN
admet-2551	1035	10	https://doi.org/10.1002/trc2.12112	https://doi.org/10.1002/trc2.12112	VERB
admet-2551	1035	11	https://doi.org/10.1186/s13195-021-00813-8	https://doi.org/10.1186/s13195-021-00813-8	NUM
admet-2551	1035	12	https://doi.org/10.1016/j.jalz.2015.06.1870	https://doi.org/10.1016/j.jalz.2015.06.1870	NOUN
admet-2551	1035	13	https://doi.org/10.1016/j.jalz.2011.09.107	https://doi.org/10.1016/j.jalz.2011.09.107	VERB
admet-2551	1035	14	https://doi.org/10.1016/j.ebiom.2023.104665	https://doi.org/10.1016/j.ebiom.2023.104665	PROPN
admet-2551	1035	15	https://doi.org/10.15252/emmm.201809316	https://doi.org/10.15252/emmm.201809316	VERB
admet-2551	1035	16	https://doi.org/10.1523/jneurosci.1405-14.2014	https://doi.org/10.1523/jneurosci.1405-14.2014	PROPN
admet-2551	1035	17	https://doi.org/10.1080/13543784.2017.1369527	https://doi.org/10.1080/13543784.2017.1369527	PROPN
admet-2551	1035	18	s.	s.	PROPN
admet-2551	1035	19	k.	k.	PROPN
admet-2551	1036	1	metkar	metkar	PROPN
admet-2551	1036	2	et	et	PROPN
admet-2551	1036	3	al	al	PROPN
admet-2551	1036	4	.	.	PROPN
admet-2551	1036	5	admet	admet	PROPN
admet-2551	1036	6	&	&	CCONJ
admet-2551	1036	7	dmpk	dmpk	PROPN
admet-2551	1036	8	12(6	12(6	NUM
admet-2551	1036	9	)	)	PUNCT
admet-2551	1036	10	(	(	PUNCT
admet-2551	1036	11	2024	2024	NUM
admet-2551	1036	12	)	)	PUNCT
admet-2551	1036	13	797	797	NUM
admet-2551	1036	14	-	-	SYM
admet-2551	1036	15	820	820	NUM
admet-2551	1036	16	820	820	NUM
admet-2551	1036	17	[	[	X
admet-2551	1036	18	152	152	NUM
admet-2551	1036	19	]	]	X
admet-2551	1036	20	a.i	a.i	PROPN
admet-2551	1036	21	.	.	PROPN
admet-2551	1036	22	abushouk	abushouk	PROPN
admet-2551	1036	23	,	,	PUNCT
admet-2551	1036	24	a.	a.	NOUN
admet-2551	1036	25	elmaraezy	elmaraezy	PROPN
admet-2551	1036	26	,	,	PUNCT
admet-2551	1036	27	a.	a.	NOUN
admet-2551	1036	28	aglan	aglan	PROPN
admet-2551	1036	29	,	,	PUNCT
admet-2551	1036	30	r.	r.	PROPN
admet-2551	1036	31	salama	salama	PROPN
admet-2551	1036	32	,	,	PUNCT
admet-2551	1036	33	s.	s.	PROPN
admet-2551	1036	34	fouda	fouda	PROPN
admet-2551	1036	35	,	,	PUNCT
admet-2551	1036	36	r.	r.	PROPN
admet-2551	1036	37	fouda	fouda	PROPN
admet-2551	1036	38	,	,	PUNCT
admet-2551	1036	39	a.m.	a.m.	PROPN
admet-2551	1036	40	alsafadi	alsafadi	PROPN
admet-2551	1036	41	.	.	PUNCT
admet-2551	1037	1	bapineuzumab	bapineuzumab	NOUN
admet-2551	1037	2	for	for	ADP
admet-2551	1037	3	mild	mild	ADJ
admet-2551	1037	4	to	to	ADP
admet-2551	1037	5	moderate	moderate	ADJ
admet-2551	1037	6	alzheimer	alzheimer	PROPN
admet-2551	1037	7	’s	’s	PART
admet-2551	1037	8	disease	disease	NOUN
admet-2551	1037	9	:	:	PUNCT
admet-2551	1037	10	a	a	DET
admet-2551	1037	11	meta	meta	ADJ
admet-2551	1037	12	-	-	PUNCT
admet-2551	1037	13	analysis	analysis	NOUN
admet-2551	1037	14	of	of	ADP
admet-2551	1037	15	randomized	randomized	ADJ
admet-2551	1037	16	controlled	control	VERB
admet-2551	1037	17	trials	trial	NOUN
admet-2551	1037	18	.	.	PUNCT
admet-2551	1038	1	bmc	bmc	PROPN
admet-2551	1038	2	neurology	neurology	NOUN
admet-2551	1038	3	17	17	NUM
admet-2551	1038	4	(	(	PUNCT
admet-2551	1038	5	2017	2017	NUM
admet-2551	1038	6	)	)	PUNCT
admet-2551	1038	7	66	66	NUM
admet-2551	1038	8	.	.	PUNCT
admet-2551	1039	1	https://doi.org/10.1186/s12883-017-0850-1	https://doi.org/10.1186/s12883-017-0850-1	PROPN
admet-2551	1039	2	.	.	PUNCT
admet-2551	1040	1	©	©	ADP
admet-2551	1040	2	2024	2024	NUM
admet-2551	1040	3	by	by	ADP
admet-2551	1040	4	the	the	DET
admet-2551	1040	5	authors	author	NOUN
admet-2551	1040	6	;	;	PUNCT
admet-2551	1040	7	licensee	licensee	PROPN
admet-2551	1040	8	iapc	iapc	PROPN
admet-2551	1040	9	,	,	PUNCT
admet-2551	1040	10	zagreb	zagreb	PROPN
admet-2551	1040	11	,	,	PUNCT
admet-2551	1040	12	croatia	croatia	PROPN
admet-2551	1040	13	.	.	PUNCT
admet-2551	1041	1	this	this	DET
admet-2551	1041	2	article	article	NOUN
admet-2551	1041	3	is	be	AUX
admet-2551	1041	4	an	an	DET
admet-2551	1041	5	open	open	ADJ
admet-2551	1041	6	-	-	PUNCT
admet-2551	1041	7	access	access	NOUN
admet-2551	1041	8	article	article	NOUN
admet-2551	1041	9	distributed	distribute	VERB
admet-2551	1041	10	under	under	ADP
admet-2551	1041	11	the	the	DET
admet-2551	1041	12	terms	term	NOUN
admet-2551	1041	13	and	and	CCONJ
admet-2551	1041	14	conditions	condition	NOUN
admet-2551	1041	15	of	of	ADP
admet-2551	1041	16	the	the	DET
admet-2551	1041	17	creative	creative	ADJ
admet-2551	1041	18	commons	common	NOUN
admet-2551	1041	19	attribution	attribution	NOUN
admet-2551	1041	20	license	license	NOUN
admet-2551	1041	21	(	(	PUNCT
admet-2551	1041	22	http://creativecommons.org/licenses/by/3.0/	http://creativecommons.org/licenses/by/3.0/	PROPN
admet-2551	1041	23	)	)	PUNCT
admet-2551	1041	24	https://doi.org/10.1186/s12883-017-0850-1	https://doi.org/10.1186/s12883-017-0850-1	PROPN
admet-2551	1041	25	http://creativecommons.org/licenses/by/3.0/	http://creativecommons.org/licenses/by/3.0/	PROPN